Citrus Sinensis ID: 020133
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 330 | 2.2.26 [Sep-21-2011] | |||||||
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.996 | 0.908 | 0.785 | 1e-161 | |
| Q940H6 | 362 | Serine/threonine-protein | yes | no | 0.993 | 0.906 | 0.802 | 1e-160 | |
| Q39193 | 361 | Serine/threonine-protein | no | no | 0.984 | 0.900 | 0.734 | 1e-152 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.990 | 0.905 | 0.752 | 1e-152 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.881 | 0.784 | 0.787 | 1e-150 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.954 | 0.870 | 0.704 | 1e-143 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.924 | 0.899 | 0.655 | 1e-126 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.836 | 0.814 | 0.699 | 1e-126 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.812 | 0.783 | 0.704 | 1e-123 | |
| P43291 | 363 | Serine/threonine-protein | no | no | 0.830 | 0.754 | 0.681 | 1e-122 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 566 bits (1458), Expect = e-161, Method: Compositional matrix adjust.
Identities = 285/363 (78%), Positives = 306/363 (84%), Gaps = 34/363 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMR + +LVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EPKNFRKTI
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILGVQY 240
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RISIPEIRNH WFLKNLPADL+ D+ ++Q+EEP
Sbjct: 241 SIPDYVHISPECRDLIARIFVANPATRISIPEIRNHPWFLKNLPADLMDDSKMSSQYEEP 300
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 327
+QPMQS+DEIMQI+AEATIPAAG+ +NQ D+ ED+D+DPDLD++SSGEIV
Sbjct: 301 EQPMQSMDEIMQILAEATIPAAGSGGINQ-FLNDGLDLDDDMEDLDSDPDLDVESSGEIV 359
Query: 328 YAM 330
YAM
Sbjct: 360 YAM 362
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 565 bits (1457), Expect = e-160, Method: Compositional matrix adjust.
Identities = 292/364 (80%), Positives = 310/364 (85%), Gaps = 36/364 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RISIPEIRNHEWFLKNLPADL+ DNT QF+E
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEM-DEDIDTDPDLDIDSSGEI 326
DQP QSI+EIMQIIAEAT+P AGTQ+LN L GSLDIDD+M ++ DLDIDSSGEI
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEI 358
Query: 327 VYAM 330
VYAM
Sbjct: 359 VYAM 362
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 539 bits (1388), Expect = e-152, Method: Compositional matrix adjust.
Identities = 269/366 (73%), Positives = 303/366 (82%), Gaps = 41/366 (11%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RISIPEI+ H WFLKNLPADL+ ++ T +QF+EP
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLD---IDDEMDEDIDTDPDLDIDSSG 324
+QPMQS+D IMQII+EATIPA N+CL+ + D+ +D D++ ++DIDSSG
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVR----NRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSG 355
Query: 325 EIVYAM 330
EIVYA+
Sbjct: 356 EIVYAL 361
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 537 bits (1383), Expect = e-152, Method: Compositional matrix adjust.
Identities = 274/364 (75%), Positives = 306/364 (84%), Gaps = 37/364 (10%)
Query: 1 MDRSAMTVGP-GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK 59
M+R+A GP GM+MPIMHD DRYELV++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1 MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------ 233
GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGVQ 238
Query: 234 ---------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 266
RI++PEI+NH WF+KN+PADL+ D +NQ+EE
Sbjct: 239 YSIPDYVHISPECRDLITRIFVGNPASRITMPEIKNHPWFMKNIPADLMDDGMVSNQYEE 298
Query: 267 PDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEI 326
PDQPMQ+++EIMQI+AEATIPAAGT +NQ L SLD+DD+M++ DLDI+SSGEI
Sbjct: 299 PDQPMQNMNEIMQILAEATIPAAGTSGINQFLTDSLDLDDDMEDMDSDL-DLDIESSGEI 357
Query: 327 VYAM 330
VYAM
Sbjct: 358 VYAM 361
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 530 bits (1365), Expect = e-150, Method: Compositional matrix adjust.
Identities = 255/324 (78%), Positives = 279/324 (86%), Gaps = 33/324 (10%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DR+A+TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD++T ELVAVKYIERG+KID
Sbjct: 12 DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDEAR+
Sbjct: 72 DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------- 233
PAYIAPEVLLKKEYDGK ADVWSCGVTLYVM+VGAYPFEDPEEPKNFRKTI
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRILNVQYS 251
Query: 234 -------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPD 268
RI+IPEIR+H WFLKNLPADL+ D++ ++Q+EEPD
Sbjct: 252 IPENVDISPECRHLISRIFVGDPSLRITIPEIRSHGWFLKNLPADLMDDDSMSSQYEEPD 311
Query: 269 QPMQSIDEIMQIIAEATIPAAGTQ 292
QPMQ++D+IMQI+ EATIP A ++
Sbjct: 312 QPMQTMDQIMQILTEATIPPACSR 335
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1310), Expect = e-143, Method: Compositional matrix adjust.
Identities = 250/355 (70%), Positives = 290/355 (81%), Gaps = 40/355 (11%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
+D+PIMHDSDRY+ V+DIGSGNFGVARLM D+ T+ELVAVKYIERG+KIDENVQREIINH
Sbjct: 12 IDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKIDENVQREIINH 71
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
RSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEARFFFQQLISGVS
Sbjct: 72 RSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEARFFFQQLISGVS 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
YCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE+LL
Sbjct: 132 YCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEILL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------ 233
++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+++RKTI
Sbjct: 192 RQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILSVTYSIPEDLHLSPE 251
Query: 234 ---------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIM 278
RI+IPEI + +WFLKNLP DL+ +N +QF+EP+QPMQS+D IM
Sbjct: 252 CRHLISRIFVADPATRITIPEITSDKWFLKNLPGDLMDENRMGSQFQEPEQPMQSLDTIM 311
Query: 279 QIIAEATIPAAGTQSLNQCLN---GSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM 330
QII+EATIP N+CL+ D+ +D D++ ++D+DSSGEIVYA+
Sbjct: 312 QIISEATIPTVR----NRCLDDFMADNLDLDDDMDDFDSESEIDVDSSGEIVYAL 362
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-126, Method: Compositional matrix adjust.
Identities = 225/343 (65%), Positives = 263/343 (76%), Gaps = 38/343 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---------------------------- 232
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 233 -----HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287
RI+IPEI+NH WFLKNLP ++ + + Q + + P Q ++EIM II EA P
Sbjct: 242 VANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKP 301
Query: 288 AAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM 330
G++ +G + M+ D D+D++ SG+ V A+
Sbjct: 302 GDGSK-----FSGQIPGLGSMELDDIDTDDIDVEDSGDFVCAL 339
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-126, Method: Compositional matrix adjust.
Identities = 216/309 (69%), Positives = 247/309 (79%), Gaps = 33/309 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---------------------------- 232
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 233 -----HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287
RI+IPEI+NH WFLKNLP ++ + + Q + + P Q ++EIM II EA P
Sbjct: 242 VANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKP 301
Query: 288 AAGTQSLNQ 296
G++ Q
Sbjct: 302 GDGSKFSGQ 310
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1135), Expect = e-123, Method: Compositional matrix adjust.
Identities = 212/301 (70%), Positives = 240/301 (79%), Gaps = 33/301 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE++RDIGSGNFGVA+L+RD T L AVK+IERG KIDE+VQREI+NHRSL+HPNI+
Sbjct: 2 ERYEVMRDIGSGNFGVAKLVRDVATNHLFAVKFIERGLKIDEHVQREIMNHRSLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---------------------------- 232
DVWSCGVTLYVMLVGAYPFEDP++P+NFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRIF 241
Query: 233 -----HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287
RI+IPEI+NH WFLKNLP ++ + + Q + + P QS++E+M II EA P
Sbjct: 242 VGNPEQRITIPEIKNHPWFLKNLPIEMTDEYQRSMQLADMNTPSQSLEEVMAIIQEARKP 301
Query: 288 A 288
Sbjct: 302 G 302
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1129), Expect = e-122, Method: Compositional matrix adjust.
Identities = 210/308 (68%), Positives = 244/308 (79%), Gaps = 34/308 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLM+ K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKMA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH--------------------------- 233
DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIQKIMAVQYKIPDYVHISQDCKNLLSRIF 241
Query: 234 ------RISIPEIRNHEWFLKNLPADLV-VDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286
RI+I EI+ H WFLKNLP +L + E P +Q+++EIM+I+A+A
Sbjct: 242 VANSLKRITIAEIKKHSWFLKNLPRELTETAQAAYFKKENPTFSLQTVEEIMKIVADAKT 301
Query: 287 PAAGTQSL 294
P ++S+
Sbjct: 302 PPPVSRSI 309
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 330 | ||||||
| 388491244 | 363 | unknown [Medicago truncatula] | 1.0 | 0.909 | 0.842 | 1e-175 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 1.0 | 0.909 | 0.826 | 1e-175 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 1.0 | 0.909 | 0.826 | 1e-175 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.909 | 0.829 | 1e-174 | |
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.906 | 0.859 | 1e-173 | |
| 224105505 | 362 | predicted protein [Populus trichocarpa] | 0.996 | 0.908 | 0.826 | 1e-173 | |
| 147788088 | 363 | hypothetical protein VITISV_025025 [Viti | 1.0 | 0.909 | 0.823 | 1e-173 | |
| 359475222 | 371 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.889 | 0.811 | 1e-172 | |
| 356521207 | 364 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.906 | 0.851 | 1e-172 | |
| 356575156 | 373 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.884 | 0.839 | 1e-171 |
| >gi|388491244|gb|AFK33688.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1600), Expect = e-175, Method: Compositional matrix adjust.
Identities = 306/363 (84%), Positives = 318/363 (87%), Gaps = 33/363 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A VGPGMDM IMHDSDRYELVRDIGSGNFGVARLMRDK+TEELVAVKYIERG+KI
Sbjct: 1 MDRPANVVGPGMDMLIMHDSDRYELVRDIGSGNFGVARLMRDKQTEELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLR PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRRPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+M+VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMEVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI+
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTINRILNVHY 240
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RISIPEIRNHEWFLKNLP DL+ DN TNNQFEEP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRISIPEIRNHEWFLKNLPTDLMDDNGTNNQFEEP 300
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 327
DQP QS++EIMQIIAEAT+PAAGTQSLN L GSLDIDD+M+ED+DTDPDLDIDSSGEIV
Sbjct: 301 DQPTQSVEEIMQIIAEATVPAAGTQSLNPYLTGSLDIDDDMEEDLDTDPDLDIDSSGEIV 360
Query: 328 YAM 330
YAM
Sbjct: 361 YAM 363
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1599), Expect = e-175, Method: Compositional matrix adjust.
Identities = 300/363 (82%), Positives = 323/363 (88%), Gaps = 33/363 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+T+GPGMD+PIMHDSDRYELV+DIG+GNFGVARLMRDK+T+ELVAVKYIERG+KI
Sbjct: 1 MDRSALTIGPGMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQTDELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 240
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RISIPEI+NHEWFLKNLPADL+ D T NNQF+EP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRISIPEIKNHEWFLKNLPADLMDDKTINNQFDEP 300
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 327
+QP+QSIDEIMQII+EATIPAAGT + NQ L GSLDIDD+M+ED+++DP+LD+DSSGEIV
Sbjct: 301 EQPVQSIDEIMQIISEATIPAAGTGNPNQYLTGSLDIDDDMEEDLESDPELDMDSSGEIV 360
Query: 328 YAM 330
YAM
Sbjct: 361 YAM 363
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1597), Expect = e-175, Method: Compositional matrix adjust.
Identities = 300/363 (82%), Positives = 317/363 (87%), Gaps = 33/363 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRS MTVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMRDK+ +ELVAVKYIERG+KI
Sbjct: 1 MDRSVMTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRDKQADELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN+GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNSGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP STVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP+NFR TIH
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRNFRSTIHRILNVQY 240
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RI+IPEIRNH+WFLKN PADL+V+N NNQFEEP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRITIPEIRNHDWFLKNFPADLMVENNMNNQFEEP 300
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 327
DQPMQSIDEIMQII EATIPAAGT SLN L GSLDIDDEM+ED+++DP+LD+DSSGEIV
Sbjct: 301 DQPMQSIDEIMQIITEATIPAAGTPSLNHYLTGSLDIDDEMEEDLESDPELDLDSSGEIV 360
Query: 328 YAM 330
YAM
Sbjct: 361 YAM 363
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1588), Expect = e-174, Method: Compositional matrix adjust.
Identities = 301/363 (82%), Positives = 317/363 (87%), Gaps = 33/363 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RI+I EIRNHEWFLKNLPADL+ + +NQ+EEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETKMDNQYEEP 300
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 327
+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLDIDSSGEIV
Sbjct: 301 EQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIV 360
Query: 328 YAM 330
YAM
Sbjct: 361 YAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1582), Expect = e-173, Method: Compositional matrix adjust.
Identities = 313/364 (85%), Positives = 323/364 (88%), Gaps = 34/364 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RISIPEIRNHEWFL+NLPADL+V+NT NNQFEEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPAQRISIPEIRNHEWFLRNLPADLMVENTMNNQFEEP 300
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPDLDIDSSGEI 326
DQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS DD+MDED++TDPDLDIDSSGEI
Sbjct: 301 DQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPDLDIDSSGEI 360
Query: 327 VYAM 330
VYAM
Sbjct: 361 VYAM 364
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105505|ref|XP_002313835.1| predicted protein [Populus trichocarpa] gi|222850243|gb|EEE87790.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1581), Expect = e-173, Method: Compositional matrix adjust.
Identities = 300/363 (82%), Positives = 321/363 (88%), Gaps = 34/363 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMD+PIMHD DRYELV+DIGSGNFGVARLMRDK+T++LVAVKYIERG+KI
Sbjct: 1 MDRSAMTVGPGMDLPIMHDGDRYELVKDIGSGNFGVARLMRDKQTDDLVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC AGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICIAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP NFR TIH
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPMNFRNTIHRILNVQY 240
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RI+IPEIRNHEWFLKNLPADL+V+NT NN+FEEP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAMRITIPEIRNHEWFLKNLPADLMVENTMNNEFEEP 300
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 327
DQPMQSI+EIMQII+EATIPAAGT SLNQ L GSLDIDD+M ED+++DP+LD+DSSGEIV
Sbjct: 301 DQPMQSIEEIMQIISEATIPAAGTPSLNQYLTGSLDIDDDM-EDLESDPELDLDSSGEIV 359
Query: 328 YAM 330
YAM
Sbjct: 360 YAM 362
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788088|emb|CAN62745.1| hypothetical protein VITISV_025025 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1577), Expect = e-173, Method: Compositional matrix adjust.
Identities = 299/363 (82%), Positives = 316/363 (87%), Gaps = 33/363 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RI+I EIRNH+WFLKNLPADL+ + +NQ+EEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHDWFLKNLPADLMDETKMDNQYEEP 300
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 327
+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLDIDSSGEIV
Sbjct: 301 EQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIV 360
Query: 328 YAM 330
YAM
Sbjct: 361 YAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475222|ref|XP_003631617.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 609 bits (1570), Expect = e-172, Method: Compositional matrix adjust.
Identities = 301/371 (81%), Positives = 317/371 (85%), Gaps = 41/371 (11%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE-- 118
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEVL 120
Query: 119 ------ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
ARFFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH
Sbjct: 121 MQLAHLARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 180
Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI
Sbjct: 181 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTI 240
Query: 233 H---------------------------------RISIPEIRNHEWFLKNLPADLVVDNT 259
RI+I EIRNHEWFLKNLPADL+ +
Sbjct: 241 QRILKVQYSIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETK 300
Query: 260 TNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLD 319
+NQ+EEP+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLD
Sbjct: 301 MDNQYEEPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLD 360
Query: 320 IDSSGEIVYAM 330
IDSSGEIVYAM
Sbjct: 361 IDSSGEIVYAM 371
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1569), Expect = e-172, Method: Compositional matrix adjust.
Identities = 310/364 (85%), Positives = 322/364 (88%), Gaps = 34/364 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------- 233
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 234 --------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RISIPEIRNHEWFLKNLPADL+V+NT N QFEEP
Sbjct: 241 SIPDYVHISSECRHLISRIFVADPAQRISIPEIRNHEWFLKNLPADLMVENTMNRQFEEP 300
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPDLDIDSSGEI 326
DQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS DD+MDED++TDPDLDIDSSGEI
Sbjct: 301 DQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPDLDIDSSGEI 360
Query: 327 VYAM 330
VYA+
Sbjct: 361 VYAI 364
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575156|ref|XP_003555708.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1562), Expect = e-171, Method: Compositional matrix adjust.
Identities = 313/373 (83%), Positives = 323/373 (86%), Gaps = 43/373 (11%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVL 171
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVL
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVHFLRTVISSSVL 180
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT
Sbjct: 181 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 240
Query: 232 IH---------------------------------RISIPEIRNHEWFLKNLPADLVVDN 258
IH RISIPEIRNHEWFL+NLPADL+V+N
Sbjct: 241 IHRILKVQYSIPDYVHISPECRHLISRIFVADPAQRISIPEIRNHEWFLRNLPADLMVEN 300
Query: 259 TTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPD 317
T NNQFEEPDQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS DD+MDED++TDPD
Sbjct: 301 TMNNQFEEPDQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPD 360
Query: 318 LDIDSSGEIVYAM 330
LDIDSSGEIVYAM
Sbjct: 361 LDIDSSGEIVYAM 373
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 330 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.706 | 0.643 | 0.940 | 8.6e-147 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.709 | 0.648 | 0.910 | 1e-139 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.724 | 0.662 | 0.786 | 4.3e-113 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.651 | 0.597 | 0.855 | 5.5e-111 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.724 | 0.677 | 0.770 | 5.5e-111 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.651 | 0.626 | 0.841 | 4.5e-107 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.651 | 0.614 | 0.818 | 7.2e-107 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.651 | 0.634 | 0.795 | 3.2e-102 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.618 | 0.458 | 0.465 | 2e-49 | |
| TAIR|locus:2102132 | 535 | KIN10 "AT3G01090" [Arabidopsis | 0.624 | 0.385 | 0.471 | 1.1e-48 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1163 (414.5 bits), Expect = 8.6e-147, Sum P(2) = 8.6e-147
Identities = 221/235 (94%), Positives = 231/235 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1147 (408.8 bits), Expect = 1.0e-139, Sum P(2) = 1.0e-139
Identities = 214/235 (91%), Positives = 229/235 (97%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RI
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1010 (360.6 bits), Expect = 4.3e-113, Sum P(2) = 4.3e-113
Identities = 192/244 (78%), Positives = 217/244 (88%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLMR K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL + EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-----SIPEIRNHEWFLKNLPADLV 255
DVWSCGVTLYVMLVGAYPFED E+PKNF+KTI RI IP+ + K+L + +
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIF 241
Query: 256 VDNT 259
V N+
Sbjct: 242 VTNS 245
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 5.5e-111, Sum P(2) = 5.5e-111
Identities = 184/215 (85%), Positives = 204/215 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YE+V+D+G+GNFGVARL+R K+T+ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
DVWSCGVTLYVMLVG YPFEDP++P+NFRKTI RI
Sbjct: 182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRI 216
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 991 (353.9 bits), Expect = 5.5e-111, Sum P(2) = 5.5e-111
Identities = 188/244 (77%), Positives = 214/244 (87%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+Y++V+D+G+GNFGVARL+R K T+ELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-----SIPEIRNHEWFLKNLPADLV 255
DVWSCGVTLYVMLVGAYPFEDP +PKNFRKTI RI IP+ + K+L + +
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIF 241
Query: 256 VDNT 259
V N+
Sbjct: 242 VTNS 245
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 977 (349.0 bits), Expect = 4.5e-107, Sum P(2) = 4.5e-107
Identities = 181/215 (84%), Positives = 203/215 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+V+DIGSGNFGVA+L+RDK ++EL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+Q+CH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL KEYDGKIA
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
DVWSCGVTLYVMLVGAYPFEDP +PK+FRKTI RI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRI 216
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 7.2e-107, Sum P(2) = 7.2e-107
Identities = 176/215 (81%), Positives = 200/215 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RY+++RD+GSGNFGVA+L+R+K E AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL +KEY+GKIA
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
DVWSCGVTLYVMLVGAYPFEDPE+P+N R TI RI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRI 216
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 3.2e-102, Sum P(2) = 3.2e-102
Identities = 171/215 (79%), Positives = 195/215 (90%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++YE+V+D+G GNFG+ARLMR+K+T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y H++Q+CH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV + EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
DVWSCGV LYVMLVGAYPFEDP++P+NFRKT+ +I
Sbjct: 182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKI 216
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 2.0e-49, Sum P(2) = 2.0e-49
Identities = 101/217 (46%), Positives = 136/217 (62%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHP 77
+YEL R IG G F + ++ +T E VA+K ++R K+ + ++REI + +RHP
Sbjct: 8 KYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLVRHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+VR EV+ + T + I++EY +GGELF++I GR SE EAR +F QLI GV YCHS
Sbjct: 68 CVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCHSKG 127
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKK 193
V HRDLK EN LLD LKI DFG S L Q K+T GTP Y+APEVL K
Sbjct: 128 VYHRDLKPENLLLDSQG--NLKISDFGLS---ALPEQGVTILKTTCGTPNYVAPEVLSHK 182
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
Y+G +AD+WSCGV LYV++ G PF++ + P + K
Sbjct: 183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSK 219
|
|
| TAIR|locus:2102132 KIN10 "AT3G01090" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 1.1e-48, Sum P(2) = 1.1e-48
Identities = 100/212 (47%), Positives = 126/212 (59%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
Y+L R +G G+FG ++ T VA+K + R +++E V+REI R HP+
Sbjct: 42 YKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 101
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
I+R EVI TPT + +VMEY + GELF+ I GR EDEAR FFQQ+ISGV YCH V
Sbjct: 102 IIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 161
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN LLD +KI DFG S K++ G+P Y APEV+ K Y G
Sbjct: 162 VHRDLKPENLLLDSKC--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 219
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
DVWSCGV LY +L G PF+D P F+K
Sbjct: 220 EVDVWSCGVILYALLCGTLPFDDENIPNLFKK 251
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.6344 | 0.8909 | 0.8802 | N/A | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.6828 | 0.8242 | 0.8192 | N/A | no |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7349 | 0.9848 | 0.9002 | no | no |
| Q39192 | SRK2D_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7042 | 0.9545 | 0.8701 | no | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.6559 | 0.9242 | 0.8997 | N/A | no |
| Q940H6 | SRK2E_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8021 | 0.9939 | 0.9060 | yes | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7851 | 0.9969 | 0.9088 | yes | no |
| Q75V57 | SAPK9_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7527 | 0.9909 | 0.9058 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 330 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-88 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-77 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-64 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-60 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-50 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-48 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-43 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-43 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-41 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-40 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-40 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-39 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-39 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-38 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-38 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-36 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-36 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-36 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-36 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-36 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-35 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-35 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-35 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-34 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-34 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-34 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-34 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-33 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-33 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-33 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-33 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-33 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-33 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-32 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-32 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-32 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-31 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-31 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-30 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-29 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-28 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-28 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-28 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-28 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-27 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-27 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-26 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-26 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-25 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-24 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-24 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-23 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-22 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-20 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-20 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-19 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-19 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-18 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.003 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 4e-88
Identities = 97/257 (37%), Positives = 134/257 (52%), Gaps = 36/257 (14%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YE++ +G G+FG L RDKKT +LVA+K I ++ K E + REI + L+HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
R +V L +VMEY GG+LF+ + GR SEDEARF+ +Q++S + Y HS + H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL K Y +
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---------------------------- 232
D+WS GV LY +L G PF ++ K I
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237
Query: 233 ---HRISIPEIRNHEWF 246
R++ E H +F
Sbjct: 238 DPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 4e-77
Identities = 97/236 (41%), Positives = 128/236 (54%), Gaps = 7/236 (2%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 79
YEL+R +GSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR + HL +VMEY GG+LF+ + G SEDEA+ Q++ G+ Y HS +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 198
HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL G
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254
DVWS GV LY +L G PF E + + I RI P + E + +
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 2e-64
Identities = 95/225 (42%), Positives = 123/225 (54%), Gaps = 21/225 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 86
+G G FG L RDKKT + VA+K I++ D E + REI + L HPNIV+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 87 LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
HL +VMEY GG L + + N G+ SEDE Q++ G+ Y HS + HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 146 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL K Y + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNF-RKTIH-----RISIPEIRNH 243
GV LY + E K+ RK + R S EI H
Sbjct: 180 LGVILYEL----------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 4e-60
Identities = 78/232 (33%), Positives = 121/232 (52%), Gaps = 16/232 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+YE+++ IG G+FG L+R K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+++ E L IVMEYA GG+L ++I + F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
S ++ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
K Y+ K +D+WS G LY + +PFE + K + P I +
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-QYPPIPSQ 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 3e-54
Identities = 84/219 (38%), Positives = 119/219 (54%), Gaps = 13/219 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G+FG L+R K T +L A+K +++ I + R+ + HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L +V+EYA GGELF + GRFSE+ ARF+ +++ + Y HS+ + +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 145 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL K Y GK D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIPE 239
WS GV LY ML G PF + + + K + + PE
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE 214
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-52
Identities = 75/212 (35%), Positives = 108/212 (50%), Gaps = 11/212 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
+ +G G+FG L DK T EL+AVK +E +E + +REI SL+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 79 IVRFK--EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR+ E L I +EY SGG L + G+ E R + +Q++ G++Y HS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ HRD+K N L+D +K+ DFG +K S GTP ++APEV+ +
Sbjct: 121 GIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
EY AD+WS G T+ M G P+ + P
Sbjct: 179 EYGRA-ADIWSLGCTVIEMATGKPPWSELGNP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-50
Identities = 77/232 (33%), Positives = 116/232 (50%), Gaps = 10/232 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
+E++ IG G FG R K+T + VA+K I + E + EI + +HPNIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L L IVME+ SGG L + + + + +E + + ++L+ G+ Y HS + H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250
AD+WS G+T + G P+ + K I P +RN E +
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSELPPMKAL-FKIATNGPPGLRNPEKWSDEF 227
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-48
Identities = 91/257 (35%), Positives = 143/257 (55%), Gaps = 37/257 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR----SLR 75
D +E ++ +G+G+FG L+R K + + A+K + + KI + Q E ++N + S+R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59
Query: 76 HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
HP +V F++ ++L +VMEY GGELF + +GRF E ARF+ Q++ +
Sbjct: 60 HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y HS+ + +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF--- 246
+L K Y GK D W+ G+ +Y ML G PF D + P + +I ++R +F
Sbjct: 170 ILSKGY-GKAVDWWALGILIYEMLAGYPPFFD-DNP---IQIYEKILEGKVRFPSFFSPD 224
Query: 247 ----LKNLPADLVVDNT 259
++NL L VD T
Sbjct: 225 AKDLIRNL---LQVDLT 238
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-43
Identities = 83/267 (31%), Positives = 129/267 (48%), Gaps = 27/267 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 84
I G +G L + K T ++ A+K I++ D I +N +++ R + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+L +VMEY GG+L + N G ED AR + +++ + Y HS + HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+N L+D + LK+ DFG SK + + K VGTP YIAPEV+L + +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIPEIRNHEWFLKNLPADL 254
K D WS G LY LVG PF + F+ ++ +I PE +L + L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237
Query: 255 VVDNTTNNQFEEPDQ--PMQSIDEIMQ 279
+V +P++ +SI+EI
Sbjct: 238 LV--------PDPEKRLGAKSIEEIKN 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 40/250 (16%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + IG G+F L ++K+T + A+K + + K+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P I++ F++ +L V+EYA GEL + I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
HS + HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
+ S VGT Y++PE+L +K GK +D+W+ G +Y ML G PF E F+K
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234
Query: 232 IHR-ISIPEI 240
+ S P
Sbjct: 235 LKLEYSFPPN 244
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 152 bits (383), Expect = 5e-43
Identities = 84/232 (36%), Positives = 119/232 (51%), Gaps = 21/232 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 77
Y ++R +G G+FG L RD+K VA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 134
NIV+ + L +VMEY GG L + + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 187
S + HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 188 EVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISI 237
EVLL Y +D+WS G+TLY +L G PFE + +T+ I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 9e-43
Identities = 76/207 (36%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
YE + +G G +GV RDKKT E+VA+K I R D +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V EY +L + + G S + + QL+ G++YCHS +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK- 192
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y + D+WS G M+ G F
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-41
Identities = 83/245 (33%), Positives = 130/245 (53%), Gaps = 13/245 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D E ++ +G+G FG L+RD+ +E A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R L ++MEY GGELF + N+GRFS F+ +++ + Y HS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ K +
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-HRISIPEIRNHEWFLKNLPAD-L 254
K D W+ G+ +Y MLVG PF D + K + ++ P R+ + + K+L L
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP--RHLDLYAKDLIKKLL 233
Query: 255 VVDNT 259
VVD T
Sbjct: 234 VVDRT 238
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 9e-41
Identities = 80/211 (37%), Positives = 115/211 (54%), Gaps = 9/211 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K +L ST GTP YIAPE+L + Y G D
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
W+ GV LY ML G PFE +E + F+ +
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 76/227 (33%), Positives = 118/227 (51%), Gaps = 12/227 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
IG G G D+ T + VA+K + + E + EI+ + +HPNIV + + L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 89 PTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VMEY GG L + I N R +E + + ++++ G+ Y HS V HRD+K +N
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146
Query: 148 TLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ +K+Y K+ D+WS
Sbjct: 147 ILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV-DIWS 201
Query: 205 CGVTLYVMLVGAYP-FEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250
G+ M G P +P P I IP ++N E +
Sbjct: 202 LGIMCIEMAEGEPPYLREP--PLRALFLITTKGIPPLKNPEKWSPEF 246
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RY+++ IG G G+ +D++T E VA+K + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
+V+ +V + +VMEY +L E + + R E + + + + L+ GV+Y H+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L ++
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 195 YDGKIADVWSCGVTLYVMLVGA 216
YD + D+W+ G +L G+
Sbjct: 178 YDPGV-DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 9e-40
Identities = 75/258 (29%), Positives = 118/258 (45%), Gaps = 43/258 (16%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G FG L++ K A+K +++ ++ Q I + + HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
++ ++MEY GGEL+ + + G F E ARF+ ++ Y H+ + +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD + +K+ DFG++K + + GTP Y+APE++L K YD D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177
Query: 205 CGVTLYVMLVGAYPF----EDPEE------------------PKNFRKTIHRI------- 235
G+ LY +L G PF EDP E K + I ++
Sbjct: 178 LGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
Query: 236 -------SIPEIRNHEWF 246
I +I+ H+WF
Sbjct: 238 RLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-39
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
YE++ IG G+FG R +R K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 79 IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 132
IVR+ + + + L IVMEY GG+L + I E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 133 CH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 186
CH V HRDLK N LD + +K+ DFG +K S T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
PE L YD K +D+WS G +Y + + PF
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 7e-39
Identities = 82/267 (30%), Positives = 128/267 (47%), Gaps = 23/267 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
++++ +G G +G L + K T E+VA+K +++ N R ++ R + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L + MEY GG+ + N G SED ARF+ ++ V H +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL K YD
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 199 IADVWSCGVTLYVMLVGAYPF--EDPEEP----KNFRKTIHRISIPEIRNHEWFLKNLPA 252
+ D WS G LY L G PF P E K +++T+ R P + + L +
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR---PVYDDPRFNLSDEAW 234
Query: 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQ 279
DL+ +P + S+++I
Sbjct: 235 DLI-----TKLINDPSRRFGSLEDIKN 256
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 9e-39
Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 7/202 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPN 78
+EL+R IG G FG +++ + T+++ A+KY+ + +++ R ++N R L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V ++ +V++ GG+L + +FSE++ +F+ +++ + Y HS +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRD+K +N LLD + I DF + + ST GTP Y+APEVL ++ Y
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178
Query: 199 IADVWSCGVTLYVMLVGAYPFE 220
D WS GVT Y L G P+
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ + L+ IG G+FG DK+T ++VA+K I E D+I++ +Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I ++ L + L I+MEY GG + + G+ E F ++++ G+ Y H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ +
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+T + G P D
Sbjct: 175 YDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 3e-38
Identities = 79/209 (37%), Positives = 111/209 (53%), Gaps = 16/209 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 80
+G G FG L+R+K T + A+K I + + I + ++ + H ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +Y G+
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
D W GV +Y M+ G PF + + K F
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 72/211 (34%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGD-KIDENVQREIINHRSLRHPN 78
R++ IG G FG + T EL+AVK I + D K + + E+ L+HPN
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHSM 136
+V++ V + + I MEY SGG L E + GR DE R + QL+ G++Y HS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 191
+ HRD+K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 192 KKEYDGKI--ADVWSCGVTLYVMLVGAYPFE 220
+ G AD+WS G + M G P+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 74/212 (34%), Positives = 110/212 (51%), Gaps = 9/212 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 83
IG G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD L DFG K + HS+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234
W G LY ML G PF + + + +++
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 78/259 (30%), Positives = 119/259 (45%), Gaps = 39/259 (15%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPN 78
Y+L IG G FGV + +T + VA+K I +E + +EI ++L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ I T L I++EYA G L + I G F E + Q++ G++Y H V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N L DG +K+ DFG + K + + S VGTP ++APEV+
Sbjct: 121 IHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFED---------------PEEPKN------------F 228
+D+WS G T+ +L G P+ D P P+ F
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235
Query: 229 RKTIH-RISIPEIRNHEWF 246
+K + R + ++ H W
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 8e-37
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
E V+ +G G+ GV +R K T ++ A+K I + Q RE+ RS P +V+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCH 140
++IV+EY GG L + + G+ E + +Q++ G+ Y H+ + H
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K N L+ G KI DFG SK +T VGT Y++PE ++ E
Sbjct: 124 RDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYS 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
AD+WS G+TL +G +PF P +P
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 88/303 (29%), Positives = 132/303 (43%), Gaps = 63/303 (20%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RH 76
D +E+++ IG G FG L+RDK T ++ A+K + + D I N + R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ F++ HL +VMEY GG+L + F E+ ARF+ +L+ +
Sbjct: 61 PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 167
H + HRD+K +N L+D +K+ DFG K
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 168 -SSVLHSQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--E 220
H Q + STVGTP YIAPEVL Y + D WS GV LY ML G PF +
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD 233
Query: 221 DPEEPK----NFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 276
+E N+++++ P + +L L+ D P+ + S +E
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPE---AIDLICRLLCD---------PEDRLGSFEE 281
Query: 277 IMQ 279
I
Sbjct: 282 IKS 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 81/206 (39%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 81
+G G+FG L KKT EL A+K +++GD I + V+ + R S RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +KI DFG K + ST GTP ++APEVL + Y +
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182
Query: 201 DVWSCGVTLYVMLVGAYPF--EDPEE 224
D W GV +Y MLVG PF +D EE
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 77/200 (38%), Positives = 109/200 (54%), Gaps = 19/200 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ YEL++ IGSG +G RD T ELVA+K I E GD + +Q+EI + RHPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV + L L IVMEY GG L + G SE + + ++ + G++Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 190
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175
Query: 191 -LKKEYDGKIADVWSCGVTL 209
K YDGK D+W+ G+T
Sbjct: 176 ERKGGYDGK-CDIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 15/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKY---IERGDKIDENVQREIINHRSLRHP 77
++YE++ +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + G D R + QL+ ++YCHS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 191
+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
GK DVW+ G + +L G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 6e-36
Identities = 72/250 (28%), Positives = 113/250 (45%), Gaps = 39/250 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
++ ++ +G G+ G L+R K T +L A+K +++ + I N ++EI+ +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 133 CHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 175
H + + +RDLK EN LL S P P K G +SSV
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 176 -----------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
S VGT YIAPEV+ + + D W+ G+ LY ML G PF+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNR 237
Query: 225 PKNFRKTIHR 234
+ F + +
Sbjct: 238 DETFSNILKK 247
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 8e-36
Identities = 80/205 (39%), Positives = 115/205 (56%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T E A+K +++ D + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T HL VMEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD +KI DFG K ++ ST GTP YIAPE+L ++Y+ + D
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-D 178
Query: 202 VWSCGVTLYVMLVGAYPF--EDPEE 224
WS GV LY ML+G PF ED +E
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-36
Identities = 79/209 (37%), Positives = 108/209 (51%), Gaps = 7/209 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 78
+YE +R +G G FG+ L R K ++LV +K I E+ K + Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
I+ + E L L IVMEYA GG L E I ED FF Q++ + + H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ K Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +D+W+ G LY + FE P
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 9/212 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPN 78
+E+ +G+G+FG R+ + K T E A+K +++ + + + + +S L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + ++E+ GGELF + AGRF D A+F+ +L+ Y HS +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+RDLK EN LLD +K+ DFG++K + + + GTP Y+APEV+ K + GK
Sbjct: 140 IYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GK 194
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D W+ GV LY + G PF D + + K
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK 226
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-35
Identities = 80/218 (36%), Positives = 114/218 (52%), Gaps = 12/218 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K T A+K + + I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS V +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIR 241
GV +Y M+ G PF + + + F I + EIR
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-35
Identities = 82/249 (32%), Positives = 138/249 (55%), Gaps = 21/249 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+Y V+ IG G+FG A L++ K+ + +K I + K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV+++E +L IVM+Y GG+L+++I NA R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 136 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 190
++ HRD+K +N L DG+ +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEIC 173
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH-EWFLKN 249
+ Y+ K +D+W+ G LY M + FE KN I R S P + +H + L+N
Sbjct: 174 ENRPYNNK-SDIWALGCVLYEMCTLKHAFE-AGNMKNLVLKIIRGSYPPVSSHYSYDLRN 231
Query: 250 LPADLVVDN 258
L + L N
Sbjct: 232 LVSQLFKRN 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 6e-35
Identities = 79/219 (36%), Positives = 118/219 (53%), Gaps = 12/219 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+EL A+K I + D I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L I G+F E A F+ ++ G+ + HS + +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N +LD +KI DFG K ++ + T GTP YIAPE++ + Y GK D
Sbjct: 127 LKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRK-TIHRISIPE 239
W+ GV LY ML G PF+ +E + F+ H +S P+
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK 222
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-35
Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 79
Y+ + IG G +GV RDK T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
++ +V L +V E+ +L++ I + R E + + QL+ G+++CHS +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEY 195
HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL +
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 196 DGKIADVWSCGVTLYVMLVG 215
D+WS G +L
Sbjct: 176 YSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 75/217 (34%), Positives = 110/217 (50%), Gaps = 10/217 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 83
IG G+FG L + K AVK +++ + + Q I+ R +L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K V + ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIP 238
W G LY ML G PF + + + +H+ + +P
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 81
IG G FG +R K T + A+K + + + + + +R I+ L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K T + L +V +Y SGGELF + GRFSED A+F+ +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL ++ K
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
D WS GV ++ M G PF + + +R
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 70/195 (35%), Positives = 105/195 (53%), Gaps = 20/195 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 76
Y++++ +G G FG L R+K+T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ KEV L V EY G L++ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LL+
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 193 -KEYDGKIADVWSCG 206
Y + D+W+ G
Sbjct: 173 STSYSSPV-DIWALG 186
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 72/210 (34%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 78
YE + IG G +G R+KKT ELVA+K I R + E REI + LRHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 79 IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
IVR KE++ + +I V EY +G L + +F+E + + + +QL+ G+ Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
L Y ++ D+WS G L + +G F
Sbjct: 174 LGATRYGPEV-DMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 5e-34
Identities = 68/233 (29%), Positives = 98/233 (42%), Gaps = 24/233 (10%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + E VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ V L IVMEY GG+L + R S + F Q+ G+ Y
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEV 189
S HRDL N L+ + +KI DFG Y K + ++APE
Sbjct: 121 SKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPES 175
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGA---YPFEDPEEPKNFRKTIHRISIPE 239
L + ++ K +DVWS GV L+ + YP E + K +R+ P
Sbjct: 176 LKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP 227
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 6e-34
Identities = 68/232 (29%), Positives = 101/232 (43%), Gaps = 23/232 (9%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + K + VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
PN+V+ V L IVMEY GG+L + N + S + F Q+ G+ Y S
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGA---YPFEDPEEPKNFRKTIHRISIPE 239
+ ++ K +DVWS GV L+ + YP EE + K +R+ P
Sbjct: 176 KEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPP 226
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 9e-34
Identities = 79/223 (35%), Positives = 122/223 (54%), Gaps = 10/223 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L +I GRF E A F+ ++ G+ + HS + +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ K+ GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-HRISIPEIRNHE 244
W+ GV LY ML G PFE +E + F+ + H ++ P+ + E
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 74/212 (34%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+E+ A+K +++ D I D++V + R L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L +I + +F E +RF+ ++ + + H V +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L + EY + D
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-D 178
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
W+ GV +Y M+ G PFE E F +H
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILH 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 76/205 (37%), Positives = 110/205 (53%), Gaps = 8/205 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K + + A+K +++ I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEY +GGELF + FSED RF+ +++S + Y HS ++ +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNF 228
GV +Y M+ G PF + + K F
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 74/210 (35%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 78
IGSG+FG L + + EL+AVK +E R + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ L HL I +EY GG + + N G F E R F +Q++ G++Y H+ +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 191
HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ Y K AD+WS G + ML G +PF D
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-33
Identities = 79/209 (37%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 80
R +G G+FG L R K++ L AVK +++ D I D++V+ + R L HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ TP L VME+ +GG+L I + RF E ARF+ ++ S + + H + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L + Y G
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
D W+ GV LY ML G PFE E F
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 72/209 (34%), Positives = 106/209 (50%), Gaps = 8/209 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 84
IG G+FG +R + T+ + A+K I + + + + R++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+P L +V+ + +GGELF + GRF ARF+ +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVW 203
EN LLD + +CDFG K ++ +T GTP Y+APE+LL Y K D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ GV LY ML G PF D + +RK +
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 77/223 (34%), Positives = 120/223 (53%), Gaps = 10/223 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I G+F E +A F+ ++ G+ + H + +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ T GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-HRISIPEIRNHE 244
W+ GV LY ML G PF+ +E + F+ + H +S P+ + E
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 74/207 (35%), Positives = 113/207 (54%), Gaps = 9/207 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T +L VMEY +GG+L I + +F A F+ ++I G+ + HS + +RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K ++L T GTP YIAPE+LL ++Y+ + D
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFR 229
WS GV LY ML+G PF +E + F+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 8e-33
Identities = 70/221 (31%), Positives = 106/221 (47%), Gaps = 8/221 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 82
+GSG+FG + + AVK + G E V+ +EI L+HPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+L I +E GG L + + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ ++ G AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
WS G T+ M G P+ E K +P I +H
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH 226
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 75/206 (36%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T HL VME+ +GG+L I + GRF A F+ +++ G+ + HS + +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K +V ST GTP YIAPE+L +Y + D
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNF 228
WS GV LY ML+G PF +E + F
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 78/206 (37%), Positives = 111/206 (53%), Gaps = 9/206 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+++K T A+K +++ + + V + +R L RHP + K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDL 143
T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KLEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNF 228
W GV +Y M+ G PF + + K F
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-32
Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHP 77
Y +R +G G FG A L R + + LV K + + E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ + + L I MEYA+GG L+++I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175
Query: 193 KEYDGKIADVWSCGVTLYVML 213
+Y+ K +D+W+ G LY +L
Sbjct: 176 VKYNFK-SDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 77/203 (37%), Positives = 104/203 (51%), Gaps = 30/203 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
D YE + I G +GV RDKKT E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 74 LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 126
L+HPNIV KEV++ + +VMEY E L E + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 184
+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 185 IAPEVLL-KKEYDGKIADVWSCG 206
APE+LL KEY I D+WS G
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 73/197 (37%), Positives = 107/197 (54%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L R K E+ AVK +++ + + ++ I++ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K ++ H+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPF 219
W G LY ML G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
V++ T L IVMEY G + + +I N +E+E Q + G+ Y HS +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ + Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 197 GKIADVWSCGVTLYVMLVGAYPFED 221
K AD+WS G+T M G P+ D
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-32
Identities = 73/209 (34%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRH--- 76
R EL IG G +G + T +VA+K I D+ ++QRE+ LR
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI ++ L L I+MEYA GG + + AG +E ++++ + Y H +
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK-KE 194
V HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ + K
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
YD K AD+WS G+T+Y M G P+ D +
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-32
Identities = 72/207 (34%), Positives = 115/207 (55%), Gaps = 14/207 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
+Y ++R +G G+FG A L++ +++ A+K I + E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
V FKE HL IVMEY GG+L ++I G+ F ED +F Q+ GV + H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKK 193
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
Y+ K +D+WS G LY + +PF+
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 75/228 (32%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ +E ++ I +G +G L+R K+T + A+K I + + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+P +V T HL +VMEY GG+ + N G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 178
+ + HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEE 224
GTP YIAPEV+L++ Y GK D W+ G+ LY LVG PF + PEE
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 73/216 (33%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 78
RYEL++ IGSG +GV DK+T VA+K I D ID + + REI R LRH N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 79 IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 124
I+ +++ P+ + IV E S L ++D ++F
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 180
Q++ G+ Y HS V HRDLK N L++ + LKICDFG ++ K V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 181 TPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
T Y APE+LL Y I D+WS G +L
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 75/207 (36%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 22 RYELVRDIGSGNFG-VARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+++++ +G G++G V ++ R D + L V K E+ EI S+ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+ +KE L L IVMEYA G+L + I + E E F QL+ G+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKK 193
++ HRDLK N LL +KI D G SK VL K+ +GTP Y+APEV +
Sbjct: 121 EQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
Y K +D+WS G LY M A PFE
Sbjct: 177 PYSYK-SDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 78/262 (29%), Positives = 120/262 (45%), Gaps = 58/262 (22%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLR---- 75
D +E ++ IG G FG RL++ K T + A+K + + + + ++E + H R+ R
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILA 56
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+P +V+ +L ++MEY GG++ + F+E+E RF+ + I +
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
H + HRD+K +N LLD +K+ DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAK--GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 172 HSQPK------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
S+P STVGTP YIAPEV L+ Y K D WS GV +Y ML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEML 233
Query: 214 VGAYPF--EDPEEPKNFRKTIH 233
VG PF ++P+E +RK I+
Sbjct: 234 VGYPPFCSDNPQE--TYRKIIN 253
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-31
Identities = 75/210 (35%), Positives = 112/210 (53%), Gaps = 18/210 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RYE+++ IG G+FG L + K E +K I + K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV F L IVMEY GG+L +RI N R FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 136 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 190
++ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ Y+ K D+WS G LY + +PFE
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-31
Identities = 83/305 (27%), Positives = 139/305 (45%), Gaps = 62/305 (20%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSL 74
+++ +G G+FG +++R+K T ++ A+K +++ + + +R+I++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
P I + + +L +VMEY GG+L + +F ED A+F+ +L+ +
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 191
H M HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 192 KKEYDGKIA-----DVWSCGVTLYVMLVGAYPFED-------------------PEEPK- 226
DGK D WS GV Y M+ G PF + PE+PK
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236
Query: 227 --NFRKTIH--------RISIPEIRNHEWF-------LKNLPADLV-----VDNTTNNQF 264
+F I R+ + H +F ++N V D+T+N F
Sbjct: 237 SSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSN--F 294
Query: 265 EEPDQ 269
+EP++
Sbjct: 295 DEPEK 299
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 9e-31
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + ++ EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+ L+I MEY GG + +++ G +E R + +Q++ GV Y HS + HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGK 198
+K N L D A +K+ DFG SK + S KS GTP +++PEV+ + Y G+
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GR 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPE 223
ADVWS G T+ ML P+ + E
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 78
E + ++G+GN GV + + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
IV F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+APE + +Y
Sbjct: 120 HKIIHRDVKPSNILVNSR--GQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +D+WS G++L + G +P+ +P
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDP 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 70/212 (33%), Positives = 109/212 (51%), Gaps = 9/212 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L + K + AVK +++ ++ Q+ I+ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V+++ +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K + S +T GTP Y+APEV+ K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234
W G LY ML G PF + + + +H+
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 72/211 (34%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 77
IG G +G L + T E++AVK +E I ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV++ T +L+I +EY GG + + GRF E RFF +Q++ G++Y HS
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLK 192
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ Y K+ D+WS G + M G P+ D E
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 15/219 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+E++ IG G+FGV + K + + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R+ E L L IVMEYA G+L + + ED+ FF Q++ G+++ HS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
++ HRD+K N LD +KI D G +K +L + VGTP Y++PE+ K
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
Y+ K +DVW+ GV LY G +PF+ + K I
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 69/232 (29%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 24 ELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
EL + +G G FG L + TE VAVK ++ G ++ E E + L HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIVR V L IV EY GG+L F R + + + + Q+ G+ Y S
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 190
HRDL N L+ + +KI DFG S+ ++ + APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED--PEEPKNFRKTIHRISIPE 239
++ K +DVWS GV L+ + +G P+ EE + +R+ PE
Sbjct: 177 KDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPE 227
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
+G G FG +L VAVK ++ +E +E + L HPN+VR
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 134
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 191
S + HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS GV L+ + +GA P+
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 65/201 (32%), Positives = 113/201 (56%), Gaps = 14/201 (6%)
Query: 29 IGSGNFGVARLMRDKKTEE---LVAVKYIERG-----DKIDENVQREIINHRSLRHPNIV 80
+G G+FG L+R + L A+K +++ D++ ++R+I+ + HP IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ T L +++++ GG+LF R+ F+E++ +F+ +L + + HS+ + +
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ ++ + +
Sbjct: 122 RDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QS 178
Query: 200 ADVWSCGVTLYVMLVGAYPFE 220
AD WS GV ++ ML G+ PF+
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 80/273 (29%), Positives = 129/273 (47%), Gaps = 53/273 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRS 73
++ +++++ IG G FG +L+R K ++++ A+K + + + I + +R+I+ H +
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV+ +L +VMEY GG+L + N E ARF+ +++ +
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 189
HSM HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214
Query: 190 LLKKEYD---GKIADVWSCGVTLYVMLVGAYPF----------------------EDPEE 224
L + D G+ D WS GV LY MLVG PF +D E
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274
Query: 225 PKNFRKTI--------HRI---SIPEIRNHEWF 246
K + I R+ + EI++H +F
Sbjct: 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 73/219 (33%), Positives = 116/219 (52%), Gaps = 11/219 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + DK T VAVK ++ R + E + E++ R +HPNIV L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S+ H+ V HRD+K ++
Sbjct: 87 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
G+ + M+ G P+ + E P K I P+++N
Sbjct: 201 LGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNL 238
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 74/204 (36%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
+E + IG G +G+ RD + E+VA+K + ER D I + REI +LRHPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPN 67
Query: 79 IVRFKEVILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV KEV+ HL +VMEY L + + FSE + + QL+ G+ Y
Sbjct: 68 IVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYL 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL- 191
H + HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
Y I D+W+ G L +L
Sbjct: 183 CTTYTTAI-DMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 69/200 (34%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
++ V IG G +GV R+K T E+VA+K I R D E V REI + L HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V E+ + F + + QL+ G+++CHS +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 193
V HRDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL
Sbjct: 121 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGC 175
Query: 194 EYDGKIADVWSCGVTLYVML 213
+Y D+WS G M+
Sbjct: 176 KYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 68/225 (30%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD-----KIDENV--QREIINHR 72
+EL+R +G+G +G L+R +L A+K +++ K E+ +R+++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
R P +V T T L ++++Y +GGELF + F+E E R + +++ + +
Sbjct: 62 R-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV+
Sbjct: 121 LHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 191 LKKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234
K D WS GV + +L GA PF E +N + I R
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISR 222
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 13/215 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG + K T ++ A K ++ R + +++I+ S R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
T L +VM +GG+L I N G F E A F+ Q+I G+ + H ++ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD R I D G + + K GTP Y+APEVL + YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
D ++ G TLY M+ G PF +E + R
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 73/232 (31%), Positives = 115/232 (49%), Gaps = 26/232 (11%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G+G F RD KT L+AVK + +++ E +++EI L HP+I+R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+H + +E+ +GG + + G F E + +QL+ G+SY H Q+ HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLKKE 194
D+K N L+D S RL+I DFG ++ L ++ +GT A++APEVL ++
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------SIPE 239
Y G+ DVWS G + M P+ + E+ N I +I SIPE
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPE 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 72/230 (31%), Positives = 110/230 (47%), Gaps = 42/230 (18%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---- 75
+ +ELV IG G +G R KKT +LVA+K ++ + +E ++ E LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61
Query: 76 HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 125
HPNI F + L +VME GG +L + + G R E+ + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
+ G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171
Query: 179 --VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
+GTP ++APEV+ E YD + +DVWS G+T + G P D
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 12/220 (5%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-----PNIV 80
++ I G FG L + + T + A+K +++ D I +N + R++ P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + +L +VMEY +GG+ I G ED A+ + +++ GV H + H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D K++
Sbjct: 121 RDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMS 174
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPE 239
D WS G ++ L G PF F + R I+ PE
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-28
Identities = 72/220 (32%), Positives = 115/220 (52%), Gaps = 14/220 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDEN------VQREIINHRSLR 75
+ +R +G+G+FG L K + VA+K E+ I + +R+I+N+ +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP V ++L +V+E+ GGE F + RF D F+ Q++ Y S
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL +
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH 205
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
GK AD W+ G+ +Y +LVG PF E ++K + I
Sbjct: 206 -GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI 244
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 67/209 (32%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENV--QREIINHR 72
+EL++ +G+G +G L+R T +L A+K +++ K E+ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T L ++++Y SGGE+F + FSEDE RF+ ++I + +
Sbjct: 62 R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
K GK D WS G+ ++ +L GA PF
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-27
Identities = 82/235 (34%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD-KIDENVQREIINH--RSLR 75
RY L + +G G+FG L++DKK E L +K I G+ +E VQ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 131
HP IV+F L I+ EY G +L ++ SE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI------SIPE 239
+ YD K +D+WS G LY M A+ FE +NF + RI S+PE
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 74/226 (32%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
D YEL+ IG G V E VA+K I+ +K +V +E+ HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 134
N+V++ + L +VM Y SGG L + G E ++++ G+ Y H
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 187
S HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 188 EVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
EV+ YD K AD+WS G+T + GA P+ K T+
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 72/222 (32%), Positives = 114/222 (51%), Gaps = 13/222 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD T+ +A+K I ER + + + EI H L+H NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 88 TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 145 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIAD 201
+N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+ K + Y G AD
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKN--FRKTIHRI--SIPE 239
+WS G T+ M G PF + EP+ F+ + +I IPE
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE 235
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 69/196 (35%), Positives = 101/196 (51%), Gaps = 17/196 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHP 77
+ +R+IG G+FG RD +T E+VA+K + K ++II + LRHP
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 78 NIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
N + +K L +VMEY S ++ E + E E + G++Y HS
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+L +
Sbjct: 134 HERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKIADVWSCGVT 208
+YDGK DVWS G+T
Sbjct: 189 GQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 79
Y+++ IG G F + +KT + A+K + +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
+R EV+ LA+V E L+E I R E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 195 YDGKIADVWSCGVTLYVML 213
Y G D+W+ G + +L
Sbjct: 175 YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 77/267 (28%), Positives = 112/267 (41%), Gaps = 61/267 (22%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ IG G FG L+R T L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L VM+Y GG++ + G F ED ARF+ +L + H M
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------S 168
HRD+K +N L+D +K+ DFG Y K S
Sbjct: 121 GFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 169 SVLHSQPK----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212
+ + K S VGTP YIAPEVLL+ Y ++ D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237
Query: 213 LVGAYPFEDPE------EPKNFRKTIH 233
LVG PF + N+ T+H
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLH 264
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 75
YE + +IG G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 76 -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 129 GVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
GV + HS ++ HRDLK +N L+ DG ++KI DFG ++ S V T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVM 212
PEVLL+ Y + D+WS G +
Sbjct: 175 PEVLLQSSYATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 16/203 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+YE V IG G +GV RD+ T E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 134
NIVR ++V+ + L +V EY +L + + ++ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 190
S +V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
L + D+WS G M+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 72/218 (33%), Positives = 109/218 (50%), Gaps = 20/218 (9%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN 78
+G G +G R + T ++ A+K +++ D +R I+ +++HP
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNIL--EAVKHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV T L +++EY SGGELF + G F ED A F+ ++ + + H +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD +K+ DFG K S+ T GT Y+APE+L++ + G
Sbjct: 122 IYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
K D WS G +Y ML GA PF +N +KTI +I
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPF----TAENRKKTIDKI 212
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVR 81
E V IGSG G + + T L A+K Y D + + REI R + HPN+V+
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
++ + +++E+ GG L +F D AR Q++SG++Y H + HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYD 196
D+K N L++ A +KI DFG S+ P S+VGT AY++PE L YD
Sbjct: 193 DIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250
Query: 197 GKIADVWSCGVTLYVMLVGAYPF 219
G D+WS GV++ +G +PF
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 17/194 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y+ V IG G +GV RDK T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
IVR +V+ + L +V E+ +L + + ++ D + QL+ G++YCHS
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 192
+V HRDLK +N L+D A LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLG 173
Query: 193 KEYDGKIADVWSCG 206
D+WS G
Sbjct: 174 SRQYSTPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLR 75
RYE + +G G + V RDK+T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
HPNI+ +V +++ +V E+ +L E++ + + + + + G+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 189
HS + HRDLK N L+ LK+ DFG ++S P V T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173
Query: 190 LLKKEYDGKIADVWSCGV 207
L + G D+WS G
Sbjct: 174 LFGARHYGVGVDMWSVGC 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-26
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+++E++ +G G +GV R K+T+E+VA+K E +++ E RE+ R+L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + N ++ R + QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 194 EYDGKIADVWSCGVTL 209
Y GK D+WS G L
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
D +E++ ++G G FG + K+T A K I+ + D V+ +I++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
NIV E L I++E+ GG L + R +E + R+ +Q++ +++ HS
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 191
+V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 192 ---KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL +
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 81
R IG G++ L+ KKT + A+K I++ D+ VQ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y +
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIIN 70
D+ + + +EL++ IGSG +G R+ T EL A+K I E G+ VQ+EII
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ +H NIV + L L I ME+ GG L + G SE + + ++ + G+
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 189
Y HS HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 190 LLKKEYDG--KIADVWSCGVT 208
+ G ++ D+W+ G+T
Sbjct: 178 AAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHP 77
RY+ + +IGSG +GV D ++ + VA+K I + +R E+ R +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 78 NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ ++++ P + +VM+ +L I + +E+ R+F QL+ G+ Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 188
HS V HRDLK N L++ L+I DFG S S H V T Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVML 213
+LL EY I D+WS G ML
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 85/260 (32%), Positives = 125/260 (48%), Gaps = 42/260 (16%)
Query: 14 MPIMHDS-----DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQR- 66
MP +D + YE+++ IG+G FG L++ K+T+E K I RG K E Q
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 67 -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 119
E+ R L+H NIVR+ + L + L I+ME+ G+L I G+ E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 120 RFFFQQLISGVSYCHSMQ-------VCHRDLKLENTLLDG---------------SPAPR 157
+QL+ ++YCH+++ V HRDLK +N L + P
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVG 215
KI DFG SK+ + S S VGTP Y +PE+LL K YD K +D+W+ G +Y + G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSG 239
Query: 216 AYPFEDPEEPKNFRKTIHRI 235
PF + NF + I +
Sbjct: 240 KTPF---HKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-26
Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ + +G G G R K T + A+K I + + + RE+ ++S + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 79 IVRFKEVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVS 131
IV++ L + + I MEY GG L + I GR E + ++ G+S
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS ++ HRD+K N LL +K+CDFG S V S + GT Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRISIPEIRNHE 244
K Y +DVWS G+TL + +PF E P P I + PE+++
Sbjct: 177 GKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS 135
NIVR +V+ + L +V EY + ++ ++ G + + F QL+ G+++CHS
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KK 193
V HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL K
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYP 218
Y I D+WS G + P
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 74/227 (32%), Positives = 112/227 (49%), Gaps = 11/227 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R +HPNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244
K+ D+WS G+ M+ G P+ + E P I PE++N E
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-25
Identities = 74/254 (29%), Positives = 116/254 (45%), Gaps = 22/254 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G G +G +L+AVK +E +K E +Q E+ +SL+H NIV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+ L ++I ME+ GG + + G E + +Q++ GV+Y H+ V HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLKKE 194
D+K N +L P +K+ DFG ++ HS KS GTP ++APEV+ +
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFED-PEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253
Y G+ +D+WS G T++ M G P F HR +P + + D
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS---FSAAAID 240
Query: 254 LVVDNTTNNQFEEP 267
V T +Q E P
Sbjct: 241 FVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-25
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + AG F E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P D
Sbjct: 187 LGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 67/191 (35%), Positives = 104/191 (54%), Gaps = 8/191 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YEL++ +GSG +G R+ T EL AVK I E GD +Q+EI + +H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L+ L I MEY GG L + G SE + + ++ + G++Y HS H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG-- 197
RD+K N LL + +K+ DFG +K + ++ KS +GTP ++APEV ++ G
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 198 KIADVWSCGVT 208
++ D+W+ G+T
Sbjct: 188 QLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KKTE + A+K +++ + ID + + ++ HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H + +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y G
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 74/211 (35%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ YE+V+ IG G FG +L+R K T ++ A+K + + + I + R +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E ARF+ +++ + HS
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL
Sbjct: 161 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPF 219
+ Y G+ D WS GV LY MLVG PF
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KK +++ A+K +++ + ID + + ++ +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +EY G
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-24
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 25 LVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ +G G+FG L R T E VAVK + ++ + +REI R+L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
IV++K V P L ++MEY G L + + + + + F Q+ G+ Y S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLL 191
+ HRDL N L++ +KI DFG +K K +P + APE L
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
++ +DVWS GVTLY + P + P P F + I
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-24
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
++ + +G G + R++ T E+VA+K I E G REI + L+H N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR +VI T L +V EY + + G + + F QL+ G+++CH
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + + + V T Y AP+VLL +
Sbjct: 120 RVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
Y I D+WS G + M+ G
Sbjct: 178 YSTSI-DIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ Y++V+ IG G FG +L+R K ++++ A+K + + + I + R +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E A+F+ +++ + HS
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPF 219
+ Y G+ D WS GV L+ MLVG PF
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-24
Identities = 71/228 (31%), Positives = 122/228 (53%), Gaps = 21/228 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + R+K + VAVK ++ R + E + E++ R +H N+V + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L ++ME+ GG L + I + R +E++ + ++ + Y HS V HRD+K ++
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 148 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
L LDG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202
Query: 205 CGVTLYVMLVGAYPF--EDP--------EEPKNFRKTIHRISIPEIRN 242
G+ + M+ G P+ + P + P K H+IS P +R+
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKIS-PVLRD 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-24
Identities = 75/209 (35%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+++++ IG G +G RDK T ELVA+K + R D E REI R L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65
Query: 77 PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 122
NIV KE I+T A +V EY G L + + FSED + F
Sbjct: 66 RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 180
+QL+ G++YCH HRD+K N LL+ ++K+ DFG ++ T V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
T Y PE+LL +E G DVWSCG L
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 9e-24
Identities = 68/196 (34%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+E+VA+K I+ + DE ++Q+EI P I R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSC 205
N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187
Query: 206 GVTLYVMLVGAYPFED 221
G+T + G P D
Sbjct: 188 GITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---- 65
+ P + +YE + IG G FG R KKT+++VA+K + + EN +
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFP 55
Query: 66 ----REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG- 112
REI + L+H N+V E+ T +V E+ +L + N
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV 114
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSV 170
+F+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFS 170
Query: 171 LHSQPKST-----VGTPAYIAPEVLLKKEYDGKIADVWSCG 206
L K V T Y PE+LL + G D+W G
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-23
Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 18/211 (8%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGDKIDE-------NVQREIINHR 72
+EL++ +G+G +G L+R + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T T L ++++Y +GGELF + RF E E + + +++ + +
Sbjct: 62 R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + + DFG SK + S GT Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 191 LKKE--YDGKIADVWSCGVTLYVMLVGAYPF 219
+ +D K D WS GV +Y +L GA PF
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDK--IDENVQREIINHRSLRHP 77
++YE + IG G++GV R+++T ++VA+K ++E D I + REI + L+HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
N+V EV L +V EY L E N E + Q + V++CH
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKE 194
HRD+K EN L+ + ++K+CDFG+++ +L V T Y APE+L+
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
G DVW+ G +L G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 70/215 (32%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI------------ERGDKIDENVQREII 69
Y ++ +GSG FG V ++ + + L+A+K I ER I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 125
LRHPNIVR+ + L L IVM+ G L E + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 126 LISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
PE++ + Y G+ ADVW+ G LY M PF
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-23
Identities = 73/227 (32%), Positives = 112/227 (49%), Gaps = 11/227 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R ++PNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244
K+ D+WS G+ M+ G P+ + E P I PE++N E
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDKIDENVQ----REIINHRSLR 75
++YE + +G G++G+ + K+T ++VA+K ++E D D+ V+ REI + LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H N+V EV L +V E+ L E+ N E R + Q++ G+ +C
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
HS + HRD+K EN L+ S + +K+CDFG+++ ++ T V T Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
G+ D+W+ G + ML G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 3e-23
Identities = 76/229 (33%), Positives = 115/229 (50%), Gaps = 15/229 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K I + E + EI+ + L++PNIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
F + L L +VMEY +GG L + + DEA+ ++ + + + H+ QV
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244
K+ D+WS G+ M+ G P+ + E P I PE++N E
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-23
Identities = 67/192 (34%), Positives = 102/192 (53%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD +T E+VA+K + K ++II + ++HPN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L + +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 203 GKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-23
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P +
Sbjct: 187 LGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-23
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD + E+VA+K + K ++II + LRHPN ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ L +VMEY S +L E + E E + G++Y HS +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L + +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-23
Identities = 81/280 (28%), Positives = 135/280 (48%), Gaps = 23/280 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA++ + + E + EI+ R ++PNIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ +K Y
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF------LKNLP 251
K+ D+WS G+ M+ G P+ + E P I PE++N E N
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 252 ADLVVDNTTN------NQFEEPDQPMQSIDEIMQIIAEAT 285
D+ V+ + +QF + +P+ S+ ++ EAT
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 7e-23
Identities = 70/255 (27%), Positives = 116/255 (45%), Gaps = 47/255 (18%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 78
D +E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 176
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 121 GFIHRDIKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 177 ----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF- 219
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237
Query: 220 -EDPEEPKNFRKTIH 233
E P+E +RK ++
Sbjct: 238 SETPQE--TYRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-23
Identities = 70/207 (33%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + K ++ EI ++LRH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ P L+I +EY GG + +++ G +E+ R + +Q++ GVSY HS + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPE 223
G+ ADVWS T+ ML P+ + E
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 65/207 (31%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
RY+ + IG G +G+ K T VA+K I + + REI R +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ + I+ P + EL E ++ S D ++F Q++ G+ Y
Sbjct: 64 NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 189
HS V HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 190 LLK-KEYDGKIADVWSCGVTLYVMLVG 215
+L K Y I D+WS G L ML
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+++ + IG G F V +VA+K ++ + +D ++ +EI + L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
HS ++ HRD+K N + + +K+ D G SK++ HS VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
E + + Y+ K +D+WS G LY M PF
Sbjct: 176 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 71/233 (30%), Positives = 116/233 (49%), Gaps = 15/233 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRH 76
+ L + +G G FG L D T +AVK ++ + E + EI ++L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 77 PNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
IV++ + P L+I ME+ GG + +++ + G +E+ R + +Q++ GVSY H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVL 190
S + HRD+K N L D +K+ DFG SK + + KS GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
+ Y G+ AD+WS G T+ ML P+ + E K + + P + H
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-22
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRH 76
++RY ++ +G G FG+ RD+ T + VA+K I + + + RE+ + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 77 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ ++ ++P + V E G R+ + + ++F Q++ G+ Y HS
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 194
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L ++
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 195 YDGKIADVWSCGVTLYVMLVGA--YPFEDP 222
YD ++ D+WS G ML G +P +D
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEGKPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-22
Identities = 67/192 (34%), Positives = 101/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 81
+ +IG G+FG + T E+VAVK + G + +E Q +E+ + L+HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L + +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-22
Identities = 86/285 (30%), Positives = 139/285 (48%), Gaps = 30/285 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 79
+ +E++ ++G G FG ++K+T L A K I+ + ++ E+ EI S HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
V+ + +L I++E+ +GG + + R +E + R +Q + ++Y H ++
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 139 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 191
HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 192 -KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPE----IRNHEW- 245
+ YD K ADVWS G+TL M E P N + + +I+ E + W
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEMA----QIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 235
Query: 246 -----FLKN-LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284
FLK L ++ TT + P + S I ++IAEA
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEA 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-22
Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 51/264 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 78
+E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 176
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 123 IHRDIKPDNLLLDSK--GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 177 --------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--E 220
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 221 DPEEP----KNFRKTIHRISIPEI 240
P+E N+++T+ I PE+
Sbjct: 240 TPQETYKKVMNWKETL--IFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 70/227 (30%), Positives = 113/227 (49%), Gaps = 15/227 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 82
+G G FG L D T +A K ++ + E + EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L I MEY GG + +++ G +E R + +Q++ G+SY HS + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
G+ ADVWS G T+ ML P+ + E K + + P++ +H
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSH 233
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-21
Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 8/170 (4%)
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRIS--IPEIRN 242
D D W+ GV Y +L G +PF+ D +E + + R +P I+N
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKN 232
|
Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 71/196 (36%), Positives = 103/196 (52%), Gaps = 16/196 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 78
+Y ++ IG G +G+ ++ +T E VA+K I ++ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 79 IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ K+ I+ P H + IV E +L + I ++ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 191
HS V HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 192 K-KEYDGKIADVWSCG 206
EY I DVWS G
Sbjct: 182 NCSEYTTAI-DVWSVG 196
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
++ +E++ ++G G FG ++K+T L A K IE + + E+ EI + HP
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ L I++E+ GG + + R +E + + +Q++ + Y HSM+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 191
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 192 --KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL M
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 71/227 (31%), Positives = 112/227 (49%), Gaps = 25/227 (11%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y + IG G +GV R+KKT ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++V++ + L ++ E+ S + + + + + + Q++ G+ +CHS
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVL 190
+V HRDLK +N L+D +K+ DFG +++ H V T Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE-----VVTLWYRAPEVL 173
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRI 235
L D+WS G T++ + P D E + FR I RI
Sbjct: 174 LGSPRYSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSL 74
H +YE+++ +G G +G+ D++T+E+VA+K I + + QR EI+ + L
Sbjct: 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL 63
Query: 75 R-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISG 129
HPNIV+ VI I + + E E + A + R+ QL+
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPA 183
+ Y HS V HRDLK N LL+ R+K+ DFG ++S + V T
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Y APE+LL K D+WS G L ML+G
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-21
Identities = 71/240 (29%), Positives = 116/240 (48%), Gaps = 18/240 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+D +E++ IG G +G + +KK L AVK ++ +DE ++ E +SL HPN
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 79 IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F + L +V+E +GG EL + + G R E + + G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 188
+ + H+ ++ HRD+K N LL +K+ DFG S + + ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 189 VL-LKKEYDGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244
V+ +++YD DVWS G+T + G P D K K I R P + + E
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPPPTLLHPE 257
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-21
Identities = 67/199 (33%), Positives = 107/199 (53%), Gaps = 11/199 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + +K T + VAVK ++ R + E + E++ R H N+V L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +SY H+ V HRD+K ++
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 205 CGVTLYVMLVGAYP-FEDP 222
G+ + M+ G P F +P
Sbjct: 204 LGIMVIEMIDGEPPYFNEP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-21
Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K TE LVA+K I E + RE+ ++L+H NIV ++I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + N G S + F QL+ G+SYCH ++ HRDLK
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY I D+W
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI-DMW 188
Query: 204 SCGVTLYVMLVG 215
G LY M G
Sbjct: 189 GVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-21
Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 11 GMDMPIMHD-SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
+D+ + D + +ELV +G+G +G R KT +L A+K ++ + +E ++ EI
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN 64
Query: 69 INHRSLRHPNIVRFKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEAR 120
+ + H NI + + P H L +VME+ G + + + N ED
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ ++++ G+++ H+ +V HRD+K +N LL + +K+ DFG S ++T +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 180 GTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234
GTP ++APEV+ E YD + +D+WS G+T M GA P D P I R
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPR 240
Query: 235 ISIPEIRNHEW 245
P++++ +W
Sbjct: 241 NPPPKLKSKKW 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 9e-21
Identities = 65/193 (33%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 40 MRDKKTEELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
R +E V K++ D+ R E+ + H IV+ + + L ++MEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 99 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154
SGG+L ++I + F E E F Q++ + HS ++ HRDLK N L P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204
Query: 155 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV 211
+K+ DFG+SK SV S GTP Y+APE+ +K Y K AD+WS GV LY
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263
Query: 212 MLVGAYPFEDPEE 224
+L PF+ P +
Sbjct: 264 LLTLHRPFKGPSQ 276
|
Length = 478 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-21
Identities = 69/215 (32%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY +R +G G+ G+ D ++ VAVK I D ++ REI R L H N
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 79 IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
IV+ EV+ T L IV EY + G SE+ AR F
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 180
QL+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K +
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
T Y +P +LL K D+W+ G ML G
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-21
Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-- 76
++ E + D+G+GN G ++ T ++A K + G K +V+++I+ + H
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHEC 60
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P IV F L ++ + ME+ G L G + ++ G++Y +
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 135 SM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
++ ++ HRD+K N L++ ++K+CDFG S +++S + VGT Y++PE +
Sbjct: 121 NVHRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGG 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
+Y K +DVWS G+++ + +G +PF
Sbjct: 178 KYTVK-SDVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 69/218 (31%), Positives = 115/218 (52%), Gaps = 11/218 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + K + +LVAVK ++ R + E + E++ R +H N+V L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S H+ V HRD+K ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ + Y G D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRN 242
G+ + M+ G P+ + E P K I P+++N
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKN 238
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-20
Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 21/225 (9%)
Query: 22 RY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSL 74
RY + +R +G G+FG L + T E+VAVK ++R G + ++EI ++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 75 RHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H NIV++K L ++MEY G L + + + + + F QQ+ G++Y
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPE 188
HS HRDL N LLD +KI DFG +K+ + + + +P + A E
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 189 VLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
L KE A DVWS GVTLY +L + P PK F + I
Sbjct: 181 CL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY++ IG G++GV D T E VA+K I + + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 76 HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
HP+IV K ++L P+ + +V E +L + I + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 186
Y H+ V HRDLK +N L + +LKICDFG ++ + + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 187 PEVL--LKKEYDGKIADVWSCGVTLYVMLVG 215
PE+ +Y I D+WS G +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-20
Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 12/216 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 84
+G G FG + + T +L A K + + K + + ++ R L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCH 140
T T L +VM +GG+L I N F E A F+ Q+ISG+ + H ++ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD ++I D G + + S+ K GTP ++APE+L +EYD +
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
D ++ GVTLY M+ PF E ++ RI
Sbjct: 179 -DYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-20
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 81
+G G FG ++ K T ++ A K +++ G+K+ +++EI+ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHSMQVC 139
+ THL +VM +GG+L I N G + R + Q+ G+ + HSM +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
+RD+K EN LLD RL D G + GT Y+APE+L ++ Y +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEE 224
D ++ G ++Y M+ G PF+D +E
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-20
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 23 YELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
+++ + IG G F A + D+K L V+ E D K ++ +EI + L HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + + L IV+E A G+L + I + E +F QL S V + H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + Y+ K +D+WS G LY M PF
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-20
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
DLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174
Query: 198 KIADVWSCGVTLYVMLVGAYPF 219
AD +S G L+ +L G PF
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-20
Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYD 196
DLK N LLD R+ CDF K P ++VGT Y+APEVL K YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174
Query: 197 GKIADVWSCGVTLYVMLVGAYPFE 220
AD +S G L+ +L G PF
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 8e-20
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSL 74
D +E+++ IG G FG +++ K TE + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
+ I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
H + HRD+K +N LLD + R LK+ G +SSV VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF 219
PE+L E G D WS GV +Y ML G PF
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-20
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + K + ++A K I +I ++ +II + H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L M +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 75/264 (28%), Positives = 109/264 (41%), Gaps = 63/264 (23%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 79
++ +G G FG L T L A+K + + D ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V+ +L VM+Y GG++ + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 140 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 176
HRD+K +N L LDG +K+ DFG Y K S + +P
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 177 ---------------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
S VGTP YIAPEVLL+K Y ++ D WS GV L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL 238
Query: 210 YVMLVGAYPFEDPEEPKNFRKTIH 233
+ MLVG PF P + K I+
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-19
Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 31/250 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
SD +E++ IG G +G + +KK AVK ++ IDE ++ E ++L HPN
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F K+ + L +V+E +GG +L + G R E + + + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 187
+ + H + HRD+K N LL + +K+ DFG S +S + ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193
Query: 188 EVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRI 235
EV+ L YD + DVWS G+T + G P D P+N T+H+
Sbjct: 194 EVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ- 251
Query: 236 SIPEIRNHEW 245
PE+ ++E+
Sbjct: 252 --PELWSNEF 259
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 71/249 (28%), Positives = 102/249 (40%), Gaps = 55/249 (22%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ +G G FG L R T+ L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 137 QVCHRDLKLENTLLD--------------------------GSPAPRLKICDFGYS---- 166
HRD+K +N L+D R DF
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 167 --------------KSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+++ H + S VGTP YIAPEVLL+ Y ++ D WS GV LY
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239
Query: 211 VMLVGAYPF 219
MLVG PF
Sbjct: 240 EMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV ++ K + ++A K I +I ++ +II + H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + A R E+ ++ G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L + +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-19
Identities = 69/238 (28%), Positives = 116/238 (48%), Gaps = 19/238 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 81
+ELV +G+G +G R KT +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 82 FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 133
+ + L +VME+ G + + I N E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 192
H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 193 KE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEW 245
E YD K +D+WS G+T M GA P D P I R P +++ +W
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKW 241
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK------YIERGDKIDENVQREIINHRSL 74
D +E+++ IG G FG +++ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 133
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 187
H + HRD+K +N LLD + RL DFG S L T VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 188 EVLLKKEYDGK-----IADVWSCGVTLYVMLVGAYPF 219
E+L E DGK D WS GV +Y ML G PF
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 24 ELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG + L + K T LVAVK I E++ Q+EII R L+HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ + + + L +V M Y S +L + G E F + +++ + Y HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 187
HR +K + LL G ++ + YS + V+H PKS+V +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 188 EVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
EVL + + Y+ K D++S G+T + G PF+D
Sbjct: 178 EVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-19
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++G+G FGV + + + + VA+K I+ G ++ E L H +V+
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
V + IV EY S G C E RF QL+ G++Y S Q
Sbjct: 67 VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVW+ GV ++ V +G P+E
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRH 76
D + E + +IGSG G MR KKT ++AVK + R +EN +R +++ H
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129
Query: 133 C-HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 190
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 130 LKEKHGVIHRDVKPSNILLDAS--GNVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERI 186
Query: 191 ----LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+YD + ADVWS G++L + G +P++
Sbjct: 187 DPPDPNPKYDIR-ADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-19
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K T+ LVA+K I E + RE+ + L+H NIV ++I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + + G + + F QL+ G++YCH +V HRDLK
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P++LL +Y +I D+W
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI-DMW 189
Query: 204 SCGVTLYVMLVGA--YPFEDPEEPKNF 228
G Y M G +P EE +F
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHF 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 6e-19
Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
+ Y+ + +G G++ R K T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHS 135
NIV ++I T L +V EY +L + + + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KK 193
+V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 194 EYDGKIADVWSCGVTLYVMLVG 215
EY + D+W G Y M G
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----- 75
DRY+ + +GSG +G D KT VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 76 ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
H N++ +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
++ G+ Y HS + HRDLK N ++ LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L + + D+WS G + +L G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 26 VRDIGSGNFGVARLMR----DKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 79
+RD+G G+FG L R T E VAVK + E G ++++EI R+L H NI
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 80 VRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 136
V++K + + ++ME+ G L E + N + + + + Q+ G+ Y S
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLK 192
Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L++
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 193 KEYDGKIADVWSCGVTLYVML 213
++ +DVWS GVTLY +L
Sbjct: 187 SKF-YIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIE----RGDKIDENVQREIINHRSLR 75
+YE+ IG G +G + K K + A+K + + I ++ REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 129
H N+V EV L ++ + +YA F R + Q+++G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 130 VSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 181
V Y HS V HRDLK N L+ +G +KI D G ++ + ++ K V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178
Query: 182 PAYIAPEVLL-KKEYDGKIADVWSCG 206
Y APE+LL + Y I D+W+ G
Sbjct: 179 IWYRAPELLLGARHYTKAI-DIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + R K TE LVA+K I E + RE+ + L+H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV +++ T L +V EY +L + + + G S + F Q++ G++YCH +
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 195
V HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 196 DGKIADVWSCGVTLYVMLVG 215
+I D+W G + M G
Sbjct: 183 STQI-DMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLRHP 77
Y VR +G G++G L+R + + +K + R ++ + ++++ L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQ--LKHP 59
Query: 78 NIVRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCH 134
NIV ++E L IVM + GG+L+ ++ G+ E++ +F Q+ + Y H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLL 191
+ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+
Sbjct: 120 EKHILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFS 175
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
K Y+ K +DVW+ G +Y M + F K+ ++RI
Sbjct: 176 NKPYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 63/268 (23%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDE----NVQREIINHRSL 74
+ + V+ IG G FG RL++ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 167
+ HRD+K +N L+D +K+ DFG Y K
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 168 --------SSVLHSQPK-------------STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
+ + S+ + STVGTP YIAPE+ L++ Y G+ D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235
Query: 207 VTLYVMLVGAYPF--EDPEEPKNFRKTI 232
++ L+G PF E+ E +RK I
Sbjct: 236 AIMFECLIGWPPFCSENSHE--TYRKII 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-18
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 9/205 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLR 75
+D YE + +G G++ + K +LVA+K I E G RE + L+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV ++I T L +V EY + G + + F QL+ G+SY H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
D+W G M+ G F
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 84
+G GN G T ++AVK I I +Q++I++ + + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 85 VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCH 140
++I E+ GG L + +I GR + ++ G++Y S+++ H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RD+K N L++ ++K+CDFG S V +S K+ VGT AY+APE + ++Y G +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKN 227
DVWS G++ + +G +P+ P+ KN
Sbjct: 175 DVWSLGISFMELALGRFPY--PQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 53/142 (37%), Positives = 82/142 (57%), Gaps = 12/142 (8%)
Query: 92 LAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
+A+V++YA+ G+L + I + + F E EA F Q++ V + HS + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 148 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ +K Y K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230
Query: 205 CGVTLYVMLVGAYPF--EDPEE 224
GV LY +L PF E+ EE
Sbjct: 231 LGVLLYELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 6e-18
Identities = 72/223 (32%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGDKIDENVQREIINHRSLR---- 75
RYEL++++G G +G+ R+ +T EE VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 76 ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 123
H NI ++ I+ P + + Y EL E +I +G ++ + F
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 178
Q++ G+ Y HS V HRDLK N L D LKICDFG ++ S + T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167
Query: 179 --VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
V T Y APE++L + K DVWS G L L+G P
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + + + ++A K I +I ++ +II + H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
P IV F + ++I ME+ GG L + + AGR E+ ++ G++Y
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
+ +D+WS G++L M +G YP P+
Sbjct: 176 TVQ-SDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-18
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSLRH 76
+E+++ IG G FG +++ K +++ A+K + + + + +R+++ + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
I +L +VM+Y GG+L + R ED ARF+ +++ + H
Sbjct: 63 --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K +N L+D + RL DFG + +S+ VGTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 194 EYDGK-----IADVWSCGVTLYVMLVGAYPF 219
E DGK D WS GV +Y ML G PF
Sbjct: 179 E-DGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 59/187 (31%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 29 IGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
IG G FG L R +K VAVK ++ + E +LRHPN+V+ V+
Sbjct: 14 IGKGEFGDVMLGDYRGQK----VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L L IV EY + G L + + + GR + + F + G+ Y HRDL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVW 203
N L+ K+ DFG +K + SQ + + P + APE L +K++ K +DVW
Sbjct: 130 ARNVLVSEDLVA--KVSDFGLAKEA---SQGQDSGKLPVKWTAPEALREKKFSTK-SDVW 183
Query: 204 SCGVTLY 210
S G+ L+
Sbjct: 184 SFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+ + + IG G F VA+K ++ D +D + + I + L HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + L IV+E A G+L I + + E +F QL S + + H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + Y+ K +D+WS G LY M PF
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
Y +++ + G+ G + + V +K ++G + E + + +NH P+++R
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122
Query: 83 KEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K+ +++ +V+ + S +L+ + + D+A +Q++ G+ Y H+ ++ HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
D+K EN ++ ++ I D G ++ V+ GT APEVL + +Y+ K AD
Sbjct: 182 DVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-AD 238
Query: 202 VWSCGVTLYVMLVGAYP---FEDP 222
+WS G+ L+ ML AYP FEDP
Sbjct: 239 IWSAGIVLFEML--AYPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D E++ ++G GN+G + + T +A+K I ++DE+ +II + H
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV F + + MEY G +L+ ED R ++ G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 134 -HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 193 KEYDGKI-----ADVWSCGVTLYVMLVGAYPFEDPE 223
+ +DVWS G+++ M +G YP+ PE
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP-PE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 29 IGSGNFGVARLMR----DKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 83
+G GNFG L R T E+VAVK ++ + +REI +SL+H NIV++K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 84 EVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + +L +VMEY G L + + R + + Q+ G+ Y S + H
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEVLLKK 193
RDL N L++ R+KI DFG +K + Q K V P + APE L +
Sbjct: 132 RDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 194 EYDGKIADVWSCGVTLY 210
++ +DVWS GV LY
Sbjct: 187 KFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 74/253 (29%), Positives = 115/253 (45%), Gaps = 28/253 (11%)
Query: 19 DSDRYELVRDIGSGNFGVARL---MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
LV++IGSG FG+ L + +K VA+K I G +E+ E L
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMSEEDFIEEAQVMMKLS 57
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP +V+ V + + +V E+ G L + + G+FS++ + G++Y
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLL 191
S V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPK-------NFRKTIHRI---SIPEI 240
+Y K +DVWS GV ++ V G P+E+ + FR R+ S+ E+
Sbjct: 175 FSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYEL 233
Query: 241 RNHEWFLKNLPAD 253
H W K P D
Sbjct: 234 MQHCW--KERPED 244
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-17
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 85
++++GSG FGV L + + + VA+K I G +E+ E L HP +V+ V
Sbjct: 9 MKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L IV E+ G L + G+ S+D Q + G+ Y HRDL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGKIAD 201
N L+ S +K+ DFG ++ VL + S+ G + PEV +Y K +D
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SD 183
Query: 202 VWSCGVTLY-VMLVGAYPFE 220
VWS GV ++ V G PFE
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-17
Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D YE + IG G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 77 -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 125
IVR +V L +V EY +L + + + GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 184
L+ GV++CH V HRDLK +N L+D LKI D G ++ S+ + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
APEVLL + D+WS G M F
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-17
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 28 DIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
+G G+FGV R R + + VAVK + DK+ + + +E SL H N+
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+R V+LT L +V E A G L +R+ +A G F + Q+ +G+ Y S +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLL 191
HRDL N LL + ++KI DFG ++ + + V P A+ APE L
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 192 KKEYDGKIADVWSCGVTLYVM 212
+ + +DVW GVTL+ M
Sbjct: 174 TRTFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPN 78
RY ++ +GSG +G DK+T E VA+K + R + + RE+ + ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ +V + +VM Y ++I SED+ ++ Q++ G+ Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + D+WS G + ML G F+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
DRY ++ +GSG +G D++T VA+K + R + + RE+ + ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L +VM + G ++ + SED +F Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + D+WS G + ML G F+
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLR--- 75
+YE V +IG G +G RD + VA+K + D + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 76 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
G+ + H+ + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML 213
VLL+ Y + D+WS G M
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 61/179 (34%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 47 ELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+LVA+K I K +E V RE + L+H NIV ++I T L V EY
Sbjct: 31 QLVALKVISM--KTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD 88
Query: 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
I + G R F QL+ G++Y H + HRDLK +N L+ S LK+ D
Sbjct: 89 LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLAD 146
Query: 163 FGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
FG +++ + SQ S+ V T Y P+VLL +Y + D+W G ML G F
Sbjct: 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-16
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++GSG FGV L + + + VA+K I G +++ E L HPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IV EY + G L + G+ + + + Y S HRDL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKKEYDGKIA 200
N L+ +K+ DFG ++ VL Q S+ GT + PEV + K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182
Query: 201 DVWSCGVTLY-VMLVGAYPFE 220
DVWS GV ++ V G P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 27 RDIGSGNFGVAR--LMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 79
+++G GNFG + K +E+ VAVK +++ + I ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR V L +VME A G L + + + + Q+ G++Y S
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLKKEY 195
HRDL N LL + KI DFG S++ ++T P + APE + ++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFED 221
K +DVWS GVTL+ GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG G FG M K + ++AVK I R ++ +R +++ RS P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 85 VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 133
+ I ME S + ++ + + ++++ ++
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ YD + +DVWS G+TLY + G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 17/229 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 78 NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRDLK N L + LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPE 239
L + + D+WS G + +L G F + + + + P
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
D E++ ++G G +GV MR T ++AVK I E Q+ + I+ RS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 131
P V F + + I ME S + ++++ + G ++ + ++ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV-SIVKALE 117
Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE-- 188
Y HS + V HRD+K N L++ ++K+CDFG S V G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI 175
Query: 189 --VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
L +K YD K +DVWS G+T+ + G +P++
Sbjct: 176 NPELNQKGYDVK-SDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-15
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 19 DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D+ ++ + IG+G FG RL K E VA+K ++ G E +R+ ++ S+
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59
Query: 76 ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ APE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 21/231 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D VAVK + R + + +R E++ + + H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + +VME +C D R + Q++ G
Sbjct: 82 IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ + V T Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEI 240
+L Y + D+WS G + ++ G+ F+ + + K I ++ P
Sbjct: 194 ILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ +V+ I G FG L R K +L AVK +++ D I++N+ ++ R + P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + ++ +VMEY GG++ + G F E+ A + ++ + Y H +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDLK +N L+ S +K+ DFG SK
Sbjct: 126 IHRDLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 21/229 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D E VA+K + R + + +R E++ + + H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + IVME +C + D R + Q++ G
Sbjct: 85 IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ V T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIP 238
+L Y + D+WS G + M+ G F + + K I ++ P
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHP 77
E R IG G FGV + D + + VA+K + + +N V RE+ +H
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHD 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSY 132
N++ + IL P H+ E EL + I + S D + F Q++ G+ Y
Sbjct: 60 NVLSALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ + LKICDFG ++ T V T Y APE+L
Sbjct: 119 LHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + Y + D+WS G +L F+
Sbjct: 177 MGSRHYTSAV-DIWSVGCIFAELLGRRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D + + VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V T + E G +L I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N ++ L+I DFG ++ + + V T Y APE++L
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + D+WS G + +L G F
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-15
Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 18/232 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
+YE V +IG G +G RD K VA+K + E G + + ++ H +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 75 RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ +++ G +E FQ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPE 239
EVLL+ Y + D+WS G M F + K + I +P
Sbjct: 179 EVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I N G F E+ A F+ +++ G+ H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD ++I D G + + VGT Y+APEVL + Y
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEE 224
D W G +Y M+ G PF +E
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 25 LVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 79
+ + IG G FG RL K E VA+K ++ G DK + E HPNI
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGV 130
+R + V+ + I+ EY G L F R E++ +F QL+ SG+
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGM 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-Y 184
Y M HRDL N L++ + K+ DFG S+ L ++T T P +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRW 174
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + +++ +DVWS G+ ++ VM G P+ D
Sbjct: 175 TAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ Y+L IG+G+FGV T E VA+K + + + RE++ ++L H NI
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINI 121
Query: 80 VRFKEVILTPT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQL 126
+ K+ T L +VME+ + + R N + + QL
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQL 179
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPA 183
++Y HS +CHRDLK +N L+D P LK+CDFG +K+ + + S + +
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218
Y APE++L D+WS G + M++G YP
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I + G F E A F+ ++ G+ H +
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
D W+ G LY M+ G PF+ + K R+ + R+
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERL 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 70/259 (27%), Positives = 101/259 (38%), Gaps = 53/259 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------ 75
RY+++R IG G G L D VA+K I R D + ++ R LR
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 122
HP IV + + M Y G L + + S++ A F
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 123 -FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 165
F ++ + + Y HS V HRDLK +N LL + I D+G
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML ++P+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233
Query: 223 EEPKNFRKTI--HRISIPE 239
K RK I P
Sbjct: 234 ---KKGRKISYRDVILSPI 249
|
Length = 932 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
YE++ +G G FG R KT +VA+K I E+ D REI + L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 77 PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 122
PN+V ++ + + +V Y SG L E + + +E + + +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------ 176
QL+ G++Y H + HRD+K N L+D LKI DFG ++ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGG 176
Query: 177 --------STVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y PE+LL ++ Y + D+W G M
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQR--EIINHRS 73
+ R +G G FG + + T ++ A K +E+ G+ + N ++ E +N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 131
+V T L +V+ +GG+L I N G F E+ A F+ ++ G+
Sbjct: 62 -----VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVL 190
H ++ +RDLK EN LLD ++I D G + + + + VGT Y+APEV+
Sbjct: 117 DLHRERIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVV 173
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
+ Y D W G +Y M+ G PF +E
Sbjct: 174 KNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 18/194 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
R + S N G + E L+A K ++ G + ++ EI+ L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHSMQVCHR 141
+ + ++ + +L+ + + +D + R +QL+ V Y H ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKI 199
D+KLEN L+ L DFG + + VGT A +PE+L Y +I
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEI 348
Query: 200 ADVWSCGVTLYVML 213
D+WSCG+ L ML
Sbjct: 349 TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 77
R +G G FG + + T ++ A K +E+ G+ + N +R E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V T L +V+ +GG+L I N G F E A F+ +L G+
Sbjct: 62 -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + VGT Y+APEV+ ++Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
D W G +Y M+ G PF +E
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 8e-14
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 81
IG+G FG RL K E VA+K ++ G E +R+ ++ S+ HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+ V+ + I+ E+ G L F R N G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 191
HRDL N L++ + K+ DFG S+ L T + + APE +
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+++ +DVWS G+ ++ VM G P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-14
Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 29/246 (11%)
Query: 29 IGSGNFGVARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G + D K E+ A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247
E+LL + K D+W+ G +L F +E H + I + +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI----FSV 240
Query: 248 KNLPAD 253
PAD
Sbjct: 241 MGFPAD 246
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 26/199 (13%)
Query: 25 LVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
L R +G+G FG V + T+ VAVK ++ G E +E + LRH +V+
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHS 135
V + IV EY S G L + + E + QL+ G++Y S
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLL 191
HRDL N L+ + KI DFG ++ ++ + P + APE
Sbjct: 122 RNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 192 KKEYDGKIADVWSCGVTLY 210
+ K +DVWS G+ L
Sbjct: 178 YGRFTIK-SDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 17/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV 80
+ L R +GSG FG + K VA+K ++ D + ++ Q+E+ + LRH +++
Sbjct: 8 FTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
V + I+ E G L + + A Q+ G++Y
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ K+ DFG + K V L S K + APE
Sbjct: 126 IHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGT 180
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVWS G+ LY + G P+
Sbjct: 181 FSTK-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 69/246 (28%), Positives = 106/246 (43%), Gaps = 29/246 (11%)
Query: 29 IGSGNFG-VARLMR-DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G V + R D K + A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247
E+LL + K D+W+ G +L F +E H + I N +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN----V 240
Query: 248 KNLPAD 253
PAD
Sbjct: 241 MGFPAD 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 29 IGSGNFG-VAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 81
IG+G FG V R L + E VA+K ++ G E +++ ++ S+ H NI+R
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ V+ I+ EY G L + + + G FS + + + +G+ Y M H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLKKE 194
RDL N L++ + K+ DFG S+ VL P+ T T + APE + ++
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ ++ VM G P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 66/198 (33%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
IG G FG +++ + T + VAVK I K D Q E L H N+VR V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCHRDL 143
IL L IVME S G L + GR + F + G+ Y S ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADV 202
N L+ S K+ DFG ++ + S P + APE L K++ K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180
Query: 203 WSCGVTLY-VMLVGAYPF 219
WS GV L+ V G P+
Sbjct: 181 WSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 7e-13
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 9/223 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D + VA+K + R + + +R E++ + + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
I+ V L + EL + +C + D R + Q++ G+ + HS
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIP 238
+ D+WS G + M+ F + + K I ++ P
Sbjct: 196 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY+ ++ IGSG G+ D T + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 76 HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 126
H NI+ V TP + +VME A+ ++ + + R S + Q+
Sbjct: 74 HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
+ G+ + HS + HRDLK N ++ LKI DFG ++++ V T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
PEV+L Y + D+WS G + M+ G F
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 34/218 (15%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDE-----N 63
S+RY +G G +G D T ++VA+K + + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 64 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 172
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
Q + S V T Y APE+L+ E D+WS G
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 21 DRYELVRDIGSGNFGVAR--LMRDKKTEEL-VAVKY--IERGDKIDENVQREIINHRSLR 75
+ L R IG G FG + + E++ VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP+IV+ VI T + IVME A GEL + N + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLLK 192
S + HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE +
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + +DVW GV ++ ++++G PF
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-- 73
++ L+R++G G+FG +A+ + + E VA+K + + E E +N S
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 74 --LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-------- 121
++VR V+ T +VME + G+L + R R +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQK 120
Query: 122 FFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
F Q ++ G++Y + + HRDL N ++ +KI DFG ++ +
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKG 178
Query: 179 VGT--PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 219
P ++APE L + K +DVWS GV L+ M + P+
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 66/246 (26%), Positives = 98/246 (39%), Gaps = 47/246 (19%)
Query: 27 RDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIV 80
IG GNFG L K VAVK R + ++ + L HPNIV
Sbjct: 1 EKIGKGNFGDVYKGVL----KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYC 133
+ V + + IVME GG L + + + R ++L+ +G+ Y
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPA 183
S HRDL N L+ + LKI DFG Y+ S L P K T
Sbjct: 110 ESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT----- 162
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEEPKNFRKTIHRISIPEI 240
APE L Y + +DVWS G+ L+ YP ++ + ++ +R+ P++
Sbjct: 163 --APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQL 219
Query: 241 RNHEWF 246
E +
Sbjct: 220 CPEEIY 225
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 65/233 (27%), Positives = 93/233 (39%), Gaps = 41/233 (17%)
Query: 24 ELVRDIGSGNFGV----------------ARLMRDKKTEELVAVKYIERG--DKIDENVQ 65
V +G G FG + LVAVK + D E+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRF 114
+E+ L PNI R V L ++MEY G+L F + CN+
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S++ L+S
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSS 183
Query: 175 PKSTVG--TPAYI---APEVLLKKEYDGKIADVWSCGVTLY--VMLVGAYPFE 220
V P I A E +L ++ K +DVW+ GVTL+ + L P+E
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
++GSGNFG + + + KK+E+ VAVK I + D D ++ E++ + L +P IVR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
I +VME A G L + + +E Q+ G+ Y HR
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLKKEYDG 197
DL N LL KI DFG SK + + + K+ P + APE + ++
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 198 KIADVWSCGVTLY 210
K +DVWS GV ++
Sbjct: 178 K-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG G + L R K T E V V+ I +E V Q E+ + HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++ + L +V + + G + IC SE + Q ++ + Y H M
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 137 QVCHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAY 184
HR +K + L +DG K+ G + V+H PK +V +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174
Query: 185 IAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++PEVL + + YD K +D++S G+T + G PF+D
Sbjct: 175 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 16/222 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG GNFG R + VAVK + + +++ + + + HPNIVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IVME GG+ + G R E + +G+ Y S HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLKKEYDGKIA 200
N L+ LKI DFG S+ +++ P + APE L Y + +
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-S 177
Query: 201 DVWSCGVTLY-VMLVGAYPFED--PEEPKNFRKTIHRISIPE 239
DVWS G+ L+ +GA P+ + ++ + + R+ PE
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE 219
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 67/240 (27%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 29 IGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+GSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 131
IV+ V L I+ME GG+L + +A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYI 185
Y M HRDL N L+ G A R +KI DFG ++ S + + + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 186 APEVLLKKEYDGKI---ADVWSCGVTLY-VMLVG--AYPFEDPEEPKNFRKTIHRISIPE 239
APE LL DGK +DVWS GV ++ ++ +G YP + +E R+ PE
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 22 RYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RS 73
E ++ +GSG FG + + + ++ VA+K + ++ +EI++ S
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMAS 65
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 132
+ HP++VR + L+ ++ + G L + + + + Q+ G+SY
Sbjct: 66 VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPEV 189
++ HRDL N L+ +P +KI DFG +K V + + G P ++A E
Sbjct: 125 LEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+L + Y K +DVWS GVT++ +M GA P+E
Sbjct: 183 ILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 47/161 (29%), Positives = 65/161 (40%), Gaps = 16/161 (9%)
Query: 45 TEELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 98
T VA+K + R D +E +RE L HPNIV P L V EY
Sbjct: 2 TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APR 157
G L E + G E Q++ ++ H+ + HRDLK +N ++ + P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 158 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 190
K+ DFG + T +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 51/189 (26%), Positives = 78/189 (41%), Gaps = 32/189 (16%)
Query: 72 RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 115
L H NI L H+ I + Y + G L F + C N S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 172
+ Q+ G+SY H V H+D+ N ++D ++KI D S+ H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173
Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFR 229
+ ++A E L+ KEY +DVWS GV L+ +M +G P+ DP E +
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232
Query: 230 KTIHRISIP 238
K +R++ P
Sbjct: 233 KDGYRLAQP 241
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-11
Identities = 67/251 (26%), Positives = 107/251 (42%), Gaps = 46/251 (18%)
Query: 29 IGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 81
+G G FG A ++ + VAVK ++ E ++ E + + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 124
L +++EYA G L F R ++ + DE
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 125 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 171
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ S V
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNF 228
S+ + V ++A E L Y + +DVWS GV L+ ++ +G YP PE N
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241
Query: 229 RKTIHRISIPE 239
KT +R+ PE
Sbjct: 242 LKTGYRMERPE 252
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 81
++GSGNFG + + + +K + VA+K ++ + +++V+ E++ + H P IVR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V L +VME ASGG L + + + Q+ G+ Y H
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLKKEYD 196
RDL N LL KI DFG SK+ + + +S P + APE + +++
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 197 GKIADVWSCGVTLYVML-VGAYPFEDPEEPK 226
+ +DVWS G+T++ G P++ + P+
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 19 DSDRYELVRDIGSGNFG-VAR--LMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ ++ R +G+G FG + R L K E VA+ + G DK E +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
H NIVR + VI + IV EY S G L F R + G+ + L SG+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMK 121
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIA 186
Y M H+ L L++ KI F KS +++ KS V + A
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAA 176
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + + +DVWS G+ ++ VM G P+ D
Sbjct: 177 PEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 19 DSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
D +L+R +G+G FG V + + T VAVK ++ G ++ E + LRHP
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 130
+++ V + IV E G L E + QLI SG+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 187
+Y + HRDL N L+ + K+ DFG ++ + ++ G I AP
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
E L + K +DVWS G+ L ++ G P+
Sbjct: 174 EAALYNRFSIK-SDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 13/189 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G +G KK VAVK ++ E +E + ++HPN+V+ V
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLE 146
I+ E+ + G L + + R + + Q+ S + Y HRDL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133
Query: 147 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
N L+ +K+ DFG S+ + H+ K + + APE L ++ K +D
Sbjct: 134 NCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 187
Query: 202 VWSCGVTLY 210
VW+ GV L+
Sbjct: 188 VWAFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 18 HDSDRYELVRDIGSGNFGV---ARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIIN 70
+ + E VRDIG G FG AR E +VAVK ++ + + QRE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 110
HPNIV+ V + ++ EY + G+L E R C
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 111 AGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRN 179
Query: 168 --SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
S+ + ++ ++ PE + Y + +DVW+ GV L+
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 69/234 (29%), Positives = 103/234 (44%), Gaps = 42/234 (17%)
Query: 29 IGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 83
+G GNFG ++DK VAVK + D E + + R L+ HPNIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 136
V + IVME GG+ + R +DE + +QL+ +G++Y S
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
HRDL N L+ + LKI DFG S+ SS L P + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164
Query: 189 VLLKKEYDGKIADVWSCGVTL---YVMLVGAYPFEDPEEPKNFRKTIHRISIPE 239
L Y + +DVWS G+ L + + V YP ++ + + +R+S P+
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQ 217
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
L R++G G FG L + + +ELVAVK ++ + ++ +RE + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 123
NIV+F V +V EY G+L + + G + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
Q+ SG+ Y S HRDL N L+ +KI DFG S+ +++ VG
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE ++ +++ + +DVWS GV L+
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 25 LVRDIGSGNFGVARLMR-----DKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
L R++G G FG L ++ + LVAVK + + D ++ RE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQ 125
IV+F V + L +V EY G+L + + G ++ + QQ
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 182
+ +G+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ +LV+ +G+G FG M VAVK ++ G + E ++L+H +V
Sbjct: 6 ESIKLVKKLGAGQFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 81 RFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R V+ + I+ EY + G L F + G+ + F Q+ G++Y
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
HRDL+ N L+ S + KI DFG ++ + ++ + G + APE + +
Sbjct: 125 IHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPF 219
K +DVWS G+ LY ++ G P+
Sbjct: 182 TIK-SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEE--------------LVAVKYIERGDKIDENVQ- 65
+ L +G G FG L + E LVAVK + R D + + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RAD-VTKTARN 62
Query: 66 ---REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL------------FERICN 110
+EI L++PNI+R V ++ L ++ EY G+L F N
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--- 167
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S+
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLY 180
Query: 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
S + V ++A E +L ++ +DVW+ GVTL+ M
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINH 71
D L+R +G G FG + R E VAVK + D+ D ++ I++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS- 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQ 124
H NIVR V I++E +GG+L F R R S + F +
Sbjct: 65 -KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVG 180
+ G Y HRD+ N LL R+ KI DFG ++ + + + +
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE L + K DVWS GV L+ + +G P+
Sbjct: 184 PIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL +IG G N L R T LV V+ + + +E++ Q E++ RHPN
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ V T + L ++ M Y S L + G SE + G++Y H
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEV 189
HR++K + L+ G L YS K+ V++ P+ + +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 190 LLKKEYDGKI-ADVWSCGVTLYVMLVGAYPFED 221
L + Y + +D++S G+T + G PF+D
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 45/230 (19%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEE-----------LVAVKYIERGDKIDENV 64
R +G G FG L M ++ LVAVK + R D ++N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62
Query: 65 Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 109
+ +EI L+ PNI+R V +T L ++ EY G+L + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 110 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ S F Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179
Query: 170 VLHS------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
L+S Q ++ + +LL K +DVW+ GVTL+ +L
Sbjct: 180 -LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA--SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 70/262 (26%), Positives = 117/262 (44%), Gaps = 41/262 (15%)
Query: 21 DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
D+ L + +G G FG + +DK E + VAVK ++ D E ++++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 72
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEAR--- 120
+ +H NI+ L +++EYAS G L E + A R +S D AR
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPD 131
Query: 121 --FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SS 169
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ ++
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNN 189
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEP 225
+ + + + P ++APE L + Y + +DVWS GV ++ + YP EE
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
Query: 226 KNFRKTIHRISIPEIRNHEWFL 247
K HR+ P +E ++
Sbjct: 249 FKLLKEGHRMDKPANCTNELYM 270
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 24 ELVRDIGSGNFG-VAR----LMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
+ ++G G FG V + ++ + VA+K ++ K+ + ++E L+H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFF 123
PNIV V ++ EY + G+L E + G S D + F
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 124 Q---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 177
Q+ +G+ Y S HRDL N L+ +KI DFG S+ S+ +
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ ++ PE +L ++ + +D+WS GV L+ + G P+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-09
Identities = 60/246 (24%), Positives = 102/246 (41%), Gaps = 41/246 (16%)
Query: 25 LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREI-------INHRSL 74
L + +G G FG +L +D ++ VAVK + K+D + EI +
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58
Query: 75 RHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI- 127
HPN+++ V + L +++ + G+L + R + Q L+
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117
Query: 128 ------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 176
G+ Y + HRDL N +L + +C DFG SK S + Q +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPE--EPKNFRKTIH 233
+IA E L + Y K +DVW+ GVT++ + G P+ E E ++ + +
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232
Query: 234 RISIPE 239
R+ PE
Sbjct: 233 RLKQPE 238
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
L R++G G FG L + K + LVAVK ++ ++ QRE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSEDEARFF 122
IV+F V L +V EY G+L F R G +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTV 179
Q+ SG+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 27 RDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
R IG G+FG L+ + AVK + R ++E Q +E I + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 82 FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVC 139
+ L +V+ Y G+L I + + + F Q+ G+ Y S +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
HRDL N +LD S +K+ DFG Y K S H+ K V ++A E L
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQ 175
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+++ K +DVWS GV L+ +M GA P+ D
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 45/214 (21%), Positives = 82/214 (38%), Gaps = 22/214 (10%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
E V +K + + L H ++V+ V + ++ +V EY
Sbjct: 25 VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83
Query: 101 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----- 150
G L E+ + + D A +QL S + Y ++ H ++ +N L+
Sbjct: 84 FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 151 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA-DVWSCGVTL 209
+ P +K+ D G + + + + +IAPE + + IA D WS G TL
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTL 196
Query: 210 Y-VMLVGAYPFE--DPEEPKNFRKTIHRISIPEI 240
+ G P E + F + HR+ +P+
Sbjct: 197 LEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDC 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V R M K ++ A+K ++ + EN R+ + HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 127
+L I +EYA G L + + + D A QQL+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 128 --SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G P
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y K +DVWS GV L+ ++ +G P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V + K + A+K ++ + ++ R+ + HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 125
+L + +EYA G L + R+ A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 32/217 (14%)
Query: 29 IGSGNFGVARLMRDKKTEE-----LVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 79
+G G FG L + K EE LV VK +++ DEN+Q RE+ R L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 130
VR + +++EY G+L F R + +Q ++ G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 131 SYCHSMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
+ + + HRDL N L+ L Y+ + ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + + ++ K +DVWS GV ++ V G PF
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 68/255 (26%), Positives = 105/255 (41%), Gaps = 47/255 (18%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDENVQREI 68
DR L + +G G FG A + + VAVK + + D + E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 121
I +H NI+ V L +V+EYA+ G L + + A R + A
Sbjct: 72 IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126
Query: 122 ----------FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
F Q+ G+ + S + HRDL N L+ + +KI DFG ++ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182
Query: 172 HSQP---KSTVGTPAY--IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPE 223
H K+T G +APE L + Y + +DVWS GV L+ + +G YP E
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVE 241
Query: 224 EPKNFRKTIHRISIP 238
E K +R+ P
Sbjct: 242 ELFKLLKEGYRMEKP 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 72/260 (27%), Positives = 113/260 (43%), Gaps = 39/260 (15%)
Query: 22 RYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL 74
R L + +G G FG + +DK + + VAVK + + D D+++ + +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVSEMEMM 71
Query: 75 R----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EAR 120
+ H NI+ L +++EYAS G L E + A R +S D E +
Sbjct: 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQ 130
Query: 121 FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLH 172
F+ L+S G+ Y S + HRDL N L+ +KI DFG ++ +
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNID 188
Query: 173 SQPKSTVG--TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEPKN 227
K+T G ++APE L + Y + +DVWS GV L+ + YP EE
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247
Query: 228 FRKTIHRISIPEIRNHEWFL 247
K HR+ P HE ++
Sbjct: 248 LLKEGHRMDKPANCTHELYM 267
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 28 DIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
++G G FG L + ++ + LVAVK + E + ++ QRE L+H +IVR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQL 126
F V L +V EY G+L F R G+ + + Q+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
SG+ Y S+ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 187
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE +L +++ + +D+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 49 VAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
VA+K I+ D+ +EI +H SL H IVR + + L +V + + G L
Sbjct: 39 VAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSL 95
Query: 105 FERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163
+ + + + Q+ G+ Y ++ HR+L N LL S + ++I DF
Sbjct: 96 LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK-SDS-IVQIADF 153
Query: 164 GYSKSSVLHSQPK----STVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAY 217
G + +L+ K S TP ++A E +L Y + +DVWS GVT++ M+ GA
Sbjct: 154 GVA--DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAE 210
Query: 218 PFED--PEEPKNFRKTIHRISIPEI 240
P+ P E + + R++ P+I
Sbjct: 211 PYAGMRPHEVPDLLEKGERLAQPQI 235
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 29/218 (13%)
Query: 27 RDIGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPN 78
+IG+G FG R M + V VK + DE + +E+ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELNHPN 56
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 133
+++ + +V+E+ G+L R A +D + ++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVL 190
H H DL L N L + +KI D+G + + K P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 191 LKKEYDGKIAD------VWSCGVTLYVML-VGAYPFED 221
+ D D +WS GVT++ + P+ D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 16/225 (7%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
+LV+ +G+G FG M VA+K +++G E E + L+HP +VR
Sbjct: 9 KLVKKLGAGQFGEV-WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
V+ T + I+ EY G L F + + + ++ Q+ G+++ HR
Sbjct: 68 AVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
DL+ N L+ S KI DFG ++ + ++ + G + APE + + K
Sbjct: 127 DLRAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 199 IADVWSCGVTLY-VMLVGAYPF---EDPEEPKNFRKTIHRISIPE 239
+DVWS G+ L ++ G P+ +PE +N + +R+ P+
Sbjct: 184 -SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPRPD 226
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 41/263 (15%)
Query: 21 DRYELVRDIGSGNFG-VARLMR---DKKTEE---LVAVKYIERGDKIDENVQREIINHRS 73
DR L + +G G FG V R DK + VAVK + + + D+++ ++I+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----E 118
L +H NI+ V L +++EYA+ G L E + A R ++ D E
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128
Query: 119 ARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 169
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHD 186
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEP 225
+ + + S P ++APE L + Y + +DVWS G+ ++ + +G YP EE
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
Query: 226 KNFRKTIHRISIPEIRNHEWFLK 248
+ HR+ P HE ++
Sbjct: 246 FKLLREGHRMDKPSNCTHELYML 268
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +L++ +G+G FG V + T+ VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 133
V+ V+ + + IV EY S G L + + + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 188
M HRDL+ N L+ KI DFG ++ L + T A + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF 219
L + K +DVWS G+ L ++ G P+
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 16 IMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
I +S R E+ +G G FG V + T VA+K ++ G E +E + L
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGV 130
RH +V+ V+ + + IV EY S G L + + G + + Q+ SG+
Sbjct: 59 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 115
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YI 185
+Y M HRDL+ N L+ + K+ DFG ++ L + T A +
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWT 170
Query: 186 APEVLLKKEYDGKIADVWSCGVTL 209
APE L + K +DVWS G+ L
Sbjct: 171 APEAALYGRFTIK-SDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 18/224 (8%)
Query: 24 ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
+L + +G+G FG V +K T+ VAVK ++ G E E ++L+H +V+
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V+ T + I+ E+ + G L F + + + F Q+ G+++ H
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
RDL+ N L+ S + KI DFG ++ K + + APE + +
Sbjct: 126 RDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSF 180
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRISIP 238
K +DVWS G+ L ++ G P+ P+ R +P
Sbjct: 181 TIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 70/263 (26%), Positives = 109/263 (41%), Gaps = 43/263 (16%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEEL--VAVKYIER-------GDKIDENVQR 66
DR L + +G G FG + + +K + VAVK ++ D I E
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED----- 117
++I +H NI+ L +++EYAS G L E R + +
Sbjct: 78 KMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 118 EARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 169
E + F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 191
Query: 170 VLHSQPKSTVG--TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEE 224
+ K+T G ++APE L + Y + +DVWS GV L+ + YP EE
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 225 PKNFRKTIHRISIPEIRNHEWFL 247
K HR+ P +E ++
Sbjct: 251 LFKLLKEGHRMDKPSNCTNELYM 273
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 9/177 (5%)
Query: 39 LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
L+ D +T++ +K + + + + II H PN+V + I++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
A GG+L+ I E+ + + +++ + H + RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+S+ S + Y APEV E + + D WS G L+ +L G
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ R++++ +G G FG D+K +E AVK + K + + EI +R +
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 80 V-RFKEVILT------PTHLAIVM-EYASGGELFERICNAGRFSEDE-ARFFFQQLISGV 130
RF + + H+ IVM +Y G L + I G FS A+ FQ +GV
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQ---TGV 242
Query: 131 S--YCHS-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHS 173
+ Y H+ + + H DLK EN L++ S P P R++ICD G HS
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHS 301
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ + V T Y +PEV+L + D+WS G +Y + G
Sbjct: 302 R-TAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 37/112 (33%), Positives = 51/112 (45%), Gaps = 17/112 (15%)
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 175
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226
TV T APEVL Y + D+WS G+ ++ V A F +
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDE 370
|
Length = 461 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 11/101 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
P ++APE + K Y + +DVWS GV L+ + +GA P+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 42 DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 100
D KT E V +K +RG E I+ R++ HP+I++ K +++ Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+L+ + + + + ++ + Y H ++ HRD+K EN ++ P +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221
Query: 161 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
C DFG + V + K GT A APE+L + Y G D+WS G+ L+ M
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
IG GNFG AR+ +D + A+K Y + D D + E++ + HPNI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNIIN 72
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF----------QQLIS--- 128
+L + +EYA G L + + R E + F QQL+
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 129 ----GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA 183
G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPV 187
Query: 184 -YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 188 RWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRH 76
++ ++ +GSG FG V + + + E++ VA+K + K ++ + E S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHS 135
P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 69 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVL 190
++ HRDL N L+ +KI DFG +K +L + K ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESI 183
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
L + Y + +DVWS GVT++ +M G+ P++
Sbjct: 184 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
P ++APE + K Y + +DVWS GV L+ + +GA P+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 22/237 (9%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINH 71
+ + +G+G FG A + VAVK ++ E + +I++H
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
H NIV + ++ EY G+L F R + ++ F Q+ G
Sbjct: 95 LG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIA 186
+++ S HRDL N LL + +KICDFG ++ + S K P ++A
Sbjct: 154 MAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTI---HRISIPE 239
PE + Y + +DVWS G+ L+ + +G+ P+ F K I +R++ PE
Sbjct: 212 PESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-------ENVQREIINHRSLRHP 77
L + +G G FG +M + ++ +K + KI E+ E + + HP
Sbjct: 3 LGKTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 78 NIVRFKEVILTPTHL------AIVMEYASGGEL-----FERICNAGRFSEDEARF-FFQQ 125
N++R V L +++ + G+L + R+ + ++ + F
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVG 180
+ SG+ Y S HRDL N +L+ + + +C DFG SK + + Q +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+IA E L + Y K +DVWS GVT++
Sbjct: 177 PVKWIAIESLADRVYTTK-SDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 26 VRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRHPNI 79
V+ +GSG FG V + + E + VA+K + K ++ + E + P +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R + LT T + +V + G L + + N R + + Q+ G+SY +++
Sbjct: 72 CRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLKKEY 195
HRDL N L+ SP +KI DFG ++ + G ++A E +L + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
+ +DVWS GVT++ +M GA P++
Sbjct: 189 THQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 26 VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIER--GDKIDENVQREIINHRSLRHPNI 79
V+ +GSG FG + + +T ++ VA+K + G K + E + S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
VR V L+PT + +V + G L + + + + Q+ G+ Y ++
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
HRDL N L+ SP +KI DFG ++ + + G ++A E + +++
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
+ +DVWS GVT++ +M G P++
Sbjct: 189 THQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 36/131 (27%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
F Q+ G+ + S HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 182 P----AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTI---H 233
++APE + Y ++DVWS G+ L+ + +G P+ F I +
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY 357
Query: 234 RISIPEIRNHE 244
R++ P+ E
Sbjct: 358 RMAKPDHATQE 368
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 26/62 (41%), Positives = 36/62 (58%), Gaps = 2/62 (3%)
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISI 237
+GTP Y+APE+LL K + G D W+ GV L+ L G PF D + F+ ++R I
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599
Query: 238 PE 239
PE
Sbjct: 600 PE 601
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 55/250 (22%), Positives = 97/250 (38%), Gaps = 31/250 (12%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
+ + V VK + G + REI +++ H I+ + + +VM
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+LF + +G ++A ++L+ ++Y H + HRD+K EN LD L
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG- 227
Query: 161 CDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217
DFG + H P+ GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 228 -DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNV 285
Query: 218 PF---EDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTN-----NQFEEPDQ 269
+ R I + + H P + + +TN Q+ +
Sbjct: 286 TLFGKQVKSSSSQLRSIIRCMQV-----H-------PLEFPQNGSTNLCKHFKQYAIVLR 333
Query: 270 PMQSIDEIMQ 279
P +I +++
Sbjct: 334 PPYTIPPVIR 343
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 38/119 (31%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178
F Q+ +G+ + S HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN--FRKTIHR 234
++APE + Y ++DVWS G+ L+ + +G P+ PE P N F I R
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
P ++APE + + Y + +DVWS GV L+ + +GA P+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 23 YELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
+ L R +G G FG R L + + + VAVK ++ +++ RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 77 PNIVRFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI--- 127
PN+++ V L L I M + G+L + R E+ Q L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119
Query: 128 ----SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKST 178
SG+ Y S HRDL N +L+ + + +C DFG SK S + Q ++
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVW+ GVT++ +M G P+
Sbjct: 176 KLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 27 RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 82
++IG+G FG L + T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHSMQ 137
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 189
H DL L N LL +KI D+G S H++ K +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 190 LLKKEYDG--------KIADVWSCGVTLYVML-VGAYPF 219
+ E G K ++VWS GVT++ + +G+ P+
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 48 LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103
LVAVK I R D ++N + + + L+ PNI+R V + L ++ EY G+
Sbjct: 48 LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 104 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHSMQVCHRDL 143
L + ++ + E Q+ SG+ Y S+ HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGK 198
N L+ + +KI DFG S++ L++ + A ++A E +L ++
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAVLPIRWMAWECILMGKFT-T 219
Query: 199 IADVWSCGVTLY--VMLVGAYPF 219
+DVW+ GVTL+ +ML P+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 25/202 (12%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
I G G + + K VK I + I + EI + L+HPNIV+ + +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRS 754
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS------YCH-SMQVCHR 141
++ EY G L E + N E R +++ G++ +C S V
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRNLSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
+L E ++DG P L++ S +L + K + + AY+APE K+ K +D
Sbjct: 808 NLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFISS-AYVAPETRETKDITEK-SD 860
Query: 202 VWSCGVTLYVMLVGAYPFEDPE 223
++ G+ L +L G P D E
Sbjct: 861 IYGFGLILIELLTGKSP-ADAE 881
|
Length = 968 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 47 ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+ VA+K ++ DK + E + E + L+HPNIV V+ L+++ Y S
Sbjct: 36 QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 103 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHSMQVCHRDLKLE 146
+L E + + G +D+ A F Q+ +G+ + S V H+DL
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 147 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
N L+ +KI D G + ++ + +++ +++PE ++ ++ +D+W
Sbjct: 154 NVLV--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ V G P+
Sbjct: 211 SYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 28/197 (14%)
Query: 47 ELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
+LVA+K ++ + + Q+E L HPNIV V+ + ++ EY + G+L
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 105 FERI----------CNAG-----RFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLEN 147
E + C++ + S D F Q+ +G+ Y S H+DL N
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154
Query: 148 TLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
L+ +KI D G S+ + QPKS + ++ PE ++ ++ +D+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ + G P+
Sbjct: 211 SFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 31/188 (16%)
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QL 126
+R L+HPNI++ + +V EY G+L + + Q ++
Sbjct: 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI 108
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTP 182
+GV++ H H DL L N L +K+ D+G K + ++ V
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL- 165
Query: 183 AYIAPEVLLKKEYDG-------KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
++APE L+ + + G K ++VW+ GVTL+ + FE+ +P +
Sbjct: 166 RWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP------YSHL 212
Query: 236 SIPEIRNH 243
S E+ NH
Sbjct: 213 SDREVLNH 220
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G FG + T + VA+K ++ G + E +E + LRH +V V+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 89 PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
+ IV E+ G L F + + + Q+ G++Y M HRDL+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGKIAD 201
N L+ + KI DFG ++ L + T A + APE L + K +D
Sbjct: 132 NILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 185
Query: 202 VWSCGVTLYVMLV-GAYPF 219
VWS G+ L ++ G P+
Sbjct: 186 VWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 39/125 (31%), Positives = 58/125 (46%), Gaps = 10/125 (8%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 179
F Q+ G+S+ S HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 180 GTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTI---HR 234
P ++APE + Y + +DVWS G+ L+ + +G+ P+ F K I +R
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335
Query: 235 ISIPE 239
+ PE
Sbjct: 336 MLSPE 340
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 174
+D RF Q + G+ + S HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 175 --PKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 219
K P ++APE + Y + +DVWS G+ L+ + +G P+
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
++ L+R++G G+FG AR + + E VAVK + + E + E +N S+
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 76 HP----NIVRFKEVILTPTHLAIVMEYASGGEL--FERIC------NAGRFSE--DEARF 121
++VR V+ +VME + G+L + R N GR E
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKG 181
Query: 179 VGTPAYIAPEVLLKKEYDGKI---ADVWSCGVTLY 210
+ ++APE L DG +D+WS GV L+
Sbjct: 182 LLPVRWMAPESL----KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 13/83 (15%)
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
+ Y K AD++S G+TLY L
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 330 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.99 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.92 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.87 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.49 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.48 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.39 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.35 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.03 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.0 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.94 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.89 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.86 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.84 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.8 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.79 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.66 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.63 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.54 | |
| PLN02236 | 344 | choline kinase | 97.38 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.35 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.34 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.2 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.07 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.87 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.74 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.74 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.67 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.57 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.49 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.49 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.96 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.86 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.68 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.45 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.19 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.45 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.43 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=363.81 Aligned_cols=212 Identities=40% Similarity=0.644 Sum_probs=194.6
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..++|.+.+.||+|+|++||+++++.++..||||.+.+.. +..+.+..|+.+|+.++|||||.++++++..+.+|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3578999999999999999999999999999999997653 3456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-CC---CceEEeecCCcccccC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSVL 171 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~-~~---~~vkL~Dfg~a~~~~~ 171 (330)
||||.||+|.+++++.+.+++..++.++.||+.||++||+++||||||||+|||++.. .. ..+||+|||+|+....
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999764 22 5699999999998888
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.....+.+|++.|||||++....|+.+ +|+||+|+++|+|++|+.||...+..+....+
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~ 226 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLLYI 226 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 888889999999999999999999888 89999999999999999999987776655533
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=363.19 Aligned_cols=207 Identities=41% Similarity=0.653 Sum_probs=184.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
.+.|.+.+.||+|+||.|-+|..+.||+.||||++++... ......+|+++|++|+|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3679999999999999999999999999999999976421 12346799999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~~~~ 170 (330)
.|+||||++||.|.+.+..++.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+. .-.+||+|||+|+...
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 999999999999999999999999999999999999999999999999999999999997652 2259999999999877
Q ss_pred CCCCCCcccCCCCCCChhhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
......+.||||.|.|||++.+.. +++.++|+|||||++|-+++|.+||.+.....
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 777778899999999999997654 44556899999999999999999998755444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=368.02 Aligned_cols=209 Identities=39% Similarity=0.622 Sum_probs=191.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeec----CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.+|...+.||+|||+.||.+++..+|+.||+|++.+ ....++.+.+||++++.|+|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 679999999999999999999999999999999987 5667789999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~ 175 (330)
|+|+.++|..++++.+++++.+++.+++||+.||.|||+++|+|||||..|+|++++-+ |||+|||+|...... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence 99999999999999999999999999999999999999999999999999999988766 999999999876644 667
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.+.||||.|.|||++...+..-. +||||+||+||.||.|++||...+-.+.+.++.
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik 231 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK 231 (592)
T ss_pred ceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH
Confidence 88999999999999987777544 999999999999999999998765544444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=345.36 Aligned_cols=215 Identities=37% Similarity=0.626 Sum_probs=194.7
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
....+.|++++.||+|+||.||+++.+.|++.||+|++++.. ...+....|..+|.+++||.||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 445688999999999999999999999999999999998753 2345678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~- 171 (330)
|+|+||+.||.|...+++++.+++..++.++.+|+.||.|||++|||||||||+|||+|.++. ++|+|||+|+....
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccC
Confidence 999999999999999999999999999999999999999999999999999999999998876 99999999985443
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
+....+.+||+.|||||++.+.+++.. +|.||||+++|+|++|.+||.+.+......++...
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~ 240 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG 240 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC
Confidence 445566799999999999999988655 99999999999999999999998877777776643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=347.33 Aligned_cols=198 Identities=33% Similarity=0.548 Sum_probs=182.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeec--CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe-EEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~-~~lv~e 97 (330)
+..+.++.||+|+.|+||+|+++.|++.+|+|.+.. ......++.+|+.++++.+||+||++|+.|..++. .+++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 367889999999999999999999999999999954 34455788999999999999999999999999994 999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||.||||.+++.+.+.+++..+..++.++++||.|||+ ++||||||||+|||++..+. |||||||.++..... ...
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~ 235 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IAN 235 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hcc
Confidence 99999999999998999999999999999999999995 99999999999999987765 999999999755444 678
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
+.+||..|||||.+.+..|..+ +||||||++++|+.+|+.||...
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCc
Confidence 8899999999999999999877 99999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=335.26 Aligned_cols=210 Identities=27% Similarity=0.477 Sum_probs=186.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|+.+.++|+|+||+||+|+++.||+.||||++..++. ..+-..|||++|++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 579999999999999999999999999999999976543 23457899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~~~ 176 (330)
||+..-|.++-..-..++...++.+++|+++|+.|+|+++++||||||+|||+..++. +||||||+|+... .+....
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchhh
Confidence 9987555444444446999999999999999999999999999999999999988765 9999999999766 555567
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
..+.|.+|+|||.+.+...+++++||||+||++.||++|.+.|.+.++.+++-.+.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ 215 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR 215 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH
Confidence 78899999999999997666777999999999999999999999999888876666
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=348.25 Aligned_cols=213 Identities=54% Similarity=0.861 Sum_probs=192.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----C--cccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----D--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~--~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~ 91 (330)
..++|.+.+.||+|+||+|+++.+..+|+.||+|++.+. . ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 357999999999999999999999999999999977653 1 23456779999999998 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc-c
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-V 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~-~ 170 (330)
+|+||||+.||.|.+++.+.+++.+.+++.++.|++.|++|||++||+||||||+|||++.+. +++||+|||++... .
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPG 173 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999998873 35999999999866 4
Q ss_pred CCCCCCcccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
......+.+||+.|+|||++.+.. |.++++||||+|++||.|++|+.||...+......++.
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~ 236 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR 236 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 556778889999999999999988 99999999999999999999999999866655555533
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=345.76 Aligned_cols=226 Identities=33% Similarity=0.538 Sum_probs=198.6
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|.+++.||+|+|++|++|++..+++.||||++.+.. ...+.+.+|-..|.+| .||.|++++--|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3578999999999999999999999999999999987642 3335577888888888 8999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
+|+||+++|.|.+++++.+.|++...+.++.||+.||+|||++|||||||||+|||++.++. ++|+|||.|+......
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999998875 9999999987433211
Q ss_pred --------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh-------
Q 020133 174 --------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI------- 232 (330)
Q Consensus 174 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~------- 232 (330)
...+.+||..|.+||++..+..... +|+|+|||++|+|+.|.+||.+.+....+++++
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 1145789999999999987776555 999999999999999999999887766665555
Q ss_pred --------------------hcCChhHHhcCchhh
Q 020133 233 --------------------HRISIPEIRNHEWFL 247 (330)
Q Consensus 233 --------------------~~~~~~~~~~~~~~~ 247 (330)
.|++..++..||||.
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 578889999999884
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=329.70 Aligned_cols=212 Identities=32% Similarity=0.506 Sum_probs=181.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeE-EEEeCCe-EEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKE-VILTPTH-LAIV 95 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~-~~~~~~~-~~lv 95 (330)
..|+|.++||.|+||.||++.+..+|..+|.|.++-. .+.+..+..|+.+|++|+|||||++++ .|..++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 5699999999999999999999999999999998743 334567889999999999999999999 4444444 8999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhh--cC--ccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS--MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~--~~--ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
||||.+|+|.++++. +..+++.++++++.|++.||..+|+ .. |+||||||.||+++.++. +||+|||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r 176 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGR 176 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHh
Confidence 999999999999864 3469999999999999999999999 44 999999999999987765 9999999999
Q ss_pred cccCCCC-CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCC
Q 020133 168 SSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIS 236 (330)
Q Consensus 168 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 236 (330)
....... ..+.+|||.||+||.+.+++|+.+ |||||+||++|||+.-++||.+.+- ..+.+.+..-.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~n~-~~L~~KI~qgd 244 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGDNL-LSLCKKIEQGD 244 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccccH-HHHHHHHHcCC
Confidence 7665544 356789999999999999999877 9999999999999999999998743 44444444333
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=338.05 Aligned_cols=211 Identities=35% Similarity=0.582 Sum_probs=187.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..+.|+++++||+|+||.||+|+-+.||..+|+|+++++... .+.+..|-.+|....+|.||+++..|.+..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 458899999999999999999999999999999999887532 3456778888888999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC---
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~--- 171 (330)
||||++||++..++.+.+.|++..++.++.+++.|+..||+.|++||||||+|+|||..|+ +||+|||+|.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999998876 99999999852111
Q ss_pred ------------C--------CC-------------------------CCcccCCCCCCChhhhhcCCCCCCccchhhHH
Q 020133 172 ------------H--------SQ-------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCG 206 (330)
Q Consensus 172 ------------~--------~~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG 206 (330)
. .. ..+.+|||-|+|||++.+.+|... +|.||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHH
Confidence 0 00 012369999999999999997655 9999999
Q ss_pred HHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 207 VTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 207 ~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
|||||||.|.+||.+.+....+++++
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~ 401 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIV 401 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999988888777776
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=317.88 Aligned_cols=208 Identities=35% Similarity=0.633 Sum_probs=190.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++++.||.|+||.|-+++++.+|..+|+|++.+..- ..+...+|..+|+.+.||.++++++.|.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4789999999999999999999999999999999987542 235677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|||.+||-|..++++.+++++..++.++.||+.||+|||+++|++||+||+|||+|.+|. +|++|||+|+..... .
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR--T 198 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc--E
Confidence 999999999999999999999999999999999999999999999999999999998876 999999999855433 6
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.+.||||.|+|||++++.++. +++|.||||+++|||+.|.+||...+......+++
T Consensus 199 ~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~ 254 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL 254 (355)
T ss_pred EEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH
Confidence 778999999999999998886 45999999999999999999999887776666666
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=336.47 Aligned_cols=227 Identities=30% Similarity=0.506 Sum_probs=198.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~l 94 (330)
.+.|+.+++||+|.||.||+|++..+|+.||+|++.... .......|||.+|++|+||||+++.++..+. +.+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 367899999999999999999999999999999987643 3445678999999999999999999999887 68999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
|+|||+. +|.-++... -.|++.+++.+++||+.||.|||++||+|||||.+|||||.++. +||+|||+|+......
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCC
Confidence 9999976 787777653 37999999999999999999999999999999999999988776 9999999999655444
Q ss_pred --CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCC
Q 020133 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
.....+.|.+|+|||.+.|...++.++|+||.||||.||++|++.|++.++.+++..+++-.+.|....++ ...+|
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~--~~kLP 350 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP--VSKLP 350 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc--cccCC
Confidence 35667889999999999998877777999999999999999999999999999999999877776655533 34444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=340.62 Aligned_cols=255 Identities=30% Similarity=0.438 Sum_probs=213.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHH--HHHHHHHHHcCC-CCCeeeeeEEEEeCC-eEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREIINHRSLR-HPNIVRFKEVILTPT-HLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~ei~~l~~l~-h~~Iv~~~~~~~~~~-~~~lv 95 (330)
.+||+++++||.|.||.||+|....+|..||||.+++.-...++ -.||+..|++|+ ||||+++.+++.+++ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 47999999999999999999999999999999999876544433 469999999998 999999999999988 89999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
||||+ .+|.++++. +..|++..++.|++||++||+|+|.+|+.|||+||+|||+.... .+||+|||+|+.......
T Consensus 89 fE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~--~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND--VIKIADFGLAREVRSKPP 165 (538)
T ss_pred HHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc--eeEecccccccccccCCC
Confidence 99995 599999975 45799999999999999999999999999999999999997543 499999999998888888
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCch---------
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEW--------- 245 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 245 (330)
...++.|.+|+|||++....+++.+.|+||+||+++|+++-++.|.+.++.+++.++..-++.|.....+-
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 88899999999999999888888889999999999999999999999999999999886544443222221
Q ss_pred -------------hhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 246 -------------FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 246 -------------~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+....+ ......+.++..++|..|+ ++++.++
T Consensus 246 f~~P~~~~~~l~~L~p~~s-~~~~~li~~ll~WDP~kRp-TA~~al~ 290 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNAS-SEAASLIERLLAWDPDKRP-TASQALQ 290 (538)
T ss_pred cCCCcCCCCChHHhCcccC-HHHHHHHHHHhcCCCccCc-cHHHHhc
Confidence 011111 1123445556668888876 7887775
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.00 Aligned_cols=228 Identities=38% Similarity=0.716 Sum_probs=207.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.+-|++.+.||.|+.|.|-+|++..||+.+|||++.+.. .....+.+||.+|+.+.|||++.+|++++.+..+|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 366999999999999999999999999999999997652 2345688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
.||++||-|.+++.++|++++.++.++++||+.|+.|+|..+|+|||+||+|+|++..++ +||+|||+|.....+...
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccc
Confidence 999999999999999999999999999999999999999999999999999999998776 999999999877777778
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh-----------------------
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----------------------- 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~----------------------- 232 (330)
.+.||+|.|.|||++.|.+|++.++||||.|+|+|.||||+.||++.+....+.+..
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~ 248 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLD 248 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhc
Confidence 889999999999999999999999999999999999999999999765433333322
Q ss_pred ----hcCChhHHhcCchhhcc
Q 020133 233 ----HRISIPEIRNHEWFLKN 249 (330)
Q Consensus 233 ----~~~~~~~~~~~~~~~~~ 249 (330)
.|+++++++.|||+.+.
T Consensus 249 VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 249 VDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred cCccccccHHHHhhCchhhcC
Confidence 57999999999998764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=332.33 Aligned_cols=255 Identities=32% Similarity=0.444 Sum_probs=203.9
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcE-EEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCC-e
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEEL-VAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT-H 91 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-~ 91 (330)
..+.....+.+.+|.|+||+||.+... |.. ||+|.+...... ...+.+|+.++.+++|||||++++++..+. .
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 334566677888999999999998876 555 999999765432 458999999999999999999999999887 7
Q ss_pred EEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcC-ccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 92 LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
.++||||+++|+|.+++.. +..++...+..++.||++|+.|||+++ ||||||||+|||++.+. ..+||+|||+++.
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSRE 193 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCcccee
Confidence 9999999999999999987 678999999999999999999999999 99999999999998876 2499999999985
Q ss_pred ccCC-CCCCcccCCCCCCChhhhh--cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh---hcCChhHHhc
Q 020133 169 SVLH-SQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---HRISIPEIRN 242 (330)
Q Consensus 169 ~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~ 242 (330)
.... .......||+.|||||++. ...++.+ +||||||+++|||+||+.||.+........... .|+.+|..
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~-- 270 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE-- 270 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc--
Confidence 5443 3444478999999999998 4567655 999999999999999999999887744333333 23333322
Q ss_pred CchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 243 HEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
+|+. +...+.+|+..+|..|+ ++.|+...|..+..
T Consensus 271 -------~~~~-l~~l~~~CW~~dp~~RP-~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 271 -------CPPH-LSSLMERCWLVDPSRRP-SFLEIVSRLESIMS 305 (362)
T ss_pred -------CCHH-HHHHHHHhCCCCCCcCC-CHHHHHHHHHHHHH
Confidence 2222 22333345556666654 99999988886644
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=338.35 Aligned_cols=226 Identities=34% Similarity=0.628 Sum_probs=199.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCccc---HHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|.+.+.||+|+||.||+++.+.+.+.||+|.+.+..+.. ..+.+|+++++.++||||+.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57999999999999999999999999999999998765444 457899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC-C
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~-~ 176 (330)
||.| +|..++...+.++++.+..++.++..||.|||+.+|+|||+||.|||++.++. +||||||+|+....+... .
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence 9987 99999999999999999999999999999999999999999999999987765 999999999866655443 4
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh------------------------
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI------------------------ 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~------------------------ 232 (330)
...|||.|||||...++.|+-. +|+|||||++||+++|++||...+....++.+.
T Consensus 159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence 4569999999999998888766 999999999999999999997654433333333
Q ss_pred ---hcCChhHHhcCchhhccC
Q 020133 233 ---HRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 233 ---~~~~~~~~~~~~~~~~~~ 250 (330)
.|+++++++.|||..+.+
T Consensus 238 dP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred ChhhcccHHHHhcChHHhhhh
Confidence 578999999999876543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=321.87 Aligned_cols=278 Identities=32% Similarity=0.486 Sum_probs=224.2
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC-----eEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-----~~~lv~ 96 (330)
.|.-.+.+|+|+||+||++....+++.||||++-.+.... .+|+.+|+.+.|||||++.-+|.... ...+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 5889999999999999999999999999999987665433 58999999999999999999987542 356799
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 97 e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
||++. +|.+.++. +..++.-.++-+.+||++||+|||+.||+||||||+|+|+|.+. +.+||||||.|+....+
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKG 179 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccC
Confidence 99975 89888874 56799999999999999999999999999999999999999774 47999999999999999
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc------------------
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR------------------ 234 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~------------------ 234 (330)
....+...|..|+|||.+.+....+.+.||||.||++.||+-|++.|.+.+..+++..+++-
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 99999999999999999998876666699999999999999999999999999998888843
Q ss_pred CChhHHhcCch---hhccCCccccccccccCCCCCCCCccCCHHHHHH--HHHHhCCCCCCCCchhhhccCCCCcccc
Q 020133 235 ISIPEIRNHEW---FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ--IIAEATIPAAGTQSLNQCLNGSLDIDDE 307 (330)
Q Consensus 235 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (330)
...|++..++| +.+..+++.+ +.+.+....+|..|. ++.|+++ .+.++..+ +...+....+...++|...
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~-dll~~~L~Y~P~~R~-~~~~~l~h~fFdelr~~-~~~l~~g~~lp~lf~f~~~ 334 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDAL-DLLSKLLQYSPSKRL-SALEALAHPFFDELRDP-NTKLPNGRPLPPLFNFKRA 334 (364)
T ss_pred ccCcccccccceeecccCCCHHHH-HHHHHHhccChhhcC-CHHHHhcchhhHHhhCc-CccCcCCCcCCCccCchHH
Confidence 34567777776 5556666544 344445556777766 5554442 34444444 3333333356666666554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=306.15 Aligned_cols=221 Identities=29% Similarity=0.472 Sum_probs=196.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.+|...+.||+|.||+||+|++..||+.||||+++.... ......|||..|+.++|+||+.+.++|.+.+++.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 579999999999999999999999999999999987643 35678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC-
Q 020133 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~- 175 (330)
|++. +|...++.+ ..++...++.++.++++||+|||++.|+||||||.|+|++.++. +||+|||+|+........
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 9975 898888754 47999999999999999999999999999999999999988775 999999999966544433
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
...+.|..|+|||.+.|...++..+|+||.||++.||+.|.+.|.+.++-+++..+++-.+.|....+|
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 334789999999999888766777999999999999999999999999999999999777666555544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=325.81 Aligned_cols=251 Identities=33% Similarity=0.490 Sum_probs=197.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc-cHHHHHHHHHHHcCCCCCeeeeeEEEEeCC--eEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~--~~~lv~ 96 (330)
..+|...+.||+|+||.||++.+..+|...|||.+...... .+.+.+|+.+|++++|||||++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 46799999999999999999999999999999988765322 356899999999999999999999854444 689999
Q ss_pred eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccC---
Q 020133 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL--- 171 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~--- 171 (330)
||+++|+|.+++.+.+ ++++..++.+.+|+++||.|||++||+||||||+|||++. ++ .+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~--~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG--DVKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC--eEEeccCccccccccccc
Confidence 9999999999999877 8999999999999999999999999999999999999987 44 499999999875543
Q ss_pred -CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC-CChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 172 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
........||+.|||||++.......+++|||||||++.||+||+.||.. ......+..+......|. +...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~------ip~~ 247 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPE------IPDS 247 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCC------CCcc
Confidence 22244578999999999998643444469999999999999999999987 333333333333333332 2222
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHH
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQI 280 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~ 280 (330)
++. ...+.+..|...+|.+|+ +++|+++-
T Consensus 248 ls~-~a~~Fl~~C~~~~p~~Rp-ta~eLL~h 276 (313)
T KOG0198|consen 248 LSD-EAKDFLRKCFKRDPEKRP-TAEELLEH 276 (313)
T ss_pred cCH-HHHHHHHHHhhcCcccCc-CHHHHhhC
Confidence 222 233344445556677766 88888763
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=326.16 Aligned_cols=231 Identities=38% Similarity=0.639 Sum_probs=193.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---------------cccHHHHHHHHHHHcCCCCCeeeeeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------------KIDENVQREIINHRSLRHPNIVRFKE 84 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~ei~~l~~l~h~~Iv~~~~ 84 (330)
.|.|++.+.||+|.||.|-+|++..+++.||+|++.+.. ...+...+||.+++++.|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 478999999999999999999999999999999986531 12257899999999999999999999
Q ss_pred EEEeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEee
Q 020133 85 VILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (330)
Q Consensus 85 ~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~D 162 (330)
+..+. +.+|||+|||..|.+.+.-.....+++.+++.++++++.||.|||.+||+||||||+|+|++.++ ++||+|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIsD 253 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKISD 253 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEeec
Confidence 98765 57999999999988865443333399999999999999999999999999999999999998876 499999
Q ss_pred cCCcccccCCC------CCCcccCCCCCCChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh-
Q 020133 163 FGYSKSSVLHS------QPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI- 232 (330)
Q Consensus 163 fg~a~~~~~~~------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~- 232 (330)
||.+....... .....+|||.|+|||.+.+ ..+.+++.||||+|++||.|+.|+.||.+....+...+++
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 99987442221 1234689999999999977 4577888999999999999999999997765544444444
Q ss_pred ----------------------------hcCChhHHhcCchhhccCCc
Q 020133 233 ----------------------------HRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 233 ----------------------------~~~~~~~~~~~~~~~~~~~~ 252 (330)
.|++++++..|||.......
T Consensus 334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 57899999999998776433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=327.39 Aligned_cols=209 Identities=29% Similarity=0.528 Sum_probs=181.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||+||+|.+..+++.||+|++.+.. .....+.+|+.++.+++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987532 22346778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--- 173 (330)
||++|++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999987764 9999999986432110
Q ss_pred ---------------------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 174 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
.....+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence 0123478999999999988777655 999999999999999999998
Q ss_pred CCChhhHHHHHh
Q 020133 221 DPEEPKNFRKTI 232 (330)
Q Consensus 221 ~~~~~~~~~~~~ 232 (330)
+.+......++.
T Consensus 238 ~~~~~~~~~~i~ 249 (363)
T cd05628 238 SETPQETYKKVM 249 (363)
T ss_pred CCCHHHHHHHHH
Confidence 776655555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.66 Aligned_cols=248 Identities=30% Similarity=0.511 Sum_probs=207.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCccc-HHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
..|+..+++|+|+.|.||.|....+++.||||.+....... +-+.+|+.+|+..+|+|||++++.|...+.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 57999999999999999999999999999999998776554 56789999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~~ 178 (330)
+||+|.+.+... .+++.++..++++++.||+|||++||+|||||.+|||++.++. +||+|||++....... ...+.
T Consensus 353 ~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred CCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence 999999998664 5999999999999999999999999999999999999988875 9999999997665544 67888
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDN 258 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (330)
+|||+|||||+.....|.++ +||||||++++||+.|++||-. ..+-.....+.....|.+..++-+-..+ .+++..|
T Consensus 430 VGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~ng~P~lk~~~klS~~~-kdFL~~c 506 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPKLKNPEKLSPEL-KDFLDRC 506 (550)
T ss_pred cCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhhcCCCCcCCccccCHHH-HHHHHHH
Confidence 99999999999999988777 9999999999999999999986 4444555555555666666555432222 3444444
Q ss_pred cccCCCCCCCCccCCHHHHHH
Q 020133 259 TTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 259 ~~~~~~~~p~~~~~s~~el~~ 279 (330)
+. .++.+|. ++.||++
T Consensus 507 L~----~dv~~Ra-sA~eLL~ 522 (550)
T KOG0578|consen 507 LV----VDVEQRA-SAKELLE 522 (550)
T ss_pred hh----cchhcCC-CHHHHhc
Confidence 43 4445444 8888775
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=309.78 Aligned_cols=213 Identities=33% Similarity=0.488 Sum_probs=185.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeC-----C
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-----~ 90 (330)
...+|..++.||.|+||.|+.|.++.+|+.||||++... ....++..||+.+++.++|+||+.+.+++..+ +
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 356777789999999999999999999999999998743 33346788999999999999999999998762 4
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.+|+|+|++ +.+|.+.++.+..++...+..+++|+++||+|+|+.+++|||+||+|++++.+.. +|+||||+|+...
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeecc
Confidence 589999999 5599999988888999999999999999999999999999999999999988775 9999999998665
Q ss_pred C---CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 171 L---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 171 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
. ...-+..+.|.+|+|||.+......+++.||||+|||+.||++|++.|.+.+...++..++.-
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 3 222355678999999999977766677799999999999999999999999888777777743
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=307.88 Aligned_cols=222 Identities=31% Similarity=0.410 Sum_probs=194.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~l 94 (330)
.+.|+.+..|++|+||.||+|+++.|++.||+|+++.... ..-.-.|||.+|.+.+|||||.+.++.... +.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3679999999999999999999999999999999976532 234568999999999999999999998754 57999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
|||||+. +|..++..-+ ++...+++.++.|+++||+|||.+.|+||||||+|+|+.+.+. +|++|||+|+......
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCc
Confidence 9999976 8988887644 8999999999999999999999999999999999999987775 9999999999665543
Q ss_pred C-CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 174 Q-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 174 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
. ....+.|.+|+|||.+.+...++.+.|+||+|||+.||+++++.|.+....+++.+++...+.|.-..+|
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 3 3556789999999999998877777999999999999999999999999999999999776666544444
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=317.69 Aligned_cols=210 Identities=40% Similarity=0.707 Sum_probs=193.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
-||++.+.||+|.||.|-+|.....|+.||||.++++.-.. -.+.+||++++.|+||||+.+|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 57999999999999999999999999999999998764322 35789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||..+|.|.+++.+.+.|++.+++.+++||..|+.|+|.++++|||||.+|||+|++++ +|++|||++..+.......
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHH
Confidence 99999999999999999999999999999999999999999999999999999998887 9999999998777777778
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
++||+|-|.+||+..+.+|.+..+|-||||+++|.|+.|.+||++.+....++++-
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs 266 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS 266 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh
Confidence 89999999999999999999999999999999999999999999877655544443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=316.45 Aligned_cols=207 Identities=35% Similarity=0.599 Sum_probs=181.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987542 22356788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Ccc
Confidence 9999999999999888999999999999999999999999999999999999998765 499999999874432 223
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
...|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+.
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~ 211 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211 (291)
T ss_pred cccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4568999999999987776554 999999999999999999998866554444443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.86 Aligned_cols=214 Identities=33% Similarity=0.471 Sum_probs=193.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-C-----CCeeeeeEEEEeCCeEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h-----~~Iv~~~~~~~~~~~~~l 94 (330)
.||.+.+.||+|+||.|.+|.+..|++.||||++++..........|+.+|..|+ | -|||+++++|...+++||
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 4789999999999999999999999999999999998887788889999999997 4 379999999999999999
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+|.+ ..+|.++++.++ .++...++.++.||+.||.+||+.||||+||||+|||+.+.....||++|||.|......
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 99999 459999998765 589999999999999999999999999999999999997766668999999998744333
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIP 238 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 238 (330)
..+.+.+..|+|||++.|.+|+.. .||||||||+.||++|.+.|.+.+..+++..+++-.+.|
T Consensus 345 --vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 345 --VYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred --ceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 337888999999999999999877 999999999999999999999999999999999765544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=319.83 Aligned_cols=223 Identities=33% Similarity=0.541 Sum_probs=187.7
Q ss_pred CCCCccccCCCCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCC
Q 020133 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76 (330)
Q Consensus 1 ~~~~~~~~~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h 76 (330)
|++..+...+...-. ..+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.++++++|
T Consensus 1 ~~~~~~~~~~~~~~~---~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h 77 (329)
T PTZ00263 1 MKAAYMFTKPDTSSW---KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77 (329)
T ss_pred CCCCceeeccccCCC---CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC
Confidence 444444444433222 2378999999999999999999999999999999987542 223567899999999999
Q ss_pred CCeeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC
Q 020133 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (330)
Q Consensus 77 ~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~ 156 (330)
|||+++++++..++..|+||||++|++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 78 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~- 156 (329)
T PTZ00263 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH- 156 (329)
T ss_pred CCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC-
Confidence 9999999999999999999999999999999998889999999999999999999999999999999999999987764
Q ss_pred ceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 157 ~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
+||+|||+++.... ......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+
T Consensus 157 -~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i 227 (329)
T PTZ00263 157 -VKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI 227 (329)
T ss_pred -EEEeeccCceEcCC--CcceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999874432 2234578999999999988777544 99999999999999999999876654444433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=308.05 Aligned_cols=222 Identities=30% Similarity=0.424 Sum_probs=195.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCC-eeeeeEEEEeCC------
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT------ 90 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~-Iv~~~~~~~~~~------ 90 (330)
..|+.+++||+|+||+||+|+++.+|+.||+|++..... ......+|+.+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 458889999999999999999999999999999976543 4467789999999999999 999999999877
Q ss_pred eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 91 HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
..++|+||+.. +|..++...+ .++...++.+++||+.||+|||+++|+||||||+|||++.++. +||+|||+|
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLA 167 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchH
Confidence 79999999954 8999987654 4888999999999999999999999999999999999998665 999999999
Q ss_pred cccc-CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCch
Q 020133 167 KSSV-LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEW 245 (330)
Q Consensus 167 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
+... ........++|..|+|||++.+........||||+||++.||++++..|.+..+..++..+....+.|....+|-
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 8655 333456778999999999999886555559999999999999999999999999999999998887776666554
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=323.96 Aligned_cols=209 Identities=34% Similarity=0.586 Sum_probs=180.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997542 22345778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--- 173 (330)
||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. ++|+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988889999999999999999999999999999999999999987765 9999999986332110
Q ss_pred ------------------------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCC
Q 020133 174 ------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (330)
Q Consensus 174 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~ 217 (330)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence 0112468999999999987777655 999999999999999999
Q ss_pred CCCCCChhhHHHHHh
Q 020133 218 PFEDPEEPKNFRKTI 232 (330)
Q Consensus 218 pf~~~~~~~~~~~~~ 232 (330)
||...+.......+.
T Consensus 238 Pf~~~~~~~~~~~i~ 252 (364)
T cd05599 238 PFCSDNPQETYRKII 252 (364)
T ss_pred CCCCCCHHHHHHHHH
Confidence 998776655444443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=323.79 Aligned_cols=207 Identities=32% Similarity=0.499 Sum_probs=178.2
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6999999999999999999999999999999997643 223467889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC----
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 173 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~---- 173 (330)
|++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ ++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCccccccccccc
Confidence 999999999998888899999999999999999999999999999999999998765 49999999875221000
Q ss_pred --------------------------------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHH
Q 020133 174 --------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 209 (330)
Q Consensus 174 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il 209 (330)
.....+||+.|+|||++.+..++.+ +|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHH
Confidence 0123468999999999988777655 9999999999
Q ss_pred HHHHhCCCCCCCCChhhHHHHH
Q 020133 210 YVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 210 ~elltg~~pf~~~~~~~~~~~~ 231 (330)
|||++|+.||...+.......+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i 260 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKV 260 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHH
Confidence 9999999999876654444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.65 Aligned_cols=206 Identities=33% Similarity=0.541 Sum_probs=181.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987542 22346778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++.... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988889999999999999999999999999999999999999987764 99999999874433 334
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
...|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 210 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210 (333)
T ss_pred CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence 5678999999999988876655 99999999999999999999876655444333
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.23 Aligned_cols=207 Identities=34% Similarity=0.540 Sum_probs=177.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+.|++++.||+|+||.||+|++..+++.||+|.+.... .....+.+|+.++++++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 22356788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC----
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~---- 172 (330)
||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987764 999999987422100
Q ss_pred ----------------------------------------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHH
Q 020133 173 ----------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (330)
Q Consensus 173 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~el 212 (330)
......+||+.|+|||++.+..++.+ +|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence 00112468999999999988777655 9999999999999
Q ss_pred HhCCCCCCCCChhhHHHH
Q 020133 213 LVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 213 ltg~~pf~~~~~~~~~~~ 230 (330)
++|+.||.+.+.......
T Consensus 238 l~G~~Pf~~~~~~~~~~~ 255 (376)
T cd05598 238 LVGQPPFLADTPAETQLK 255 (376)
T ss_pred hhCCCCCCCCCHHHHHHH
Confidence 999999987665444333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=318.63 Aligned_cols=210 Identities=32% Similarity=0.519 Sum_probs=181.3
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCC-cEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
...++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 34578999999999999999999976654 689999986532 2335678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+||||+++++|.+++..++.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecCC-
Confidence 999999999999999998889999999999999999999999999999999999999987664 99999999874432
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
......||+.|+|||++.+..++.. +|+|||||++|+|++|+.||.+.+.......+.
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 241 (340)
T PTZ00426 184 -RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL 241 (340)
T ss_pred -CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 2345578999999999987766544 999999999999999999998876655444444
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=322.48 Aligned_cols=247 Identities=33% Similarity=0.548 Sum_probs=200.3
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999987542 23356788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--- 173 (330)
||+++++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988888999999999999999999999999999999999999987765 9999999987443322
Q ss_pred ---------------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 174 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
......||+.|+|||++.+..++.. +|||||||++|+|++|+.||...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2234568999999999988877655 999999999999999999998877555
Q ss_pred HHHHHhh---cCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 227 NFRKTIH---RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 227 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
...++.. ....|... .++++ +.+.+.++. .+|..|+.+++++++
T Consensus 238 ~~~~i~~~~~~~~~p~~~-------~~~~~-~~~li~~ll-~dp~~R~~s~~~ll~ 284 (350)
T cd05573 238 TYNKIINWKESLRFPPDP-------PVSPE-AIDLICRLL-CDPEDRLGSFEEIKS 284 (350)
T ss_pred HHHHHhccCCcccCCCCC-------CCCHH-HHHHHHHHc-cChhhcCCCHHHHhc
Confidence 5544443 11111111 01221 222233333 378888877999886
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=322.59 Aligned_cols=209 Identities=34% Similarity=0.531 Sum_probs=179.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.+|++++.||+|+||.||+|++..+++.||+|.+.... .....+.+|+.++++++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999987642 22346788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC----
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~---- 172 (330)
||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987764 999999987422100
Q ss_pred --------------------------------------------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHH
Q 020133 173 --------------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (330)
Q Consensus 173 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~i 208 (330)
......+||+.|+|||++.+..++.+ +|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHH
Confidence 00112468999999999988877655 999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHh
Q 020133 209 LYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 209 l~elltg~~pf~~~~~~~~~~~~~ 232 (330)
+|||++|+.||...+......++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999998766555444444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.07 Aligned_cols=209 Identities=31% Similarity=0.540 Sum_probs=178.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||.||++.+..+++.||+|++.+.. .....+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986532 22345778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--- 173 (330)
||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987664 9999999985221100
Q ss_pred ---------------------------------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHH
Q 020133 174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (330)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~i 208 (330)
.....+||+.|+|||++.+..+..+ +|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence 0012468999999999988777655 999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHh
Q 020133 209 LYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 209 l~elltg~~pf~~~~~~~~~~~~~ 232 (330)
+|||++|+.||...+.......+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHH
Confidence 999999999998766554444443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=309.83 Aligned_cols=200 Identities=28% Similarity=0.420 Sum_probs=174.5
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.|++.+.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+.++++++|+||+++++++...+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3889999999999999999999999999999887542 222456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 99999998877543 36899999999999999999999999999999999999987654 999999998754433334
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
....|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.....
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCc
Confidence 45678999999999988777655 9999999999999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=307.71 Aligned_cols=213 Identities=30% Similarity=0.476 Sum_probs=179.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++.+.||.|+||+||++.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3478999999999999999999999999999999986542 23456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-C
Q 020133 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~ 174 (330)
||+++ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 99976 8988886544 5899999999999999999999999999999999999987764 9999999987433222 2
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
.....+++.|+|||++.+....+.++|+|||||++|+|+||+.||.+.+....+..+...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 234567899999999876544455599999999999999999999887766655555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=315.45 Aligned_cols=200 Identities=38% Similarity=0.618 Sum_probs=173.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~ 102 (330)
+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.++++++||||+++++++..++..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987542 22345678999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccCC
Q 020133 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (330)
Q Consensus 103 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~~ 181 (330)
+|.+++..++.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+++.... .......+|+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988889999999999999999999999999999999999999987664 99999999874322 2233455799
Q ss_pred CCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 182 ~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+......
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~ 205 (323)
T cd05571 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205 (323)
T ss_pred ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 99999999987777655 999999999999999999998765544333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=302.35 Aligned_cols=237 Identities=30% Similarity=0.474 Sum_probs=196.4
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
....+.|++.+.||.|..++||+|+...++..||||++.... ...+.+.+|+..++.++||||++++..|..+..+|+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 345688999999999999999999999999999999997543 334689999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
||.||.+||+.++++.. ..+++..+..+++++++||.|||.+|.||||||+.||||+.+|. |||+|||.+......
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDS 179 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeeccc
Confidence 99999999999999864 34999999999999999999999999999999999999998886 999999987533222
Q ss_pred CC-----CCcccCCCCCCChhhhh--cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh-------------
Q 020133 173 SQ-----PKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI------------- 232 (330)
Q Consensus 173 ~~-----~~~~~~~~~y~aPE~~~--~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~------------- 232 (330)
.. .....|+++|||||++. ..+|+.+ +||||||++..||.+|..||......+.+...+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 11 14568999999999953 3356555 999999999999999999997655433332222
Q ss_pred ------------------------hcCChhHHhcCchhhccCCccccc
Q 020133 233 ------------------------HRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 233 ------------------------~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
.|++...+++|+||.+..+.+...
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~ 306 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLV 306 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcc
Confidence 466777777777777666555443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=306.48 Aligned_cols=206 Identities=31% Similarity=0.502 Sum_probs=177.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|+..++.++||||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 57999999999999999999999999999999987643 234567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--CC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~~ 175 (330)
|++++++..+......+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9999877766655567999999999999999999999999999999999999987664 9999999987543222 22
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
....+++.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred cccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 34568999999999987776554 999999999999999999998766544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=316.42 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=211.6
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
....+++++.||+|.||.||++.... ...||+|.++......+.+.+|+.+|++|+|+|||+++++|..++.+||||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 34556789999999999999999875 34699999998877778999999999999999999999999998899999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC-
Q 020133 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (330)
Q Consensus 99 ~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~- 175 (330)
++.|+|.++++. ++.+...+.+.++.||++|.+||+++++|||||...|||++++. .+|++|||+|+........
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~--~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL--VVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc--eEEEcccccccccCCCceee
Confidence 999999999986 55799999999999999999999999999999999999998776 4999999999933322221
Q ss_pred -CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 176 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
...--...|.|||.+....++.+ |||||||++|||++| |+.||.+.+..+.+..+-+...+|... .+|.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~-------~CP~- 431 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE-------GCPD- 431 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC-------CCCH-
Confidence 11223457999999998888777 999999999999999 999999998888777776555444322 2233
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
.+-+.+..|+..+|+.|+ |++.+...+.......
T Consensus 432 ~vY~lM~~CW~~~P~~RP-tF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRP-TFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHHHHHhhCCcccCC-CHHHHHHHHHHhhhcc
Confidence 333455566667777765 9998888887765543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=317.25 Aligned_cols=211 Identities=32% Similarity=0.505 Sum_probs=180.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||+|+||.||++.+..+++.||+|.+.+.. .....+.+|+.+++.++||||+++++++..++.+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3478999999999999999999999999999999986532 223457789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+|.......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCc
Confidence 9999999999998865 46899999999999999999999999999999999999987764 9999999987543222
Q ss_pred -CCCcccCCCCCCChhhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
......||+.|+|||++.+.. ..+.++|+|||||++|+|++|+.||...+......++.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 123557999999999997643 23455999999999999999999998877655555554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=306.25 Aligned_cols=203 Identities=29% Similarity=0.481 Sum_probs=173.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 4588999999999999999999999999999999987543 22346778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCC
Q 020133 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~ 174 (330)
||+.+ +|.+++.. .+.+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||+++.... ...
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCcc
Confidence 99964 77776654 357999999999999999999999999999999999999987664 99999999864322 222
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
.....+++.|+|||++.+......++|+|||||++|+|++|+.||.+...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 34456889999999987655445559999999999999999999987544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.99 Aligned_cols=228 Identities=40% Similarity=0.664 Sum_probs=202.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~l 94 (330)
...|++.+.||.|.||.||.|.++.+|+.+|+|.+.+... ..+.+.+|+.+|+++. ||||+.+++.|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4689999999999999999999999999999999977543 3468999999999998 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC--CCceEEeecCCcccccCC
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLH 172 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~--~~~vkL~Dfg~a~~~~~~ 172 (330)
|||+|.||.|.+.+.+. .+++..+..++.|++.+++|||+.|++||||||+|+|+.... .+.+|++|||+|......
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999999876 499999999999999999999999999999999999996543 347999999999877776
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh--------------------
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-------------------- 232 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~-------------------- 232 (330)
......+||+.|+|||++....+... +|+||+|+++|.|++|.+||.+.+......++.
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd 271 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKD 271 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHH
Confidence 66778899999999999987777665 999999999999999999999877655554444
Q ss_pred -----------hcCChhHHhcCchhhcc
Q 020133 233 -----------HRISIPEIRNHEWFLKN 249 (330)
Q Consensus 233 -----------~~~~~~~~~~~~~~~~~ 249 (330)
.|+++.+.+.|||+...
T Consensus 272 ~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 272 FIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHhcccCcccCCCHHHHhcCccccCC
Confidence 57888999999997653
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=316.42 Aligned_cols=209 Identities=30% Similarity=0.538 Sum_probs=180.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+.|++++.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999987532 22356778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--- 173 (330)
||++|++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988889999999999999999999999999999999999999987664 9999999986332110
Q ss_pred ---------------------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 174 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
.....+||+.|+|||++.+..++.. +|+|||||++|+|++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence 0123468999999999988877655 999999999999999999998
Q ss_pred CCChhhHHHHHh
Q 020133 221 DPEEPKNFRKTI 232 (330)
Q Consensus 221 ~~~~~~~~~~~~ 232 (330)
..+.......+.
T Consensus 238 ~~~~~~~~~~i~ 249 (360)
T cd05627 238 SETPQETYRKVM 249 (360)
T ss_pred CCCHHHHHHHHH
Confidence 766555444443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=322.26 Aligned_cols=209 Identities=29% Similarity=0.445 Sum_probs=175.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--------Ce
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------TH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--------~~ 91 (330)
..+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 367999999999999999999999999999999886543 3446899999999999999999987532 24
Q ss_pred EEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 92 LAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
+++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccch
Confidence 6799999976 6766654 3467999999999999999999999999999999999999976542 59999999998
Q ss_pred cccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
............+|+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+.+++.
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 665555555667899999999987654344559999999999999999999998877666666654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=309.74 Aligned_cols=239 Identities=31% Similarity=0.518 Sum_probs=190.8
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 29 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++.+++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999999999999999987532 2234577899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCcccCCCC
Q 020133 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (330)
Q Consensus 105 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~~~~ 183 (330)
.+++..++.+++..+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||+++..... .......|++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988889999999999999999999999999999999999999987764 999999998743222 22334578999
Q ss_pred CCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCC
Q 020133 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 263 (330)
Q Consensus 184 y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+..... -+...++ ..+.+.+.++.
T Consensus 159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~li~~~L 228 (312)
T cd05585 159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL--------RFPDGFD-RDAKDLLIGLL 228 (312)
T ss_pred cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--------CCCCcCC-HHHHHHHHHHc
Confidence 999999988777655 9999999999999999999987666555444432210 0111121 12234444555
Q ss_pred CCCCCCcc--CCHHHHHH
Q 020133 264 FEEPDQPM--QSIDEIMQ 279 (330)
Q Consensus 264 ~~~p~~~~--~s~~el~~ 279 (330)
..+|.+|+ .++.|+++
T Consensus 229 ~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 229 SRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCHHHcCCCCCHHHHHc
Confidence 56777776 35666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=288.58 Aligned_cols=210 Identities=35% Similarity=0.628 Sum_probs=190.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||.|.||.||+|+.+.++-.||+|++.++. .....+.+|+++.+.|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4588999999999999999999999999999999998753 334678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 95 VMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 95 v~e~~~g~sL~~~l~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
++||.++|++...++ ....+++.....+++|++.||.|+|.++++||||||+|+|++..+. +|++|||.+.... .
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-S 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-C
Confidence 999999999999998 5667999999999999999999999999999999999999987765 9999999986444 6
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
....+.+||.-|.+||...+..++.. +|+|++|++.||++.|.+||.+.+..+.++++.
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~ 235 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR 235 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH
Confidence 67788999999999999999888777 999999999999999999999888666666665
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.27 Aligned_cols=199 Identities=36% Similarity=0.614 Sum_probs=172.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~ 102 (330)
+.||+|+||.||++.+..+++.||+|++.+.. .....+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987542 22346778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccCC
Q 020133 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (330)
Q Consensus 103 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~~ 181 (330)
+|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... ........|+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99999988888999999999999999999999999999999999999987664 99999999874322 2223345789
Q ss_pred CCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHH
Q 020133 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (330)
Q Consensus 182 ~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~ 228 (330)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.....
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~~~ 204 (328)
T cd05593 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204 (328)
T ss_pred cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHHHH
Confidence 99999999987777555 99999999999999999999876554433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=313.50 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=194.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC-
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP- 89 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~- 89 (330)
..++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3478999999999999999999853 3467899999875432 235688999999999 899999999988764
Q ss_pred CeEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 020133 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~---------------------------------------------------------- 111 (330)
+.+++||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4589999999999999988642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---CCCcccCCCCC
Q 020133 112 ----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAY 184 (330)
Q Consensus 112 ----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y 184 (330)
.++++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++...... ......+++.|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccc
Confidence 2478889999999999999999999999999999999998765 49999999987432221 12233456789
Q ss_pred CChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCC
Q 020133 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 263 (330)
Q Consensus 185 ~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
+|||++.+..++.+ +|||||||++|||++ |..||.+......+...+.....+ ......++ .+.+.+.+++
T Consensus 243 ~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~-~l~~li~~cl 314 (338)
T cd05102 243 MAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM------RAPENATP-EIYRIMLACW 314 (338)
T ss_pred cCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC------CCCCCCCH-HHHHHHHHHc
Confidence 99999988777655 999999999999997 999998755444333333221110 01111222 2334455566
Q ss_pred CCCCCCccCCHHHHHHHHHHhC
Q 020133 264 FEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 264 ~~~p~~~~~s~~el~~~l~~~~ 285 (330)
..+|.+|+ ++.|+++.|.++.
T Consensus 315 ~~dp~~RP-s~~el~~~l~~~~ 335 (338)
T cd05102 315 QGDPKERP-TFSALVEILGDLL 335 (338)
T ss_pred cCChhhCc-CHHHHHHHHHHHH
Confidence 67788875 9999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.09 Aligned_cols=202 Identities=36% Similarity=0.601 Sum_probs=174.0
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~ 102 (330)
+.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+.+++.++||||+++++++..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 22345678999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCcccCC
Q 020133 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 181 (330)
Q Consensus 103 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~~ 181 (330)
+|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... .......|+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99999988888999999999999999999999999999999999999987664 999999998743222 223345789
Q ss_pred CCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 182 ~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
+.|+|||++.+..++.+ +|+|||||++|+|++|+.||...+.......+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~ 207 (323)
T cd05595 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207 (323)
T ss_pred cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999987777555 99999999999999999999876655444443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=313.18 Aligned_cols=212 Identities=34% Similarity=0.517 Sum_probs=180.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++.+..++.+|+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3589999999999999999999999999999999986532 222456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 121 v~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 121 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCc
Confidence 9999999999998865 46899999999999999999999999999999999999987764 9999999987543222
Q ss_pred -CCCcccCCCCCCChhhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...+......++..
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 261 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 223557999999999987543 234559999999999999999999998776655555543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=295.47 Aligned_cols=228 Identities=36% Similarity=0.621 Sum_probs=198.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.+.|++.+.||+|.|++||.+.+..||+.+|+|+++.. ....+.+.+|+++.+.|+||||+++.+.+...+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 36799999999999999999999999999999988643 334578999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|++.|+.|..-+-...-+++..+-..++||+.+|.|+|.+||||||+||.|+++.. +...-+||+|||+|.....+...
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 99999999766555566899999999999999999999999999999999999943 22335999999999877766677
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh-----------------------
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----------------------- 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~----------------------- 232 (330)
....|||.|+|||++...++... +||||.|+++|-|+.|.+||.+.+....+..+.
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr 248 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR 248 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence 78899999999999988888655 999999999999999999998866544444444
Q ss_pred --------hcCChhHHhcCchhhc
Q 020133 233 --------HRISIPEIRNHEWFLK 248 (330)
Q Consensus 233 --------~~~~~~~~~~~~~~~~ 248 (330)
+|++..+.++|||+..
T Consensus 249 rML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 249 RMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHhccChhhhccHHHHhCCchhcc
Confidence 5789999999999865
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.82 Aligned_cols=199 Identities=33% Similarity=0.576 Sum_probs=171.7
Q ss_pred CeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeE
Q 020133 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~ 92 (330)
.|++++.||+|+||.||++++. .+++.||+|++.+.. ...+.+.+|+.+++.+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 478999999987532 2234577899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+||||+++++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999987764 999999998754322
Q ss_pred C--CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
. ......||+.|+|||++.+....+.++|||||||++|+|+||+.||...
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 2 2234578999999999977654455699999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=319.37 Aligned_cols=212 Identities=36% Similarity=0.588 Sum_probs=188.0
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCe
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~ 91 (330)
....+.|.+.++||.|+||+|+++..+.+++.+|||.+++.. ...+....|.+++... +||.++.++..|..+.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578999999999999999999999999999999998863 3346677888888777 59999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~- 170 (330)
+|+||||+.||++.. ++..+.+++..++.++..++.||.|||++|||+||||.+|||+|.+|. +||+|||+++...
T Consensus 444 l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCC
Confidence 999999999999543 344578999999999999999999999999999999999999998876 9999999998654
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.+...++.+|||.|+|||++.+..|+.. +|.|||||+||||+.|+.||.+.++.+....++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV 581 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 5566788999999999999999888544 999999999999999999999988877766665
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=307.07 Aligned_cols=205 Identities=38% Similarity=0.603 Sum_probs=173.5
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHH---HcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l---~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
|++++.||+|+||.||++.+..+++.||+|.+.+.. ...+.+.+|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999987542 2234566666655 466899999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~ 174 (330)
|||++|++|...+.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||+++.... ...
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999888754 57999999999999999999999999999999999999987764 99999999864322 223
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.....|++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||.+.+.......+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~~i 213 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 345678999999999987777555 99999999999999999999887665544443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=306.49 Aligned_cols=210 Identities=29% Similarity=0.509 Sum_probs=177.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||.||++.+..+++.||+|++.+.. .....+.+|+.++..++|+||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987532 22345778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-
Q 020133 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~- 174 (330)
||++|++|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999976 457999999999999999999999999999999999999987664 99999999864433222
Q ss_pred -CCcccCCCCCCChhhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 175 -PKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 175 -~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....|++.|+|||++.+ ....+.++|||||||++|+|++|+.||...+.......+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 223468999999999863 2233445999999999999999999998766554444443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=310.50 Aligned_cols=211 Identities=33% Similarity=0.515 Sum_probs=179.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||+|+||.||++.+..+++.||+|.+.+.. .....+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4578999999999999999999999999999999987532 223456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
||||++||+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCc
Confidence 9999999999998865 46899999999999999999999999999999999999987764 9999999987543222
Q ss_pred -CCCcccCCCCCCChhhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
......||+.|+|||++.+.. ..+.++|+|||||++|+|++|+.||...+......++.
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 223457899999999986543 23455999999999999999999999877655555554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=308.46 Aligned_cols=201 Identities=33% Similarity=0.512 Sum_probs=170.4
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC-----CeEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 93 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-----~~~~ 93 (330)
+|++.+.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999886432 2234678999999999999999999998643 2489
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
+||||+. ++|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999995 689999988888999999999999999999999999999999999999987764 9999999987432221
Q ss_pred C----CCcccCCCCCCChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 174 Q----PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 174 ~----~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
. .....+++.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+.+...
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccC-chhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 1 134578999999999865 3444 44999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=314.73 Aligned_cols=255 Identities=29% Similarity=0.452 Sum_probs=205.5
Q ss_pred CCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
..........|+..+.||.|+||.||++.+..+++.||+|++.... ...+.+++|+.++.+++++||.++|+.+..+.
T Consensus 5 ~~~~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~ 84 (467)
T KOG0201|consen 5 DVLKIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT 84 (467)
T ss_pred hhhcCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence 3334445578999999999999999999999999999999987653 34578999999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.++++||||.||++.+.++..+.+.+..+..++++++.||.|||..+.+|||||+.|||+..++. +||+|||++....
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLT 162 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeee
Confidence 99999999999999999998888899999999999999999999999999999999999987754 9999999987544
Q ss_pred CCC-CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 171 LHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 171 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
... ...+.+|||.|||||++....|+.+ +||||||++.+||.+|.+||........+ -.+.+-..|.+.. .|= +.
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvl-flIpk~~PP~L~~-~~S-~~ 238 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVL-FLIPKSAPPRLDG-DFS-PP 238 (467)
T ss_pred chhhccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEE-EeccCCCCCcccc-ccC-HH
Confidence 333 3478899999999999998889888 89999999999999999999876653222 2222222233222 221 11
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
-.+++..|+. ++|..|+ ++.++++
T Consensus 239 -~kEFV~~CL~----k~P~~Rp-sA~~LLK 262 (467)
T KOG0201|consen 239 -FKEFVEACLD----KNPEFRP-SAKELLK 262 (467)
T ss_pred -HHHHHHHHhh----cCcccCc-CHHHHhh
Confidence 1345555554 4555554 7777763
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.49 Aligned_cols=210 Identities=31% Similarity=0.525 Sum_probs=178.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||.||++.+..+|+.||+|.+..... ....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999876432 3356788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-
Q 020133 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~- 174 (330)
||+++++|.+++.+. +.+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999999876 68999999999999999999999999999999999999987664 99999999875433222
Q ss_pred -CCcccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 175 -PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 175 -~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....+++.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+.++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 222 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH
Confidence 233468999999999863 2222345999999999999999999998766655555444
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=306.70 Aligned_cols=204 Identities=32% Similarity=0.523 Sum_probs=173.9
Q ss_pred eceeccCCceEEEEEEEC---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++.||+|+||.||++++. .+++.||+|.+.... .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 478899999987532 223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~ 176 (330)
|+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888999999999999999999999999999999999999987664 99999999864322 22233
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
...|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~ 213 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213 (323)
T ss_pred ccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 4578999999999987766544 999999999999999999998876655444443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=304.86 Aligned_cols=208 Identities=33% Similarity=0.555 Sum_probs=177.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCC-CCeeeeeEEEEeCCeEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.|++.+.||+|+||.||+|.+..+++.||+|++.+.. ...+.+..|+.++..++| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4899999999999999999999999999999987532 223456788888888876 46889999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~~ 175 (330)
||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999987764 9999999986432 22233
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
....|++.|+|||++.+..++.+ +|+|||||++|+|+||+.||.+.+.......+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (324)
T ss_pred eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 44578999999999988777655 999999999999999999998776655444443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=308.36 Aligned_cols=200 Identities=38% Similarity=0.609 Sum_probs=172.5
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~ 102 (330)
+.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+.+++.++||||+++++++..++..|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 22345678899999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 103 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
+|..++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++. +||+|||+++.... ........|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999999888889999999999999999999997 79999999999999987764 99999999864322 222334568
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+......
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~~~ 206 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206 (325)
T ss_pred CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHHHH
Confidence 999999999987777555 999999999999999999998766544333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=304.58 Aligned_cols=203 Identities=35% Similarity=0.560 Sum_probs=173.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||+|.+..+++.||+|++.+.. .....+.+|+..+..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 2234566788888766 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|.+++...+.+++..++.++.|++.||.|||++|++||||||+|||++.++. +||+|||+++.... ........|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999999988889999999999999999999999999999999999999987764 99999999874322 222344578
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
++.|+|||++.+..++.+ +|+|||||++|+|++|+.||...+.......+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 209 (320)
T cd05590 159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209 (320)
T ss_pred CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 999999999987777655 999999999999999999998876655444443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=304.06 Aligned_cols=241 Identities=33% Similarity=0.522 Sum_probs=189.0
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHc-CCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~-l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||+|.+..+++.||+|.++... ...+....|...+.. .+||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 222344556666654 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||+++.... .......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988889999999999999999999999999999999999999987764 99999999874332 223345578
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccc
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTT 260 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (330)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+... .+.+...++. ...+.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------~~~~~~~~~~-~~~~ll~ 228 (316)
T cd05592 159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--------RPHFPRWISK-EAKDCLS 228 (316)
T ss_pred CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------CCCCCCCCCH-HHHHHHH
Confidence 999999999988777655 99999999999999999999887665544443321 1111122222 2233444
Q ss_pred cCCCCCCCCccCCHHHHHH
Q 020133 261 NNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 261 ~~~~~~p~~~~~s~~el~~ 279 (330)
++...+|.+|+...+++.+
T Consensus 229 ~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 229 KLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHccCCHHHcCCChHHHHc
Confidence 5555778888766666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=311.74 Aligned_cols=211 Identities=34% Similarity=0.536 Sum_probs=191.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe-EEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~-~~lv 95 (330)
.++|..++++|.|+||.+++++++..+..||+|.+.... ..+....+|+.++++++|||||.+.+.|..++. .|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 368999999999999999999999999999999987543 344578899999999999999999999999988 9999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
|+||+||++.+.+.+.+ .+++..+..|+.|++.|+.|||++.|+|||||++|||+..++. |+|+|||+|+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence 99999999999997643 6999999999999999999999999999999999999988875 8999999999777666
Q ss_pred -CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
...+.+||+.|++||.+.+.+|..+ +|||||||++|||++-+++|.+.+....+.++..
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~ 220 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINR 220 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhh
Confidence 6678899999999999999999877 9999999999999999999999887766666663
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=303.30 Aligned_cols=208 Identities=34% Similarity=0.565 Sum_probs=177.3
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.|++.+.||+|+||.||++.+..+++.||+|.+.+... .......|...+..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48899999999999999999999999999999876421 123455677777766 5899999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~ 175 (330)
||+++++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999987764 99999999874332 2233
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
....|++.|+|||++.+..++.+ +|+|||||++|+|+||+.||.+.+.......+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 214 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45578999999999988777655 999999999999999999998876655444443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=303.33 Aligned_cols=202 Identities=30% Similarity=0.513 Sum_probs=178.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++.+.||+|+||.||++.+..++..||+|.+.... .....+.+|+..+++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3578999999999999999999999999999999887542 23457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-ccc
Confidence 9999999999998888899999999999999999999986 6999999999999987764 99999999864432 223
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
....+++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 44578999999999988777655 9999999999999999999976554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=307.65 Aligned_cols=192 Identities=32% Similarity=0.543 Sum_probs=168.6
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.+..+++.||+|++++.. .....+.+|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997642 2234577889998888 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~ 180 (330)
++|.+++.+++.+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++... .........|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999999988889999999999999999999999999999999999999987664 9999999987432 2233345678
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
++.|+|||++.+..++.+ +|+|||||++|+|++|+.||..
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCccc
Confidence 999999999988777655 9999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=303.06 Aligned_cols=203 Identities=33% Similarity=0.542 Sum_probs=173.5
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.+..+++.||+|.+.... .....+..|..++..+ +||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987642 2224466788888765 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|...+...+.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++..... ........|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999987764 99999999874322 222344568
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
++.|+|||++.+..++.+ +|+|||||++|+|++|+.||...+.......+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~ 209 (321)
T cd05591 159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209 (321)
T ss_pred CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999987777655 999999999999999999998877655554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.35 Aligned_cols=201 Identities=28% Similarity=0.424 Sum_probs=174.4
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4899999999999999999999999999999987542 122456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999999887643 46999999999999999999999999999999999999987654 999999998754433333
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
....+++.|+|||++.+..++.. +|+||+||++|+|++|+.||.+.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~ 207 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEK 207 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchh
Confidence 45578999999999987766555 99999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=303.74 Aligned_cols=209 Identities=30% Similarity=0.518 Sum_probs=177.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||.||++++..+++.||+|.+.+.. .....+.+|+.++..++|+||+++++++..++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999987532 22234678889999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-
Q 020133 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~- 174 (330)
||++||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 467999999999999999999999999999999999999987664 99999999874433222
Q ss_pred -CCcccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 175 -PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 175 -~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....|++.|+|||++.+ ..+ +.++|+|||||++|+|++|+.||...+.......+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCC-CCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH
Confidence 223568999999999865 234 344999999999999999999998766555444443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=303.07 Aligned_cols=210 Identities=28% Similarity=0.502 Sum_probs=176.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||.||++.+..+++.||+|.+.+.. .....+.+|+.++..++|++|+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986522 22234778889999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-
Q 020133 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~- 174 (330)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 467999999999999999999999999999999999999987664 99999999864332221
Q ss_pred -CCcccCCCCCCChhhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 175 -PKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 175 -~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....||+.|+|||++.+ ....+.++|+|||||++|+|++|+.||...+.......+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 233578999999999863 2223445999999999999999999998766555555444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=299.92 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=191.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECC----------------CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeee
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR 81 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~ 81 (330)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+|+..+.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4789999999999999999998532 345799998876432 2356889999999999999999
Q ss_pred eeEEEEeCCeEEEEEeccCCCChHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccC
Q 020133 82 FKEVILTPTHLAIVMEYASGGELFERICNA-------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (330)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~d 142 (330)
+++++...+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 999999999999999999999999988643 2367888999999999999999999999999
Q ss_pred CCCCcEEecCCCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh--CCC
Q 020133 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAY 217 (330)
Q Consensus 143 ikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt--g~~ 217 (330)
|||+|||++.++. +||+|||+++....... .....++..|+|||++.+..++.+ +||||||+++|+|++ +..
T Consensus 164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCC
Confidence 9999999987654 99999999874432211 123345778999999887776555 999999999999987 667
Q ss_pred CCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 218 PFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
||...+....+.....................+|. .+.+.+.+++..+|.+|+ +++++.+.|.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~cl~~~p~~RP-s~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQ-GLYELMLQCWSRDCRERP-SFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCH-HHHHHHHHHccCCchhCc-CHHHHHHHHh
Confidence 88776544433322211000000000111111222 234455556666777765 9999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=301.93 Aligned_cols=240 Identities=31% Similarity=0.493 Sum_probs=187.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHc-CCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~-l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.+..+|+.||+|.++... ........|..++.. ++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999987642 223455667777765 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|..++..++.+++..+..++.|++.||+|||++||+||||||+||+++.++. ++|+|||+++.... ........|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999988888999999999999999999999999999999999999987764 99999999864322 222344578
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccc
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTT 260 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (330)
++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+.... +.. ..|+ +. .+.+.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~~~--~~~~----~~-~~~~li~ 228 (316)
T cd05620 159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHY--PRWI----TK-ESKDILE 228 (316)
T ss_pred CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCC--CCCC----CH-HHHHHHH
Confidence 999999999988777655 999999999999999999998766544433332111 100 1111 11 1223344
Q ss_pred cCCCCCCCCccCCHHHHH
Q 020133 261 NNQFEEPDQPMQSIDEIM 278 (330)
Q Consensus 261 ~~~~~~p~~~~~s~~el~ 278 (330)
++...+|.+|....+++.
T Consensus 229 ~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 229 KLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHccCCHHHcCCChHHHH
Confidence 455577788776666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=299.01 Aligned_cols=212 Identities=27% Similarity=0.454 Sum_probs=177.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..+++++||||+++++++..++..|+||
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 3478999999999999999999999999999999987543 23346778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CC
Q 020133 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~ 174 (330)
||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++..... ..
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccc
Confidence 99976 787777654 45899999999999999999999999999999999999987664 999999998643322 22
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.....+++.|+|||.+.+....+.++|||||||++|+|+||+.||.+.+..+....+..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 219 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 23456789999999987654445559999999999999999999988766555544443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=304.81 Aligned_cols=203 Identities=33% Similarity=0.584 Sum_probs=171.2
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHH-HHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~-~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||+||++.+..+|+.||+|++.... .....+.+|.. +++.++||||+++++.+...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 11233444444 55778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... ........|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988889999999999999999999999999999999999999987764 99999999874322 222344568
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 209 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209 (323)
T ss_pred ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 999999999988777655 999999999999999999998766555444444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.65 Aligned_cols=208 Identities=27% Similarity=0.432 Sum_probs=175.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~------ 90 (330)
.++|++.+.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999999999999999986542 23356778999999999999999999986543
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~ 174 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAC 174 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccc
Confidence 47999999976 5666654 35899999999999999999999999999999999999987764 9999999987544
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.........+++.|+|||++.+..+..+ +|||||||++|+|++|+.||.+.+....+.....
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4444455678999999999988777665 9999999999999999999998776555544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=305.48 Aligned_cols=228 Identities=36% Similarity=0.642 Sum_probs=203.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.+-|.+.+.||+|.|.+|-+|++.-||+.||||++.+.. .....+.+|++.++.++|||||++|++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 356999999999999999999999999999999997753 33467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|.-.+|+|.+++-+. ..+.+...++++.||+.|+.|+|+..+|||||||+||.+-.. .+-|||+|||++..+.++...
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcchh
Confidence 999999999998654 469999999999999999999999999999999999988544 235999999999999999999
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh-----------------------
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----------------------- 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~----------------------- 232 (330)
.+.||+..|.|||++.+..|+.+++||||||+|+|.|++|++||+..++.+.+-.++
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLV 255 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999998766654444443
Q ss_pred ----hcCChhHHhcCchhhc
Q 020133 233 ----HRISIPEIRNHEWFLK 248 (330)
Q Consensus 233 ----~~~~~~~~~~~~~~~~ 248 (330)
+|.+++++.+++|++.
T Consensus 256 RdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 256 RDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred cCchhhccHHHHhccccccC
Confidence 4677888888888754
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=308.82 Aligned_cols=194 Identities=22% Similarity=0.330 Sum_probs=170.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..++|++++.||+|+||.||+|.+..+++.||+|... ...+.+|+.++++++||||+++++++..+...|+|+|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3468999999999999999999999999999999643 23567999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC--CCCCC
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~--~~~~~ 176 (330)
+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... .....
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccc
Confidence 95 688888888788999999999999999999999999999999999999987664 99999999864322 12233
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
...||+.|+|||++.+..+..+ +|||||||++|+|++|+.||..
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCC
Confidence 4579999999999988777555 9999999999999999988754
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=300.58 Aligned_cols=208 Identities=32% Similarity=0.561 Sum_probs=176.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ...+.+..|+.++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999987532 22245667888888775 577889999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~ 175 (330)
||++|++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++..... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988889999999999999999999999999999999999999987764 999999998743222 223
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
....|++.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+.......+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 44568999999999987777555 999999999999999999998876655444444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=305.65 Aligned_cols=191 Identities=33% Similarity=0.566 Sum_probs=167.3
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.+..+++.||+|++.+.. .....+.+|+.++.++ +||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987642 2234567888888766 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~ 180 (330)
++|..++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++... .........|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999999988889999999999999999999999999999999999999987764 9999999987432 2223344578
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
++.|+|||++.+..++.+ +|+|||||++|+|++|+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCc
Confidence 999999999988777655 999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=303.82 Aligned_cols=203 Identities=34% Similarity=0.603 Sum_probs=171.1
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHH-HHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei-~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||+||++++..+++.||+|++.... .....+.+|. ..++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987532 1122334444 456778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... ........|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999987664 99999999874322 223345578
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+..+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209 (325)
T ss_pred CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999988777655 999999999999999999998776655554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=327.54 Aligned_cols=255 Identities=27% Similarity=0.372 Sum_probs=199.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||.||+|.+..+|+.||+|++..... ...++.+|+.++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999999875422 2356889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 97 EYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 97 e~~~g~sL~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++.++. ++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence 999999999988631 23566788999999999999999999999999999999987765 99999999
Q ss_pred cccccCC-------------------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 166 SKSSVLH-------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 166 a~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||...+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 8744110 01122468999999999987777555 999999999999999999998644322
Q ss_pred HHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 227 NFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.... .....|... .++ ..+|.. +.+.+.++...+|.+|+++++++.+.|...
T Consensus 239 i~~~--~~i~~P~~~-~p~--~~iP~~-L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISYR--DVILSPIEV-APY--REIPPF-LSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhh--hhccChhhc-ccc--ccCCHH-HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2111 111111110 111 122222 334455667789999999999999988765
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=295.77 Aligned_cols=210 Identities=30% Similarity=0.458 Sum_probs=174.2
Q ss_pred CCeEEeceeccCCceEEEEEEECC-CCcEEEEEEeecCC---cccHHHHHHHHHHHcC---CCCCeeeeeEEEEe-----
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT----- 88 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l---~h~~Iv~~~~~~~~----- 88 (330)
++|++++.||+|+||.||+|.+.. +++.||+|.+.... .....+.+|+..++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 46889999886542 2234566777777665 69999999999863
Q ss_pred CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
...+++||||++ ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 356899999996 5898888653 35899999999999999999999999999999999999987764 999999998
Q ss_pred ccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
+............+++.|+|||++.+..++.+ +|||||||++|+|++|++||.+.+....+..++..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~ 224 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 224 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH
Confidence 75544444455678999999999987777655 99999999999999999999988777766666643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=300.00 Aligned_cols=241 Identities=32% Similarity=0.516 Sum_probs=186.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHc-CCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~-l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.+..+++.||+|.++... ........|...+.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987642 223445667777765 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|.+.+.....+++.++..++.|++.||.|||+.|++||||||+||+++.++. +||+|||+++.... ........|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999988788999999999999999999999999999999999999987764 99999999864322 222344578
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccc
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTT 260 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (330)
++.|+|||++.+..++.+ +|+|||||++|+|++|+.||...+.......+.... + ...+|+ + ....+.+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~--~~~~~~----~-~~~~~li~ 228 (316)
T cd05619 159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--P--CYPRWL----T-REAKDILV 228 (316)
T ss_pred CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C--CCCccC----C-HHHHHHHH
Confidence 999999999988777655 999999999999999999998766544333322110 0 001111 1 11223334
Q ss_pred cCCCCCCCCccCCHHHHHH
Q 020133 261 NNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 261 ~~~~~~p~~~~~s~~el~~ 279 (330)
++...+|.+|+...+++.+
T Consensus 229 ~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 229 KLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHhccCHhhcCCChHHHHc
Confidence 4445677777755556653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=302.55 Aligned_cols=203 Identities=34% Similarity=0.588 Sum_probs=170.9
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHH-HHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei-~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||+|++..+++.||+|.+.+.. .....+.+|. .+++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 1223344454 457889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~ 180 (330)
++|...+.....+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||+++... .........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999987764 9999999987432 2223344578
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209 (321)
T ss_pred CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence 999999999987777655 999999999999999999998876554444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=294.84 Aligned_cols=193 Identities=33% Similarity=0.456 Sum_probs=165.9
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 29 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
||+|+||+||++.+..+++.||+|.+..... ..+.+..|+.+++.++||||+++.+++..++..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999999999999999875422 124567899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCccc
Q 020133 105 FERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (330)
Q Consensus 105 ~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~ 179 (330)
...+.. +..+++..++.++.||+.||.|||++||+||||||+||+++.++. ++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 887742 356999999999999999999999999999999999999987654 9999999986443322 223456
Q ss_pred CCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 180 ~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
+++.|+|||++.+..++.+ +|+|||||++|+|++|+.||.....
T Consensus 159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 8999999999988777655 9999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=301.34 Aligned_cols=209 Identities=28% Similarity=0.436 Sum_probs=178.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------C
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~ 90 (330)
.++|++.+.||+|+||.||.+.+..+++.||||.+.... .....+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999999999999999987532 2335678899999999999999999987643 3
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~ 177 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 177 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccC
Confidence 57999999975 67776653 5889999999999999999999999999999999999987764 9999999997554
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
.........+++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+++..
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 4444455678999999999988777655 99999999999999999999988776666666543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=299.25 Aligned_cols=201 Identities=37% Similarity=0.609 Sum_probs=172.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||+||++.+..+++.||+|.+.+.. .....+.+|+.++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987642 2234566788888877 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|...+...+.+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++.... .......++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999988889999999999999999999999999999999999999987764 99999999864322 222334568
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
++.|+|||++.+..++.+ +|+|||||++|+|++|+.||...+.......
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~~~ 207 (318)
T cd05570 159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQS 207 (318)
T ss_pred CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 999999999988777655 9999999999999999999987665444333
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=292.09 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=196.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
+.++|++.+.||+|+||.||++... ..+..||+|.++.... ....+.+|+..+++++||||+++++++..++..|
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4578999999999999999999865 3467899998876532 2346789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++ .++++|||.+......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCccccccccc
Confidence 999999999999998764 5799999999999999999999999999999999999998765 4999999987543222
Q ss_pred CCC--CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 173 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
... ....++..|+|||.+.+..++.+ +|||||||++|++++ |+.||...+.......+......+. ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~ 232 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-------PRN 232 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC-------CCC
Confidence 111 12234578999999987777655 999999999999775 9999987766554444332221111 111
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+|. .+.+...+++..+|.+|+ +++++.+.|.+.
T Consensus 233 ~~~-~~~~li~~c~~~~p~~RP-~~~~i~~~l~~~ 265 (266)
T cd05064 233 CPN-LLHQLMLDCWQKERGERP-RFSQIHSILSKM 265 (266)
T ss_pred CCH-HHHHHHHHHcCCCchhCC-CHHHHHHHHHhh
Confidence 222 233334445556777765 999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=302.17 Aligned_cols=203 Identities=33% Similarity=0.559 Sum_probs=171.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHH-HHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~-~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.+..+|+.||+|++.... .....+.+|.. +++.++||||+++++.+...+..|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999987542 12233445544 46778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++. +||+|||+++.... ........|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999999988889999999999999999999999999999999999999987764 99999999874322 223344578
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~ 209 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209 (325)
T ss_pred ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence 999999999988777655 999999999999999999998766555544444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=299.66 Aligned_cols=200 Identities=32% Similarity=0.523 Sum_probs=176.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... .....+.+|+.++++++||||+++++++..++..|+|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999999999999999887642 223568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
|+++++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++. +||+|||++..... ....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~ 160 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMAN 160 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hccc
Confidence 999999999998888899999999999999999999975 7999999999999987664 99999999864322 2223
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
...++..|+|||++.+..++.+ +|+|||||++|+|++|+.||....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcc
Confidence 4568899999999987766555 999999999999999999997644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=300.44 Aligned_cols=199 Identities=27% Similarity=0.388 Sum_probs=173.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc-cHHHHHHHHHHHcCCCCCeeeeeEEEEeCC-eEEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME 97 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-~~~lv~e 97 (330)
.+.|.-...||+|+||.||++.-.. |..||||.+...... ..+|.+|+.++.+++|||+|+++|||.+.+ ..+||+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 4567777899999999999998865 488999988776554 566999999999999999999999999988 5999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcC---ccccCCCCCcEEecCCCCCceEEeecCCcccccC-
Q 020133 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~- 171 (330)
|+++|+|.+.+.... +++|....+|+.++|+||+|||+.. |+||||||+|||+|.+.+ .||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEG 230 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCcc
Confidence 999999999998655 8999999999999999999999843 999999999999998876 99999999975554
Q ss_pred CCCCCcc-cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 172 HSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 172 ~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
....... .||.+|+|||.+..+..+.+ +||||||+++.|++||+.|.+..
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCC
Confidence 3333333 89999999999987666555 99999999999999999888753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.22 Aligned_cols=208 Identities=29% Similarity=0.450 Sum_probs=173.3
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcC---CCCCeeeeeEEEEeC-----C
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILTP-----T 90 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l---~h~~Iv~~~~~~~~~-----~ 90 (330)
+|++++.||+|+||+||+|.+..+++.||+|.+.... .......+|+..++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5999999999999999999999999999999887532 2234566777777665 699999999998642 4
Q ss_pred eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
..++||||+++ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||+++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 58999999975 888888653 34899999999999999999999999999999999999987764 99999999875
Q ss_pred ccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
...........++..|+|||++.+..++.+ +|||||||++|+|++|++||..........++..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 544444445568899999999987776555 9999999999999999999988776666555554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.61 Aligned_cols=243 Identities=18% Similarity=0.166 Sum_probs=192.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEe----CCeEEEEEec
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEY 98 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~ei~~l~~l~h~~Iv~~~~~~~~----~~~~~lv~e~ 98 (330)
..+|+|++|.||++.. +|+.||+|.+....... +.+.+|+..+++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999987 58899999987654333 456799999999999999999999877 3468999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
+++|+|.+++.+.+.+++.....++.|++.||.+||+ .+++||||||+||+++.++. +||+|||+++.... ....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~--~~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSS--PPFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhcc--cccc
Confidence 9999999999988889999999999999999999998 59999999999999987764 99999999874322 2234
Q ss_pred ccCCCCCCChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 178 TVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~--~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
..++..|+|||.+.+ ..++. ++|||||||++|||++|+.||...+.......+......+.. .... +..+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~-k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~------~~~~-~~~l 251 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTI-KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL------PLDC-PLEI 251 (283)
T ss_pred ccCcccccCHHHhhhccccccc-hhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC------CCcC-cHHH
Confidence 567899999999875 45544 499999999999999999999977655444444322111110 1111 2234
Q ss_pred ccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+.+.+++..+|..|+ +++|+++.|...
T Consensus 252 ~~li~~cl~~dp~~Rp-s~~ell~~l~~~ 279 (283)
T PHA02988 252 KCIVEACTSHDSIKRP-NIKEILYNLSLY 279 (283)
T ss_pred HHHHHHHhcCCcccCc-CHHHHHHHHHHH
Confidence 4555666677888875 999999988754
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.10 Aligned_cols=263 Identities=30% Similarity=0.452 Sum_probs=199.2
Q ss_pred cccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--C
Q 020133 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--T 90 (330)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~ 90 (330)
.....++|++++.||.|+||+||+|.+..++..||+|.+.... .....+.+|+.++++++||||++++++|... .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3344578999999999999999999999999999999887542 2335688999999999999999999998653 5
Q ss_pred eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhc-------CccccCCCCCcEEecCC------
Q 020133 91 HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QVCHRDLKLENTLLDGS------ 153 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-------~ivH~dikp~NIli~~~------ 153 (330)
.+|+||||+++++|.+++.. .+.+++..++.|+.||+.||.|||+. +|+||||||+|||++.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 68999999999999998865 35799999999999999999999985 49999999999999642
Q ss_pred ---------CCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 154 ---------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 154 ---------~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
+...+||+|||++.............+++.|+|||++.+.. ..+.++|||||||++|+|+||+.||...+
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23358999999997554444445567899999999986432 22344999999999999999999998766
Q ss_pred hhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHH--HHHHHhCCC
Q 020133 224 EPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIM--QIIAEATIP 287 (330)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~--~~l~~~~~~ 287 (330)
....+...+.+...... ... ...+.+.+..++..+|.+|+ ++.+++ ..+.....+
T Consensus 248 ~~~qli~~lk~~p~lpi-------~~~-S~eL~dLI~~~L~~dPeeRP-Sa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 248 NFSQLISELKRGPDLPI-------KGK-SKELNILIKNLLNLSAKERP-SALQCLGYQIIKNVGPP 304 (1021)
T ss_pred cHHHHHHHHhcCCCCCc-------CCC-CHHHHHHHHHHhcCChhHCc-CHHHHhccHHHhhcCCC
Confidence 55555444433211100 011 11233344445556777766 677776 455544433
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=302.33 Aligned_cols=203 Identities=31% Similarity=0.551 Sum_probs=173.6
Q ss_pred eceeccCCceEEEEEEEC---CCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
++.||+|+||.||++++. .+|+.||+|++.... .....+.+|+.++++++||||+++++++..++..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999874 578999999987542 22345678999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~~ 178 (330)
++++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++..... ......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence 99999999988888999999999999999999999999999999999999987764 999999998754332 223345
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.|++.|+|||.+.+..+..+ +|||||||++|+|++|+.||...+.......+
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred cCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 78999999999987766544 99999999999999999999876655444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=291.74 Aligned_cols=213 Identities=29% Similarity=0.477 Sum_probs=184.5
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
+..++|++++.||.|.-|+||+|+...++..+|+|++.+.. +...+.+.|-.+|+.++||.++.+|..|+.+...|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 34577999999999999999999999999999999998753 22346677889999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
+|||||+||+|..+++++ +.+++..++.++.+++.||+|||-.|||.|||||+|||+.++|. +.|+||.++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPV 231 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCC
Confidence 999999999999998875 46999999999999999999999999999999999999998886 99999987531100
Q ss_pred ---------------------------------C------------------------CCCCcccCCCCCCChhhhhcCC
Q 020133 172 ---------------------------------H------------------------SQPKSTVGTPAYIAPEVLLKKE 194 (330)
Q Consensus 172 ---------------------------------~------------------------~~~~~~~~~~~y~aPE~~~~~~ 194 (330)
. ....+.+||-.|.|||++.|.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0112335788999999999988
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 195 ~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.... +|.|+||+.+|||+.|.-||.+.++...+.+++.
T Consensus 312 HgsA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~ 349 (459)
T KOG0610|consen 312 HGSA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG 349 (459)
T ss_pred CCch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc
Confidence 8554 9999999999999999999999988888888773
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.86 Aligned_cols=206 Identities=26% Similarity=0.446 Sum_probs=171.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC------CCeeeeeEEEEeC-CeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-THL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h------~~Iv~~~~~~~~~-~~~ 92 (330)
.++|++.+.||+|+||+||+|.+..+++.||||+++...........|+.+++.++| .+++++++++..+ +++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 478999999999999999999999999999999997654444556677777776654 4589999998765 578
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCC--------------Cc
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA--------------PR 157 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~--------------~~ 157 (330)
|+||+++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++. ..
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 9999988 67899988888899999999999999999999997 69999999999999976542 14
Q ss_pred eEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 158 vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
+||+|||.+... .......+||+.|+|||++.+..+... +|||||||++|||++|+.||.+.+....+.
T Consensus 287 vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 287 VRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred EEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 999999987532 222345678999999999988877655 999999999999999999998766544433
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=305.91 Aligned_cols=208 Identities=27% Similarity=0.408 Sum_probs=176.2
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC-----eEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-----~~~ 93 (330)
.|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 3788999999999999999999999999999886532 22356789999999999999999999998776 789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++|++||||||+|||++.++. +||+|||+++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 9999996 588888887788999999999999999999999999999999999999987764 9999999987433221
Q ss_pred --CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 22334678899999999876544555999999999999999999999877665555544
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=305.29 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=193.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC-----CcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~ 91 (330)
.++|++++.||+|+||.||++.+..+ +..||+|.+..... ....+.+|+.+++.+ +||||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 46799999999999999999986543 45799999875432 235678999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc------------------------------------------------------------
Q 020133 92 LAIVMEYASGGELFERICNA------------------------------------------------------------ 111 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~------------------------------------------------------------ 111 (330)
.|+||||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999988542
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC---CCcc
Q 020133 112 ----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178 (330)
Q Consensus 112 ----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~---~~~~ 178 (330)
.++++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCC
Confidence 2478889999999999999999999999999999999998765 499999999874432221 1122
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
.++..|+|||++.+..++.+ +|||||||++|+|++ |+.||..................+. .....+. .+.+
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~-~l~~ 346 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS------RPDFAPP-EIYS 346 (374)
T ss_pred CCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc------CCCCCCH-HHHH
Confidence 34567999999987776555 999999999999997 9999987554433333332110000 0011122 2334
Q ss_pred ccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+.+++..+|.+|+ ++.++.+.|.++
T Consensus 347 li~~cl~~dp~~RP-s~~~l~~~l~~~ 372 (374)
T cd05106 347 IMKMCWNLEPTERP-TFSQISQLIQRQ 372 (374)
T ss_pred HHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 44555667777764 999999998875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=304.77 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=195.5
Q ss_pred CCCeEEeceeccCCceEEEEEEE-----CCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~ 91 (330)
.++|++.+.||+|+||.||+|.. ..++..||+|+++.... ..+.+.+|+.++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35899999999999999999974 34577899999875432 235678999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-----------------------------------------------------------
Q 020133 92 LAIVMEYASGGELFERICNAG----------------------------------------------------------- 112 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~----------------------------------------------------------- 112 (330)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886421
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--
Q 020133 113 ----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (330)
Q Consensus 113 ----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-- 174 (330)
.+++..+..++.||+.||.|||++|++||||||+|||++.+. .+||+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCccccc
Confidence 478889999999999999999999999999999999998765 499999999874432221
Q ss_pred -CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc
Q 020133 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 175 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (330)
.....++..|+|||++.+..++.+ +|||||||++|+|++ |..||..........+.+.....+. ... ..+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~-~~~ 343 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML------SPE-CAP 343 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC------CCC-CCC
Confidence 112234567999999987777555 999999999999998 8999987655444444443211100 001 112
Q ss_pred cccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
..+.+.+.++...+|.+|+ ++.|+++.|.+
T Consensus 344 ~~l~~li~~cl~~dP~~RP-s~~eil~~l~~ 373 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRP-TFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHHHHHccCChhHCc-CHHHHHHHHHh
Confidence 2334455556667787775 99999998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=311.67 Aligned_cols=209 Identities=31% Similarity=0.463 Sum_probs=177.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCC-CcEEEEEEeecCCcc-cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~-~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..|.+.+.||.|++|.||+|.+..+ ++.||+|.+...... ...+.+|+..++.++||||+++++++..++.+|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4599999999999999999999887 788999977554322 34577899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 99 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 99 ~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
++|++|.+.+.. ..++++.++..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCccc
Confidence 999999887753 457999999999999999999999999999999999999987664 9999999997543322
Q ss_pred --CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....+||+.|+|||++.+..+..+ +|||||||++|+|++|+.||...+.........
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~ 284 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2344568999999999987777555 999999999999999999998766554444443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=287.22 Aligned_cols=197 Identities=41% Similarity=0.656 Sum_probs=174.0
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHH---HHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
|++++.||+|+||+||++.+..+++.||+|.+......... ..+|+..+++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999877544332 345999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc-cCCCCCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~-~~~~~~~~~ 178 (330)
.+++|.+++...+.+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999997889999999999999999999999999999999999999986654 999999998643 223334456
Q ss_pred cCCCCCCChhhhh-cCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 179 VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 179 ~~~~~y~aPE~~~-~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
.++..|+|||++. +... +.++|+||||+++|+|++|..||...
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccc
Confidence 7889999999987 4444 45599999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=302.68 Aligned_cols=200 Identities=35% Similarity=0.559 Sum_probs=167.0
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcC---CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 29 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l---~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
||+|+||+||++++..+++.||+|++.+... .......|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999865321 112334555565554 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~ 180 (330)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||+++.... .......+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988889999999999999999999999999999999999999987764 99999999874322 223345678
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~ 208 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN 208 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH
Confidence 99999999997655445559999999999999999999987665444433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=298.44 Aligned_cols=208 Identities=27% Similarity=0.412 Sum_probs=175.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------C
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~ 90 (330)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 479999999999999999999999999999999987542 2235677899999999999999999998654 3
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~ 170 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 170 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCC
Confidence 57999999976 66666643 5899999999999999999999999999999999999987764 9999999997554
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.........+++.|+|||++.+..+..+ +|+|||||++|+|++|+.||.+.+....+...+.
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred CccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4444455678999999999988777655 9999999999999999999988766555544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=296.57 Aligned_cols=192 Identities=31% Similarity=0.549 Sum_probs=168.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.+..+++.||+|++.+.. .....+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997642 2234577888888887 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCCCCcccC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~ 180 (330)
++|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+++... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999999988889999999999999999999999999999999999999987765 9999999987432 2223345678
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
++.|+|||++.+..++.+ +|+|||||++|+|++|+.||..
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCc
Confidence 999999999988777555 9999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=285.29 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=196.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.+.|++.+.||+|+||.||++.... +..+|+|.+.........+.+|+..+++++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4679999999999999999998754 567999988766555678889999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC--C
Q 020133 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--K 176 (330)
Q Consensus 100 ~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~--~ 176 (330)
++++|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.++........ .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC--eEEECCCCCccccCCCceeccC
Confidence 99999999875 35689999999999999999999999999999999999998765 4999999988744322211 1
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
...++..|+|||.+.+..+..+ +|+||||+++|+|++ |+.||...+.......+...... .. .......+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-------~~-~~~~~~~~ 230 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-------YR-PKLASMTV 230 (256)
T ss_pred CCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-------CC-CCCCCHHH
Confidence 2234568999999877766554 999999999999999 99999877665555544332111 00 11112233
Q ss_pred ccccccCCCCCCCCccCCHHHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
.+.+.++...+|..|+ +++|+++.|
T Consensus 231 ~~li~~c~~~~p~~Rp-s~~~l~~~l 255 (256)
T cd05114 231 YEVMYSCWHEKPEGRP-TFAELLRAI 255 (256)
T ss_pred HHHHHHHccCCcccCc-CHHHHHHhh
Confidence 4555566667777765 999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=283.13 Aligned_cols=226 Identities=33% Similarity=0.535 Sum_probs=193.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---------cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
+.|.-.+.||.|..++|..+.++.+|..+|+|++.... ...++-.+|+.+|+++ .||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 56888999999999999999999999999999986421 1224556899999988 6999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.+++|+|.|+.|.|.+++...-.+++...+++++|++.|+.|||.++||||||||+|||++++-+ +||+|||+|....
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence 99999999999999999998889999999999999999999999999999999999999988765 9999999999888
Q ss_pred CCCCCCcccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh-------------
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI------------- 232 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~------------- 232 (330)
.+......||||+|+|||.+.- .+-+++.+|+||+|++||.|+.|.+||......-.++.+.
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad 254 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD 254 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence 8888888999999999998742 2333556999999999999999999985432222222111
Q ss_pred ------------------hcCChhHHhcCchhhc
Q 020133 233 ------------------HRISIPEIRNHEWFLK 248 (330)
Q Consensus 233 ------------------~~~~~~~~~~~~~~~~ 248 (330)
.|++..+.+.||||.+
T Consensus 255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred ccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 5788889999999854
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=289.67 Aligned_cols=203 Identities=28% Similarity=0.427 Sum_probs=175.3
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.|+..+.||+|+||+||++.+..+++.||+|.+.... .....+.+|+.+++.++|+||+++.+.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4888999999999999999999999999999986542 122456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|+++++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCCcc
Confidence 99999998887643 3699999999999999999999999999999999999998765 4999999998654433333
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhH
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~ 227 (330)
....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||........
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~ 209 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVK 209 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 45578999999999987776555 9999999999999999999987655433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=286.15 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=200.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
....|.+.+.||+|++|.||++.+..+++.||+|.+..+......+.+|+..+++++||||+++++++...+.+++||||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 34679999999999999999999999999999999876655556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC-
Q 020133 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~- 175 (330)
+++++|.+++... ..+++..++.++.|++.||.+||+.|++||||||+||++++++. +||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeec
Confidence 9999999998753 35899999999999999999999999999999999999987654 999999998754332211
Q ss_pred -CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 176 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+..|+|||.+.+..++.. +|+|||||++|+|++ |..||.+.+..............+ +....|.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 232 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME-------RPEGCPP- 232 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-------CCCCCCH-
Confidence 11223567999999887777655 999999999999998 999998766544444433222111 1112222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+.+.+.++...+|..|+ ++.++.+.|..+
T Consensus 233 ~~~~li~~cl~~~p~~Rp-~~~~l~~~l~~~ 262 (263)
T cd05052 233 KVYELMRACWQWNPSDRP-SFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHccCCcccCC-CHHHHHHHHHhh
Confidence 233344555556777764 999999988764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=285.45 Aligned_cols=248 Identities=29% Similarity=0.423 Sum_probs=193.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
+.|++.+.||+|++|.||.+.+..+++.||+|.+..... ....+.+|+..+++++||||+++++++..+...|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 569999999999999999999999999999998865421 12457889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
|+||+++++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~--~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceecccccc
Confidence 999999999999998888899999999999999999999999999999999999998765 499999999864332211
Q ss_pred C----CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccC
Q 020133 175 P----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 175 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
. ....++..|+|||.+.+...+.+ +|+||||+++|+|++|+.||...+..............+. +....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~ 232 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ------LPSHV 232 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC------CCccC
Confidence 1 23457789999999987765544 9999999999999999999987655444433332211111 11111
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHH
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+ ..+.+.+.++...+|..|+ ++.++++
T Consensus 233 ~-~~~~~li~~~l~~~p~~Rp-t~~~ll~ 259 (263)
T cd06625 233 S-PDARNFLRRTFVENAKKRP-SAEELLR 259 (263)
T ss_pred C-HHHHHHHHHHhhcCcccCC-CHHHHhh
Confidence 1 1222334444445666654 7777754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=288.25 Aligned_cols=206 Identities=37% Similarity=0.652 Sum_probs=179.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+..+++++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999987542 23456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. +||+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988889999999999999999999999999999999999999987764 999999998754333 33
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
...+++.|+|||.+.+...+. ++|+||||+++|+|++|+.||...+.......+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 210 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGK-AVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210 (290)
T ss_pred CCCCCccccChhhhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 456889999999987766544 499999999999999999999876644333333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=287.10 Aligned_cols=199 Identities=28% Similarity=0.427 Sum_probs=173.1
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.|++.+.||+|+||.||++.+..+++.||+|.+...... ...+.+|+.++++++|++|+++++.+...+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 478899999999999999999999999999988754221 2346789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|++|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 99999999888643 35899999999999999999999999999999999999987654 999999998754433333
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
....++..|+|||++.+..++.+ +|+||||+++|+|++|+.||....
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCC
Confidence 44578999999999987776655 999999999999999999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=297.35 Aligned_cols=197 Identities=31% Similarity=0.509 Sum_probs=167.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
....|++++.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++|+||+++++++...+.+|+||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 3467999999999999999999999999999999986543 22456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~ 175 (330)
||+.+++|... ...++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ..
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPC 225 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccccc
Confidence 99999998643 34678888999999999999999999999999999999987764 9999999987543222 22
Q ss_pred CcccCCCCCCChhhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 176 KSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~----~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
....|+..|+|||++... .+...++|||||||++|+|++|+.||..
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 345789999999987432 3334469999999999999999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=287.99 Aligned_cols=192 Identities=28% Similarity=0.442 Sum_probs=165.5
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 29 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
||+|+||.||++.+..+|+.||+|.+..... ....+..|+.++++++||||+++++++..+...|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999999999999999865321 223456799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCC
Q 020133 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (330)
Q Consensus 105 ~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 182 (330)
.+.+...+ .+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.............+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 88876543 5899999999999999999999999999999999999987664 9999999987554433334456889
Q ss_pred CCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 183 ~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.|+|||++.+..++.+ +|+|||||++|+|++|+.||....
T Consensus 159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999987776555 999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=309.62 Aligned_cols=210 Identities=31% Similarity=0.467 Sum_probs=176.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~------ 90 (330)
.++|++.+.||+|+||+||++.+..+|+.||+|.+..... ....+.+|+..+..++|+||+++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 4799999999999999999999999999999999876432 2345778999999999999999988775432
Q ss_pred --eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecC
Q 020133 91 --HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (330)
Q Consensus 91 --~~~lv~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg 164 (330)
.+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecc
Confidence 36899999999999998864 246999999999999999999999999999999999999987664 9999999
Q ss_pred CcccccCC---CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 165 YSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 165 ~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 98744322 22345578999999999988777655 999999999999999999998766544444433
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=290.33 Aligned_cols=211 Identities=27% Similarity=0.465 Sum_probs=178.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..++.++||||+++++++...+..|+||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4578999999999999999999999999999999987543 23346788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-C
Q 020133 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~ 174 (330)
||+++ +|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++....... .
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 99974 88888765 356899999999999999999999999999999999999987764 9999999986433222 2
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....+++.|+|||++.+....+.++||||||+++|+|+||++||...+....+..+.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2334578899999998766544556999999999999999999998877655554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=284.53 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=198.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..++|+++++||+|++|.||++.+. ++..||+|.+.......+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4578999999999999999999975 466799998876655567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--
Q 020133 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (330)
Q Consensus 99 ~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-- 174 (330)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+++||||||+||+++.++ .++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC--cEEECCCccceecCCCceec
Confidence 999999999865 34689999999999999999999999999999999999998766 499999999875432221
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....++..|+|||.+.+..++.+ +|+|||||++|+|+| |+.||...........+......+.. ...+.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~- 231 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM-------ENCPD- 231 (261)
T ss_pred cCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC-------CCCCH-
Confidence 122234668999999877766555 999999999999998 99999876655444443322211111 11222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
.+.+...++...+|.+|+ +++++.+.|..
T Consensus 232 ~~~~li~~~l~~~p~~Rp-~~~~i~~~l~~ 260 (261)
T cd05072 232 ELYDIMKTCWKEKAEERP-TFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHHHccCCcccCc-CHHHHHHHHhc
Confidence 233445555666777764 99999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=288.65 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=197.3
Q ss_pred CCeEEeceeccCCceEEEEEEECCCC-----cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTE-----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
++|++.+.||+|+||.||++.....+ ..||+|.+..... ....+.+|+..+++++||||+++++++...+..|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 57999999999999999999986655 6799998865432 2356889999999999999999999999989999
Q ss_pred EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCc
Q 020133 94 IVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~ 157 (330)
++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||++++++.
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~-- 162 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT-- 162 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--
Confidence 999999999999999764 45888999999999999999999999999999999999987654
Q ss_pred eEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhh
Q 020133 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 158 vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 233 (330)
++|+|||+++...... ......+++.|+|||.+.+..++.+ +|+|||||++|||++ |..||.+.........+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987432221 1233456788999999887776555 999999999999998 9999987665444333332
Q ss_pred cCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 234 RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+...+ ....+| ..+.+....++..+|.+|+ ++.|+.+.|++
T Consensus 242 ~~~~~-------~~~~~~-~~~~~l~~~c~~~~p~~Rp-~~~~i~~~l~~ 282 (283)
T cd05048 242 RQLLP-------CPEDCP-ARVYALMIECWNEIPARRP-RFKDIHTRLRS 282 (283)
T ss_pred CCcCC-------CcccCC-HHHHHHHHHHccCChhhCc-CHHHHHHHHhc
Confidence 21111 111222 2234455556667777765 99999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=290.93 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=193.6
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcE--EEEEEeecCC--cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~--~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~ 93 (330)
..+.|++.+.||+|+||.||+|.+..++.. +++|.+.... .....+.+|+..+.++ +||||+++++++...+.+|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 457899999999999999999999877754 5777665422 2234678899999999 8999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCc
Q 020133 94 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~ 157 (330)
+||||+++++|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-- 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--
Confidence 9999999999999987543 4789999999999999999999999999999999999987664
Q ss_pred eEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCC
Q 020133 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIS 236 (330)
Q Consensus 158 vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 236 (330)
+||+|||++..............+..|+|||.+.+..++.+ +|||||||++|+|+| |..||...+.............
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence 99999999863322222222234567999999877666544 999999999999998 9999987655443333322111
Q ss_pred hhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 237 IPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+ .....+. .+.+.+.++...+|.+| ++++++++.+...
T Consensus 242 ~~-------~~~~~~~-~~~~li~~~l~~~p~~R-p~~~~il~~l~~~ 280 (303)
T cd05088 242 LE-------KPLNCDD-EVYDLMRQCWREKPYER-PSFAQILVSLNRM 280 (303)
T ss_pred CC-------CCCCCCH-HHHHHHHHHcCCChhhC-cCHHHHHHHHHHH
Confidence 10 0111222 23345556666778777 4899998887754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.65 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=197.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999876432 22345788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 97 e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999988753 345899999999999999999999999999999999999987664 999999988744322
Q ss_pred CC-CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh-hhHHHHHhhcCChhHHhcCchhhccC
Q 020133 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 173 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
.. .....+++.|+|||.+.+...+.+ +|+||||+++|+|++|+.||..... ...+...+.....+... ....
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 233 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP-----TEHY 233 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCC-----hhhc
Confidence 21 223467889999999987776555 9999999999999999999965432 22233333222211111 0111
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+.+.+.+++..+|.+|+ ++.|+++.++..
T Consensus 234 -~~~~~~li~~cl~~~p~~Rp-~~~~vl~~~~~~ 265 (267)
T cd08228 234 -SEKLRELVSMCIYPDPDQRP-DIGYVHQIAKQM 265 (267)
T ss_pred -CHHHHHHHHHHCCCCcccCc-CHHHHHHHHHHh
Confidence 12233445555666777665 999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=294.35 Aligned_cols=207 Identities=26% Similarity=0.445 Sum_probs=173.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------C
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~ 90 (330)
.++|++.+.||.|+||+||++.+..+++.||+|.+..... ....+.+|+..+++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 5789999999999999999999999999999999875422 234577899999999999999999988643 3
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
..|++++++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~ 169 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQAD 169 (343)
T ss_pred cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecC
Confidence 479999988 778987775 357999999999999999999999999999999999999987764 9999999987443
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
. ......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 170 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07878 170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229 (343)
T ss_pred C--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 2 23445789999999999775444555999999999999999999998766554444443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=283.68 Aligned_cols=206 Identities=30% Similarity=0.486 Sum_probs=177.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999999999999999999886542 233567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
|+++++|..+......+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCccccc
Confidence 999999988877777899999999999999999999999999999999999998766 49999999987544332 223
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHH
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~ 228 (330)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+.....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~ 210 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 4457889999999876544445599999999999999999999876654443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=282.28 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=196.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.++||+|++|.||++.+..++ .||+|.+.......+.+.+|+..+++++||||+++++++. ....|+||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 468999999999999999999987654 5999998876555677899999999999999999999875 45679999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--C
Q 020133 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (330)
Q Consensus 100 ~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--~ 175 (330)
++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||||+||++++++. ++|+|||.++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccccccc
Confidence 999999999753 35899999999999999999999999999999999999987664 99999999864432221 1
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....++..|+|||+..+..++.+ +|+||||+++|+|+| |..||.+.........+......+. ...++.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 231 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------PPECPES- 231 (262)
T ss_pred cCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC-------ccccCHH-
Confidence 22345678999999877776555 999999999999999 8999987665544444332221111 1122222
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+.+.+.++...+|.+|+ ++.++.+.|...
T Consensus 232 l~~li~~~l~~~p~~Rp-~~~~~~~~l~~~ 260 (262)
T cd05071 232 LHDLMCQCWRKEPEERP-TFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHHHccCCcccCC-CHHHHHHHHHHh
Confidence 23455556667777775 999999888763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=282.25 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=197.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..++|++.+.||+|++|.||++.+.. ++.||+|.++........+.+|+..+++++||||+++++++...+..|+||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 45789999999999999999999754 56799999877655566788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC-
Q 020133 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~- 175 (330)
+++++|.+++.... .+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccc
Confidence 99999999997644 6899999999999999999999999999999999999987764 999999998754322111
Q ss_pred -CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 176 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+..|+|||.+.+..++.+ +|+||||+++|+|++ |+.||.+.+.......+......+. ....+.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~- 231 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-------PPGCPK- 231 (261)
T ss_pred cCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------CCcCCH-
Confidence 11122357999999877766555 999999999999999 9999987665544444433222110 011111
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
.+.+...++...+|.+|+ +++++.+.|.+
T Consensus 232 ~~~~li~~~l~~~P~~Rp-~~~~l~~~l~~ 260 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRP-TFETLQWKLED 260 (261)
T ss_pred HHHHHHHHHhhcCcccCC-CHHHHHHHHhc
Confidence 223334445556676665 99999988865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=308.41 Aligned_cols=217 Identities=32% Similarity=0.429 Sum_probs=183.5
Q ss_pred cccCCCCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeee
Q 020133 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFK 83 (330)
Q Consensus 6 ~~~~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~ 83 (330)
|+..|++.... ..-|...+.||+|+||.||+++++.+|+.||||.+++.. ...++.-+|+.++++++|||||++.
T Consensus 1 ms~~~~l~~~~---~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f 77 (732)
T KOG4250|consen 1 MSYPPVLTSGE---NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLF 77 (732)
T ss_pred CCCCcccccCC---CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhc
Confidence 34444444433 256788999999999999999999999999999987743 4457888999999999999999999
Q ss_pred EEEEeCC------eEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec--C
Q 020133 84 EVILTPT------HLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD--G 152 (330)
Q Consensus 84 ~~~~~~~------~~~lv~e~~~g~sL~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~--~ 152 (330)
++-+... ...+|||||.||||+..+.. ...|++.+++.++..+..||.|||++||+||||||.||++- .
T Consensus 78 ~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge 157 (732)
T KOG4250|consen 78 DIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE 157 (732)
T ss_pred ccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Confidence 9865543 46899999999999999964 23599999999999999999999999999999999999983 3
Q ss_pred CCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 153 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
++..-.||+|||.|+....+....+..||+.|.+||.+.++.+.+.-+|.|||||++|++.||..||.....+
T Consensus 158 dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 158 DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 3455689999999998888888889999999999999986444444499999999999999999999754443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=280.58 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=194.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+..+|++.+.||+|++|.||++.... +..+|+|.+.......+.+.+|+..+++++||||+++++++...+..|+||||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 35679999999999999999998754 45699998876655556789999999999999999999999988889999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--C
Q 020133 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--~ 175 (330)
+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ ++||+|||.++....... .
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCceeec
Confidence 9999999998764 4689999999999999999999999999999999999998765 499999998874432221 1
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...........+...... +.... ....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~-~~~~ 229 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-------YRPHL-ASEK 229 (256)
T ss_pred CCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-------CCCCC-CCHH
Confidence 12234567999999987766555 999999999999999 99999876655444444322111 11111 1222
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
+.+.+.+++..+|.+|+ ++.++++.+
T Consensus 230 ~~~li~~cl~~~p~~Rp-~~~~ll~~~ 255 (256)
T cd05113 230 VYAIMYSCWHEKAEERP-TFQQLLSSI 255 (256)
T ss_pred HHHHHHHHcCCCcccCC-CHHHHHHhh
Confidence 33344455556676664 888887655
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=285.93 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=196.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|.+.+.||+|+||.||++.+.. +++.||+|.+...... ...+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4679999999999999999998753 4678999988765433 45788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCce
Q 020133 93 AIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~--------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~v 158 (330)
|+||||+++++|.+++...+ .+++..+..++.|++.||.+||++|++||||||+||+++.++. +
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~ 161 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--V 161 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--E
Confidence 99999999999999997543 4789999999999999999999999999999999999987754 9
Q ss_pred EEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhc
Q 020133 159 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 159 kL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 234 (330)
+|+|||.++...... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||...+.......+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999986432221 1233345678999999988777655 999999999999998 99999876655444433321
Q ss_pred CChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 235 ISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
..+. ..... +..+.+.+.++...+|.+|+ ++.|+++.|.
T Consensus 241 -~~~~------~~~~~-~~~~~~li~~~l~~~p~~Rp-~~~eil~~l~ 279 (280)
T cd05049 241 -RLLQ------RPRTC-PSEVYDIMLGCWKRDPQQRI-NIKDIHERLQ 279 (280)
T ss_pred -CcCC------CCCCC-CHHHHHHHHHHcCCCcccCC-CHHHHHHHhh
Confidence 1110 00111 22233445555566777775 9999988875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.85 Aligned_cols=254 Identities=23% Similarity=0.292 Sum_probs=193.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCc--EEEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 95 (330)
++|++.+.||+|+||.||++....++. .+++|.++.. ....+.+.+|+..+.++ +||||+++++++...+.+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 679999999999999999999877664 4688877642 22235678899999999 799999999999999999999
Q ss_pred EeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceE
Q 020133 96 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vk 159 (330)
|||+++++|.+++.+.. .+++..++.++.|++.||++||++|++||||||+||+++.++. +|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence 99999999999997542 4889999999999999999999999999999999999987654 99
Q ss_pred EeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChh
Q 020133 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIP 238 (330)
Q Consensus 160 L~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (330)
|+|||++..............+..|+|||.+.+..++.+ +|||||||++|+|++ |..||..................+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999999863322211222233557999999877776555 999999999999997 999998766655444443322111
Q ss_pred HHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 239 EIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
....++. .+.+.+.++...+|..|+ +++++.+.|..+..
T Consensus 239 -------~~~~~~~-~~~~li~~~l~~~p~~Rp-~~~~i~~~l~~~~~ 277 (297)
T cd05089 239 -------KPRNCDD-EVYELMRQCWRDRPYERP-PFAQISVQLSRMLE 277 (297)
T ss_pred -------CCCCCCH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHHHHH
Confidence 0011222 223444455556666654 89999888776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=303.62 Aligned_cols=229 Identities=31% Similarity=0.508 Sum_probs=190.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.|.-++.||.|+||-||.|++..+.+.||||++.-+.+. ..++..|+.+|++++|||++.+.++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 467789999999999999999999999999998765332 2468899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||-| |-.+++.. .+++-+.++..|+.+.+.||+|||+.+.||||||..|||+.+.+. |||+|||.|.. ..+..
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi---~~PAn 180 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASI---MAPAN 180 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhh---cCchh
Confidence 9965 88888864 468999999999999999999999999999999999999988775 99999998753 33557
Q ss_pred cccCCCCCCChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh---------------------
Q 020133 177 STVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--------------------- 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~---~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~--------------------- 232 (330)
+++|||+|||||++. .+.|+++ +||||||++..||...++|+.+.+....+..+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 889999999999984 4568888 999999999999999999987655433222222
Q ss_pred --------hcCChhHHhcCchhhccCCcccccc
Q 020133 233 --------HRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 233 --------~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
.|++...++.|+|+.+.-|+..+.+
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~d 292 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRERPPTVIMD 292 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCCCchHHHH
Confidence 4566666777777666666555443
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=287.05 Aligned_cols=199 Identities=31% Similarity=0.527 Sum_probs=174.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++.+.||+|+||.||++.+..++..+|+|.+..... ....+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 469999999999999999999999999999998875422 234678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
+++++|.+++.+.+.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++. ++|+|||++..... .....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-ccccc
Confidence 9999999999888889999999999999999999997 69999999999999987664 99999998864322 22344
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
..+++.|+|||.+.+..+..+ +|+||||+++|+|++|+.||...+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcc
Confidence 578899999999877666544 999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=280.20 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=193.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
..+|++.+.||+|++|.||++.+. ++..+|+|.+.........+.+|+..++.++||||+++++++...+..|+||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 457999999999999999999886 4667999988766555567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC--C
Q 020133 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--K 176 (330)
Q Consensus 100 ~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~--~ 176 (330)
+|++|.+++..+ +.+++..++.++.|++.||++||+.|++||||||+||+++.++. +||+|||.++........ .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccC
Confidence 999999998753 46899999999999999999999999999999999999987664 999999988644322111 1
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
...++..|+|||.+.+..++.+ +|+||||+++|++++ |+.||...+..............+ ..... +..+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~~~ 230 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY-------RPKLA-PTEV 230 (256)
T ss_pred CCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC-------CCCCC-CHHH
Confidence 1123457999999987777655 999999999999999 899998766554444333221111 01111 2223
Q ss_pred ccccccCCCCCCCCccCCHHHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
.+...++...+|.+|+ ++.|+++.|
T Consensus 231 ~~li~~cl~~~p~~Rp-t~~~~l~~l 255 (256)
T cd05059 231 YTIMYSCWHEKPEDRP-AFKKLLSQL 255 (256)
T ss_pred HHHHHHHhcCChhhCc-CHHHHHHHh
Confidence 4445555556777764 899888765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=284.07 Aligned_cols=201 Identities=32% Similarity=0.485 Sum_probs=173.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++++.||+|+||.||++.+..+++.||+|++..... ....+.+|+..+++++||||+++++++..++..|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 4679999999999999999999999999999998875432 234677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
+++++|.+++..++++++..+..++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++....... ....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCc
Confidence 999999999988888999999999999999999999999999999999999987664 9999999987543222 2234
Q ss_pred ccCCCCCCChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 178 TVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~---~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
..+++.|+|||.+.. ..+ +.++|+|||||++|+|++|+.||....
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred cccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccc
Confidence 568889999998743 223 345999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=283.91 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=197.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
....|.+.+.||+|+||.||++.+. .++..+|+|.+.... .....+.+|+..+++++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3567999999999999999999863 346679999886543 2345688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceE
Q 020133 93 AIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vk 159 (330)
++||||+++++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||+++.++. ++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~k 160 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VK 160 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EE
Confidence 99999999999999987543 3899999999999999999999999999999999999987764 99
Q ss_pred EeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcC
Q 020133 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (330)
Q Consensus 160 L~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 235 (330)
|+|||+++....... .....++..|+|||++.+..++.+ +|+|||||++|+|++ |..||...........+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999874432211 123345678999999987766555 999999999999998 999998766544444433221
Q ss_pred ChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 236 SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
. +. .....+. .+.+.+.++...+|.+|+ ++.|+.+.|..+..
T Consensus 240 ~-~~------~~~~~~~-~l~~li~~~l~~~p~~Rp-t~~~v~~~l~~~~~ 281 (288)
T cd05093 240 V-LQ------RPRTCPK-EVYDLMLGCWQREPHMRL-NIKEIHSLLQNLAK 281 (288)
T ss_pred c-CC------CCCCCCH-HHHHHHHHHccCChhhCC-CHHHHHHHHHHHHH
Confidence 1 11 0111222 233444555556677765 99999888887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=285.70 Aligned_cols=210 Identities=28% Similarity=0.435 Sum_probs=178.1
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc------cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
+|++.+.||+|++|.||++.+..+++.||+|.+...... ...+.+|+..+++++|+||+++++++..++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999998765322 34567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
|||+ +++|.+++.... .+++..++.++.||++||.|||++|++|+||+|+||+++.++. ++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999998766 7999999999999999999999999999999999999987654 9999999987543322
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
......+++.|+|||.+.+....+.++|+|||||++|+|++|.+||...+......+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~ 218 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA 218 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH
Confidence 2233456788999999866544455699999999999999998888876665555555433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=299.17 Aligned_cols=202 Identities=43% Similarity=0.717 Sum_probs=189.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.+.|.+.+.||+|.|++|.++.+..++..||+|.+.+... ....+.+|+.++..++|||||+++.+.+.+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 3679999999999999999999999999999999987533 3345789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||+.+|.+.+++.+.+...+..++..+.|+..|++|||+++|+|||||.+|||++.+.+ +||+|||++..+.......
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeeccccccc
Confidence 99999999999999999999999999999999999999999999999999999988776 9999999999888888889
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
+.+|++.|.|||++.+..+++..+|+||+|+++|.|+.|.+||++.+
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 99999999999999999999999999999999999999999998754
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=296.69 Aligned_cols=256 Identities=25% Similarity=0.305 Sum_probs=195.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC-----CcEEEEEEeecCCc--ccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||.||++.+... +..||+|.+..... ..+.+.+|+.+++++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 357899999999999999999987533 34699999875432 2356889999999996 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc-----------------------------------------------------------
Q 020133 91 HLAIVMEYASGGELFERICNA----------------------------------------------------------- 111 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~----------------------------------------------------------- 111 (330)
..|+||||+++|+|.+++..+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999887642
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC
Q 020133 112 -------------------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (330)
Q Consensus 112 -------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~ 154 (330)
..+++..+..++.|++.||.|||+.|++||||||+||+++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 2377888999999999999999999999999999999998765
Q ss_pred CCceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 020133 155 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (330)
Q Consensus 155 ~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~ 230 (330)
.+||+|||+++...... ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||...........
T Consensus 275 --~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 275 --IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred --EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 49999999987443221 1223346778999999987776555 999999999999997 9999986544333333
Q ss_pred HhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 231 TIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+.....+ .....++. .+.+.+.+++..+|.+|+ ++.++.+.|..+.
T Consensus 352 ~~~~~~~~------~~~~~~~~-~l~~li~~cl~~dP~~RP-t~~~l~~~l~~l~ 398 (400)
T cd05105 352 KIKSGYRM------AKPDHATQ-EVYDIMVKCWNSEPEKRP-SFLHLSDIVESLL 398 (400)
T ss_pred HHhcCCCC------CCCccCCH-HHHHHHHHHCccCHhHCc-CHHHHHHHHHHHc
Confidence 22221100 01112222 233445556667787774 9999999988754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=282.54 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=192.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
..++|++.+.||+|+||.||++.+.. ++..||+|.+..... ....+.+|+.+++.++||||+++++++..++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35789999999999999999998652 456799998865432 23457899999999999999999999999899
Q ss_pred EEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEe
Q 020133 92 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~ 161 (330)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEEC
Confidence 999999999999999986532 3577889999999999999999999999999999999987664 9999
Q ss_pred ecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCCh
Q 020133 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISI 237 (330)
Q Consensus 162 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 237 (330)
|||+++....... .....+++.|+|||++.+..++.+ +|+|||||++|+|++ |..||.+.............. .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~ 239 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-L 239 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c
Confidence 9999864332211 122345678999999987776555 999999999999999 789998766544443333221 1
Q ss_pred hHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 238 PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
+ .+...++. .+.+...++...+|.+|+ ++.|+++.|.
T Consensus 240 ~------~~~~~~~~-~~~~li~~~l~~~p~~Rp-s~~e~l~~l~ 276 (277)
T cd05062 240 L------DKPDNCPD-MLFELMRMCWQYNPKMRP-SFLEIISSIK 276 (277)
T ss_pred C------CCCCCCCH-HHHHHHHHHcCCChhhCc-CHHHHHHHhh
Confidence 1 11112222 233344455556777765 8999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=279.45 Aligned_cols=246 Identities=31% Similarity=0.456 Sum_probs=192.3
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----------cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
+|.+.+.||.|++|.||+|.+..+++.||+|.+...... .+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588899999999999999999989999999988654221 1457789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
.++||||+++++|.+++...+.+++..+..++.|++.||.+||++|++||||+|+||+++.++. ++|+|||.++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988888999999999999999999999999999999999999987654 99999999874432
Q ss_pred CC-------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 172 HS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 172 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
.. ......++..|+|||.+.+..++.+ +|+|||||++|+|++|+.||...+......+..... .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~ 230 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-------SP 230 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC-------CC
Confidence 11 1122357889999999987766555 999999999999999999998765544443332211 01
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
-+....+. .+.+.+.++...+|..|+ +++|+++
T Consensus 231 ~~~~~~~~-~~~~li~~~l~~~p~~Rp-~~~~il~ 263 (267)
T cd06628 231 EIPSNISS-EAIDFLEKTFEIDHNKRP-TAAELLK 263 (267)
T ss_pred cCCcccCH-HHHHHHHHHccCCchhCc-CHHHHhh
Confidence 11111222 223344455556666654 7777654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=278.19 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=199.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..++|++.+.||+|++|.||++.+. +++.||+|.+.........+.+|+..+++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3578999999999999999999976 457799999987666667899999999999999999999999988899999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--
Q 020133 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (330)
Q Consensus 99 ~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-- 174 (330)
+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTA 160 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhh
Confidence 99999999997643 6899999999999999999999999999999999999987764 99999999874432111
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
......+..|+|||.+.+.....+ +|+||||+++|++++ |+.||.+.+.......+......+... ..|.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~- 231 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP-------NCPE- 231 (261)
T ss_pred hhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-------CCCH-
Confidence 112234568999999987666544 999999999999999 999998877666555554432211111 1111
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
.+.+...++...+|.+|+ +++++.+.|..
T Consensus 232 ~~~~~i~~~l~~~p~~Rp-~~~~l~~~l~~ 260 (261)
T cd05034 232 ELYDLMLQCWDKDPEERP-TFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHHcccCcccCC-CHHHHHHHHhc
Confidence 223334444556677765 89999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.86 Aligned_cols=207 Identities=29% Similarity=0.505 Sum_probs=172.2
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+|++.+.||+|++|.||++.+..+|+.||+|.+.... .....+.+|+..+++++||||+++++++.+.+..|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 6999999999999999999999999999999986532 2235677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
+++ +|.+++.. .+.+++..++.++.||++||.|||++|++||||||+||+++.++. ++|+|||+++...... ...
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 975 77777654 567999999999999999999999999999999999999987654 9999999987443222 223
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC-CCChhhHHHHH
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKT 231 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~-~~~~~~~~~~~ 231 (330)
...+++.|+|||++.+....+.++|||||||++|+|+||..||. +.+....+..+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence 44678899999998776544455999999999999999988854 44444444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=276.38 Aligned_cols=247 Identities=29% Similarity=0.486 Sum_probs=195.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+|++++.||.|+||.||.+++..+++.+++|.+.... .....+.+|+..+++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6999999999999999999999999999999886542 3335678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CC
Q 020133 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~ 175 (330)
+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. +||+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999999764 46899999999999999999999999999999999999987664 9999999987443332 23
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.......+......+.. ...+. .+
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~ 229 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV-------SVYSS-EL 229 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc-------cccCH-HH
Confidence 44568899999999887766555 99999999999999999999876655555444432111110 11111 12
Q ss_pred ccccccCCCCCCCCccCCHHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQI 280 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~~ 280 (330)
.+.+.++...+|.+| .++.++++.
T Consensus 230 ~~~i~~~l~~~p~~R-~s~~~ll~~ 253 (256)
T cd08221 230 ISLVHSLLQQDPEKR-PTADEVLDQ 253 (256)
T ss_pred HHHHHHHcccCcccC-CCHHHHhhC
Confidence 223334444567776 488887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=285.06 Aligned_cols=193 Identities=27% Similarity=0.459 Sum_probs=168.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++++.||+|++|.||++.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36889999999999999999999999999999887542 2235678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~ 178 (330)
+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCC
Confidence 999998654 35789999999999999999999999999999999999987765 999999998644322 23345
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
.++..|+|||.+.+..+..+ +|+||||+++|+|++|+.||..
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchh
Confidence 78899999999987776555 9999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=282.84 Aligned_cols=250 Identities=27% Similarity=0.446 Sum_probs=195.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
...+|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++||||+++++.+..+...|+|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 34789999999999999999999999999999998876433 23567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
|+++++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....... ...
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred ccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccccccC
Confidence 9999999998865 46899999999999999999999999999999999999987664 9999999887443322 223
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
...+++.|+|||.+.+.....+ +|+|||||++|+|++|+.||............... ..+.... ...++ ..+.
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~----~~~~~-~~l~ 247 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN----PEKLS-AIFR 247 (296)
T ss_pred cccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCCCC----ccccC-HHHH
Confidence 3468889999999887666554 99999999999999999999865543333222211 1111111 01111 1223
Q ss_pred cccccCCCCCCCCccCCHHHHHH
Q 020133 257 DNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.++...+|..|+ ++.|+++
T Consensus 248 ~li~~~l~~~p~~Rp-t~~eil~ 269 (296)
T cd06654 248 DFLNRCLDMDVEKRG-SAKELLQ 269 (296)
T ss_pred HHHHHHCcCCcccCc-CHHHHhh
Confidence 334455556777764 8888876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=281.70 Aligned_cols=207 Identities=30% Similarity=0.473 Sum_probs=173.6
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.|++++.||+|++|.||++.+..+++.||+|.+.... .....+.+|+..+++++||||+++++++..++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4899999999999999999999999999999886542 2235678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-C
Q 020133 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (330)
Q Consensus 99 ~~g~sL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~ 174 (330)
++ ++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 97 5888877542 46899999999999999999999999999999999999987765 9999999986433222 1
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.....+++.|+|||.+.+....+.++|+|||||++|+|+||+.||.+.+........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~ 214 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 233456889999999876554445599999999999999999999876655444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.08 Aligned_cols=225 Identities=37% Similarity=0.658 Sum_probs=192.0
Q ss_pred eEE--eceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 23 YEL--VRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 23 y~i--~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
|+| .+.||+|.||+||-++++.+|+.||||++.+- .+....+.+|+.+|+.+.||.||.+.-.|+..+.+++|||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 444 47899999999999999999999999998763 3445788999999999999999999999999999999999
Q ss_pred ccCCCChHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccCCCC
Q 020133 98 YASGGELFERI-C-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 98 ~~~g~sL~~~l-~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
-+.| +..+.+ . +.+.+++...+.++.||+.||+|||-++|+|+||||+|||+.. +..+++||||||+|+......-
T Consensus 644 Kl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 9976 444544 3 4678999999999999999999999999999999999999943 4556899999999998888877
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh-hhHHH------------------------
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFR------------------------ 229 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~-~~~~~------------------------ 229 (330)
..+.+|||.|+|||++.+++|+.. -|+||.|+++|--++|..||....+ .++++
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 888999999999999999999766 8999999999999999999975432 12221
Q ss_pred ----HHhhcCChhHHhcCchhhcc
Q 020133 230 ----KTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 230 ----~~~~~~~~~~~~~~~~~~~~ 249 (330)
++.+|+++...+.|+|++..
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhcc
Confidence 12267888888888887653
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=273.31 Aligned_cols=202 Identities=29% Similarity=0.471 Sum_probs=171.2
Q ss_pred cccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC----
Q 020133 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 90 (330)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~---- 90 (330)
+..+.+||++.+.||+|||+.||++++..+++.||+|++.... ...+...+|+...++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3456789999999999999999999999999999999987655 45677899999999999999999998876443
Q ss_pred -eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecCCCCCceEEeec
Q 020133 91 -HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 91 -~~~lv~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
..|++++|...|||.+.+.. +..+++.+++.|+.++.+||++||+.. ++||||||.|||+.+++. ++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEec
Confidence 48999999999999998864 336999999999999999999999998 999999999999987665 999999
Q ss_pred CCcccccCCCCCC----------cccCCCCCCChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 164 GYSKSSVLHSQPK----------STVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 164 g~a~~~~~~~~~~----------~~~~~~~y~aPE~~~~---~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
|.+.......... ....|..|+|||.+.- ...+.+ +|||||||++|.|+.|..||.
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcch
Confidence 9886443322221 2246889999998843 334444 999999999999999999996
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=276.72 Aligned_cols=207 Identities=33% Similarity=0.490 Sum_probs=174.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~ 92 (330)
..|++.+.||+|+||.||.+.+..+++.||+|.+..... ....+.+|+..+++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998864321 124678899999999999999999998764 468
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
++||||+++++|.+++...+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence 899999999999999988778999999999999999999999999999999999999987664 999999988743221
Q ss_pred ----CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 173 ----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 173 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
.......++..|+|||++.+...+.+ +|+|||||++|+|++|+.||...+......+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 220 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK 220 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHHHH
Confidence 11223457889999999987666544 9999999999999999999987655444443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=281.78 Aligned_cols=256 Identities=29% Similarity=0.405 Sum_probs=189.5
Q ss_pred CCe-EEeceeccCCceEEEEEEE----CCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--Ce
Q 020133 21 DRY-ELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (330)
Q Consensus 21 ~~y-~i~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~ 91 (330)
+|| ++++.||+|+||+||++.. ..++..||+|.+..... ....+.+|+..+++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 466 9999999999999988653 34688999998876432 346778999999999999999999988653 46
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence 8999999999999999876 46999999999999999999999999999999999999987654 99999999875433
Q ss_pred CCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh----cCC---hhHH
Q 020133 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----RIS---IPEI 240 (330)
Q Consensus 172 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~----~~~---~~~~ 240 (330)
... .....++..|+|||.+.+...+.+ +||||||+++|+|+||..||...... ...... ... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh
Confidence 221 122335667999999877766555 99999999999999999998654321 111110 000 0000
Q ss_pred hcCch---hhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 241 RNHEW---FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 241 ~~~~~---~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..... ..... +..+.+.+.++...+|..|+ +++++++.|..+
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~li~~cl~~~p~~Rp-s~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNC-PQEVYILMKNCWETEAKFRP-TFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCC-CHHHHHHHHHHhccChhhCC-CHHHHHHHHHHh
Confidence 00000 01111 22344455566667777765 999999888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.20 Aligned_cols=249 Identities=28% Similarity=0.423 Sum_probs=188.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeec---CCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~l 94 (330)
....|+++++||+||.+.||++.... .+.||+|++.. +......+.+|+.+|.+| .|.+|++++||-..++.+|+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 45679999999999999999999865 45577776543 334446789999999999 49999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 95 VMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
||||- ..+|..++++... .+...++.+.+||+.|+.++|..||||.||||.|+|+- .|++||+|||+|......+
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeechhcccCccc
Confidence 99986 5699999987654 44468899999999999999999999999999999994 3469999999998655444
Q ss_pred C---CCcccCCCCCCChhhhhcCCC----------CCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 174 Q---PKSTVGTPAYIAPEVLLKKEY----------DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 174 ~---~~~~~~~~~y~aPE~~~~~~~----------~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
. ..+.+||+.||+||.+..... -.+++||||||||||+|+.|+.||..... .+.+ +..+.-|
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aK-l~aI~~P-- 588 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAK-LHAITDP-- 588 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHH-HHhhcCC--
Confidence 3 467799999999999853322 24559999999999999999999964321 1111 1121111
Q ss_pred hcCchhhccCCc-cccccccccCCCCCCCCccCCHHHHHH
Q 020133 241 RNHEWFLKNLPA-DLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 241 ~~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+|..--+.+|. ...++.+.+|...+|.+|+ +++|+++
T Consensus 589 -~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~-si~eLLq 626 (677)
T KOG0596|consen 589 -NHEIEFPDIPENDELIDVMKCCLARDPKKRW-SIPELLQ 626 (677)
T ss_pred -CccccccCCCCchHHHHHHHHHHhcCcccCC-CcHHHhc
Confidence 12110111222 2255666677778888877 8888876
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.39 Aligned_cols=203 Identities=33% Similarity=0.504 Sum_probs=175.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc-cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
..++|++.+.||+|+||.||++.+..+++.||+|.++..... ...+.+|+..++.++||||+++++.+...+.+|+|||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346899999999999999999999999999999998765322 3457789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~ 176 (330)
|+++++|.+++...+.+++.+++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... ....
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRK 164 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccc
Confidence 9999999999988889999999999999999999999999999999999999986654 999999998644322 1223
Q ss_pred cccCCCCCCChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 177 STVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~---~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
...++..|+|||.+. ...++ .++|+|||||++|+|++|..||.....
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred cccCcccccChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccc
Confidence 457889999999974 23344 459999999999999999999975443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=279.02 Aligned_cols=244 Identities=26% Similarity=0.346 Sum_probs=188.5
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..++.++||||+++++++...+..|+||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999999999999999876432 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC---CcccC
Q 020133 105 FERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (330)
Q Consensus 105 ~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~ 180 (330)
.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 99987644 6899999999999999999999999999999999999987654 999999998643321111 11122
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccccc
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNT 259 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (330)
+..|+|||.+.+..+..+ +|+||||+++|+|++ |..||.................. .+....+. .+.+.+
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~li 229 (252)
T cd05084 159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-------PCPELCPD-AVYRLM 229 (252)
T ss_pred ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-------CCcccCCH-HHHHHH
Confidence 456999999877776555 999999999999998 99999765544333322221111 11111222 233455
Q ss_pred ccCCCCCCCCccCCHHHHHHHHH
Q 020133 260 TNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 260 ~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
.++...+|.+|+ +++++.+.|+
T Consensus 230 ~~~l~~~p~~Rp-s~~~~~~~l~ 251 (252)
T cd05084 230 ERCWEYDPGQRP-SFSTVHQELQ 251 (252)
T ss_pred HHHcCCChhhCc-CHHHHHHHHh
Confidence 556667777764 9999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.70 Aligned_cols=254 Identities=22% Similarity=0.373 Sum_probs=192.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC-C
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP-T 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~-~ 90 (330)
.++|++++.||+|+||.||+|.+.. +++.||+|.+..... ....+.+|+..+.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4689999999999999999997543 457899998865432 224577899999999 899999999988754 5
Q ss_pred eEEEEEeccCCCChHHHHHhc-----------------------------------------------------------
Q 020133 91 HLAIVMEYASGGELFERICNA----------------------------------------------------------- 111 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~----------------------------------------------------------- 111 (330)
.++++|||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999988542
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---CCCcccCCCCCCC
Q 020133 112 --GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIA 186 (330)
Q Consensus 112 --~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~a 186 (330)
.++++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||+++...... ......++..|+|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578999999999999999999999999999999999998765 49999999987543221 1223345678999
Q ss_pred hhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCC
Q 020133 187 PEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 265 (330)
Q Consensus 187 PE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
||++.+..++.+ +|||||||++|+|++ |..||.+..........+.....+ ......+.+ +.+.+.++...
T Consensus 244 PE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~l~~~cl~~ 315 (337)
T cd05054 244 PESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM------RAPEYATPE-IYSIMLDCWHN 315 (337)
T ss_pred cHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC------CCCccCCHH-HHHHHHHHccC
Confidence 999988877666 999999999999998 999997654433333333221111 011111122 23344455556
Q ss_pred CCCCccCCHHHHHHHHHHh
Q 020133 266 EPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 266 ~p~~~~~s~~el~~~l~~~ 284 (330)
+|..|+ +++|+++.|..+
T Consensus 316 ~p~~RP-s~~ell~~l~~~ 333 (337)
T cd05054 316 NPEDRP-TFSELVEILGDL 333 (337)
T ss_pred ChhhCc-CHHHHHHHHHHH
Confidence 777775 999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=288.09 Aligned_cols=254 Identities=20% Similarity=0.331 Sum_probs=193.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCc----EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
...+|++.+.||+|+||.||++.+..++. .||+|.+.... .....+.+|+..++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 45789999999999999999999866555 48999886542 2345788899999999999999999998764 57
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
++|+||+++|+|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccC
Confidence 8999999999999998764 46899999999999999999999999999999999999987764 99999999975443
Q ss_pred CCCC---CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcC-ChhHHhcCchh
Q 020133 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI-SIPEIRNHEWF 246 (330)
Q Consensus 172 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 246 (330)
.... .....+..|+|||.+.+..++.+ +||||||+++|+|++ |+.||.+..... +...+... ..+. .
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~---~--- 233 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQ---P--- 233 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCC---C---
Confidence 2221 12234567999999987777655 999999999999998 999998755433 33333221 1110 0
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
...+.+ +...+.+++..+|..|+ ++.+++..+.....
T Consensus 234 -~~~~~~-~~~li~~cl~~~p~~Rp-s~~~l~~~l~~~~~ 270 (316)
T cd05108 234 -PICTID-VYMIMVKCWMIDADSRP-KFRELIIEFSKMAR 270 (316)
T ss_pred -CCCCHH-HHHHHHHHccCChhhCc-CHHHHHHHHHHHHc
Confidence 111111 22333444556777764 89999988876644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=278.81 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=197.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++.+.||+|+||.||++....+ ...||+|.+..... ....+.+|+..+++++||||+++++++...+..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 357899999999999999999998654 45799998865432 2346788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+|+||||+||+++.++. ++|+|||+++.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccc
Confidence 999999999999998764 47899999999999999999999999999999999999987664 999999998755311
Q ss_pred CC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhc
Q 020133 173 SQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248 (330)
Q Consensus 173 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
.. .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...........+......+.. .
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~ 231 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP-------M 231 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC-------C
Confidence 11 112234568999999887776555 999999999999998 99999876655444333322111111 1
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..+. .+.+...++...+|.+|+ ++.|+++.|.++
T Consensus 232 ~~~~-~l~~li~~cl~~~p~~Rp-~~~ei~~~l~~~ 265 (266)
T cd05033 232 DCPS-ALYQLMLDCWQKDRNERP-TFSQIVSTLDKM 265 (266)
T ss_pred CCCH-HHHHHHHHHcCCCcccCc-CHHHHHHHHHhh
Confidence 1122 233445555666777764 999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=284.89 Aligned_cols=249 Identities=30% Similarity=0.455 Sum_probs=193.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+.|++.+.||+|+||.||++.+..+++.|++|.+..... ....+.+|+..++.++||||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 469999999999999999999999999999998876532 2346778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--- 173 (330)
||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988888999999999999999999999999999999999999987654 9999999886311100
Q ss_pred -------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 174 -------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 174 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
......++..|+|||.+.+..+..+ +|+|||||++|+|++|..||.+.+............ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-~--- 233 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-I--- 233 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-c---
Confidence 0012346778999999877766555 999999999999999999998765544333332211 0
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCC--HHHHH
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS--IDEIM 278 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s--~~el~ 278 (330)
..+.....++ ..+.+.+.++...+|.+|+.+ +.+++
T Consensus 234 -~~~~~~~~~~-~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 234 -EWPEGDEALP-ADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred -CCCCccccCC-HHHHHHHHHHhccChhhccCccCHHHHH
Confidence 0111111122 223445556666788887754 44443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=281.37 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=191.6
Q ss_pred CCCeEEeceeccCCceEEEEEEEC----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
...|++.+.||+|+||.||++... .+++.|++|.+..... ....+.+|+.++++++||||+++++++......|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 367999999999999999999853 4567899998875332 2246788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC
Q 020133 94 IVMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~ 156 (330)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~- 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH- 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-
Confidence 999999999999998532 24788999999999999999999999999999999999987654
Q ss_pred ceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHh
Q 020133 157 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 157 ~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~ 232 (330)
+||+|||+++...... ......++..|+|||.+.+..++.. +|+||||+++|+|++ |..||.+...........
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 163 -VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred -EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999987443221 1223345678999999977766554 999999999999998 999998755433332222
Q ss_pred hcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 233 HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
.+...+ . ...++. .+.+...++...+|..|+ +++++.+.|..
T Consensus 241 ~~~~~~----~---~~~~~~-~~~~li~~cl~~~p~~Rp-~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQLLP----C---SEDCPP-RMYSLMTECWQEGPSRRP-RFKDIHTRLRS 282 (283)
T ss_pred cCCcCC----C---CCCCCH-HHHHHHHHHcccCcccCc-CHHHHHHHhhc
Confidence 221111 1 111222 223344455556676665 89999887753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=283.44 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=199.0
Q ss_pred CCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCcc-cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..+|.+.+.||+|+||.||++.+. .++..+++|.+...... ...+.+|+..+++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 467999999999999999999864 34567899987654332 356889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCc
Q 020133 94 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~ 157 (330)
+||||+++++|.+++...+ .+++..++.++.||+.||.|||++|++||||||+||+++.++ .
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~ 161 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--L 161 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--c
Confidence 9999999999999997543 389999999999999999999999999999999999998776 4
Q ss_pred eEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhh
Q 020133 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 158 vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 233 (330)
++|+|||++....... ......++..|+|||.+.+..+..+ +||||||+++|+|+| |+.||...+....+..+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 9999999986443221 1233456788999999987776555 999999999999999 9999987665444333222
Q ss_pred cCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCC
Q 020133 234 RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287 (330)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~ 287 (330)
...+. .....|. .+.+.+.++...+|.+|+ ++.++.+.|..+..+
T Consensus 241 -~~~~~------~~~~~~~-~~~~li~~~l~~~P~~Rp-t~~~v~~~l~~~~~~ 285 (291)
T cd05094 241 -GRVLE------RPRVCPK-EVYDIMLGCWQREPQQRL-NIKEIYKILHALGKA 285 (291)
T ss_pred -CCCCC------CCccCCH-HHHHHHHHHcccChhhCc-CHHHHHHHHHHHHhh
Confidence 11111 1111222 233445556667777765 999999999887554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=277.29 Aligned_cols=247 Identities=29% Similarity=0.425 Sum_probs=191.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~ 92 (330)
..|++.+.||+|+||.||++.+..++..|++|.+..... ....+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 579999999999999999999999999999998864321 124578899999999999999999998763 578
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
++++||+++++|.+++...+.+++..++.++.|++.||.+||+++++||||+|+||+++.++. ++|+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence 999999999999999988888999999999999999999999999999999999999987654 999999998643321
Q ss_pred C----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhc
Q 020133 173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248 (330)
Q Consensus 173 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
. ......++..|+|||.+.+..++.. +|+|||||++|+|++|+.||..................+.+ ..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~ 232 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL------PS 232 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCC------ch
Confidence 1 1123457889999999987766544 99999999999999999999876655544443322221111 11
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
..+.. +...+ +++..+|.+|+ +++|+++
T Consensus 233 ~~~~~-~~~li-~~~~~~p~~Rp-~~~eil~ 260 (266)
T cd06651 233 HISEH-ARDFL-GCIFVEARHRP-SAEELLR 260 (266)
T ss_pred hcCHH-HHHHH-HHhcCChhhCc-CHHHHhc
Confidence 11111 11222 33445777765 8888864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=283.84 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=195.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCC----------------cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeee
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTE----------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR 81 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~ 81 (330)
.++|++++.||+|+||.||++.+..++ ..||+|.+.... ...+.+.+|+..+++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 478999999999999999999886543 568999887653 23456788999999999999999
Q ss_pred eeEEEEeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEe
Q 020133 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (330)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli 150 (330)
+++++..++..++||||+++++|.+++.... .+++..++.++.|++.||+|||++|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999999997765 68999999999999999999999999999999999999
Q ss_pred cCCCCCceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCCChh
Q 020133 151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP 225 (330)
Q Consensus 151 ~~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt--g~~pf~~~~~~ 225 (330)
+.++ .++|+|||+++...... ......+++.|+|||.+.+..+..+ +|||||||++|+|++ |..||...+..
T Consensus 164 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 164 GKNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred cCCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 8775 49999999987433221 1223445778999999887666555 999999999999998 78888776554
Q ss_pred hHHHHHhhcC---ChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 226 KNFRKTIHRI---SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 226 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
..+.....-. ..+.....+ ...| ..+.+.+.++...+|.+|+ ++.|+.+.|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~l~~li~~cl~~~p~~Rp-t~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRP---PNCP-KDIYELMLECWRRDEEDRP-TFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccccccCCCc---cCCC-HHHHHHHHHHhccChhcCC-CHHHHHHHhc
Confidence 4443332210 000000000 1111 2234455556667777765 9999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=298.76 Aligned_cols=257 Identities=26% Similarity=0.359 Sum_probs=204.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCc---E-EEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEE---L-VAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
.++-.+.++||+|+||.||++..+..+. . ||+|..+.+. .....+.+|+++++.++|||||++||+...+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455667999999999999999876422 3 8999887522 234578899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
+++|||+|.||+|.+++++++ .++..+...++.+.+.||+|||+++++||||-..|+|++.+.. +|++|||+++...
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGS 313 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCc
Confidence 999999999999999999887 4999999999999999999999999999999999999987664 8999999987544
Q ss_pred CCCCCC-cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhh---cCChhHHhcCch
Q 020133 171 LHSQPK-STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH---RISIPEIRNHEW 245 (330)
Q Consensus 171 ~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~ 245 (330)
.-.... .......|+|||.+....++.+ +|||||||++||+++ |..||.+........++.. |...|.
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~------ 386 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS------ 386 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC------
Confidence 211112 2235678999999988877666 999999999999999 8889999887665555522 222222
Q ss_pred hhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCCCC
Q 020133 246 FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAG 290 (330)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~~~ 290 (330)
.++..+......++..+|..|. ++.++.+.+..+......
T Consensus 387 ----~~p~~~~~~~~~c~~~~p~~R~-tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 387 ----KTPKELAKVMKQCWKKDPEDRP-TMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----CCHHHHHHHHHHhccCChhhcc-CHHHHHHHHHHHHhcccc
Confidence 2233444445566667777765 999999988887666543
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.70 Aligned_cols=200 Identities=32% Similarity=0.554 Sum_probs=177.7
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
+|++.+.||.|+||.||++.+..+++.||+|.+.... .....+.+|+..+++++||||+++++.+..+...|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999999999999987543 234578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
|+.|++|.+++....++++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999988778999999999999999999999999999999999999987765 99999999875544434445
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
..++..|+|||.+.+.....+ +|+||||+++|+|++|+.||...+.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCc
Confidence 567889999999977775545 9999999999999999999987654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=275.54 Aligned_cols=207 Identities=33% Similarity=0.516 Sum_probs=178.0
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.|.+.+.||+|++|.||++.+..+++.|++|.+... ......+.+|+..++.++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 488999999999999999999999999999988653 23346788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-C
Q 020133 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-~ 175 (330)
++|++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||+++....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999998764 57999999999999999999999999999999999999987654 99999998875433222 2
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
....+++.|+|||++.+..++.+ +|+||||+++|+|++|+.||...+........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 213 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKI 213 (256)
T ss_pred hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33467889999999987776655 99999999999999999999877654444433
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=276.89 Aligned_cols=246 Identities=29% Similarity=0.446 Sum_probs=192.2
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
+|++.+.||.|+||.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++.+...+.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5899999999999999999999999999999886432 23456788999999999999999999999999999999999
Q ss_pred CCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 100 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 100 ~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 99999998864 345899999999999999999999999999999999999987664 9999999986443322 223
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
...+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+............ .+. +...++. .+.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~------~~~~~~~-~~~ 229 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS-YKP------LPSHYSY-ELR 229 (255)
T ss_pred cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC-CCC------CCcccCH-HHH
Confidence 4568889999999977766555 999999999999999999998765444433332211 110 0111111 122
Q ss_pred cccccCCCCCCCCccCCHHHHHH
Q 020133 257 DNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.++...+|..|+ ++.|++.
T Consensus 230 ~li~~~l~~~P~~Rp-~~~~il~ 251 (255)
T cd08219 230 SLIKQMFKRNPRSRP-SATTILS 251 (255)
T ss_pred HHHHHHHhCCcccCC-CHHHHhh
Confidence 333444556677664 8888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=276.54 Aligned_cols=206 Identities=35% Similarity=0.516 Sum_probs=178.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++.+.||.|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++||||+++++++...+.+|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4789999999999999999999999999999999876533 346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
+++++|.+++... .++++.++..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence 9999999998776 78999999999999999999999999999999999999987764 9999999986443322 223
Q ss_pred cccCCCCCCChhhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHH
Q 020133 177 STVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~---~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~ 228 (330)
...++..|+|||.+.+. .++. ++|+||||+++|+|++|+.||...+.....
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~-~~Di~slG~~l~~~~tg~~p~~~~~~~~~~ 213 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRAL 213 (262)
T ss_pred cccCCccccCchhhcccccCCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 45678899999998765 5554 499999999999999999999876644433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=285.10 Aligned_cols=248 Identities=30% Similarity=0.470 Sum_probs=195.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+..++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 479999999999999999999999999999999876532 2346788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
||+.|++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999998754 56999999999999999999999999999999999999987654 99999998763322111
Q ss_pred ------------------------------CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 175 ------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 175 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
.....|+..|+|||.+.+..++. ++||||||+++|+|++|+.||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11235788899999998776654 49999999999999999999988776
Q ss_pred hhHHHHHhhcC-ChhHHhcCchhhccCCccccccccccCCCCCCCCccCC---HHHHHH
Q 020133 225 PKNFRKTIHRI-SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS---IDEIMQ 279 (330)
Q Consensus 225 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s---~~el~~ 279 (330)
.....+..... ..+.. ......+.+.+.++...+|..|+.+ ++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSNILKKEVTFPGS--------PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHhcCCccCCCc--------cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 66555544321 11110 0012234455556666778777754 444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=281.68 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=195.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.+.|++.+.||+|++|.||++.+.. ++..||+|.+..... ....+.+|+..++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999987 778899998764432 234688899999999999999999999998899
Q ss_pred EEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecC
Q 020133 93 AIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFG 164 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg 164 (330)
++||||++|++|.+++...+ .+++..++.++.||+.||.|||+++++||||||+||+++.++ ...+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999999987653 489999999999999999999999999999999999997654 2358999999
Q ss_pred CcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 165 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
+++....... ......+..|+|||++.+..++.+ +|||||||++|+|++ |+.||...+.......+......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-- 241 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD-- 241 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC--
Confidence 9875422111 112233567999999987777655 999999999999997 999998766554443332221110
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
....+|. .+.+.+.++...+|.+|+ ++.++++.|.
T Consensus 242 -----~~~~~~~-~~~~~i~~cl~~~p~~Rp-s~~~vl~~l~ 276 (277)
T cd05036 242 -----PPKGCPG-PVYRIMTDCWQHTPEDRP-NFATILERIQ 276 (277)
T ss_pred -----CCCCCCH-HHHHHHHHHcCCCcccCc-CHHHHHHHhh
Confidence 0112222 233445555666777764 9999988764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=280.76 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=195.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC-----CcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
..++|++.+.||+|+||.||++.+... +..||+|.+...... ...+.+|+..++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 357899999999999999999998754 378999998655322 3467889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEe
Q 020133 92 LAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~ 161 (330)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~ 161 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIG 161 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEEC
Confidence 99999999999999998643 23688899999999999999999999999999999999987764 9999
Q ss_pred ecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCCh
Q 020133 162 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISI 237 (330)
Q Consensus 162 Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 237 (330)
|||+++...... ......++..|+|||.+.+..++.+ +|||||||++|+++| |..||...+......... ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCC
Confidence 999987433221 1233446778999999877766555 999999999999998 999998766544433332 1111
Q ss_pred hHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 238 PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
+. +....+ ..+.+.+.++...+|.+| +++.++++.|.
T Consensus 240 ~~------~~~~~~-~~~~~li~~~l~~~p~~R-pt~~~l~~~l~ 276 (277)
T cd05032 240 LD------LPENCP-DKLLELMRMCWQYNPKMR-PTFLEIVSSLK 276 (277)
T ss_pred CC------CCCCCC-HHHHHHHHHHcCCChhhC-CCHHHHHHHhc
Confidence 11 111112 223345555666778777 49999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=277.28 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=192.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.+.||+|++|.||++.+. .+..+|+|.+.......+.+.+|+.++++++|+||+++++++. ....|++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 468999999999999999999876 4667999998876655678899999999999999999999875 45689999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--C
Q 020133 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (330)
Q Consensus 100 ~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--~ 175 (330)
++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||++++++ .++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCcccccc
Confidence 999999998753 3589999999999999999999999999999999999998765 499999999874432221 1
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+.......+......+. ....+ ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~ 231 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC-------PQDCP-IS 231 (260)
T ss_pred cCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------CCcCC-HH
Confidence 22234567999999877666555 999999999999999 8999987665544444332221111 01111 12
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+.+.+.++...+|.+|+ +++++.+.|..
T Consensus 232 ~~~li~~~l~~~p~~Rp-t~~~l~~~l~~ 259 (260)
T cd05070 232 LHELMLQCWKKDPEERP-TFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHcccCcccCc-CHHHHHHHHhc
Confidence 33344445556666655 88998887753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=279.44 Aligned_cols=253 Identities=21% Similarity=0.348 Sum_probs=194.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCc---EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
.+.|++.+.||+|+||.||++....+++ .||+|.+.... .....+.+|+..++.++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 4679999999999999999999887664 59999886542 234578899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
||||+++++|.+++.. .+.+++.+++.++.|++.||.+||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCc
Confidence 9999999999999875 35689999999999999999999999999999999999997665 49999999886433222
Q ss_pred CCCc---cc---CCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchh
Q 020133 174 QPKS---TV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246 (330)
Q Consensus 174 ~~~~---~~---~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (330)
.... .. .+..|+|||.+.+..++.+ +|||||||++||+++ |..||...+.......+......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 233 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP------ 233 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc------
Confidence 1111 11 2347999999987777555 999999999999886 99999876655444433222221111
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...|. .+.+...++...+|.+|+ ++.++++.|..+
T Consensus 234 -~~~~~-~~~~li~~~l~~~p~~Rp-~~~~i~~~l~~~ 268 (269)
T cd05065 234 -MDCPT-ALHQLMLDCWQKDRNARP-KFGQIVSTLDKM 268 (269)
T ss_pred -ccCCH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHhh
Confidence 11222 123334445556677764 899999887753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=280.20 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=195.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||.|++|.||++.+..+++.+|+|.+.... .....+.+|+..++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999886532 22346788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 97 e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEECcchhhhccccC
Confidence 99999999998863 34689999999999999999999999999999999999998765 4999999988644332
Q ss_pred CC-CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh-hHHHHHhhcCChhHHhcCchhhccC
Q 020133 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 173 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
.. .....++..|+|||.+.+...+.+ +|+||||+++|+|++|..||.+.... ....+.+.....+... ....
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 233 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP-----SDHY 233 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCC-----cccc
Confidence 22 233468889999999977776555 99999999999999999999754322 1111221111111110 0111
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+.+.+.++...+|.+|+ ++.++.+.+++.
T Consensus 234 -~~~~~~li~~~l~~~p~~Rp-t~~~i~~~~~~~ 265 (267)
T cd08229 234 -SEELRQLVNMCINPDPEKRP-DITYVYDVAKRM 265 (267)
T ss_pred -cHHHHHHHHHhcCCCcccCC-CHHHHHHHHhhh
Confidence 11233344445556676655 999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=294.67 Aligned_cols=196 Identities=24% Similarity=0.362 Sum_probs=169.5
Q ss_pred CCCeEEeceeccCCceEEEEEEEC--CCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
..+|++++.||+|+||.||++... .+++.||+|.+... ....+|+.++++++||||+++++++......|+|||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 357999999999999999999764 35688999987654 345689999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC---
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--- 174 (330)
++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||+++.......
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence 996 588888877788999999999999999999999999999999999999987664 99999999864433222
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.....||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+..
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCC
Confidence 234568999999999988777655 999999999999999999997644
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=280.00 Aligned_cols=247 Identities=29% Similarity=0.474 Sum_probs=193.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++.+.||.|++|.||++.+..+++.||+|.+.... .....+.+|+..++.++|+||+++++++..+...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999999999999999987543 2234678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~ 177 (330)
+++++|.+++... ++++..++.++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||+++..... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999998764 8999999999999999999999999999999999999987765 999999998755433 23344
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..+++.|+|||.+.+..++.+ +|+||||+++|+|+||+.||...+.......+. ....+.+.... .+. .+.+
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~-~~~~ 229 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNK-----FSK-PFKD 229 (274)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-hcCCCCCcccc-----cCH-HHHH
Confidence 567889999999987776555 999999999999999999998655333222222 11111111110 111 1223
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ ++.++++
T Consensus 230 ~l~~~l~~~p~~Rp-t~~~il~ 250 (274)
T cd06609 230 FVSLCLNKDPKERP-SAKELLK 250 (274)
T ss_pred HHHHHhhCChhhCc-CHHHHhh
Confidence 33444556777764 7777764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=280.89 Aligned_cols=211 Identities=27% Similarity=0.446 Sum_probs=180.6
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+|++.+.||+|++|.||+|.+..+|+.||+|.+.... .....+.+|+..+++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5999999999999999999999999999999987643 2345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--CC
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~~ 175 (330)
+ +++|.+++.. ..++++.+++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+....... ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC--cEEEeeeeecccccCCCCCcc
Confidence 9 9999998864 45799999999999999999999999999999999999998765 49999999987544332 13
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 235 (330)
....++..|+|||.+.+....+.++||||||+++|+|++|.+||.+......+...+...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~ 217 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTL 217 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHc
Confidence 345688899999998766554556999999999999999999998777666665555443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=278.83 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=195.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCC---cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
+.++|++.+.||+|+||.||++.+..++ ..+|+|.+.... ...+.+.+|+..+++++||||+++++++..++..|
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3578999999999999999999986544 379999886542 23457889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++... +.+++.++..++.|++.||.+||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCcccccccc
Confidence 999999999999998764 4689999999999999999999999999999999999998765 4999999998754332
Q ss_pred CCC----CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 173 SQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 173 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
... ....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||...........+......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 231 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP------- 231 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC-------
Confidence 211 11223467999999987776555 999999999999886 99999876655444444332211111
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...|.. +.+...++...+|..|+ ++.++++.|.+.
T Consensus 232 ~~~~~~-~~~li~~~l~~~p~~Rp-~~~~i~~~l~~~ 266 (267)
T cd05066 232 MDCPAA-LHQLMLDCWQKDRNERP-KFEQIVSILDKL 266 (267)
T ss_pred CCCCHH-HHHHHHHHcccCchhCC-CHHHHHHHHHhh
Confidence 112222 23344445556677665 899999988763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=274.04 Aligned_cols=201 Identities=37% Similarity=0.579 Sum_probs=173.6
Q ss_pred ccCCCCeEEe-ceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC----C
Q 020133 17 MHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP----T 90 (330)
Q Consensus 17 ~~~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~----~ 90 (330)
....+.|++- ++||-|-.|.|..+.++.||+.+|+|++..+ ....+|+++.-.. .|||||.++++|+.. .
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3345667764 5789999999999999999999999988655 4567888877655 699999999998743 4
Q ss_pred eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-CCCceEEeecCCcc
Q 020133 91 HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSK 167 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~-~~~~vkL~Dfg~a~ 167 (330)
++.+|||+++||.|...++.++. +++.++..|+.||..|+.|||+.+|.||||||+|+|.... .+..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 67889999999999999988764 9999999999999999999999999999999999999532 34469999999999
Q ss_pred cccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
.........+.+.||+|.|||++....|+-. .|+||+|++||-|++|.+||.+.
T Consensus 213 ~t~~~~~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 213 ETQEPGDLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred ccCCCccccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhcCCCccccc
Confidence 7776777788899999999999988887644 99999999999999999999754
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=274.87 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=196.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|++|.||++.+..+|+.||+|.++... ...+.+.+|+..+++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999886422 22457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 97 e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
||+++++|..++.. ...+++..++.++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999998864 345899999999999999999999999999999999999987664 999999998644332
Q ss_pred C-CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh-hHHHHHhhcCChhHHhcCchhhccC
Q 020133 173 S-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 173 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
. ......+++.|+|||.+.+..+..+ +|+||||+++|+|++|+.||...... ....+.+.....+.. + ....
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~ 233 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL---P--ADHY 233 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC---C--hhhc
Confidence 2 2233467889999999987776555 99999999999999999999654321 111111111111100 0 0011
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+.+.+.++...+|.+|+ ++.++++.++..
T Consensus 234 -~~~~~~~i~~cl~~~p~~Rp-~~~~il~~~~~~ 265 (267)
T cd08224 234 -SEELRDLVSRCINPDPEKRP-DISYVLQVAKEM 265 (267)
T ss_pred -CHHHHHHHHHHcCCCcccCC-CHHHHHHHHHHh
Confidence 11223344445556677666 999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=275.00 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=193.6
Q ss_pred ceeccCCceEEEEEEECCC---CcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.+... +..|++|.+...... ...+.+|+..++.++|+||+++++++.....+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999876 889999998765443 46788999999999999999999999999999999999999
Q ss_pred CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 102 ~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC--cEEEcccccccccccc
Confidence 9999999875 7899999999999999999999999999999999999998775 4999999998755433
Q ss_pred C---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhc
Q 020133 173 S---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248 (330)
Q Consensus 173 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
. ......++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+..............+ ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~ 230 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP-------KPE 230 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------CCc
Confidence 2 2334456789999999877766544 999999999999999 699998876544444433211110 011
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHHHH
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
.++. .+.+.+.++...+|.+|+ ++.++++.|
T Consensus 231 ~~~~-~~~~li~~~l~~~p~~Rp-s~~~l~~~l 261 (262)
T cd00192 231 YCPD-ELYELMLSCWQLDPEDRP-TFSELVERL 261 (262)
T ss_pred cCCh-HHHHHHHHHccCCcccCc-CHHHHHHhh
Confidence 1122 233444555567777764 999988765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=276.09 Aligned_cols=250 Identities=21% Similarity=0.357 Sum_probs=195.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|+++++||+|+||.||+|... +++.||+|.+.........+.+|+.++++++||||+++++++. .+..|++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 478999999999999999999865 4678999998876666678899999999999999999999874 45689999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--C
Q 020133 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (330)
Q Consensus 100 ~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--~ 175 (330)
++++|.+++... ..+++.++..++.|++.||+|||+.|++||||+|+||++++++. ++|+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcccc
Confidence 999999988653 46899999999999999999999999999999999999987764 99999999864432211 1
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....++..|+|||.+.+..+..+ +|+||||+++|++++ |+.||.+.+..............+. .... +..
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~ 231 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR-------PDNC-PEE 231 (260)
T ss_pred cCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC-------CCCC-CHH
Confidence 22345678999999877666544 999999999999999 9999987766554444333222111 0111 223
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+.+...++...+|.+|+ +++++...|..
T Consensus 232 ~~~li~~~l~~~p~~Rp-~~~~l~~~l~~ 259 (260)
T cd05067 232 LYELMRLCWKEKPEERP-TFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHccCChhhCC-CHHHHHHHhhc
Confidence 44455555667777764 99999888764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=275.74 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=196.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..+.|++.+.||.|++|.||++... |+.||+|.+.........+.+|+.+++.++|+||+++++++...+..|+||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3578999999999999999999875 78899999877655456788999999999999999999999988999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++|+|||.++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~--~ 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQ--D 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEccccccccccccc--c
Confidence 99999999997665 6999999999999999999999999999999999999987664 9999999987553222 2
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
....+..|+|||.+.+..+..+ +|+||||+++|++++ |+.||.................. . .....| ..+
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~------~~~~~~-~~~ 228 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM-E------APEGCP-PEV 228 (256)
T ss_pred cCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-C------CccCCC-HHH
Confidence 3334567999999877666554 999999999999997 99999876544333222221111 0 011122 223
Q ss_pred ccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
.+.+.++...+|.+| +++.|+++.|..
T Consensus 229 ~~li~~~l~~~p~~R-p~~~~l~~~l~~ 255 (256)
T cd05039 229 YKVMKDCWELDPAKR-PTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHhccChhhC-cCHHHHHHHHhc
Confidence 344445555677766 499999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=278.28 Aligned_cols=257 Identities=19% Similarity=0.308 Sum_probs=195.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCc----EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
..++|++.+.||+|+||+||++.+..+++ .||+|.+..... ....+.+|+..++.+.||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 45789999999999999999999876665 489998865432 24567889999999999999999999875 457
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
+++++|+++|+|.+++..+ +.+++..+..++.|++.||.|||++|++||||||+||++++++. +||+|||+++....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~ 161 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDI 161 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeeccc
Confidence 8999999999999998764 56999999999999999999999999999999999999977654 99999999875433
Q ss_pred CCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 172 HSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 172 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
... .....++..|+|||.+.+..++.+ +|||||||++|||++ |..||....... ....+.....+.. .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~------~ 233 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLLEKGERLPQ------P 233 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCC------C
Confidence 222 122234678999999987776655 999999999999998 999997654433 2233322111110 0
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
...+.+ +.+....++..+|.+| +++.++++.+......+
T Consensus 234 ~~~~~~-~~~li~~~l~~dp~~R-p~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 PICTID-VYMIMVKCWMIDSECR-PRFRELVDEFSRMARDP 272 (279)
T ss_pred ccCCHH-HHHHHHHHcCCChhhC-cCHHHHHHHHHHhhcCC
Confidence 111222 2334445566777777 59999999888765443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=277.21 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=196.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCc---EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
.++|+..+.||+|++|.||++.+..++. .+|+|.+.... .....+.+|+..+++++||||+++.+++...+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4689999999999999999999876554 79999886542 224568889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
||||+++++|.+++.. .+.+++.++..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceeccccc
Confidence 9999999999999875 35789999999999999999999999999999999999998765 49999999986443222
Q ss_pred CCC----cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhc
Q 020133 174 QPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248 (330)
Q Consensus 174 ~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
... ....+..|+|||.+.+..++.+ +|+|||||++|++++ |+.||...+.......+......|.. .
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------~ 233 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP-------M 233 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC-------C
Confidence 111 1123457999999987766555 999999999999998 99999876655544444332221111 1
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..+. .+.+...++...+|..|+ ++.++.+.|.++
T Consensus 234 ~~~~-~~~~li~~c~~~~p~~Rp-~~~~i~~~l~~~ 267 (268)
T cd05063 234 DCPS-AVYQLMLQCWQQDRARRP-RFVDIVNLLDKL 267 (268)
T ss_pred CCCH-HHHHHHHHHcCCCcccCc-CHHHHHHHHHhh
Confidence 1222 223444455556677665 999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=285.23 Aligned_cols=196 Identities=29% Similarity=0.423 Sum_probs=160.1
Q ss_pred eceeccCCceEEEEEEEC--CCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEe--CCeEEEEEeccCC
Q 020133 26 VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 101 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~e~~~g 101 (330)
.++||+|+||+||+|.+. .+++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....|+||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999976 467899999886543 34567899999999999999999999865 3568999999965
Q ss_pred CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC--CCCceEEeecCCccccc
Q 020133 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 170 (330)
Q Consensus 102 ~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~--~~~~vkL~Dfg~a~~~~ 170 (330)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ ..+.+||+|||+++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 787776532 258999999999999999999999999999999999999432 23469999999997543
Q ss_pred CCC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 171 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
... ......+|+.|+|||++.+....+.++|+|||||++|+|++|++||....
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 221 12345689999999999876544566999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=279.42 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=198.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
..|++++.||.|++|.||++.+.. +..+++|.+..... ....+.+|+..++.++||||+++++++......++||||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 569999999999999999999988 88899999876654 3567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-CC
Q 020133 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (330)
Q Consensus 100 ~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-~~ 176 (330)
++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. +||+|||.+........ ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence 999999999753 46899999999999999999999999999999999999987764 99999999864432211 12
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
...++..|+|||.+.+..+..+ +|+||||+++|+|++ |+.||...+..............+ ....++.. +
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-~ 233 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP-------CPAKCPQE-I 233 (261)
T ss_pred CCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-------CCCCCCHH-H
Confidence 2335668999999877766555 999999999999998 899998766555554444321111 11122222 2
Q ss_pred ccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
.+...++...+|.+| +++.++.+.|..
T Consensus 234 ~~~i~~~l~~~p~~R-pt~~~l~~~L~~ 260 (261)
T cd05148 234 YKIMLECWAAEPEDR-PSFKALREELDN 260 (261)
T ss_pred HHHHHHHcCCCchhC-cCHHHHHHHHhc
Confidence 334445555677776 599999998865
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=282.89 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=197.0
Q ss_pred cCCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~ 89 (330)
...++|.+.+.||+|+||.||++.+. .++..||+|.++.... ..+.+.+|+..++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34578999999999999999999863 3456899998875432 235688999999999 799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 90 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
+..|+||||+++++|.+++.... .+++.++..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||+++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~ 189 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLAR 189 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCcccc
Confidence 99999999999999999987543 389999999999999999999999999999999999998665 49999999987
Q ss_pred cccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcC
Q 020133 168 SSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNH 243 (330)
Q Consensus 168 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
....... .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||..........+.+.....+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---- 264 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA---- 264 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC----
Confidence 4433221 122345678999999987776555 999999999999998 9999987665444434332211000
Q ss_pred chhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 244 EWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..... ...+.+...++...+|.+| ++++++++.|.++
T Consensus 265 --~~~~~-~~~~~~li~~cl~~~p~~R-pt~~ell~~l~~~ 301 (302)
T cd05055 265 --QPEHA-PAEIYDIMKTCWDADPLKR-PTFKQIVQLIGKQ 301 (302)
T ss_pred --CCCCC-CHHHHHHHHHHcCCCchhC-cCHHHHHHHHHhh
Confidence 00111 1223344555555777777 4999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=281.36 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=196.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC-----CcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||.||++..... ...+|+|.+..... ....+.+|+..++++ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 347899999999999999999998643 36799998875432 224578899999999 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC
Q 020133 91 HLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~ 154 (330)
.++++|||+++++|.+++... +.+++..++.++.|++.||.|||+.||+||||||+||+++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 999999999999999998642 4589999999999999999999999999999999999998765
Q ss_pred CCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 020133 155 APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (330)
Q Consensus 155 ~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~ 230 (330)
.+||+|||+++....... .....++..|+|||.+.+..++.+ +|||||||++|++++ |..||...........
T Consensus 170 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 170 --VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred --eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 499999999875432211 112234567999999877766555 999999999999998 9999987665544443
Q ss_pred HhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 231 TIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.......+ .+ ...+ ..+.+.+.++...+|.+|+ |+.|+++.|.++
T Consensus 247 ~~~~~~~~----~~---~~~~-~~~~~li~~~l~~~p~~Rp-s~~eil~~l~~~ 291 (293)
T cd05053 247 LKEGYRME----KP---QNCT-QELYHLMRDCWHEVPSQRP-TFKQLVEDLDRM 291 (293)
T ss_pred HHcCCcCC----CC---CCCC-HHHHHHHHHHcccCcccCc-CHHHHHHHHHHh
Confidence 33222111 11 1111 2233445555667788776 999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=282.84 Aligned_cols=252 Identities=20% Similarity=0.316 Sum_probs=193.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC-----CcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
..+|++.+.||+|+||.||++.+..+ ++.||+|.+..... ..+.+.+|+.++..++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 35688999999999999999987543 57899999875432 235678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC
Q 020133 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~ 156 (330)
++++||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~- 162 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN- 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc-
Confidence 9999999999999998532 34888999999999999999999999999999999999987654
Q ss_pred ceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHh
Q 020133 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 157 ~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~ 232 (330)
+||+|||+++....... .....+++.|+|||++.+..+..+ +|||||||++|||++ |..||.+.........+.
T Consensus 163 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 163 -VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred -eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999874432221 123345678999999987776555 999999999999998 888998765544433333
Q ss_pred hcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 233 HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
... .+ .....+|. .+.+....+...+|.+|+ +++++.+.|+.
T Consensus 241 ~~~-~~------~~~~~~~~-~~~~li~~cl~~~p~~RP-~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQ-VL------PCPDDCPA-WVYTLMLECWNEFPSRRP-RFKDIHSRLRT 282 (283)
T ss_pred cCC-cC------CCCCCCCH-HHHHHHHHHhCCCcccCC-CHHHHHHHhhC
Confidence 221 11 11122222 233444555556676666 89999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=290.15 Aligned_cols=192 Identities=25% Similarity=0.446 Sum_probs=165.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
...+|++++.||+|+||.||++.+..+++.||+|..... ....|+.++++++||||+++++++...+..|+|||+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 346799999999999999999999999999999975432 235789999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||+++..........
T Consensus 139 ~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 139 YSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred cCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCccccc
Confidence 965 77777754 457999999999999999999999999999999999999987664 99999999874433333345
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCC
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf 219 (330)
..|++.|+|||++.+..++.+ +|||||||++|+|+++..|+
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCcc
Confidence 678999999999988777655 99999999999999855444
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=276.36 Aligned_cols=202 Identities=29% Similarity=0.495 Sum_probs=177.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.+.||+|++|.||++....+++.+++|.+..... .+.+.+|+..+++++||||+++++++......|+++||+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 3789999999999999999999998899999999876543 568899999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 100 ~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999999875 457899999999999999999999999999999999999987764 9999999987544332 2234
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
..++..|+|||++.+..++.+ +|+||||+++|+|++|+.||......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 457889999999987776555 99999999999999999999865543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=281.54 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=191.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.+.|++++.||.|+||.||++.+..+++.|++|.+..... ....+.+|+..++.++||||+++++.+..++.+|+||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4679999999999999999999999999999999875532 345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCC
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~ 176 (330)
+++++|..++.+ ...+++..++.++.|++.+|.+||+.|++||||+|+||+++.++ .++|+|||++...... ....
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceeccccccccc
Confidence 999999887754 45789999999999999999999999999999999999997665 4999999987643222 2223
Q ss_pred cccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCC
Q 020133 177 STVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
...+++.|+|||++.+ ..++ .++|+|||||++|+|++|+.||...+......+.... ..+..... ..++
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~ 242 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLSQP----SKWS 242 (292)
T ss_pred eecCCccccCceeeccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC-CCccCCCC----cccC
Confidence 4467889999998853 2233 3499999999999999999999876544433333211 11111100 0111
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHH
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+ +.+.+.++...+|.+|+ ++.++++
T Consensus 243 ~~-~~~li~~~l~~~p~~Rp-~~~~il~ 268 (292)
T cd06644 243 ME-FRDFLKTALDKHPETRP-SAAQLLE 268 (292)
T ss_pred HH-HHHHHHHHhcCCcccCc-CHHHHhc
Confidence 11 22334444556777775 7787764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=296.72 Aligned_cols=189 Identities=35% Similarity=0.530 Sum_probs=171.0
Q ss_pred EeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
-++.||+|+.|-||+++.. ++.||||+++ +....+|..|++|+||||+.+.++|.....+|||||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4688999999999999875 7889999764 3445789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCC
Q 020133 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (330)
Q Consensus 105 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y 184 (330)
...++...+++......|..+|+.|+.|||.+.|||||||.-||||..+.. |||+|||-++........-+++||..|
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaW 277 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAW 277 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhh
Confidence 999999999999999999999999999999999999999999999976654 999999998866555556678899999
Q ss_pred CChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 185 ~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
||||++.+.+...+ +|||||||+|||||||..||...+.
T Consensus 278 MAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 278 MAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred hCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccch
Confidence 99999998888777 9999999999999999999986554
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=275.27 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=193.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.+.||+|++|.||++.+..+ ..+|+|.+.......+.+.+|+.++++++|||++++++++. .+..|+||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 36799999999999999999988665 45899988766655677889999999999999999999875 45679999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--C
Q 020133 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (330)
Q Consensus 100 ~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--~ 175 (330)
++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCccccc
Confidence 999999999753 34899999999999999999999999999999999999987764 99999999864432221 1
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....++..|+|||...+...+.+ +|+||||+++|+|+| |+.||.+.........+......+ .....+. .
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~ 231 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-------CPQGCPE-S 231 (260)
T ss_pred CCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------CCcccCH-H
Confidence 22345678999999877666544 999999999999999 999998766555444443332211 0111222 2
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+.+...++...+|.+|+ +++++.+.|.+
T Consensus 232 ~~~li~~~l~~~p~~Rp-~~~~i~~~l~~ 259 (260)
T cd05069 232 LHELMKLCWKKDPDERP-TFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHccCCcccCc-CHHHHHHHHhc
Confidence 33344455556777765 89999888764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=282.15 Aligned_cols=208 Identities=28% Similarity=0.502 Sum_probs=177.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++.+.||+|++|.||++.+..+++.||+|.+..... ..+.+.+|+..++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 479999999999999999999998999999998765432 23567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
|+++++|..+......+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9999999888776667999999999999999999999999999999999999987664 9999999987543322 223
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
...++..|+|||.+.+....+.++|+||||+++|+|++|++||...+.......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 345788999999987655445569999999999999999999987665444333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=283.45 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=193.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECC-------CCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~ 89 (330)
.++|.+.+.||+|+||.||++.+.. +...+|+|.+..... ....+.+|+..++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3789999999999999999998753 235799998875422 234577899999999 799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC
Q 020133 90 THLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~ 153 (330)
+..|+||||+++++|.+++...+ .+++.+++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 99999999999999999997542 48899999999999999999999999999999999999877
Q ss_pred CCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 020133 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (330)
Q Consensus 154 ~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~ 229 (330)
+ .++|+|||.++....... .....+++.|+|||++.+..++.+ +|+|||||++|+|++ |..||..........
T Consensus 177 ~--~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 177 N--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred C--cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 5 499999999864432111 112234568999999987766555 999999999999998 899997655433332
Q ss_pred HHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 230 KTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
........+ +....+. .+.+.+.++...+|.+|+ ++.++++.|.++..
T Consensus 254 ~~~~~~~~~-------~~~~~~~-~~~~li~~~l~~~p~~Rp-s~~evl~~l~~~~~ 301 (307)
T cd05098 254 LLKEGHRMD-------KPSNCTN-ELYMMMRDCWHAVPSQRP-TFKQLVEDLDRILA 301 (307)
T ss_pred HHHcCCCCC-------CCCcCCH-HHHHHHHHHcccChhhCc-CHHHHHHHHHHHHH
Confidence 222211100 0111122 233344555556777776 99999998887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=278.00 Aligned_cols=203 Identities=28% Similarity=0.441 Sum_probs=170.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++++.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+..++.++|+||+++++++..++..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999999999999999986543 22346788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CC
Q 020133 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~ 174 (330)
||+. ++|.+.+.. .+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||+++..... ..
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCC
Confidence 9996 566666544 456889999999999999999999999999999999999987664 999999998643222 22
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|+.||...+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 23345788999999987654334459999999999999999999986554
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=280.65 Aligned_cols=210 Identities=29% Similarity=0.441 Sum_probs=176.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++++.||.|++|.||++.+..++..||+|.+..... ..+.+.+|+..+++++||||+++++++..++..|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 3679999999999999999999998999999999875532 235678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCC
Q 020133 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~ 176 (330)
+++++|.+++.+. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccc
Confidence 9999999998763 57999999999999999999999999999999999999987654 999999987643222 2223
Q ss_pred cccCCCCCCChhhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 177 STVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~----~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
...+++.|+|||.+... ...+.++|+||||+++|+|++|+.||...+......++
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~ 220 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI 220 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH
Confidence 44688899999998532 12233499999999999999999999876554444333
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=279.30 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=190.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEE-----eCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~-----~~~~~ 92 (330)
..++|++.+.||+|+||.||++.+..+++.+|+|.+.........+.+|+..++.+ +||||+++++++. ..+.+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 45899999999999999999999999999999998866544456788899999999 6999999999884 33568
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+|||+++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~ 173 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 173 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceee
Confidence 999999999999988752 356899999999999999999999999999999999999987764 99999999875
Q ss_pred ccCCC-CCCcccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhc
Q 020133 169 SVLHS-QPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRN 242 (330)
Q Consensus 169 ~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (330)
..... ......+++.|+|||.+.. ..+ +.++|+|||||++|+|++|+.||........+....... .+....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 251 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP-PPTLHQ 251 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-CCcccC
Confidence 43322 2234568899999998753 223 345999999999999999999998765433333222111 111100
Q ss_pred CchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 243 HEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.. .. ...+...+.++...+|.+| +++.|+++
T Consensus 252 ~~----~~-~~~~~~li~~~l~~~p~~R-ps~~ell~ 282 (286)
T cd06638 252 PE----LW-SNEFNDFIRKCLTKDYEKR-PTVSDLLQ 282 (286)
T ss_pred CC----Cc-CHHHHHHHHHHccCCcccC-CCHHHHhh
Confidence 00 01 1122334445555677776 48888765
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=277.53 Aligned_cols=209 Identities=31% Similarity=0.501 Sum_probs=175.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC------eE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------HL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~------~~ 92 (330)
.++|++.+.||+|++|.||++.+..+++.+++|.+.......+.+.+|+..++++ .|+||+++++++.... .+
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 5899999999999999999999998999999999887766567889999999998 6999999999997644 48
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
|+||||+++++|.+++.. +..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~ 162 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQ 162 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCcccee
Confidence 999999999999998864 357999999999999999999999999999999999999987654 99999998864
Q ss_pred ccCC-CCCCcccCCCCCCChhhhhcCC----CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 169 SVLH-SQPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 169 ~~~~-~~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
.... .......++..|+|||.+.... ....++|+||||+++|+|++|+.||...........
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 229 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH
Confidence 3322 2223456888999999875422 223449999999999999999999986554444433
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=274.77 Aligned_cols=204 Identities=32% Similarity=0.492 Sum_probs=176.5
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
+|+..+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++|+||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58889999999999999999998999999998865431 235688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
+||+++++|.+++.+.+++++..+..++.|++.||++||+.|++|+||+|+||+++.++. +||+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988888999999999999999999999999999999999999987664 999999998754433333
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhH
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~ 227 (330)
....++..|+|||.+......+.++|+||||+++|+|++|+.||........
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~ 210 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH
Confidence 4556888999999987665234459999999999999999999977554333
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=287.27 Aligned_cols=199 Identities=27% Similarity=0.494 Sum_probs=178.3
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
.-|.++++||+|+||.||+|.++.+|+.+|||.+.... ....+.+|+.+++++..|++|++|+.+..+..+|+|||||.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 34788999999999999999999999999999886653 34678899999999999999999999999999999999999
Q ss_pred CCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCCCCcc
Q 020133 101 GGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKST 178 (330)
Q Consensus 101 g~sL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~~~~~ 178 (330)
-|++.++++ +++++++.++..+++.-++||.|||...-+|||||..|||++-++. .||+|||+|-... .-....+.
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCcc
Confidence 999999987 4678999999999999999999999999999999999999987765 8999999985332 22334677
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
+|||.|||||++..-+|++. +||||||++..||..|++||....
T Consensus 190 IGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred ccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCccccc
Confidence 89999999999999999988 899999999999999999997643
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=282.79 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=190.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC--------------CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeee
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT--------------EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFK 83 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~ 83 (330)
.++|++.+.||+|+||.||++.+..+ ...||+|.+.... .....+.+|+..+++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46899999999999999999987543 2358999887542 2234688999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec
Q 020133 84 EVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (330)
Q Consensus 84 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~ 151 (330)
+++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999886432 368889999999999999999999999999999999998
Q ss_pred CCCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCCChhh
Q 020133 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPK 226 (330)
Q Consensus 152 ~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt--g~~pf~~~~~~~ 226 (330)
.++. +||+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+...
T Consensus 164 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred CCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 7654 99999999864332211 122344678999999887776554 999999999999998 678888765544
Q ss_pred HHHHHhhcC---ChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 227 NFRKTIHRI---SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 227 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
.+.....-. ........+ ...| ..+.+...++...+|.+|+ +++++.+.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~---~~~~-~~l~~li~~~l~~~p~~RP-s~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQT---PLCP-SPVFKLMMRCWSRDIKDRP-TFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCCC---CCCC-HHHHHHHHHHcCCCchhCc-CHHHHHHHHh
Confidence 333322100 000000001 0111 2233444555556777764 9999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=272.02 Aligned_cols=247 Identities=34% Similarity=0.498 Sum_probs=195.6
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+|++.+.||+|++|.||++.+..+++.+|+|.+.... .....+.+|+..+++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5999999999999999999999999999999987542 2345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
+++++|.+++... ..+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999999763 35899999999999999999999999999999999999975543 58999999987655444444
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
...++..|+|||.+.+...+.+ +|+||||+++|+|++|+.||...+..............+ +....+.+ +.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-l~ 230 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-------ISDRYSPD-LR 230 (256)
T ss_pred ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC-------CCCCcCHH-HH
Confidence 5678889999999977665544 999999999999999999998766555544443321111 11111121 22
Q ss_pred cccccCCCCCCCCccCCHHHHHH
Q 020133 257 DNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.++...+|..|+ ++.|+++
T Consensus 231 ~li~~~l~~~p~~Rp-t~~~ll~ 252 (256)
T cd08220 231 QLILSMLNLDPSKRP-QLSQIMA 252 (256)
T ss_pred HHHHHHccCChhhCC-CHHHHhh
Confidence 233344445666655 8888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=276.34 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=191.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC------CeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------THL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~------~~~ 92 (330)
.++|++.+.||+|+||.||++.+..+++.||+|.+.........+.+|+..++++ +||||+++++++... ..+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 4679999999999999999999999999999999987666667788999999998 699999999998753 468
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
|+||||+++++|.+++... ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++. ++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~ 162 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecc
Confidence 9999999999999998763 46899999999999999999999999999999999999987764 9999999987443
Q ss_pred CC-CCCCcccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 171 LH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 171 ~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
.. .......+++.|+|||++.+ ..++ .++|+|||||++|+|++|+.||............... ..+.
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~----- 235 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PAPR----- 235 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCC-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC-CCCC-----
Confidence 22 22344568899999999863 2343 4499999999999999999999765443332222111 1111
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
......+ ..+.+.+.++...+|.+|+ ++++++.
T Consensus 236 ~~~~~~~-~~~~~li~~~l~~~p~~Rp-t~~~il~ 268 (272)
T cd06637 236 LKSKKWS-KKFQSFIESCLVKNHSQRP-TTEQLMK 268 (272)
T ss_pred CCCCCcC-HHHHHHHHHHcCCChhhCC-CHHHHhh
Confidence 1111111 1233344455556677765 7787764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=279.33 Aligned_cols=249 Identities=28% Similarity=0.453 Sum_probs=194.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..+|++.+.||.|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++||||+++++++.....+|+|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3679999999999999999999999999999998865432 345778999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-CCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-~~~ 177 (330)
+++++|..++.. ..+++.++..++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++........ ...
T Consensus 98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 98 LAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred cCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCC
Confidence 999999998865 46899999999999999999999999999999999999987654 99999998874433222 233
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..++..|+|||.+.+..+... +|+|||||++|+|++|+.||...+............ .+... .+ ..++. .+.+
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~-~~---~~~~~-~~~~ 247 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQ-NP---EKLSP-IFRD 247 (296)
T ss_pred cCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CcccC-Cc---ccCCH-HHHH
Confidence 467889999999887766555 999999999999999999998766544333322111 11110 01 11111 2223
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+| .++.++++
T Consensus 248 li~~~l~~dp~~R-pt~~~il~ 268 (296)
T cd06655 248 FLNRCLEMDVEKR-GSAKELLQ 268 (296)
T ss_pred HHHHHhhcChhhC-CCHHHHhh
Confidence 3445555677776 48888774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=273.30 Aligned_cols=209 Identities=33% Similarity=0.497 Sum_probs=176.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC------cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~ 92 (330)
..|++.+.||+|++|.||++.+..+++.||+|.+.... .....+.+|+..+++++||||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875421 1224678899999999999999999998764 468
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
++|+||+++++|.+++...+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECccccccccccc
Confidence 89999999999999998878899999999999999999999999999999999999998765 4999999998743221
Q ss_pred ----CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 173 ----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 173 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.......++..|+|||.+.+...+.+ +|+|||||++|+|++|+.||..........+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 222 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH
Confidence 11123457889999999987766544 999999999999999999998766555544443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.99 Aligned_cols=195 Identities=22% Similarity=0.288 Sum_probs=166.6
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.....+|.+.+.||+|+||.||++.+..+++.||||... ...+.+|+.++++++|+||+++++++...+..|+||
T Consensus 165 ~~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 165 VVAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred ccccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 334568999999999999999999999999999999532 234578999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-
Q 020133 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~- 174 (330)
|++. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccc
Confidence 9995 5888877653 57999999999999999999999999999999999999987654 99999999874432211
Q ss_pred --CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 175 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 175 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
.....||+.|+|||++.+..++.+ +|||||||++|||++|..|+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcc
Confidence 223468999999999988877655 999999999999999876653
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=271.19 Aligned_cols=246 Identities=25% Similarity=0.452 Sum_probs=191.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEe-CCeEEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~-~~~~~lv~e 97 (330)
.|++.+.||.|++|.||++.+..+++.||+|.+..... ..+.+.+|+..+++++|+|++++++.+.. .+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 49999999999999999999999999999999875432 23467889999999999999999998764 446899999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-C
Q 020133 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~ 174 (330)
|+++++|.+++.. ...+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 9999999998875 346899999999999999999999999999999999999987654 9999999987443222 2
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
.....+++.|+|||++.+..++.+ +|+||||+++++|++|+.||...+............ .+.. ....+ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~------~~~~~-~~ 229 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPM------PKDYS-PE 229 (257)
T ss_pred cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCC------ccccC-HH
Confidence 234467889999999987776655 999999999999999999998766544443333221 1111 11111 22
Q ss_pred cccccccCCCCCCCCccCCHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.+.++...+|..|+ ++.++++
T Consensus 230 ~~~li~~~l~~~p~~Rp-~~~~~l~ 253 (257)
T cd08223 230 LGELIATMLSKRPEKRP-SVKSILR 253 (257)
T ss_pred HHHHHHHHhccCcccCC-CHHHHhc
Confidence 33444555556777775 7888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=279.66 Aligned_cols=208 Identities=30% Similarity=0.468 Sum_probs=174.3
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
+-|++.+.||+|+||.||++.+..++..+++|.+.... .....+.+|+..++.++||||+++++++...+..|+|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34789999999999999999999999999999886543 23456788999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCc
Q 020133 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (330)
Q Consensus 100 ~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~ 177 (330)
++++|..++.. ..++++..+..++.|++.||.|||+.|++||||+|+||+++.++ +++|+|||++...... .....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--CEEEcccccccccccccccccc
Confidence 99999887754 46799999999999999999999999999999999999998765 4999999998643322 22234
Q ss_pred ccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 178 TVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
..++..|+|||++.. ..+ +.++|+|||||++|+|++|+.||...+........
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 220 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI 220 (282)
T ss_pred ccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHH
Confidence 568889999999842 223 34599999999999999999999876654444443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=276.77 Aligned_cols=255 Identities=19% Similarity=0.261 Sum_probs=190.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCc----EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
..++|++.+.||+|+||+||++....+++ .+++|.+..... ....+..|+..+.+++||||+++++++. ....
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 34789999999999999999999977766 477777654321 2245677888889999999999999875 4557
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
++++||+++++|.+++.. .+.+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||+++....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccC
Confidence 899999999999999975 45789999999999999999999999999999999999998765 499999999874432
Q ss_pred CCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 172 HSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 172 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
... .....++..|+|||.+.+..++.+ +|+||||+++||+++ |+.||.+..... ....+.....+. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~------~~ 233 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERLA------QP 233 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCC------CC
Confidence 221 122345678999999987776555 999999999999998 999998755432 233332211111 00
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
...+. .+.....+++..+|..|+ ++.|+.+.|..+..
T Consensus 234 ~~~~~-~~~~li~~c~~~~p~~Rp-s~~el~~~l~~~~~ 270 (279)
T cd05111 234 QICTI-DVYMVMVKCWMIDENVRP-TFKELANEFTRMAR 270 (279)
T ss_pred CCCCH-HHHHHHHHHcCCCcccCc-CHHHHHHHHHHHHh
Confidence 11111 122334455667777764 99999998877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=272.56 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=194.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
..+|++.+.||.|+||.||++.+.. +..+|+|.+.........+.+|+..+++++||||+++++++......|+||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4689999999999999999998854 678999988766555678899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--CC
Q 020133 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PK 176 (330)
Q Consensus 100 ~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--~~ 176 (330)
++++|.+++... +.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+........ ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcccccC
Confidence 999999998754 5689999999999999999999999999999999999998665 499999998864332211 12
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
...++..|+|||.+.+..+..+ +|+||||+++|+|++ |+.||................. .+.....+..+
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 230 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR--------LYKPRLASQSV 230 (256)
T ss_pred CCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC--------CCCCCCCCHHH
Confidence 2334568999999987766554 999999999999998 9999987655443333321110 00111112334
Q ss_pred ccccccCCCCCCCCccCCHHHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
.+...++...+|..| ++++|+++.|
T Consensus 231 ~~l~~~~l~~~p~~R-p~~~~~l~~l 255 (256)
T cd05112 231 YELMQHCWKERPEDR-PSFSLLLHQL 255 (256)
T ss_pred HHHHHHHcccChhhC-CCHHHHHHhh
Confidence 444555556677776 4999998866
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=277.32 Aligned_cols=210 Identities=30% Similarity=0.486 Sum_probs=175.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC-----CeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----THLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~-----~~~~ 93 (330)
.++|++.+.||+|+||.||++.+..+++.+|+|.+.........+.+|+..++++ +|||++++++++... +..|
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 5789999999999999999999999999999999876554556778899999998 799999999998754 3589
Q ss_pred EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 94 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+||||+++++|.++++. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~ 178 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQL 178 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhc
Confidence 99999999999988753 457899999999999999999999999999999999999987664 999999998744
Q ss_pred cCCC-CCCcccCCCCCCChhhhhcCC----CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 170 VLHS-QPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 170 ~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.... ......++..|+|||.+.... ..+.++|+|||||++|+|++|+.||........+..+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 3322 223446788999999985432 1234599999999999999999999876554444443
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=287.70 Aligned_cols=208 Identities=28% Similarity=0.431 Sum_probs=176.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------C
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~ 90 (330)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 478999999999999999999999999999999886432 2234677899999999999999999998644 3
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
..|+||||+.+ +|.+.+... ++...+..++.|++.||.+||++|++||||||+||+++.++. +||+|||+++...
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~ 169 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 169 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCC
Confidence 57999999965 888877654 899999999999999999999999999999999999987764 9999999997554
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.........+++.|+|||++.+..+..+ +|+|||||++|+|++|+.||...+....+.+++.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 4433344567889999999988777655 9999999999999999999988776655555543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=277.00 Aligned_cols=201 Identities=31% Similarity=0.501 Sum_probs=170.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.++|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 4789999999999999999999999999999999865432 23456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CC
Q 020133 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~ 175 (330)
|+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||+++...... ..
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence 9975 898888654 46899999999999999999999999999999999999987664 9999999986432221 12
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
....++..|+|||.+.+....+.++|+||||+++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 233567889999998765434455999999999999999999997655
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=276.97 Aligned_cols=193 Identities=33% Similarity=0.482 Sum_probs=167.9
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 29 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
||+|+||+||+|.+..+|+.||+|.+.... .....+.+|+.++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999999999999886532 2234567899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCC
Q 020133 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (330)
Q Consensus 105 ~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~ 182 (330)
.+++.+.+ .+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||.+.............++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99987765 7999999999999999999999999999999999999987764 9999999987544433444556788
Q ss_pred CCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 183 ~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
.|+|||.+.+..++.+ +|+||||+++|+|++|+.||.....
T Consensus 159 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 159 GYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 9999999877765544 9999999999999999999976544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=278.55 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=194.8
Q ss_pred CCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..+|++.++||+|+||.||++... .++..+++|.+.... .....+.+|+..++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 467899999999999999999753 356789999876543 23457889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCce
Q 020133 94 IVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~---------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~v 158 (330)
++|||+++++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||++++++ .+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~ 161 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CE
Confidence 9999999999999987643 488999999999999999999999999999999999998765 49
Q ss_pred EEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhc
Q 020133 159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 159 kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 234 (330)
+|+|||++........ .....+++.|+|||.+.+..++.+ +|+|||||++|+|++ |..||...............
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 9999999864332211 122334678999999987777655 999999999999998 99999876655544444332
Q ss_pred CChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 235 ISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
...+ ....+|.. +.+.+.+++..+|.+|+ +++|+.+.|.
T Consensus 241 ~~~~-------~~~~~~~~-~~~li~~cl~~~P~~Rp-~~~~l~~~l~ 279 (280)
T cd05092 241 RELE-------RPRTCPPE-VYAIMQGCWQREPQQRM-VIKDIHSRLQ 279 (280)
T ss_pred ccCC-------CCCCCCHH-HHHHHHHHccCChhhCC-CHHHHHHHHh
Confidence 2111 11122222 33455556667777765 8999988775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.10 Aligned_cols=246 Identities=25% Similarity=0.312 Sum_probs=186.6
Q ss_pred ceeccCCceEEEEEEECCCCc--EEEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.+..++. .+++|.+... ......+.+|+..+.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999988775 4688877643 22335678899999999 799999999999999999999999999
Q ss_pred CChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 102 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 102 ~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
++|.+++..+. .+++..++.++.|++.||+|||+.|++||||||+||+++.++ .+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC--eEEECCCCC
Confidence 99999987543 478999999999999999999999999999999999998765 499999999
Q ss_pred cccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 166 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
+..............+..|+|||++....++.+ +|+||||+++|+|++ |..||...+..............+ .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~----~~ 233 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE----KP 233 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCC----CC
Confidence 863322212222234567999999877666544 999999999999997 999998765544444333221111 00
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+. .+.+.+.++...+|.+|+ +++++++.|..+
T Consensus 234 ---~~~~~-~~~~li~~~l~~~p~~Rp-s~~~il~~l~~~ 268 (270)
T cd05047 234 ---LNCDD-EVYDLMRQCWREKPYERP-SFAQILVSLNRM 268 (270)
T ss_pred ---CcCCH-HHHHHHHHHcccChhhCC-CHHHHHHHHHHh
Confidence 11112 233445555566777655 899999888754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=275.17 Aligned_cols=201 Identities=30% Similarity=0.482 Sum_probs=172.1
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc-------cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
+|++.+.||.|+||.||++.+ .+++.+|+|.+...... ...+.+|+..+++++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 488999999999999999987 46889999988654221 2457889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC---
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~--- 171 (330)
|+||+++++|.+++.+.+++++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999988888999999999999999999999999999999999999987654 99999998864321
Q ss_pred ----CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 172 ----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 172 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
........++..|+|||.+.+..++.. +|+||||+++|+|++|+.||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHH
Confidence 111223457889999999987776555 999999999999999999998655443
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=273.31 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=195.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.+.||+|+||.||++.+.. +..+|+|.+.........+.+|+.++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4789999999999999999998654 5569999887665555678899999999999999999999887 7789999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--C
Q 020133 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (330)
Q Consensus 100 ~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--~ 175 (330)
++++|.+++.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCCcccc
Confidence 999999999763 3578899999999999999999999999999999999998765 499999998864432221 1
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....++..|+|||.+....++.+ +|+||||+++|+++| |+.||...+.......+......+.. ...+. .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-~ 231 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP-------ENCPE-E 231 (260)
T ss_pred cCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCc-------ccCCH-H
Confidence 22234567999999977666555 999999999999999 99999876665544444333222111 11222 2
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+.+.+.++...+|.+|+ +++++.+.|..
T Consensus 232 ~~~~i~~~l~~~p~~Rp-~~~~l~~~L~~ 259 (260)
T cd05073 232 LYNIMMRCWKNRPEERP-TFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHcccCcccCc-CHHHHHHHHhc
Confidence 33445555666777765 89999888864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=273.30 Aligned_cols=201 Identities=34% Similarity=0.543 Sum_probs=174.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
||++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+..+++++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999999999999999876544 346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC---
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--- 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~--- 175 (330)
+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEcccccccccCCCCCcccc
Confidence 99999999998877899999999999999999999999999999999999998765 4999999998754332221
Q ss_pred --CcccCCCCCCChhhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 176 --KSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 176 --~~~~~~~~y~aPE~~~~~~--~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
....++..|+|||.+.+.. ....++|+||||+++|++++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~ 211 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence 1245788999999987654 134449999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=273.25 Aligned_cols=245 Identities=25% Similarity=0.322 Sum_probs=188.4
Q ss_pred ceeccCCceEEEEEEECCCC---cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTE---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++....++ ..+|+|.+..... ..+.+.+|+..++.+.||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 47999999999999876544 7899998876554 34578899999999999999999998764 567999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC----c
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----S 177 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~----~ 177 (330)
++|.+++...+.+++..+..++.|++.||++||+.|++|+||||+||+++.++. +||+|||.++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988888999999999999999999999999999999999999987764 9999999987543332211 1
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
..++..|+|||.+.+..++.+ +|+||||+++|++++ |..||...+.......+......+ . ....+. .+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~----~---~~~~~~-~l~ 228 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP----R---PEECPQ-EIY 228 (257)
T ss_pred ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC----C---CCCCCH-HHH
Confidence 122457999999977776555 999999999999998 999998766544333332221111 0 011111 223
Q ss_pred cccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 257 DNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+.+.++...+|.+|+ ++.++.+.|...
T Consensus 229 ~li~~cl~~~p~~Rp-~~~~l~~~l~~~ 255 (257)
T cd05060 229 SIMLSCWKYRPEDRP-TFSELESTFRRD 255 (257)
T ss_pred HHHHHHhcCChhhCc-CHHHHHHHHHhc
Confidence 444455556677765 999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=280.54 Aligned_cols=202 Identities=26% Similarity=0.484 Sum_probs=176.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+.++|++.+.||+|+||+||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3468999999999999999999999999999999886543 23467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+++++|.+++.+.+.+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~~-~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELINS-IA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhhh-cc
Confidence 999999999999888889999999999999999999997 6899999999999998765 4999999987643221 22
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
....++..|+|||++.+..++.+ +|+|||||++|+++||+.||.....
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred CccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccch
Confidence 34568899999999877766555 9999999999999999999986443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=305.56 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=211.9
Q ss_pred CCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..-+..+.||+|+||.||+++-.. ....||||.++.... .+.+|+||+.++..++|||||+++|+|..++.+|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 456789999999999999999764 346799999987643 4678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceE
Q 020133 94 IVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~--------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vk 159 (330)
+|+||+..|+|.+++...+ +|+..+.+.|+.|||.|..||-++.+|||||...|+||.++-. ||
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VK 643 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VK 643 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EE
Confidence 9999999999999996432 2889999999999999999999999999999999999987664 99
Q ss_pred EeecCCcccccCCCCCC---cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcC
Q 020133 160 ICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (330)
Q Consensus 160 L~Dfg~a~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 235 (330)
|+|||+++......... ......+|||||.+..+.+++. |||||+||+|||+++ |+.||.+.++.+.+..+..+-
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 99999998655444332 2345679999999999999877 999999999999998 999999999988887777664
Q ss_pred ChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCCCCCCc
Q 020133 236 SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQS 293 (330)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~~~~~~ 293 (330)
-++.. ..+|.+ +-..+..|+.+.|.+|+ ++.||-..|+..........+
T Consensus 723 lL~~P-------e~CP~~-vY~LM~~CW~~~P~~RP-sF~eI~~~L~~~~~~s~~~~~ 771 (774)
T KOG1026|consen 723 LLSCP-------ENCPTE-VYSLMLECWNENPKRRP-SFKEIHSRLQAWAQASPKYSS 771 (774)
T ss_pred cccCC-------CCCCHH-HHHHHHHHhhcCcccCC-CHHHHHHHHHHHHhcCccccc
Confidence 33322 233332 22333344445555544 999999999988765554443
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=273.68 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=186.2
Q ss_pred ceeccCCceEEEEEEE--CCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|+||.||++.. ..++..+|+|++..... ..+.+.+|+..++.++||||+++++++. ....++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 3689999999999964 45688999998865432 2356788999999999999999999875 4567999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC----CCc
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKS 177 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~----~~~ 177 (330)
++|.+++...+.+++..+..++.|++.||.+||++|++||||||+||+++.++ .++|+|||+++....... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCC
Confidence 99999998878899999999999999999999999999999999999998765 499999999875433222 122
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
..++..|+|||.+....+..+ +|+|||||++|||++ |+.||......... ..+.....++ +...++.+ +.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~i~~~~~~~------~~~~~~~~-l~ 228 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGERME------CPQRCPPE-MY 228 (257)
T ss_pred CCCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCCC------CCCCCCHH-HH
Confidence 234578999999876665544 999999999999998 99999876544333 3332211111 11122222 33
Q ss_pred cccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 257 DNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+.+.++...+|..|+ +++++.+.|++
T Consensus 229 ~li~~~~~~~p~~Rp-~~~~i~~~l~~ 254 (257)
T cd05116 229 DLMKLCWTYGVDERP-GFAVVELRLRN 254 (257)
T ss_pred HHHHHHhccCchhCc-CHHHHHHHHhc
Confidence 455555556777664 99999888865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.29 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=189.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECC----------------CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeee
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR 81 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~ 81 (330)
.++|++.+.||+|+||.||++.+.. ++..||+|.+..... ....+.+|+..++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3689999999999999999986532 345789998875432 2357889999999999999999
Q ss_pred eeEEEEeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEe
Q 020133 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (330)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli 150 (330)
+++++...+..|+||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999987542 36778899999999999999999999999999999999
Q ss_pred cCCCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCCChh
Q 020133 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP 225 (330)
Q Consensus 151 ~~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt--g~~pf~~~~~~ 225 (330)
+.++ .++|+|||+++....... .....++..|++||...+..++.+ +|+|||||++|||++ |..||...+..
T Consensus 164 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 164 GKNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred cCCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 8665 499999999874432221 122234578999999877776554 999999999999998 78899765554
Q ss_pred hHHHHHhhcCChhHHhcCchh--hccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 226 KNFRKTIHRISIPEIRNHEWF--LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
..+........ .. .....+ ...++ ..+.+...++...+|.+|+ ++.|+.+.|.
T Consensus 241 ~~~~~~~~~~~-~~-~~~~~~~~~~~~~-~~~~~li~~cl~~~p~~Rp-~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFR-DQ-GRQVYLPKPALCP-DSLYKLMLSCWRRNAKERP-SFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHh-hc-cccccCCCCCCCC-HHHHHHHHHHcCCCcccCC-CHHHHHHHHh
Confidence 43322211000 00 000000 01111 2233444455556777764 9999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=272.90 Aligned_cols=200 Identities=31% Similarity=0.537 Sum_probs=177.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+.|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+..+++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468999999999999999999999999999999876643 356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC-C
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 176 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~-~ 176 (330)
+++++|.+++....++++..++.++.|++.||.+||+ .|++|+||+|+||+++.++. ++|+|||.+......... .
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999888889999999999999999999999 99999999999999987654 999999998755433332 2
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
...++..|+|||.+.+..++.+ +|+||||+++|+|++|+.||....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccc
Confidence 4467889999999877765544 999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=278.92 Aligned_cols=201 Identities=30% Similarity=0.510 Sum_probs=174.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..+|++++.||+|++|.||++.+..+++.||+|.+..... ..+.+.+|+..++.++||||+++++++...+..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 3789999999999999999999999999999999876433 235678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
+++++|.+++.+ ..+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||.+....... ....
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCcCc
Confidence 999999998865 56899999999999999999999999999999999999987664 9999999986443322 2234
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
..+++.|+|||.+.+..+..+ +|+|||||++|++++|+.||...+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred ccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 467889999999987766544 9999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=279.91 Aligned_cols=211 Identities=34% Similarity=0.469 Sum_probs=177.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~l 94 (330)
.+.|++.+.||.|++|.||+|.+..+++.+|+|.++.... ....+.+|+..+++++||||+++++++... +..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 3679999999999999999999999999999999875432 223567899999999999999999999877 88999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-
Q 020133 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~- 172 (330)
||||+.+ +|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence 9999975 8988887643 5999999999999999999999999999999999999987754 999999998754433
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+......++..
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2223445788999999987665445559999999999999999999998776665555543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.34 Aligned_cols=200 Identities=31% Similarity=0.515 Sum_probs=173.2
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
+|+..+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+..+++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48889999999999999999999999999998865321 23567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
|+||++|++|.+++...+++++..++.++.|++.||.+||++|++|+||+|+||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988889999999999999999999999999999999999999976543 499999999864432211
Q ss_pred -----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 175 -----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 175 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCC
Confidence 123457889999999877666554 999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=276.48 Aligned_cols=209 Identities=30% Similarity=0.488 Sum_probs=176.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
+|++++.||.|++|.||++.+..+|+.||+|.+..... ....+.+|+..+++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999876532 2356778999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CC
Q 020133 100 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (330)
Q Consensus 100 ~g~sL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~ 175 (330)
++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 86 888877653 36899999999999999999999999999999999999987664 9999999986443221 22
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
....++..|++||.+.+....+.++|+||||+++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 215 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 3345688999999987655445559999999999999999999998776666555543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=280.70 Aligned_cols=246 Identities=32% Similarity=0.474 Sum_probs=185.9
Q ss_pred EEeceeccCCceEEEEEEEC----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 24 ELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.+.+.||.|+||.||.|... ..+..|+||.++.... ..+.+.+|+..+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57889999999999999998 3567899999965432 24688999999999999999999999998888999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--
Q 020133 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (330)
Q Consensus 98 ~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-- 173 (330)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++++|++|+|+||+++.++ .+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT--EEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccc
Confidence 99999999999886 6799999999999999999999999999999999999998766 49999999987542211
Q ss_pred -CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCC
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
..........|+|||.+.+..++.+ +||||||+++||+++ |+.||...+........... ..+. ....+|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-~~~~------~~~~~~ 231 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG-QRLP------IPDNCP 231 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-EETT------SBTTSB
T ss_pred cccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc-ccce------eccchh
Confidence 1233346678999999987776544 999999999999999 78999887655544444222 1111 111122
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHHHH
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
.. +...+.+|+..+|..|+ ++.++.+.|
T Consensus 232 ~~-~~~li~~C~~~~p~~RP-s~~~i~~~L 259 (259)
T PF07714_consen 232 KD-IYSLIQQCWSHDPEKRP-SFQEILQEL 259 (259)
T ss_dssp HH-HHHHHHHHT-SSGGGS---HHHHHHHH
T ss_pred HH-HHHHHHHHcCCChhhCc-CHHHHHhcC
Confidence 22 33445555556676655 999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=272.98 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=194.7
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++.+.||.|++|+||++....++..+++|++..+.. ....+.+|+..++.++|+||+++++.+......|+|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 479999999999999999999998999999998865432 345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-
Q 020133 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (330)
Q Consensus 99 ~~g~sL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~- 174 (330)
+++++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||++++++. ++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999999764 45899999999999999999999999999999999999987654 99999999864433222
Q ss_pred ----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccC
Q 020133 175 ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 175 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
.....++..|+|||.+......+.++|+||||+++|+|++|+.||...+......+...... +.. ........+
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~ 236 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSL-ETGADYKKY 236 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-CCc-CCccccccc
Confidence 13346788999999987763344559999999999999999999987666554444443311 111 000000111
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHH
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+. .+.+.+.++...+|..|+ ++.++++
T Consensus 237 ~~-~~~~li~~~l~~~p~~Rp-~~~~ll~ 263 (267)
T cd06610 237 SK-SFRKMISLCLQKDPSKRP-TAEELLK 263 (267)
T ss_pred cH-HHHHHHHHHcCCChhhCc-CHHHHhh
Confidence 11 122334444556677664 7777654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=274.51 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=190.8
Q ss_pred eEEeceeccCCceEEEEEEECC---CCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe-----
Q 020133 23 YELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~----- 91 (330)
|++.+.||+|+||.||.+.... ++..||+|.++..... ...+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998765 3478999988754322 2467889999999999999999998876543
Q ss_pred -EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecC
Q 020133 92 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (330)
Q Consensus 92 -~~lv~e~~~g~sL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg 164 (330)
.++||||+++++|..++... ..+++..++.++.|++.||.|||+.|++||||||+||++++++ .+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCcc
Confidence 79999999999999888532 3589999999999999999999999999999999999998765 49999999
Q ss_pred CcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 165 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
+++....... ......+..|+|||.+.+..++.+ +|||||||++|||++ |..||.+.+..............+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-- 235 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK-- 235 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence 9874432221 112234668999999877666555 999999999999999 999998766554443333221110
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+ ...+ ..+.+.+.++...+|.+| +++.|+.+.|..+
T Consensus 236 --~~---~~~~-~~~~~li~~~l~~~p~~R-p~~~e~~~~l~~~ 272 (273)
T cd05035 236 --QP---EDCL-DELYDLMYSCWRADPKDR-PTFTKLREVLENI 272 (273)
T ss_pred --CC---cCCC-HHHHHHHHHHcCCChhhC-cCHHHHHHHHHhh
Confidence 01 1111 223344455666778887 4999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=277.13 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=194.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
..++|++.+.||+|+||.||++..+. .+..||+|.+...... ...+.+|+..++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35789999999999999999987652 3557999987654322 2457789999999999999999999999899
Q ss_pred EEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEe
Q 020133 92 LAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~ 161 (330)
.|+||||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||+++.++ .++|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--~~~L~ 161 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--TVKIG 161 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--cEEEC
Confidence 99999999999999999752 2356778899999999999999999999999999999998765 49999
Q ss_pred ecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCCh
Q 020133 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISI 237 (330)
Q Consensus 162 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 237 (330)
|||+++....... .....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+.............. .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~ 239 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-Y 239 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C
Confidence 9999874332211 122344678999999987776555 999999999999998 789998766544333322211 1
Q ss_pred hHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 238 PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
+. +....+ ..+.+...++...+|.+|+ ++.++++.+++...
T Consensus 240 ~~------~~~~~~-~~~~~li~~~l~~~p~~Rp-s~~~ll~~l~~~~~ 280 (288)
T cd05061 240 LD------QPDNCP-ERVTDLMRMCWQFNPKMRP-TFLEIVNLLKDDLH 280 (288)
T ss_pred CC------CCCCCC-HHHHHHHHHHcCCChhHCc-CHHHHHHHHHhhcC
Confidence 10 111111 2233444555556777765 99999999887644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=277.68 Aligned_cols=207 Identities=33% Similarity=0.545 Sum_probs=177.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++.+.||+|++|.||++.+..+++.||+|.++.. ......+.+|+..+++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999999999999999988653 2334678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--CC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~~ 175 (330)
|++++.+..+..+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9998777776766677999999999999999999999999999999999999987654 9999999987554433 23
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
....++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+........
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 212 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 345678899999999877344455999999999999999999998766554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=294.87 Aligned_cols=209 Identities=27% Similarity=0.475 Sum_probs=180.9
Q ss_pred CCCe-EEeceeccCCceEEEEEEECCCCcEEEEEEeec-----CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe--
Q 020133 20 SDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-- 91 (330)
Q Consensus 20 ~~~y-~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~-- 91 (330)
.+|| +...+||+|+|-+||+|.|..+|..||--.++. .....+++..|+.+|+.|+||||+++|+++.+..+
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 4566 567889999999999999999999998665432 33444789999999999999999999999998655
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+-+|+|.+..|+|+.|+++.+.++...++.|++||++||.|||++. |+|||||.+||||+.+ .+.|||+|+|+|...
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHHh
Confidence 7789999999999999999999999999999999999999999986 9999999999999865 357999999999744
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
... ...+.+|||.|||||++. ..|+.. +||||||++|.||+|+..||..-.++.++-+.+
T Consensus 197 r~s-~aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV 256 (632)
T KOG0584|consen 197 RKS-HAKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV 256 (632)
T ss_pred hcc-ccceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH
Confidence 433 334478999999999986 667766 999999999999999999999887777665555
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=272.45 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=191.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEE-eCCeEEEEEe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVME 97 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~-~~~~~~lv~e 97 (330)
+..+|++.+.||+|++|.||++... |..||+|.+.... ..+.+.+|+..+++++|+|++++++++. ..+..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 3468999999999999999999765 7789999876543 3457889999999999999999999765 4567899999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|+++++|.+++.+.+ .+++..+..++.|++.||.+||++|++||||||+||++++++. +||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC--
Confidence 999999999987644 4899999999999999999999999999999999999987764 9999999987433222
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
.....+..|+|||++.+..++.+ +|+|||||++|+|++ |+.||...........+..... +.+...+|. .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~ 227 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------MDAPDGCPP-V 227 (256)
T ss_pred CCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-------CCCCCCCCH-H
Confidence 23344568999999877766555 999999999999998 9999986554333222221111 011112222 2
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+.+.+.++...+|.+|+ ++.++.+.|..
T Consensus 228 ~~~li~~~l~~~p~~Rp-t~~~l~~~l~~ 255 (256)
T cd05082 228 VYDVMKQCWHLDAATRP-SFLQLREQLEH 255 (256)
T ss_pred HHHHHHHHhcCChhhCc-CHHHHHHHHhc
Confidence 33444555557788774 99999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=273.36 Aligned_cols=192 Identities=33% Similarity=0.580 Sum_probs=170.2
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 29 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
||.|++|.||++.+..+++.||+|.+.... .....+.+|+..++.++||||+++++.+.++...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999999999999999987643 2335688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCC
Q 020133 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (330)
Q Consensus 105 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y 184 (330)
.+++.+...+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||++.............+++.|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988888999999999999999999999999999999999999987764 999999998755443333445688899
Q ss_pred CChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 185 ~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
++||.+.+..++.+ +|+||||+++|+|++|..||....
T Consensus 159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCC
Confidence 99999877766555 999999999999999999998765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=280.28 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=194.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECC-------CCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~ 89 (330)
.++|.+.+.||+|+||.||++.+.. ....+|+|.+..... ....+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4789999999999999999998642 345799998875432 234677899999999 699999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC
Q 020133 90 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~ 153 (330)
+.+|+||||+++++|.+++... ..+++.++..++.|++.||.|||++|++||||||+||+++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 9999999999999999999653 348899999999999999999999999999999999999876
Q ss_pred CCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 020133 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (330)
Q Consensus 154 ~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~ 229 (330)
+ .+||+|||.++....... .....++..|+|||++.+..++.+ +|+||||+++|+|++ |..||..........
T Consensus 171 ~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 171 N--VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred C--cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5 499999999874432111 122234567999999987766555 999999999999999 899998765444333
Q ss_pred HHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 230 KTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
....... ..+....+.+ +.+...++...+|.+|+ ++.++++.|.....
T Consensus 248 ~~~~~~~-------~~~~~~~~~~-l~~li~~cl~~~p~~Rp-s~~~ll~~l~~~~~ 295 (314)
T cd05099 248 LLREGHR-------MDKPSNCTHE-LYMLMRECWHAVPTQRP-TFKQLVEALDKVLA 295 (314)
T ss_pred HHHcCCC-------CCCCCCCCHH-HHHHHHHHcCCCcccCc-CHHHHHHHHHHHHH
Confidence 3322111 0111122222 22344455556777765 99999998887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=280.69 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=196.3
Q ss_pred cCCCCeEEeceeccCCceEEEEEEEC-------CCCcEEEEEEeecCC--cccHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~ 87 (330)
...++|++.+.||+|+||.||++... ..+..||+|.+.... .....+.+|+..++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34588999999999999999999753 234579999886532 2235688999999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec
Q 020133 88 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (330)
Q Consensus 88 ~~~~~~lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~ 151 (330)
..+..|+||||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 999999999999999999998753 2478888999999999999999999999999999999998
Q ss_pred CCCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhH
Q 020133 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (330)
Q Consensus 152 ~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~ 227 (330)
.++ .+||+|||+++....... .....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+....
T Consensus 172 ~~~--~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 172 ENN--VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred CCC--cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 665 499999999875432221 222345678999999987776555 999999999999998 8899987665444
Q ss_pred HHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 228 FRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
........... .....+ ..+.+.+.++....|..|+ ++.|+++.|.++..
T Consensus 249 ~~~~~~~~~~~-------~~~~~~-~~~~~li~~cl~~~p~~Rp-s~~e~l~~l~~~~~ 298 (304)
T cd05101 249 FKLLKEGHRMD-------KPANCT-NELYMMMRDCWHAIPSHRP-TFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHcCCcCC-------CCCCCC-HHHHHHHHHHcccChhhCC-CHHHHHHHHHHHHH
Confidence 43332221110 011111 2233344455556777765 99999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=275.43 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=188.8
Q ss_pred eEEeceeccCCceEEEEEEECCCCc--EEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------Ce
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 91 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~~ 91 (330)
|.+.+.||+|+||.||++.+..++. .||+|.++... ...+.+.+|+..++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999887765 68999886542 2235678899999999999999999987532 24
Q ss_pred EEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 92 LAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
.+++|||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++. ++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 6899999999999988742 234899999999999999999999999999999999999987654 99999999
Q ss_pred cccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHh
Q 020133 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIR 241 (330)
Q Consensus 166 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (330)
++....... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |+.||..................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--- 234 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK--- 234 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 875432221 122345678999999987766555 999999999999999 899998765543333332211110
Q ss_pred cCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 242 NHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
....++. .+.+.+.++...+|.+| ++++|+++.|.++
T Consensus 235 ----~~~~~~~-~~~~li~~~l~~~p~~R-ps~~~l~~~l~~~ 271 (272)
T cd05075 235 ----QPPDCLD-GLYSLMSSCWLLNPKDR-PSFETLRCELEKA 271 (272)
T ss_pred ----CCCCCCH-HHHHHHHHHcCCCcccC-cCHHHHHHHHHhh
Confidence 1111222 23344556666788887 5999999988763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=294.37 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=191.3
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
+...+.+.||+|+||+||+++... .||||.++... ...+.|++|+..+++-+|.||+-+.|+|..++. .||+-
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 456789999999999999998854 49999997653 344678999999999999999999999988776 99999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc---cCCC
Q 020133 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHS 173 (330)
Q Consensus 98 ~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~---~~~~ 173 (330)
+|+|.+|..+++.. .+|.....+.|++|+++|+.|||.++|||||||..||++.++. +|||+|||++... ....
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~--kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL--KVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC--cEEEecccceeeeeeecccc
Confidence 99999999998753 4699999999999999999999999999999999999998875 4999999998522 2223
Q ss_pred CCCcccCCCCCCChhhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhcc
Q 020133 174 QPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKN 249 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 249 (330)
......|+..|||||++..+ ++. ..+||||||+++|||+||..||.. ...+++.-.+.| +..|+.... ...
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS-~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG~l~pd~s~~---~s~ 620 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFS-FQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRGYLMPDLSKI---RSN 620 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCC-cccchhhhhHHHHHHHhCcCCcCC-CChhheEEEecccccCccchhh---hcc
Confidence 33445688899999999644 343 449999999999999999999994 444444333333 223333221 122
Q ss_pred CC---ccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 250 LP---ADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 250 ~~---~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
+| .+++.+|+. .++++|+ .+.+|+..|.....
T Consensus 621 ~pk~mk~Ll~~C~~----~~~~eRP-~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWK----FDREERP-LFPQLLSKLEELLP 655 (678)
T ss_pred CHHHHHHHHHHHHh----cCcccCc-cHHHHHHHHHHhhh
Confidence 22 344455555 4445544 88888886665543
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=289.67 Aligned_cols=258 Identities=23% Similarity=0.340 Sum_probs=195.8
Q ss_pred cccCCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCC-CCCeeeeeEEEE
Q 020133 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVIL 87 (330)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~-h~~Iv~~~~~~~ 87 (330)
.-...++|.+.+.||+|+||.||++.+. .+++.||+|+++..... ...+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344578999999999999999999864 35578999999764322 246789999999997 999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhcC-------------------------------------------------------
Q 020133 88 TPTHLAIVMEYASGGELFERICNAG------------------------------------------------------- 112 (330)
Q Consensus 88 ~~~~~~lv~e~~~g~sL~~~l~~~~------------------------------------------------------- 112 (330)
.++..++||||+++|+|.+++.+++
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986532
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEE
Q 020133 113 -------------------------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (330)
Q Consensus 113 -------------------------------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl 149 (330)
.+++..++.++.|++.||.|||+.+++||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 3577788999999999999999999999999999999
Q ss_pred ecCCCCCceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChh
Q 020133 150 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (330)
Q Consensus 150 i~~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~ 225 (330)
++.++ .++|+|||+++...... ......+++.|+|||.+.+..+..+ +|+||||+++|||++ |..||......
T Consensus 272 l~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 272 ICEGK--LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EeCCC--EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 98765 49999999987432211 1223456788999999987766555 999999999999998 89999875554
Q ss_pred hHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 226 KNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
......+.+-..+. .| ... ...+.+.+.+++..+|..|+ +++++++.|..+
T Consensus 349 ~~~~~~~~~~~~~~---~p---~~~-~~~l~~li~~cl~~~P~~RP-s~~ell~~L~~~ 399 (401)
T cd05107 349 EQFYNAIKRGYRMA---KP---AHA-SDEIYEIMQKCWEEKFEIRP-DFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHHcCCCCC---CC---CCC-CHHHHHHHHHHcCCChhHCc-CHHHHHHHHHHH
Confidence 44433332211000 01 111 12233444455556777764 999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=275.65 Aligned_cols=205 Identities=30% Similarity=0.463 Sum_probs=171.0
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCC-CCCeeeeeEEEEeC--CeEEEEEe
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME 97 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~--~~~~lv~e 97 (330)
|++++.||+|+||.||++.+..+++.||+|.+..... ......+|+..+.++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999998876422 2234457888888885 99999999999987 88999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
|+++ +|.+.+.. .+.+++..++.++.|++.||.+||+.|++||||+|+||+++. + .+||+|||+++.........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D--ILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C--CeEEEecccccccccCCCcC
Confidence 9975 77777765 457899999999999999999999999999999999999987 3 59999999987554444444
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
...++..|+|||.+......+.++|+|||||++|+|++|..||.+.+....+...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 4567889999998765555455699999999999999999999876655444433
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=274.45 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=193.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCc----EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
...+|++.+.||+|+||.||++.+..+|+ .+|+|....... ....+.+|+..+++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 35789999999999999999999876654 589998765532 23567899999999999999999999987 788
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
++||||+++++|.+++..+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++. +||+|||.++....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccC
Confidence 9999999999999998764 46999999999999999999999999999999999999987654 99999999875443
Q ss_pred CCCCC---cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 172 HSQPK---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 172 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
..... ...++..|+|||.+....++.+ +|+||||+++|++++ |+.||..................+. +
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~--- 233 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ----P--- 233 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC----C---
Confidence 22211 1223567999999877666555 999999999999998 9999987654433332222111110 0
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
...+. .+.+.+.+++..+|..|+ ++.++.+.|....
T Consensus 234 ~~~~~-~~~~~~~~~l~~~p~~Rp-~~~~l~~~l~~~~ 269 (279)
T cd05057 234 PICTI-DVYMVLVKCWMIDAESRP-TFKELINEFSKMA 269 (279)
T ss_pred CCCCH-HHHHHHHHHcCCChhhCC-CHHHHHHHHHHHH
Confidence 01111 122233344445666654 9999999988763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=276.77 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=191.0
Q ss_pred CeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
+|++.+.||+|+||.||++.+.. ....+++|.+..... ....+.+|+..++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 48899999999999999998753 235688888765432 23468889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEe
Q 020133 95 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli 150 (330)
|+||+.+++|.+++... .++++..++.++.|++.||.|||+.|++||||||+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987642 247889999999999999999999999999999999999
Q ss_pred cCCCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhh
Q 020133 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (330)
Q Consensus 151 ~~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~ 226 (330)
++++ .++|+|||+++....... .....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+.....
T Consensus 161 ~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 161 AEGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred cCCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 8765 499999999874322211 122345678999999877766544 999999999999998 999998765443
Q ss_pred HHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 227 NFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
. .+...+..... . ....+.+ +...+..+...+|..| +++.|+.+.|+++-
T Consensus 238 ~-~~~~~~~~~~~---~---~~~~~~~-~~~~i~~cl~~~P~~R-p~~~~i~~~l~~~~ 287 (290)
T cd05045 238 L-FNLLKTGYRME---R---PENCSEE-MYNLMLTCWKQEPDKR-PTFADISKELEKMM 287 (290)
T ss_pred H-HHHHhCCCCCC---C---CCCCCHH-HHHHHHHHccCCcccC-CCHHHHHHHHHHHH
Confidence 3 33332211000 0 0111122 2233444555677776 59999999888753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=278.95 Aligned_cols=213 Identities=32% Similarity=0.482 Sum_probs=177.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~ 93 (330)
..++|++.+.||.|+||.||++.+..+|+.||+|.+..... ......+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 45789999999999999999999999999999999875432 223566899999999999999999998765 5689
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+.+ +|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||.+......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCc
Confidence 99999975 78887765 367999999999999999999999999999999999999987664 999999998754332
Q ss_pred C-CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 173 S-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 173 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
. ......+++.|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+....+..+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~ 224 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 2 2223345778999999876554455699999999999999999999987776666665544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=283.63 Aligned_cols=199 Identities=27% Similarity=0.441 Sum_probs=165.3
Q ss_pred EeceeccC--CceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 25 LVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 25 i~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
++++||+| +|++||++.+..+|+.||+|.+.... .....+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 78899999999999999999987542 22346778999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC----
Q 020133 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 173 (330)
Q Consensus 100 ~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~---- 173 (330)
++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++. ++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccccccc
Confidence 999999998653 45899999999999999999999999999999999999987664 9999998653221111
Q ss_pred ----CCCcccCCCCCCChhhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 174 ----QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 174 ----~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
......++..|+|||++.+. .++ .++|||||||++|+|++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 11223466789999998763 344 44999999999999999999998655433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=275.02 Aligned_cols=251 Identities=21% Similarity=0.342 Sum_probs=195.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++++.||+|+||.||++.... +.+.|++|.+..... ....+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 4689999999999999999999754 356799998765433 245788999999999999999999999988899
Q ss_pred EEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeec
Q 020133 93 AIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
|+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++. ++|+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~ 161 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLL 161 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEccc
Confidence 99999999999999998655 6999999999999999999999999999999999999987664 999999
Q ss_pred CCcccccCCC--CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 164 GYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 164 g~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
|++....... ......++..|+|||.+.+.....+ +||||||+++|++++ |..||........+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~----- 235 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK----- 235 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-----
Confidence 9886432211 1223345677999999877766544 999999999999999 889997655544333322111
Q ss_pred hcCchh-hccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 241 RNHEWF-LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 241 ~~~~~~-~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
.+|. ...+ +..+.+.+.++...+|..| +++.++++.|.
T Consensus 236 --~~~~~~~~~-~~~l~~~i~~~l~~~p~~R-p~~~~~l~~l~ 274 (275)
T cd05046 236 --LELPVPEGC-PSRLYKLMTRCWAVNPKDR-PSFSELVSALG 274 (275)
T ss_pred --cCCCCCCCC-CHHHHHHHHHHcCCCcccC-CCHHHHHHHhc
Confidence 0111 1112 2234445556666778877 59999988775
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=275.55 Aligned_cols=193 Identities=32% Similarity=0.476 Sum_probs=159.8
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHH---cCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHR---SLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 28 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~---~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
.||+|+||.||++.+..+++.||+|.+.+.... .....++...++ ..+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999988654221 122334443333 3479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccC
Q 020133 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (330)
Q Consensus 101 g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 180 (330)
+++|.+++..++.+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999999988888999999999999999999999999999999999999987664 999999998644322 2233468
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
+..|+|||.+.+....+.++|+|||||++|+|++|+.||....
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 9999999998644333445999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=271.57 Aligned_cols=199 Identities=31% Similarity=0.509 Sum_probs=169.8
Q ss_pred eEE-eceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 23 YEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 23 y~i-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
|++ .+.||+|+|+.|--+.+..+|..||||++.+.. ..+.++.+|++.+.+. .|+||++++++|+++..+|||||-+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 444 467899999999999999999999999997754 4567899999999988 5999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccCC------
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH------ 172 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~~------ 172 (330)
.||+|.+.+++...+++.++.+++.+|+.||.+||.+||.|||+||+|||-.. +...-||||||.+.......
T Consensus 159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 99999999999999999999999999999999999999999999999999843 33334899999876522111
Q ss_pred --CCCCcccCCCCCCChhhhh---c-CCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 173 --SQPKSTVGTPAYIAPEVLL---K-KEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 173 --~~~~~~~~~~~y~aPE~~~---~-~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
....+.+|+..|||||+.. + ..++.++.|+||||+++|-|++|.+||.+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 1224557899999999863 2 23445669999999999999999999965
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=276.59 Aligned_cols=209 Identities=31% Similarity=0.479 Sum_probs=175.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.|++++.||.|++|.||++.+..+++.||+|.+..... ....+.+|+..+++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48999999999999999999999999999998865422 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CC
Q 020133 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (330)
Q Consensus 99 ~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~ 175 (330)
+. ++|..++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 96 588888764 356899999999999999999999999999999999999987764 9999999986443222 22
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
....+++.|+|||++.+....+.++|+||||+++|+|+||+.||...+......+...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 215 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 3345678899999887655445559999999999999999999988776655555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=276.86 Aligned_cols=201 Identities=27% Similarity=0.437 Sum_probs=170.7
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++++.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..+++++||||+++++.+..++..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46899999999999999999999999999999886532 2235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 99 ~~g~sL~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA-SL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC-Cc
Confidence 9999999888763 379999999999999999999996 5999999999999998755 499999999864322 22
Q ss_pred CCcccCCCCCCChhhhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~-----~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
.....+++.|+|||.+.+... .+.++|+|||||++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 234467889999999855432 24459999999999999999999976443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=285.14 Aligned_cols=256 Identities=22% Similarity=0.353 Sum_probs=191.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEE-----CCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC-
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP- 89 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~- 89 (330)
..++|++.+.||+|+||.||+|.+ ..+++.||||.+..... ....+.+|+..+.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 347899999999999999999985 34678999999875432 234678899999999 689999999988654
Q ss_pred CeEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 020133 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~---------------------------------------------------------- 111 (330)
...++||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4679999999999999988642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC---CCccc
Q 020133 112 ---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTV 179 (330)
Q Consensus 112 ---------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~ 179 (330)
..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCCCC
Confidence 2367888899999999999999999999999999999998765 499999999874322211 12223
Q ss_pred CCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccc
Q 020133 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDN 258 (330)
Q Consensus 180 ~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (330)
++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||............+.....+. .|. ..++ .+.+.
T Consensus 243 ~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~-~~~~~ 314 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---APD---YTTP-EMYQT 314 (343)
T ss_pred CCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC---CCC---CCCH-HHHHH
Confidence 4567999999987776555 999999999999997 9999987554333333322111110 011 1111 22334
Q ss_pred cccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 259 TTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 259 ~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
+.+++..+|.+|+ +++|+++.|+.+.
T Consensus 315 ~~~cl~~~p~~Rp-s~~eil~~l~~~~ 340 (343)
T cd05103 315 MLDCWHGEPSQRP-TFSELVEHLGNLL 340 (343)
T ss_pred HHHHccCChhhCc-CHHHHHHHHHHHH
Confidence 4455667788875 9999999888753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.91 Aligned_cols=198 Identities=31% Similarity=0.541 Sum_probs=173.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++.+.||.|++|.||++.+..+++.+|+|.+.... .....+.+|+..+++++||||+++++.+...+.+++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46889999999999999999999999999999887653 2345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
+++++|.+++... .++++..+..++.|++.||.+||+ .|++|+||+|+||+++.++ .++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~-~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSLA-K 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHHh-h
Confidence 9999999999876 789999999999999999999999 9999999999999998765 499999998864432221 1
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
...++..|+|||.+.+..++.+ +|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcc
Confidence 2667889999999987766555 99999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=272.64 Aligned_cols=198 Identities=31% Similarity=0.504 Sum_probs=170.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~lv~ 96 (330)
++|+..+.||.|++|.||++.+..+++.+|+|.+..... ....+.+|+..+++++||||+++++++... +.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 479999999999999999999999999999998876433 345788999999999999999999998654 4789999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 97 e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999887653 346899999999999999999999999999999999999987664 999999998643322
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
. .....++..|+|||.+.+..++.+ +|+|||||++|+|++|+.||...
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred c-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 223457889999999987777655 99999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=273.85 Aligned_cols=247 Identities=29% Similarity=0.503 Sum_probs=190.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCC---CCCeeeeeEEEEeCCeEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~---h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.++++++ |||++++++++..+...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5889999999999999999999999999999886542 23456888999999886 999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~ 175 (330)
||+++++|.+++.. +.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+....... ..
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCcccc
Confidence 99999999998865 5799999999999999999999999999999999999998765 49999999987544332 22
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+....... +.....+.+... ..+. .+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~-~~ 231 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKSKPPRLEDN-----GYSK-LL 231 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-cccCCCCCCCcc-----cCCH-HH
Confidence 3446888999999987654444559999999999999999999987554332221 111111111110 1111 23
Q ss_pred ccccccCCCCCCCCccCCHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.+.++...+|..|+ ++.+++.
T Consensus 232 ~~~i~~~l~~~p~~R~-~~~~il~ 254 (277)
T cd06917 232 REFVAACLDEEPKERL-SAEELLK 254 (277)
T ss_pred HHHHHHHcCCCcccCc-CHHHHhh
Confidence 3444455556777766 6777764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=281.71 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=196.3
Q ss_pred CCeEEeceeccCCceEEEEEEECCC-------CcEEEEEEeecCC--cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~--~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
.+|++++.||+|+||.||+|.+... +..||+|.+.... .....+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 5799999999999999999986432 3468999876532 2235688999999999 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC
Q 020133 91 HLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~ 154 (330)
..+++|||+++++|.+++.+.. .++..++..++.|++.||.|||++|++||||||+||+++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 9999999999999999987532 478889999999999999999999999999999999998765
Q ss_pred CCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHH
Q 020133 155 APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (330)
Q Consensus 155 ~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~ 230 (330)
. +||+|||+++....... .....++..|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+.......
T Consensus 172 ~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 172 V--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred c--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 4 99999999874432211 122234567999999987777655 999999999999998 8999987665444433
Q ss_pred HhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 231 TIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
+......+ .....+. .+.+.+.++...+|.+|+ ++.|+++.|.++....
T Consensus 249 ~~~~~~~~-------~~~~~~~-~l~~li~~cl~~~p~~Rp-s~~ell~~l~~~~~~~ 297 (334)
T cd05100 249 LKEGHRMD-------KPANCTH-ELYMIMRECWHAVPSQRP-TFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHcCCCCC-------CCCCCCH-HHHHHHHHHcccChhhCc-CHHHHHHHHHHHhhhc
Confidence 32221111 0111112 233445556667788875 9999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=282.67 Aligned_cols=204 Identities=32% Similarity=0.491 Sum_probs=172.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeC-----Ce
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-----~~ 91 (330)
.++|++.+.||+|+||+||++.+..+++.||+|.+... ......+.+|+..++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46899999999999999999999999999999988653 22234677899999999999999999988654 34
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
.|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCC
Confidence 799999996 689999988888999999999999999999999999999999999999987654 99999999875433
Q ss_pred C-CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 172 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
. .......++..|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 216 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 2 222344678899999998754334455999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=297.81 Aligned_cols=198 Identities=33% Similarity=0.540 Sum_probs=171.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecC-CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCChH
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 105 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~ 105 (330)
-+||+|.||+||-++|..|....|||.+... .....-+..||.+.++|+|.|||+++|.+..++.+-+.||..+||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3699999999999999999999999988654 344567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCC--CHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCCCCcccCC
Q 020133 106 ERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGT 181 (330)
Q Consensus 106 ~~l~~~-~~l--~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~~ 181 (330)
++++.. |++ .+.++-.+.+||++||+|||++.|||||||-+|||++- ..+.+|++|||-++... .+....+..||
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCccccccccc
Confidence 999754 677 88899999999999999999999999999999999964 23469999999987543 34445677899
Q ss_pred CCCCChhhhhc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 182 PAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 182 ~~y~aPE~~~~-~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
..|||||++.. ..-+++++|||||||++.||.||++||.....+
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp 784 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP 784 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh
Confidence 99999999954 334567799999999999999999999765443
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.33 Aligned_cols=246 Identities=28% Similarity=0.496 Sum_probs=193.0
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+|++.+.||+|+||.+|++.+..+|+.||+|.+.... .....+.+|+..+++++||||+++.+++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6999999999999999999999999999999987532 2335788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-C
Q 020133 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-~ 175 (330)
+++++|.+.+.... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999999887543 5899999999999999999999999999999999999987654 99999998864432221 2
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
....+++.|+|||++.+...+.+ +|+|||||++++|++|+.||...+.......++.... +. .....+.+ +
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~-~ 229 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PP------VSSHYSYD-L 229 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CC------CcccCCHH-H
Confidence 23457888999999977766544 9999999999999999999987666555554443221 10 11111221 2
Q ss_pred ccccccCCCCCCCCccCCHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.+.++...+|.+|+ ++.++++
T Consensus 230 ~~li~~~l~~~p~~Rp-~~~~vl~ 252 (256)
T cd08218 230 RNLVSQLFKRNPRDRP-SVNSILE 252 (256)
T ss_pred HHHHHHHhhCChhhCc-CHHHHhh
Confidence 2233334445677665 8888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=251.95 Aligned_cols=222 Identities=27% Similarity=0.485 Sum_probs=193.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
..|.-.++||+|.||+||++++..+++.||+|.+..++ .......+|+-+++.++|.|||+++++...+..+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35777899999999999999999999999999987653 334678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CC
Q 020133 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~ 175 (330)
||. .+|..+... ++.++...++.++.|+++||.++|++++.|||+||.|.+|+.++. +||+|||+++.+.... ..
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 995 477777653 678999999999999999999999999999999999999987775 9999999998554433 44
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCch
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEW 245 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
+..+.|..|++|.++.+....+...|+||-||++.|+.. |++.|.+.+-.+++.++++..+.|.-.++|-
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 566789999999999988876666999999999999987 8999999999999999998777666555553
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=269.95 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=188.9
Q ss_pred ceeccCCceEEEEEEECC-CC--cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKK-TE--ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|++|.||++.+.. ++ ..||+|.+..... ....+.+|+..+++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 33 3689998876544 34578899999999999999999999988 889999999999
Q ss_pred CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC----C
Q 020133 102 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P 175 (330)
Q Consensus 102 ~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~----~ 175 (330)
++|.+.+.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .+||+|||+++....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccceecc
Confidence 99999997754 689999999999999999999999999999999999998775 499999999875433211 1
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....++..|+|||.+.+..++.+ +|+|||||++|+|++ |+.||...+.......+....... . .....|. .
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~-~ 229 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL---E---RPEACPQ-D 229 (257)
T ss_pred cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---C---CCccCCH-H
Confidence 22346778999999887776555 999999999999999 999998766555444433211110 0 0111222 2
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
+.+.+.++...+|.+|+ +++++.+.|.
T Consensus 230 ~~~li~~~l~~~p~~Rp-s~~~~~~~l~ 256 (257)
T cd05040 230 IYNVMLQCWAHNPADRP-TFAALREFLP 256 (257)
T ss_pred HHHHHHHHCCCCcccCC-CHHHHHHHhc
Confidence 33444555556777766 9999988765
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=274.57 Aligned_cols=211 Identities=31% Similarity=0.402 Sum_probs=173.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCe-----
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTH----- 91 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~----- 91 (330)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+..+++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999998765422 2356788999999995 6999999999987655
Q ss_pred EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 92 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++||||+|+||+++.+. +.++|+|||++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~-~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK-GLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCC-CeEEEeecccc
Confidence 8999999986 788877542 3589999999999999999999999999999999999998722 35999999998
Q ss_pred ccccCC-CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 167 KSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
+..... .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.+......++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 744322 2223345688899999986654444559999999999999999999988776665555543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=269.97 Aligned_cols=247 Identities=28% Similarity=0.375 Sum_probs=192.2
Q ss_pred eEEeceeccCCceEEEEEEECCCC----cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+++.+.||.|+||.||++.+..++ ..||+|.+..... ....+.+|+..++.++|+||+++++++...+..|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 357789999999999999998766 8999999876543 3567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
||+++++|.+++..... +++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC--eEEEcccCCceecccccc
Confidence 99999999999976554 99999999999999999999999999999999999998776 499999999874443311
Q ss_pred CC--cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCC
Q 020133 175 PK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 175 ~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
.. ...+++.|+|||.+.+..++. ++|+||||+++|+|++ |+.||...+.............. ......+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 230 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTS-KSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL-------PKPENCP 230 (258)
T ss_pred cccccCCCcccccChHHhccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------CCCCcCC
Confidence 11 123678899999986665554 4999999999999998 89999876555444444322211 1111122
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHHHH
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
. .+.+.+.++...+|.+|+ ++.++++.|
T Consensus 231 ~-~~~~~i~~~l~~~p~~Rp-t~~~ll~~l 258 (258)
T smart00219 231 P-EIYKLMLQCWAEDPEDRP-TFSELVEIL 258 (258)
T ss_pred H-HHHHHHHHHCcCChhhCc-CHHHHHhhC
Confidence 2 223344455556677765 888887653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=269.89 Aligned_cols=244 Identities=24% Similarity=0.346 Sum_probs=184.1
Q ss_pred eeccCCceEEEEEEEC--CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCC
Q 020133 28 DIGSGNFGVARLMRDK--KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (330)
Q Consensus 28 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~s 103 (330)
.||+|+||.||++... .++..||+|.+..... ..+.+.+|+..+++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999998765 3456799998865432 23568899999999999999999998754 56899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC----CCcc
Q 020133 104 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST 178 (330)
Q Consensus 104 L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~----~~~~ 178 (330)
|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++........ ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9999874 457999999999999999999999999999999999999987654 99999999874332211 1112
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
.++..|+|||++.+..++.+ +|+||||+++|++++ |..||................. +. +....+. .+.+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~------~~~~~~~-~l~~ 229 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-LD------CPAECPP-EMYA 229 (257)
T ss_pred CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CC------CCCCCCH-HHHH
Confidence 23568999999877766554 999999999999996 9999987665443333322111 11 1111222 2334
Q ss_pred ccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+.+++..+|.+|+ +++++.+.|+..
T Consensus 230 li~~c~~~~~~~Rp-~~~~i~~~l~~~ 255 (257)
T cd05115 230 LMKDCWIYKWEDRP-NFAKVEERMRTY 255 (257)
T ss_pred HHHHHcCCChhhCc-CHHHHHHHHhhh
Confidence 45555666776654 999999888764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=273.31 Aligned_cols=210 Identities=31% Similarity=0.481 Sum_probs=174.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++.+.||.|++|.||++.+..+|+.||+|.+.... .....+.+|+..+++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999999999999999886542 223567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-C
Q 020133 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~ 174 (330)
|+++ +|.+.+.... .+++..++.++.||+.||.|||++|++|+||+|+||+++.++. .+||+|||++....... .
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9965 7877776544 3588889999999999999999999999999999999975443 58999999986443222 2
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....+++.|+|||.+.+......++|+||||+++|+|+||+.||...+....+.+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~ 217 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2334568899999998765444455999999999999999999998776655555544
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=274.43 Aligned_cols=208 Identities=33% Similarity=0.532 Sum_probs=176.3
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeEEEEEe
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME 97 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~lv~e 97 (330)
|++.+.||+|++|.||++.+..+++.+|+|.+.... .....+.+|+..+++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999999999999998653 2335678899999999999999999999988 78999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--C
Q 020133 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~ 174 (330)
|+++ +|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||++++++. ++|+|||++....... .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9975 888888765 57999999999999999999999999999999999999987764 9999999987544332 1
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 23345678899999876654445559999999999999999999988776665555544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=311.75 Aligned_cols=212 Identities=32% Similarity=0.505 Sum_probs=180.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..+.|.|++.||.|+||.|.+++++.|++.||.|++++-. ....-|..|-.+|.--+.+=|+.++-.|.++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3578999999999999999999999999999999987722 223345566667776678889999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
||||++||+|..++.+.+++|+.-++.++..|..||..||+.|+|||||||+|||+|..|+ +||+|||.+-......
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGT 230 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCc
Confidence 9999999999999999889999999999999999999999999999999999999998876 9999999886554333
Q ss_pred -CCCcccCCCCCCChhhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 -QPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....+|||-|.|||++... ..+++.+|.||+|+++|||+.|..||...+-...+.+++
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm 294 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM 294 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh
Confidence 34567899999999999532 344666999999999999999999997655444444444
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=272.12 Aligned_cols=204 Identities=34% Similarity=0.492 Sum_probs=172.7
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-----------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
+|.+.+.||+|++|.||++.+..+|+.||+|.+..... ..+.+.+|+..+++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68999999999999999999999999999998764211 1135778999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++||||+|+||+++.++ .++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG--ICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC--eEEEeecccccccc
Confidence 9999999999999999998888899999999999999999999999999999999999998765 49999999986432
Q ss_pred CCC---CCCcccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChhhH
Q 020133 171 LHS---QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (330)
Q Consensus 171 ~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~ 227 (330)
... ......++..|+|||.+.... ..+.++|+||||+++|++++|..||...+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 220 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH
Confidence 211 122345788999999987654 234459999999999999999999976554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=272.15 Aligned_cols=240 Identities=18% Similarity=0.167 Sum_probs=181.5
Q ss_pred ceeccCCceEEEEEEECCCC----------cEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 27 RDIGSGNFGVARLMRDKKTE----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+.||+|+||.||++.+..++ ..+++|.+.........+.+|+..+++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999998776 458888776554445778899999999999999999999988 7789999
Q ss_pred eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC-----ceEEeecCCccccc
Q 020133 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 170 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~-----~vkL~Dfg~a~~~~ 170 (330)
||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.. .++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999998766 79999999999999999999999999999999999999766521 59999999987443
Q ss_pred CCCCCCcccCCCCCCChhhhhcC-CCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhc
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
. .....++..|+|||++.+. ...+.++|+||||+++|+|++ |..||...+..............+ .+.
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~--- 229 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP----MPD--- 229 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCC----CCC---
Confidence 2 2234566789999998766 233445999999999999999 688887654322221111110000 000
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHHHH
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
...+.+.+.++...+|.+|+ ++.++++.|
T Consensus 230 ---~~~~~~li~~~l~~~p~~Rp-t~~~il~~l 258 (259)
T cd05037 230 ---CAELANLINQCWTYDPTKRP-SFRAILRDL 258 (259)
T ss_pred ---chHHHHHHHHHhccChhhCC-CHHHHHHhc
Confidence 02223334444456666664 888887765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.17 Aligned_cols=200 Identities=30% Similarity=0.510 Sum_probs=166.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC-CcccHHHHHHHHHHHcCC-CCCeeeeeE-EEEeC---C---
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLR-HPNIVRFKE-VILTP---T--- 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~ei~~l~~l~-h~~Iv~~~~-~~~~~---~--- 90 (330)
..+++|.+.|.+|||+.||+|.+...|..||+|++-.. ......+.+||.++++|. |+|||.++| ..... +
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 46789999999999999999999998899999987544 344567899999999996 999999999 33221 2
Q ss_pred eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 91 HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
.+.|.||||.||+|.+++.. +..|++.++++|++++++|+.+||.++ |||||||-+||||+.+++ .||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccccc
Confidence 36889999999999999974 345999999999999999999999998 999999999999988875 999999988
Q ss_pred ccccCCCCCC----------cccCCCCCCChhhh---hcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 167 KSSVLHSQPK----------STVGTPAYIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 167 ~~~~~~~~~~----------~~~~~~~y~aPE~~---~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
.......... ...-|+.|+|||++ .+.+.+.+ +|||+|||+||-|+....||...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcC
Confidence 6332222111 12358999999997 45556555 99999999999999999999864
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=272.97 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=196.0
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECC----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEe-CC
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT-PT 90 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~-~~ 90 (330)
.+.++|++.+.||+|+||.||.+.+.. ++..|++|.+..... ....+.+|+..+++++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 356899999999999999999999876 367899998765432 23567889999999999999999998776 46
Q ss_pred eEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEee
Q 020133 91 HLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~D 162 (330)
..+++++|+++++|.+++... ..+++.+++.++.|++.||.|||+.+++|+||||+||+++.++ .+||+|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECC
Confidence 789999999999999998653 4589999999999999999999999999999999999998765 499999
Q ss_pred cCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhc-CCh
Q 020133 163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR-ISI 237 (330)
Q Consensus 163 fg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~-~~~ 237 (330)
||+++....... .....++..|+|||++.+..++.+ +|||||||++|++++ |+.||...+... +...+.. ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~ 238 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRL 238 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHHcCCCC
Confidence 999874432211 122345667999999987776555 999999999999999 999998755433 3333222 111
Q ss_pred hHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 238 PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
+. ...+|. .+.+...+++..+|.+| +++.++++.|....
T Consensus 239 ~~-------~~~~~~-~~~~li~~~l~~~p~~R-ps~~~~~~~l~~~~ 277 (280)
T cd05043 239 AQ-------PINCPD-ELFAVMACCWALDPEER-PSFSQLVQCLTDFH 277 (280)
T ss_pred CC-------CCcCCH-HHHHHHHHHcCCChhhC-CCHHHHHHHHHHHH
Confidence 10 011222 23344455566678777 59999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=271.44 Aligned_cols=248 Identities=19% Similarity=0.315 Sum_probs=179.9
Q ss_pred ceeccCCceEEEEEEECC--CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 020133 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~ 102 (330)
+.||+|+||.||++.... ....+++|.+..... ....+.+|+..++.++||||+++++.+...+..|+||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996533 456788887754432 2245778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---C
Q 020133 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (330)
Q Consensus 103 sL~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~---~ 174 (330)
+|.+++.... ..++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence 9999987643 2467888999999999999999999999999999999987764 9999999986432221 1
Q ss_pred CCcccCCCCCCChhhhhcC------CCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 175 PKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
.....++..|+|||++... ...+.++|||||||++|+|++ |..||............+.....+ ...+.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 236 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK--LPKPQLD 236 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc--CCCCccc
Confidence 2233456779999997532 223455999999999999999 889998766555444444322110 1111222
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHH
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
...+..+ ...+..++ .+|.+|+ +++++++.+
T Consensus 237 ~~~~~~~-~~~~~~~~-~dp~~Rp-t~~~v~~~l 267 (269)
T cd05042 237 LKYSDRW-YEVMQFCW-LDPETRP-TAEEVHELL 267 (269)
T ss_pred ccCCHHH-HHHHHHHh-cCccccc-CHHHHHHHh
Confidence 2222211 11222222 3777765 899998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=272.16 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=195.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++.+.||.|+||.||++.+... ...|++|...... ...+.+.+|+..++.++||||+++++++.. ...|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 457799999999999999999987654 4568999876543 234578899999999999999999999875 4578
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||+++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 160 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccc
Confidence 9999999999999997644 5899999999999999999999999999999999999987654 999999998744332
Q ss_pred CC--CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 173 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
.. .....++..|+|||.+....+... +|+||||+++|++++ |..||...+.......+......+ ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~~ 232 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP-------MPPN 232 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC-------CCCC
Confidence 21 112234567999999877666544 999999999999986 999998776554443333221111 1112
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
+|. .+.+.+.++...+|..|+ ++.++++.|.++.
T Consensus 233 ~~~-~~~~li~~~l~~~P~~Rp-t~~~~~~~l~~~~ 266 (270)
T cd05056 233 CPP-TLYSLMTKCWAYDPSKRP-RFTELKAQLSDIL 266 (270)
T ss_pred CCH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHHHH
Confidence 222 344455566667888876 9999999988753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=269.59 Aligned_cols=246 Identities=32% Similarity=0.504 Sum_probs=189.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEe--CCeEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~ 96 (330)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ..+.+.+|+..+++++||||+++++++.. +...|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999998875432 23467789999999999999999998764 35689999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhh-----hcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 97 e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH-----~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
||+++++|.+++.. ..++++..++.++.|++.||.+|| +.+++|+||+|+||+++.++ .++|+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEecccccc
Confidence 99999999999865 467999999999999999999999 89999999999999998765 49999999987
Q ss_pred cccCCCC-CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchh
Q 020133 168 SSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246 (330)
Q Consensus 168 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (330)
....... .....+++.|+|||.+.+...+.+ +|+||||+++|+|++|+.||...+... ..+.+.....+. +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~------~ 230 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQLQ-LASKIKEGKFRR------I 230 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHHH-HHHHHhcCCCCC------C
Confidence 5544332 334568899999999977666544 999999999999999999998766333 333332222111 1
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
....+. .+.+.+..+...+|.+|+ ++.++++
T Consensus 231 ~~~~~~-~~~~l~~~~l~~~p~~Rp-~~~~il~ 261 (265)
T cd08217 231 PYRYSS-ELNEVIKSMLNVDPDKRP-STEELLQ 261 (265)
T ss_pred ccccCH-HHHHHHHHHccCCcccCC-CHHHHhh
Confidence 111212 122333344445666654 7777754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=273.28 Aligned_cols=246 Identities=27% Similarity=0.436 Sum_probs=191.7
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..|+..+.||.|+||.||.+.+..++..||+|.+.... .....+.+|+..+++++||||+++++++..++..|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46889999999999999999999999999999887543 2235678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
++|++|.+++.. +++++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence 999999998865 57999999999999999999999999999999999999987654 9999999986443322 2233
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..++..|+|||.+.+...+.+ +|+||||+++|+|++|..||...+....... +..... +.+....+.+ +.+
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~------~~~~~~~~~~-~~~ 231 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFL-IPKNNP------PTLTGEFSKP-FKE 231 (277)
T ss_pred ccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-hhcCCC------CCCchhhhHH-HHH
Confidence 457888999999987766555 9999999999999999999986554332221 111111 1111112221 223
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ ++.++++
T Consensus 232 li~~~l~~~p~~Rp-~~~~il~ 252 (277)
T cd06640 232 FIDACLNKDPSFRP-TAKELLK 252 (277)
T ss_pred HHHHHcccCcccCc-CHHHHHh
Confidence 33444556677765 8888765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=272.48 Aligned_cols=192 Identities=32% Similarity=0.463 Sum_probs=160.2
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHH---HHHHcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREI---INHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 28 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei---~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
.||+|+||.||++.+..+++.||+|.+.+.... ......|. ..++...||+|+++++++...+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999988754211 11233333 33445679999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccC
Q 020133 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (330)
Q Consensus 101 g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 180 (330)
|++|.+++...+.+++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++...... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~--~~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC--CEEEccCcCccccCcc-CCcCcCC
Confidence 999999998888899999999999999999999999999999999999998765 4999999998644322 2234578
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
+..|+|||.+.+....+.++|+||+|+++|+|++|+.||...
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 999999999875533334599999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=273.04 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=182.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHH-HHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~-l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++++.||+|+||.||++.+..+|+.||+|.+..... ....+..|+.. ++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999999876532 22345556554 566789999999999999999999999
Q ss_pred ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 98 ~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|++ ++|.+++.. +..+++..++.++.|++.||.|||++ +++||||||+||+++.++. +||+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 996 578777653 34689999999999999999999997 9999999999999987664 999999998754333
Q ss_pred CCCCcccCCCCCCChhhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCh-hhHHHHHhhcCChhHHhcCchhh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~SlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
.......++..|+|||.+.+. .++ .++|+|||||++|+|++|+.||..... ...+........ +... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-----~ 230 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-PQLP-----A 230 (283)
T ss_pred cccccccCCccccChhhcCCcccccccC-ccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC-CCCC-----c
Confidence 223335678899999988642 233 449999999999999999999975332 223333222111 0000 0
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
...+. .+.+.+.++...+|.+|+ +++++++
T Consensus 231 ~~~~~-~l~~li~~~l~~~p~~Rp-~~~~il~ 260 (283)
T cd06617 231 EKFSP-EFQDFVNKCLKKNYKERP-NYPELLQ 260 (283)
T ss_pred cccCH-HHHHHHHHHccCChhhCc-CHHHHhc
Confidence 11222 223344445556677765 7777764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=281.82 Aligned_cols=207 Identities=32% Similarity=0.478 Sum_probs=170.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC-----CeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-----~~~ 92 (330)
.++|++.+.||+|++|.||++.+..+|+.||+|.+.... .....+.+|+..+++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999999999999999986432 2335678899999999999999999987654 357
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+|+||+.+ +|.+.+.. ..+++..++.++.|++.||.+||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence 999999965 78777744 57999999999999999999999999999999999999987664 999999998644322
Q ss_pred CC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 173 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
.. .....+++.|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+.......
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~ 221 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 21 12346788999999876654345559999999999999999999987655444333
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=274.21 Aligned_cols=201 Identities=17% Similarity=0.194 Sum_probs=156.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCCccc--H----------HHHHHHHHHHcCCCCCeeeeeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKID--E----------NVQREIINHRSLRHPNIVRFKE 84 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~--~----------~~~~ei~~l~~l~h~~Iv~~~~ 84 (330)
.++|++.+.||+|+||.||++.+..+ +..+|+|......... + ....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 47899999999999999999998877 6677777543322110 1 1122334455678999999999
Q ss_pred EEEeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEE
Q 020133 85 VILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (330)
Q Consensus 85 ~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL 160 (330)
++.... ..+++++++. .++.+.+......++..++.++.|++.||.|||+.+|+||||||+|||++.++ .++|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEE
Confidence 876543 3478888874 47777776666678999999999999999999999999999999999998665 4999
Q ss_pred eecCCcccccCCC--------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 161 CDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 161 ~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
+|||+|+...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999987443211 1123468999999999988777555 9999999999999999999987643
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=274.50 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=192.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
..++|++.+.||.|+||.||++.+.. ++..||+|.+..... ....+.+|+..+++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 34789999999999999999999753 678899998875432 23568889999999999999999999999899
Q ss_pred EEEEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEE
Q 020133 92 LAIVMEYASGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~----------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl 149 (330)
.|+||||+++++|.+++.... .+++..++.++.|++.||.+||++|++||||||+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 999999999999999987432 3788889999999999999999999999999999999
Q ss_pred ecCCCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChh
Q 020133 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (330)
Q Consensus 150 i~~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~ 225 (330)
++.++. ++|+|||++........ ......+..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.+....
T Consensus 163 ~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 163 VGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred ecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 987664 99999999864332211 122334667999999887776555 999999999999998 88899876554
Q ss_pred hHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 226 KNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
.....+. ...... .....+. .+.+.+.++...+|.+|+ ++.|+.+.|.
T Consensus 240 ~~~~~~~-~~~~~~------~~~~~~~-~l~~li~~~l~~~p~~Rp-t~~el~~~l~ 287 (288)
T cd05050 240 EVIYYVR-DGNVLS------CPDNCPL-ELYNLMRLCWSKLPSDRP-SFASINRILQ 287 (288)
T ss_pred HHHHHHh-cCCCCC------CCCCCCH-HHHHHHHHHcccCcccCC-CHHHHHHHhh
Confidence 4333322 111110 0111222 233344455556677764 8999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=272.68 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=191.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEe------CCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~------~~~ 91 (330)
..+.|++.+.||.|+||.||++.+..+++.+|+|.+.........+..|+..++++ +||||+++++++.. ...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 45789999999999999999999999999999999877655556788899999888 69999999999853 457
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+|++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~ 171 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 171 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhh
Confidence 89999999999999988753 45889999999999999999999999999999999999987664 999999998644
Q ss_pred cCC-CCCCcccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcC
Q 020133 170 VLH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243 (330)
Q Consensus 170 ~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
... .......+++.|+|||++.. ..++ .++|+|||||++|+|++|..||............... ..+.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~---- 245 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPK---- 245 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC-CCCC----
Confidence 321 22344568899999999853 2343 4499999999999999999999765543333222111 1111
Q ss_pred chhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 244 EWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
......+. .+.+.+.++...+|.+|+ ++.|+++
T Consensus 246 -~~~~~~~~-~~~~li~~cl~~~p~~Rp-~~~ell~ 278 (282)
T cd06636 246 -LKSKKWSK-KFIDFIEGCLVKNYLSRP-STEQLLK 278 (282)
T ss_pred -CcccccCH-HHHHHHHHHhCCChhhCc-CHHHHhc
Confidence 11111222 233344455556677766 7888764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=277.04 Aligned_cols=196 Identities=29% Similarity=0.425 Sum_probs=158.9
Q ss_pred eceeccCCceEEEEEEECC--CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEe--CCeEEEEEeccCC
Q 020133 26 VRDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 101 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~e~~~g 101 (330)
..+||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...|+||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3679999999999999754 56889999886543 34567899999999999999999999864 4678999999965
Q ss_pred CChHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC--CCCceEEeecCCccccc
Q 020133 102 GELFERICN---------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 170 (330)
Q Consensus 102 ~sL~~~l~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~--~~~~vkL~Dfg~a~~~~ 170 (330)
+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||++..+ ..+++||+|||+++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 77777642 1258999999999999999999999999999999999999432 23469999999997543
Q ss_pred CCC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 171 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
... ......+++.|+|||++.+....+.++|||||||++|+|+||++||....
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 222 12334678999999999775544556999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=279.00 Aligned_cols=249 Identities=26% Similarity=0.465 Sum_probs=192.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.+.|.....||+|+||.||++.+..++..||||.+..... ..+.+.+|+..++.++||||+++++.+...+..|+||||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3557778889999999999999999999999998865432 235678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++. ++|+|||++....... ....
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCce
Confidence 999999988754 56899999999999999999999999999999999999987754 9999999886432222 2234
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..++..|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+............. +.... .... ...+.+
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----~~~~-~~~~~~ 250 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKD----SHKV-SSVLRG 250 (292)
T ss_pred eecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-Ccccc----cccc-CHHHHH
Confidence 568889999999877666554 9999999999999999999987655443333221110 00000 0011 112233
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ ++.++++
T Consensus 251 li~~~l~~~P~~Rp-t~~~il~ 271 (292)
T cd06658 251 FLDLMLVREPSQRA-TAQELLQ 271 (292)
T ss_pred HHHHHccCChhHCc-CHHHHhh
Confidence 34445556777765 8888875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=274.57 Aligned_cols=208 Identities=28% Similarity=0.432 Sum_probs=170.9
Q ss_pred cccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC--
Q 020133 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-- 90 (330)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-- 90 (330)
.....++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..+++++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3444578999999999999999999999999999999886532 22345678999999999999999999987653
Q ss_pred ------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeec
Q 020133 91 ------HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 91 ------~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
..++||||+.+ +|.+.+... ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++. +||+||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~df 163 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLADF 163 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEECcC
Confidence 45999999965 787777654 37899999999999999999999999999999999999987664 999999
Q ss_pred CCcccccCCCC-----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 164 GYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 164 g~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
|++........ .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~ 231 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99874433221 1234567889999998765533455999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=281.30 Aligned_cols=209 Identities=29% Similarity=0.456 Sum_probs=175.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEe----CCeEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 93 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~----~~~~~ 93 (330)
++|++.+.||.|++|.||++.+..+|+.||+|.+.... .....+.+|+.++++++||||+++++++.. ....|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 78999999999999999999999999999999987642 234567789999999999999999998763 34689
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
+||||+. ++|.+++..++.+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccC
Confidence 9999996 589999987788999999999999999999999999999999999999987764 9999999986433221
Q ss_pred C-----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 Q-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
. .....++..|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+....+..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL 225 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHH
Confidence 1 1234678899999998664434555999999999999999999998766555444433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=272.18 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=190.1
Q ss_pred CCCeEEeceeccCCceEEEEEE----ECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~ 92 (330)
..+|++++.||+|+||.||.+. +..+++.||+|.+..... ....+.+|+..+++++||||+++++++... ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 4689999999999999999997 445788999999875532 235678999999999999999999987543 468
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~ 160 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccC
Confidence 9999999999999998764 46899999999999999999999999999999999999987664 99999999875433
Q ss_pred CCCC----CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCC--------hhH
Q 020133 172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIS--------IPE 239 (330)
Q Consensus 172 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------~~~ 239 (330)
.... ....++..|+|||++.+..++.+ +|+||||+++|||++|..|+..... .+........ ..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPA--EFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcch--hhhhhcccccccccchHHHHH
Confidence 2211 11223446999999977766554 9999999999999999877654321 1111110000 000
Q ss_pred HhcCc---hhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 240 IRNHE---WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 240 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..... .....++ ..+.+.+.++...+|.+| +++.|+.+.|..+
T Consensus 238 ~~~~~~~~~~~~~~~-~~~~~li~~cl~~~p~~R-pt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCP-AEIYAIMKECWNNDPSQR-PSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCC-HHHHHHHHHHccCChhhC-CCHHHHHHHHHhc
Confidence 00000 0011121 234455566666788887 4999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=268.66 Aligned_cols=246 Identities=27% Similarity=0.337 Sum_probs=188.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.+.||+|+||.||.+.. +++.||+|.+.... ....+.+|+..+++++||||+++++++..+ ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 46799999999999999998864 67889999886543 346788999999999999999999998765 479999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 100 ~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
++++|.+++.... .+++..+..++.|++.||.+||+.|++||||||+||+++.++ .++|+|||++...... ...
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~--~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--cEEECCCccceecccc--CCC
Confidence 9999999987543 589999999999999999999999999999999999998765 4999999998643221 122
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
...+..|+|||.+.+..++.+ +|+||||+++|+|++ |+.||...+..............+. ....|. .+.
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~-~~~ 227 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP-------PEGCPA-DVY 227 (254)
T ss_pred CCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCC-------CCcCCH-HHH
Confidence 334568999999877666554 999999999999998 9999987665443333222211110 011222 223
Q ss_pred cccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 257 DNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+...+++..+|..|+ +++++.+.|++
T Consensus 228 ~li~~~l~~~p~~Rp-~~~~l~~~l~~ 253 (254)
T cd05083 228 VLMTSCWETEPKKRP-SFHKLREKLEK 253 (254)
T ss_pred HHHHHHcCCChhhCc-CHHHHHHHHcc
Confidence 444555556677665 89999888764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=280.13 Aligned_cols=267 Identities=28% Similarity=0.430 Sum_probs=204.4
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC-----eEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-----~~~ 93 (330)
+|++.+.||.|++|.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++.+++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6999999999999999999999999999999887643 23457889999999999999999999988775 789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
+||||+++ +|.+++..+.++++..++.++.|++.||++||+.|++||||||+||+++.++ .++|+|||.+.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccc
Confidence 99999974 8999988878999999999999999999999999999999999999998775 59999999987544332
Q ss_pred ----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhh--
Q 020133 174 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL-- 247 (330)
Q Consensus 174 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 247 (330)
......++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+.......+......+......+..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 23344678899999999877334455999999999999999999999877666555555433222211111000
Q ss_pred ---------------------ccCCccccccccccCCCCCCCCccCCHHHHHH--HHHHhCCCCCCCCc
Q 020133 248 ---------------------KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ--IIAEATIPAAGTQS 293 (330)
Q Consensus 248 ---------------------~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~--~l~~~~~~~~~~~~ 293 (330)
..++ ..+.+.+.++...+|.+|+ ++.++++ .++....+...+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~~P~~Rp-t~~~ll~~~~~~~~~~~~~~~~~ 304 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGAS-PEAIDLLEKMLVFDPKKRI-TADEALAHPYLAQLHDPEDEPVA 304 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCC-HHHHHHHHHHccCChhhCC-CHHHHHhCccHHhhcccccCCCC
Confidence 0111 1123344555556777766 7777775 46665555444333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=263.19 Aligned_cols=201 Identities=35% Similarity=0.566 Sum_probs=176.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
.|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 48899999999999999999998999999999877643 45678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCccc
Q 020133 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (330)
Q Consensus 101 g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~ 179 (330)
+++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++ .++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG--EVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--eEEEeecccccccccccccccee
Confidence 99999998775 5899999999999999999999999999999999999998765 49999999987554433234556
Q ss_pred CCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 180 ~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
++..|+|||.+.+...+.+ +|+||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~ 203 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPM 203 (253)
T ss_pred cCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 7889999999877665444 99999999999999999999876443
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=279.36 Aligned_cols=211 Identities=25% Similarity=0.379 Sum_probs=176.2
Q ss_pred CCCeEE-eceeccCCceEEEEEEECCCCcEEEEEEeecCCccc---------------HHHHHHHHHHHcCCCCCeeeee
Q 020133 20 SDRYEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRFK 83 (330)
Q Consensus 20 ~~~y~i-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------------~~~~~ei~~l~~l~h~~Iv~~~ 83 (330)
.++|.. .+.||.|+||+||++.+..+++.||+|.+....... ..+.+|+..++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 478865 577999999999999999999999999886543221 2467899999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeec
Q 020133 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 84 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
+++..++..|+||||+. ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCc
Confidence 99999999999999997 589999988788999999999999999999999999999999999999987764 999999
Q ss_pred CCcccccC---------------CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHH
Q 020133 164 GYSKSSVL---------------HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (330)
Q Consensus 164 g~a~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~ 228 (330)
|.+..... ........+++.|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 98864331 111122346788999999876554455699999999999999999999987766655
Q ss_pred HHHhh
Q 020133 229 RKTIH 233 (330)
Q Consensus 229 ~~~~~ 233 (330)
..+..
T Consensus 244 ~~i~~ 248 (335)
T PTZ00024 244 GRIFE 248 (335)
T ss_pred HHHHH
Confidence 55443
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=318.91 Aligned_cols=248 Identities=29% Similarity=0.431 Sum_probs=199.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
-||+....+|.|.||.||-|.+..+|...|+|.++-.+ +......+|..++..++|||+|++|++-.+....+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 46888899999999999999999999999999876433 223467899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC----
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 173 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~---- 173 (330)
||+||+|.+.+..++..++.....+..|++.|+.|||++|||||||||.||+++.++. +|++|||.|.....+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence 9999999999998888899999999999999999999999999999999999988774 9999999997554443
Q ss_pred -CCCcccCCCCCCChhhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccC
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
......||+.|||||++.+.. -...+.|||||||++.||+||+.||...+..-++...+.-...|++... ....
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~---ls~~ 1469 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER---LSSE 1469 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh---hhHh
Confidence 124568999999999997654 2345699999999999999999999988877666666543333333222 1111
Q ss_pred CccccccccccCCCCCCCCccCCHHHHH
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIM 278 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~ 278 (330)
-.+++ .+|...+|..|+ ++.+|+
T Consensus 1470 g~dFl----e~Cl~~dP~~Rw-~~~qll 1492 (1509)
T KOG4645|consen 1470 GRDFL----EHCLEQDPKMRW-TASQLL 1492 (1509)
T ss_pred HHHHH----HHHHhcCchhhh-HHHHHH
Confidence 12333 334446788876 554443
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=265.17 Aligned_cols=243 Identities=24% Similarity=0.312 Sum_probs=186.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
+.||+|+||.||++... ++..+|+|.+..... ....+.+|+..+++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 588899998765432 234678999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC--CcccCC
Q 020133 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGT 181 (330)
Q Consensus 105 ~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~~ 181 (330)
.+++... ..+++..+..++.|++.+|.++|+.|++||||+|+||+++.++. ++|+|||++......... ....++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9988653 46899999999999999999999999999999999999987664 999999998643322211 122345
Q ss_pred CCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccc
Q 020133 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTT 260 (330)
Q Consensus 182 ~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (330)
..|+|||++.+..+..+ +|+||||+++|++++ |..||.................. .+...++. .+.+...
T Consensus 158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~li~ 228 (250)
T cd05085 158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-------SCPQKCPD-DVYKVMQ 228 (250)
T ss_pred ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC-------CCCCCCCH-HHHHHHH
Confidence 67999999977766555 999999999999998 99999876554433333222111 00111222 2334455
Q ss_pred cCCCCCCCCccCCHHHHHHHHH
Q 020133 261 NNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 261 ~~~~~~p~~~~~s~~el~~~l~ 282 (330)
++...+|.+| +++.|+.+.|.
T Consensus 229 ~~l~~~p~~R-p~~~~l~~~l~ 249 (250)
T cd05085 229 RCWDYKPENR-PKFSELQKELA 249 (250)
T ss_pred HHcccCcccC-CCHHHHHHHhc
Confidence 5566778887 59999988764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=268.35 Aligned_cols=199 Identities=25% Similarity=0.348 Sum_probs=160.5
Q ss_pred ceeccCCceEEEEEEEC--CCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 020133 27 RDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~ 102 (330)
+.||+|+||.||++... .++..+|+|.+...... ...+.+|+..+++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999864 35677999988654322 246788999999999999999999999888899999999999
Q ss_pred ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---C
Q 020133 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (330)
Q Consensus 103 sL~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~---~ 174 (330)
+|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||.+....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceeec
Confidence 9999986432 456778889999999999999999999999999999998765 49999999986432221 1
Q ss_pred CCcccCCCCCCChhhhhcCC------CCCCccchhhHHHHHHHHHh-CCCCCCCCChhhH
Q 020133 175 PKSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~ 227 (330)
.....++..|+|||++.+.. ..+.++|+||||+++|+|++ |+.||........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 12335678899999986432 12445999999999999996 9999987655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=270.10 Aligned_cols=194 Identities=30% Similarity=0.553 Sum_probs=163.6
Q ss_pred CCeEEecee--ccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDI--GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
+.|++.+.+ |+|+||.||++.+..+++.+|+|.+....... .|+.....+ +||||+++++.+..++.+|+|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 567777776 99999999999999999999999887643221 122222222 79999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
|+++++|.+++..+..+++.+++.++.|+++||.+||+.|++||||+|+||+++.++. .++|+|||+++.... ...
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~---~~~ 165 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIGT---PSC 165 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecCC---Ccc
Confidence 9999999999988789999999999999999999999999999999999999987652 599999998864332 233
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
..++..|+|||++.+..++.+ +|+||||+++|+|++|+.||....
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCC
Confidence 467889999999987777655 999999999999999999998543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=273.18 Aligned_cols=241 Identities=18% Similarity=0.206 Sum_probs=181.9
Q ss_pred ceeccCCceEEEEEEECCCCc-------EEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 27 RDIGSGNFGVARLMRDKKTEE-------LVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+.||+|+||.||++.+...+. .+++|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999999865443 48888775543 2235678899999999999999999999998999999999
Q ss_pred cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC------ceEEeecCCcccccC
Q 020133 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL 171 (330)
Q Consensus 99 ~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~------~vkL~Dfg~a~~~~~ 171 (330)
+++++|.+++..++ .+++..++.++.||+.||+|||++||+||||||+||+++.++.. .++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 99999999997654 58999999999999999999999999999999999999766531 379999998764322
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChhhHHHHHhhcCChhHHhcCchhhccC
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
.....++..|+|||++.+....+.++|+||||+++|+|++| ..||...+..........+...|.. .
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~---~------ 228 (258)
T cd05078 161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAP---K------ 228 (258)
T ss_pred ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCC---C------
Confidence 23345788999999997654444559999999999999998 5676654443322222222221110 0
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHHHH
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
...+.+.+.++...+|.+| ++++++++.|
T Consensus 229 -~~~~~~li~~~l~~~p~~R-ps~~~il~~l 257 (258)
T cd05078 229 -WTELANLINQCMDYEPDFR-PSFRAIIRDL 257 (258)
T ss_pred -cHHHHHHHHHHhccChhhC-CCHHHHHHhc
Confidence 1112334444555777777 4999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=275.38 Aligned_cols=248 Identities=26% Similarity=0.456 Sum_probs=190.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
..|.....||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++++..++..|+||||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 34666778999999999999999999999999986543 23456789999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~~ 178 (330)
++++|..++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccce
Confidence 99999887754 56899999999999999999999999999999999999987764 9999999886433222 22345
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDN 258 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (330)
.++..|+|||.+.+..+.. ++|+|||||++|+|++|+.||...+.......+... ..+..... ...+ ..+.+.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~-~~l~~~ 250 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGT-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNA----HKIS-PVLRDF 250 (297)
T ss_pred ecCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCCCcccc----CCCC-HHHHHH
Confidence 6889999999998776654 499999999999999999999876544443332211 11111000 0111 112233
Q ss_pred cccCCCCCCCCccCCHHHHHH
Q 020133 259 TTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 259 ~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.++...+|.+|+ ++.++++
T Consensus 251 i~~~l~~~P~~Rp-s~~~ll~ 270 (297)
T cd06659 251 LERMLTREPQERA-TAQELLD 270 (297)
T ss_pred HHHHhcCCcccCc-CHHHHhh
Confidence 3344445666654 7888776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=273.94 Aligned_cols=255 Identities=20% Similarity=0.300 Sum_probs=190.7
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCc----EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
...++|++.+.||+|+||.||++.+..+|. .||+|.+..... ....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 445789999999999999999999887775 468887765432 123578899999999999999999998754 4
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.++++||+++|+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++. +||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEcccccccccc
Confidence 679999999999999987644 6899999999999999999999999999999999999987654 9999999987543
Q ss_pred CCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchh
Q 020133 171 LHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246 (330)
Q Consensus 171 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (330)
.... .....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+... ......+.....+ ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~------~~ 232 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLLEKGERL------PQ 232 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHCCCCC------CC
Confidence 2221 122335678999999887776555 999999999999997 9999976543 2233333221110 00
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
....+.+ +...+..++..+|..| +++.++++.+..+.
T Consensus 233 ~~~~~~~-~~~li~~c~~~~p~~R-p~~~~l~~~l~~~~ 269 (303)
T cd05110 233 PPICTID-VYMVMVKCWMIDADSR-PKFKELAAEFSRMA 269 (303)
T ss_pred CCCCCHH-HHHHHHHHcCCChhhC-cCHHHHHHHHHHHH
Confidence 0111111 1222334444566666 48999999888763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=278.72 Aligned_cols=210 Identities=33% Similarity=0.453 Sum_probs=171.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC---------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--------- 89 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--------- 89 (330)
.++|++.+.||.|+||.||++.+..+|+.||+|.+..... ..+.+.+|+..+++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4799999999999999999999999999999998866543 335688999999999999999999876654
Q ss_pred -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecC
Q 020133 90 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (330)
Q Consensus 90 -----~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg 164 (330)
...|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.|++||||||+||+++.++. .++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFG 160 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcc
Confidence 35799999997 488887754 57999999999999999999999999999999999999975432 58999999
Q ss_pred CcccccCCCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 165 ~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.++....... .....++..|+|||.+.+......++|+|||||++|+|++|+.||...+........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9864322111 1223568899999987654444555999999999999999999998766555544444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=271.68 Aligned_cols=207 Identities=32% Similarity=0.483 Sum_probs=174.6
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
|++.+.||.|++|.||++.+..+|..||+|.+.... .....+.+|+..++.++||||+++++++...+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999999999999999887543 22356788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 100 ~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
+ ++|.+++.... .+++..++.++.|++.||.|||+.+++||||+|+||+++.++ .++|+|||++....... ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCccccC
Confidence 5 58999987765 799999999999999999999999999999999999998765 49999999986443222 123
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
...++..|+|||++.+......++|+||||+++|+|++|+.||...+......++.
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 213 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF 213 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 34568899999988665443445999999999999999999998776655555444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.27 Aligned_cols=202 Identities=29% Similarity=0.395 Sum_probs=168.0
Q ss_pred CeEEeceeccCCceEEEEEEECC--CCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKK--TEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~ 93 (330)
+|++.+.||+|++|.||++.+.. +++.||+|.+.... .....+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 89999999987632 3346778899999999999999999999988 7899
Q ss_pred EEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC--CCceEEeecCCc
Q 020133 94 IVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYS 166 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~--~~~vkL~Dfg~a 166 (330)
+||||+++ +|.+.+... ..+++..++.++.|++.||.|||+.+++||||||+||+++.++ .+.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 676665421 3689999999999999999999999999999999999997611 235999999998
Q ss_pred ccccCCCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 167 KSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 167 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
........ .....++..|+|||++.+....+.++|+|||||++|+|++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 75433222 22346788999999987654444559999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=269.47 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=187.0
Q ss_pred ceeccCCceEEEEEEECCCC------cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 27 RDIGSGNFGVARLMRDKKTE------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+.||+|+||.||++.+.... +.+|+|.+.... .....+.+|+..++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986543 689999876543 3345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC---CCceEEeecCCccc
Q 020133 99 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 168 (330)
Q Consensus 99 ~~g~sL~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~---~~~vkL~Dfg~a~~ 168 (330)
+++++|.+++... ..+++.++..++.|++.||.|||+.+++|+||+|+||+++.+. ...++|+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999998642 3478899999999999999999999999999999999997654 12599999999864
Q ss_pred ccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 169 SVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 169 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
..... ......++..|+|||.+.+.....+ +|||||||++|+|++ |+.||...+.......+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------- 232 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL------- 232 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc-------
Confidence 43221 1123345678999999987776554 999999999999998 99999876654433332211111
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
......|. .+.+.+.++...+|.+|+ +++++.+.|.
T Consensus 233 ~~~~~~~~-~~~~li~~~l~~~p~~Rp-~~~~i~~~l~ 268 (269)
T cd05044 233 QKPENCPD-KIYQLMTNCWAQDPSERP-TFDRIQEILQ 268 (269)
T ss_pred CCcccchH-HHHHHHHHHcCCCcccCC-CHHHHHHHHh
Confidence 01112222 233444555556777765 9999988875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=264.97 Aligned_cols=243 Identities=25% Similarity=0.322 Sum_probs=187.4
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
++||.|++|.||++.+.. ++.||+|.+..... ....+.+|+..+++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999987 99999998876533 345788999999999999999999999999999999999999999
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC---CcccC
Q 020133 105 FERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (330)
Q Consensus 105 ~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~ 180 (330)
.+++.. ...+++..+..++.+++.||.+||+++++||||+|+||+++.++ .++|+|||.+......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcceeccccCcc
Confidence 999865 35689999999999999999999999999999999999998765 4999999998744321111 11223
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccccc
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNT 259 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (330)
+..|+|||.+.+..+..+ +|+||||+++|+|+| |..||...........+......+ .....|. .+.+..
T Consensus 158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~li 228 (251)
T cd05041 158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP-------APQLCPE-EIYRLM 228 (251)
T ss_pred eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC-------CCccCCH-HHHHHH
Confidence 557999999877766544 999999999999999 899998765443333322211111 0111122 233344
Q ss_pred ccCCCCCCCCccCCHHHHHHHHH
Q 020133 260 TNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 260 ~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
.++...+|.+|+ ++.|+++.|.
T Consensus 229 ~~~l~~~p~~Rp-~~~ell~~l~ 250 (251)
T cd05041 229 LQCWAYDPENRP-SFSEIYNELQ 250 (251)
T ss_pred HHHhccChhhCc-CHHHHHHHhh
Confidence 445556777764 9999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.78 Aligned_cols=240 Identities=22% Similarity=0.226 Sum_probs=179.2
Q ss_pred eeccCCceEEEEEEECC------------------------CCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeee
Q 020133 28 DIGSGNFGVARLMRDKK------------------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 82 (330)
Q Consensus 28 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~ 82 (330)
.||+|+||.||++.... ....|++|.+..... ....+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999987432 224588898765432 23467788999999999999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-----CC
Q 020133 83 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----AP 156 (330)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-----~~ 156 (330)
++++...+..++||||+++++|..++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++..+ ..
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999998865 46789999999999999999999999999999999999997543 22
Q ss_pred ceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHH-hCCCCCCCCChhhHHHHHhhcC
Q 020133 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRI 235 (330)
Q Consensus 157 ~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~ 235 (330)
.++++|||.+..... .....++..|+|||.+.+....+.++|+||||+++|+++ +|+.||................
T Consensus 162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 238 (274)
T cd05076 162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKH 238 (274)
T ss_pred eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhcc
Confidence 489999998753322 123356788999999876443445599999999999985 6999998755433222111111
Q ss_pred ChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHH
Q 020133 236 SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
..++ ..+. .+.+.+.+++..+|.+| +++.++++.|
T Consensus 239 ~~~~---------~~~~-~~~~li~~cl~~~p~~R-ps~~~il~~L 273 (274)
T cd05076 239 RLPE---------PSCK-ELATLISQCLTYEPTQR-PSFRTILRDL 273 (274)
T ss_pred CCCC---------CCCh-HHHHHHHHHcccChhhC-cCHHHHHHhh
Confidence 1111 0111 13344455566778887 4999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=268.14 Aligned_cols=198 Identities=32% Similarity=0.522 Sum_probs=165.1
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHH-HHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~-l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
+.||+|++|.||+|.+..+++.||+|.+.+.... ...+..|... ....+|+||+++++++...+.+|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998654321 1223344433 3455899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCC
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~ 181 (330)
++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||+++.... .....++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence 999999988888999999999999999999999999999999999999987654 99999998864322 2344578
Q ss_pred CCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 182 ~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
..|+|||.+.+..+. .++|+||||+++|+|++|..||...+....+..
T Consensus 157 ~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 204 (260)
T cd05611 157 PDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204 (260)
T ss_pred cCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 899999999877654 449999999999999999999987665443333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=273.71 Aligned_cols=211 Identities=26% Similarity=0.417 Sum_probs=172.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC-------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------- 89 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------- 89 (330)
.++|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+..+++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999999999999998865322 234677899999999999999999987543
Q ss_pred -CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 90 -THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 90 -~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
..+|+||||+.+ +|...+.. ...+++..++.++.|+++||.|||+.|++|+||||+||+++.++. ++|+|||+++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccch
Confidence 346999999975 66666654 457999999999999999999999999999999999999987764 9999999986
Q ss_pred cccCCCC------------CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 168 SSVLHSQ------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 168 ~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
....... .....+++.|+|||.+.+....+.++|+|||||++|+|++|++||.+.+.......+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4332211 11224678899999987654344559999999999999999999988776665555543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=264.64 Aligned_cols=247 Identities=31% Similarity=0.472 Sum_probs=194.1
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+|++.+.||.|+||.||++.++.+|..+|+|.+.... ...+.+.+|+..++.++|+||+++++.+...+..|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5899999999999999999999999999999986542 3345678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-C
Q 020133 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-~ 175 (330)
+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. .++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999987643 4799999999999999999999999999999999999987643 479999998864433222 2
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
....+++.|+|||++.+...+.+ +|+||||++++++++|..||...+............. +.+....+. .+
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~ 230 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-------APISPNFSR-DL 230 (257)
T ss_pred cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-------CCCCCCCCH-HH
Confidence 23457889999999877766555 9999999999999999999987655444443332211 111111111 22
Q ss_pred ccccccCCCCCCCCccCCHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.+.++...+|.+|+ +++++++
T Consensus 231 ~~~i~~~l~~~p~~Rp-t~~~ll~ 253 (257)
T cd08225 231 RSLISQLFKVSPRDRP-SITSILK 253 (257)
T ss_pred HHHHHHHhccChhhCc-CHHHHhh
Confidence 3334445556777775 8988875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=271.48 Aligned_cols=199 Identities=31% Similarity=0.550 Sum_probs=169.7
Q ss_pred CeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeE
Q 020133 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~ 92 (330)
.|++.+.||.|+||.||+|.+. .+|+.||+|.+.... ...+.+.+|+.+++++ +|+||+++++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 478999999987532 2235678899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+||||+++++|.+++.....+++..+..++.|++.||.+||+.|++||||+|+||+++.++ +++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceecccc
Confidence 99999999999999998888899999999999999999999999999999999999998765 4999999998754332
Q ss_pred C--CCCcccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 173 S--QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 173 ~--~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
. ......++..|+|||.+.+.. ....++|+||||+++|+|++|+.||...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 2 122346788999999986532 2344599999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=272.76 Aligned_cols=210 Identities=33% Similarity=0.530 Sum_probs=173.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~------ 90 (330)
.++|++.+.||+|++|.||++.+..+|+.||+|.++... .....+.+|+..+++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 478999999999999999999999999999999987542 23356778999999999999999999987654
Q ss_pred ----eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 91 ----HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 91 ----~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
.+|+|+||+++ ++...+... ..+++..++.++.|++.||.|||+.||+|+||+|+||++++++. +||+|||.
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~ 162 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGL 162 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccc
Confidence 78999999986 666666543 46999999999999999999999999999999999999987664 99999999
Q ss_pred cccccCCC--CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 166 SKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 166 a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
+....... ......++..|+|||++.+....+.++|||||||++|+|++|++||...+.......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 87543322 11223457789999998765444455999999999999999999998766655554444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=273.16 Aligned_cols=246 Identities=28% Similarity=0.431 Sum_probs=190.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+.|+..+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..+++++||||+++++++..++..|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45788899999999999999999999999999887443 2335688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence 999999988864 57899999999999999999999999999999999999987664 9999999986443322 1223
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..++..|+|||++.+..++.+ +|+||||+++|+|++|+.||........... +.....+ .+....+. .+.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~------~~~~~~~~-~~~~ 231 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPKNSPP------TLEGQYSK-PFKE 231 (277)
T ss_pred ccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhcCCCC------CCCcccCH-HHHH
Confidence 457889999999987776555 9999999999999999999975443222211 1111111 11111111 1223
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|..|+ ++.++++
T Consensus 232 li~~~l~~~p~~Rp-~~~~il~ 252 (277)
T cd06642 232 FVEACLNKDPRFRP-TAKELLK 252 (277)
T ss_pred HHHHHccCCcccCc-CHHHHHH
Confidence 34444556777764 8888876
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.07 Aligned_cols=210 Identities=30% Similarity=0.471 Sum_probs=182.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC-CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.+.|.|+..||.|+||.||+|.++.++...|.|++... ....+.+.-||.+|..+.||+||++++.|..++.+|++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 36689999999999999999999999998899988653 34456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc-cCCCCCC
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~-~~~~~~~ 176 (330)
|.||-+..++.. ...|++.++..+++|++.||.|||+++|+|||||..|||+.-+|. ++|+|||++... .......
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhc
Confidence 999999887765 457999999999999999999999999999999999999988876 999999987533 3344567
Q ss_pred cccCCCCCCChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 177 STVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~-----~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
+++|||+|||||+.. ..+|+.+ +||||||++|.||..+.+|....+....+.++.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKia 248 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 248 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHh
Confidence 889999999999863 4567666 999999999999999999998776655555544
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=262.82 Aligned_cols=199 Identities=37% Similarity=0.547 Sum_probs=176.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~lv~ 96 (330)
+|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..+++++||||+++++.+... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999999999999999987654 2356788999999999999999999999988 8899999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-- 174 (330)
||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecccccccc
Confidence 9999999999998877999999999999999999999999999999999999998765 499999999875554432
Q ss_pred -CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 175 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.....++..|+|||.+.+.....+ +|+||||+++++|++|..||....
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 344568889999999877765444 999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=269.71 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=196.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..+.|++.+.||+|++|.||.+.+..++..|++|.+.......+.+.+|+..++.++|+||+++++.+...+..|+|+||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 34679999999999999999999998899999999987655456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhc
Confidence 99999999998876 8999999999999999999999999999999999999987664 9999999876433221 123
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
...++..|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+.......+... ..+.....+ .++. .+.
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~-~l~ 247 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPPLKNPE----KWSP-EFK 247 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCcchh----hCCH-HHH
Confidence 3457789999999887766555 99999999999999999999876554333332221 111111110 0111 222
Q ss_pred cccccCCCCCCCCccCCHHHHHH
Q 020133 257 DNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.++...+|..|+ ++.+++.
T Consensus 248 ~li~~~l~~~p~~Rp-t~~~il~ 269 (286)
T cd06614 248 DFLNKCLVKDPEKRP-SAEELLQ 269 (286)
T ss_pred HHHHHHhccChhhCc-CHHHHhh
Confidence 334444556666664 7887764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=272.70 Aligned_cols=249 Identities=28% Similarity=0.451 Sum_probs=192.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+..+++++||||+++++.+...+..|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 478999999999999999999998899999999886433 2345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
+++++|.+++.+ ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred CCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccccc
Confidence 999999998865 45899999999999999999999999999999999999987654 9999999876443322 2233
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..+++.|+|||.+.+..++.. +|+||||+++|++++|+.||...+......... ....+.... ...++ ..+.+
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~~~----~~~~~-~~l~~ 247 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN----PEKLS-AIFRD 247 (293)
T ss_pred ccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-cCCCCCCCC----ccccC-HHHHH
Confidence 467889999999877766554 999999999999999999998655433222111 111111000 00111 11223
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+| .++++++.
T Consensus 248 li~~~l~~~p~~R-p~~~~il~ 268 (293)
T cd06647 248 FLNRCLEMDVEKR-GSAKELLQ 268 (293)
T ss_pred HHHHHccCChhhC-cCHHHHhc
Confidence 4445555677777 48888874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.37 Aligned_cols=207 Identities=32% Similarity=0.496 Sum_probs=175.3
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEecc
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
|++.+.||.|++|+||++....+++.|++|.+..... ......+|+..+++++ ||||+++++++..++..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999999999999998865432 2234567899999998 999999999999999999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 100 ~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
+++|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 779988887654 7899999999999999999999999999999999999987654 99999999875544434445
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
..++..|+|||++.+....+.++|+||||+++++|++|+.||..........+..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~ 212 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC 212 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH
Confidence 5678899999988655444555999999999999999999998776655554443
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.96 Aligned_cols=197 Identities=30% Similarity=0.451 Sum_probs=165.4
Q ss_pred CCeEEeceeccCCceEEEEEEE----CCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeE
Q 020133 21 DRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~ 92 (330)
..|++++.||+|+||.||++.. ..++..||+|.+.... .....+.+|+..+++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4589999999999999999984 4578899999986542 2235788999999999999999999998875 568
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
++||||++|++|.+++.++. .+++..+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||+++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCcccccccc
Confidence 99999999999999987643 6899999999999999999999999999999999999987654 99999999875433
Q ss_pred CCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 172 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
... .....++..|+|||.+.+..+..+ +|+||||+++|+|+|++.|+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCc
Confidence 221 123345678999999887766555 999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=260.13 Aligned_cols=246 Identities=29% Similarity=0.432 Sum_probs=194.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+..+++++|||++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999999999999999876643 345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-CCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-~~~ 177 (330)
+++++|.+++...+.+++..+..++.|++.||.+||+.|++||||+|+||+++.++ .++|+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCcccccc
Confidence 99999999998888999999999999999999999999999999999999998765 499999999875443322 234
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..++..|+|||.+.+.... .++|+||||+++|+|++|+.||...+............ ++-+....+ +.+.+
T Consensus 159 ~~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~ 229 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-------HPPLPEGIS-PELKD 229 (254)
T ss_pred cccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-------CCCCCCCCC-HHHHH
Confidence 4678899999998776654 44999999999999999999998765433333332111 111111111 12223
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ ++.+++.
T Consensus 230 ~i~~~l~~~p~~R~-~~~~~l~ 250 (254)
T cd06627 230 FLMQCFQKDPNLRP-TAKQLLK 250 (254)
T ss_pred HHHHHHhCChhhCc-CHHHHhc
Confidence 33444446677764 7887764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=270.45 Aligned_cols=209 Identities=37% Similarity=0.629 Sum_probs=185.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+.|..++.||+|.||.|-+++.+.+++.||+|++++.--. ...-..|-+.|+..+||.+..+...|..++++|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 6788999999999999999999999999999998875322 223456778899999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc-cCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~-~~~~~~ 175 (330)
||..||.|.-.+.+...+++...+.+...|+.||.|||+++||.||||.+|.|+|.++. +|++|||+++.. ..+...
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhccccccee
Confidence 99999999998988888999999999999999999999999999999999999999986 999999999844 344556
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.+.||||.|+|||++....|. +++|.|.+|++||||++|+.||.+.+....+.-++
T Consensus 326 kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred ccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence 788999999999999888774 55999999999999999999999888766655554
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=270.82 Aligned_cols=199 Identities=32% Similarity=0.495 Sum_probs=168.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.+|++.+.||+|++|.||++.+..+++.||+|.+...... ...+.+|+.+++.++||||+++.+++...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 6799999999999999999999999999999988654321 245788999999999999999999999999999999
Q ss_pred eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+.| ++.+.+. ..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... .
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~---~ 168 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP---A 168 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC---C
Confidence 99975 6666665 3567999999999999999999999999999999999999987764 99999998864332 2
Q ss_pred CcccCCCCCCChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 176 KSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~---~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
....+++.|+|||++.+ ..+. .++||||||+++|+|+||+.||...+...
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~ 221 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMS 221 (307)
T ss_pred CCccCCccccCceeeeccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHH
Confidence 33467889999998742 3343 44999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=278.19 Aligned_cols=208 Identities=32% Similarity=0.481 Sum_probs=172.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC--CeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~--~~~~ 93 (330)
.++|++.+.||+|+||.||++.+..+++.+|+|.+... ......+.+|+..++++ +||||+++++++... ...|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 47899999999999999999999989999999988542 22234577899999999 999999999998654 3689
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
+||||+++ +|.+++..+ .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++.......
T Consensus 86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELE 161 (337)
T ss_pred EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccc
Confidence 99999975 898888765 7899999999999999999999999999999999999987765 9999999987443322
Q ss_pred ------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 174 ------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 174 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
......++..|+|||.+.+......++|+||||+++|+|++|+.||.+........+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 1123457889999998866554455699999999999999999999876655544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=264.96 Aligned_cols=201 Identities=32% Similarity=0.459 Sum_probs=167.7
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
.......||+|+||.||++.+..++..|++|.+..... ..+.+.+|+..+++++|+||+++++++..++..++|+||++
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 34445689999999999999999999999998876533 34578899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 101 GGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 101 g~sL~~~l~~~-~~l--~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
+++|.+++... .++ ++..+..++.|++.||.|||+.||+||||||+||+++.+. +.++|+|||.+....... ...
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~ 167 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTE 167 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCccc
Confidence 99999998764 455 8889999999999999999999999999999999997633 259999999886443222 223
Q ss_pred cccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 177 STVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
...+++.|+|||.+.+.. ..+.++|+||||+++|+|++|+.||....
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 345788999999986543 23445999999999999999999997644
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=266.06 Aligned_cols=250 Identities=30% Similarity=0.464 Sum_probs=191.0
Q ss_pred CeEEeceeccCCceEEEEEEECC-CCcEEEEEEeecCC-----------cccHHHHHHHHHHHc-CCCCCeeeeeEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD-----------KIDENVQREIINHRS-LRHPNIVRFKEVILT 88 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-----------~~~~~~~~ei~~l~~-l~h~~Iv~~~~~~~~ 88 (330)
.|++.+.||+|+||.||++.+.. +++.+|+|.+.... .....+.+|+..+.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 68899999875321 112345677777764 799999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeec
Q 020133 89 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
++..++||||++|++|.+++.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 9999999999999999988742 3469999999999999999999996 78999999999999987664 999999
Q ss_pred CCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcC
Q 020133 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243 (330)
Q Consensus 164 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
|.+.............++..|+|||.+.+..+..+ +|+||||+++|+|++|+.||..................+ ..
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~-- 234 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LP-- 234 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-CC--
Confidence 99875444333345568889999999987666544 999999999999999999998765544433333221111 00
Q ss_pred chhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 244 EWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
.... ...+.+.+.++...+|..|+ ++.|+...+.
T Consensus 235 ---~~~~-~~~l~~li~~cl~~~p~~Rp-~~~e~~~~~~ 268 (269)
T cd08528 235 ---EGMY-SEDVTDVITSCLTPDAEARP-DIIQVSAMIS 268 (269)
T ss_pred ---cccC-CHHHHHHHHHHCCCCCccCC-CHHHHHHHhc
Confidence 0011 12233444556667777766 8888877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=267.92 Aligned_cols=208 Identities=34% Similarity=0.545 Sum_probs=177.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv 95 (330)
++|++.+.||+|++|.||++.+..+++.||+|++.... .....+.+|+..+++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999887632 22356788999999998 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-- 173 (330)
|||+++++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999998889999999999999999999999999999999999999987664 9999999886433221
Q ss_pred -------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 174 -------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 174 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
......++..|+|||...+..... ++|+||||++++++++|+.||...+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCCh-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 112335678999999987766544 499999999999999999999877654444333
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=260.73 Aligned_cols=246 Identities=33% Similarity=0.531 Sum_probs=195.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+|++.+.||.|++|.||++.+..+++.|++|.+.... .....+.+|+..++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5899999999999999999999999999999987643 2345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 99 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 99 ~~g~sL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
+++++|.+.+... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999998763 67999999999999999999999999999999999999987654 9999999987443332
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
......+++.|+|||.+.+.....+ +|+||+|+++++|++|+.||...+..........+. .+.+ ....+ .
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~------~~~~~-~ 229 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPI------PSQYS-S 229 (258)
T ss_pred eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCC------CCCCC-H
Confidence 2334567889999999877776555 999999999999999999998766544444433221 1111 11121 2
Q ss_pred ccccccccCCCCCCCCccCCHHHHHH
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.+.+.++...+|.+|+ ++.|+++
T Consensus 230 ~~~~~i~~~l~~~p~~Rp-~~~~ll~ 254 (258)
T cd08215 230 ELRNLVSSLLQKDPEERP-SIAQILQ 254 (258)
T ss_pred HHHHHHHHHcCCChhhCc-CHHHHhc
Confidence 233344455556676665 7787764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.01 Aligned_cols=209 Identities=32% Similarity=0.483 Sum_probs=174.9
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcC---CCCCeeeeeEEEEeCCe-----
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILTPTH----- 91 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l---~h~~Iv~~~~~~~~~~~----- 91 (330)
|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+..++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998999999999875422 224566777776655 59999999999988776
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
.+++|||+.+ +|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceec
Confidence 9999999975 7888887643 589999999999999999999999999999999999998775 4999999998755
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 235 (330)
..........++..|+|||.+.+..+..+ +|+|||||++|+|++|++||...+....+.++....
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 44433344457889999999987776555 999999999999999999999877777666666543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=265.16 Aligned_cols=246 Identities=28% Similarity=0.449 Sum_probs=191.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+-|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+..+++++||||+++++++..+...|+||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 347889999999999999999998999999998765432 235678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
+++++|.+++.. +.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence 999999988864 57899999999999999999999999999999999999987654 9999999886443222 1233
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..++..|+|||.+.+...+.+ +|+|||||++|+|++|..||........... +.....+ .+....+.+ +.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~------~~~~~~~~~-~~~ 231 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPP------TLEGNYSKP-LKE 231 (277)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCC------CCCcccCHH-HHH
Confidence 467889999999877666544 9999999999999999999986554333222 2111111 111112221 223
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|..|+ ++.++++
T Consensus 232 ~i~~~l~~~p~~Rp-~~~~~l~ 252 (277)
T cd06641 232 FVEACLNKEPSFRP-TAKELLK 252 (277)
T ss_pred HHHHHccCChhhCc-CHHHHHh
Confidence 33444556677764 8888887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.37 Aligned_cols=227 Identities=29% Similarity=0.394 Sum_probs=189.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCc----EEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEe-CCeE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHL 92 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~-~~~~ 92 (330)
..|+++..||+|.||.||+|..+.++. .+|+|.++... .......||+.+++.++|||++.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 569999999999999999997766533 68999887653 334678899999999999999999999987 7789
Q ss_pred EEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC--CCCceEEeecCC
Q 020133 93 AIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGY 165 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~--~~~~vkL~Dfg~ 165 (330)
++++||.+. +|.++++- ...++...++.+++||+.|+.|||++-|+||||||+|||+..+ ..++|||+|||+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999999976 78888753 3469999999999999999999999999999999999999655 346799999999
Q ss_pred cccccCCCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh---------hhHHHHHh
Q 020133 166 SKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---------PKNFRKTI 232 (330)
Q Consensus 166 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~---------~~~~~~~~ 232 (330)
++.....-. ....+.|..|+|||.+.|....+++.|+||.|||+.||+|-++.|.+... .+++.+++
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 985443322 23446788999999999998888989999999999999999999976432 35777888
Q ss_pred hcCChhHHhcCchhhc
Q 020133 233 HRISIPEIRNHEWFLK 248 (330)
Q Consensus 233 ~~~~~~~~~~~~~~~~ 248 (330)
+-.+.|.-..+|.+.+
T Consensus 263 ~vLG~Pt~~~Wp~lkk 278 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKK 278 (438)
T ss_pred HHcCCCccccchhhhh
Confidence 7777777777776543
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=265.42 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=193.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
..|...+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++||||+++++++...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 456677899999999999999999999999998865432 2346788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~~ 178 (330)
+|++|.+++.. +++++..+..++.|++.||++||++|++||||+|+||+++.++ .++|+|||.+....... .....
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC--cEEEcccccchhhccCCcccccc
Confidence 99999999877 6799999999999999999999999999999999999998765 49999999876433222 22334
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDN 258 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (330)
.+++.|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+........... ..+.... + ... +..+.+.
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~-~---~~~-~~~l~~l 248 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKN-L---HKV-SPRLRSF 248 (285)
T ss_pred cCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcc-c---ccC-CHHHHHH
Confidence 68899999999877766555 99999999999999999999875544433333222 1111110 0 001 1223344
Q ss_pred cccCCCCCCCCccCCHHHHHH
Q 020133 259 TTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 259 ~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.++...+|.+|+ ++.++++
T Consensus 249 i~~~l~~~p~~Rp-t~~~il~ 268 (285)
T cd06648 249 LDRMLVRDPAQRA-TAAELLN 268 (285)
T ss_pred HHHHcccChhhCc-CHHHHcc
Confidence 4555567787775 8888874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=269.07 Aligned_cols=208 Identities=32% Similarity=0.483 Sum_probs=176.2
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6788999999999999999999999999998876432 2457788999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 100 ~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
++ +|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 76 78777765 468999999999999999999999999999999999999987654 9999999987554333 2233
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
..++..|+|||.+.+....+.++|+||||+++|+|+||+.||...+....+.....
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 213 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR 213 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 45778899999987763445559999999999999999999988776665555543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=270.63 Aligned_cols=200 Identities=26% Similarity=0.373 Sum_probs=166.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|+..+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..+.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46778899999999999999999999999999887543 22346788999999996 9999999999999899999999
Q ss_pred ccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 98 YASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 98 ~~~g~sL~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
|+.+ ++.++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++. ++|+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence 9864 5554332 24679999999999999999999997 59999999999999987654 99999999875443
Q ss_pred CCCCCcccCCCCCCChhhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
........++..|+|||++.+. ...+.++|+|||||++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 3333445678899999998766 233445999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=262.60 Aligned_cols=201 Identities=35% Similarity=0.551 Sum_probs=174.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+|++.+.||+|++|.||++.+..+++.+|+|.+.... .....+.+|+..++.++|+||+++.+++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999987543 2234677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 99 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 99 ~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccC-C
Confidence 999999998865 35689999999999999999999999999999999999998765 4999999998754433 3
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+...
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 334567889999999987766555 999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=267.77 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=192.8
Q ss_pred CCCeEEeceeccCCceEEEEEEEC----CCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEe--CCe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT--PTH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~--~~~ 91 (330)
...|++.+.||+|+||.||++... .++..||+|.+...... ...+.+|+..++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 357889999999999999999865 34889999998866553 5678999999999999999999999887 457
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.++||||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccccccccc
Confidence 899999999999999997654 699999999999999999999999999999999999998775 49999999987544
Q ss_pred CCCCC----CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh--------------HHHHHh
Q 020133 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK--------------NFRKTI 232 (330)
Q Consensus 171 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~--------------~~~~~~ 232 (330)
..... ....++..|+|||.+.+..+... +|+||||+++|+|++|..||....... .+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 22111 12234567999999877766544 999999999999999999986533211 111111
Q ss_pred hcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 233 HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..... .+ .....| ..+.+...++...+|.+|+ ++.|+.+.|.++
T Consensus 240 ~~~~~-----~~-~~~~~~-~~~~~li~~cl~~~p~~Rp-t~~ei~~~l~~i 283 (284)
T cd05038 240 KEGER-----LP-RPPSCP-DEVYDLMKLCWEAEPQDRP-SFADLILIVDRL 283 (284)
T ss_pred HcCCc-----CC-CCccCC-HHHHHHHHHHhccChhhCC-CHHHHHHHHhhc
Confidence 11000 00 001111 2233445555666777765 999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=263.10 Aligned_cols=200 Identities=36% Similarity=0.579 Sum_probs=171.2
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 29 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
||.|+||.||++.+..+|+.+++|.+..... ....+.+|+..+++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999998865432 345688899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---------CC
Q 020133 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QP 175 (330)
Q Consensus 105 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~---------~~ 175 (330)
.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999988778999999999999999999999999999999999999987764 9999999986433321 12
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
....++..|+|||...+.... .++|+||||+++|++++|..||............
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 213 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHS-KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI 213 (265)
T ss_pred cCcccCccccCHHHhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 234577899999998776654 4499999999999999999999876655444343
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=265.21 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=187.6
Q ss_pred eEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC------
Q 020133 23 YELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~------ 90 (330)
|++.+.||+|+||.||++... .+++.||+|.+.... ...+.+.+|+..+++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 357899999886542 22346788999999999999999999886532
Q ss_pred eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecC
Q 020133 91 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg 164 (330)
..+++++|+.+++|.+++... ..++...++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 247899999999998877432 24789999999999999999999999999999999999986654 9999999
Q ss_pred CcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 165 YSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 165 ~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
+++...... ......+++.|++||.+.+..++.+ +|||||||++|+|++ |+.||...+.......+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-- 235 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK-- 235 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC--
Confidence 987543222 1122335578999999877766554 999999999999999 899998765543333332211100
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..+ ..+ ..+.+...++...+|..| .|+.|+++.|..+
T Consensus 236 -~~~----~~~-~~~~~l~~~~l~~~p~~R-ps~~~~~~~l~~~ 272 (273)
T cd05074 236 -QPP----DCL-EDVYELMCQCWSPEPKCR-PSFQHLRDQLELI 272 (273)
T ss_pred -CCC----CCC-HHHHHHHHHHcCCChhhC-cCHHHHHHHHHhh
Confidence 001 111 223344555566778777 4999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=276.82 Aligned_cols=201 Identities=31% Similarity=0.472 Sum_probs=182.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..+.|+.-++||.|+||.||-+.-+.||+.||.|.+.+. .....-..+|-.+|.+++.+.||.+-..|++.+.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 347789999999999999999999999999999988653 2233456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+..|.||+|.-.+.+.+ .+++..++.++.+|+.||.+||+.+||.||+||+|||+|+.++ ++|+|+|+|.....+
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g 340 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEG 340 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCC
Confidence 999999999988776655 6999999999999999999999999999999999999998876 999999999988888
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
......+||.+|||||++.+..|+.. .|.|||||++|||+.|+.||...
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhh
Confidence 88888899999999999998887666 89999999999999999999754
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.43 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=181.5
Q ss_pred ceeccCCceEEEEEEECC---CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEE-eCCeEEEEEeccC
Q 020133 27 RDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYAS 100 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~-~~~~~~lv~e~~~ 100 (330)
+.||+|+||.||++.+.. .+..||+|.+.... .....+.+|+..++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 34679999875432 22356778999999999999999999876 4556899999999
Q ss_pred CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-----C
Q 020133 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q 174 (330)
Q Consensus 101 g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-----~ 174 (330)
+++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++. +||+|||+++...... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 99999998764 45678888999999999999999999999999999999987664 9999999986432211 1
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....++..|+|||.+.+..++.+ +|||||||++|+|++ |.+||...+..............+ .....|.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 229 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL-------QPEYCPD- 229 (262)
T ss_pred cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC-------CCCcCCH-
Confidence 112335668999999877766555 999999999999999 566776554433333222211110 0111222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+.+....+...+|.+| +++.++++.+.++-
T Consensus 230 ~~~~li~~cl~~~p~~R-p~~~~il~~l~~~~ 260 (262)
T cd05058 230 PLYEVMLSCWHPKPEMR-PTFSELVSRIEQIF 260 (262)
T ss_pred HHHHHHHHHcCCChhhC-CCHHHHHHHHHHHh
Confidence 22334444555677776 49999999888753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=273.11 Aligned_cols=208 Identities=26% Similarity=0.436 Sum_probs=171.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------ 89 (330)
..++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+..+++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 45899999999999999999999999999999999875422 235677899999999999999999988643
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
...|++++++ |++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||+++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccc
Confidence 3478888887 7799887754 46999999999999999999999999999999999999987764 999999998743
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.. ......++..|+|||.+.+....+.++|+|||||++|+|++|+.||...+.......+.
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 171 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred cc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22 22345678899999998764333445999999999999999999998766555444433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=289.92 Aligned_cols=195 Identities=25% Similarity=0.430 Sum_probs=154.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCC-cEEEEE------------------EeecCCcccHHHHHHHHHHHcCCCCCeee
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTE-ELVAVK------------------YIERGDKIDENVQREIINHRSLRHPNIVR 81 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~-~~vavK------------------~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~ 81 (330)
++|++++.||+|+||+||++..+... ..++.| .+.........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 67999999999999999998765322 112222 22222223356789999999999999999
Q ss_pred eeEEEEeCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC
Q 020133 82 FKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (330)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~ 156 (330)
+++++...+..|+|++++.+ +|.+++... .......++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~- 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK- 305 (501)
T ss_pred EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence 99999999999999999954 676666432 22446778899999999999999999999999999999987664
Q ss_pred ceEEeecCCcccccCCCC--CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCC
Q 020133 157 RLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (330)
Q Consensus 157 ~vkL~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf 219 (330)
+||+|||+++....... .....|+..|+|||++.+..++.+ +|||||||++|||++|..++
T Consensus 306 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 306 -IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred -EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCC
Confidence 99999999975433222 234578999999999988777655 99999999999999987643
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=271.22 Aligned_cols=208 Identities=30% Similarity=0.453 Sum_probs=170.3
Q ss_pred CeEEeceeccCCceEEEEEEECCC--CcEEEEEEeecCC---cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC----Ce
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 91 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~---~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~----~~ 91 (330)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... .....+.+|+..++++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999988 8999999886432 2235677899999999 599999999975432 45
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
.|++++|+. ++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++.++. ++|+|||.++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 789999986 589999988888999999999999999999999999999999999999987764 99999999874432
Q ss_pred CCC-----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 172 HSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 172 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
... .....++..|+|||.+.+....+.++|+||||+++|+|++|++||...+....+...+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~ 223 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL 223 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHH
Confidence 211 1234688999999988664433455999999999999999999998766544444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=297.68 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=203.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC-C----cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT-E----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-~----~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
....-++.+.||+|.||.||.+..... | ..||+|.+.+.. .....|.+|..+++.++|||||+++|++.+.+.
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 357788999999999999999998753 2 349999988763 344679999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecC
Q 020133 92 LAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg 164 (330)
.++++|||+||+|..++++. ..++..+.+.++.||++|..||+++++|||||..+|+|++... .+|++|||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r--~VKIaDFG 847 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR--VVKIADFG 847 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC--cEEEcccc
Confidence 99999999999999999875 3599999999999999999999999999999999999998774 59999999
Q ss_pred CcccccCCCCC---CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 165 YSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 165 ~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
+|+........ ....-...|||||.+....++++ +||||||+++||++| |..||.+.++.+........-. +
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR---L 923 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR---L 923 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc---c
Confidence 99844333221 12244568999999998888777 999999999999999 9999998887666655554332 2
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
... ..+|..+. +.+.+|+..+|..|+ ++..|.+.+..+
T Consensus 924 ~~P----~~CP~~ly-~lM~~CW~~~pe~RP-~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 924 DPP----SYCPEKLY-QLMLQCWKHDPEDRP-SFRTIVEQDPAI 961 (1025)
T ss_pred CCC----CCCChHHH-HHHHHHccCChhhCc-cHHHHHhhhhhh
Confidence 222 22333333 555666667777765 777777755554
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=263.35 Aligned_cols=241 Identities=21% Similarity=0.203 Sum_probs=176.5
Q ss_pred ceeccCCceEEEEEEECC------------CCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 27 RDIGSGNFGVARLMRDKK------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
+.||+|+||.||++.... ....|++|.+..... ....+.+|+..++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 234588998765432 2346788899999999999999999999988999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC-----CceEEeecCCcc
Q 020133 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSK 167 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~-----~~vkL~Dfg~a~ 167 (330)
+||||+++++|..++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++. ..++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999888875 457999999999999999999999999999999999999975442 138999999886
Q ss_pred cccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHH-hCCCCCCCCChhhHHHHHhhcCChhHHhcCchh
Q 020133 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246 (330)
Q Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (330)
.... .....++..|+|||.+.+....+.++|||||||++|+|+ +|..||........ ....... .+ ...+
T Consensus 161 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~-~~--~~~~-- 231 (262)
T cd05077 161 TVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQ-CM--LVTP-- 231 (262)
T ss_pred cccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcC-cc--CCCC--
Confidence 4322 223457788999999874444455599999999999998 58889876443222 1111110 00 0000
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHHHH
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
. .+.+.+.+.+++..+|.+|+ ++.++++.|
T Consensus 232 ---~-~~~~~~li~~cl~~dp~~Rp-~~~~il~~~ 261 (262)
T cd05077 232 ---S-CKELADLMTHCMNYDPNQRP-FFRAIMRDI 261 (262)
T ss_pred ---C-hHHHHHHHHHHcCCChhhCc-CHHHHHHhc
Confidence 0 11122334445556676655 888887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=265.08 Aligned_cols=208 Identities=35% Similarity=0.538 Sum_probs=177.2
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
|++.+.||+|++|.||++.+..+++.||+|.+... ....+.+.+|+..+++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999998764 333456788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 100 ~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
++ +|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||++++++. ++|+|||.++...... ....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 74 899999876 57999999999999999999999999999999999999987654 9999999987543322 2233
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
...+..|+|||.+.+....+.++|+||||+++|++++|+.||...+....+.++..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 45677899999987663444559999999999999999999988776666555543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=273.24 Aligned_cols=210 Identities=28% Similarity=0.441 Sum_probs=174.2
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC---
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT--- 90 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~--- 90 (330)
....++|++++.||+|++|.||++.+..++..||+|.+.... .....+.+|+..+++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 334688999999999999999999999999999999886532 22346789999999999999999999987653
Q ss_pred ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 91 ---HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 91 ---~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
.+++||||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~dfg~~~ 166 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLAR 166 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeccccc
Confidence 468999999 7789887764 5799999999999999999999999999999999999998765 49999999987
Q ss_pred cccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.... ......+++.|+|||.+.+....+.++|+||||+++|++++|+.||...+......++.
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07880 167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229 (343)
T ss_pred cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4432 22334678899999998764434555999999999999999999998766554444433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=261.69 Aligned_cols=204 Identities=23% Similarity=0.325 Sum_probs=160.8
Q ss_pred ceeccCCceEEEEEEECCC--CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCC
Q 020133 27 RDIGSGNFGVARLMRDKKT--EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~ 102 (330)
+.||+|+||.||++..... ...+++|.+.... .....+.+|+..++.++||||+++++.+......|+||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975432 3456777765543 23457889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC---CCC
Q 020133 103 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 175 (330)
Q Consensus 103 sL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~---~~~ 175 (330)
+|.+++.+. ..++...++.++.|++.||.|||+.+++||||||+|||++.++. ++|+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999998753 34677788999999999999999999999999999999987654 999999987532221 122
Q ss_pred CcccCCCCCCChhhhhcCC------CCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~------~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~ 232 (330)
....++..|+|||++.... ..+.++||||||+++|+|++ |..||...+....+...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 222 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI 222 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 3456788999999875321 12345999999999999997 577887766655555443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=265.38 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=187.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..|+..+.||+|+||.||++.+..++..||+|.+..... ....+.+|+..+++++|||++++++++......|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 448899999999999999999999999999999875422 2245778999999999999999999999999999999
Q ss_pred eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+.| +|.+.+. ...++++..+..++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++.... ..
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PA 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---Cc
Confidence 99976 6766664 3567999999999999999999999999999999999999987654 9999999876332 22
Q ss_pred CcccCCCCCCChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc
Q 020133 176 KSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~---~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (330)
....+++.|+|||.+.+ ... +.++|+|||||++|+|++|+.||...+.......+...... +...... .
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~-~ 250 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP------TLQSNEW-S 250 (317)
T ss_pred ccccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC------CCCCccc-c
Confidence 34467889999999742 334 44499999999999999999999876554444443322110 0000011 1
Q ss_pred cccccccccCCCCCCCCccCCHHHHHHHH
Q 020133 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQII 281 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s~~el~~~l 281 (330)
..+.+.+.++...+|..|+ ++.++++..
T Consensus 251 ~~l~~li~~~l~~~p~~Rp-t~~~il~~~ 278 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRP-TSEELLKHM 278 (317)
T ss_pred HHHHHHHHHHccCCcccCc-CHHHHHhCh
Confidence 1222333444446666664 888887643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=259.43 Aligned_cols=243 Identities=28% Similarity=0.407 Sum_probs=189.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc--cHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 95 (330)
+.+..+.+..||+|+.|+|++++.+.+|...|||.+.+.... .++++..+.++... .+|+||+.+++|..+..+++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 345667889999999999999999999999999999876433 35677777766655 489999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
||.+. ..+..+++. .+++++..+-.+...+++||.||.+ +||+|||+||+|||+|..++ +||||||++-......
T Consensus 170 MelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccc
Confidence 99884 345454443 5689999999999999999999986 58999999999999998876 9999999997666666
Q ss_pred CCCcccCCCCCCChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh-HHHHHhhcCChhHHhcCchhhcc
Q 020133 174 QPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
......|.+.|||||-+.- ..|+-+ +||||||++++||.||+.||.+.+... .+.+++...+ |.+..+.-|.+.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~ 324 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPD 324 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHH
Confidence 6667789999999999853 356666 999999999999999999999865544 4444444222 444444433222
Q ss_pred CCccccccccccCCCCCC
Q 020133 250 LPADLVVDNTTNNQFEEP 267 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p 267 (330)
+ .+++..|+.++.-++|
T Consensus 325 F-~~fv~~CL~kd~r~RP 341 (391)
T KOG0983|consen 325 F-QSFVKDCLTKDHRKRP 341 (391)
T ss_pred H-HHHHHHHhhcCcccCc
Confidence 2 3456666666655555
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=265.57 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=191.5
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
.|+-..+||+|+||.||++.+..+++.||+|.+..... ....+.+|+..++.++|+||+++++.+...+..|+||||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 34556789999999999999999999999998865432 34568889999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCccc
Q 020133 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (330)
Q Consensus 101 g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~ 179 (330)
+++|.+++.. +.+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccc
Confidence 9999987754 56899999999999999999999999999999999999987654 9999999876443222 223456
Q ss_pred CCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccccc
Q 020133 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNT 259 (330)
Q Consensus 180 ~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (330)
+++.|+|||.+.+..+.. ++|+||||+++|+|++|..||.+............... +... ....++.+ +.+.+
T Consensus 178 ~~~~y~~pE~~~~~~~~~-~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~-l~~li 250 (292)
T cd06657 178 GTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLK----NLHKVSPS-LKGFL 250 (292)
T ss_pred cCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccC----CcccCCHH-HHHHH
Confidence 788999999987666654 49999999999999999999987554433322221110 0000 00111221 22233
Q ss_pred ccCCCCCCCCccCCHHHHHH--HHHHhCC
Q 020133 260 TNNQFEEPDQPMQSIDEIMQ--IIAEATI 286 (330)
Q Consensus 260 ~~~~~~~p~~~~~s~~el~~--~l~~~~~ 286 (330)
.++...+|.+|+ ++.++++ .+.+...
T Consensus 251 ~~~l~~~P~~R~-~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 251 DRLLVRDPAQRA-TAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHhCCcccCc-CHHHHhcChHHhccCC
Confidence 344445677666 7777775 5555554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=281.55 Aligned_cols=210 Identities=30% Similarity=0.501 Sum_probs=190.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++++..||-|+||.|=++........+|+|++++.. +..+.+..|-.++..++.|.||++|.-|.++..+|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 56788899999999999999988776678999887643 33456778889999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
|-|-||.|...++..+.|+..+.+.++..+++|+.|||++|||.|||||+|.+++.++. +||.|||+|+....+....
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCcee
Confidence 99999999999999999999999999999999999999999999999999999987765 9999999999999999999
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
+.+|||.|.|||++.+++.+.. +|.||||+++|||++|.+||.+.+....+..++.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk 633 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILK 633 (732)
T ss_pred eecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence 9999999999999999988755 9999999999999999999999887766666653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=267.14 Aligned_cols=266 Identities=29% Similarity=0.468 Sum_probs=209.1
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCe
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~ 91 (330)
+.....|..+.+||.|+||.|.++..+.+.+.||||+++++-- ..+--..|-++|... +-|.+++++..|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4455779999999999999999999999999999999877521 111122344555544 46789999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~- 170 (330)
+|+||||+.||+|-..++.-+.+.+..+..++..|+-||-+||++||+.||||.+|||++.++. +||+|||+++...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeeccccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999988776 9999999998543
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc----------------
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR---------------- 234 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~---------------- 234 (330)
......+.+|||.|+|||++.-++|. +++|.||+|++||||+.|++||++.++....+.+...
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 34456778999999999999888875 5599999999999999999999998887777666621
Q ss_pred ----------------CChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 235 ----------------ISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 235 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
..-+++..||+|.. +.++-+..+..+-.++.......+++.+-..+.+..+
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~-iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~ 648 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR-IDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPT 648 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhh-ccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCC
Confidence 23467778887743 3343333333333333333344566766666665444
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=274.36 Aligned_cols=209 Identities=27% Similarity=0.434 Sum_probs=174.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe----
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH---- 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~---- 91 (330)
..++|++.+.||+|++|.||++.+..+++.||+|.+.... .....+.+|+.++++++||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3678999999999999999999999999999999886532 223456789999999999999999998876544
Q ss_pred --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 92 --LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 92 --~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
.|+|+||+ +++|.+++.. ..+++..++.++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccccccc
Confidence 89999999 5699888865 57999999999999999999999999999999999999987654 999999998744
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
... .....++..|+|||.+.+....+.++||||||+++|+|++|+.||.+.+....+..+..
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred ccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 322 33446788999999986644444559999999999999999999987766555555443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=271.11 Aligned_cols=206 Identities=29% Similarity=0.471 Sum_probs=170.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------C
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~ 90 (330)
.++|.+.+.||+|++|.||++.+..+|+.||+|.+.... .....+.+|+..+++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999999999999999886532 2234678999999999999999999998754 2
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.+|+|+||+.. +|..+. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus 94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHAD 168 (342)
T ss_pred eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCC
Confidence 46999999964 776654 34689999999999999999999999999999999999998765 49999999987432
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
. ......+++.|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+....+..++
T Consensus 169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~ 228 (342)
T cd07879 169 A--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228 (342)
T ss_pred C--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2 22344678889999998764434455999999999999999999998766555544444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=269.38 Aligned_cols=204 Identities=23% Similarity=0.322 Sum_probs=164.8
Q ss_pred ceeccC--CceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 27 RDIGSG--NFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 27 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
..||.| +||+||++.+..+|+.||+|.+..... ..+.+.+|+.+++.++||||++++++|..++..|+|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 999999999999999999998875432 235678899999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-----
Q 020133 102 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----- 174 (330)
Q Consensus 102 ~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~----- 174 (330)
++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccCcccccc
Confidence 9999998764 3589999999999999999999999999999999999998765 499999985432211111
Q ss_pred ---CCcccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 175 ---PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 175 ---~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....++..|+|||++.+.. ..+.++|+|||||++|+|++|+.||............+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 223 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHh
Confidence 11123456799999987642 12345999999999999999999998766555544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=266.28 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=185.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..+|+..+.||+|++|.||++.+..+++.+|+|.+.... .....+.+|+..++.++|+|++++.+++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 356889999999999999999999999999999886432 1224577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 96 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 96 ~e~~~g~sL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
|||+.| ++.+.+. ...++++..+..++.|++.||.|||+.+++||||+|+||+++.++ .++|+|||++.....
T Consensus 94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeecC---
Confidence 999975 7777664 355789999999999999999999999999999999999998765 499999998864332
Q ss_pred CCcccCCCCCCChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCC
Q 020133 175 PKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
.....+++.|+|||.+.+ ... +.++|||||||++|+|++|..||...+............ . ++......
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~------~~~~~~~~ 239 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S------PALQSGHW 239 (308)
T ss_pred cccccCCccccCHHHHhhcccCCC-CcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-C------CCcCcccc
Confidence 233467889999999853 233 344999999999999999999997655433333222211 1 11111111
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHHH
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQI 280 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~~ 280 (330)
...+.+.+.++...+|.+|+ ++++++..
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp-~~~~ll~~ 267 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRP-TSEVLLKH 267 (308)
T ss_pred cHHHHHHHHHHhhCCcccCC-CHHHHhhC
Confidence 11223334445556677765 67877753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=265.88 Aligned_cols=202 Identities=30% Similarity=0.484 Sum_probs=169.5
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEe-CCeEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA 93 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~-~~~~~ 93 (330)
...++|++++.||.|+||.||++.+..+++.||+|.+.... .....+.+|+.++++++||||+++.+++.. ....|
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 34689999999999999999999999999999999876432 234567889999999999999999999876 45789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
+|+||+ +++|..++.. .++++..+..++.|++.||.+||+.|++||||+|+||+++.++ .++|+|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARIQDP-- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccccCC--
Confidence 999998 5688887754 5689999999999999999999999999999999999998765 499999999864322
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
......++..|+|||.+.+....+.++|+||||+++|+|++|+.||......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 2233456888999998766443445599999999999999999999876543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=255.65 Aligned_cols=195 Identities=40% Similarity=0.655 Sum_probs=170.0
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 29 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
||.|++|.||.+.+..+++.+|+|.+..... ....+.+|+..+++++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999998899999999876532 234688899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCcccCCCC
Q 020133 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (330)
Q Consensus 105 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~~~~ 183 (330)
.+++.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+...... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988888999999999999999999999999999999999999987664 999999998754333 22344567889
Q ss_pred CCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 184 y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
|+|||...+.....+ +|+||||+++|++++|+.||...+...
T Consensus 159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~ 200 (250)
T cd05123 159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKE 200 (250)
T ss_pred ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999877665544 999999999999999999998766533
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=263.09 Aligned_cols=202 Identities=30% Similarity=0.425 Sum_probs=166.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..+.|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+..+.+. .||||+++++++......|+|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 45889999999999999999999999999999999876432 234556677666666 499999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
|||+++ ++..++.. .+.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++ .++|+|||++.......
T Consensus 93 ~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccCCC
Confidence 999854 77776654 4579999999999999999999997 6999999999999998765 49999999987543333
Q ss_pred CCCcccCCCCCCChhhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 174 QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
......++..|+|||.+.+.. ..+.++|+||||+++|+|++|+.||....
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 222 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence 333445778999999986553 12344999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=288.22 Aligned_cols=146 Identities=31% Similarity=0.476 Sum_probs=133.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++++.||.|+||.||++.+..+++.||+|++...... ...+.+|+..+..++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 37899999999999999999999999999999998764322 25678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCc
Confidence 99999999999998888899999999999999999999999999999999999998765 49999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=263.50 Aligned_cols=199 Identities=32% Similarity=0.558 Sum_probs=168.4
Q ss_pred CeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeE
Q 020133 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~ 92 (330)
.|++.+.||+|++|.||++.+. .++..||+|.+.... .....+.+|+..+.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 467889999887532 2234577899999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+||||+++++|.+.+..+..+++..++.++.|++.+|.+||+.|++||||+|+||+++.++ .++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999998765 4999999998754333
Q ss_pred CC--CCcccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 173 SQ--PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 173 ~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
.. .....++..|+|||.+.+.. ....++|+||||+++|+|++|..||...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 22 22345788999999986554 2234499999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=258.52 Aligned_cols=245 Identities=30% Similarity=0.460 Sum_probs=186.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC------cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
||.+.+.||+|+||.||++.+..++..+++|.++... .....+.+|+..+++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998877777777665321 1223566789999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
|||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++++ .++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence 999999999988753 3569999999999999999999999999999999999999743 499999998864432
Q ss_pred CC-CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccC
Q 020133 172 HS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
.. ......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||............... ..+. +....
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~------~~~~~ 229 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-PTPS------LPETY 229 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCC------Ccchh
Confidence 22 2234457889999999877766655 99999999999999999999765544443333221 1111 11111
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHH
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+. .+.+.+.++...+|..|+ ++.|+++
T Consensus 230 ~~-~~~~li~~~l~~~p~~Rp-~~~~il~ 256 (260)
T cd08222 230 SR-QLNSIMQSMLNKDPSLRP-SAAEILR 256 (260)
T ss_pred cH-HHHHHHHHHhcCChhhCc-CHHHHhh
Confidence 12 223344445556677764 7888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=267.18 Aligned_cols=203 Identities=32% Similarity=0.479 Sum_probs=178.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-C-CC----eeeeeEEEEeCCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-H-PN----IVRFKEVILTPTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h-~~----Iv~~~~~~~~~~~~~ 93 (330)
.+||++++.+|+|.||.|-.+.+..++..||||+++.-.+.+++..-|+..+.++. + |+ ++.+.++|...++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 58999999999999999999999999999999999988888999999999999994 2 33 888999999999999
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-----------------
Q 020133 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------- 154 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~----------------- 154 (330)
+|+|.+ |-|+.+++.+++ +++...++.+++|++.++++||+.+++|.||||+|||+.++.
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 999988 679999998765 699999999999999999999999999999999999983111
Q ss_pred -CCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 155 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 155 -~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
+..++++|||.|+... ......+.|..|+|||++.+-+++.+ +||||+||||+|++||...|+.-++.+
T Consensus 247 ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred CCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHH
Confidence 1248999999987433 23356678999999999999999877 999999999999999999998766544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=273.96 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=198.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.++..++++||+|.||.|-+|+-.. +..||+|.++.... .+.+|.+|+++|.+|+||||+.++++|..++.+|+|+|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3677899999999999999998754 78999999987543 35689999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|++.|+|.+++.++. .+......+++.||+.|++||.+.++|||||.+.|+|++.+.+ +|++|||.++....+...
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCce
Confidence 999999999998763 3355667789999999999999999999999999999987665 999999999865554433
Q ss_pred ---CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccC
Q 020133 176 ---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 176 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
...+...+|||||.+..+++++. +|+|+||+++||+++ ...||...++...+.+.-.-...+.....+-....+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 23456789999999998888766 999999999999865 789999887766655544322222111111111223
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
|..+. +.+.+|+-.+. .++++++++-..|++.
T Consensus 773 p~~ly-elml~Cw~~es-~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 773 PQGLY-ELMLRCWRRES-EQRPSFEQLHLFLQED 804 (807)
T ss_pred cHHHH-HHHHHHhchhh-hcCCCHHHHHHHHHHh
Confidence 33222 33333332222 3344899888777654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=260.81 Aligned_cols=203 Identities=30% Similarity=0.465 Sum_probs=168.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+.|...+.||+|+||.||++.+..+++.|++|.+..... ....+.+|+..++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 347778889999999999999999999999999875422 2245778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+.+ ++.+.+.. ..++++.++..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.... ..
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PA 174 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CC
Confidence 99965 67666654 457999999999999999999999999999999999999987664 9999999875322 22
Q ss_pred CcccCCCCCCChhhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 176 KSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~---~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
....++..|+|||.+.. ..+ ..++|+||||+++|+|++|..||...+.......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~-~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~ 231 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 231 (313)
T ss_pred CCccccccccChhhccccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 34567889999999842 334 3449999999999999999999987655444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.52 Aligned_cols=192 Identities=28% Similarity=0.464 Sum_probs=159.4
Q ss_pred CceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCChHHHHH
Q 020133 33 NFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 109 (330)
Q Consensus 33 ~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~ 109 (330)
++|.||++++..+++.||+|.+... ......+.+|+..++.++||||+++++++...+..|++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 5566778888889999999998764 2233578899999999999999999999999999999999999999999987
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--------CCccc
Q 020133 110 NA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTV 179 (330)
Q Consensus 110 ~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~ 179 (330)
.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||.+........ .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence 53 46899999999999999999999999999999999999987664 99999998763322111 22334
Q ss_pred CCCCCCChhhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhH
Q 020133 180 GTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (330)
Q Consensus 180 ~~~~y~aPE~~~~~--~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~ 227 (330)
++..|+|||.+.+. .+. .++|+|||||++|+|++|+.||........
T Consensus 170 ~~~~y~aPE~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~ 218 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQM 218 (314)
T ss_pred ccccccCHHHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 67789999998653 344 449999999999999999999987654443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=272.69 Aligned_cols=200 Identities=35% Similarity=0.553 Sum_probs=173.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.-|..++.||-|+||.|.+++...|+..||.|.+.+.+... .....|-.+|..-..+-||++|..|.+.+++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45888999999999999999999999999999998764322 34567778888889999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-----
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL----- 171 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~----- 171 (330)
+|++||++-.++.+-+-|++..++.++.++..|++++|..|+|||||||+|||||.++. +||+|||++..+.-
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccc
Confidence 99999999999999899999999999999999999999999999999999999999886 99999999752110
Q ss_pred ----CC----------------------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHH
Q 020133 172 ----HS----------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (330)
Q Consensus 172 ----~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ell 213 (330)
+. ..-..+||+.|+|||++...+++.. +|.||.|++||||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHh
Confidence 00 0012358999999999998888666 99999999999999
Q ss_pred hCCCCCCCCC
Q 020133 214 VGAYPFEDPE 223 (330)
Q Consensus 214 tg~~pf~~~~ 223 (330)
.|++||-..+
T Consensus 866 ~g~~pf~~~t 875 (1034)
T KOG0608|consen 866 VGQPPFLADT 875 (1034)
T ss_pred hCCCCccCCC
Confidence 9999996543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=249.86 Aligned_cols=181 Identities=23% Similarity=0.308 Sum_probs=154.9
Q ss_pred CCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCChHHHHHhc
Q 020133 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 111 (330)
Q Consensus 32 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~ 111 (330)
|.+|.||+|++..+++.||+|.+.... ...+|...+....||||+++++++......|+||||++|++|.+++.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999999999999999987653 2334455555667999999999999999999999999999999999887
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhh
Q 020133 112 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (330)
Q Consensus 112 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (330)
..+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||.+...... .....++..|+|||.+.
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999987764 999999987543322 23344567899999987
Q ss_pred cCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 192 ~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
+..++.+ +|+||+|+++|+|++|+.||..
T Consensus 156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 156 ISEETEA-CDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CCCCCch-hhHHHHHHHHHHHHHCcchhhc
Confidence 6666554 9999999999999999998764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=270.37 Aligned_cols=199 Identities=29% Similarity=0.462 Sum_probs=178.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---------cHHHHHHHHHHHcCC---CCCeeeeeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSLR---HPNIVRFKEVIL 87 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~ei~~l~~l~---h~~Iv~~~~~~~ 87 (330)
...|...+.+|+|+||.|++|.++.+...|+||.+.+..-. ...+-.||.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 45699999999999999999999999999999998775321 123457999999997 999999999999
Q ss_pred eCCeEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 88 TPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 88 ~~~~~~lv~e~~-~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
+++.+||+||-. +|.+|.+++..+..+++.++..|++|++.|+++||++||||||||-+|+.++.++ .+||+|||.|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g--~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG--FVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC--eEEEeeccch
Confidence 999999999854 6889999999999999999999999999999999999999999999999998665 4999999987
Q ss_pred ccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
. .....+.....||..|.|||++.|..|.++.-|||+||+++|.++....||.+
T Consensus 718 a-~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 A-YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred h-hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 5 44556677889999999999999999999989999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=278.55 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=210.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCC---cEEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~--~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
.+...|.++||.|.||.|+.++.+..| ..||||.++.. .+.+..|+.|+.+|-++.||||+++.++......+.|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 344579999999999999999998655 46999999875 3445689999999999999999999999999899999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
|+|||++|+|..+++++ +.|+.-++..+++.|+.|.+||-+.|+|||||...|||++.+- .+|++|||+++......
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL--vCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce--EEEeccccceeecccCC
Confidence 99999999999999864 6899999999999999999999999999999999999997664 59999999998553332
Q ss_pred CC--Ccc--cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhc
Q 020133 174 QP--KST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248 (330)
Q Consensus 174 ~~--~~~--~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
.. .+. .-..+|.|||.+...++++. |||||+|++|||.++ |..||-..++.+.+..+-+.+.+|.....|--.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL- 863 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL- 863 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH-
Confidence 11 111 23468999999998888666 999999999999886 999999999999988888777766554443211
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCC
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~ 287 (330)
-.++.+|+.+....+| .+++|...|.+.-.+
T Consensus 864 ---~qLMldCWqkdR~~RP-----~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 864 ---YQLMLDCWQKDRNRRP-----KFAQIVSTLDKLIRN 894 (996)
T ss_pred ---HHHHHHHHHHHhhcCC-----CHHHHHHHHHHHhcC
Confidence 2456777776665554 889998888876433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=243.33 Aligned_cols=220 Identities=23% Similarity=0.440 Sum_probs=190.4
Q ss_pred cccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCC--eE
Q 020133 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HL 92 (330)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~--~~ 92 (330)
.+..++.|++++++|.|.|+.||.+.+..+++.++||++++-. .+.+.+|+.+|..|+ ||||++++++..+.. ..
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3456789999999999999999999999999999999987653 367899999999996 999999999998764 47
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
.+|+||..+.+...+. ..++...++..++++++||.|+|+.||+|||+||.|++||.... .++|+|+|+|.+.-++
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCC
Confidence 8999999887776665 56899999999999999999999999999999999999987654 6999999999988888
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC-CCChhhHHHHHhhcCChhHHh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRISIPEIR 241 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~-~~~~~~~~~~~~~~~~~~~~~ 241 (330)
......+.+..|-.||.+..-+.....-|+|||||++..|+..+.||. +.++.+++.++..-.+..++.
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 777888889999999999776655555899999999999999988874 667788888888666655543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=269.03 Aligned_cols=208 Identities=27% Similarity=0.390 Sum_probs=185.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC------CCeeeeeEEEEeCCeEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h------~~Iv~~~~~~~~~~~~~l 94 (330)
++|.+....|.|-||+|..|.+...|..||||++.++....+.=++|+.+|++|+. -|+++++..|...+++||
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 78999999999999999999999999999999999988777778899999999963 479999999999999999
Q ss_pred EEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 95 VMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
|+|-+. .+|.+++++.| .|....++.++.|++.||..|-.+||+|.||||.|||++...+ .+||||||.|....
T Consensus 512 VFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~- 588 (752)
T KOG0670|consen 512 VFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS- 588 (752)
T ss_pred Eehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc-
Confidence 999884 59999998765 4888999999999999999999999999999999999987765 69999999886433
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
......+..+..|+|||++.|.+|+.. .|+||.||+||||+||+..|.+.++...+.-.+
T Consensus 589 eneitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 589 ENEITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cccccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 333455667889999999999999887 899999999999999999999988877665555
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.89 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=196.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC----CcEEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~--~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
....++.+.||+|.||.||.+....- .--||||..+.+ ....+.|..|+.+++.++||||++++|+|.+ ...|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 34455678999999999999987642 335899988774 2346789999999999999999999999976 4679
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+|||.++-|-|+.+++.++ .++......+++||..||.|||+..+|||||...|||+.... .|||+|||+++.....
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~--CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ--CVKLADFGLSRYLEDD 544 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc--eeeecccchhhhcccc
Confidence 9999999999999998754 699999999999999999999999999999999999997654 5999999999865544
Q ss_pred CCCC--cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHh--hcCChhHHhcCchhh
Q 020133 173 SQPK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI--HRISIPEIRNHEWFL 247 (330)
Q Consensus 173 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 247 (330)
.... ......-|||||.+.-..+++. ||||-||++|||++. |..||.+..+.+.+..+- .|++.|+
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~-------- 615 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP-------- 615 (974)
T ss_pred chhhccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC--------
Confidence 3332 2234567999999987777655 999999999999987 999999877665543333 3444433
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+|+.+. ....+|+..+|..|+ .+.|+...|..+
T Consensus 616 -nCPp~LY-slmskcWayeP~kRP-rftei~~~lsdv 649 (974)
T KOG4257|consen 616 -NCPPALY-SLMSKCWAYEPSKRP-RFTEIKAILSDV 649 (974)
T ss_pred -CCChHHH-HHHHHHhccCcccCC-cHHHHHHHHHHH
Confidence 3444443 344556667776654 788887776655
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=247.82 Aligned_cols=207 Identities=31% Similarity=0.547 Sum_probs=181.9
Q ss_pred CCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcC-CCCCeeeeeEE
Q 020133 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEV 85 (330)
Q Consensus 11 g~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~ 85 (330)
|.........+.|.++++||.|+|..|.+++.+.|.+.||+|++++. +......+.|-....+- +||.+|-++.+
T Consensus 240 g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 240 GIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred ccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 33444455568899999999999999999999999999999998763 33345666676666554 79999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 86 ~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
|..+..+++|.||.+||+|--.++++.++|++.++.+...|..||.|||++||+.||||..|+|++..+. +||+|+|.
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygm 397 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGM 397 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccch
Confidence 9999999999999999999888888899999999999999999999999999999999999999987775 99999999
Q ss_pred cccc-cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 166 SKSS-VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 166 a~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
++.. ..+...++.+|||.|.|||.+.+..|.-. +|.|+||++|+||+.|+.||+
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcc
Confidence 9844 44556678899999999999998888544 999999999999999999996
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=272.66 Aligned_cols=206 Identities=30% Similarity=0.531 Sum_probs=180.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEe-----CCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----PTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~-----~~~~~ 93 (330)
.+.|++.+.+|.|.+|.||++++..+++.+|+|+........+++..|.++++.+ .|||++.+|++|.. ++.+|
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 3679999999999999999999999999999999988888888999999999988 69999999999874 36799
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-
Q 020133 94 IVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 170 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~- 170 (330)
||||||.|||..+++++ ...+.+..+..|++.++.||.+||+..++|||||-.|||++.++. |||+|||++....
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDS 175 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeec
Confidence 99999999999999975 357899999999999999999999999999999999999987765 9999999987443
Q ss_pred CCCCCCcccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHH
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~ 228 (330)
......+.+|||.|||||++.- ..|+.+ +|+||||++..||-.|.+|+........+
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhh
Confidence 3445677899999999999843 235555 99999999999999999999765544333
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=254.09 Aligned_cols=202 Identities=29% Similarity=0.451 Sum_probs=168.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.....+-+..||.|+||+|++..++.+|+..|||.+..... ...+++.|.....+- +.||||++|+.+..++..|+.
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 44667778899999999999999999999999999976543 345677777665544 799999999999999999999
Q ss_pred EeccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 96 MEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 96 ~e~~~g~sL~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
||.+. .||..+.+ ++..+++..+-.+......||.||-. ..|+|||+||+|||++..+. +||||||++-..
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQL 218 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhH
Confidence 99994 47755442 34579999999999999999999985 68999999999999987765 999999998655
Q ss_pred cCCCCCCcccCCCCCCChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
..........|...|||||-+.. .+|+-+ ||+||||++|||+.||..||...+.
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH
Confidence 54444556678899999999853 346666 9999999999999999999987554
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=235.49 Aligned_cols=208 Identities=27% Similarity=0.400 Sum_probs=169.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
+...-+..||.|++|.|-+.++.++|...|+|.+... .+..+++.+|+.+..+. .+|.+|.+|+.+..++..++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3445578899999999999999999999999998654 34445677888776555 69999999999999999999999
Q ss_pred ccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 98 YASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 98 ~~~g~sL~~~l----~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
.+. .||..+. .+++.+++..+-+++..+..||.|||++ .++|||+||+|||++.++. +|+||||++-.....
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhh
Confidence 995 4776543 4567899999999999999999999975 7999999999999987764 999999998644433
Q ss_pred CCCCcccCCCCCCChhhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 173 SQPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.......|...|+|||.+.. ..|+-+ +||||||++++||.+++.||.....+.+..+.+
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 33334678889999998843 356555 999999999999999999998765554433333
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=286.04 Aligned_cols=248 Identities=31% Similarity=0.480 Sum_probs=184.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEe----------
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT---------- 88 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~---------- 88 (330)
+.|+.++.||+||||.||+|+++-+|+.||||++... ......+.+|+..+.+|+|||||+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4467899999999999999999999999999999765 4445678999999999999999997432110
Q ss_pred --------------------------------------------------------------------------------
Q 020133 89 -------------------------------------------------------------------------------- 88 (330)
Q Consensus 89 -------------------------------------------------------------------------------- 88 (330)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C--------CeEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHhhhcCc
Q 020133 89 ---------------------P--------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQV 138 (330)
Q Consensus 89 ---------------------~--------~~~~lv~e~~~g~sL~~~l~~~~~l-~~~~~~~i~~qi~~~L~~LH~~~i 138 (330)
+ ..+||-||||+..+|.+++..+... .....++++++|+.||.|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0 1258899999998888888776554 578899999999999999999999
Q ss_pred cccCCCCCcEEecCCCCCceEEeecCCccccc------------------CC-CCCCcccCCCCCCChhhhhcCC---CC
Q 020133 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV------------------LH-SQPKSTVGTPAYIAPEVLLKKE---YD 196 (330)
Q Consensus 139 vH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~------------------~~-~~~~~~~~~~~y~aPE~~~~~~---~~ 196 (330)
|||||||.||+++.+.. |||+|||+|.... .. ......+||.-|+|||++.+.. |+
T Consensus 719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999997765 9999999986411 00 1224457999999999997655 55
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHH
Q 020133 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 276 (330)
Q Consensus 197 ~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~e 276 (330)
.+ +|+||||++++||+ .||...-+...+...+++..+|.. ..++.+..|.+. ..+.+....+|.+|+ |+.|
T Consensus 797 ~K-iDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~--~~f~~~~~~~e~--slI~~Ll~hdP~kRP-tA~e 867 (1351)
T KOG1035|consen 797 SK-IDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEP--ADFFDPEHPEEA--SLIRWLLSHDPSKRP-TATE 867 (1351)
T ss_pred ch-hhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCC--cccccccchHHH--HHHHHHhcCCCccCC-CHHH
Confidence 55 99999999999998 457655555555555566655544 223333333221 122233345666655 7777
Q ss_pred HHH
Q 020133 277 IMQ 279 (330)
Q Consensus 277 l~~ 279 (330)
+++
T Consensus 868 LL~ 870 (1351)
T KOG1035|consen 868 LLN 870 (1351)
T ss_pred Hhh
Confidence 654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=268.47 Aligned_cols=202 Identities=34% Similarity=0.518 Sum_probs=170.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.+.|.+...+|.|+|+.|-.+.+..+++..++|++.+.. ....+|+.++... +||||+++.+++.+..+.|+|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 467999999999999999999999999999999998763 2345667555444 799999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec-CCCCCceEEeecCCcccccCCCCCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~-~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
+.|+-+.+.+.....+. .++..|+.+|+.|+.|||++|+||||+||+|||++ +.+ .++|+|||.++..... ..+
T Consensus 398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g--~lrltyFG~a~~~~~~--~~t 472 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG--HLRLTYFGFWSELERS--CDT 472 (612)
T ss_pred ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC--cEEEEEechhhhCchh--hcc
Confidence 99998888887765555 78888999999999999999999999999999995 444 4999999998754433 345
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
.+.|..|.|||++....++.. +|+||||++||+|++|+.||.......++..
T Consensus 473 p~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~ 524 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT 524 (612)
T ss_pred cchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCchHHHHH
Confidence 577889999999997777665 9999999999999999999986554433333
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=293.80 Aligned_cols=250 Identities=19% Similarity=0.258 Sum_probs=183.5
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
.|...+.||+|+||.||++.+..++..||+|.+...... ..+|+..+++++||||+++++++.+.+..|+||||+++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 456677899999999999999999999999988654332 23568889999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh---hcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcc
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~ 178 (330)
++|.++++ .+++..+..++.|++.||+||| +.+|+||||||+||+++.+.. .++. ||.+.... .....
T Consensus 768 g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~ 838 (968)
T PLN00113 768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKC 838 (968)
T ss_pred CcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCc
Confidence 99999995 3899999999999999999999 669999999999999987765 4443 55443221 11233
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh-hhHHHHHhhcCChhHHhcCchhhccC------C
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRISIPEIRNHEWFLKNL------P 251 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 251 (330)
.+++.|+|||++.+..++.+ +|||||||++|||+||+.||..... ...+.++.... ........|+...+ +
T Consensus 839 ~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 839 FISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC-YSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred cccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh-cCccchhheeCccccCCCCcc
Confidence 67899999999987777655 9999999999999999999954221 11111111100 00000011111111 0
Q ss_pred cc---ccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 252 AD---LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 252 ~~---~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
.. .+.+...+|+..+|.+|+ ++.|+++.|.....
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RP-t~~evl~~L~~~~~ 953 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARP-CANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCc-CHHHHHHHHHHhhc
Confidence 00 122334456667888875 99999999987744
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=248.03 Aligned_cols=217 Identities=27% Similarity=0.400 Sum_probs=182.1
Q ss_pred CCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeec---CCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeC
Q 020133 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (330)
Q Consensus 13 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~ 89 (330)
..|.....+.|.-..++|+|.||.||+|+...+|+.||+|++-- .........+|+.+|..+.|+|++.++++|...
T Consensus 9 ~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 9 YEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred cCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 34445556889999999999999999999999999999987643 234456788999999999999999999888642
Q ss_pred --------CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEE
Q 020133 90 --------THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (330)
Q Consensus 90 --------~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL 160 (330)
..+|+|+.+|+. +|.-++... ..++..++..++.+++.||.|+|...|+|||+||+|+||+.++. +||
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lkl 165 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKL 165 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEe
Confidence 358999999976 777777654 57999999999999999999999999999999999999988775 999
Q ss_pred eecCCcccccCCCC-----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 161 CDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 161 ~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
+|||+++.+..... ....+.|..|++||.+.+...++++.|+|.-||+|.+|+|+.+.+++.++..++..+.
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 99999975443322 2334668999999999988777777999999999999999999999988776665544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=259.99 Aligned_cols=205 Identities=31% Similarity=0.448 Sum_probs=172.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCccc--------HHHHHHHHHHHcCCCCCeeeeeEEEE-eCC
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVIL-TPT 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~ei~~l~~l~h~~Iv~~~~~~~-~~~ 90 (330)
.+||-++..||.|||+.||+|.|...++.||+|+-..+...+ +..-+|..+.+.|.||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 468999999999999999999999999999999765443322 34568999999999999999999997 456
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecC-CCCCceEEeecCCcc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSK 167 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~ 167 (330)
.+|-|+|||+|.+|.-+++.+..+++.+++.|+.||+.||.||.+.. |+|-||||.|||+-+ ..-+.+||+|||+++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 79999999999999999999999999999999999999999999864 999999999999843 334569999999998
Q ss_pred cccCCCC--------CCcccCCCCCCChhhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 168 SSVLHSQ--------PKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 168 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
....... .+...||.+|++||.+.-. +..+.++||||+|+++|.++.|+.||.....
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 5443322 2345799999999998533 2224459999999999999999999976544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=251.74 Aligned_cols=132 Identities=26% Similarity=0.420 Sum_probs=118.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----C---CCeeeeeEEEEeC-
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----H---PNIVRFKEVILTP- 89 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-----h---~~Iv~~~~~~~~~- 89 (330)
..+||.++++||-|.|++||+|+|+++.+.||+|+.+....+.+....||.+|++++ | .+||++++.|...
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 348999999999999999999999999999999999888888899999999999884 2 3699999999864
Q ss_pred ---CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEec
Q 020133 90 ---THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLD 151 (330)
Q Consensus 90 ---~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~ 151 (330)
.++|+|+|++ |.+|..++... ..++...++.|++||+.||.|||. +||+|.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 4799999999 66888888754 469999999999999999999995 7999999999999983
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.81 Aligned_cols=214 Identities=27% Similarity=0.427 Sum_probs=178.8
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC-----eEEE
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAI 94 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-----~~~l 94 (330)
.+--+.||-|+||+||-+.|..+|+.||+|++..- -...+.+.+|+.++...+|.|++..+++..-.. .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44558999999999999999999999999987542 234578899999999999999999988875432 3688
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
++|.+.. +|..++-.-..++.+.++-+++||++||+|||+.+|.||||||.|.|++.+.. +|+||||+++......
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhh
Confidence 8898854 78777777678999999999999999999999999999999999999987765 9999999998443322
Q ss_pred -CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhH
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPE 239 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 239 (330)
.....+.|.+|+|||.+.|...++.+.||||.||++.||+..+..|+......++.-+..-.+.|+
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs 278 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS 278 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence 223456788999999999887777779999999999999999999998888777777765544443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=243.00 Aligned_cols=209 Identities=26% Similarity=0.415 Sum_probs=182.9
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeC----
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~---- 89 (330)
.....||.-++.+|.|.- .|..|-|.-++++||+|+.... ....++..+|..++..++|+||++++.+|.-.
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 445689999999999999 7888999999999999987653 23346788999999999999999999998744
Q ss_pred --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 90 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 90 --~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
...|+|||++. .+|.+.+. -.++-..+..+++|++.|+++||+.||+||||||+||++..+.. +|+.|||+|+
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar 166 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLAR 166 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhc
Confidence 35799999995 48988887 35788999999999999999999999999999999999987765 9999999998
Q ss_pred cccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
........+..+.+..|+|||++.+..+... +||||+||++.||++|+..|.+.+.-+++-+++
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~ 230 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKII 230 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHH
Confidence 6666666677889999999999998887766 999999999999999999999988888877777
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=234.18 Aligned_cols=238 Identities=39% Similarity=0.618 Sum_probs=186.8
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCChHHHHHh
Q 020133 33 NFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 110 (330)
Q Consensus 33 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~ 110 (330)
+||.||++....+++.+|+|.+...... ...+.+|+..+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5899999999989999999998765432 46888999999999999999999999999999999999999999999987
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhh
Q 020133 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190 (330)
Q Consensus 111 ~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~ 190 (330)
...++...+..++.+++.++.+||+.+++|+||+|+||+++.++ .++|+|||.+.............++..|++||.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 76799999999999999999999999999999999999998775 4999999998755544344556688899999999
Q ss_pred hcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCc
Q 020133 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 270 (330)
Q Consensus 191 ~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 270 (330)
.+...+. ++|+||||++++++++|..||..........+.......+..... ..++. .+.....++...+|.+|
T Consensus 159 ~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 159 LGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE----WKISP-EAKDLIRKLLVKDPEKR 232 (244)
T ss_pred ccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccc----ccCCH-HHHHHHHHHccCCchhc
Confidence 8777766 499999999999999999999874444444444432221110000 00111 12233444555667776
Q ss_pred cCCHHHHHH
Q 020133 271 MQSIDEIMQ 279 (330)
Q Consensus 271 ~~s~~el~~ 279 (330)
+ ++.++++
T Consensus 233 p-~~~~~~~ 240 (244)
T smart00220 233 L-TAEEALQ 240 (244)
T ss_pred c-CHHHHhh
Confidence 6 7777764
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=259.27 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=192.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC-C--cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT-E--ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~-~--~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
.+..++.+.||+|.||+|+.+..+.. | ..||||++..... .-.+|.+|+..+.+|+|||++++|++..+ ....+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 45667889999999999999998752 3 4689999876543 34689999999999999999999999987 66789
Q ss_pred EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 95 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|||.++.|||.+.+++ +..|.......++.||+.|+.||.+++.|||||...|+++-... .|||+|||+.+....+
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--tVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--TVKICDFGLMRALGEN 265 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--eeeeecccceeccCCC
Confidence 9999999999999986 45699999999999999999999999999999999999997644 5999999999876665
Q ss_pred CCCCcc----cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 173 SQPKST----VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 173 ~~~~~~----~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
.....+ .....|.|||.+....+... +|+|++|+++|||+| |+.||.+......+.++-.+ +.+..|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~----erLpRP--- 337 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG----ERLPRP--- 337 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc----ccCCCC---
Confidence 544332 24568999999998888766 999999999999998 89999987765444443322 222222
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.++.+ +-+.+.+|+...|..|. ++..|..
T Consensus 338 k~csed-IY~imk~cWah~paDRp-tFsair~ 367 (1039)
T KOG0199|consen 338 KYCSED-IYQIMKNCWAHNPADRP-TFSAIRE 367 (1039)
T ss_pred CCChHH-HHHHHHHhccCCccccc-cHHHHHH
Confidence 222222 22334445555555554 7777763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-31 Score=229.07 Aligned_cols=205 Identities=42% Similarity=0.681 Sum_probs=175.3
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
|.+.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999999998899999999876543 35678899999999999999999999998899999999999
Q ss_pred CCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--CCCc
Q 020133 101 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 177 (330)
Q Consensus 101 g~sL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~~~~ 177 (330)
+++|.+++..... +++..+..++.+++.+|.+||+++++|+||+|+||+++.++ .++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG--LVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeCceeeEecCcccccccc
Confidence 9999999987766 89999999999999999999999999999999999998764 59999999887554332 3344
Q ss_pred ccCCCCCCChhhh-hcCCCCCCccchhhHHHHHHHHHhCCCCCCC-CChhhHHHH
Q 020133 178 TVGTPAYIAPEVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPKNFRK 230 (330)
Q Consensus 178 ~~~~~~y~aPE~~-~~~~~~~~~~Di~SlG~il~elltg~~pf~~-~~~~~~~~~ 230 (330)
..++..|++||.+ ....+.. ++|+||||+++++|++|+.||.. .+....+.+
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 5678889999998 4445544 59999999999999999999977 344333333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=262.46 Aligned_cols=198 Identities=20% Similarity=0.238 Sum_probs=142.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC----CcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEE------EEe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------ILT 88 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~------~~~ 88 (330)
..++|++.+.||+|+||.||++.+..+ +..||+|.+...... +....+ .++...+.++..+... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 457899999999999999999999988 899999987643221 111111 1111122222222111 234
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcE
Q 020133 89 PTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~~~~--------------------l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NI 148 (330)
...+++|+||+++++|.+++..... .....+..++.|++.||.|||++||+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 5678999999999999998865321 12344678999999999999999999999999999
Q ss_pred EecCCCCCceEEeecCCcccccC--CCCCCcccCCCCCCChhhhhcCCCC---------------------CCccchhhH
Q 020133 149 LLDGSPAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLKKEYD---------------------GKIADVWSC 205 (330)
Q Consensus 149 li~~~~~~~vkL~Dfg~a~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~---------------------~~~~Di~Sl 205 (330)
|++.+. +.+||+|||+|+.... ........+++.|+|||++...... +.++|||||
T Consensus 287 Ll~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 997542 2599999999974432 2233456789999999977433211 123699999
Q ss_pred HHHHHHHHhCCCCCC
Q 020133 206 GVTLYVMLVGAYPFE 220 (330)
Q Consensus 206 G~il~elltg~~pf~ 220 (330)
||++|||+++..|+.
T Consensus 366 GviL~el~~~~~~~~ 380 (566)
T PLN03225 366 GLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHhCcCCCc
Confidence 999999999776654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=252.33 Aligned_cols=201 Identities=21% Similarity=0.285 Sum_probs=150.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC----------------CCCcEEEEEEeecCCcc---------------cHHHHHH
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK----------------KTEELVAVKYIERGDKI---------------DENVQRE 67 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~---------------~~~~~~e 67 (330)
+.++|.+.++||+|+||+||++... ..++.||||.+...... .+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4689999999999999999998752 24567999998653211 1223346
Q ss_pred HHHHHcCCCCC-----eeeeeEEEEe--------CCeEEEEEeccCCCChHHHHHhc-----------------------
Q 020133 68 IINHRSLRHPN-----IVRFKEVILT--------PTHLAIVMEYASGGELFERICNA----------------------- 111 (330)
Q Consensus 68 i~~l~~l~h~~-----Iv~~~~~~~~--------~~~~~lv~e~~~g~sL~~~l~~~----------------------- 111 (330)
+..+.+++|.+ +++++++|.. .+..|+||||+++++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 66677776654 4667777653 35689999999999999988632
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC--cccCCCCCCChh
Q 020133 112 -GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPE 188 (330)
Q Consensus 112 -~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~~~~y~aPE 188 (330)
..+++..++.++.|++.+|.|||+.+|+||||||+||+++.++. +||+|||++.......... ...+++.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12456778999999999999999999999999999999987654 9999999986443322222 234578999999
Q ss_pred hhhcCCCC---------------------CCccchhhHHHHHHHHHhCCC-CCCC
Q 020133 189 VLLKKEYD---------------------GKIADVWSCGVTLYVMLVGAY-PFED 221 (330)
Q Consensus 189 ~~~~~~~~---------------------~~~~Di~SlG~il~elltg~~-pf~~ 221 (330)
++...... +...|+||+||++++|++|.. ||..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 98543211 123699999999999999986 7754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=252.38 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=198.5
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
......+||-|.||.||.+..+.-.-.||||.++.+....+.|+.|+.+++.+.|||+|+++++|..+..+|||+|||..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 45678899999999999999998888999999999888889999999999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc--
Q 020133 102 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-- 177 (330)
Q Consensus 102 ~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~-- 177 (330)
|+|.+++++- ..++.-..+.++.||..|+.||..+++|||||...|+|+..+.. ||++|||+++..........
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecccC
Confidence 9999999763 35788889999999999999999999999999999999987654 99999999985544433221
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc---c
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA---D 253 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 253 (330)
.-...-|.|||.+.-+.+..+ +|||+||++|||+.| |-.||.+.+....+.-.-..+.+... +.+|+ +
T Consensus 426 AKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P-------eGCPpkVYe 497 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP-------EGCPPKVYE 497 (1157)
T ss_pred ccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC-------CCCCHHHHH
Confidence 223567999999988888777 999999999999998 89999987765544333322222211 22333 3
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
++..|+. +.|..|+ ++.|+-+++...
T Consensus 498 LMraCW~----WsPsDRP-sFaeiHqafEtm 523 (1157)
T KOG4278|consen 498 LMRACWN----WSPSDRP-SFAEIHQAFETM 523 (1157)
T ss_pred HHHHHhc----CCcccCc-cHHHHHHHHHHH
Confidence 3444444 4555544 778777766654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=255.39 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=189.0
Q ss_pred eEEeceeccCCceEEEEEEECCCC----cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.+..++||+|+||+||++..-..| .+||+|++.... +...++.+|+..+.+++|||++++++++.... +-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 455789999999999999886554 468999876543 34678999999999999999999999998755 78999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
+|+++|+|.++++.+ +++-....+.|++||++|+.|||.+++|||||-..|||+..... +|+.|||+++........
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCccccc
Confidence 999999999999864 57999999999999999999999999999999999999987654 999999999865544433
Q ss_pred Cc---ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHh---hcCChhHHhcCchhhc
Q 020133 176 KS---TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI---HRISIPEIRNHEWFLK 248 (330)
Q Consensus 176 ~~---~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 248 (330)
.. ....+-|+|-|.+....+... +||||||+++||++| |..||.+.... .+.+.+ .|.+-|++....-
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~-eI~dlle~geRLsqPpiCtiDV--- 929 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAE-EIPDLLEKGERLSQPPICTIDV--- 929 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHH-HhhHHHhccccCCCCCCccHHH---
Confidence 22 223567999999988888666 999999999999999 99999986543 233333 3333333322221
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.-++.+|++ .++ .+++.+.++...+.+.
T Consensus 930 ---y~~mvkCwm----id~-~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 930 ---YMVMVKCWM----IDA-DSRPTFKELAEEFSRM 957 (1177)
T ss_pred ---HHHHHHHhc----cCc-ccCccHHHHHHHHHHH
Confidence 112333333 333 3445888888777655
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=237.07 Aligned_cols=201 Identities=29% Similarity=0.410 Sum_probs=159.9
Q ss_pred ccCCCCCCCcccC---CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHH--cCCCCCeee
Q 020133 7 TVGPGMDMPIMHD---SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVR 81 (330)
Q Consensus 7 ~~~pg~~~~~~~~---~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~--~l~h~~Iv~ 81 (330)
|-|-|+-.+.+.+ ..+.++++.+|+|.||.||++..+ |+.||||++...+. ....+|.++.+ .|+|+||+.
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhh
Confidence 3444555444432 467899999999999999999876 88999999876543 45566666554 569999999
Q ss_pred eeEEEEeC----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-----c---CccccCCCCCcEE
Q 020133 82 FKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-----M---QVCHRDLKLENTL 149 (330)
Q Consensus 82 ~~~~~~~~----~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~---~ivH~dikp~NIl 149 (330)
+++.=... ..+|||++|.+.|||.|++.+ ..++.+...+++..++.||++||. + .|.|||||+.|||
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 98764322 258999999999999999988 679999999999999999999995 2 3999999999999
Q ss_pred ecCCCCCceEEeecCCcccccCC-----CCCCcccCCCCCCChhhhhcCC----C-CCCccchhhHHHHHHHHHh
Q 020133 150 LDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKE----Y-DGKIADVWSCGVTLYVMLV 214 (330)
Q Consensus 150 i~~~~~~~vkL~Dfg~a~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~----~-~~~~~Di~SlG~il~ellt 214 (330)
+..++. +-|+|+|+|...... ......+||.+|||||++...- + ..+.+||||||.++||+..
T Consensus 349 VKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 349 VKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 987775 999999999754433 2346678999999999985431 1 2344899999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=240.32 Aligned_cols=191 Identities=27% Similarity=0.344 Sum_probs=156.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHH--HcCCCCCeeeeeEEEEeCC----eEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--RSLRHPNIVRFKEVILTPT----HLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l--~~l~h~~Iv~~~~~~~~~~----~~~ 93 (330)
-...++.+.+|+|.||.||++... ++.||||++..... +.++.|-.+. -.++|+||+++++.-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 356788999999999999999875 58999999876544 4455555444 4568999999998866554 789
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc---------CccccCCCCCcEEecCCCCCceEEeecC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICDFG 164 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~ivH~dikp~NIli~~~~~~~vkL~Dfg 164 (330)
||++|.+.|+|.++++. ..+++....+++..+++||+|||+- .|+|||||+.|||+..|.+ ..|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccc
Confidence 99999999999999976 4689999999999999999999962 4999999999999988875 8999999
Q ss_pred CcccccCCCC---CCcccCCCCCCChhhhhcCCCC-----CCccchhhHHHHHHHHHhCCC
Q 020133 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVGAY 217 (330)
Q Consensus 165 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-----~~~~Di~SlG~il~elltg~~ 217 (330)
+|........ .-..+||.+|||||++.+...- -+..||||+|.++||+++...
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 9975554332 2346899999999999765322 234899999999999998543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=230.73 Aligned_cols=211 Identities=26% Similarity=0.442 Sum_probs=170.4
Q ss_pred cCCCCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEE-
Q 020133 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV- 85 (330)
Q Consensus 8 ~~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~- 85 (330)
+.|...++-+.-.+.|.|.+.||+|.||.+-+|++++++..+|+|.+...-....+|.+|...--.| .|.||+.-|++
T Consensus 11 ~I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 11 LIPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred ccccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence 4455555555566889999999999999999999999999999999988877778899999877666 48999988776
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 86 ~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
|+..+.+.+++||++.|+|.+-+... .+-+...+.++.|++.||.|+|+.++||||||.+||||-.....++||||||.
T Consensus 91 Fqt~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 91 FQTSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred hhcCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence 55667888999999999998877653 47899999999999999999999999999999999999544444899999998
Q ss_pred cccccCCCCCCcccCCCCCCChhhhhcCC---C-CCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKE---Y-DGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 166 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~-~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
++....... ..-.+..|.+||.+.... + ..+.+|+|.||+++|.++||..||+.
T Consensus 170 t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 170 TRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 863322211 112345688999874321 1 12338999999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=253.61 Aligned_cols=199 Identities=35% Similarity=0.521 Sum_probs=176.4
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc-cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.-.++|.++..+|+|.||.||++++..+++..|+|.++..... ..-+++|+.+++..+||||+.+++.+......|++|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3458899999999999999999999999999999999876433 456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~ 175 (330)
|||.||+|.+..+..+++++.++..+++..++||+|||+.|-+|||||-.||++.+.+. +||.|||.+..... -...
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKR 169 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999988775 99999999864433 3345
Q ss_pred CcccCCCCCCChhhh---hcCCCCCCccchhhHHHHHHHHHhCCCCC
Q 020133 176 KSTVGTPAYIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~---~~~~~~~~~~Di~SlG~il~elltg~~pf 219 (330)
.+.+||++|||||+. ....|... +|+|++|++..|+-.-++|-
T Consensus 170 ksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPL 215 (829)
T ss_pred hcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcc
Confidence 788999999999986 33456555 99999999999987777664
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=251.91 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=192.8
Q ss_pred CCeEEeceeccCCceEEEEEEECC-------CCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
++..+.+.||+|.||.|+++.-.. ....||||.++.... ..+.+..|+..++.+ .|+||+.+.+.+...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 445778899999999999998542 145799998876543 346789999999998 5999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC
Q 020133 91 HLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~ 154 (330)
..++|+||+..|+|..+++..+ .++..+...+++||+.|++||++.+++||||...|||+..+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999999999999998765 489999999999999999999999999999999999998775
Q ss_pred CCceEEeecCCcccccCCCCCC--ccc--CCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 020133 155 APRLKICDFGYSKSSVLHSQPK--STV--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (330)
Q Consensus 155 ~~~vkL~Dfg~a~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~ 229 (330)
.+|++|||+|+......... ... ....|||||.+....++.+ +||||+|+++||++| |..||.+......+.
T Consensus 456 --~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 456 --VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred --EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 49999999998544333221 112 3456999999988777666 999999999999999 899998755233333
Q ss_pred HHh---hcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 230 KTI---HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 230 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+.+ .|+..|... +.++ -..+..|+..+|..|+ ++.++.+.+...
T Consensus 533 ~~l~~G~r~~~P~~c---------~~ei-Y~iM~~CW~~~p~~RP-~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHC---------SDEI-YDLMKSCWNADPEDRP-TFSECVEFFEKH 579 (609)
T ss_pred HHHhcCCCCCCCCCC---------CHHH-HHHHHHHhCCCcccCC-CHHHHHHHHHHH
Confidence 333 233333322 2222 2333344456666655 889998888873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=251.00 Aligned_cols=219 Identities=29% Similarity=0.365 Sum_probs=170.9
Q ss_pred eEEeceeccCCceE-EEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 23 YELVRDIGSGNFGV-ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 23 y~i~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
|.-.+.+|.|+.|+ ||++.. .|+.||||.+-... ....++|+..|+.. .||||+++++.-.+.+..||+.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 33456789999875 777665 48899999775432 34678999999988 59999999999888899999999995
Q ss_pred CCChHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC---CCCCceEEeecCCcccccCCC
Q 020133 101 GGELFERICNAG-R---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 101 g~sL~~~l~~~~-~---l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~---~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
.+|.+++...+ . ...-..+.++.|+++||++||+.+||||||||.||||.. ++..+++|+|||+++....+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 59999997631 1 111346788999999999999999999999999999965 465689999999998665544
Q ss_pred C----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChh-----------------h--HHH
Q 020133 174 Q----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEP-----------------K--NFR 229 (330)
Q Consensus 174 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg-~~pf~~~~~~-----------------~--~~~ 229 (330)
. .....||.+|+|||++...... +++|||||||++|+.++| .+||...-.. . ...
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~ 744 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEAK 744 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHHH
Confidence 3 3445799999999999877654 459999999999999995 9999642110 1 222
Q ss_pred HHh---------hcCChhHHhcCchhh
Q 020133 230 KTI---------HRISIPEIRNHEWFL 247 (330)
Q Consensus 230 ~~~---------~~~~~~~~~~~~~~~ 247 (330)
..+ .|+++.++..||+|.
T Consensus 745 dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 745 DLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred HHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 222 578888999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=207.22 Aligned_cols=182 Identities=46% Similarity=0.706 Sum_probs=157.3
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCChHH
Q 020133 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (330)
Q Consensus 29 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~ 106 (330)
||+|++|.||++.+..+++.+++|.+...... ...+.+|+..++.++|++|+++++++......++++|+++|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999988999999998766542 4678999999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccCCC-CCCcccCCCC
Q 020133 107 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 183 (330)
Q Consensus 107 ~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~~~~ 183 (330)
++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++ .++|+|||.+....... ......+...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC--cEEEecCCceEEccCCcchhhcccCCCC
Confidence 98765 47999999999999999999999999999999999999987 44 59999999886443322 1334557889
Q ss_pred CCChhhhhcCCCCCCccchhhHHHHHHHH
Q 020133 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (330)
Q Consensus 184 y~aPE~~~~~~~~~~~~Di~SlG~il~el 212 (330)
|++||.+......+.++|+||+|++++++
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 99999987662334559999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=226.46 Aligned_cols=208 Identities=26% Similarity=0.433 Sum_probs=172.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECC---CCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.+.|.++++||+|+|++||++.+.. .++.||+|.+.... ...++.+|++.|..+ .+.||+++.+++..++..++|
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 4779999999999999999999987 78899999886643 345789999999998 589999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-----
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV----- 170 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~----- 170 (330)
+||++.....++.. .++..+++.+++.++.||+++|.+|||||||||+|+|.+.... +-.|+|||+|....
T Consensus 114 lp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhhh
Confidence 99999999888884 4789999999999999999999999999999999999986544 67899999975100
Q ss_pred ------------C--C--------------------------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHH
Q 020133 171 ------------L--H--------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210 (330)
Q Consensus 171 ------------~--~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ 210 (330)
. + .......||++|+|||++..-+..+.++||||.|+++.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 0 0 00012248999999999988777777799999999999
Q ss_pred HHHhCCCCCCC-CChhhHHHHHh
Q 020133 211 VMLVGAYPFED-PEEPKNFRKTI 232 (330)
Q Consensus 211 elltg~~pf~~-~~~~~~~~~~~ 232 (330)
.+++++.||-. .++...+.++.
T Consensus 270 slls~~~PFf~a~dd~~al~ei~ 292 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIA 292 (418)
T ss_pred hhhccccccccCccccchHHHHH
Confidence 99999999854 33333333333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=202.61 Aligned_cols=208 Identities=25% Similarity=0.298 Sum_probs=169.4
Q ss_pred CcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC-CCeeeeeEEEEeCCeEE
Q 020133 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLA 93 (330)
Q Consensus 15 ~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h-~~Iv~~~~~~~~~~~~~ 93 (330)
+.++..++|+++++||+|+||.+|++.+..+|..||||.-... .....+..|..+.+.|++ ..|..+..++.+...-.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 3455568999999999999999999999999999999965443 334567888999888875 67888888888888889
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC-CceEEeecCCcccccC
Q 020133 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVL 171 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~-~~vkL~Dfg~a~~~~~ 171 (330)
+||+.+ |.||.++..- ...++..+++-++-|++.-++|+|.++++||||||+|+|..-+.. .++.|+|||+|+....
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999988 7799988753 457999999999999999999999999999999999999843211 2699999999974432
Q ss_pred C--------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 172 H--------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 172 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
. .......||.+|.+--...+...+ +..|+-|+|.++.++.-|..||++....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchh
Confidence 2 223445789999988776655544 4499999999999999999999986543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=211.47 Aligned_cols=201 Identities=28% Similarity=0.294 Sum_probs=165.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCC-cEEEEEEeecCCcc-cHHHHHHHHHHHcCC----CCCeeeeeEEE-EeCCeEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKI-DENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI 94 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~-~~~~~~ei~~l~~l~----h~~Iv~~~~~~-~~~~~~~l 94 (330)
+|++.+.||+|+||.||++.+..++ ..+|+|........ ...+..|+.++..+. .+++..+++.+ ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998875 67889977654322 226788888888886 36899999999 47778899
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-C--CceEEeecCCcc--
Q 020133 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK-- 167 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~--~~vkL~Dfg~a~-- 167 (330)
||+.+ |.+|.++.... +.++..++..++.|++.+|.+||+.|++||||||+|+++.... . ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99988 78999988654 4799999999999999999999999999999999999997553 1 359999999998
Q ss_pred cccCCC--------C-CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 168 SSVLHS--------Q-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 168 ~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
...... . .....||..|.++.+..+.....+ .|+||++.++.+++.|..||.....
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccc
Confidence 321111 1 123459999999999888776544 9999999999999999999977654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=204.10 Aligned_cols=202 Identities=24% Similarity=0.326 Sum_probs=171.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.-.|++.++||+|+||+.+.+.+.-++++|||| +.+.......+..|.+..+.| ..++|..+|.+....-+-.||+|.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIK-fEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIK-FEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEE-eccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 357999999999999999999999999999999 444444556888999998888 479999999998888788899998
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC---CceEEeecCCcccccCC--
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLH-- 172 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~---~~vkL~Dfg~a~~~~~~-- 172 (330)
+ |-||.|+..- ...|+..++..++.|++.-++++|++.+|.|||||+|+||...++ ..+.++|||+|+.....
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 8 7799998864 457999999999999999999999999999999999999964432 25899999999744322
Q ss_pred ------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 173 ------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 173 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
....+..||.+||+--...+..-..+ .|+-|||-++++.|-|.+||++...
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence 22355679999999888887776545 9999999999999999999998654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=209.65 Aligned_cols=168 Identities=17% Similarity=0.163 Sum_probs=129.5
Q ss_pred CCCCCCCcccCCCCeEEeceeccCCceEEEEEEECC-CCcEEEEEEeecC------CcccHHHHHHHHHHHcCCCCCeee
Q 020133 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR 81 (330)
Q Consensus 9 ~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~------~~~~~~~~~ei~~l~~l~h~~Iv~ 81 (330)
-||.+++.. .++|++.+.||+|+||+||+|.+.. +++.||||++... ......+.+|+.++++++|+||++
T Consensus 8 ~~~~~~~~~--~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~ 85 (365)
T PRK09188 8 LPGDQIPAL--SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVP 85 (365)
T ss_pred Ccccccccc--cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCc
Confidence 366666655 4689999999999999999999876 6788899986532 112456899999999999999985
Q ss_pred -eeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCC-CCCcEEecCCCCCceE
Q 020133 82 -FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLK 159 (330)
Q Consensus 82 -~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~di-kp~NIli~~~~~~~vk 159 (330)
+++. +..|+||||++|++|.. +. +.. ...++.|++++|.+||++||+|||| ||+|||++.++ +++
T Consensus 86 ~l~~~----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ik 152 (365)
T PRK09188 86 QLLAT----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAA 152 (365)
T ss_pred EEEEc----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEE
Confidence 4432 45799999999999963 21 111 2567899999999999999999999 99999997665 499
Q ss_pred EeecCCcccccCCCCC---------CcccCCCCCCChhhhh
Q 020133 160 ICDFGYSKSSVLHSQP---------KSTVGTPAYIAPEVLL 191 (330)
Q Consensus 160 L~Dfg~a~~~~~~~~~---------~~~~~~~~y~aPE~~~ 191 (330)
|+|||+|+........ ....+++.|.|||.+.
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 9999999744332211 2334677789999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=204.31 Aligned_cols=254 Identities=18% Similarity=0.210 Sum_probs=194.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeC-Ce
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTP-TH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-~~ 91 (330)
..|+++...+.+|.||.||.+...+ +.+.|.+|.++..... ...+..|...+..+.|||+..+.+++... ..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 5678888999999999999996653 2344667766554332 24577888888889999999999998654 56
Q ss_pred EEEEEeccCCCChHHHHH-----h---cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeec
Q 020133 92 LAIVMEYASGGELFERIC-----N---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~-----~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
.++++.+..-|+|..++. + ...++..++..++.|++.|++|||+.|+||.||...|.+|++.- ++||+|=
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDs 440 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDS 440 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccc
Confidence 788899999999999987 1 12477788899999999999999999999999999999998663 6999999
Q ss_pred CCcccccCCCCC---CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhH
Q 020133 164 GYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPE 239 (330)
Q Consensus 164 g~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (330)
.+++...+.... ...-....||+||.+.+..+... +|+||||++||||+| |+.||...+..+....+.....+.+
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 999865544332 23345678999999999988766 999999999999999 9999998877666555554444333
Q ss_pred HhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 240 IRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
..+ +| +.+-..+.+|+.-.|++|+ +.+++.+-|.+..
T Consensus 520 P~N-------CP-DeLf~vMacCWallpeeRP-sf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 520 PFN-------CP-DELFTVMACCWALLPEERP-SFSQLVICLSEFH 556 (563)
T ss_pred CCC-------Cc-HHHHHHHHHHHhcCcccCC-CHHHHHHHHHHHH
Confidence 222 33 3333445555666677665 8888888777643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-26 Score=230.31 Aligned_cols=147 Identities=18% Similarity=0.197 Sum_probs=113.0
Q ss_pred cCCC-CCeeeeeEEE-------EeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCC
Q 020133 73 SLRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143 (330)
Q Consensus 73 ~l~h-~~Iv~~~~~~-------~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~di 143 (330)
.++| +||+.++++| .....+++++||+ +++|.+++.. ...+++.+++.+++||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5777777776 2234567788987 5699999965 356999999999999999999999999999999
Q ss_pred CCCcEEecCC-----------------CCCceEEeecCCcccccCCC-----------------CCCcccCCCCCCChhh
Q 020133 144 KLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEV 189 (330)
Q Consensus 144 kp~NIli~~~-----------------~~~~vkL~Dfg~a~~~~~~~-----------------~~~~~~~~~~y~aPE~ 189 (330)
||+|||++.. ....+|++|||+++...... .....++|+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999532 22347778888775321100 0012357889999999
Q ss_pred hhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 190 ~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
+.+..+..+ +|||||||++|||++|..|+..
T Consensus 187 ~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 187 DNGSSSNCA-SDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hccCCCCch-hhhhhHHHHHHHHhhCCCchhh
Confidence 988887555 9999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=189.56 Aligned_cols=198 Identities=41% Similarity=0.676 Sum_probs=169.0
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCC-CeeeeeEEEEeCCeEEEEEe
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~-~Iv~~~~~~~~~~~~~lv~e 97 (330)
|.+.+.||.|+||.||.+.+. ..+++|.+..... ....+.+|+..+..+.|+ +|+++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999997 7789998876543 345788999999999988 79999999987777899999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
++.++++.+++.... .++......++.|++.++.++|+.+++|||+||+||+++.... .++++|||.++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence 999999997777664 7999999999999999999999999999999999999986652 48999999987433322
Q ss_pred ------CCCcccCCCCCCChhhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 174 ------QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 174 ------~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
......++..|++||.+.+. .......|+||+|++++++++|..||.....
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 23566899999999999873 3444559999999999999999999877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=187.00 Aligned_cols=169 Identities=15% Similarity=0.172 Sum_probs=129.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHH----------HHHHHHHHHcCCCCCeeeeeEEEEeC
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILTP 89 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----------~~~ei~~l~~l~h~~Iv~~~~~~~~~ 89 (330)
.++|++.+.||.|+||.||++.+ ++..+|+|.+.......+. +.+|+..+.+++||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 58999999999999999999755 3668999998754333222 57899999999999999999987643
Q ss_pred --------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEe
Q 020133 90 --------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (330)
Q Consensus 90 --------~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~ 161 (330)
+..++||||++|.+|.+.. .+++ ....+++.+|..+|+.|++|||++|+||+++.++ ++|+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~li 176 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRII 176 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEE
Confidence 3579999999999998873 2333 3456999999999999999999999999998654 9999
Q ss_pred ecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHH
Q 020133 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (330)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ell 213 (330)
|||.++........ ........++. ++|+||||+++..+.
T Consensus 177 Dfg~~~~~~e~~a~-----------d~~vler~y~~-~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK-----------DRIDLERHYGI-KNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH-----------HHHHHHhHhcc-cccccceeEeehHHH
Confidence 99977533211100 11233445654 489999999886543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=182.36 Aligned_cols=136 Identities=21% Similarity=0.202 Sum_probs=108.9
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----------c-----------------HHHHHHHHHHHcCCCCC
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------D-----------------ENVQREIINHRSLRHPN 78 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~-----------------~~~~~ei~~l~~l~h~~ 78 (330)
...||+|++|.||+|.+. +|+.||+|+++..... . ....+|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8999999998754211 0 12235999999998877
Q ss_pred eeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhcCccccCCCCCcEEecCCCCCc
Q 020133 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPR 157 (330)
Q Consensus 79 Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivH~dikp~NIli~~~~~~~ 157 (330)
+.....+... ..++||||++|+++.....+.++++...+..++.|++.+|.++ |+.||+||||||+||+++. ++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---GK 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---Cc
Confidence 6443333222 2389999999988766555557899999999999999999999 7999999999999999973 25
Q ss_pred eEEeecCCcc
Q 020133 158 LKICDFGYSK 167 (330)
Q Consensus 158 vkL~Dfg~a~ 167 (330)
++|+|||+|.
T Consensus 156 v~LiDFG~a~ 165 (190)
T cd05147 156 LYIIDVSQSV 165 (190)
T ss_pred EEEEEccccc
Confidence 9999999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=176.93 Aligned_cols=138 Identities=18% Similarity=0.147 Sum_probs=111.0
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---------------------------cHHHHHHHHHHHcCCCCC
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHPN 78 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~ei~~l~~l~h~~ 78 (330)
.+.||+|++|.||+|.+. +|+.||||+++..... ...+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 478999999999999987 8999999998764211 112357889999999998
Q ss_pred eeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCc
Q 020133 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPR 157 (330)
Q Consensus 79 Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~ 157 (330)
+.....+.... .|+||||++|+++.........++...+..++.|++.++.++|+ .||+||||||+||+++ ++ +
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--~ 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--K 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--C
Confidence 75544443332 48999999988665443345678899999999999999999999 9999999999999997 33 5
Q ss_pred eEEeecCCcccc
Q 020133 158 LKICDFGYSKSS 169 (330)
Q Consensus 158 vkL~Dfg~a~~~ 169 (330)
++|+|||++...
T Consensus 156 ~~liDFG~a~~~ 167 (190)
T cd05145 156 PYIIDVSQAVEL 167 (190)
T ss_pred EEEEEcccceec
Confidence 999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=176.63 Aligned_cols=108 Identities=27% Similarity=0.336 Sum_probs=91.7
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccC
Q 020133 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (330)
Q Consensus 102 ~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 180 (330)
|+|.+++.. +.++++.+++.++.|++.||.|||+.+ ||+||+++.++. +++ ||.++..... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 689999986 456999999999999999999999999 999999987764 788 9988644322 2267
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
++.|+|||++.+..++.+ +|||||||++|||+||+.||.....
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccch
Confidence 899999999988877655 9999999999999999999976543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-23 Score=171.12 Aligned_cols=185 Identities=17% Similarity=0.157 Sum_probs=139.4
Q ss_pred EEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccH-----HHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEe
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.++..|++|+||+||++.. .+.+++.+.+........ .+.+|+.++++|. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678899999999997766 477788777766554333 5789999999995 5889999886 34699999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCC-CCCcEEecCCCCCceEEeecCCcccccCCCCC-
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~di-kp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~- 175 (330)
|+.|.+|.+.... ....++.|++.+|.++|++||+|||| ||+|||++.++ .++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcchHH
Confidence 9999998654321 12457889999999999999999999 79999998665 4999999999743332210
Q ss_pred -------------CcccCCCCCCChhhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 176 -------------KSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 176 -------------~~~~~~~~y~aPE~~~~~-~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.....++.+++|+.-..- ..+-...+.++.|+-+|.++|+..|+-+..
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 011357888999865322 222122689999999999999999876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-24 Score=210.43 Aligned_cols=199 Identities=35% Similarity=0.594 Sum_probs=161.2
Q ss_pred EEeceeccCCceEEEEEEECCCCcEEEEEEee----cCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE----RGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.....+|.|++|.|+.+........++.|.+. ..... ...+..|+.+-..+.|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988888887666656666543 21111 112455666677889999988877777665555569
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--- 173 (330)
|||++ +|..++...+.++..++..++.|++.|++|+|+.||.|||+||+|+++..++. +|++|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchh
Confidence 99999 99999988778999999999999999999999999999999999999987764 9999999986433222
Q ss_pred --CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
.....+|+..|+|||++.+..|+++..||||.|++++.|.+|+.||......
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 2345679999999999999999999999999999999999999999765443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=204.68 Aligned_cols=205 Identities=23% Similarity=0.331 Sum_probs=165.1
Q ss_pred cCCCCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC---CCCeeeeeE
Q 020133 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKE 84 (330)
Q Consensus 8 ~~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~---h~~Iv~~~~ 84 (330)
+.|+..... ....|.|.+.+|+|+||.||+|.+.. |+.||||+-+......-.+-.+ ++.+|+ -+.|+.+..
T Consensus 687 l~~~~~~~~--~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q--~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 687 LNPNTEFEV--GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQ--VMERLKPQMLPSIMHISS 761 (974)
T ss_pred cCccceeee--cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHH--HHHhhchhhhcchHHHHH
Confidence 344444433 35789999999999999999999987 9999999776665443333222 233343 456777777
Q ss_pred EEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec-----CCCCCceE
Q 020133 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-----GSPAPRLK 159 (330)
Q Consensus 85 ~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~-----~~~~~~vk 159 (330)
.+...+..+||+||.+.|||.+++..++.+++..+..+..|++..+..||.++||||||||+|+|+. +.....++
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence 7777788899999999999999999888899999999999999999999999999999999999983 22234599
Q ss_pred EeecCCcccc---cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC
Q 020133 160 ICDFGYSKSS---VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218 (330)
Q Consensus 160 L~Dfg~a~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~p 218 (330)
|+|||.|-.. ..+.......+|-.+-.+|...|..++.. +|.|.|+.+++-||.|+.-
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHHH
Confidence 9999998532 33344556678999999999999999777 9999999999999999753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=166.16 Aligned_cols=133 Identities=18% Similarity=0.234 Sum_probs=107.3
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcC-----CCCCeeeeeEEEEeCC---eEE-EE
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---HLA-IV 95 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l-----~h~~Iv~~~~~~~~~~---~~~-lv 95 (330)
.+.||+|++|.||. ++.++.. +||++.... ...+.+.+|+..++.+ .||||++++++++++. .++ +|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 47899999999995 7777766 699887542 2346789999999999 5799999999999873 434 78
Q ss_pred Eec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHhhhcCccccCCCCCcEEecCC--CCCceEEeecC
Q 020133 96 MEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFG 164 (330)
Q Consensus 96 ~e~--~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~ivH~dikp~NIli~~~--~~~~vkL~Dfg 164 (330)
+|| +.+++|.+++++ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +..+++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 557999999976 356666 46688888888 89999999999999999999743 33469999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=168.86 Aligned_cols=139 Identities=17% Similarity=0.110 Sum_probs=112.0
Q ss_pred CeEEeceeccCCceEEEEEE-ECCCCcEEEEEEeecCCcc-------------------------cHHHHHHHHHHHcCC
Q 020133 22 RYELVRDIGSGNFGVARLMR-DKKTEELVAVKYIERGDKI-------------------------DENVQREIINHRSLR 75 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~-------------------------~~~~~~ei~~l~~l~ 75 (330)
-|.+.+.||+|++|.||+|. +..+|+.||+|++...... ...+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999999 6678999999998754210 123568999999997
Q ss_pred CCC--eeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC-ccccCCCCCcEEecC
Q 020133 76 HPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDG 152 (330)
Q Consensus 76 h~~--Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~dikp~NIli~~ 152 (330)
+.+ +.++++. +..++||||++|.+|.........+...++..++.|++.+|.+||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 3444432 235899999999888776545556777778899999999999999999 99999999999998
Q ss_pred CCCCceEEeecCCcc
Q 020133 153 SPAPRLKICDFGYSK 167 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~ 167 (330)
++ +++|+|||.+.
T Consensus 184 ~~--~i~LiDFg~a~ 196 (237)
T smart00090 184 DG--KVVIIDVSQSV 196 (237)
T ss_pred CC--CEEEEEChhhh
Confidence 33 59999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.2e-22 Score=184.40 Aligned_cols=186 Identities=30% Similarity=0.498 Sum_probs=155.4
Q ss_pred eeccCCceEEEEEEEC---CCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 28 DIGSGNFGVARLMRDK---KTEELVAVKYIERGDKI---DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 28 ~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
.+|+|.||.|++++-. ..|..+|.|+.++.... ...-..|..++...+ ||.++++...+..++..++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3799999999987643 35777899987654211 112334556667775 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccC
Q 020133 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (330)
Q Consensus 101 g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~ 180 (330)
||.|...+.+...+.+.........++.++.++|+.+|+|||+|++||+++.+|. +++.|||.++........ +|
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence 9999988888888999999999999999999999999999999999999988775 999999999855443332 89
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
+.-|||||++. ..... +|.||||+++++|+||..||..
T Consensus 156 t~eymApEI~~--gh~~a-~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSA-ADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred chhhhhhHhhh--ccCCc-ccchhhhhhHHHHhhCCCCCch
Confidence 99999999987 33334 8999999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=190.88 Aligned_cols=193 Identities=26% Similarity=0.407 Sum_probs=150.6
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHH---HHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENV---QREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~---~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.|..++.||++.|=.|.+|++.+ |. |+||++-+.+. ....+ .+|+. ...+++||++++..+.+.+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68899999999999999998865 55 89998865432 12233 34444 55668999999998887788889999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-C
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-~ 175 (330)
+|... +|.|.+..+.-+..-+.+.++.|++.||..+|..||+|||||.+||||..=+ .+.|+||..-+....... +
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCccCCCCCc
Confidence 99965 9999998877889999999999999999999999999999999999997533 489999986653322111 1
Q ss_pred -------CcccCCCCCCChhhhhcCC---------C-CCCccchhhHHHHHHHHHh-CCCCCC
Q 020133 176 -------KSTVGTPAYIAPEVLLKKE---------Y-DGKIADVWSCGVTLYVMLV-GAYPFE 220 (330)
Q Consensus 176 -------~~~~~~~~y~aPE~~~~~~---------~-~~~~~Di~SlG~il~ellt-g~~pf~ 220 (330)
.+.....+|.|||-+.... . ..++=||||+||++.||++ |++||.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1122445899999875421 1 2344799999999999998 799985
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=163.79 Aligned_cols=197 Identities=23% Similarity=0.248 Sum_probs=126.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCC----------CCeeeeeEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRH----------PNIVRFKEVIL 87 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h----------~~Iv~~~~~~~ 87 (330)
.+...+.||.|+++.||.+.+..||+.+|+|++..... ..+.+.+|......+.+ -.++.-.+...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46788999999999999999999999999998754321 22455555544444322 12333333332
Q ss_pred eC------------C-----eEEEEEeccCCCChHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHhhhcCccccCC
Q 020133 88 TP------------T-----HLAIVMEYASGGELFERICN---AGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDL 143 (330)
Q Consensus 88 ~~------------~-----~~~lv~e~~~g~sL~~~l~~---~~~----l~~~~~~~i~~qi~~~L~~LH~~~ivH~di 143 (330)
.. + +.+++|+-+. ++|.+++.. ... +.......+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 2367888774 488777542 221 223334556689999999999999999999
Q ss_pred CCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcC-------CCCCCccchhhHHHHHHHHHhCC
Q 020133 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVGA 216 (330)
Q Consensus 144 kp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~Di~SlG~il~elltg~ 216 (330)
+|+|++++.++. ++|+||+.......... ....+..|.+||..... ...+.+.|.|+||+++|.|.+|+
T Consensus 172 ~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGG--VFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS---EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCC--EEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999998765 99999987653322211 13455789999987432 12244589999999999999999
Q ss_pred CCCCCCC
Q 020133 217 YPFEDPE 223 (330)
Q Consensus 217 ~pf~~~~ 223 (330)
.||....
T Consensus 248 lPf~~~~ 254 (288)
T PF14531_consen 248 LPFGLSS 254 (288)
T ss_dssp -STCCCG
T ss_pred CCCCCCC
Confidence 9998643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=154.75 Aligned_cols=132 Identities=23% Similarity=0.226 Sum_probs=110.6
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
+.||+|++|.||++.. .|..+++|....... ....+.+|+..+..+.|++|.....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 577899997653221 11356789999999999998877777777778899999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++ .++|+|||.+.
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC--CEEEEECCccc
Confidence 9999999998865332 8889999999999999999999999999999998 33 49999999876
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=150.80 Aligned_cols=133 Identities=22% Similarity=0.261 Sum_probs=105.4
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-----------------------ccHHHHHHHHHHHcCCCCC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHPN 78 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~ei~~l~~l~h~~ 78 (330)
.|.+.+.||+|+||.||++... +|+.||||++..+.. ......+|+..+.++.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 799999998764321 0123567888888887774
Q ss_pred --eeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC
Q 020133 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (330)
Q Consensus 79 --Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~ 156 (330)
++..++ .+..++||||++|++|..... ......++.+++.++.++|+.|++||||+|+||+++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-- 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-- 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--
Confidence 444443 244589999999999876532 134667889999999999999999999999999998755
Q ss_pred ceEEeecCCcc
Q 020133 157 RLKICDFGYSK 167 (330)
Q Consensus 157 ~vkL~Dfg~a~ 167 (330)
.++|+|||.+.
T Consensus 163 ~~~liDfg~~~ 173 (198)
T cd05144 163 KIYIIDWPQMV 173 (198)
T ss_pred cEEEEECCccc
Confidence 49999999885
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-20 Score=157.49 Aligned_cols=199 Identities=22% Similarity=0.365 Sum_probs=160.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.....+..+|.+...|..|+++.. |..++.|+++.. ......|..|.-.++-+.||||+.+++.|....++.++.
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 345677889999999999999876 445677776543 233457888888888889999999999999999999999
Q ss_pred eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
.|++.|||...++.+.. .+-.++.+++.++++|.+|||+.. |.-.-+.+..+++|++-+.++..+|--++.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----- 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----- 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence 99999999999987653 677889999999999999999976 555578999999999887677767744332
Q ss_pred CCCCcccCCCCCCChhhhhcCCCC--CCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~--~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
+......+|.|++||.++..+.+ .+++|+|||++++|||.|...||...+..+
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 22344568999999999877644 456899999999999999999998766543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-19 Score=149.65 Aligned_cols=129 Identities=21% Similarity=0.199 Sum_probs=103.6
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecCC-cc--------cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGD-KI--------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 28 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~--------~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.||+|++|.||++.. ++..|++|...... .. ...+.+|+.++..++|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999984 57789999854321 11 14567899999999988766555555666677999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ + ++++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~--~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D--DKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C--CcEEEEECCCCcC
Confidence 999999988754321 7899999999999999999999999999998 3 3599999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-18 Score=166.91 Aligned_cols=134 Identities=22% Similarity=0.178 Sum_probs=107.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEee-cCC--------cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGD--------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~~--------~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.|...+.||+|+||+||++..... .+++|... +.. ...+.+.+|+.+++.++|++++....++......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345678999999999999887543 34444322 111 1124578999999999999998887777777778
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||+++ ++ .++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence 99999999999998875 3577899999999999999999999999999994 33 499999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-19 Score=173.77 Aligned_cols=175 Identities=34% Similarity=0.592 Sum_probs=130.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..+.|..++.+..|+||-||+++++.+.+.+|+| +++... +.|- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc--cccccCCccee------------------
Confidence 4578999999999999999999999999999995 443321 1111 22222333333
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-----
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----- 173 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~----- 173 (330)
|+-...++.-++++... +.+++|||+.||+|||+||+|.+|..-+ .+||+|||+++......
T Consensus 136 ---gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG--hiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred ---chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc--cccccchhhhhhhhhhccchhh
Confidence 34445555556676554 6789999999999999999999997665 49999999986322211
Q ss_pred -----------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 -----------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....+|||.|.|||++..++|. +.+|.|++|+++|+.+-|..||.+.+.++.+...+
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 11234799999999999988885 55999999999999999999999877655554444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-18 Score=160.76 Aligned_cols=213 Identities=21% Similarity=0.273 Sum_probs=153.1
Q ss_pred HHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCc-cccCCCCCcE
Q 020133 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQV-CHRDLKLENT 148 (330)
Q Consensus 71 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~i-vH~dikp~NI 148 (330)
|+.+.|.|+.++++.+.+....+.|.+||+.|+|.+.+.. .-.+++.....++++|++||.|||+..| .|+.++++|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3568899999999999999999999999999999999987 4468888899999999999999998876 9999999999
Q ss_pred EecCCCCCceEEeecCCcccccCC---CCCCcccCCCCCCChhhhhcCCC------CCCccchhhHHHHHHHHHhCCCCC
Q 020133 149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY------DGKIADVWSCGVTLYVMLVGAYPF 219 (330)
Q Consensus 149 li~~~~~~~vkL~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~------~~~~~Di~SlG~il~elltg~~pf 219 (330)
+++.... +||+|||+....... .......-..-|.|||.+.+... .+++.|+||+|++++|+++.+.||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9988775 999999987644321 11111123457999999876421 245589999999999999999999
Q ss_pred CCCChhh---HHHHHhhcCChhHHhcCchhh--ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCCC
Q 020133 220 EDPEEPK---NFRKTIHRISIPEIRNHEWFL--KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAA 289 (330)
Q Consensus 220 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~~ 289 (330)
....... .+...+.....+ .-+|.+. ...++ ....+..+|+.+.|..|+ +++.+...+........
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~--~~rP~i~~~~e~~~-~l~~l~~~cw~e~P~~rP-s~~~i~~~~~~~~~~~~ 229 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSN--PFRPSIELLNELPP-ELLLLVARCWEEIPEKRP-SIEQIRSKLLTINKGGS 229 (484)
T ss_pred ccccccCChHHHHHHHHhcCCC--CcCcchhhhhhcch-HHHHHHHHhcccChhhCc-cHHHHHhhhhhhccccc
Confidence 8643322 222222221111 1122211 12222 344555666667776655 88888888877665443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.4e-17 Score=142.12 Aligned_cols=132 Identities=20% Similarity=0.248 Sum_probs=102.5
Q ss_pred ceec-cCCceEEEEEEECCCCcEEEEEEeecCC--------------cccHHHHHHHHHHHcCCCCCe--eeeeEEEEeC
Q 020133 27 RDIG-SGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILTP 89 (330)
Q Consensus 27 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~ei~~l~~l~h~~I--v~~~~~~~~~ 89 (330)
..|| .||.|+||.+... +..++||.+.... .....+.+|+.++.+++|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 8899999998775 7789999885421 122467889999999998875 6666664433
Q ss_pred C----eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecC
Q 020133 90 T----HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (330)
Q Consensus 90 ~----~~~lv~e~~~g-~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg 164 (330)
. ..++|||+++| .+|.+++.. .+++... +.+++.+|.+||++||+|+||||.|||++.++ .++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECC
Confidence 2 23599999997 689888765 4566543 57899999999999999999999999998665 49999999
Q ss_pred Ccc
Q 020133 165 YSK 167 (330)
Q Consensus 165 ~a~ 167 (330)
.+.
T Consensus 188 ~~~ 190 (239)
T PRK01723 188 RGE 190 (239)
T ss_pred Ccc
Confidence 875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.3e-18 Score=141.65 Aligned_cols=132 Identities=21% Similarity=0.266 Sum_probs=94.6
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHH-------------------------HHHHHHHHHcCCCCC--
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------------------------VQREIINHRSLRHPN-- 78 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-------------------------~~~ei~~l~~l~h~~-- 78 (330)
.+.||+|+||.||++.+. +++.||||++......... ...|...+.++.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 7999999988754221111 134555555554332
Q ss_pred eeeeeEEEEeCCeEEEEEeccCCCChHHH-HHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCC
Q 020133 79 IVRFKEVILTPTHLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP 156 (330)
Q Consensus 79 Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~-l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~ 156 (330)
+.+.++. ...++||||++|+++... +.. .... ..+..++.+++.++.++|+ .||+|+||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-- 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-VRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-- 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhh-hhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--
Confidence 4444433 235899999998543221 111 1111 6788999999999999999 9999999999999998 43
Q ss_pred ceEEeecCCcc
Q 020133 157 RLKICDFGYSK 167 (330)
Q Consensus 157 ~vkL~Dfg~a~ 167 (330)
.++|+|||.+.
T Consensus 152 ~~~liDfg~a~ 162 (187)
T cd05119 152 KVYIIDVPQAV 162 (187)
T ss_pred cEEEEECcccc
Confidence 49999999885
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=148.16 Aligned_cols=145 Identities=30% Similarity=0.460 Sum_probs=114.0
Q ss_pred CCCCeeeeeEEEEeC---------------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 020133 75 RHPNIVRFKEVILTP---------------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127 (330)
Q Consensus 75 ~h~~Iv~~~~~~~~~---------------------------~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~ 127 (330)
+|||||.+..+|.+. ..+|+||...+ .+|++++..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 599999998887542 24799999885 4999999764 467777888999999
Q ss_pred HHHHHhhhcCccccCCCCCcEEe--cCCCCCceEEeecCCcccccC-------CCCCCcccCCCCCCChhhhhcCC----
Q 020133 128 SGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL-------HSQPKSTVGTPAYIAPEVLLKKE---- 194 (330)
Q Consensus 128 ~~L~~LH~~~ivH~dikp~NIli--~~~~~~~vkL~Dfg~a~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~---- 194 (330)
+|+.|||.+|+.|||+|++|||+ ++|.-+.++++|||++-.... ....-...|...-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 666667899999998742221 11112334677889999875332
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 195 -YDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 195 -~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
.+..++|.|+.|.+.||+++...||..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccc
Confidence 223348999999999999999999986
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.2e-17 Score=129.23 Aligned_cols=131 Identities=24% Similarity=0.272 Sum_probs=110.7
Q ss_pred EeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC--CCeeeeeEEEEeCCeEEEEEeccCCC
Q 020133 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 102 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h--~~Iv~~~~~~~~~~~~~lv~e~~~g~ 102 (330)
+++.||.|.++.||++.... ..+++|....... ...+.+|+..++.+++ .++++++.++...+..+++|||++|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999854 6799998866544 5678899999999976 58999998888778899999999988
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc---CccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 103 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
++..+ +......++.+++.+|+.+|.. +++|+|++|.||+++..+ .++++|||.+.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAG 137 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEeccccc
Confidence 77543 5667788899999999999985 799999999999998643 59999999775
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-17 Score=152.66 Aligned_cols=188 Identities=22% Similarity=0.260 Sum_probs=130.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeE-------EEE--
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKE-------VIL-- 87 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~-------~~~-- 87 (330)
..+.+.+..+..+++.+.......+ ...++-+....+. .......+++..+....|-+..-+.+ .+.
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN 323 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence 4455666666666666655444332 2333333333322 22233444554444443333222222 111
Q ss_pred ---eCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEe
Q 020133 88 ---TPTHLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (330)
Q Consensus 88 ---~~~~~~lv~e~~~g~sL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~ 161 (330)
...++|+.|++|.-.+|.+++.... ..+....+.++.|++.|+.| +|.+|+|+||.||++..+. .+||.
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIg 398 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIG 398 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhh
Confidence 1235789999999999999997433 47888899999999999999 9999999999999997766 49999
Q ss_pred ecCCcccccCCC-------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh
Q 020133 162 DFGYSKSSVLHS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214 (330)
Q Consensus 162 Dfg~a~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt 214 (330)
|||+........ ......||..||+||++.++.|..+ +||||||++++|++.
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLI 457 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHH
Confidence 999976443333 3345679999999999999999777 999999999999997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-17 Score=160.97 Aligned_cols=203 Identities=36% Similarity=0.574 Sum_probs=166.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECC-CCcEEEEEEeecCCccc---HHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDKID---ENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~---~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~l 94 (330)
...|.+.+.||+|+++.|-.+.... ....+|.|.+....... +....|..+...+. |+|++.+++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4679999999999999998888754 34556777665543222 33445777777776 9999999999999999999
Q ss_pred EEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHhh-hcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 95 VMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 95 v~e~~~g~sL~~~l-~~~~-~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
+++|..|+++.+.+ .... ..+.......+.|+..++.|+| ..++.|+||||+|.+++..+. .+++.|||+|.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccccc
Confidence 99999999999888 5444 6788889999999999999999 999999999999999987763 499999999975544
Q ss_pred -CC---CCCcccC-CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 172 -HS---QPKSTVG-TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 172 -~~---~~~~~~~-~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.. .....+| ++.|+|||...+..+.....|+||.|+++.-+++|..|+....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 22 2234567 9999999999887676677999999999999999999987543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.56 E-value=2e-14 Score=118.64 Aligned_cols=127 Identities=20% Similarity=0.257 Sum_probs=95.8
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~I-v~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
++.|+.|.++.||.+... ++.|++|.............+|+..++.+.+.++ .+++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999875 7789999876554333456789999988865444 4455443 2335899999999888
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCc-----cccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 105 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i-----vH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
.+. . ......+.+++.+|+.||+.++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 79 ~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 79 LTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred ccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 643 0 1123456899999999999985 9999999999998 33 49999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-13 Score=115.85 Aligned_cols=135 Identities=15% Similarity=0.186 Sum_probs=99.3
Q ss_pred ceeccCCceEEEEEEECC------CCcEEEEEEeecC-------------C-c---------ccHH----HHHHHHHHHc
Q 020133 27 RDIGSGNFGVARLMRDKK------TEELVAVKYIERG-------------D-K---------IDEN----VQREIINHRS 73 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~-------------~-~---------~~~~----~~~ei~~l~~ 73 (330)
..||.|--+.||.|.... .+..+|||+.+.+ + . .... ..+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998764 3578999987421 0 0 0112 3489999998
Q ss_pred CCC--CCeeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhcCccccCCCCCcEEe
Q 020133 74 LRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLL 150 (330)
Q Consensus 74 l~h--~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivH~dikp~NIli 150 (330)
+.. -++.+.+++ ...++||||+.+..+..-..+...++..+...+..+++.++..+ |..|++||||++.||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 853 356666654 34589999997654432222233566677788899999999998 89999999999999999
Q ss_pred cCCCCCceEEeecCCccc
Q 020133 151 DGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 151 ~~~~~~~vkL~Dfg~a~~ 168 (330)
+++ .+.|+|||.|..
T Consensus 159 ~~~---~v~iIDF~qav~ 173 (197)
T cd05146 159 HDG---KVWFIDVSQSVE 173 (197)
T ss_pred ECC---cEEEEECCCcee
Confidence 643 499999998763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.6e-14 Score=131.59 Aligned_cols=137 Identities=18% Similarity=0.184 Sum_probs=93.9
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCccc-----------------------------------------HHHH
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----------------------------------------ENVQ 65 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------------------------------~~~~ 65 (330)
+.||+|++|.||+|... +|+.||||+.+++-... -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999875 68999999875431000 0133
Q ss_pred HHHHHHHcC----CCCCeeeeeEEEE-eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHhhhcCc
Q 020133 66 REIINHRSL----RHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHSMQV 138 (330)
Q Consensus 66 ~ei~~l~~l----~h~~Iv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~-~L~~LH~~~i 138 (330)
+|+..+.++ ++.+-+.+-.++. ..+..++||||++|++|.+..... ...+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 455544444 2332233333332 234569999999999998876432 1222 3445566655 4788999999
Q ss_pred cccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 139 vH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+|+|++|.||+++.++ +++|+|||++...
T Consensus 279 ~H~D~hPgNilv~~~g--~i~liDfG~~~~l 307 (437)
T TIGR01982 279 FHADLHPGNIFVLKDG--KIIALDFGIVGRL 307 (437)
T ss_pred eeCCCCcccEEECCCC--cEEEEeCCCeeEC
Confidence 9999999999997765 4999999988643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.4e-14 Score=138.87 Aligned_cols=141 Identities=24% Similarity=0.355 Sum_probs=96.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-----------------------------------ccHH--
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------------------IDEN-- 63 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------------------------------~~~~-- 63 (330)
..|.. +.||+|++|.||.|+.+.+|+.||||+..++-. ..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44666 899999999999999988899999999865310 0111
Q ss_pred ----HHHHHHHHHcCC----CCCeeeeeEEEEe-CCeEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHHHH
Q 020133 64 ----VQREIINHRSLR----HPNIVRFKEVILT-PTHLAIVMEYASGGELFER--ICNAG----RFSEDEARFFFQQLIS 128 (330)
Q Consensus 64 ----~~~ei~~l~~l~----h~~Iv~~~~~~~~-~~~~~lv~e~~~g~sL~~~--l~~~~----~l~~~~~~~i~~qi~~ 128 (330)
+.+|+..+.+++ +.+.+.+-.++.+ .+..++||||+.|+++.+. +...+ .+....+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 234444444442 4444444444433 4556899999999999774 33333 244444455555554
Q ss_pred HHHHhhhcCccccCCCCCcEEecCCC--CCceEEeecCCcccc
Q 020133 129 GVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 169 (330)
Q Consensus 129 ~L~~LH~~~ivH~dikp~NIli~~~~--~~~vkL~Dfg~a~~~ 169 (330)
..|++|+|++|.||+++.++ .++++++|||++...
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 58999999999999997664 236999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.9e-13 Score=129.75 Aligned_cols=183 Identities=18% Similarity=0.270 Sum_probs=136.1
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCC
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g 101 (330)
|++ ....-++.+..--+..+.++.+|.|..++.+.. ..+...+.+..++.++||||+++++.++..+..|+|+|.+.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~- 92 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR- 92 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc-
Confidence 555 333333333322345566788999998877654 23457788899999999999999999999999999999884
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh-hcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-CCccc
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV 179 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~ 179 (330)
.|..++++ +....+..-++||+.||.+|| .++++|++|.-+.|+++..+. .||++|.++........ .....
T Consensus 93 -Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~ 166 (690)
T KOG1243|consen 93 -PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLY 166 (690)
T ss_pred -cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccch
Confidence 67777765 347778888999999999997 678999999999999988876 99999987753322221 12222
Q ss_pred CCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCC
Q 020133 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA 216 (330)
Q Consensus 180 ~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~ 216 (330)
.--.|..|+.+..... . .|.|-|||++++++.|.
T Consensus 167 ~~~s~~~P~~~~~s~~--s-~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 167 LIESFDDPEEIDPSEW--S-IDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhcccChhhcCcccc--c-hhhhhHHHHHHHHhCcc
Confidence 2335677776544332 2 69999999999999993
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.2e-12 Score=103.41 Aligned_cols=128 Identities=23% Similarity=0.220 Sum_probs=94.0
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----------cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..+++|+-+.+|.+.. -|.++++|.= ..... .++-.+|+.++.+++--.|..-.=+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~R-i~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKER-IPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEee-cCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 3578899999998854 3555777742 22111 134568999998886555544444455667778999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
||.+|..|.+.+... . ..++..+-.-+.-||..||+|+||.++||++..+ ++.++|||++.
T Consensus 79 e~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~---~i~~IDfGLg~ 139 (204)
T COG3642 79 EYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG---RIYFIDFGLGE 139 (204)
T ss_pred EEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC---cEEEEECCccc
Confidence 999999999888764 2 4455666666777999999999999999999754 38999999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.5e-13 Score=126.62 Aligned_cols=197 Identities=21% Similarity=0.199 Sum_probs=156.6
Q ss_pred CCeEEeceecc--CCceEEEEEEE--CCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeE
Q 020133 21 DRYELVRDIGS--GNFGVARLMRD--KKTEELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHL 92 (330)
Q Consensus 21 ~~y~i~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~ 92 (330)
.++.+.+.+|+ |.+|.||.+.. ..++..+|+|.-+.. ......-.+|+...+.++ |++.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 56778899999 99999999998 788999999974432 223344567777777774 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 93 AIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~-l~~~~~~~i~~qi~~----~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
|+-+|+|. .+|..+...-.. ++...++..+.+... ||.++|+.+++|-|+||.||+...+.. ..+++|||+..
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~-s~~~~df~~v~ 271 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT-SCKLTDFGLVS 271 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc-eeecCCcceeE
Confidence 99999995 688887765544 899999999999999 999999999999999999999987742 48999999887
Q ss_pred cccCCCCCC------cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 168 SSVLHSQPK------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 168 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
......... ...+...|++||...+. .+..+|+||||.++.+-.++..++..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccC
Confidence 554433221 11466789999987544 34558999999999998887666543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.4e-11 Score=100.09 Aligned_cols=141 Identities=16% Similarity=0.108 Sum_probs=104.6
Q ss_pred EeceeccCCceEEEEEEECCCCcEEEEEEee-cC--------CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RG--------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~--------~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
....+.+|+-+.|+.+... |+.++||.-. +. .-.+.+..+|++.+.++.--.|.--.=++.+...-+++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4567889999988887664 8888888432 11 11224567899999888655555544556666777899
Q ss_pred EeccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC-ceEEeecCCcc
Q 020133 96 MEYASG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSK 167 (330)
Q Consensus 96 ~e~~~g-~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~-~vkL~Dfg~a~ 167 (330)
|||++| .++.+++.... .....-...+++.|-..+.-||..+|+||||..+||++..+++. .+.|+|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999987 57788876543 23333347889999999999999999999999999999766552 34899999875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.6e-12 Score=107.22 Aligned_cols=139 Identities=20% Similarity=0.267 Sum_probs=105.7
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCC--CeeeeeEEEEeC---CeEEEEEecc
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP--NIVRFKEVILTP---THLAIVMEYA 99 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~--~Iv~~~~~~~~~---~~~~lv~e~~ 99 (330)
+.|+.|..+.||++.... |+.+++|....... ....+.+|+..+..+++. .+.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999998754 67899998765443 356788999999998753 456777776553 3678999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh--------------------------------------------
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-------------------------------------------- 135 (330)
+|.++.+.+.. ..++......++.+++++|..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99988765432 356777777888888888888874
Q ss_pred ------------cCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 136 ------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 136 ------------~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
..++|+|++|.||+++.+..+.+.++||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23689999999999987322247899999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-12 Score=121.03 Aligned_cols=196 Identities=21% Similarity=0.187 Sum_probs=145.6
Q ss_pred CCCeEEeceeccCCceEEEEEEEC-CCCcEEEEEEeecCCccc---HHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~---~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~l 94 (330)
..+|..+..||.|.|+.|+.+.-. .++..|++|...+..... ..-..|+.+...+ .|.+++.++..+......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 357889999999999999887755 678889999776542211 1223455555555 58899998888888888889
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
--|||.++++.....-...+.+...+++..|++.++.++|+..++|+|++|+||++..++ ...++.|||.+.... ..
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~--~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLA--FS 420 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccc--ee
Confidence 999999999877665445688999999999999999999999999999999999997754 347999999876411 11
Q ss_pred CCcccCCCCCC-ChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC
Q 020133 175 PKSTVGTPAYI-APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218 (330)
Q Consensus 175 ~~~~~~~~~y~-aPE~~~~~~~~~~~~Di~SlG~il~elltg~~p 218 (330)
........++. ..|.+........++|++|||..+.+..++...
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 11222233444 255554443334449999999999999988653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.8e-10 Score=100.58 Aligned_cols=129 Identities=13% Similarity=0.059 Sum_probs=93.0
Q ss_pred EEEEEECCCCcEEEEEEeecCC------------cccHHHHHHHHHHHcCCCCCe--eeeeEEEEe-----CCeEEEEEe
Q 020133 37 ARLMRDKKTEELVAVKYIERGD------------KIDENVQREIINHRSLRHPNI--VRFKEVILT-----PTHLAIVME 97 (330)
Q Consensus 37 Vy~~~~~~~~~~vavK~~~~~~------------~~~~~~~~ei~~l~~l~h~~I--v~~~~~~~~-----~~~~~lv~e 97 (330)
|+.+.. .|+.|.||...... .....+.+|+..+.+|..-+| ++...+++. ....++|||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 444433 46788899663322 111247789988888754333 334445543 234689999
Q ss_pred ccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-----CCCCceEEeecCCcc
Q 020133 98 YASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 167 (330)
Q Consensus 98 ~~~g~-sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-----~~~~~vkL~Dfg~a~ 167 (330)
++++. +|.+++.. ..+.+......++.+++..+..||..||+|+|++++|||++. ++...+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99885 89888753 345667788899999999999999999999999999999975 234569999999764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.5e-12 Score=112.67 Aligned_cols=147 Identities=20% Similarity=0.314 Sum_probs=107.7
Q ss_pred HHHHcCCCCCeeeeeEEEEeCC-----eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcC--
Q 020133 69 INHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-- 137 (330)
Q Consensus 69 ~~l~~l~h~~Iv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~-- 137 (330)
..+-.+-|.|||+++.++.+.. ...+++||++.|++.+++++. ..+......+|+.||+.||.|||++.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3445567999999999987543 478899999999999999753 45888999999999999999999986
Q ss_pred ccccCCCCCcEEecCCCCCceEEeecCCcccccC-----CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHH
Q 020133 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (330)
Q Consensus 138 ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~el 212 (330)
|+|+++....|++..++. +|+.--.-...... ........+-++|.+||.=......+. +|||+||....+|
T Consensus 199 iihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHH
Confidence 999999999999986653 55432211110000 011122245678999986443344444 9999999999999
Q ss_pred HhCCCC
Q 020133 213 LVGAYP 218 (330)
Q Consensus 213 ltg~~p 218 (330)
..+..-
T Consensus 276 ailEiq 281 (458)
T KOG1266|consen 276 AILEIQ 281 (458)
T ss_pred HHheec
Confidence 888764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4e-12 Score=125.85 Aligned_cols=212 Identities=26% Similarity=0.380 Sum_probs=158.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..+.+.+.+.+.+|+++.++.+.-..+|...+.|.....+... +...++-..+..-++|.++....-+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4577889999999999999999888888777777654433222 112222222222345656654444445567899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-C--
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L-- 171 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~-- 171 (330)
|++|+.|++|...+++.+..+.+-.+.....+..++.+||+..+.|+|++|.|.++..++. .++.|||...... .
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccC
Confidence 9999999999999998888888888888999999999999999999999999999987765 7899997322000 0
Q ss_pred ------------------C-----------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 172 ------------------H-----------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 172 ------------------~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
. .......+|+.|.+||.+.+...... +|.|++|+++++.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCc
Confidence 0 00112347899999999988877555 89999999999999999999987
Q ss_pred ChhhHHHHHhh
Q 020133 223 EEPKNFRKTIH 233 (330)
Q Consensus 223 ~~~~~~~~~~~ 233 (330)
.....+..+..
T Consensus 1039 tpq~~f~ni~~ 1049 (1205)
T KOG0606|consen 1039 TPQQIFENILN 1049 (1205)
T ss_pred chhhhhhcccc
Confidence 77666666553
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=96.57 Aligned_cols=122 Identities=26% Similarity=0.303 Sum_probs=81.0
Q ss_pred EEEEEEECCCCcEEEEEEeecC--------------Cc-------------ccHHHHHHHHHHHcCCCC--CeeeeeEEE
Q 020133 36 VARLMRDKKTEELVAVKYIERG--------------DK-------------IDENVQREIINHRSLRHP--NIVRFKEVI 86 (330)
Q Consensus 36 ~Vy~~~~~~~~~~vavK~~~~~--------------~~-------------~~~~~~~ei~~l~~l~h~--~Iv~~~~~~ 86 (330)
.||.|... .|..+|+|+.... .. ......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48889885 4778999987421 00 113567899999999765 466666542
Q ss_pred EeCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HhhhcCccccCCCCCcEEecCCCCCceEEeec
Q 020133 87 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVS-YCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 87 ~~~~~~~lv~e~~~--g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
+ .++||||++ |..+..+... .++......++.+++..+. .+|..||+|||+++.||+++++ .+.++||
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf 150 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDF 150 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--G
T ss_pred --C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEec
Confidence 2 379999998 7666554432 2224556777888888544 4689999999999999999866 4999999
Q ss_pred CCcc
Q 020133 164 GYSK 167 (330)
Q Consensus 164 g~a~ 167 (330)
|.+.
T Consensus 151 ~qav 154 (188)
T PF01163_consen 151 GQAV 154 (188)
T ss_dssp TTEE
T ss_pred Ccce
Confidence 9875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.5e-10 Score=95.55 Aligned_cols=133 Identities=20% Similarity=0.222 Sum_probs=101.0
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecC-----------------------CcccHHHHHHHHHHHcCCCC--
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------------------DKIDENVQREIINHRSLRHP-- 77 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~ei~~l~~l~h~-- 77 (330)
+.+..+||.|--|.||.+.+. .|.++|||.-... ...+...++|...|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457789999999999999986 5889999953211 01124567899999998654
Q ss_pred CeeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCc
Q 020133 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (330)
Q Consensus 78 ~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~ 157 (330)
.+.+.+++ +...+|||+.+|..|...- ++......++..|+.-+..+-..|+||||+++-||+++.++.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 66666554 5678999999997664332 245556666777777777677999999999999999998865
Q ss_pred eEEeecCCcc
Q 020133 158 LKICDFGYSK 167 (330)
Q Consensus 158 vkL~Dfg~a~ 167 (330)
+.++||-.+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999997654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.4e-09 Score=97.74 Aligned_cols=167 Identities=19% Similarity=0.249 Sum_probs=124.8
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEe----CCeEEEEEeccCC-CChHH
Q 020133 33 NFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASG-GELFE 106 (330)
Q Consensus 33 ~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~----~~~~~lv~e~~~g-~sL~~ 106 (330)
...+.|++....+|..|++|+++-... .....-.-+..++++.|+|+|++.++|.. ...+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346899999999999999999943321 11223345678899999999999999873 3468999999985 67776
Q ss_pred HHHh---------------cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 107 RICN---------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 107 ~l~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
+.-. +...++..+|.++.|+..||.++|+.|..-+-|.|.+|+++.+. ++++...|+......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecC
Confidence 6522 23478899999999999999999999999999999999997553 688888776542222
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~p 218 (330)
.. . +-+.+.+ + -|.=.||.++..|.||..-
T Consensus 446 d~-----------~--~~le~~Q---q-~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP-----------T--EPLESQQ---Q-NDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC-----------C--cchhHHh---h-hhHHHHHHHHHHHhhcccc
Confidence 11 1 1122221 2 5888999999999999543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.1e-08 Score=93.19 Aligned_cols=190 Identities=14% Similarity=0.097 Sum_probs=127.7
Q ss_pred EeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEE------EEeCC-eEEEEE
Q 020133 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV------ILTPT-HLAIVM 96 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~------~~~~~-~~~lv~ 96 (330)
..+.||+|+-+.+|-..... -.+.|++......... +-+..|... .||-+-.-+.+ .-..+ ...+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45779999999998765432 2466877765432222 222233332 45533221111 01122 267788
Q ss_pred eccCCCCh-HHHHH------hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 97 EYASGGEL-FERIC------NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 97 e~~~g~sL-~~~l~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
..++|.-- ..++. .-..+.+....+.++.++.+.+.||+.|.+-||+.++|+|+++++. |.|.|-..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence 88876422 22221 1234788999999999999999999999999999999999988775 888885433333
Q ss_pred cCCCCCCcccCCCCCCChhhhh-----cCCCCCCccchhhHHHHHHHHHhC-CCCCCCC
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVG-AYPFEDP 222 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~Di~SlG~il~elltg-~~pf~~~ 222 (330)
..+....+.+|.+.|.+||.-. +..-+.. .|.|.||+++|+++.| ++||.+.
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcc
Confidence 4445556778999999999754 2223344 8999999999999986 9999763
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-08 Score=87.09 Aligned_cols=107 Identities=18% Similarity=0.195 Sum_probs=84.6
Q ss_pred cHHHHHHHHHHHcCCCCC--eeeeeEEEEeCC----eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh
Q 020133 61 DENVQREIINHRSLRHPN--IVRFKEVILTPT----HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYC 133 (330)
Q Consensus 61 ~~~~~~ei~~l~~l~h~~--Iv~~~~~~~~~~----~~~lv~e~~~g-~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~L 133 (330)
.....+|...+..|..-+ +++.+.+.+... ..++|+|++++ .+|.+++......+......++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346778888887775333 455556655432 35899999987 48999988755578888999999999999999
Q ss_pred hhcCccccCCCCCcEEecCCC-CCceEEeecCCcc
Q 020133 134 HSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 167 (330)
Q Consensus 134 H~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~ 167 (330)
|..||+|+|++|.|||++.+. ...+.|+||+-++
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999997664 3469999999665
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.8e-08 Score=84.13 Aligned_cols=135 Identities=16% Similarity=0.194 Sum_probs=89.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccH----------HHHHHHHHHHcCCC---CCeeeeeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----------NVQREIINHRSLRH---PNIVRFKEVI 86 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------~~~~ei~~l~~l~h---~~Iv~~~~~~ 86 (330)
.+.|.+.+.+-.....-|.+..- .|+.+++|.......-.+ ...+.+....+++. .....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 47889999998888777766654 478899997765332111 12233333333332 2233333332
Q ss_pred Ee-----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEe
Q 020133 87 LT-----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (330)
Q Consensus 87 ~~-----~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~ 161 (330)
+. ....+++|||++|..|.+... +++ .+...+..++..||+.|++|+|.+|+|+++.+++ ++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEE
Confidence 22 234578999999988866532 333 2445677788999999999999999999998554 8999
Q ss_pred ecCCcc
Q 020133 162 DFGYSK 167 (330)
Q Consensus 162 Dfg~a~ 167 (330)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.5e-08 Score=81.59 Aligned_cols=135 Identities=10% Similarity=0.098 Sum_probs=99.0
Q ss_pred ccCCceEEEEEEECCCCcEEEEEEeec----C---CcccHHHHHHHHHHHcCCCCC--eeeeeEEEE-e--C--CeEEEE
Q 020133 30 GSGNFGVARLMRDKKTEELVAVKYIER----G---DKIDENVQREIINHRSLRHPN--IVRFKEVIL-T--P--THLAIV 95 (330)
Q Consensus 30 g~G~~g~Vy~~~~~~~~~~vavK~~~~----~---~~~~~~~~~ei~~l~~l~h~~--Iv~~~~~~~-~--~--~~~~lv 95 (330)
|.||.|.|+..... |+.+-+|.-.. + +.....+.+|+..+.+|..-+ +.++. ++. . . -..+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 45888888887654 44678886541 1 234578999999999885322 44444 322 1 1 136899
Q ss_pred EeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 96 MEYASG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 96 ~e~~~g-~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
+|-++| .+|.+++... .+.+......++.+++.+++-||+.|+.|+|+.+.||+++.++...++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 6888887653 35678888999999999999999999999999999999975554459999998654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4e-07 Score=78.09 Aligned_cols=133 Identities=18% Similarity=0.161 Sum_probs=90.3
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCC--------------------ccc-----HHHHHHHHHHHcCCCC--C
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------------KID-----ENVQREIINHRSLRHP--N 78 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------------~~~-----~~~~~ei~~l~~l~h~--~ 78 (330)
.-.|++|.-+.||+|.. .++..+|+|++.... ... ....+|...|+++.-. .
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 33677788889999987 458889999885321 111 2345788888877433 3
Q ss_pred eeeeeEEEEeCCeEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCC
Q 020133 79 IVRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP 156 (330)
Q Consensus 79 Iv~~~~~~~~~~~~~lv~e~~~g~sL-~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~ 156 (330)
+.+-+.+. ...|||||++.... .-.++. -++...+...+..++++.+.-|-. .++||+||+.=|||+.+ +
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~-~-- 203 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD-G-- 203 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC-C--
Confidence 44444443 23699999965311 111111 234444688888888888887766 99999999999999983 3
Q ss_pred ceEEeecCCcc
Q 020133 157 RLKICDFGYSK 167 (330)
Q Consensus 157 ~vkL~Dfg~a~ 167 (330)
.+.++|||.|.
T Consensus 204 ~p~iID~~QaV 214 (268)
T COG1718 204 EPYIIDVSQAV 214 (268)
T ss_pred eEEEEECcccc
Confidence 38999999876
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.3e-07 Score=88.86 Aligned_cols=136 Identities=21% Similarity=0.230 Sum_probs=89.9
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC-----------------------c------------ccH------HHH
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------------K------------IDE------NVQ 65 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------------------~------------~~~------~~~ 65 (330)
+.++.++-|.||.|+... |+.||||+..++- . ..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678999999999999865 9999999875421 0 001 134
Q ss_pred HHHHHHHcCC-----CCCeeeeeEEE-EeCCeEEEEEeccCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 020133 66 REIINHRSLR-----HPNIVRFKEVI-LTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137 (330)
Q Consensus 66 ~ei~~l~~l~-----h~~Iv~~~~~~-~~~~~~~lv~e~~~g~sL~~~l--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 137 (330)
+|+..+.+++ .|++ .+=.++ +..+.-.++|||+.|..+.+.. +. ..++...+...+.++. +..+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 4555555442 2332 232333 3345668999999999998874 33 3455444333333221 33444589
Q ss_pred ccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 138 ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+.|.|.+|.||+++.++ ++.+.|||+....
T Consensus 286 ffHaDpHpGNi~v~~~g--~i~~lDfGi~g~l 315 (517)
T COG0661 286 FFHADPHPGNILVRSDG--RIVLLDFGIVGRL 315 (517)
T ss_pred ccccCCCccceEEecCC--cEEEEcCcceecC
Confidence 99999999999998775 4999999987533
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.6e-07 Score=76.69 Aligned_cols=72 Identities=17% Similarity=0.168 Sum_probs=54.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeEEEEeCCeEEEEEeccCCCC
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE 103 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~--Iv~~~~~~~~~~~~~lv~e~~~g~s 103 (330)
..+|+|..+.||+. .+..+++|...... ......+|...++.+..-+ +.+++++....+..++|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999974 24567899776533 3456789999998886433 5777888877778899999999964
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-08 Score=98.23 Aligned_cols=94 Identities=21% Similarity=0.406 Sum_probs=69.6
Q ss_pred HHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC----------CCcccCCCCCCChhhhhcC
Q 020133 125 QLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----------PKSTVGTPAYIAPEVLLKK 193 (330)
Q Consensus 125 qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~----------~~~~~~~~~y~aPE~~~~~ 193 (330)
+++.|+.++|. .++||++|.|++|.++..+. +||+.|+++........ +........|.|||.+.+.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44489999996 58999999999999987665 99999998753332111 1112345679999999774
Q ss_pred CCCCCccchhhHHHHHHHHH-hCCCCCCC
Q 020133 194 EYDGKIADVWSCGVTLYVML-VGAYPFED 221 (330)
Q Consensus 194 ~~~~~~~Di~SlG~il~ell-tg~~pf~~ 221 (330)
. .+.++|+||||+.+|.+. .|+..+..
T Consensus 185 ~-~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 185 T-NTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred c-ccccccceeeeeEEEEEecCCcchhhc
Confidence 4 455599999999999998 45555544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.5e-09 Score=97.78 Aligned_cols=197 Identities=22% Similarity=0.264 Sum_probs=145.0
Q ss_pred CCCCcccCC-CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEeC
Q 020133 12 MDMPIMHDS-DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTP 89 (330)
Q Consensus 12 ~~~~~~~~~-~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~-Iv~~~~~~~~~ 89 (330)
.+-+...+. .-|.....+++++++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..+
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E 306 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGE 306 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence 333333333 33567788999999999999887766554 6655444 34456788999999999 66666666667
Q ss_pred CeEEEEEeccCCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 90 THLAIVMEYASGG-ELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 90 ~~~~lv~e~~~g~-sL~~~l-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
...+++++++.++ +..... ...-.+...+...+++.-+++|+++|+.--+|+| ||+.... ..++.||+...
T Consensus 307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~---~~~~~~~~v~~ 379 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE---EVKLLDFAVPP 379 (829)
T ss_pred cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc---ccccccccCCc
Confidence 7889999999876 222111 1112355556667777888899999998889998 8887653 37999999887
Q ss_pred cccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
.........+..+++.|+|||+...+.+... .|.||+|.-..++--|-+|-..
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCC
Confidence 6666656778889999999999988888776 8999999877777777777543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-06 Score=73.20 Aligned_cols=132 Identities=21% Similarity=0.242 Sum_probs=94.9
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC-----------------cccHHHHHHHHHHHcCC------CCCeeeee
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRFK 83 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~ei~~l~~l~------h~~Iv~~~ 83 (330)
..||+|+.-.||.--+ ....+||+..... .......+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5689999999986543 3446899876654 22355677777766665 77899999
Q ss_pred EEEEeCCeEEEEEeccC------CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC-
Q 020133 84 EVILTPTHLAIVMEYAS------GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP- 156 (330)
Q Consensus 84 ~~~~~~~~~~lv~e~~~------g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~- 156 (330)
|+.+++-...+|+|... ..||.+++.. +.++. .....+. .-..+|-+.+|+.+|++|.||++.....+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 99999988889998753 3567888854 44665 4444433 34568889999999999999999654432
Q ss_pred -ceEEee-cCCc
Q 020133 157 -RLKICD-FGYS 166 (330)
Q Consensus 157 -~vkL~D-fg~a 166 (330)
++.|+| ||..
T Consensus 159 ~~lvlIDG~G~~ 170 (199)
T PF10707_consen 159 FRLVLIDGLGEK 170 (199)
T ss_pred eEEEEEeCCCCc
Confidence 588888 6643
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.7e-06 Score=75.75 Aligned_cols=75 Identities=12% Similarity=0.050 Sum_probs=53.5
Q ss_pred eeccCCc-eEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEeccCCCChH
Q 020133 28 DIGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 105 (330)
Q Consensus 28 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~ 105 (330)
.|..|.. +.||.+... +..+++|...... ...+.+|+..++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555655 788988654 4678888765443 345678888888773 344667888777666789999999998776
Q ss_pred H
Q 020133 106 E 106 (330)
Q Consensus 106 ~ 106 (330)
.
T Consensus 81 ~ 81 (244)
T cd05150 81 A 81 (244)
T ss_pred H
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.2e-06 Score=87.92 Aligned_cols=80 Identities=19% Similarity=0.231 Sum_probs=58.7
Q ss_pred EeceeccCCceEEEEEEECCCC--cEEEEEEeecCC--cccHHHHHHHHHHHcCC-CCCe--eeeeEEEEeC---CeEEE
Q 020133 25 LVRDIGSGNFGVARLMRDKKTE--ELVAVKYIERGD--KIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAI 94 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~--~~vavK~~~~~~--~~~~~~~~ei~~l~~l~-h~~I--v~~~~~~~~~---~~~~l 94 (330)
-++.++.|.++.+|++.....+ ..+++|+..... .....+.+|+.+++.+. |+++ .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677899999999998775432 467888765432 22356889999999995 6664 7777777654 46799
Q ss_pred EEeccCCCCh
Q 020133 95 VMEYASGGEL 104 (330)
Q Consensus 95 v~e~~~g~sL 104 (330)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999998653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-06 Score=75.63 Aligned_cols=78 Identities=18% Similarity=0.210 Sum_probs=56.5
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCC--CeeeeeEEEEe---CCeEEEEEeccC
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEVILT---PTHLAIVMEYAS 100 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~--~Iv~~~~~~~~---~~~~~lv~e~~~ 100 (330)
++.|+.|..+.||.+.... ..+++|..... .....+.+|...++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 5789999999999999865 47999976554 4456778888888877433 35566654432 345799999999
Q ss_pred CCChHH
Q 020133 101 GGELFE 106 (330)
Q Consensus 101 g~sL~~ 106 (330)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.9e-06 Score=69.09 Aligned_cols=129 Identities=19% Similarity=0.192 Sum_probs=93.0
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEeCCeEEEEEeccC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~I-v~~~~~~~~~~~~~lv~e~~~ 100 (330)
.-+..+.|++|.+|.||++... |..+|+| +...+..+..+..|++++..+.-.++ .++|.+..+ ++.|||+.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~K-vrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR--GGEVALK-VRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc--CceEEEE-EecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 3467789999999999999865 6689999 55666678899999999999986665 446555433 46699999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCC-CC-cEEecCCCCCceEEeecCCcc
Q 020133 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK-LE-NTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 101 g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dik-p~-NIli~~~~~~~vkL~Dfg~a~ 167 (330)
|..|.+.-... +.. -+..++..---|-..||-|+.|+ |. ||++.+. .+.|+||..|+
T Consensus 96 G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~---~~~iIDFd~At 154 (201)
T COG2112 96 GRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR---DVYIIDFDSAT 154 (201)
T ss_pred Ccchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCC---cEEEEEccchh
Confidence 98886654321 233 33445555556778899999986 44 5666432 48999998775
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.35 E-value=2e-05 Score=66.16 Aligned_cols=124 Identities=19% Similarity=0.290 Sum_probs=88.6
Q ss_pred CCeEEeceeccCCc-eEEEEEEECCCCcEEEEEEeec---C------------C-------cccHHHHHHHHHHHcCC--
Q 020133 21 DRYELVRDIGSGNF-GVARLMRDKKTEELVAVKYIER---G------------D-------KIDENVQREIINHRSLR-- 75 (330)
Q Consensus 21 ~~y~i~~~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~---~------------~-------~~~~~~~~ei~~l~~l~-- 75 (330)
..++.++.||.|.- |.||+++-. |+.||+|.+.. . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 999999875 77999998321 0 0 11234666776666664
Q ss_pred -CCCe--eeeeEEEEeC------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh
Q 020133 76 -HPNI--VRFKEVILTP------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134 (330)
Q Consensus 76 -h~~I--v~~~~~~~~~------------------~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH 134 (330)
+.++ |+++++..-. ....||.||.+... .++... +.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 5556 8999987422 12467888876543 233333 455666678899
Q ss_pred hcCccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 135 ~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
..||+-+|+++.|.. + -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---G----GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---C----CEEEecccC
Confidence 999999999999997 2 389999854
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.2e-06 Score=80.18 Aligned_cols=137 Identities=18% Similarity=0.178 Sum_probs=88.8
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCC--------------------------------cccH------HHHHHH
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------------------------KIDE------NVQREI 68 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------------------------~~~~------~~~~ei 68 (330)
+.||..+.|.|++|+.+. |+.||||+-+++- ...+ .+.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999877 9999999764320 0001 133444
Q ss_pred HHHHc----CCCCC------eeeeeEEEEeCCeEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHhhhc
Q 020133 69 INHRS----LRHPN------IVRFKEVILTPTHLAIVMEYASGGELFER--ICNAGRFSEDEARFFFQQLISGVSYCHSM 136 (330)
Q Consensus 69 ~~l~~----l~h~~------Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~--l~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 136 (330)
+...+ +.|-+ |.+++-.+ .....|+|||++|..+.+. +.+ ..++...+..-+.++. +..|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHH--HHHHHhc
Confidence 33332 23434 44443333 3456899999999887655 333 3466665444433332 2333457
Q ss_pred CccccCCCCCcEEecCC--CCCceEEeecCCcccc
Q 020133 137 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSS 169 (330)
Q Consensus 137 ~ivH~dikp~NIli~~~--~~~~vkL~Dfg~a~~~ 169 (330)
|++|+|=+|.||++..+ +...+.+.|||+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 89999999999999853 3557999999987643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.1e-06 Score=72.93 Aligned_cols=74 Identities=11% Similarity=-0.006 Sum_probs=47.3
Q ss_pred eceeccCCce-EEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCC---CeeeeeEEEEeC---CeEEEEEec
Q 020133 26 VRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEY 98 (330)
Q Consensus 26 ~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~---~Iv~~~~~~~~~---~~~~lv~e~ 98 (330)
++.++.|+.. .||.+ +..+++|.... ......+.+|...+..+... .+.++++..... +..|++|++
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567777766 58876 23478886544 33345788999999877532 244444443322 235889999
Q ss_pred cCCCChH
Q 020133 99 ASGGELF 105 (330)
Q Consensus 99 ~~g~sL~ 105 (330)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.0001 Score=63.94 Aligned_cols=75 Identities=15% Similarity=0.224 Sum_probs=49.6
Q ss_pred eceeccCCceEEEEEEECC-CCcEEEEEEeecCCcccHHHHHHHHHHHcCCC-CCeeeeeEEEEeCCeEEEEEeccCCCC
Q 020133 26 VRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGE 103 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~e~~~g~s 103 (330)
++.|..|-...+|++.... .++.|++|.............+|+..++.+.. .-.++++..+. + .+||||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 4667888888999997543 35679999776543322334578888888743 33445544332 2 48999999977
Q ss_pred h
Q 020133 104 L 104 (330)
Q Consensus 104 L 104 (330)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 6
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00023 Score=66.46 Aligned_cols=76 Identities=18% Similarity=0.110 Sum_probs=54.2
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecC--------CcccHHHHHHHHHHHcCC---CCCeeeeeEEEEeCCeEEE
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~~~ei~~l~~l~---h~~Iv~~~~~~~~~~~~~l 94 (330)
.+.||.|.++.||.+.+...++.++||.-.+. ....++...|...|+.+. -.++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 47799999999999999754468999974311 123356777888887763 2457777776 4455789
Q ss_pred EEeccCCCC
Q 020133 95 VMEYASGGE 103 (330)
Q Consensus 95 v~e~~~g~s 103 (330)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.9e-05 Score=69.56 Aligned_cols=138 Identities=20% Similarity=0.225 Sum_probs=97.7
Q ss_pred EEeceeccCCceEEEEEEECCCCcEEEEEEeecC--------------------------C-cccHHHHHHHHHHHcCCC
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------------------------D-KIDENVQREIINHRSLRH 76 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------------------------~-~~~~~~~~ei~~l~~l~h 76 (330)
.+-..|..|--+.||.|... .|..+|||+++.+ . ...-....|++.|.+++.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34556888999999998775 4778999987531 0 011345789999999876
Q ss_pred CCeeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhcCccccCCCCCcEEecCCCC
Q 020133 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPA 155 (330)
Q Consensus 77 ~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivH~dikp~NIli~~~~~ 155 (330)
..|.----+... ...|||+|+.+.....-..+.-+++...+..+-.|++.-+.-| |.+++||.||+-=|+|+.++
T Consensus 226 aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG-- 301 (520)
T KOG2270|consen 226 AGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG-- 301 (520)
T ss_pred cCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC--
Confidence 665433222222 2479999997543332223345688888888888888777766 57899999999999999644
Q ss_pred CceEEeecCCcc
Q 020133 156 PRLKICDFGYSK 167 (330)
Q Consensus 156 ~~vkL~Dfg~a~ 167 (330)
.+.++|.+.+.
T Consensus 302 -~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 -KLYIIDVSQSV 312 (520)
T ss_pred -EEEEEEccccc
Confidence 49999999775
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.94 E-value=6e-05 Score=66.47 Aligned_cols=131 Identities=15% Similarity=0.100 Sum_probs=75.0
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecCCccc-HHHHHHHHHHHcCCCCCe-eeeeEEEEeCCeEEEEEeccCCCChH
Q 020133 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGELF 105 (330)
Q Consensus 28 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~ei~~l~~l~h~~I-v~~~~~~~~~~~~~lv~e~~~g~sL~ 105 (330)
.+..|-.+.+|++. .+++.+++|......... -...+|...++.+...++ .+++... . -++||||++|.++.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 35567778899886 346678999765433221 235778888888854333 3444332 2 26899999987653
Q ss_pred HH--------------HH---hc----CCCCHH-HHHHHHHHH---------HHHHHHhhh--------cCccccCCCCC
Q 020133 106 ER--------------IC---NA----GRFSED-EARFFFQQL---------ISGVSYCHS--------MQVCHRDLKLE 146 (330)
Q Consensus 106 ~~--------------l~---~~----~~l~~~-~~~~i~~qi---------~~~L~~LH~--------~~ivH~dikp~ 146 (330)
.. +. .. .+++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 11 10 111211 111211111 111221211 24899999999
Q ss_pred cEEecCCCCCceEEeecCCcc
Q 020133 147 NTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 147 NIli~~~~~~~vkL~Dfg~a~ 167 (330)
||+++.++ +.|+||..|.
T Consensus 157 Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC---CEEEeccccC
Confidence 99998654 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=66.24 Aligned_cols=76 Identities=13% Similarity=0.121 Sum_probs=50.4
Q ss_pred eceeccCCceEEEEEEECC------CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEeCCeEEEEEec
Q 020133 26 VRDIGSGNFGVARLMRDKK------TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~-Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++.+..|-...+|++.... +++.+++|+............+|..++..+...+ ..+++.++. + .+|+||
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 3556667777899887643 2578999987665444345678888888775333 345555543 2 368999
Q ss_pred cCCCChH
Q 020133 99 ASGGELF 105 (330)
Q Consensus 99 ~~g~sL~ 105 (330)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9987764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00017 Score=64.95 Aligned_cols=136 Identities=17% Similarity=0.134 Sum_probs=80.2
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeE------EEEeCCeEEEEEe
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME 97 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~--Iv~~~~------~~~~~~~~~lv~e 97 (330)
++.+..|....+|++... +..+++|.... .....+..|+..+..+...+ +.+++. +...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 567777888899998653 34689998764 23456777887777774322 334333 1233456789999
Q ss_pred ccCCCChHH----H-------H---Hh-cCCC----------CHHHH----------HHHHHHHHHHHHHhhh-------
Q 020133 98 YASGGELFE----R-------I---CN-AGRF----------SEDEA----------RFFFQQLISGVSYCHS------- 135 (330)
Q Consensus 98 ~~~g~sL~~----~-------l---~~-~~~l----------~~~~~----------~~i~~qi~~~L~~LH~------- 135 (330)
|++|.++.. . + +. ...+ .+... ......+..++.++.+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 0 0 10 0000 00000 0011112233344432
Q ss_pred cCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 136 ~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
.+++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDE--LSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCc--eEEEeehhhhc
Confidence 4699999999999998654 25799998664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.84 E-value=5.8e-05 Score=63.30 Aligned_cols=97 Identities=14% Similarity=0.071 Sum_probs=76.0
Q ss_pred HHHHHHHHcCCC-CCeeeeeEEEEeCCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHhhh---cC
Q 020133 65 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHS---MQ 137 (330)
Q Consensus 65 ~~ei~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~---l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ 137 (330)
..|..+++.+++ +++++++|+|-. ++|.||.+.+++... +..-...++....+++.++++.+.++++ ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 467888888875 699999999832 678899986655321 1111246899999999999999999997 34
Q ss_pred ccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 138 ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
+.-+|++|+|+-+++++. +|++|...+.
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 788999999999987764 9999998653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00011 Score=75.05 Aligned_cols=155 Identities=21% Similarity=0.278 Sum_probs=112.6
Q ss_pred HHHHHHHHHcCCCCCeeeeeEEEEeCCeEE----EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCcc
Q 020133 64 VQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139 (330)
Q Consensus 64 ~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~----lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv 139 (330)
..-|...+.+..|+|++.++.+........ +..++|+..++.+.++.-+.++..+.+.+..++++||+++|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 445667778889999999999877654333 3458899999999999889999999999999999999999999766
Q ss_pred ccCCCCC---cEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCC-CCccchhhHHHHHHHHHhC
Q 020133 140 HRDLKLE---NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-GKIADVWSCGVTLYVMLVG 215 (330)
Q Consensus 140 H~dikp~---NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~SlG~il~elltg 215 (330)
|.-+..+ +...+..+....-+.||+.++.............+..+.++|....+... .+..|+|.+|.....+..|
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhc
Confidence 6655544 33333333322333488877755555555555566778888877555433 2236999999999998887
Q ss_pred CCC
Q 020133 216 AYP 218 (330)
Q Consensus 216 ~~p 218 (330)
..+
T Consensus 389 ~~i 391 (1351)
T KOG1035|consen 389 EDI 391 (1351)
T ss_pred Ccc
Confidence 654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=1.6e-05 Score=70.89 Aligned_cols=132 Identities=14% Similarity=0.138 Sum_probs=93.5
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC-----------------C------cccHHHHHHHHHHHcCCC-C
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------------D------KIDENVQREIINHRSLRH-P 77 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----------------~------~~~~~~~~ei~~l~~l~h-~ 77 (330)
-|.+..+||-|.-+.+|++-+. .|.+.++|.-... . -++-+..+|...++.|.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4667899999999999999885 4888899953210 0 011235678888888843 2
Q ss_pred -CeeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC
Q 020133 78 -NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (330)
Q Consensus 78 -~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~ 156 (330)
-+.+.+++ +..|+|||++.|-.|.+..+- .+ +..+...+..-+.-|-++|+||||..-=||+++++..
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~- 240 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK- 240 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence 24445444 567999999999888665422 12 2334455555567788999999999999999987654
Q ss_pred ceEEeecCCc
Q 020133 157 RLKICDFGYS 166 (330)
Q Consensus 157 ~vkL~Dfg~a 166 (330)
++++||-..
T Consensus 241 -i~vIDFPQm 249 (465)
T KOG2268|consen 241 -IVVIDFPQM 249 (465)
T ss_pred -EEEeechHh
Confidence 999999754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0011 Score=59.99 Aligned_cols=140 Identities=16% Similarity=0.148 Sum_probs=79.2
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeEE------EEeCCeEEE
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI 94 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~--Iv~~~~~------~~~~~~~~l 94 (330)
..-++.++.|....+|++... +| .+++|...... ....+..|+..+..|...+ +.+++.. ....+..++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ceeccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 334667788877899998643 34 58889765432 2345566677666663222 3333321 122456789
Q ss_pred EEeccCCCChH-----------HHH---Hh-cCCCC--------HH---HH-H-----------HHHHHHHHHHHHhh--
Q 020133 95 VMEYASGGELF-----------ERI---CN-AGRFS--------ED---EA-R-----------FFFQQLISGVSYCH-- 134 (330)
Q Consensus 95 v~e~~~g~sL~-----------~~l---~~-~~~l~--------~~---~~-~-----------~i~~qi~~~L~~LH-- 134 (330)
+++|++|.++. ..+ +. ...++ .. .. . .....+...+.++.
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999985542 111 10 00110 00 00 0 00111223444443
Q ss_pred -----hcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 135 -----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 135 -----~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
..+++|+|+++.||+++.++ .+.++||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDS--VKGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence 26799999999999998664 25899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0018 Score=58.98 Aligned_cols=75 Identities=11% Similarity=0.030 Sum_probs=44.8
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeE------EEEeCCeEEEEEe
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME 97 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~--Iv~~~~------~~~~~~~~~lv~e 97 (330)
.+.++.|....+|.+... +| .+++|++.. ...+.+..++..+..|...+ +.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456777877899998754 33 689998752 22344445555555553111 223322 1223566899999
Q ss_pred ccCCCCh
Q 020133 98 YASGGEL 104 (330)
Q Consensus 98 ~~~g~sL 104 (330)
|++|..+
T Consensus 103 ~l~G~~~ 109 (319)
T PRK05231 103 FLEGKWP 109 (319)
T ss_pred ecCCCCC
Confidence 9998754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0047 Score=56.73 Aligned_cols=72 Identities=19% Similarity=0.169 Sum_probs=48.3
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeec-----C---CcccHHHHHHHHHHHcCC--CC-CeeeeeEEEEeCCeEEEEE
Q 020133 28 DIGSGNFGVARLMRDKKTEELVAVKYIER-----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 28 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~---~~~~~~~~~ei~~l~~l~--h~-~Iv~~~~~~~~~~~~~lv~ 96 (330)
.+|.|....||++.+...++.|+||.-.. + ....++..-|...|+... .| .+++++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999865446899996421 1 223355667777776653 34 45555443 455567999
Q ss_pred eccCC
Q 020133 97 EYASG 101 (330)
Q Consensus 97 e~~~g 101 (330)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00093 Score=60.29 Aligned_cols=105 Identities=12% Similarity=0.061 Sum_probs=76.8
Q ss_pred EEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC---CCeeeeeEEEEeC---CeEEEEEe
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILTP---THLAIVME 97 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h---~~Iv~~~~~~~~~---~~~~lv~e 97 (330)
.-.+.||.|..+.||...... + .+++|.. +.......+.+|+..++.+.- -.+.++++++..+ +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 446789999999999986543 3 4677864 332234688999999998853 3578888877543 66899999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 136 (330)
+++|.++.+. ..+......+..+++++|+.||+.
T Consensus 94 ~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 94 RLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred ccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9999888651 134455666778888999999985
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0019 Score=59.54 Aligned_cols=140 Identities=15% Similarity=0.190 Sum_probs=80.6
Q ss_pred CeEEeceeccCCceEEEEEEECC----CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEeCCeEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~I-v~~~~~~~~~~~~~lv~ 96 (330)
...+ +.|..|-...+|++.... .++.|++|+........-.-.+|..+++.+..-++ .++++.+. ++ .|+
T Consensus 38 ~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~ 112 (344)
T PLN02236 38 ALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFP-NG---RVE 112 (344)
T ss_pred cEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEEC-Cc---eEE
Confidence 3444 455557788999987432 34689999876654332233678888887754333 45555553 22 589
Q ss_pred eccCCCChHHH----------H-------HhcC------CCCHHHHHHHHHHHH-----------------HHHHH----
Q 020133 97 EYASGGELFER----------I-------CNAG------RFSEDEARFFFQQLI-----------------SGVSY---- 132 (330)
Q Consensus 97 e~~~g~sL~~~----------l-------~~~~------~l~~~~~~~i~~qi~-----------------~~L~~---- 132 (330)
+|++|.++... + +... ......+..+..++. ..+..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99988776421 0 1100 111233333332221 11111
Q ss_pred h----hhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 133 C----HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 133 L----H~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
+ +...++|+|+++.||+++++. +.+.|+||..|.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 1 123589999999999997532 259999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0015 Score=58.21 Aligned_cols=30 Identities=23% Similarity=0.325 Sum_probs=23.6
Q ss_pred CccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 137 ~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
.++|+|++|.||++++++. ..-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 3899999999999986432 24699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0023 Score=58.68 Aligned_cols=79 Identities=15% Similarity=0.214 Sum_probs=48.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~I-v~~~~~~~~~~~~~lv~ 96 (330)
+..++.. |..|-...+|++..... +..|++|+........-.-.+|..+++.+..-++ .++++++ .++ +|.
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~ 89 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQ 89 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe-CCc---Eee
Confidence 3444444 44477778898875432 3479999876654332234578888887754444 4555555 233 589
Q ss_pred eccCCCCh
Q 020133 97 EYASGGEL 104 (330)
Q Consensus 97 e~~~g~sL 104 (330)
+|++|.+|
T Consensus 90 ~fi~g~~l 97 (330)
T PLN02421 90 SFINARTL 97 (330)
T ss_pred hhhcCCCC
Confidence 99988766
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0043 Score=57.73 Aligned_cols=77 Identities=18% Similarity=0.142 Sum_probs=52.3
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeec----C---CcccHHHHHHHHHHHcCC--CC-CeeeeeEEEEeCCe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTH 91 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~---~~~~~~~~~ei~~l~~l~--h~-~Iv~~~~~~~~~~~ 91 (330)
.++ .+.||.|....||++.+...++.|+||.-.. + .-..++..-|...|+... .| ++++++.+ ++..
T Consensus 31 ~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~ 107 (409)
T PRK12396 31 GLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVM 107 (409)
T ss_pred cce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHH
Confidence 344 6788999999999999854456799996421 1 223356677777777663 34 45666544 4455
Q ss_pred EEEEEeccCC
Q 020133 92 LAIVMEYASG 101 (330)
Q Consensus 92 ~~lv~e~~~g 101 (330)
..+|||+++.
T Consensus 108 ~~~vMEdL~~ 117 (409)
T PRK12396 108 NCCVMEDLSD 117 (409)
T ss_pred hhHHHHhCcc
Confidence 6789999864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.004 Score=56.33 Aligned_cols=141 Identities=12% Similarity=0.097 Sum_probs=81.2
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeec---CCcccHHHHHHHHHHHcCCC--CCeeeeeEEEEeCC--eEEEE
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH--PNIVRFKEVILTPT--HLAIV 95 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~ei~~l~~l~h--~~Iv~~~~~~~~~~--~~~lv 95 (330)
..+++....|....+|...++ ++++++. ... .........+|...++.+.- --+...+++|..+. ..|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 445666655655667777665 7888888 321 12233566788888887743 22344555555544 67999
Q ss_pred EeccCCCChHH----------HHH--------h-------c-------CCCCHHHHHHHHHHH--------------HHH
Q 020133 96 MEYASGGELFE----------RIC--------N-------A-------GRFSEDEARFFFQQL--------------ISG 129 (330)
Q Consensus 96 ~e~~~g~sL~~----------~l~--------~-------~-------~~l~~~~~~~i~~qi--------------~~~ 129 (330)
|+|++|..+.. +.. . . +.....++..+..+. ...
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 99998833211 111 0 0 001111122222222 122
Q ss_pred HHHhhh--------cCccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 130 VSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 130 L~~LH~--------~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
..+|+. -.++|||+++.|++++.+.. +-+.||+.+..
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~l 228 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATL 228 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEecccccc
Confidence 333332 23899999999999987765 88999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.011 Score=55.43 Aligned_cols=73 Identities=16% Similarity=0.186 Sum_probs=50.6
Q ss_pred EeceeccCCceEEEEEEECCCCcEEEEEEeec-----CC---cccHHHHHHHHHHHcCC---CCCeeeeeEEEEeCCeEE
Q 020133 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GD---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~---~~~~~~~~ei~~l~~l~---h~~Iv~~~~~~~~~~~~~ 93 (330)
..+.+|.|....||++.+. +..++||.-.. +. ....+...|+..|+.+. -.++.+++.++.+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 4678899999999999874 45689997541 21 12344455666666553 2478888888763 457
Q ss_pred EEEeccCC
Q 020133 94 IVMEYASG 101 (330)
Q Consensus 94 lv~e~~~g 101 (330)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999977
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.00015 Score=76.14 Aligned_cols=152 Identities=16% Similarity=0.136 Sum_probs=109.2
Q ss_pred HHHHHHHHcCCCCCeeeeeEEEEeC--CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcC-
Q 020133 65 QREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ- 137 (330)
Q Consensus 65 ~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~- 137 (330)
..|...++...|+++...+.-.... ..-|.+++|+.+|.+...+-++ .++...-+.....+......-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 3444455667898887765544322 3468899999999999988654 23444444444444467777777542
Q ss_pred ----ccccCCCCCcEEecCCCCCceEEeecCCcc-cccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHH
Q 020133 138 ----VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (330)
Q Consensus 138 ----ivH~dikp~NIli~~~~~~~vkL~Dfg~a~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~el 212 (330)
.+|+++|+.|.+|..+.+ +++.++|+.+ ............+++.|++|++...-.++.+ +|+|+.|+-+|..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHH
Confidence 789999999999976654 9999999988 3333334456678888999998876666655 9999999999998
Q ss_pred HhCCCCC
Q 020133 213 LVGAYPF 219 (330)
Q Consensus 213 ltg~~pf 219 (330)
..|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887776
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.023 Score=53.13 Aligned_cols=77 Identities=9% Similarity=0.011 Sum_probs=46.4
Q ss_pred EeceeccCCceEEEEEEECCC-Cc-----EEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEeCCeEEEEEe
Q 020133 25 LVRDIGSGNFGVARLMRDKKT-EE-----LVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~-~~-----~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~-Iv~~~~~~~~~~~~~lv~e 97 (330)
.++.|..|-...+|++..... +. .|+++.........-.-.+|+.+++.+...+ -.++++.+.. ++|.|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 344565588889999975432 12 2444443222222223357888888886544 4556666532 69999
Q ss_pred ccCCCChH
Q 020133 98 YASGGELF 105 (330)
Q Consensus 98 ~~~g~sL~ 105 (330)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.038 Score=49.95 Aligned_cols=29 Identities=31% Similarity=0.641 Sum_probs=24.1
Q ss_pred cCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 136 ~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
.+++|+|+.+.||+++.+ .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~---~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN---EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCC---cEEEEECcccc
Confidence 478999999999999762 38899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.016 Score=52.01 Aligned_cols=76 Identities=11% Similarity=0.069 Sum_probs=49.5
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC---CCCeeeeeEEEEeCCeEEEEEecc
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~---h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
-+-.+.++.|..+.+|.+. .+++.+.||.-. ......+..|+.-|+.|. --.+.+++.+....+..||||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3456788889999999887 567889999765 334467888888888884 345788999888777779999999
Q ss_pred CCC
Q 020133 100 SGG 102 (330)
Q Consensus 100 ~g~ 102 (330)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0057 Score=52.17 Aligned_cols=55 Identities=16% Similarity=0.061 Sum_probs=34.0
Q ss_pred CcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 46 EELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 46 ~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~-Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
++.|++++........-.-.+|...++.+...+ -.++++.+. + ..|.+|++|.+|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~-~---g~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFE-N---GRVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEET-T---EEEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcC-C---CcEEEEeccccc
Confidence 467899988877555566678888888775433 355555542 2 257799877665
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.07 Score=48.37 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=24.7
Q ss_pred CccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 137 ~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
+++|+|+.+.|++++.++. +.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 6999999999999976654 8899998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.081 Score=48.37 Aligned_cols=72 Identities=13% Similarity=0.059 Sum_probs=44.0
Q ss_pred CCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eee---eeE--EEEeCCeEEEEEeccCCCCh
Q 020133 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVR---FKE--VILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 32 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~--Iv~---~~~--~~~~~~~~~lv~e~~~g~sL 104 (330)
+.-..||.+... ++..+++|+..........+..|+..+..|.... ++. .-+ +...++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 344578888753 4667999987654445566778887777663211 111 111 22335667889999987643
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.091 Score=50.11 Aligned_cols=76 Identities=16% Similarity=0.041 Sum_probs=47.9
Q ss_pred EeceeccCCceEEEEEEECC--------CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEeCCeEEEE
Q 020133 25 LVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIV 95 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~I-v~~~~~~~~~~~~~lv 95 (330)
-++.|..|-...+|++.... .++.|++++........-.-.+|...++.+...+| .++++.+. + +.|
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence 55667667777888887542 25679999876654333334567777777654343 34555442 2 468
Q ss_pred EeccCCCCh
Q 020133 96 MEYASGGEL 104 (330)
Q Consensus 96 ~e~~~g~sL 104 (330)
.+|++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899988755
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.042 Score=50.22 Aligned_cols=136 Identities=16% Similarity=0.192 Sum_probs=80.1
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC------eeeeeEEE--EeCC--eEEEEE
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVI--LTPT--HLAIVM 96 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~------Iv~~~~~~--~~~~--~~~lv~ 96 (330)
..|.+ .-..+|++.... |+ +++|+.... .....+..|...+..|.-.+ +...-|-. .-.+ ..+-++
T Consensus 32 ~~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34444 556788887654 44 499988777 66677888888888774222 11111111 1123 677899
Q ss_pred eccCCCChHH-H-----------H---Hh---c-C--------CCCHH----H---------HHHHHHHHHHHHHHhh--
Q 020133 97 EYASGGELFE-R-----------I---CN---A-G--------RFSED----E---------ARFFFQQLISGVSYCH-- 134 (330)
Q Consensus 97 e~~~g~sL~~-~-----------l---~~---~-~--------~l~~~----~---------~~~i~~qi~~~L~~LH-- 134 (330)
+|++|..+.. . + +. + . ...+. . -.....++...++.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988872 1 0 00 0 0 01121 0 0112233344444444
Q ss_pred ------hcC--ccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 135 ------SMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 135 ------~~~--ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
+.+ +||+|+.|.||+++.+.. .+.++||+-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 234 999999999999987653 37899999764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.33 Score=51.33 Aligned_cols=138 Identities=14% Similarity=0.169 Sum_probs=75.0
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-------CCCCeeeee-----EEEEe-CC--e
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-------RHPNIVRFK-----EVILT-PT--H 91 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-------~h~~Iv~~~-----~~~~~-~~--~ 91 (330)
+.|+. ..-.+|++.. .+|+.+++|+.+... .......|...+..| .-|.+++-. ..... ++ .
T Consensus 31 ~~L~s-~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLDG-ERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecCC-cCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 56653 4577888865 457789999887643 233444444455433 233333321 11111 22 4
Q ss_pred EEEEEeccCCCChHHH-------H----------Hh----c------CCCCH-----------------HHHHHHHHHHH
Q 020133 92 LAIVMEYASGGELFER-------I----------CN----A------GRFSE-----------------DEARFFFQQLI 127 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~-------l----------~~----~------~~l~~-----------------~~~~~i~~qi~ 127 (330)
.+-+++|++|..+.+. + +. - ..+.| ...+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 6678999999877541 0 00 0 00111 11122333333
Q ss_pred HHHH-----Hhh--hcCccccCCCCCcEEecCCCCCceE-EeecCCcc
Q 020133 128 SGVS-----YCH--SMQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK 167 (330)
Q Consensus 128 ~~L~-----~LH--~~~ivH~dikp~NIli~~~~~~~vk-L~Dfg~a~ 167 (330)
.... .+. -.++||+|+.+.||+++.+...++. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3222 122 2469999999999999876422455 99999764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.11 Score=47.73 Aligned_cols=102 Identities=21% Similarity=0.248 Sum_probs=67.3
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
..|++|++. |+++. .+ ..-..+++..++++.+..+.-+.. ...-||++.-.||+|+ +|+ |.|+||-+++..
T Consensus 300 y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfklsRl~ 371 (488)
T COG5072 300 YLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKLSRLS 371 (488)
T ss_pred EEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeeeeecc
Confidence 467888876 55553 22 234678889999998887777764 4689999999999998 454 999999998732
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHH
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCG 206 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG 206 (330)
..+ ..+.....--|-.+.|.. + ...+||-+-
T Consensus 372 ~~q----~~isy~rldhp~lF~G~d-d-~QFeIYrlM 402 (488)
T COG5072 372 YSQ----GIISYNRLDHPDLFNGVD-D-YQFEIYRLM 402 (488)
T ss_pred cCC----ceeeccccCchhhhcCcc-c-eeeeHHHHH
Confidence 222 112222334455555444 2 226888754
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.12 Score=48.10 Aligned_cols=61 Identities=16% Similarity=0.107 Sum_probs=44.3
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-hhhcCccccCCCCCcEEecCC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQVCHRDLKLENTLLDGS 153 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~ivH~dikp~NIli~~~ 153 (330)
..++-+|..|.++..+++.. ..+++...+++.-..+||.. +--.+.+|.|+.|.||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 46677888899998888653 35666666666666666443 445689999999999999533
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.34 Score=41.77 Aligned_cols=78 Identities=21% Similarity=0.185 Sum_probs=53.7
Q ss_pred EEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC---CCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~---h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
+..+.+.-|-....|.+.+- ..++.+|+-... ....+..|+.-|..|. .-.+.+++.+....++.|+||||++
T Consensus 19 ~er~~v~gG~inea~~v~dg--~~~~FvK~n~~~--~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDG--TDPFFVKCNQRE--QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred hcccccCCccccceeEeecC--CcceEEEecchh--hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 34456666666777776653 456888853322 2345667777666663 4567888888888999999999998
Q ss_pred CCChH
Q 020133 101 GGELF 105 (330)
Q Consensus 101 g~sL~ 105 (330)
-+.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 76664
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.042 Score=49.57 Aligned_cols=134 Identities=19% Similarity=0.215 Sum_probs=89.7
Q ss_pred EEeceeccCCceEEEEEEE---------CC-CCcEEEEEEeecC-------C-----c----------c-----cHHHHH
Q 020133 24 ELVRDIGSGNFGVARLMRD---------KK-TEELVAVKYIERG-------D-----K----------I-----DENVQR 66 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~---------~~-~~~~vavK~~~~~-------~-----~----------~-----~~~~~~ 66 (330)
+|...|..|.-++|+.|.. .+ .-..+|||+++.. + . . .-...+
T Consensus 255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk 334 (531)
T KOG2269|consen 255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK 334 (531)
T ss_pred hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence 3556788898999988832 11 2345889876420 0 0 0 012345
Q ss_pred HHHHHHcC-----CCCCeeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhcCccc
Q 020133 67 EIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCH 140 (330)
Q Consensus 67 ei~~l~~l-----~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivH 140 (330)
|...|.++ .+|.+|.+... .|||-|+...-+..--.++-.|+..+....-.|+..+...| |++-+||
T Consensus 335 EmhNL~RMq~~GlpcP~vV~lkkh-------vLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVH 407 (531)
T KOG2269|consen 335 EMHNLSRMQKHGLPCPQVVKLKKH-------VLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVH 407 (531)
T ss_pred HHHHHHHHHhcCCCCCceeeeecc-------eEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheee
Confidence 66666665 36777776443 68999986543322212334588888888888888887666 6889999
Q ss_pred cCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 141 RDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 141 ~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
-|++--|+|...+ ++-++|...+.
T Consensus 408 ADlSEyN~Lw~~g---Kvw~IDVsQsv 431 (531)
T KOG2269|consen 408 ADLSEYNLLWTPG---KVWVIDVSQSV 431 (531)
T ss_pred cchhhhhheecCC---ceEEEechhcc
Confidence 9999999999654 48999987664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 330 | ||||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-157 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-157 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-157 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-155 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-149 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-147 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-47 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-46 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-46 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-45 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-42 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-42 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-42 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-42 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-42 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-42 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-42 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-42 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-42 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-42 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-41 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-41 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-41 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-41 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-35 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-35 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-35 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-35 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-34 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-34 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-34 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-34 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-34 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-34 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-34 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-34 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-34 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-34 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-34 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-34 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-34 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-34 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-34 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-34 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-34 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-34 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-34 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-34 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-34 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-34 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-34 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-34 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-34 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-34 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-34 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-34 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-34 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-34 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-34 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-34 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-34 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-34 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-34 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-34 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-34 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-34 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-34 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-34 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-33 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-33 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-33 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-33 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-33 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-33 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-33 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-33 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-33 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-33 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-33 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-33 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-33 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-32 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-31 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-31 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-30 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-30 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-30 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-30 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-30 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-30 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-30 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-30 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-30 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-30 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-30 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-30 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-30 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-30 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-30 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-30 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-30 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-30 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-30 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-29 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-29 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-29 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-29 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-29 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-29 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-29 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-29 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-29 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-29 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-29 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-29 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-29 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-29 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-29 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-29 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-29 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-29 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-29 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-29 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-29 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-29 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-29 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-29 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-29 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-29 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-29 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-29 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-29 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-29 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-29 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-29 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-29 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-29 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-28 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-28 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-28 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-28 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-28 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-28 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-28 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-28 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-28 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-28 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-28 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-28 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-28 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-28 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-28 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-28 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-28 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-28 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-28 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-28 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-28 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-28 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-28 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-28 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-28 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-27 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-27 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-27 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-27 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-27 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-27 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-27 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-27 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-27 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-27 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-27 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-26 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-26 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-25 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-25 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-25 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-25 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-25 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-25 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-25 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-25 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-25 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-25 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-25 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-25 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-25 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-24 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-23 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-23 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-22 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-22 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-22 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-21 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-21 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-21 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-21 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-21 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-21 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-19 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-19 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-19 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-19 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-18 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-18 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-18 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-18 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-18 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-18 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-18 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-18 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-18 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-18 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-18 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-18 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-18 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-18 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-18 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-18 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-17 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-17 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-17 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-09 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-07 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 6e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-06 |
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 516 bits (1332), Expect = 0.0
Identities = 269/363 (74%), Positives = 305/363 (84%), Gaps = 35/363 (9%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERG I
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-------- 232
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 233 -------------------------HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP 267
RISIPEI+ H WFLKNLPADL+ ++ T +QF+EP
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299
Query: 268 DQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIV 327
+QPMQS+D IMQII+EATIPA + L+ + +LD+DD+M +D D++ ++DIDSSGEIV
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDM-DDFDSESEIDIDSSGEIV 358
Query: 328 YAM 330
YA+
Sbjct: 359 YAL 361
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-136
Identities = 94/321 (29%), Positives = 153/321 (47%), Gaps = 44/321 (13%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTI------------- 232
PE+L ++E+ + DVWSCG+ L ML G P++ P + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 233 ----------------HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEP----DQPMQ 272
RI+IP+I+ W+ K L T+ E + +Q
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQ 295
Query: 273 SIDEIMQIIAEATIPAAGTQS 293
S + + + + P +G
Sbjct: 296 SNLDFSPVNSASRTPGSGWSK 316
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 373 bits (959), Expect = e-131
Identities = 88/278 (31%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTI------------- 232
PE+L ++E+ + DVWSCG+ L ML G P++ P + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 233 ----------------HRISIPEIRNHEWFLKNLPADL 254
RI+IP+I+ W+ K L
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = e-101
Identities = 106/265 (40%), Positives = 137/265 (51%), Gaps = 35/265 (13%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + T VAVK + R KI ++REI N + RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR FQQ++S V YCH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------------------- 233
G D+WSCGV LY +L G PF+D P F+K
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQV 248
Query: 234 ----RISIPEIRNHEWFLKNLPADL 254
R +I +IR HEWF ++LP+ L
Sbjct: 249 DPLKRATIKDIREHEWFKQDLPSYL 273
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 4e-99
Identities = 107/297 (36%), Positives = 151/297 (50%), Gaps = 35/297 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + + T VAVK + R KI ++REI N + RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R FQQ++SGV YCH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------------------- 233
G D+WS GV LY +L G PF+D P F+K
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQV 253
Query: 234 ----RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286
R +I +IR HEWF ++LP L ++ + + D+ ++ + E + E +
Sbjct: 254 DPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVL 310
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 2e-98
Identities = 95/289 (32%), Positives = 138/289 (47%), Gaps = 38/289 (13%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
Y L++ IG GNF +L R T VA+K I++ +++ + + RE+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ EVI T L ++MEYASGGE+F+ + GR E EAR F+Q++S V YCH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ K+YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------------ 233
DVWS GV LY ++ G+ PF+ + + +
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLN 252
Query: 234 ---RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279
R ++ +I W D + E D Q +IM
Sbjct: 253 PIKRGTLEQIMKDRWINAGHEEDEL----KPFVEPELDISDQKRIDIMV 297
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 5e-97
Identities = 110/297 (37%), Positives = 151/297 (50%), Gaps = 37/297 (12%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y + +G G+FG +L KT++ VA+K+I R + V+REI + LRH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R FFQQ+I + YCH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ K Y
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------------------- 233
G DVWSCG+ LYVMLVG PF+D P F+K
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA 245
Query: 234 ----RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286
RI+I EIR WF NLP L + + + + E M + +
Sbjct: 246 DPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRI-VSKLGEAMGFSEDYIV 301
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 8e-97
Identities = 81/267 (30%), Positives = 116/267 (43%), Gaps = 36/267 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT------------------------ 231
+ DVWS G +Y +LVG PFE + + +
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 251
Query: 232 ---IHRISIPEIRNHEWFLKN-LPADL 254
R +I E+ N E+F +PA L
Sbjct: 252 TDPTARPTINELLNDEFFTSGYIPARL 278
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 2e-96
Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 46/301 (15%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLR 75
+Y + +G G++G + + D +T AVK +++ K+ + NV++EI R LR
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64
Query: 76 HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 131
H N+++ +V+ + +VMEY G E+ + + RF +A +F QLI G+
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 188
Y HS + H+D+K N LL LKI G +++ + +++ G+PA+ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT---------------- 231
+ + G D+WS GVTLY + G YPFE K F
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 232 -----------IHRISIPEIRNHEWFLKNLPADLV-VDNTTNNQFEEPDQPMQSIDEIMQ 279
R SI +IR H WF K P V + ++ + M + +
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLED 301
Query: 280 I 280
+
Sbjct: 302 L 302
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 5e-95
Identities = 81/267 (30%), Positives = 116/267 (43%), Gaps = 36/267 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT------------------------ 231
+ DVWS G +Y +LVG PFE + + +
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277
Query: 232 ---IHRISIPEIRNHEWFLKN-LPADL 254
R +I E+ N E+F +PA L
Sbjct: 278 TDPTARPTINELLNDEFFTSGYIPARL 304
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 1e-93
Identities = 70/264 (26%), Positives = 118/264 (44%), Gaps = 36/264 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
+ +++ +G G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
P+I+ ++ +V+E GE+ + N FSE+EAR F Q+I+G+ Y HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ +
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---------------------- 232
+ + +DVWS G Y +L+G PF+ K +
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247
Query: 233 -----HRISIPEIRNHEWFLKNLP 251
R+S+ + +H + +N
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRNSS 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 2e-92
Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 35/262 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
D +++ R +G G FG L R+K+ + ++A+K + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R + +++E+A GEL++ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ K +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI------------------------ 232
K D+W GV Y LVG PF+ P + R+ +
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 249
Query: 233 ---HRISIPEIRNHEWFLKNLP 251
R+ + + H W N
Sbjct: 250 HPPQRLPLKGVMEHPWVKANSR 271
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 4e-91
Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 35/262 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ + +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI------------------------ 232
K D+WS GV Y LVG PFE + +++
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 244
Query: 233 ---HRISIPEIRNHEWFLKNLP 251
R + E+ H W N
Sbjct: 245 NPSQRPMLREVLEHPWITANSS 266
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 8e-91
Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 42/270 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHR 72
+Y++ +GSG FG VA+K++E+ D+I + V E++ +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101
Query: 73 SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 129
+ ++R + P +++E +LF+ I G E+ AR FF Q++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 186
V +CH+ V HRD+K EN L+D + LK+ DFG K +V GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--------PKNF----RKTIH- 233
PE + Y G+ A VWS G+ LY M+ G PFE EE + + I
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 276
Query: 234 --------RISIPEIRNHEWFLK-NLPADL 254
R + EI+NH W LP +
Sbjct: 277 CLALRPSDRPTFEEIQNHPWMQDVLLPQET 306
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 2e-90
Identities = 87/292 (29%), Positives = 126/292 (43%), Gaps = 72/292 (24%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------------- 56
+Y L +IG G++GV +L ++ A+K + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 57 --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 112
E V +EI + L HPN+V+ EV+ P HL +V E + G + E +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 167
SED+ARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190
Query: 168 SSVLHSQPKSTVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
++L +TVGTPA++APE L +K + GK DVW+ GVTLY + G PF D
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 226 KNFRKTIH-----------------------------RISIPEIRNHEWFLK 248
K RI +PEI+ H W +
Sbjct: 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 5e-90
Identities = 69/272 (25%), Positives = 101/272 (37%), Gaps = 43/272 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHR 72
Y L +G G FG VA+K I R +++ E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89
Query: 73 SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 127
+ HP ++R + T +V+E +LF+ I G E +R FF Q++
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 184
+ + +CHS V HRD+K EN L+D K+ DFG GT Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--------PKNF----RKTI 232
PE + + +Y A VWS G+ LY M+ G PFE +E P + I
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALI 264
Query: 233 H---------RISIPEIRNHEWFLKNLPADLV 255
R S+ EI W +
Sbjct: 265 RRCLAPKPSSRPSLEEILLDPWMQTPAEDVPL 296
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 5e-90
Identities = 70/261 (26%), Positives = 109/261 (41%), Gaps = 33/261 (12%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIINHR 72
+Y + +GSG FG DK+ + V VK+I++ D V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 73 SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ H NI++ ++ +VME + SG +LF I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y + HRD+K EN ++ +K+ DFG + + GT Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--------PKNF-------------RK 230
Y G ++WS GVTLY ++ PF + EE P
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPV 262
Query: 231 TIHRISIPEIRNHEWFLKNLP 251
R ++ ++ W + +
Sbjct: 263 PERRTTLEKLVTDPWVTQPVN 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 6e-83
Identities = 87/267 (32%), Positives = 126/267 (47%), Gaps = 37/267 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHP 77
+ Y L IG G++G ++ K T A K I + ++ + ++EI +SL HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+R E T + +VME +GGELFER+ + F E +A + ++S V+YCH +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 138 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+VL + Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------------------- 233
G D WS GV +YV+L G PF P + + K
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
Query: 234 --------RISIPEIRNHEWFLKNLPA 252
RI+ + HEWF K L +
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 8e-82
Identities = 55/312 (17%), Positives = 99/312 (31%), Gaps = 86/312 (27%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------GDKIDE 62
+ Y ++R + G F L K + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 63 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 114
+ + E+ +++ + + +I + I+ EY + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 115 SEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + +++ SY H+ +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206
Query: 171 LHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
+ + GT ++ PE + Y+G D+WS G+ LYVM PF
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 230 KTI-----------------------------------------------HRISIPEIRN 242
I RI+ +
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
Query: 243 HEWFLKNLPADL 254
HEW DL
Sbjct: 323 HEWLADTNIEDL 334
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-81
Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 18/233 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
+K+Y D+WS GVT Y G+ PF E P+ ++ +++I
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 2e-81
Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 36/272 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---------------------- 233
K D+W+CGV LY++LVG PF D ++ + + +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 234 ---------RISIPEIRNHEWFLKNLPADLVV 256
RI+ + W +
Sbjct: 244 SMLTVNPKKRITADQALKVPWICNRERVASAI 275
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-80
Identities = 81/371 (21%), Positives = 129/371 (34%), Gaps = 69/371 (18%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
+E+ +G+G FG + T E VA+K + K E EI + L HPN
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 129
+V +EV LA + MEY GG+L + + N E R + S
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 130 VSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ Y H ++ HRDLK EN +L G KI D GY+K VGT Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---------------- 232
+L +K+Y D WS G + + G PF +P + +
Sbjct: 194 LLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 233 -----------------------------------HRISIPEIRNHEWF-----LKNLPA 252
R + P+ N F + +L
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312
Query: 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDI 312
V++ + P +++ + + + T Q L Q +L+ + + +
Sbjct: 313 LSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLALNSAQPLTQYV 372
Query: 313 DTDPDLDIDSS 323
+D
Sbjct: 373 IDCTVIDGRQG 383
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 1e-80
Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 18/233 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
+K+Y D+WS GVT Y G+ PF E P+ ++ +++I
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-80
Identities = 79/282 (28%), Positives = 115/282 (40%), Gaps = 45/282 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA+K I + NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--------------- 232
L+ + D WS GV L++ L G PF + + + I
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 233 -----------------HRISIPEIRNHEWFLKNLPADLVVD 257
R + E H W D
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-79
Identities = 82/281 (29%), Positives = 130/281 (46%), Gaps = 37/281 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 78
+ + +GSG F L++ + T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV +++ + TH +VM+ SGGELF+RI G ++E +A QQ++S V Y H +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 139 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYD 196
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL +K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI------------------------ 232
K D WS GV Y++L G PF + E K F K
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244
Query: 233 -------HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 266
R + + +H W N + + + Q ++
Sbjct: 245 LLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQK 285
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 3e-79
Identities = 79/264 (29%), Positives = 118/264 (44%), Gaps = 39/264 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 77
D + R +GSG FG L+ ++ + +K I ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 133
NI++ EV ++ IVME GGEL ERI SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 134 HSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS V H+DLK EN L SP +KI DFG ++ + GT Y+APEV K
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------- 233
++ K D+WS GV +Y +L G PF + +K +
Sbjct: 200 RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258
Query: 234 -----------RISIPEIRNHEWF 246
R S ++ +HEWF
Sbjct: 259 LKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 8e-79
Identities = 77/271 (28%), Positives = 114/271 (42%), Gaps = 45/271 (16%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA++ I + NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--------------- 232
L+ + D WS GV L++ L G PF + + + I
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372
Query: 233 -----------------HRISIPEIRNHEWF 246
R + E H W
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWL 403
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 3e-78
Identities = 80/265 (30%), Positives = 113/265 (42%), Gaps = 42/265 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
+D YE+ DIG G++ V + K T AVK I DK + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
I+ K+V ++ +V E GGEL ++I FSE EA + V Y H+ V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 139 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRDLK N L ++ICDFG++K + T T ++APEVL ++ Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 196 DGKIADVWSCGVTLYVMLVG----------------------AYPFEDP------EEPKN 227
D D+WS GV LY ML G + + K+
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256
Query: 228 F-RKTIH-----RISIPEIRNHEWF 246
K +H R++ + H W
Sbjct: 257 LVSKMLHVDPHQRLTAALVLRHPWI 281
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 4e-78
Identities = 74/282 (26%), Positives = 116/282 (41%), Gaps = 49/282 (17%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI- 68
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
I + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 189 VLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---------- 233
++ D GK D+WS GV +Y +L G+ PF ++ R +
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 234 ---------------------RISIPEIRNHEWFLKNLPADL 254
R + E H +F + + ++
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 7e-78
Identities = 87/265 (32%), Positives = 127/265 (47%), Gaps = 37/265 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---------------------- 233
D K DVWS GV LY++L G PF E ++
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 234 ---------RISIPEIRNHEWFLKN 249
RI+ + H W K
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-77
Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 36/269 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKID-ENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---------------------- 233
K D+W+CGV LY++LVG PF D ++ + + +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266
Query: 234 ---------RISIPEIRNHEWFLKNLPAD 253
RI+ + W
Sbjct: 267 SMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-77
Identities = 77/220 (35%), Positives = 119/220 (54%), Gaps = 10/220 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D YE+ ++GSG F + R R K T + A K+I R E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+RHPNI+ ++ T + +++E SGGELF+ + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS ++ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ G AD+WS GV Y++L GA PF + +
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 7e-77
Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 48/275 (17%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREI-I 69
+Y+ IG G V R + T AVK +E +++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
+ HP+I+ + + + + +V + GELF+ + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
VS+ H+ + HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------- 233
L + GK D+W+CGV L+ +L G+ PF + R +
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 234 --------------------RISIPEIRNHEWFLK 248
R++ + H +F +
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 1e-76
Identities = 67/288 (23%), Positives = 104/288 (36%), Gaps = 66/288 (22%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +E + +G G FG R+ A+K I ++ + E++ SL H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 80 VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 125
VR+ L + L I MEY G L++ I + DE F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 170
++ +SY HS + HRDLK N +D S +KI DFG +K+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE------ 224
S +GT Y+A EVL + + D++S G+ + M+ YPF E
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239
Query: 225 ---------PKNFRKTI-----------------HRISIPEIRNHEWF 246
P +F R + N W
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 3e-76
Identities = 88/280 (31%), Positives = 134/280 (47%), Gaps = 36/280 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
SD +E+ ++G G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ KE+ TPT +++V+E +GGELF+RI G +SE +A +Q++ V+Y H +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 140 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y G
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229
Query: 199 IADVWSCGVTLYVMLVGAYPFED------------------PEEP--------KNF-RKT 231
D+WS G+ Y++L G PF D K+ RK
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKL 289
Query: 232 IH-----RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 266
I R++ + H W + A+ V +T + +E
Sbjct: 290 IVLDPKKRLTTFQALQHPW-VTGKAANFVHMDTAQKKLQE 328
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 8e-76
Identities = 75/220 (34%), Positives = 121/220 (55%), Gaps = 10/220 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ G AD+WS GV Y++L GA PF + +
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-75
Identities = 71/220 (32%), Positives = 116/220 (52%), Gaps = 10/220 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ H N++ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ G AD+WS GV Y++L GA PF + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-75
Identities = 73/220 (33%), Positives = 117/220 (53%), Gaps = 10/220 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ HPNI+ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ G AD+WS GV Y++L GA PF + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-75
Identities = 70/313 (22%), Positives = 113/313 (36%), Gaps = 83/313 (26%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKID-ENVQREIINHRS 73
+Y L IG G++GV R+ + +T + A+K + + + D E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
L HPNI R EV ++ +VME GG L +++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 114 --------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
E +Q+ S + Y H+ +CHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 154 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYD-GKIADVWSCGV 207
+ +K+ DFG SK + + GTP ++APEVL G D WS GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 208 TLYVMLVGAYPFEDPEEPKNFRKTI-------------------------------HRIS 236
L+++L+GA PF + + + R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 237 IPEIRNHEWFLKN 249
H W +
Sbjct: 325 AMRALQHPWISQF 337
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-75
Identities = 89/277 (32%), Positives = 129/277 (46%), Gaps = 47/277 (16%)
Query: 20 SDRYEL---VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLR 75
Y+L + +G G+F + R KK+ + AVK I + +++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPNIV+ EV H +VME +GGELFERI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 136 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKK 193
+ V HRDLK EN L D + +KI DFG+++ +QP T T Y APE+L +
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 194 EYDGKIADVWSCGVTLYVMLVG--------------------------AYPFEDP----- 222
YD + D+WS GV LY ML G + FE
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 223 -EEPKNF-RKTIH-----RISIPEIRNHEWFLKNLPA 252
+E K+ + + R+ + +R +EW
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 8e-75
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 2/212 (0%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
++Y + D+G G FG+ + +++ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ E + L ++ E+ SG ++FERI + +E E + Q+ + + HS +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+WS G +YV+L G PF +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-74
Identities = 59/276 (21%), Positives = 103/276 (37%), Gaps = 53/276 (19%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEE------------------- 224
+DVWS G LY M G PF+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 225 --PKNFRKTI---------HRISIPEIRNHEWFLKN 249
K+ + + RISIPE+ H +
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 2e-74
Identities = 97/335 (28%), Positives = 149/335 (44%), Gaps = 47/335 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL + Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---------------------- 233
D K DVWS GV LY++L G PF E ++
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 234 ---------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284
RI+ + H W K + + + + ++ I Q AE
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE--------SAMTNIRQFQAEK 310
Query: 285 TIPAAGTQSLNQCLNGSLDIDD--EMDEDIDTDPD 317
+ A + L + E+ +DT+ D
Sbjct: 311 KLAQAALLYMASKLTTLDETKQLTEIFRKLDTNND 345
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-74
Identities = 63/328 (19%), Positives = 117/328 (35%), Gaps = 59/328 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEP------------------ 225
+DVWS G LY M G PF+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 226 ---KNFRKTI---------HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS 273
K+ + + RISIPE+ H + + T + +
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK------YV 298
Query: 274 IDEIMQIIAEATIPAAGTQSLNQCLNGS 301
+ +++ + + +I A G
Sbjct: 299 LGQLVGLNSPNSILKAAKTLYEHYSGGE 326
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 6e-74
Identities = 78/219 (35%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
++ Y+L ++G G F V R + A I D + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I H ++ + +GGELFE I +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 137 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K Y GK D+W+CGV LY++LVG PF D ++ + +++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-73
Identities = 58/303 (19%), Positives = 108/303 (35%), Gaps = 53/303 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++ +++ A+KY+ + + ++ + EI L+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----------- 232
+DVWS G LY M G PF+ + I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 233 -------------------HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS 273
RISIPE+ H + + T + + +
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVG 351
Query: 274 IDE 276
++
Sbjct: 352 LNS 354
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-73
Identities = 99/299 (33%), Positives = 138/299 (46%), Gaps = 40/299 (13%)
Query: 3 RSAMTVGPGM--DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---G 57
+ PGM SDRY+ R +G G+FG L +DK T + AVK I +
Sbjct: 6 MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK 65
Query: 58 DKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 116
K D E++ RE+ + L HPNI++ E + +V E +GGELF+ I + RFSE
Sbjct: 66 QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 175
+A +Q++SG++Y H ++ HRDLK EN LL+ S ++I DFG S +
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-- 233
K +GT YIAPEV L YD K DVWS GV LY++L G PF E +K
Sbjct: 186 KDKIGTAYYIAPEV-LHGTYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243
Query: 234 -----------------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQ 263
RIS + +HEW + VD + +
Sbjct: 244 YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 5e-73
Identities = 86/268 (32%), Positives = 124/268 (46%), Gaps = 37/268 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
S+ Y+ V+ +GSG +G L RDK T A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ + + +VME GGELF+ I + +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL +KI DFG S + K +GT YIAPEV L+K+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKY 214
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---------------------- 233
D K DVWS GV L+++L G PF + + RK
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 234 ---------RISIPEIRNHEWFLKNLPA 252
RIS + H W +
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMCSK 301
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 6e-73
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 9/219 (4%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREI-INHRSL 74
++ Y L +++G G F V R K T + A K+++ RG + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 132
P ++ EV + + +++EYA+GGE+F A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
H + H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+W+ G+ Y++L PF + + +
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 7e-73
Identities = 76/321 (23%), Positives = 127/321 (39%), Gaps = 36/321 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQ 137
++ + + +++E+ SGGELF+RI + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ H D+K EN + + A +KI DFG + K T T + APE++ ++ G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228
Query: 198 KIADVWSCGVTLYVMLVGAYPFED-----------------PEEP--------KNF-RKT 231
D+W+ GV YV+L G PF E+ K+F +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288
Query: 232 IH-----RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286
+ R+++ + H W + ++ + D A I
Sbjct: 289 LQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRI 348
Query: 287 PAAGTQSLNQCLNGSLDIDDE 307
A SL + I D
Sbjct: 349 --ANFSSLRKHRPQEYQIYDS 367
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-72
Identities = 75/272 (27%), Positives = 116/272 (42%), Gaps = 43/272 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRS 73
D YEL IG G F V R +++T + AVK ++ E+++RE
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISG 129
L+HP+IV E + L +V E+ G +L I +SE A + +Q++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 130 VSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAP 187
+ YCH + HRD+K LL + +K+ FG + VGTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVG------------------AYPFEDP------E 223
EV+ ++ Y GK DVW CGV L+++L G Y E
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISE 261
Query: 224 EPKNF-RKTIH-----RISIPEIRNHEWFLKN 249
K+ R+ + RI++ E NH W +
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 3e-72
Identities = 93/348 (26%), Positives = 146/348 (41%), Gaps = 63/348 (18%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--------------GDKIDENVQ 65
+ Y VR +GSG +G L ++K A+K I++ +K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------- 233
IAPEVL KK+Y+ K DVWSCGV +Y++L G PF + +K
Sbjct: 215 IAPEVL-KKKYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK 272
Query: 234 --------------------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS 273
R + E N W K N + DQ
Sbjct: 273 NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY-----------ANNINKSDQKTLC 321
Query: 274 --IDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDD--EMDEDIDTDPD 317
+ + + + A + L + + ++ + +D + D
Sbjct: 322 GALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGD 369
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 9e-72
Identities = 87/294 (29%), Positives = 136/294 (46%), Gaps = 49/294 (16%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
V G+ + D Y++ + +G G G + +K+T+E A+K ++
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98
Query: 62 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 114
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 173
+E EA + + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG------------------ 215
+ TP Y+APEVL ++YD K D+WS GV +Y++L G
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
Query: 216 -----AYPFEDPE------EPKNF-RKTIH-----RISIPEIRNHEWFLKNLPA 252
Y F +PE E K R + R++I E NH W +++
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-71
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 5/215 (2%)
Query: 20 SDRYELVR--DIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRH 76
+ Y + + +G G FG + T +A K I+ RG K E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
N+++ + + + +VMEY GGELF+RI + +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
M + H DLK EN L A ++KI DFG ++ + K GTP ++APEV + ++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+WS GV Y++L G PF + +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 3e-71
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 3/213 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y++ ++G+G FGV + ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
H DLK EN + + LK+ DFG + K T GT + APEV K G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+WS GV Y++L G PF + + R
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 367
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-70
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREI-INHRSLRH 76
D Y+L D +G G + + T + AVK IE + I V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
N++ E +V E GG + I F+E EA Q + S + + H+
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 186
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF 219
PEV+ + K D+WS GV LY++L G PF
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-70
Identities = 58/272 (21%), Positives = 101/272 (37%), Gaps = 47/272 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++ + IGSG FG + + + +K + +E +RE+ L H NIV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67
Query: 81 RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 122
+ + L I ME+ G L + I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
F+Q+ GV Y HS ++ +RDLK N L + ++KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--------------PKNF 228
Y++PE + ++Y + D+++ G+ L +L + + K
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKE 244
Query: 229 RKTI---------HRISIPEIRNHEWFLKNLP 251
+ + R + EI K P
Sbjct: 245 KTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-70
Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 17/226 (7%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHP 77
+D Y+L + +G G G ++T + A+K + ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82
Query: 78 NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 131
+IV +V H I+ME GGELF RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 132 YCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 189
+ HS + HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
L ++YD K D+WS GV +Y++L G PF RI
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 9e-69
Identities = 65/226 (28%), Positives = 113/226 (50%), Gaps = 10/226 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
++Y ++ IG G+FG A L++ + +K I E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV+++E L IVM+Y GG+LF+RI F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEI 240
Y+ K +D+W+ G LY + + FE K I S P +
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLK-IISGSFPPV 245
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-68
Identities = 76/273 (27%), Positives = 121/273 (44%), Gaps = 46/273 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 78 NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T L IVMEY GG+L I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHSM-----QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------------------K 226
+PE + + Y+ K +D+WS G LY + PF +
Sbjct: 184 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242
Query: 227 NFRKTI---------HRISIPEIRNHEWFLKNL 250
+ I HR S+ EI + L++
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 6e-66
Identities = 59/282 (20%), Positives = 97/282 (34%), Gaps = 53/282 (18%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHP 77
D+ Y ++ +G G F L+ A+K I ++ D E QRE HR HP
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 78 NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 129
NI+R L +++ + G L+ I +ED+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 179
+ H+ HRDLK N LL + + D G + +H +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 180 GTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----- 232
T +Y APE+ + + + DVWS G LY M+ G P++ + +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
Query: 233 -------------------------HRISIPEIRNHEWFLKN 249
R IP + + L+
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-64
Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 13/230 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+ + + IG G F VA+K ++ D +D + +EI + L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL 191
HS +V HRD+K N + + +K+ D G + S + S VGTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRISIPEI 240
+ Y+ K +D+WS G LY M PF D + K I + P +
Sbjct: 210 ENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 258
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 7e-64
Identities = 54/257 (21%), Positives = 92/257 (35%), Gaps = 36/257 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSL-RH 76
++ + +G G++G +R K+ L AVK RG K E+ +H + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
P VR ++ L + E G L + G E + + + + +++ HS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+K N L P R K+ DFG + G P Y+APE+L + Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGSY 232
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----------------------- 232
ADV+S G+T+ + E + R+
Sbjct: 233 GTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEP 291
Query: 233 ---HRISIPEIRNHEWF 246
R + +
Sbjct: 292 DPKLRATAEALLALPVL 308
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-62
Identities = 80/306 (26%), Positives = 127/306 (41%), Gaps = 69/306 (22%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
D + +G G G + +K+T+E A+K ++ +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72
Query: 79 IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 132
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
HS+ + HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT- 171
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG-----------------------AYPFEDP------ 222
++YD K D+WS GV +Y++L G Y F +P
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230
Query: 223 EEPKNF-RKTIH-----RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 276
EE K R + R++I E NH W +++ +T+ E+ ++ +E
Sbjct: 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290
Query: 277 IMQIIA 282
+ +A
Sbjct: 291 MTSALA 296
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-61
Identities = 59/253 (23%), Positives = 93/253 (36%), Gaps = 36/253 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 79 IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 123
IVR+ L +L I M+ L + + C F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 170
Q+ V + HS + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+++ VGT Y++PE + Y K D++S G+ L+ +L YPF E
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERVRTLT 238
Query: 231 TIHRISIPEIRNH 243
+ + P +
Sbjct: 239 DVRNLKFPPLFTQ 251
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-61
Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 56/284 (19%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 79
R + R + G F +D + A+K + ++ + +E+ + L HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 80 VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 129
V+F KE T +++ G+L E + G S D F Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 130 VSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 178
V + H + + HRDLK+EN LL +K+CDFG + + + +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 179 ----VGTPAYIAPEV--LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED----------- 221
TP Y PE+ L G+ D+W+ G LY++ +PFED
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY 266
Query: 222 -----PEEPKNFRKTI---------HRISIPEIRNHEWFLKNLP 251
+ F I R+SI E+ + +
Sbjct: 267 SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 5e-60
Identities = 64/330 (19%), Positives = 111/330 (33%), Gaps = 67/330 (20%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 79
+ + +G G+ G + VAVK + + EI + S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 132
+R+ T L I +E L + + + E+ +Q+ SGV++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 133 CHSMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 176
HS+++ HRDLK +N L+ S R+ I DFG K S +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 177 STVGTPAYIAPEVLLKKEYD------GKIADVWSCGVTLYVMLVGAY-PFEDP------- 222
+ GT + APE+L + + D++S G Y +L PF D
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 223 -------------------EEPKNF-RKTIH-----RISIPEIRNHEWFLKNLPADLVVD 257
E + + I R + ++ H F +
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLL 310
Query: 258 NTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287
++ E P ++ ++ IP
Sbjct: 311 KVSDRLEIENRDPPSALLMKFDAGSDFVIP 340
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-58
Identities = 42/248 (16%), Positives = 85/248 (34%), Gaps = 29/248 (11%)
Query: 19 DSDRYELVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGDKIDENVQREIIN-HR 72
S + +G G F + D K ++ +K + + + + +++ +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 127
++F L +V E S G L I + F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 178
+ H ++ H D+K +N +L + L + D G S + PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240
Query: 179 V-----GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTI 232
+ T + E+L K ++ +I D + T+Y ML G Y ++
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 233 HRISIPEI 240
R+ ++
Sbjct: 300 RRLPHLDM 307
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-57
Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 47/266 (17%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + +G G+F L R+ T A+K +I + +K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIP-------------- 238
K +D+W+ G +Y ++ G PF E F+K I P
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 266
Query: 239 ------------------EIRNHEWF 246
++ H +F
Sbjct: 267 LVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 7e-57
Identities = 63/287 (21%), Positives = 98/287 (34%), Gaps = 49/287 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 80
+ +G G G R VAVK I + RE+ + S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVC 139
R+ I +E L E + E QQ SG+++ HS+ +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 140 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL-- 190
HRDLK N L+ + + I DFG K S+ GT +IAPE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVML------------------VGAYPFEDPEEP------ 225
K+ D++S G Y ++ +GA +
Sbjct: 201 DCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259
Query: 226 -KNF-RKTIH-----RISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 265
+ K I R S + H +F +L L +++ E
Sbjct: 260 ARELIEKMIAMDPQKRPSAKHVLKHPFF-WSLEKQLQFFQDVSDRIE 305
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-55
Identities = 31/295 (10%), Positives = 68/295 (23%), Gaps = 75/295 (25%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 76 -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 104
++R + L+ Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251
Query: 165 YSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKIADVWSCGVTLYVMLV 214
V + + + PE+ ++ D W+ G+ +Y +
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 215 GAYPFEDPEEPKNFRKTIH-----------------------RISIPEIRNHEWF 246
P R+ + +
Sbjct: 309 ADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-55
Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 30/237 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSL-R 75
+ + + IGSG FG + + A+K + G ++N RE+ H L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
H ++VR+ H+ I EY +GG L + I R F E E + Q+ G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 132 YCHSMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 174
Y HSM + H D+K N + S KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 175 PKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
P+ G ++A EVL + K AD+++ +T+ + ++ R+
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 6e-53
Identities = 64/229 (27%), Positives = 119/229 (51%), Gaps = 17/229 (7%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----S 73
++EL++ +G G+FG + + + +L A+K + + + + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 134 HSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 190
HS+ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIP 238
++ + + AD WS GV ++ ML G PF+ + + + ++ +P
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 6e-53
Identities = 76/266 (28%), Positives = 121/266 (45%), Gaps = 53/266 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
++++R +G+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 135 SMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
S + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIP------------- 238
K Y K D WS G+ +Y ML G PF D K + K ++ + P
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236
Query: 239 ------------------EIRNHEWF 246
+++NH WF
Sbjct: 237 LITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-52
Identities = 72/264 (27%), Positives = 131/264 (49%), Gaps = 45/264 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + +N + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L K
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIP--------------- 238
Y K D W+ GV +Y M G PF + + + K + ++ P
Sbjct: 215 Y-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273
Query: 239 ----------------EIRNHEWF 246
+I+NH+WF
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-52
Identities = 80/229 (34%), Positives = 116/229 (50%), Gaps = 18/229 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
D +E +R +G G+FG L R K+T +L AVK + + D I +Q + +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIP 238
+ Y G D W+ GV LY ML G PFE E F ++ + P
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 244
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-52
Identities = 78/230 (33%), Positives = 119/230 (51%), Gaps = 21/230 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
+ ++ ++ +G G FG L+R+K T A+K + R + I + ++ + H +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
HS V +RD+KLEN +LD G +KI DFG K + T GTP Y+APEV
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIP 238
L +Y G+ D W GV +Y M+ G PF + + + F + I P
Sbjct: 177 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP 225
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-52
Identities = 80/266 (30%), Positives = 117/266 (43%), Gaps = 49/266 (18%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + L + +G G+FG L KKT + A+K + K D + + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ HS + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIP--------- 238
+LL ++Y D WS GV LY ML+G PF +E + F P
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247
Query: 239 ------------------EIRNHEWF 246
+IR H F
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-52
Identities = 77/269 (28%), Positives = 120/269 (44%), Gaps = 52/269 (19%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ ++ IG G+FG L R K E AVK + + I ++++ H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y HS+ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIP--------- 238
VL K+ Y + D W G LY ML G PF + + ++ + +
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 268
Query: 239 ---------------------EIRNHEWF 246
EI++H +F
Sbjct: 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-51
Identities = 68/230 (29%), Positives = 112/230 (48%), Gaps = 17/230 (7%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR---- 72
+ +EL+R +G G +G R + T ++ A+K +++ + R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIP 238
L++ + + D WS G +Y ML GA PF K K + ++++P
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-51
Identities = 75/231 (32%), Positives = 113/231 (48%), Gaps = 22/231 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + +G G+FG L K T+EL AVK + + D + +Q + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL-KKDVV---IQDDDVECTMVEKRVLA 75
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ S + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIP 238
++ + Y GK D W+ GV LY ML G PFE +E + F+ + ++ P
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 241
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-51
Identities = 68/236 (28%), Positives = 114/236 (48%), Gaps = 21/236 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A+K + + + + E I+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244
+L ++Y G D W+ GV ++ M+ G PF+ N + I +
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 9e-51
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 13/226 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 79
E++R IG G+FG +++ T+++ A+KY+ + ++ N R + L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V + +V++ GG+L + F E+ + F +L+ + Y + ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 140 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
HRD+K +N LLD G + I DF + +Q + GT Y+APE+ ++ G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 198 --KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIR 241
D WS GVT Y +L G P+ + ++ +H +
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVT 238
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-50
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 12/214 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +G G+FG M+DK+T AVK + ++ E++ L P
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPR 111
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + I ME GG L + I G ED A ++ Q + G+ Y H+ ++
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLK 192
H D+K +N LL R +CDFG++ GT ++APEV++
Sbjct: 172 LHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
K D K D+WS + ML G +P+
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGP 263
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 8e-50
Identities = 78/226 (34%), Positives = 116/226 (51%), Gaps = 10/226 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
+ +E ++ +G G FG L+++K T A+K +++ + ++ + + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIPE 239
Y G+ D W GV +Y M+ G PF + + K F + I P
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 370
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-50
Identities = 67/236 (28%), Positives = 114/236 (48%), Gaps = 21/236 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A++ + + + + E I+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244
+L ++Y G D W+ GV ++ M+ G PF+ N + I +
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 169 bits (428), Expect = 9e-50
Identities = 41/301 (13%), Positives = 69/301 (22%), Gaps = 79/301 (26%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
+ +LV + G+ V L+RD + E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 78 NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 105
+ ++ + ++M AS L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165
G QLI + S + H +N + RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239
Query: 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ P AP L + W G+++Y + PF
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 224 E-----------------PKNFRKTIH-------------------RISIPEIRNHEWFL 247
F R+ E FL
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 248 K 248
+
Sbjct: 358 Q 358
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-49
Identities = 74/226 (32%), Positives = 115/226 (50%), Gaps = 12/226 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ + +G G+FG L K T+EL AVK +++ I ++ V++ ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 193
S + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIP 238
Y GK D W+ GV LY ML G PFE +E + F+ + ++ P
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 562
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-49
Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 26/230 (11%)
Query: 24 ELVRDIGSGNFG---VARLMRDKKTEELVAVK-----YIERGDKIDENVQRE-----IIN 70
EL++ +G+G +G + R + T +L A+K I + K E+ + E I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 131 SYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 186
+ H + + +RD+KLEN LLD G + + DFG SK V ++ GT Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 187 PEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
P+++ + K D WS GV +Y +L GA PF E + + RI
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-48
Identities = 79/270 (29%), Positives = 114/270 (42%), Gaps = 53/270 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
YE+V+ IG G FG +L+R K T ++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
SM HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 193 KEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-HRISIP---------- 238
+ D G+ D WS GV LY MLVG PF + K + H+ S+
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303
Query: 239 ----------------------EIRNHEWF 246
EI+ H +F
Sbjct: 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFF 333
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 11/230 (4%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------SLRH 76
+ R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ + H+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246
AD +S G L+ +L G PF + K+ + + + F
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDSF 417
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-47
Identities = 73/273 (26%), Positives = 119/273 (43%), Gaps = 17/273 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
D +E + ++G+GN GV + K + ++A K I K + RE+ + H
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K N L++ +K+CDFG S + S S VGT +Y++PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254
Y + +D+WS G++L M VG YP P+ + ++ P
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA--------AETPPRP 257
Query: 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287
N+F +P +I E++ I P
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 23/231 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
D +E+++ IG G F +++ K+T ++ A+K + + ++R ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 131
+ I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 189
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 190 LLKKEYD------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234
L G D W+ GV Y M G PF + + K +H
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 62/286 (21%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
+E+++ IG G FG +++ K +++ A+K + E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 133
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 192 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---RISIP------ 238
E G D WS GV +Y ML G PF + + K ++ R P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
Query: 239 -------------------------EIRNHEWF-------LKNLPA 252
+ + H +F ++N A
Sbjct: 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEA 355
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 9/232 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRH 76
+ + R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 134
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ +RDLK EN LLD ++I D G + K VGT Y+APEV+ +
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246
Y D W+ G LY M+ G PF+ ++ + + E F
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD + +A+K I D + + EI H+ L+H NIV++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 88 TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+ I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 145 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKE--YDGKIAD 201
+N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ K Y AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEP 225
+WS G T+ M G PF + EP
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEP 231
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 65/237 (27%), Positives = 101/237 (42%), Gaps = 16/237 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D + R +G G FG + K T +L A K + + + + + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 132
IV T T L +VM +GG++ I N F E A F+ Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
H + +RDLK EN LLD G ++I D G + GTP ++APE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246
LL +EY D ++ GVTLY M+ PF E ++ R+ + + F
Sbjct: 361 LLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-46
Identities = 35/299 (11%), Positives = 75/299 (25%), Gaps = 69/299 (23%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 76 --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 104
P + V L + ++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256
Query: 165 YSKS--SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI----ADVWSCGVTLYVMLVGAYP 218
+ + S P A +L ++ + D W+ G+ +Y + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 219 FEDPEEPKNFRKTI-----------------------HRISIPEIRNHEWFLKNLPADL 254
D R+ + + + L +L
Sbjct: 317 NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTEL 374
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-46
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 7/223 (3%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDK 59
+ PGM + + + IG G+FG D +T+++VA+K I E +
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
E++Q+EI P + ++ L T L I+MEY GG + + G E +
Sbjct: 63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQI 121
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 178
++++ G+ Y HS + HRD+K N LL +K+ DFG + ++T
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTF 179
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
VGTP ++APEV+ + YD K AD+WS G+T + G P +
Sbjct: 180 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSE 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-45
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
V++ T L IVMEY G + + I +EDE Q + G+ Y H M+
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ + Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFED 221
+ AD+WS G+T M G P+ D
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD 227
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-44
Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D E+ +G G FGV + + K + VA+K I + + E+ + HPN
Sbjct: 6 DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHS 135
IV+ L P + +VMEYA GG L+ + A A + GV+Y HS
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 136 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
MQ + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
Y K DV+S G+ L+ ++ PF++
Sbjct: 178 SNYSEK-CDVFSWGIILWEVITRRKPFDE 205
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-44
Identities = 70/236 (29%), Positives = 114/236 (48%), Gaps = 13/236 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
+Y IG G G D T + VA++ + ++ K + + EI+ R ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV + + L L +VMEY +GG L + + E + ++ + + + HS Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ +K
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250
Y K D+WS G+ M+ G P+ + E P I PE++N E
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIF 246
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-44
Identities = 68/235 (28%), Positives = 119/235 (50%), Gaps = 11/235 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 78
+ IG G+ G+ L R+K + VAVK ++ R + E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V + L L ++ME+ GG L + I + R +E++ + ++ ++Y H+ V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ + Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250
+ D+WS G+ + M+ G P+ + P K + P+++N L
Sbjct: 219 ATE-VDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVL 271
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 12/237 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREI-INHRSLR 75
+ + E + ++GSG G MR +KT ++AVK + + ++ + ++ + +S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV+ +T T + I ME + G E ++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 190
V HRD+K N LLD ++K+CDFG S V + G AY+APE +
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246
K +YD + ADVWS G++L + G +P+++ + + + P + H F
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-43
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
+D E + ++G G +GV MR + +++AVK I E + ++ I+ R++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 132
P V F + + I ME + ++++ + ED ++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 133 CHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
HS + V HRD+K N L++ ++K+CDFG S V K G Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 191 L----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+K Y K +D+WS G+T+ + + +P++ P
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRH 76
+ D YEL IGSG V + +E VA+K I E+ + + +EI H
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 128
PNIV + + L +VM+ SGG + + +G E ++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTP 182
G+ Y H HRD+K N LL + ++I DFG S + K+ VGTP
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++APEV+ + + YD K AD+WS G+T + GA P+
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 17/232 (7%)
Query: 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN 63
+ + P ++ + + +IG G +G M K + +++AVK I +K +
Sbjct: 9 LKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 64 VQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA--GRFSEDE 118
+ ++ + RS P IV+F + I ME S + ++ + + E+
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 119 ARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ +++ +++ HRD+K N LLD S +K+CDFG S V
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTR 184
Query: 178 TVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
G Y+APE + ++ YD + +DVWS G+TLY + G +P+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSV 235
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-42
Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
++ +E+V ++G G FG ++K+T L A K I + +++++ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSM 136
IV+ L I++E+ GG + + +E + + +Q++ +++ HS
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLL-- 191
++ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 192 ---KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+TL M P +
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE 224
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-42
Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 80
+ IG+G+FG + R + VAVK + D E V RE+ + LRHPNIV
Sbjct: 40 NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSM- 136
F + P +L+IV EY S G L+ + +G E + G++Y H+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLK 192
+ HR+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ + K +DV+S GV L+ + P+ +
Sbjct: 214 EPSNEK-SDVYSFGVILWELATLQQPWGN 241
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-41
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 19 DSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRS 73
+ YEL+ IG G + L R K T E V V+ I +++ +Q E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 131
HPNIV ++ + L +V + + G + IC +E + Q ++ +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 183
Y H M HR +K + L+ + + + + V+H PK +V
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 184 YIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+++PEVL + YD K +D++S G+T + G PF+D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 68/212 (32%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 78
L IG G FG ++ R + VAVK D ENV++E L+HPN
Sbjct: 10 TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-- 136
I+ + V L +L +VME+A GG L + R D + Q+ G++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 137 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ HRDLK N L+ LKI DFG ++ + S G A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ + +DVWS GV L+ +L G PF
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRG 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-41
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+ +ELV +G+G +G R KT +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 79 IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 130
I + K L +VME+ G + + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 131 SYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 187
S+ H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 188 EVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
EV+ E YD K +D+WS G+T M GA P D
Sbjct: 199 EVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
+ +R+IG G+FG RD + E+VA+K + + +K + + +E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
RHPN ++++ L +VMEY G + E E + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 191
S + HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ +YDGK DVWS G+T + P +
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFN 255
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 13/224 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 82
IG G+F D +T VA ++ QR E + L+HPNIVRF
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 83 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VC 139
+ + + +V E + G L + R + +Q++ G+ + H+ +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +++YD
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDES- 209
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
DV++ G+ + M YP+ + + + + P +
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV--------QREIINHRSLR 75
E + IG G FG+ R K + +VA+K + GD E QRE+ +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
HPNIV+ ++ P +VME+ G+L+ R+ + + G+ Y
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 135 SM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HRDL+ N L + K+ DFG S+ +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 190 LL--KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ ++ Y K AD +S + LY +L G PF++
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 40/199 (20%), Positives = 68/199 (34%), Gaps = 22/199 (11%)
Query: 58 DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 114
+ +I N V + +L I M+ L + + C+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F Q+ V + HS + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219
Query: 175 PKST-------------VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++ VGT Y++PE + Y K D++S G+ L+ +L Y F
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275
Query: 222 PEEPKNFRKTIHRISIPEI 240
E + + P +
Sbjct: 276 QMERVRIITDVRNLKFPLL 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I ++ E V RE+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 79 IVRFKE 84
IVR+
Sbjct: 66 IVRYFN 71
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
E+ IG G FG R + VA++ I+ ++ ++ RE++ +R RH
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
N+V F ++P HLAI+ G L+ + +A ++ R Q+++ G+ Y H+
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 190
+ H+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 191 ---------LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
K + +DV++ G Y + +PF+
Sbjct: 207 RQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKT 245
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
DRY + +G G +G D T E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NI+ K VI L ++ EYA +L + + S + F QLI+GV++CHS
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 137 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+ HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
+ Y + D+WS ML+
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMK 234
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-39
Identities = 42/209 (20%), Positives = 82/209 (39%), Gaps = 19/209 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIV 80
+ + + G R + + + VK ++ D + + E R HPN++
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 81 RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
+P H ++ + G L+ + F D+++ F + G+++ H++
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 137 Q--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ + L + ++D +I S Q + PA++APE L KK
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184
Query: 195 YDGKI--ADVWSCGVTLYVMLVGAYPFED 221
D AD+WS V L+ ++ PF D
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + DK +N R
Sbjct: 43 TPGQGPDRPQ---EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--R 96
Query: 67 EIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A LK+CDFG +K L +
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPN 213
Query: 178 T--VGTPAYIAPEVLLK-KEYDGKIADVWSCG 206
+ + Y APE++ +Y I DVWS G
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSI-DVWSAG 244
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-38
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 24 ELVRDIGSGNFG-VAR-LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPN 78
+ + IGSG+FG V + VAVK + + +Q E+ R RH N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I+ F T LAIV ++ G L+ + + +F + +Q G+ Y H+
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ HRDLK N L +KI DFG + Q + G+ ++APEV+ ++
Sbjct: 141 IIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 195 ---YDGKIADVWSCGVTLYVMLVGAYPFED 221
Y + +DV++ G+ LY ++ G P+ +
Sbjct: 199 SNPYSFQ-SDVYAFGIVLYELMTGQLPYSN 227
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
M S +++ + +G+G + +K T VA+K + + + REI + L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 129
+H NIVR +VI T L +V E+ + + ++F QL+ G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 188
+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVG 215
VL+ + Y I D+WSCG L M+ G
Sbjct: 179 VLMGSRTYSTSI-DIWSCGCILAEMITG 205
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
+ V G + ++YE + +G G++G+ R+K T +VA+K D+
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65
Query: 63 NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 116
V REI + LRH N+V EV +V E+ + E N
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176
+ + Q+I+G+ +CHS + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181
Query: 177 ST-VGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
V T Y APE+L+ +Y + DVW+ G
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAV-DVWAIG 212
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIVR +V+ + L +V E+ + F+ G + + F QL+ G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
S V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y I D+WS G + P
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPL 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++YE + IG G++GV R++ T ++VA+K + D ++ REI + L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
PN+V EV L +V EY +R E + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 191
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175
Query: 192 K-KEYDGKIADVWSCG 206
+Y + DVW+ G
Sbjct: 176 GDTQYGPPV-DVWAIG 190
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------ 65
M + + + RYE + +G G F RDK T ++VA+K I + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59
Query: 66 -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 122
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173
Query: 180 GTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
T Y APE+L + Y + D+W+ G L +L+
Sbjct: 174 VTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLR 209
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + + K T+ LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++I T L +V EY + + + + F QL+ G++YCH
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
Y +I D+W G Y M G
Sbjct: 178 YSTQI-DMWGVGCIFYEMATG 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
Y + IG+G+FGV + +++E VA+K + DK +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94
Query: 80 VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 130
V K + L +V+EY + + QL+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+Y HS+ +CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
++ Y I D+WS G + ++ G
Sbjct: 212 LIFGATNYTTNI-DIWSTGCVMAELMQG 238
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PN
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 193
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+ +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF 219
YD + D+WS G L M+ PF
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPF 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-36
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++Y + IG G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIV+ +VI T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
+V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVG 215
K+Y I D+WS G M+ G
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNG 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 1e-35
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 15/223 (6%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
M ++ ++Y+ + +G G +GV +D +VA+K I R D
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58
Query: 61 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 114
DE + REI + L HPNIV +VI + L +V E+ ++ + N
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174
Query: 175 PKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y AP+VL+ K+Y + D+WS G M+ G
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITG 216
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G FG A + ++T E++ +K + R ++ +E+ R L HPN+++F V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 88 TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L + EY GG L I + + + F + + SG++Y HSM + HRDL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 147 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 191
N L+ + + + DFG ++ + + VG P ++APE++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ YD K DV+S G+ L ++ D
Sbjct: 196 GRSYDEK-VDVFSFGIVLCEIIGRVNADPDY 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----Q 65
++ P + +YE + IG G FG R +KT + VA+K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 115
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 171
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 172 HSQP-KSTVGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
+ V T Y PE+LL +++Y I D+W G
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAG 216
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 29/226 (12%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF- 82
L+ +G G +G + R E VAVK D+ + E+ N LRH NI+ F
Sbjct: 11 TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 83 ---KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 137
+ T L ++ Y G L++ + + SG+++ H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 138 ------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
+ HRDLK +N L+ + + I D G + ++ L VGT Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 187 PEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
PEVL + + D+W+ G+ L+ + E+ K
Sbjct: 186 PEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 21 DRYELVRD-IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
D +E +G G +G A+ +D K ++ A+K IE I + REI R L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77
Query: 77 PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 126
PN++ ++V L+ + + +YA + + + Q+
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 180
+ G+ Y H+ V HRDLK N L+ G R +KI D G ++ + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 181 TPAYIAPEVLL-KKEYDGKIADVWSCG 206
T Y APE+LL + Y I D+W+ G
Sbjct: 198 TFWYRAPELLLGARHYTKAI-DIWAIG 223
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 55/246 (22%), Positives = 101/246 (41%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
+ G G +P++ + + ++V+ IG G +G + K E VAVK ++
Sbjct: 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWF 77
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSM 136
Query: 120 RFFFQQLISGVSYCHSMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
+SG+ + H+ + HRDLK +N L+ + I D G +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFIS 194
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
++ + P + VGT Y+ PEVL + AD++S G+ L+ +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGG 253
Query: 221 DPEEPK 226
EE +
Sbjct: 254 IVEEYQ 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-34
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 19/228 (8%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
++ D + DR+++ R G G FG +L ++K T VA+K + D
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR 63
Query: 63 N-VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR- 113
N + + + L HPNIV+ + T L +VMEY L N R
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR 122
Query: 114 ---FSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
+ F QLI + H S+ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK 181
Query: 169 SVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
+ + + Y APE++ + Y + D+WS G M++G
Sbjct: 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 28/206 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
RYE V +IG G +G RD + VA+K + R RE+ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67
Query: 74 LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 123
L HPN+VR +V T + +V E+ ++ + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 180
+Q + G+ + H+ + HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCG 206
T Y APEVLL+ Y + D+WS G
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVG 206
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 71/207 (34%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLR 75
++RY++V +G G L D VA+K I + E +RE+ N L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV +V +VMEY G L E I + G S D A F Q++ G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKK 193
M++ HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE +
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
D D++S G+ LY MLVG PF
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 62/246 (25%), Positives = 98/246 (39%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
T G G +P++ + L IG G FG + R K E VAVK ++
Sbjct: 25 TSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWF 82
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI LRH NI+ F + T T L +V +Y G LF+ + N + +
Sbjct: 83 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM 141
Query: 120 RFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
SG+++ H + HRDLK +N L+ + I D G +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDS 199
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + P VGT Y+APEVL E + AD+++ G+ + +
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGG 258
Query: 221 DPEEPK 226
E+ +
Sbjct: 259 IHEDYQ 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY ++ +G G G+ D ++ VA+K I D ++ REI R L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 126
IV+ E++ + E E + G E+ AR F QL
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y +P +LL Y I D+W+ G ML G
Sbjct: 189 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTG 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 49/230 (21%), Positives = 83/230 (36%), Gaps = 23/230 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEE-LVAVKYIERGDKIDENVQ----REIINHRSL 74
+ +YE+ I G G L D+ V +K + D Q E +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136
Query: 75 RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
HP+IV+ + IVMEY G L + EA + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+SY HS+ + + DLK EN +L +LK+ D G + GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPE 239
+ D+++ G TL + + + + +
Sbjct: 249 VRTGPTVA--TDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTYD 295
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 9/205 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRHP 77
Y L R +G G G D E +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
++V + L + M +G +L + G + A +Q+ S + H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE +
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE 220
+ AD+++ LY L G+ P++
Sbjct: 213 TYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-32
Identities = 68/250 (27%), Positives = 99/250 (39%), Gaps = 30/250 (12%)
Query: 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---- 64
G M P DRYEL +G G L RD + VAVK + D +
Sbjct: 1 GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 65 QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
+RE N +L HP IV + IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 176
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--------------EDP 222
+ +GT Y++PE D + +DV+S G LY +L G PF EDP
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 223 EEPKNFRKTI 232
P + +
Sbjct: 237 IPPSARHEGL 246
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQ----REI---INHR 72
+YE V +IG G +G RD K VA+K + R +E + RE+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 73 SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 125
+ HPN+VR +V T L +V E+ ++ + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
L+ G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ Q T V T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 184 YIAPEVLLKKEYDGKIADVWSCG 206
Y APEVLL+ Y + D+WS G
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVG 206
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R I + RE+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +V G +L I + ++D +F Q++ G+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
++L Y+ + D+WS G + +L G
Sbjct: 200 IMLNWMHYNQTV-DIWSVGCIMAELLTG 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
S +Y L + +G+G+FG+ + D ++ + A+K + + D +N RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 112
++ + T N G
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 113 --------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
+ + QL V + HS+ +CHRD+K +N L++ L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
K+CDFG +K + + + + Y APE++L EY I D+WS G +++G
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y +GSG +G DK++ E VA+K + R +I + RE++ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V + L +VM + +L + + +FSE++ ++ Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS V HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V+L Y+ + D+WS G + ML G
Sbjct: 194 VILSWMHYNQTV-DIWSVGCIMAEMLTG 220
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 29/240 (12%)
Query: 9 GPGMDMP-IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
G + + S +L+ G FG + + + E VAVK DK + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYE 68
Query: 68 IINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
+ + ++H NI++F K L ++ + G L + + A S +E
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIA 127
Query: 124 QQLISGVSYCHSMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ + G++Y H + HRD+K +N LL + I DFG +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGK 185
Query: 174 QPKST---VGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
T VGT Y+APEVL +++ + D+++ G+ L+ + + P +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D E VA+K + R ++ + RE++ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L IVME L ++ + + Q++ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG 215
L Y + D+WS G + M+ G
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKG 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y ++ +GSG +G D +T VA+K + R ++ + RE+ + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +VM + G +L ++ + ED +F Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y H+ + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V+L Y + D+WS G + M+ G
Sbjct: 196 VILNWMRYTQTV-DIWSVGCIMAEMITG 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-30
Identities = 67/214 (31%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REIINH 71
RY + IG G +G+ D + VA+K KI E+ REI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79
Query: 72 RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 126
RH NI+ ++I PT + IV + +L ++ S D +F Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N LL+ + LKICDFG ++ + V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L K Y I D+WS G L ML
Sbjct: 196 WYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSN 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-30
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REII 69
+ S ++L +G G +GV K T E+VA+K KI+ + REI
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
+ +H NI+ + + I+ E +L R+ + S+D ++F
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 178
Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 179 -----VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APEV+L +Y + DVWSCG L + +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLR 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D + VA+K + R ++ + RE++ + + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L +VME L + I + + Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+ HS + HRDLK N ++ LKI DFG +++ + T V T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVG 215
V+L Y + D+WS G + M+
Sbjct: 234 VILGMGYKENV-DIWSVGCIMGEMVRH 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 37/238 (15%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D D +L+ IG G +G + + E VAVK ++ + ++ I + H N
Sbjct: 11 DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
I RF + +VMEY G L + + + + + G++Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 134 HSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 175
H+ + HRDL N L+ I DFG S +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 176 KSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEE 224
S VGT Y+APEVL E K D+++ G+ + + +P E E
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 24/217 (11%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------------ 65
Y + R I SG++G D + VA+K + V
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 66 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 119
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 180 GTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y APE++++ K + + D+WS G + M
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNR 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSL 74
DRYE+ IG+G++G DK + +VA+K I R D ID + + REI L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 75 RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
H ++V+ ++++ L +V+E A + + +E + L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
V Y HS + HRDLK N L++ +K+CDFG +++ S +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 184 ----------------------YIAPEVLL-KKEYDGKIADVWSCG 206
Y APE++L ++ Y I DVWS G
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIG 271
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 54/238 (22%), Positives = 92/238 (38%), Gaps = 26/238 (10%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR 72
+ RY LVR +G G+F L +D VA+K + E + EI +N
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 73 SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 120
+I++ + H+ +V E G L + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 121 FFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 175
+QL+ G+ Y H + H D+K EN L++ +P +KI D G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+++ T Y +PEVLL + D+WS ++ ++ G + FE E + H
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 18 HDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
H + RYE+++ IG G+FG V + D K + VA+K + + EI R L H
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149
Query: 77 ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 125
N++ E H+ + E S L+E I FS R F
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 184
++ + H ++ H DLK EN LL +K+ DFG SS Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
APEV+L Y I D+WS G L +L G
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTG 295
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 36/239 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
D Y + IG G++G L DK TE+ VA+K + R D ID + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
I+R ++I+ L IV+E A +L + +E+ + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 183
+ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 184 ---------------YIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
Y APE++L + Y I D+WS G +L + +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLR- 75
+YELV+ +G G +G+ D++T E+VAVK I + D + REI+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 76 HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
H NIV V+ + +V +Y +L + A ++ QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 178
HS + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 179 -------VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCG 227
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 19/239 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 128 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWY 184
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244
APE L + ++ +DVWS GV LY + Y + P F + I ++
Sbjct: 185 APESLTESKFSVA-SDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 19/239 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 98
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 159 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWY 215
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244
APE L + ++ +DVWS GV LY + Y + P F + I ++
Sbjct: 216 APESLTESKFSVA-SDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 64/206 (31%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--- 77
DRYE+ IG G+FG D+ +E VA+K I+ Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 78 ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
IV K + HL +V E S L++ + N S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
+ + + H DLK EN LL +KI DFG SS Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVG 215
LL YD I D+WS G L M G
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTG 254
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 60/207 (28%), Positives = 80/207 (38%), Gaps = 14/207 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
L IG GNFG R + LVAVK D + +E + HPNIVR
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + IVME GG+ + R +G+ Y S H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEY 195
RDL N L+ LKI DFG S+ + G + APE L Y
Sbjct: 237 RDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ L+ +GA P+ +
Sbjct: 293 SSE-SDVWSFGILLWETFSLGASPYPN 318
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 33/209 (15%), Positives = 59/209 (28%), Gaps = 35/209 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
RY L+ G D + VA+ +++ + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + R +V+ T +V E+ GG L E S A Q L + H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V + S + + PA +
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA-------- 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
D+ G +LY +LV +P +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVR 208
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 64/241 (26%), Positives = 92/241 (38%), Gaps = 24/241 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + + +G GNFG L T LVAVK + G + QREI ++
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L IV+++ V P L +VMEY G L + + + R + Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI---- 185
Y S + HRDL N L+ S A +KI DFG +K +L V P
Sbjct: 141 EYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAK--LLPLDKDYYVVREPGQSPIFW 196
Query: 186 -APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
APE L + + +DVWS GV LY + P +
Sbjct: 197 YAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSC----SPSAEFLRMMGCERDVPALS 251
Query: 244 E 244
Sbjct: 252 R 252
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 21/213 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
L+ +G G+FGV VAVK ++ + I SL H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
N++R V+LTP + +V E A G L +R+ + G F + Q+ G+ Y S
Sbjct: 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEV 189
+ HRDL N LL + +KI DFG + L APE
Sbjct: 140 KRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
L + + +D W GVTL+ + G P+
Sbjct: 196 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYI--ERGDKIDENVQREIINHR 72
+ + +RD+G G+FG R T E VAVK + E G ++++EI R
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 73 SLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISG 129
+L H NIV++K + + ++ME+ G L E + N + + + + Q+ G
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI--- 185
+ Y S Q HRDL N L+ S ++KI DFG +K + + + TV
Sbjct: 139 MDYLGSRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVF 194
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY 210
APE L++ ++ +DVWS GVTL+
Sbjct: 195 WYAPECLMQSKFYIA-SDVWSFGVTLH 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 8/208 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HR+L N L+ + +K+ DFG S+ + APE L +
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVW+ GV L+ + G P+
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 21 DRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
+ +RD+G G+FG L + T E+VAVK + + G + ++EI R+L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 75 RHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H +I+++K L +VMEY G L + + + F QQ+ G++Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAY 149
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 187
H+ HRDL N LL + +KI DFG +K +V V AP
Sbjct: 150 LHAQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAP 206
Query: 188 EVLLKKEYDGKIADVWSCGVTLY 210
E L + ++ +DVWS GVTLY
Sbjct: 207 ECLKEYKFYYA-SDVWSFGVTLY 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RSLR 75
+ ++ +GSG FG + + + ++ VA+K + +EI++ S+
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
+P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLL 191
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ Y + +DVWS GVT++ +M G+ P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 10/209 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLKK 193
HRDL N L+ + +K+ DFG S+ + + G P + APE L
Sbjct: 131 NFIHRDLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
++ K +DVW+ GV L+ + G P+
Sbjct: 188 KFSIK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
+ + ++R +G G FG V + ++ AVK + K + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
+ NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 133 CHSMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 169
M + H DLK EN LLD +K+ DFG +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 170 VLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
S + + T Y APEV+L +D D+WS G L + G
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-23
Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 32/222 (14%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP-- 77
+RYE+V ++G G FG V + + + VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 78 ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 131
V + H+ I E G FE + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 132 YCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 174
+ H Q+ H DLK EN L S +++ DFG S+ +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 175 PKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+T V T Y PEV+L+ + DVWS G L+ G
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRG 235
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-22
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
++ R + + IGSG+ G RL + + VA+K ++ G ++ + E
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ IV EY G L F R + G+F+ + + + +G+
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMR 165
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---AP 187
Y + HRDL N L+D + K+ DFG S+ +T G I AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + + + +DVWS GV ++ V+ G P+ +
Sbjct: 224 EAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-22
Identities = 66/223 (29%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR-- 72
RYE+V +G G FG V + K VAVK ++ D+ E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 130
+ V+ E H+ IV E G ++ I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 173
++ HS ++ H DLK EN L S P +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 174 QPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ ST V T Y APEV+L + DVWS G L +G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLG 230
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-22
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V L + +V E+ G L + R G F+ + + G++Y
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 124 CVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y K +DVWS GV ++ V G P+E+
Sbjct: 181 RYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-21
Identities = 57/275 (20%), Positives = 98/275 (35%), Gaps = 66/275 (24%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
RY ++R +G G+F L D + ++ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 76 HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 126
PN +V+ FK + TH+ +V E + + N + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155
Query: 127 ISGVSYCHS-MQVCHRDLKLENTLLD---------------------------------- 151
+ G+ Y H+ ++ H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 152 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+ ++KI D G + +H + T Y + EVL+ Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
AD+WS + + G Y FE + R H
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 61/222 (27%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 21 DRYELVRD--------IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+ L RD +G GNFG KK + VA+K +++G E + RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMRE 60
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
L +P IVR V + +VME A GG L + + Q+
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT-- 181
G+ Y HRDL N LL + KI DFG SK L + +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKW 175
Query: 182 P-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
P + APE + +++ + +DVWS GVT++ + G P++
Sbjct: 176 PLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ + + +G+G FG RL K E VA+K ++ G +K + E
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ + IV EY G L F R + +F+ + + + SG+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI--- 185
Y M HRDL N L++ + K+ DFG + VL P +T G I
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWT 217
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + +++ +DVWS G+ L+ VM G P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 21 DRYELV---RDIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH---- 71
DR L +++GSGNFG + + KK + VAVK + + + D ++ E++
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVM 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ L +P IVR + + + +VME A G L + + + Q+ G+
Sbjct: 73 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYI 185
Y HRDL N LL + KI DFG SK L + K+ P +
Sbjct: 132 YLEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWY 187
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + ++ K +DVWS GV ++ G P+
Sbjct: 188 APECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ ++ +GSG FG + + + ++ VA+K + K ++ + E S+ +P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 136
++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLKK 193
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L +
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y + +DVWS GVT++ +M G+ P++
Sbjct: 195 IYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYI--ERGDKIDENVQREIINHR 72
++ +GSG FG + + ++ ++ V +K I + G + + V ++
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 131
SL H +IVR + + L +V +Y G L + + + G + Q+ G+
Sbjct: 71 SLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----A 186
Y + HR+L N LL SP+ ++++ DFG + +L K + + A A
Sbjct: 130 YLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + +Y + +DVWS GVT++ +M GA P+
Sbjct: 186 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-21
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L + +G+G FG + K + VAVK ++ G E E ++L+H
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDK 244
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ T + I+ E+ + G L F + + + F Q+ G+++
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ S KI DFG ++ + ++ + G I APE +
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 361 SFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83
+G GNFG KK + VA+K +++G E + RE L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 84 EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
V + +VME A GG L + + Q+ G+ Y HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLKKEYD 196
L N LL + KI DFG SK L + + + APE + +++
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS GVT++ + G P++
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
+ L++++GSG FGV + K + VAVK I+ G ++ +E L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
HP +V+F V + IV EY S G L + R + + + G+++
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L+D +K+ DFG ++ VL Q S+VGT + APEV
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+Y K +DVW+ G+ ++ V +G P++
Sbjct: 178 HYFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D ++++G+G FGV + + + VA+K I+ G ++ E +L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 77
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H +V+ V + I+ EY + G L + R RF + + + + Y
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L++ +K+ DFG S+ VL + S+VG+ + PEVL
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVL 193
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ ++ K +D+W+ GV ++ + +G P+E
Sbjct: 194 MYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 247
Query: 79 IVRFKEVILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ K+ DFG +K + + + APE L +
Sbjct: 308 NNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 360
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 361 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L F + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ + + KI DFG ++ + ++ + G I APE +
Sbjct: 129 NYIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 186 TFTIK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-20
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75
Query: 79 IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ S K+ DFG +K + + + APE L +
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 188
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 56/250 (22%), Positives = 97/250 (38%), Gaps = 37/250 (14%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHR 72
++ L R +G G FG A+L ++ + VAVK ++ +++ RE +
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 73 SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
HP++ + +++ + G+L F A R E+ Q
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137
Query: 125 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
L+ G+ Y S HRDL N +L + + DFG S+ ++S
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193
Query: 178 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFR 229
G + + A E L Y +DVW+ GVT++ +M G Y + E N+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
Query: 230 KTIHRISIPE 239
+R+ P
Sbjct: 253 IGGNRLKQPP 262
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-20
Identities = 57/265 (21%), Positives = 97/265 (36%), Gaps = 43/265 (16%)
Query: 10 PGMDMPIMHDSDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDK 59
P + + + L + +G G FG L ++ T VAVK ++ +
Sbjct: 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75
Query: 60 IDENVQ---REIINHRSLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERIC 109
++ E + HPN++R + +++ + G+L +
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 110 NAGRFSEDEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
R Q L+ G+ Y + HRDL N +L + + D
Sbjct: 136 ---RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVAD 190
Query: 163 FGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA 216
FG SK ++S G A + A E L + Y K +DVW+ GVT++ + G
Sbjct: 191 FGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGM 247
Query: 217 --YPFEDPEEPKNFRKTIHRISIPE 239
YP E ++ HR+ PE
Sbjct: 248 TPYPGVQNHEMYDYLLHGHRLKQPE 272
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-20
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG L +E+ VA+K ++ G +K + E
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 130
H NI+R + VI + I+ EY G L F R G FS + + + +G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 160
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---A 186
Y +M HRDL N L++ + K+ DFG S+ + +T G I A
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 219 PEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 8e-20
Identities = 51/219 (23%), Positives = 85/219 (38%), Gaps = 22/219 (10%)
Query: 20 SDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+Y L R +G G FG K + VAVK ++ E E
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
+ ++L HP+IV+ +I I+ME GEL + N + Q+
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI- 185
++Y S+ HRD+ + N L+ +K+ DFG S+ + T I
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIK 179
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + + + +DVW V ++ ++ G PF
Sbjct: 180 WMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-20
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HP+IV+ VI I+ME + GEL F + + QL + ++
Sbjct: 73 FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALA 130
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPE 188
Y S + HRD+ N L+ + +K+ DFG S+ + S P ++APE
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE 187
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ + + +DVW GV ++ +++ G PF+
Sbjct: 188 SINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 53/220 (24%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I+ME +GG+L + + L+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAML 207
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
PE ++ + K D WS GV L+ + +G P+
Sbjct: 208 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPN 78
EL R IG G FG M + VA+K + D + E +E + R HP+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ VI I+ME + GEL + + QL + ++Y S +
Sbjct: 453 IVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLKK 193
HRD+ N L+ + +K+ DFG S+ + K++ G P ++APE + +
Sbjct: 512 FVHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVW GV ++ +++ G PF+
Sbjct: 568 RFTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 63/244 (25%), Positives = 100/244 (40%), Gaps = 22/244 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 183
Q+ G+ Y S + HRDL N +LD +K+ DFG ++ + + S
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR-DMYDKEYYSVHNKTGA 192
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRI 235
++A E L +++ K +DVWS GV L+ +M GA YP + + + R+
Sbjct: 193 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251
Query: 236 SIPE 239
PE
Sbjct: 252 LQPE 255
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-19
Identities = 57/242 (23%), Positives = 90/242 (37%), Gaps = 26/242 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I++E +GG+L + + L+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAML 248
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRISI 237
PE ++ + K D WS GV L+ + +G YP + +E F + R+
Sbjct: 249 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP 307
Query: 238 PE 239
P+
Sbjct: 308 PK 309
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L R++G G FG + K + LVAVK ++ QRE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQ 125
+H +IV+F V L +V EY G+L + I G+ + + Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 126 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
++ SG+ Y S HRDL N L+ +KI DFG S+ ++S
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYR 190
Query: 179 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
VG + PE ++ +++ + +DVWS GV L+
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 63/243 (25%), Positives = 98/243 (40%), Gaps = 20/243 (8%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
Q+ G+ + S + HRDL N +LD +K+ DFG ++ T A
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 185 I-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRIS 236
+ A E L +++ K +DVWS GV L+ +M GA YP + + + R+
Sbjct: 258 LPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 316
Query: 237 IPE 239
PE
Sbjct: 317 QPE 319
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 37/219 (16%), Positives = 72/219 (32%), Gaps = 29/219 (13%)
Query: 24 ELVRDIGSGNFGV-------ARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR 75
+G G F + E V +K +++ E+ L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H ++V V + +V E+ G L + + N + +QL + + +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL 129
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
+ H ++ +N LL + K+ D G S + + + + ++ P
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPP 186
Query: 188 EVLLKKEYDGKI----ADVWSCGVTLY-VMLVGAYPFED 221
E + + K D WS G TL+ + G P
Sbjct: 187 ECIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 48/244 (19%), Positives = 96/244 (39%), Gaps = 30/244 (12%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
++ + R++G G+FG VA+ + + E VA+K + + E + E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFF 123
++VR V+ ++ME + G+L + R +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
++ G++Y ++ + HRDL N ++ + +KI DFG ++ ++ G
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200
Query: 184 YI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRI 235
+ +PE L + +DVWS GV L+ + + Y E+ F +
Sbjct: 201 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259
Query: 236 SIPE 239
P+
Sbjct: 260 DKPD 263
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 64/244 (26%), Positives = 104/244 (42%), Gaps = 22/244 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
D+ I H+ R IG G+FGV + + A+K + R ++ + RE
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 68 IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 123
+ R L HPN++ ++L +++ Y G+L F R + + F
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 180
Q+ G+ Y + HRDL N +LD S +K+ DFG ++ +S +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHA 188
Query: 181 T-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRI 235
P + A E L + K +DVWS GV L+ ++ GA Y DP + +F R+
Sbjct: 189 RLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL 247
Query: 236 SIPE 239
PE
Sbjct: 248 PQPE 251
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L ++G G FG + ++ + LVAVK ++ + QRE L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQL 126
+H +IVRF V L +V EY G+L AG QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 127 I-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
+ +G+ Y + HRDL N L+ +KI DFG S+ ++S V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRV 216
Query: 180 GTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
G + PE +L +++ + +DVWS GV L+ + G P+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 44/230 (19%), Positives = 87/230 (37%), Gaps = 34/230 (14%)
Query: 19 DSDRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINH 71
+ ++G FG + + VA+K ++ + E + E +
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFF 122
L+HPN+V V+ L+++ Y S G+L + + ++
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 123 FQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
+ +G+ Y S V H+DL N L+ +KI D G + +++
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAAD 182
Query: 176 KSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + APE ++ ++ +D+WS GV L+ V G P+
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 55/235 (23%), Positives = 86/235 (36%), Gaps = 47/235 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+R + +G+G FG A + VAVK + ER + E V
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSE 116
+ H NIV ++ EY G+L + +
Sbjct: 83 L-----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE + L+S G+++ S HRDL N LL KICDFG ++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR-- 193
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ + V A + APE + Y + +DVWS G+ L+ + +G+ P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 55/268 (20%), Positives = 101/268 (37%), Gaps = 27/268 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ E ++ E ++ L I
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
H +V++ S +L +C +FS +Q+++ V H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 138 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIA 186
+ +RD+K +N L+ + A + + DFG K + H + K+ GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 187 PEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
L +E D D+ + G L G+ P++ + N +K +
Sbjct: 187 INTHLGREQSRRD----DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242
Query: 244 EWFLKNLPADLV--VDNTTNNQFEE-PD 268
P + + N F+ PD
Sbjct: 243 RELCAGFPEEFYKYMHYARNLAFDATPD 270
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
+++ L R IGSG+FG L + +T E VA+K E + E +R L+ I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +VM+ S +LF C+ + S Q+I+ V + HS
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 138 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G A ++ I DFG +K S+ H + K+ GT Y +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L L G+ P
Sbjct: 184 THLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 59/258 (22%), Positives = 98/258 (37%), Gaps = 44/258 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+ E VRDIG G FG A + + +VAVK ++ + + QRE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+PNIV+ V + ++ EY + G+L + A S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 117 DEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ + +G++Y + HRDL N L+ +KI DFG S++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN- 223
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFED 221
++S I PE + Y + +DVW+ GV L+ + G Y
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 222 PEEPKNFRKTIHRISIPE 239
EE + + + ++ PE
Sbjct: 282 HEEVIYYVRDGNILACPE 299
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 44/258 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
L + +G G FG A ++ + VAVK ++ ++ E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+ HP++++ L +++EYA G L ++
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE LIS G+ Y M++ HRDL N L+ +KI DFG S+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD- 199
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFED 221
++ + + I A E L Y + +DVWS GV L+ ++ +G YP
Sbjct: 200 -VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 222 PEEPKNFRKTIHRISIPE 239
PE N KT HR+ P+
Sbjct: 258 PERLFNLLKTGHRMERPD 275
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 47/233 (20%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
D + + IG GNFG AR+ +D + A+K + + D E V +
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 118
+ HPNI+ +L + +EYA G L E +
Sbjct: 82 L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 119 ARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
+ QQL+ G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEV 194
Query: 172 HSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ T + A E L Y +DVWS GV L+ ++ +G P
Sbjct: 195 Y-----VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 80
+ + + IG GNFG RL ++ T E VA+K +E + E ++ L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 81 RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+ + A+V+E S +LF +C+ FS QLIS + Y HS +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 139 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAP 187
+RD+K EN L+ ++ DF +K + H + KS GT Y++
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 188 EVLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L KE D D+ + G L G+ P
Sbjct: 187 NTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 42/222 (18%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVK-------YIERGDKIDE-NVQRE 67
+ + + +G+G FG A + + VAVK E+ + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 120
+ +H NIV + ++ EY G+L + F+ +
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 121 FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ L+ G+++ S HRD+ N LL + KI DFG ++ + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMN 216
Query: 174 QPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
V A + APE + Y + +DVWS G+ L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLW 257
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
+RY L R IGSG+FG L D E VA+K E + E ++ ++ I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + +VME S +LF C+ +FS Q+IS + Y HS
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 138 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G + I DFG +K + H + K+ GT Y +
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L +G+ P
Sbjct: 186 THLGIEQSRRD----DLESLGYVLMYFNLGSLP 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 63/253 (24%), Positives = 102/253 (40%), Gaps = 39/253 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG A + K +E VAVK ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNI 256
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPK 226
T + APE L + Y + +DVWS GV ++ + +G YP EE
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315
Query: 227 NFRKTIHRISIPE 239
K HR+ P
Sbjct: 316 KLLKEGHRMDKPA 328
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 53/249 (21%)
Query: 14 MPIMHDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYI------- 54
+ +D+ ++E L + +G G FG A + T VAVK +
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 55 ERGDKIDE-NVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL-------- 104
E + E + I H N+V P L +++E+ G L
Sbjct: 73 EHRALMSELKILIHI-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 105 -FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAP 156
+ + LI G+ + S + HRDL N LL
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV- 186
Query: 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY- 210
+KICDFG ++ ++ P A + APE + + Y + +DVWS GV L+
Sbjct: 187 -VKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWE 242
Query: 211 VMLVGAYPF 219
+ +GA P+
Sbjct: 243 IFSLGASPY 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 39/253 (15%)
Query: 21 DRYELVRDIGSGNFG------VARLMRDKKTEEL-VAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG + +DK E + VAVK ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 210
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPK 226
T + APE L + Y + +DVWS GV ++ + +G YP EE
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 227 NFRKTIHRISIPE 239
K HR+ P
Sbjct: 270 KLLKEGHRMDKPA 282
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 67/258 (25%), Positives = 99/258 (38%), Gaps = 49/258 (18%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYI-------ERGDKIDE-NVQ 65
DR L + +G G FG A + K VAVK + + D I E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSE 116
+ I +H NI+ L +++EYAS G L +
Sbjct: 129 KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
E + + L+S G+ Y S + HRDL N L+ + +KI DFG ++
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR-- 239
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFED 221
+H T + APE L + Y + +DVWS GV L+ + +G YP
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVP 298
Query: 222 PEEPKNFRKTIHRISIPE 239
EE K HR+ P
Sbjct: 299 VEELFKLLKEGHRMDKPS 316
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 56/240 (23%), Positives = 85/240 (35%), Gaps = 52/240 (21%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+ E + +GSG FG A + VAVK + ER + E + +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNA 111
+ H NIV + ++ EY G+L
Sbjct: 105 L-----GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 112 GRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
ED F+ L+ G+ + HRDL N L+ +KICDFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217
Query: 165 YSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
++ + S V A + APE L + Y K +DVWS G+ L+ + +G P
Sbjct: 218 LARD--IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 3e-12
Identities = 39/196 (19%), Positives = 59/196 (30%), Gaps = 52/196 (26%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---------VQREIIN 70
+++ + IG G FG T VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 71 HRSL---------RHPNIVRFKEVIL------------------------------TPTH 91
+ L R + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLL 150
L IV+E+ GG E++ S A+ QL + ++ S++ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 151 DGSPAPRLKICDFGYS 166
+ +L G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 52/215 (24%)
Query: 29 IGSGNFG-VAR-LMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF-- 82
IG G FG V + ++RD VA+K I+E + EI RHP++V
Sbjct: 47 IGHGVFGKVYKGVLRDGAK---VALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIG 102
Query: 83 --KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQQLIS 128
E + ++ +Y G L + + + AR
Sbjct: 103 FCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-------- 150
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYI 185
G+ Y H+ + HRD+K N LLD + P KI DFG SK Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 186 APE-----VLLKKEYDGKIADVWSCGVTLYVMLVG 215
PE L +K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK------SDVYSFGVVLFEVLCA 237
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 15/106 (14%)
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 185
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 186 APEVLLKKEY-DGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
AP E G+I +D++S GV L ++ G ++ EP+
Sbjct: 203 AP------EALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 26/197 (13%), Positives = 62/197 (31%), Gaps = 37/197 (18%)
Query: 22 RYELVRDIGSGNFGV--------ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
+++L N G+ ++ ++K ++ D N Q R+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99
Query: 74 LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 116
+ + ++K++ TP + +V+ S + SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH- 172
+L+ + + H + H ++ EN +D ++ + +G++ S H
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
Query: 173 ----SQPKSTVGTPAYI 185
G +I
Sbjct: 219 AYVEGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 30/167 (17%), Positives = 60/167 (35%), Gaps = 24/167 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
++ L + IGSG FG+ L E A ++ + + + E+ ++ + + ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 82 FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 120
+L I VME ++ N G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 27/169 (15%), Positives = 54/169 (31%), Gaps = 25/169 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEEL-----VAVK---------------YIERGDKID 61
+++ IG G FG L +E + VK Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 62 ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 118
+ L P ++ ++M+ + +++E RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153
Query: 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 56/215 (26%), Positives = 82/215 (38%), Gaps = 61/215 (28%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQRE------IINHRSLRHPNI 79
+G G FG RL D LVAVK ++ + + + +I+ H N+
Sbjct: 38 LGRGGFGKVYKGRL-ADGT---LVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89
Query: 80 VRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQQLI 127
+R + +TPT +V Y + G L ER + AR
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR------- 142
Query: 128 SGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 179
G++Y H ++ HRD+K N LLD + DFG +K L + V
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVR 196
Query: 180 GTPAYIAPE-----VLLKKEYDGKIADVWSCGVTL 209
GT +IAPE +K DV+ GV L
Sbjct: 197 GTIGHIAPEYLSTGKSSEK------TDVFGYGVML 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 8e-08
Identities = 35/127 (27%), Positives = 60/127 (47%), Gaps = 14/127 (11%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ Q+ G+ + S + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 182 PAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTI--- 232
A + APE + + Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
Query: 233 HRISIPE 239
R+ P+
Sbjct: 313 TRMRAPD 319
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 31/153 (20%), Positives = 55/153 (35%), Gaps = 22/153 (14%)
Query: 18 HDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG----DKID 61
+D+ ++E L + +G G FG A + T VAVK ++ G +
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEAR 120
+ +I+ H H N+V P L +++E+ G L + + R +
Sbjct: 72 LMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYK 129
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
+ G Y + DLK + S
Sbjct: 130 TKGARFRQGKDYVGA---IPVDLKRRLDSITSS 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 2e-06
Identities = 52/397 (13%), Positives = 125/397 (31%), Gaps = 130/397 (32%)
Query: 23 YELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ V ++ N+ ++ + +++ ++ YIE+ D++ + Q + S R +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138
Query: 81 RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 131
+ ++ + L P ++ + G + +C + + + + F+ ++ +
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 132 YCHS-------MQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
C+S +Q + ++ + D S +L+I +L S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242
Query: 184 YIAPEVLLKKEYDGKI-ADVWS----------C---------GVTLYVMLVGAY------ 217
Y LL + +V + C VT ++
Sbjct: 243 Y--ENCLL-------VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 218 ---PFEDPE-----------EPKNFRKTIHRIS------IPE-IRNH-----EW------ 245
E P++ + + + I E IR+ W
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353
Query: 246 --------FLKNL-PADLVVDNTTNNQFEE----PDQ---PMQSIDEIMQIIAEATIPAA 289
L L PA+ F+ P P ++ +I I +
Sbjct: 354 KLTTIIESSLNVLEPAEY------RKMFDRLSVFPPSAHIPTI----LLSLIWFDVIKSD 403
Query: 290 GTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEI 326
+N+ SL ++ + E + P + ++ ++
Sbjct: 404 VMVVVNKLHKYSL-VEKQPKESTISIPSIYLELKVKL 439
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 330 | |||
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.52 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.32 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.17 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.77 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.27 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.04 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.02 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.79 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.75 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.64 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.59 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.38 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.23 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.94 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.91 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.52 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 83.05 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.28 |
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-59 Score=428.67 Aligned_cols=328 Identities=81% Similarity=1.321 Sum_probs=220.1
Q ss_pred CCCCccccCCCCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCee
Q 020133 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80 (330)
Q Consensus 1 ~~~~~~~~~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv 80 (330)
|++.+++.+| ..++++...++|++++.||+|+||+||++.+..+++.||+|++.......+.+.+|+..++.++||||+
T Consensus 1 m~~~~~~~~p-~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCC-CCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence 7777777777 566778888999999999999999999999999999999999988777778899999999999999999
Q ss_pred eeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEE
Q 020133 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (330)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL 160 (330)
++++++...+..|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+++||
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999999999999999998888999999999999999999999999999999999999998777667999
Q ss_pred eecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh---------------
Q 020133 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--------------- 225 (330)
Q Consensus 161 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~--------------- 225 (330)
+|||+++............||+.|+|||++.+..+.++++|||||||++|+|++|+.||.+....
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence 99999975555555566789999999999988888777689999999999999999999764321
Q ss_pred ---------hHHHHHh---------hcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCC
Q 020133 226 ---------KNFRKTI---------HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287 (330)
Q Consensus 226 ---------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~ 287 (330)
..+...+ .|+++.++..||||.+.++.++.........+..|.++.++++++.+.+.+...+
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC------------------CCHHHHHHHHHHHTCC
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCc
Confidence 1122222 6899999999999999988887766656666777888899999999999999998
Q ss_pred CCCCCchhhhccCCCCccccccccCCCCCCcCCCCCCceeecC
Q 020133 288 AAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEIVYAM 330 (330)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (330)
........+...+.++.+++++ +.|.+.+.|.|++|+|.|||
T Consensus 320 ~~~~~~~~~~~~~~~d~d~~~~-~~d~~~~~d~d~~g~~~~~~ 361 (361)
T 3uc3_A 320 AVRNRCLDDFMTDNLDLDDDMD-DFDSESEIDIDSSGEIVYAL 361 (361)
T ss_dssp -------------------------------------------
T ss_pred ccccccchhccccccccccccc-cccchhhhccCCCCcEEecC
Confidence 8877777777777776655433 45677889999999999997
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=403.73 Aligned_cols=246 Identities=41% Similarity=0.663 Sum_probs=191.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||+||+|.++.+|+.||+|++.+.. .....+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 78999999999999999999999999999999997642 23457899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||| +|+|.+++.+++++++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.........
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC----------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCccC
Confidence 999 6799999999999999999999999999999999999999999999999987764 9999999998665555556
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
+.+||+.|+|||++.+..+++.++|||||||++|+|+||+.||.+.+.......+..... -+.+.++++ ..
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--------~~p~~~s~~-~~ 240 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--------TLPKFLSPG-AA 240 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------CCCTTSCHH-HH
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCHH-HH
Confidence 778999999999999888877679999999999999999999998766555544432211 011222222 23
Q ss_pred cccccCCCCCCCCccCCHHHHHH
Q 020133 257 DNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.++...+|.+|+ |++|+++
T Consensus 241 ~li~~~L~~dP~~R~-s~~eil~ 262 (275)
T 3hyh_A 241 GLIKRMLIVNPLNRI-SIHEIMQ 262 (275)
T ss_dssp HHHHHHSCSSGGGSC-CHHHHHH
T ss_pred HHHHHHccCChhHCc-CHHHHHc
Confidence 444555567777776 8888876
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-56 Score=403.78 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=207.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
..|++.++||+|+||+||+|.++.+|+.||||++.... ...+.+.+|+.++++++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999997543 33456889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~~ 178 (330)
+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+..... ....+.
T Consensus 154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence 99999998876 57999999999999999999999999999999999999987765 999999999865433 344567
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDN 258 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (330)
+||+.|+|||++.+..|+.+ +|||||||++|||++|+.||.+.+....+..+..... +.... ...++++ ..+.
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~----~~~~s~~-~~dl 303 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKN----LHKVSPS-LKGF 303 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSC----GGGSCHH-HHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCc----cccCCHH-HHHH
Confidence 89999999999988888655 9999999999999999999998776666555543321 11100 1122222 2334
Q ss_pred cccCCCCCCCCccCCHHHHHH--HHHHhCC
Q 020133 259 TTNNQFEEPDQPMQSIDEIMQ--IIAEATI 286 (330)
Q Consensus 259 ~~~~~~~~p~~~~~s~~el~~--~l~~~~~ 286 (330)
+.++...+|.+|+ |++|+++ .+++...
T Consensus 304 i~~~L~~dP~~R~-ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 304 LDRLLVRDPAQRA-TAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHSCSSTTTSC-CHHHHTTCGGGGGCCC
T ss_pred HHHHcCCChhHCc-CHHHHhcCHhhcCCCC
Confidence 4455557777775 8888875 4555443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-56 Score=401.18 Aligned_cols=210 Identities=31% Similarity=0.506 Sum_probs=188.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. ....+.+.+|+.++++++|||||+++++|.+++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999999999999999999753 23456789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC---
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 172 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~--- 172 (330)
||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCc
Confidence 999999999999999899999999999999999999999999999999999999987765 999999999855332
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
....+.+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+....+.++.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 247 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII 247 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 23456789999999999998888655 999999999999999999999877666655555
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=406.74 Aligned_cols=212 Identities=30% Similarity=0.522 Sum_probs=180.3
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
.+-++|++++.||+|+||+||+|+++.+|+.||||++..... ..+.+.+|+.++++++|||||++++++.+++.+|+
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 345899999999999999999999999999999999976532 34578899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|||||+||+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNST 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCC
Confidence 99999999999999754 35799999999999999999999999999999999999987765 999999999854332
Q ss_pred C-CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 173 S-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 173 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
. .....+||+.|+|||++.+..++.+ +|||||||++|||+||+.||.+.+....+.++.
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 238 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 1 2234579999999999998888655 999999999999999999999877666555554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-56 Score=401.78 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=207.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.++++++|||||++++++.+++.+||||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34679999999999999999999999999999999986533 24799999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-----
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----- 173 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~----- 173 (330)
|+||+|.+++++.+++++..++.++.||+.||.|||++||+||||||+|||++.++. ++||+|||+|+......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC---------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccce
Confidence 999999999999899999999999999999999999999999999999999987753 49999999997543322
Q ss_pred -CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (330)
.....+||+.|||||++.+..++.+ +|||||||++|||+||+.||.+.+......++....... .. +...+++
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--~~---~~~~~s~ 284 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI--RE---IPPSCAP 284 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG--GG---SCTTSCH
T ss_pred ecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc--hh---cCccCCH
Confidence 1234579999999999998888765 999999999999999999998877666665555432211 00 1122222
Q ss_pred cccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+.+.+.++...+|.+|+ |+.|+++.+...
T Consensus 285 -~~~~li~~~L~~dP~~R~-sa~el~~~l~~~ 314 (336)
T 4g3f_A 285 -LTAQAIQEGLRKEPVHRA-SAMELRRKVGKA 314 (336)
T ss_dssp -HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred -HHHHHHHHHccCCHhHCc-CHHHHHHHHHHH
Confidence 233455566667888875 999998877654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-55 Score=405.58 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=207.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
+.|+++++||+|+||+||+|.++.+|+.||||++.... ...+.+.+|+.+++.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999999999999999997653 33467889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~~ 178 (330)
+||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+..... ....+.
T Consensus 231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence 99999999865 56999999999999999999999999999999999999987765 999999999855433 344567
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDN 258 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (330)
+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+....+..+..... +.+... ..++. ...+.
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~----~~~s~-~~~dl 380 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNL----HKVSP-SLKGF 380 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCT----TSSCH-HHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCccc----ccCCH-HHHHH
Confidence 89999999999988888655 9999999999999999999998776666555543321 111111 11222 22334
Q ss_pred cccCCCCCCCCccCCHHHHHH--HHHHhCC
Q 020133 259 TTNNQFEEPDQPMQSIDEIMQ--IIAEATI 286 (330)
Q Consensus 259 ~~~~~~~~p~~~~~s~~el~~--~l~~~~~ 286 (330)
+.++...+|.+|+ +++|+++ .|++...
T Consensus 381 i~~~L~~dP~~R~-ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 381 LDRLLVRDPAQRA-TAAELLKHPFLAKAGP 409 (423)
T ss_dssp HHHHSCSSTTTSC-CHHHHTTCGGGGGCCC
T ss_pred HHHHcCCChhHCc-CHHHHhcCHHhcCCCC
Confidence 4555557777776 8888876 4555433
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=394.73 Aligned_cols=247 Identities=28% Similarity=0.508 Sum_probs=196.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
+.++|++++.||+|+||+||+|++. .+++.||+|++++.. .....+.+|+.++++++|||||++++++.+++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 3468999999999999999999984 468899999987542 2334688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~- 171 (330)
|+|||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC----
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCC
Confidence 999999999999999999999999999999999999999999999999999999999987765 99999999985433
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccC
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNL 250 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 250 (330)
.....+.+||+.|+|||++.+..++.+ +|||||||++|||+||+.||.+.+.......+... +..| ..+
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p---------~~~ 249 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP---------QFL 249 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------TTS
T ss_pred CccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC---------CcC
Confidence 334456789999999999998888765 99999999999999999999987776666665532 1111 122
Q ss_pred CccccccccccCCCCCCCCccCC----HHHHH
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQS----IDEIM 278 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s----~~el~ 278 (330)
+++ ..+.+.++...+|.+|+.+ ++|++
T Consensus 250 s~~-~~~li~~~L~~dP~~R~ta~~~~~~eil 280 (304)
T 3ubd_A 250 SPE-AQSLLRMLFKRNPANRLGAGPDGVEEIK 280 (304)
T ss_dssp CHH-HHHHHHHHTCSSGGGSTTCSTTTHHHHH
T ss_pred CHH-HHHHHHHHcccCHHHCCCCCcCCHHHHH
Confidence 222 2233444455666666654 56655
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=386.76 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=198.8
Q ss_pred CCe-EEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEe----CCeE
Q 020133 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (330)
Q Consensus 21 ~~y-~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~----~~~~ 92 (330)
++| ++.++||+|+||+||+|.+..+++.||+|.+.... ...+.+.+|+.++++++|||||+++++|.+ ++.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 455 78889999999999999999999999999997543 223568899999999999999999999975 3568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecC-CCCCceEEeecCCcccc
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 169 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~ 169 (330)
|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. ++ .+||+|||+|+..
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g--~vKl~DFGla~~~ 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS--CEEECCTTGGGGC
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC--CEEEEeCcCCEeC
Confidence 999999999999999999899999999999999999999999999 999999999999974 44 5999999999743
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
. .....+.+||+.|||||++.+ .++.+ +|||||||++|||+||+.||.+.+....+.+.+.....|. .+...
T Consensus 183 ~-~~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~-----~~~~~ 254 (290)
T 3fpq_A 183 R-ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-----SFDKV 254 (290)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-----GGGGC
T ss_pred C-CCccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC-----CCCcc
Confidence 2 233456789999999998865 56555 9999999999999999999987666666555554322211 12222
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+++ +.+.+.++...+|.+|+ |++|+++
T Consensus 255 ~~~~-~~~li~~~L~~dP~~R~-s~~e~l~ 282 (290)
T 3fpq_A 255 AIPE-VKEIIEGCIRQNKDERY-SIKDLLN 282 (290)
T ss_dssp CCHH-HHHHHHHHSCSSGGGSC-CHHHHHT
T ss_pred CCHH-HHHHHHHHccCChhHCc-CHHHHhc
Confidence 2222 33445555667777776 8888764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=385.28 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=204.2
Q ss_pred cCCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
+..++|.+.+.||+|+||+||+|+.. .++..||||.++.... ..+.+.+|+.++++++|||||+++++|.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 34578999999999999999999875 3578999999976532 34678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCce
Q 020133 92 LAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~v 158 (330)
+|+|||||++|+|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+|||++.++. +
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--E
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--E
Confidence 99999999999999999764 36999999999999999999999999999999999999987765 9
Q ss_pred EEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhc
Q 020133 159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 159 kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 234 (330)
||+|||+|+....... .....||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+....+..+...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999974433222 233468999999999998888665 999999999999999 89999987766555554432
Q ss_pred CChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 235 ISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
... -....+|.+ +.+.+.+|+..+|.+|+ |+.++.+.|+++
T Consensus 247 ~~~-------~~p~~~~~~-~~~li~~cl~~dP~~RP-s~~~i~~~L~~~ 287 (299)
T 4asz_A 247 RVL-------QRPRTCPQE-VYELMLGCWQREPHMRK-NIKGIHTLLQNL 287 (299)
T ss_dssp CCC-------CCCTTCCHH-HHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CCC-------CCCccchHH-HHHHHHHHcCCChhHCc-CHHHHHHHHHHH
Confidence 111 111223332 33445556667787775 999998888765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=381.29 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=204.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
..+.+++.++||+|+||+||++... .+++.||||.++... ...+.+.+|+.++++++|||||+++++|.+++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 3467899999999999999999853 467899999986543 334689999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC
Q 020133 92 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~ 155 (330)
+|+|||||++|+|.+++... ..+++.++..++.||+.||.|||+++||||||||+|||+++++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 99999999999999999653 35899999999999999999999999999999999999987765
Q ss_pred CceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 020133 156 PRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 156 ~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~ 231 (330)
+||+|||+|+...... ......||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+.......+
T Consensus 184 --~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 184 --VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp --EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred --EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999998543322 2345678999999999998888655 999999999999998 89999988776655554
Q ss_pred hhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 232 IHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
......| ....+|.+ +.+.+.+|+..+|.+|+ |+.|+.+.|+..
T Consensus 261 ~~~~~~~-------~p~~~~~~-~~~li~~C~~~dP~~RP-s~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 RNRQVLP-------CPDDCPAW-VYALMIECWNEFPSRRP-RFKDIHSRLRAW 304 (308)
T ss_dssp HTTCCCC-------CCTTCCHH-HHHHHHHHTCSSGGGSC-CHHHHHHHHHTS
T ss_pred HcCCCCC-------CcccchHH-HHHHHHHHcCCChhHCc-CHHHHHHHHHhc
Confidence 4332211 11223332 33445556667777765 999999988753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=383.15 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=201.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
...+|.+.++||+|+||+||+|+.. .+++.||||.++.... ..+.+.+|+.++++++|||||+++++|.+.+.+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467899999999999999999865 3688999999976543 346789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCc
Q 020133 93 AIVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~ 157 (330)
|+|||||++|+|.++++.. +++++.+++.++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~-- 196 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV-- 196 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--
Confidence 9999999999999998753 35999999999999999999999999999999999999987764
Q ss_pred eEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhh
Q 020133 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 158 vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 233 (330)
+||+|||+|+...... ......||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+....+..+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999998543322 2234578999999999998888655 999999999999999 8999998777665555543
Q ss_pred cCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 234 RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.... -+...+|++ +.+.+.+|+..+|.+|+ |++|+.+.|+.+.
T Consensus 276 g~~~-------~~p~~~~~~-~~~li~~cl~~dP~~RP-s~~ei~~~L~~l~ 318 (329)
T 4aoj_A 276 GREL-------ERPRACPPE-VYAIMRGCWQREPQQRH-SIKDVHARLQALA 318 (329)
T ss_dssp TCCC-------CCCTTCCHH-HHHHHHHHCCSSTTTSC-CHHHHHHHHHHHH
T ss_pred CCCC-------CCcccccHH-HHHHHHHHcCcChhHCc-CHHHHHHHHHHHh
Confidence 2111 111233332 34455666778888876 9999999888753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=376.80 Aligned_cols=256 Identities=24% Similarity=0.356 Sum_probs=198.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..+++++.++||+|+||+||++... ..||||+++.... ..+.+.+|+.++++++|||||++++++.. +.+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 4578999999999999999999864 3599999875432 23578899999999999999999998754 568999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC--
Q 020133 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-- 172 (330)
||||+||+|.+++... +++++.++..++.||+.||.|||+++||||||||+|||++.++. +||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCc
Confidence 9999999999999754 57999999999999999999999999999999999999987764 999999999754322
Q ss_pred -CCCCcccCCCCCCChhhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC-ChhHHhcCchhhc
Q 020133 173 -SQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-SIPEIRNHEWFLK 248 (330)
Q Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 248 (330)
......+||+.|||||++.+.. ..+.++|||||||++|||+||+.||.+.+....+...+.+. ..|.... +..
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~---~~~ 264 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK---LYK 264 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT---SCT
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc---ccc
Confidence 2234568999999999997542 22445999999999999999999999877666665555432 2221111 112
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+|. .+.+.+.+|+..+|.+|+ |+.|+++.|..+.
T Consensus 265 ~~~~-~l~~li~~cl~~dP~~RP-s~~ei~~~Le~l~ 299 (307)
T 3omv_A 265 NCPK-AMKRLVADCVKKVKEERP-LFPQILSSIELLQ 299 (307)
T ss_dssp TSCH-HHHHHHHHHTCSSSTTSC-CHHHHHHHHHHHH
T ss_pred cchH-HHHHHHHHHcCCCHhHCc-CHHHHHHHHHHHh
Confidence 2333 233455566667888876 9999998887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=386.19 Aligned_cols=212 Identities=28% Similarity=0.458 Sum_probs=185.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeC------C
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~ 90 (330)
.++|++++.||+|+||+||+|+++.+|+.||||++...... .+.+.+|+.+|+.++|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36899999999999999999999999999999999765332 34678999999999999999999998643 5
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.+|+|||||+ |+|.+++.+++++++..++.+++||+.||.|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence 7899999996 579999998899999999999999999999999999999999999999987765 9999999997543
Q ss_pred C-----CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 171 L-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 171 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
. .....+.+||+.|+|||++.+..+.+.++||||+||++|||++|++||.+.+...++..+...
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 2 223456789999999999988777667799999999999999999999998888877777643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=369.59 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=181.7
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC--------
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-------- 90 (330)
++|++++.||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+.++++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 359999999999999999999999999999999976543 2357889999999999999999999997654
Q ss_pred ----eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeec
Q 020133 91 ----HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 91 ----~~~lv~e~~~g~sL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
.+|+|||||+||+|.+++...+. .++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 37999999999999999987654 456678999999999999999999999999999999987765 999999
Q ss_pred CCcccccCCCC-------------CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 164 GYSKSSVLHSQ-------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 164 g~a~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
|+|+....... ....+||+.|||||++.+..++.+ +|||||||++|||++ ||...........
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 99975433211 234579999999999998888655 999999999999996 8865333222222
Q ss_pred HhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 231 TIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.....|... .... ++ ..+.+.++...+|.+|+ |+.|+++
T Consensus 239 ~~~~~~~p~~~-----~~~~-~~-~~~li~~~L~~dP~~Rp-s~~eil~ 279 (299)
T 4g31_A 239 DVRNLKFPPLF-----TQKY-PC-EYVMVQDMLSPSPMERP-EAINIIE 279 (299)
T ss_dssp HHHTTCCCHHH-----HHHC-HH-HHHHHHHHTCSSGGGSC-CHHHHHT
T ss_pred HHhcCCCCCCC-----cccC-HH-HHHHHHHHcCCChhHCc-CHHHHhc
Confidence 23333333221 1111 11 11233444556777765 8888765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=374.17 Aligned_cols=255 Identities=22% Similarity=0.352 Sum_probs=201.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC-----CcEEEEEEeecCCc--ccHHHHHHHHHHHcCCC-CCeeeeeEEEEeC-
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRH-PNIVRFKEVILTP- 89 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h-~~Iv~~~~~~~~~- 89 (330)
..++|++.+.||+|+||+||+|.+..+ ++.||||.+..... ..+.+.+|+.++++++| ||||+++++|...
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 347899999999999999999997653 46899999876543 23568899999999965 8999999999765
Q ss_pred CeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC
Q 020133 90 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~ 153 (330)
+.+|+|||||++|+|.++++.. ..+++..+..++.||+.||.|||+++||||||||+|||++.+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 5689999999999999999753 348999999999999999999999999999999999999877
Q ss_pred CCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 020133 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (330)
Q Consensus 154 ~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~ 229 (330)
+. +||+|||+|+....... .....||+.|||||++.+..++.+ +|||||||++|||+| |+.||.+.+....+.
T Consensus 222 ~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 222 NV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 65 99999999985543322 234568999999999998888655 999999999999998 999999876655555
Q ss_pred HHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 230 KTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+.+.....+. +...++++ +.+.+.+|+..+|.+|+ |+.|+++.|.++
T Consensus 299 ~~i~~g~~~~------~p~~~~~~-~~~li~~c~~~dP~~RP-t~~eil~~L~~l 345 (353)
T 4ase_A 299 RRLKEGTRMR------APDYTTPE-MYQTMLDCWHGEPSQRP-TFSELVEHLGNL 345 (353)
T ss_dssp HHHHHTCCCC------CCTTCCHH-HHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHcCCCCC------CCccCCHH-HHHHHHHHcCcChhHCc-CHHHHHHHHHHH
Confidence 5543211110 11122222 33444556667777765 999999887764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=387.15 Aligned_cols=200 Identities=31% Similarity=0.468 Sum_probs=174.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHH---HHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQRE---IINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~e---i~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+.. .......+| +.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999999999999999997531 222233333 5666778999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~- 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK- 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC-
Confidence 999999999999999999999999999999999999999999999999999999999988775 99999999975433
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
....+.+||+.|+|||++.++...+.++|+|||||++|||++|++||.+.
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 33456799999999999975433345599999999999999999999764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=366.68 Aligned_cols=208 Identities=25% Similarity=0.409 Sum_probs=174.3
Q ss_pred CCCeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++.+.||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.+++.+ +||||++++++|.+++++|+|
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 478999999999999999999875 467899999886653 345688999999988 699999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC---
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 172 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~--- 172 (330)
||||+|++|.+++ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+.....
T Consensus 99 mE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 99 MPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp EECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCG
T ss_pred EeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCcccc
Confidence 9999999999998 4599999999999999999999999999999999999997653 35999999999633211
Q ss_pred --------------------------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-hh
Q 020133 173 --------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-EP 225 (330)
Q Consensus 173 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~-~~ 225 (330)
....+.+||+.|+|||++.+....+.++||||+||++|+|+||+.||...+ ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 112345799999999999887655666999999999999999999996543 34
Q ss_pred hHHHHHh
Q 020133 226 KNFRKTI 232 (330)
Q Consensus 226 ~~~~~~~ 232 (330)
.++..+.
T Consensus 255 ~~l~~I~ 261 (361)
T 4f9c_A 255 TALAQIM 261 (361)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 4444443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=388.97 Aligned_cols=211 Identities=31% Similarity=0.557 Sum_probs=188.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
++|++.+.||+|+||+||+|.++.+|+.||+|++..... ..+.+.+|+.+|+.++||||++++++|.+++.+|+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 689999999999999999999999999999999976543 3457889999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcc
Q 020133 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~ 178 (330)
+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+...........
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~ 316 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeee
Confidence 99999999864 46799999999999999999999999999999999999998665557999999999876655555667
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..+.
T Consensus 317 ~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~ 369 (573)
T 3uto_A 317 TGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369 (573)
T ss_dssp CSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred EECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 89999999999998888655 999999999999999999998877655555443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=361.54 Aligned_cols=254 Identities=23% Similarity=0.268 Sum_probs=187.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC----eEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~----~~~lv~ 96 (330)
.+|.+.+.||+|+||+||++.. +|+.||||++............|+..+.+++|||||++++++..++ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4699999999999999999987 4899999999765433333445666677899999999999998754 589999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc--------CccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
|||+||+|.++++. .++++..+.+++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence 99999999999976 5699999999999999999999987 8999999999999987765 99999999975
Q ss_pred ccCCC-----CCCcccCCCCCCChhhhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCCCCCh--------------
Q 020133 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEE-------------- 224 (330)
Q Consensus 169 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-----~~~~~Di~SlG~il~elltg~~pf~~~~~-------------- 224 (330)
..... .....+||+.|+|||++.+... .+.++|||||||++|||+||..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 43322 2234579999999999976421 13349999999999999999877643211
Q ss_pred hhHHHHHhh----cCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 225 PKNFRKTIH----RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 225 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
...+.+.+. ++..|......- . ...+.+.+.+|+..+|.+|+ |+.|+.+.|.++.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~----~-~~~l~~li~~cl~~dP~~RP-t~~ei~~~L~~l~ 296 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCE----A-LRVMAKIMRECWYANGAARL-TALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSH----H-HHHHHHHHHTTCCSSGGGSC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchH----H-HHHHHHHHHHHcccCHhHCc-CHHHHHHHHHHHH
Confidence 112222221 112221111000 0 11233445566667887775 9999999888753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=347.30 Aligned_cols=209 Identities=41% Similarity=0.697 Sum_probs=187.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 3789999999999999999999999999999999976432 2356789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++.........
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence 99999999999988889999999999999999999999999999999999999987765 9999999998665555556
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
..+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 225 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 678999999999999888876679999999999999999999988665444433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=339.39 Aligned_cols=262 Identities=29% Similarity=0.395 Sum_probs=210.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
-.++|++++.||+|+||.||++.+..+++.||+|.+...... .+.+.+|+..+++++||||+++++++..++..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 357999999999999999999999999999999998654332 2567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
||||++|++|.+++...+++++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccc
Confidence 9999999999999998889999999999999999999999999999999999999987764 9999999997543322
Q ss_pred -CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (330)
......||+.|+|||++.+..++.+ +||||||+++|+|+||+.||.+.+......+.+.....+... .+...+|.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 242 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT---DVRKDIPQ 242 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHH---HSCTTSCH
T ss_pred cccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcch---hcccCCCH
Confidence 2334568999999999988777655 999999999999999999999877666555554332111100 01122222
Q ss_pred cccccccccCCCCCCCCccCCHHHHHHHHHHhCCC
Q 020133 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~ 287 (330)
.+.+.+.++...+|.+|+++++++.+.|......
T Consensus 243 -~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 243 -SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 3445566677789999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=364.10 Aligned_cols=322 Identities=32% Similarity=0.531 Sum_probs=240.6
Q ss_pred cccCCCCCCCcccC--CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCee
Q 020133 6 MTVGPGMDMPIMHD--SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIV 80 (330)
Q Consensus 6 ~~~~pg~~~~~~~~--~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv 80 (330)
+...||+.+..... .++|++++.||+|+||+||+|.+..++..||+|++... ......+.+|+.+++.++||||+
T Consensus 20 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 99 (494)
T 3lij_A 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99 (494)
T ss_dssp CCCCGGGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBC
T ss_pred eccchhheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCC
Confidence 45666665544322 24799999999999999999999999999999998764 23457889999999999999999
Q ss_pred eeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceE
Q 020133 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLK 159 (330)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vk 159 (330)
++++++.+.+.+|+||||++|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+|
T Consensus 100 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 179 (494)
T 3lij_A 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179 (494)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred eEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEE
Confidence 99999999999999999999999999998888999999999999999999999999999999999999997533 34599
Q ss_pred EeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH--------
Q 020133 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT-------- 231 (330)
Q Consensus 160 L~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~-------- 231 (330)
|+|||+++...........+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||.+.+.......+
T Consensus 180 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (494)
T 3lij_A 180 IVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDE-KCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257 (494)
T ss_dssp ECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred EEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCC-chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 999999986665555566789999999999864 4554 499999999999999999999876543322222
Q ss_pred --------------h---------hcCChhHHhcCchhhccCCcc-------ccccccccC-CCCCCC------------
Q 020133 232 --------------I---------HRISIPEIRNHEWFLKNLPAD-------LVVDNTTNN-QFEEPD------------ 268 (330)
Q Consensus 232 --------------~---------~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~p~------------ 268 (330)
+ .|+++.++..|||+....... .......+. .+....
T Consensus 258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~ 337 (494)
T 3lij_A 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMAS 337 (494)
T ss_dssp SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHH
T ss_pred chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 1 578999999999987532110 000000000 000000
Q ss_pred --CccCCHHHHHHHHHHhCCCCCCCCchhhhccCCCCcccc---------ccccCC-CCCCcCCCCCCceeec
Q 020133 269 --QPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDE---------MDEDID-TDPDLDIDSSGEIVYA 329 (330)
Q Consensus 269 --~~~~s~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~-~~~~~~~~~~~~~~~~ 329 (330)
.......++.+.+...+....|..+.+++......+... ..++++ .+...|.|++|.|.|.
T Consensus 338 ~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~ 410 (494)
T 3lij_A 338 KLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYS 410 (494)
T ss_dssp HSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHH
T ss_pred hcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHH
Confidence 011235567778888888888888888876555433211 122344 6667888888888763
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=363.99 Aligned_cols=324 Identities=31% Similarity=0.536 Sum_probs=244.0
Q ss_pred CccccCCCCCCCcccC--CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--------------cccHHHHHH
Q 020133 4 SAMTVGPGMDMPIMHD--SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQRE 67 (330)
Q Consensus 4 ~~~~~~pg~~~~~~~~--~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e 67 (330)
..+++.||+....... .++|++++.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|
T Consensus 17 ~~~~~~~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 96 (504)
T 3q5i_A 17 QGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96 (504)
T ss_dssp CCCCCCGGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHH
T ss_pred cceeechhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHH
Confidence 4566777776655433 478999999999999999999999999999999987543 234678899
Q ss_pred HHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCc
Q 020133 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (330)
Q Consensus 68 i~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~N 147 (330)
+.++++++||||+++++++.+.+.+|+|||||+|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 97 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N 176 (504)
T 3q5i_A 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176 (504)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHH
Confidence 99999999999999999999999999999999999999999888899999999999999999999999999999999999
Q ss_pred EEecCCCC-CceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 148 TLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 148 Ili~~~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
||++.++. ..+||+|||+++............||+.|+|||++.+ .++. ++|||||||++|+|++|..||.+.+...
T Consensus 177 il~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~ 254 (504)
T 3q5i_A 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQD 254 (504)
T ss_dssp EEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99976642 2599999999986665555566789999999999864 4544 4999999999999999999998765433
Q ss_pred HHHHH----------------------h---------hcCChhHHhcCchhhccCCccc------cccccccCCCCCCCC
Q 020133 227 NFRKT----------------------I---------HRISIPEIRNHEWFLKNLPADL------VVDNTTNNQFEEPDQ 269 (330)
Q Consensus 227 ~~~~~----------------------~---------~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~p~~ 269 (330)
.+..+ + .|+++.++..|||+.+...... +...+.+........
T Consensus 255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (504)
T 3q5i_A 255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQ 334 (504)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCS
T ss_pred HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHH
Confidence 22221 1 5789999999999976543210 000000000001111
Q ss_pred ---------------ccCCHHHHHHHHHHhCCCCCCCCchhhhccCCCCccc---------cccccCC-CCCCcCCCCCC
Q 020133 270 ---------------PMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDD---------EMDEDID-TDPDLDIDSSG 324 (330)
Q Consensus 270 ---------------~~~s~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-~~~~~~~~~~~ 324 (330)
..+...++.+.+...+....|..+.+++......+.. .-.++++ .+...|.|++|
T Consensus 335 kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG 414 (504)
T 3q5i_A 335 KLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNG 414 (504)
T ss_dssp HHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSS
T ss_pred HHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCC
Confidence 1123566777888888888888888776543222211 1112333 66677888888
Q ss_pred ceeec
Q 020133 325 EIVYA 329 (330)
Q Consensus 325 ~~~~~ 329 (330)
.|.|.
T Consensus 415 ~I~~~ 419 (504)
T 3q5i_A 415 YIEYS 419 (504)
T ss_dssp SEEHH
T ss_pred cEeHH
Confidence 88763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=340.75 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=204.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.........+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 47899999999999999999999999999999999876655667889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcc
Q 020133 100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~ 178 (330)
+|++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.+..+.+||+|||+++...........
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 9999999997653 799999999999999999999999999999999999998744456999999999765544444556
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCC-hhHHhcCchhhccCCcccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIS-IPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 257 (330)
.+|+.|+|||++.+..++. ++|||||||++|+|++|..||.+.+.......+..... .+.. ....++. .+.+
T Consensus 164 ~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~s~-~~~~ 236 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-----AFKEISI-EAMD 236 (321)
T ss_dssp ESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH-----HHTTSCH-HHHH
T ss_pred cCChhhcCcHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh-----hhccCCH-HHHH
Confidence 7899999999998776654 49999999999999999999998776655555543211 1110 0111222 2233
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ |+.|+++
T Consensus 237 li~~~L~~dp~~Rp-t~~e~l~ 257 (321)
T 1tki_A 237 FVDRLLVKERKSRM-TASEALQ 257 (321)
T ss_dssp HHHTTSCSSGGGSC-CHHHHHH
T ss_pred HHHHHcCCChhHCc-CHHHHhc
Confidence 44445556666655 7777765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=338.44 Aligned_cols=247 Identities=32% Similarity=0.554 Sum_probs=202.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++++.||+|+||.||+|++..+|+.||+|++.+. ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 47899999999999999999999999999999999753 23446788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 174 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~ 174 (330)
|||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++... ....
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCc
Confidence 999999999999998889999999999999999999999999999999999999987764 9999999997533 2333
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 253 (330)
....+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+.......+... ...| ..++.
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p---------~~~s~- 230 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---------RTLSP- 230 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------TTSCH-
T ss_pred ccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---------CCCCH-
Confidence 456689999999999988777655 99999999999999999999887665555444422 1111 11222
Q ss_pred ccccccccCCCCCCCCcc----CCHHHHHH
Q 020133 254 LVVDNTTNNQFEEPDQPM----QSIDEIMQ 279 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~----~s~~el~~ 279 (330)
...+.+.++...+|.+|+ .+++|+++
T Consensus 231 ~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 122333444445666665 57888765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=340.49 Aligned_cols=207 Identities=34% Similarity=0.609 Sum_probs=184.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++.+.||+|+||+||+|.+..+|+.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4689999999999999999999999999999999976532 236789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC--CceEEeecCCccccc
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 170 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~--~~vkL~Dfg~a~~~~ 170 (330)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. ..+||+|||+++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 999999999999999988889999999999999999999999999999999999999976552 259999999998665
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhH
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~ 227 (330)
........+||+.|+|||++.+..++.. +|+|||||++|+|++|..||.+.+....
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~ 226 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQET 226 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred CCCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5555566789999999999987777555 9999999999999999999987654433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=342.31 Aligned_cols=212 Identities=36% Similarity=0.573 Sum_probs=180.8
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~ 92 (330)
...++|++++.||+|+||.||+|++..+|+.||+|++.+. ....+.+.+|..+++.+ +||||+++++++.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4458899999999999999999999999999999999753 23345678899999988 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-C
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~ 171 (330)
|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+... .
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccC
Confidence 999999999999999998889999999999999999999999999999999999999987765 9999999997533 2
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.......+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+.......+.
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 237 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 333456689999999999988777655 999999999999999999999877665555554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=340.80 Aligned_cols=229 Identities=46% Similarity=0.791 Sum_probs=198.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 7899999999999999999999999999999998653 234568899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||+ +|+|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++..........
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTTC
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcccc
Confidence 999 6799999988889999999999999999999999999999999999999987764 9999999998666555566
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh------------------hhHHHHHh------
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE------------------PKNFRKTI------ 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~------------------~~~~~~~~------ 232 (330)
..+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||..... ...+...+
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 245 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA 245 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCS
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCC
Confidence 778999999999998887766669999999999999999999975322 12223333
Q ss_pred ---hcCChhHHhcCchhhccCCc
Q 020133 233 ---HRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 233 ---~~~~~~~~~~~~~~~~~~~~ 252 (330)
.|+++.++..||||...+|.
T Consensus 246 dP~~Rpt~~eil~hp~~~~~~~~ 268 (336)
T 3h4j_B 246 DPMQRITIQEIRRDPWFNVNLPD 268 (336)
T ss_dssp SGGGSCCHHHHTTCHHHHTTCCG
T ss_pred ChhHCcCHHHHHhChhhccCCcc
Confidence 57788888888888766553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=333.87 Aligned_cols=211 Identities=34% Similarity=0.624 Sum_probs=186.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999876432 346789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC--CCceEEeecCCccccc
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 170 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~--~~~vkL~Dfg~a~~~~ 170 (330)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ ...+||+|||+++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888999999999999999999999999999999999999997655 2259999999998665
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 5555566789999999999987777555 99999999999999999999876655444433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=364.05 Aligned_cols=307 Identities=35% Similarity=0.550 Sum_probs=233.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.++++++||||+++++++...+.+|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 68999999999999999999999999999999987542 33467899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-CCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~-~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++........
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 185 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence 999999999999988899999999999999999999999999999999999999532 2346999999999765554444
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH----------------------h-
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT----------------------I- 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~----------------------~- 232 (330)
...+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||.+.+.......+ +
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 263 (484)
T 3nyv_A 186 KDKIGTAYYIAPEVLHG-TYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263 (484)
T ss_dssp HHHTTGGGTCCHHHHHT-CCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHH
T ss_pred ccCCCCccccCceeecC-CCCC-cceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHH
Confidence 55679999999999876 4544 499999999999999999999876543322221 1
Q ss_pred --------hcCChhHHhcCchhhccCCcccccc------ccccC-CCCC--------------CCCccCCHHHHHHHHHH
Q 020133 233 --------HRISIPEIRNHEWFLKNLPADLVVD------NTTNN-QFEE--------------PDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 233 --------~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-~~~~--------------p~~~~~s~~el~~~l~~ 283 (330)
.|+++.++..|||+........... ...+. .+.. .-.......++.+.+..
T Consensus 264 ~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~F~~ 343 (484)
T 3nyv_A 264 KMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHK 343 (484)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHHHHHHH
Confidence 6899999999999976432111000 00000 0000 00001234466677778
Q ss_pred hCCCCCCCCchhhhccCCCCc------ccc------ccccCC-CCCCcCCCCCCceeec
Q 020133 284 ATIPAAGTQSLNQCLNGSLDI------DDE------MDEDID-TDPDLDIDSSGEIVYA 329 (330)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~------~~~------~~~~~~-~~~~~~~~~~~~~~~~ 329 (330)
.+....|..+.+++......+ ..+ .+++++ .+...|.|++|.|.|.
T Consensus 344 ~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~ 402 (484)
T 3nyv_A 344 MDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYS 402 (484)
T ss_dssp HCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHH
T ss_pred hCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHH
Confidence 888888888887773222111 111 023344 6777889999998873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.46 Aligned_cols=201 Identities=31% Similarity=0.540 Sum_probs=178.9
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~ 92 (330)
...++|++++.||+|+||.||+|++..+++.||+|++++.. .....+.+|..++.++ +||||+++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34578999999999999999999999999999999997642 2234578889888876 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc-cC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~-~~ 171 (330)
|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.. ..
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccC
Confidence 999999999999999998889999999999999999999999999999999999999987765 999999999753 33
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
.......+||+.|+|||++.+..++.. +|+|||||++|+|++|+.||..
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTT
T ss_pred CCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcc
Confidence 344556789999999999988877655 9999999999999999999964
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=334.65 Aligned_cols=257 Identities=27% Similarity=0.381 Sum_probs=203.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCC----e
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~----~ 91 (330)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+|+..+++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999999999999999999765322 246789999999999999999999987654 3
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
.|+||||++|++|.+++...+++++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC-----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccc
Confidence 5999999999999999998889999999999999999999999999999999999999987764 99999999874433
Q ss_pred CC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 172 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
.. ......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.+.+..............+.....
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 243 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH---- 243 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS----
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc----
Confidence 21 2234568999999999988777555 99999999999999999999987776665555544333222111
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..++. .+.+.+.++...+|.+|+++++++...+...
T Consensus 244 ~~~~~-~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 244 EGLSA-DLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TTCCH-HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCH-HHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 11222 2334555666788999999999999888765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=331.49 Aligned_cols=209 Identities=33% Similarity=0.590 Sum_probs=186.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++++.||+|+||.||+|++..+|+.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 378999999999999999999999999999999987542 3346778999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VT 160 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CB
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--cc
Confidence 999999999999998889999999999999999999999999999999999999987764 99999999974432 33
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
...+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||...+......++..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 217 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred ccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 45679999999999988877655 9999999999999999999988776666655553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=335.31 Aligned_cols=211 Identities=35% Similarity=0.575 Sum_probs=183.7
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~ 92 (330)
...++|++.+.||+|+||.||+|++..+|+.||+|.+++. ......+.+|..++..+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3458999999999999999999999999999999999764 23345677888888876 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~- 171 (330)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccC
Confidence 999999999999999998889999999999999999999999999999999999999987764 99999999975432
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.......+||+.|+|||++.+..++.. +|+|||||++|+|++|+.||.+.+.......+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 230 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 233456689999999999988877555 99999999999999999999876655444433
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=357.16 Aligned_cols=307 Identities=34% Similarity=0.558 Sum_probs=231.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.++|++++.||+|+||+||+|.+..+++.||+|++... ......+.+|+.++++++||||+++++++...+.+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 37899999999999999999999999999999998643 334567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-CCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~-~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ....+||+|||+++........
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 999999999999888899999999999999999999999999999999999999643 2345999999999866555555
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH----------------------h-
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT----------------------I- 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~----------------------~- 232 (330)
...+||+.|+|||++.+. ++ .++|||||||++|+|++|+.||.+.+....+..+ +
T Consensus 181 ~~~~gt~~y~aPE~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 258 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258 (486)
T ss_dssp -CCTTGGGGCCGGGGGSC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHH
T ss_pred CCCcCCCCCCCHHHhCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHH
Confidence 667899999999998753 54 4599999999999999999999776543322221 1
Q ss_pred --------hcCChhHHhcCchhhccCCccccc----------cccccCCCCCC---------C---CccCCHHHHHHHHH
Q 020133 233 --------HRISIPEIRNHEWFLKNLPADLVV----------DNTTNNQFEEP---------D---QPMQSIDEIMQIIA 282 (330)
Q Consensus 233 --------~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~p---------~---~~~~s~~el~~~l~ 282 (330)
.|+++.++..|||+.+........ ..+.+...... . .......++.+.+.
T Consensus 259 ~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~F~ 338 (486)
T 3mwu_A 259 KMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFR 338 (486)
T ss_dssp HHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred HHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHHHH
Confidence 578999999999997643321000 00000000000 0 01123456777888
Q ss_pred HhCCCCCCCCchhhhccCCCCccc---------------cccccCC-CCCCcCCCCCCceee
Q 020133 283 EATIPAAGTQSLNQCLNGSLDIDD---------------EMDEDID-TDPDLDIDSSGEIVY 328 (330)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~-~~~~~~~~~~~~~~~ 328 (330)
..+....|..+.+++......+.. ...+.++ .+...|.|++|.|.|
T Consensus 339 ~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~ 400 (486)
T 3mwu_A 339 KLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEY 400 (486)
T ss_dssp HHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCH
T ss_pred HhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcH
Confidence 888888888888777332221110 0122233 556677777777765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=326.19 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=199.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++++.||+|+||+||+|.+..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4789999999999999999999999999999999875433 346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~ 177 (330)
++|++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++....... ....
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCC
Confidence 9999999998764 6999999999999999999999999999999999999987764 9999999987544332 3345
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.............. ... ....++ ..+.+
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~----~~~~~~-~~~~~ 248 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQ----NPEKLS-AIFRD 248 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCS----CGGGSC-HHHHH
T ss_pred ccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCC----CccccC-HHHHH
Confidence 679999999999988887655 99999999999999999999887665544443322110 000 011121 12233
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ ++.|+++
T Consensus 249 li~~~l~~dp~~Rp-s~~ell~ 269 (297)
T 3fxz_A 249 FLNRCLEMDVEKRG-SAKELLQ 269 (297)
T ss_dssp HHHHHSCSSTTTSC-CHHHHTT
T ss_pred HHHHHccCChhHCc-CHHHHhh
Confidence 44445556676664 7777765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=341.18 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=201.8
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
....++|++++.||+|+||.||+|.+..+++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 33458899999999999999999999999999999998753 23346788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCC
Confidence 999999999999999998889999999999999999999999999999999999999987765 999999999866555
Q ss_pred CCCCcccCCCCCCChhhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCCChh--hHHHHHhhcCChhHHhcCchhh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--KNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~SlG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
......+||+.|+|||++.+. .++ .++|+|||||++|+|++|+.||...... ......+..... -+.
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------~~p 240 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-------TYP 240 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC-------CCC
T ss_pred CceeccCCCccccCCeeeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc-------CCC
Confidence 556677899999999998643 344 4499999999999999999999754322 122221111100 001
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
..++ ..+.+.+.++...+|.+|+.+++++.+
T Consensus 241 ~~~s-~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 SAWS-QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTSC-HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CcCC-HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1111 223344455556777888777777764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=334.73 Aligned_cols=205 Identities=37% Similarity=0.628 Sum_probs=182.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 479999999999999999999999999999999976532 23567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecCCcccccCCCCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
|++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||++..........
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~ 188 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence 999999999998888899999999999999999999999999999999999997643 2469999999998665544455
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
...||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~ 237 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHR 237 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 6789999999999988777655 999999999999999999998765433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=333.05 Aligned_cols=203 Identities=38% Similarity=0.670 Sum_probs=178.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3789999999999999999999999999999999865432 23568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC---CC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~---~~ 174 (330)
|++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++..... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccc
Confidence 9999999999988888999999999999999999999999999999999999987664 999999999743322 22
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
.....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.....
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 34567999999999998887766669999999999999999999976544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=347.68 Aligned_cols=230 Identities=44% Similarity=0.788 Sum_probs=200.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999987542 2346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|||++|++|.+++..++.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++........
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCB
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccc
Confidence 999999999999988889999999999999999999999999999999999999987764 999999999865555455
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh-----------------------
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----------------------- 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~----------------------- 232 (330)
...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...+......++.
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 252 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQ 252 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTC
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcC
Confidence 667899999999999888776667999999999999999999998765443333322
Q ss_pred ----hcCChhHHhcCchhhccCC
Q 020133 233 ----HRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 233 ----~~~~~~~~~~~~~~~~~~~ 251 (330)
.|+++.++..||||...++
T Consensus 253 ~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 253 VDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp SSTTTSCCHHHHHTCHHHHTTCC
T ss_pred CCchhCcCHHHHHhCHHhhhcCc
Confidence 4677777788887766544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=343.23 Aligned_cols=211 Identities=35% Similarity=0.590 Sum_probs=182.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 679999999999999999999999999999999876542 23568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-CCCceEEeecCCcccccCCC-CC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS-QP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~-~~~~vkL~Dfg~a~~~~~~~-~~ 175 (330)
|++|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+++...... ..
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~ 170 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence 99999999999998999999999999999999999999999999999999999753 23469999999997554332 23
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+.......+.
T Consensus 171 ~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 226 (444)
T 3soa_A 171 FGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226 (444)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 45679999999999988777655 999999999999999999998776655544443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=333.06 Aligned_cols=211 Identities=34% Similarity=0.558 Sum_probs=185.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++++.||+|+||.||+|++..+|+.||+|++.+. ....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 457899999999999999999999999999999999764 23346678899999887 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~ 172 (330)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++... ..
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCC
Confidence 99999999999999998889999999999999999999999999999999999999987764 9999999997533 23
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
......+||+.|+|||++.+..++.. +|+|||||++|+|++|+.||.+.+.......+.
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 234 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 33456689999999999988877555 999999999999999999999877655555544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=340.54 Aligned_cols=211 Identities=34% Similarity=0.495 Sum_probs=183.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++++.||+|+||.||+|++..+++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 457899999999999999999999999999999998752 2233457899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSE
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCc
Confidence 9999999999998875 57999999999999999999999999999999999999987765 9999999997543332
Q ss_pred -CCCcccCCCCCCChhhhhcCCC---CCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~---~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....+||+.|+|||++.+... .+.++|+|||||++|+|++|+.||.+.+......++.
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 286 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence 2346689999999999976551 2345999999999999999999999877666665554
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=321.04 Aligned_cols=210 Identities=27% Similarity=0.470 Sum_probs=177.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++++.||+|+||+||+|.+..+++.||+|++...... ...+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999765332 3678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~ 176 (330)
|++++.+..+...++.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++..... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccccc
Confidence 9987544444445678999999999999999999999999999999999999987764 999999999754322 3334
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCCChhhHHHHHh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTI 232 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~p-f~~~~~~~~~~~~~ 232 (330)
...+|+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+.......+.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 567899999999998776545669999999999999988777 45555555554444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=332.79 Aligned_cols=199 Identities=32% Similarity=0.551 Sum_probs=177.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~l 94 (330)
.++|++++.||+|+||.||+|++..+++.||+|++.+... ....+.+|+.+++++ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 4789999999999999999999999999999999986532 234577899999887 89999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCC
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~ 173 (330)
||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++... ...
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTTC
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCCC
Confidence 9999999999999998889999999999999999999999999999999999999987764 9999999997533 233
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
.....+||+.|+|||++.+..++.. +|+|||||++|+|++|+.||..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCC
Confidence 4456689999999999988777554 9999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=327.16 Aligned_cols=257 Identities=29% Similarity=0.416 Sum_probs=195.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..++|++.+.||+|+||+||++.+ +|+.||+|++...... ...+.+|+.++++++||||+++++++...+..|+|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 457899999999999999999987 4888999998765432 24678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 96 MEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
|||+++++|.+++...+. +++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCcccc
Confidence 999999999999987553 999999999999999999999999 999999999999987764 9999999987433
Q ss_pred CC-CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 171 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+................ +...
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~ 263 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE------IPRN 263 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC------CCTT
T ss_pred ccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------CCcc
Confidence 22 22345678999999999988777555 9999999999999999999998776555444432211110 1112
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
++. .+.+.+.++...+|.+|+ ++.++++.|..+....
T Consensus 264 ~~~-~l~~li~~~l~~dP~~Rp-s~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 264 LNP-QVAAIIEGCWTNEPWKRP-SFATIMDLLRPLIKSA 300 (309)
T ss_dssp SCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHHC--
T ss_pred CCH-HHHHHHHHHccCChhhCc-CHHHHHHHHHHHHHhC
Confidence 222 223344455556777764 9999999988775543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=331.67 Aligned_cols=246 Identities=28% Similarity=0.514 Sum_probs=202.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++++.||+|+||.||+|.+..+|+.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3478999999999999999999999999999999987542 334678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~--~ 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--R 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--C
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--C
Confidence 9999999999999998889999999999999999999999999999999999999987764 99999999975432 2
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 253 (330)
....+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+.+.......+... ...| ..++.
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p---------~~~~~- 263 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP---------SHFSS- 263 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------TTCCH-
T ss_pred cccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---------CCCCH-
Confidence 345679999999999988877655 99999999999999999999987766555555432 1111 11222
Q ss_pred ccccccccCCCCCCCCccCC----HHHHHH
Q 020133 254 LVVDNTTNNQFEEPDQPMQS----IDEIMQ 279 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s----~~el~~ 279 (330)
.+.+.+.++...+|.+|+.+ ++++++
T Consensus 264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 22334444455667777653 666654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=327.00 Aligned_cols=212 Identities=31% Similarity=0.515 Sum_probs=176.6
Q ss_pred cCCCCeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~ 89 (330)
...++|++.+.||+|+||.||++++. .+++.||+|++.+.. .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34578999999999999999999985 689999999987642 2335678899999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~ 171 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKES 171 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC---
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCccccc
Confidence 999999999999999999998889999999999999999999999999999999999999987764 999999998743
Q ss_pred cC-CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 170 VL-HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 170 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.. ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 234 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 32 223345679999999999987777554 999999999999999999999877666555554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=336.90 Aligned_cols=208 Identities=29% Similarity=0.510 Sum_probs=182.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4689999999999999999999999999999999876532 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+++..........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 209 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence 99999999987654 79999999999999999999999999999999999999865555799999999986554444455
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHH
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~ 228 (330)
..+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.....
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~ 259 (387)
T 1kob_A 210 TTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETL 259 (387)
T ss_dssp ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred eccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 679999999999987777554 99999999999999999999876544333
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=340.98 Aligned_cols=211 Identities=27% Similarity=0.510 Sum_probs=181.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++++.||+|+||+||++++..+++.||+|++.+. ......+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 347899999999999999999999999999999998753 1223347889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDG 229 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCC
Confidence 9999999999999987 578999999999999999999999999999999999999987765 9999999997543332
Q ss_pred C--CCcccCCCCCCChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 Q--PKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 ~--~~~~~~~~~y~aPE~~~-----~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
. ....+||+.|+|||++. ...+ +.++|||||||++|||++|+.||.+.+......+++
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 294 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence 2 23468999999999987 3344 445999999999999999999998877655555443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=328.20 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=201.2
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
...++|++.+.||+|+||+||++.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 34689999999999999999999999999999999886543 33467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+++++|.+++.. .+.+++.++..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccc
Confidence 99999999999987 567999999999999999999999999999999999999987764 999999998744322211
Q ss_pred ---------------CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh-----HHHHHhhcC
Q 020133 176 ---------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----NFRKTIHRI 235 (330)
Q Consensus 176 ---------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~-----~~~~~~~~~ 235 (330)
....||+.|+|||++.+..++.+ +||||||+++|+|++|..||....... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 14578999999999988777655 999999999999999999987533211 11111111
Q ss_pred ChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 236 SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+...+|. .+.+.+.++...+|.+|+ ++.++.+.|..+.
T Consensus 243 ---------~~~~~~~~-~l~~li~~~l~~dP~~Rp-s~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 ---------YCPPNCPP-SFFPITVRCCDLDPEKRP-SFVKLEHWLETLR 281 (310)
T ss_dssp ---------TCCTTCCT-THHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred ---------cCCCCCCH-HHHHHHHHHccCChhhCc-CHHHHHHHHHHHH
Confidence 01122222 233444555567777764 8999998888764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=324.13 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=200.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||+|+||.||++.+..+++.||+|++...... .+.+.+|+..+++++||||+++++++..++..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 348899999999999999999999999999999998754322 3568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
||||++|++|.+++...+++++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC---------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcccccccc
Confidence 9999999999999998889999999999999999999999999999999999999987764 9999999987443322
Q ss_pred -CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccCC
Q 020133 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 251 (330)
......+++.|+|||++.+..++.+ +||||||+++|+|++|+.||...+.. .....+.. ...+.. +...+|
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~ 262 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPST-----VRPGIP 262 (309)
T ss_dssp -------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGG-----TSTTCC
T ss_pred ccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccc-----cCCCCC
Confidence 2234568999999999987776555 99999999999999999999875543 33333222 111111 112233
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCCC
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAA 289 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~~ 289 (330)
. .+.+.+.++...+|.+|+++++++.+.|...-....
T Consensus 263 ~-~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 263 V-AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp T-HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred H-HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 2 234455666678899999999999999998755443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=325.13 Aligned_cols=252 Identities=30% Similarity=0.527 Sum_probs=205.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3679999999999999999999999999999999876432 246789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC--CceEEeecCCccccc
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 170 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~--~~vkL~Dfg~a~~~~ 170 (330)
|+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. ..+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 999999999999999998888999999999999999999999999999999999999986652 159999999998665
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC-ChhHHhcCchhhcc
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-SIPEIRNHEWFLKN 249 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (330)
.........+++.|+|||++.+..++.+ +||||||+++|+|++|+.||.+.........+.... ..+. -+...
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-----~~~~~ 244 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE-----EFFSH 244 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-----HHHTT
T ss_pred ccccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-----hhhcc
Confidence 5555566679999999999987777555 999999999999999999998877665555444321 1111 01112
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+ ..+.+.+.++...+|.+|+ ++.|+++
T Consensus 245 ~~-~~~~~li~~~l~~dp~~Rp-s~~e~l~ 272 (321)
T 2a2a_A 245 TS-ELAKDFIRKLLVKETRKRL-TIQEALR 272 (321)
T ss_dssp CC-HHHHHHHHTTSCSSTTTSC-CHHHHHH
T ss_pred cC-HHHHHHHHHHcCCChhhCc-CHHHHhc
Confidence 22 2233445556667777766 7787765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=331.27 Aligned_cols=212 Identities=33% Similarity=0.576 Sum_probs=178.6
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHH-HHcCCCCCeeeeeEEEEeCCeE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~-l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
...++|++++.||+|+||.||+|++..+++.||+|++.+... ....+.+|... ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 345789999999999999999999999999999999976532 22345556655 4668999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-C
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~ 171 (330)
|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++... .
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccC
Confidence 999999999999999998889999999999999999999999999999999999999987764 9999999997533 3
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.......+||+.|+|||++.+..++.. +|+|||||++|||++|+.||.+.+.......++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 252 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 334556789999999999988777555 999999999999999999998877665555554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=323.20 Aligned_cols=211 Identities=29% Similarity=0.457 Sum_probs=182.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC------cccHHHHHHHHHHHcCC---CCCeeeeeEEEEeCC
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLR---HPNIVRFKEVILTPT 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~ei~~l~~l~---h~~Iv~~~~~~~~~~ 90 (330)
.++|++++.||+|+||+||+|.+..+++.||+|.+.... .....+.+|+..+++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 479999999999999999999999999999999986422 23457778888877764 999999999998765
Q ss_pred -----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeec
Q 020133 91 -----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 91 -----~~~lv~e~~~g~sL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
..++||||+.+ +|.+++..... +++..++.++.|++.||.|||++||+||||||+||+++.++. +||+||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Df 164 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADF 164 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSC
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeC
Confidence 58999999974 99999987654 999999999999999999999999999999999999987764 999999
Q ss_pred CCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 164 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
|+++............+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+...
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99986655555566789999999999988877655 99999999999999999999988877777666644
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=321.46 Aligned_cols=209 Identities=30% Similarity=0.481 Sum_probs=177.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++++.||+|+||+||+|.+ .+|+.||+|++.... .....+.+|+.++++++||||+++++++...+..|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999999 678999999986543 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCC
Q 020133 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~ 175 (330)
|+++ +|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++..... ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence 9976 898888754 67999999999999999999999999999999999999987764 999999998744322 223
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
....+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4457899999999997655445569999999999999999999998877766666554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=329.71 Aligned_cols=253 Identities=23% Similarity=0.259 Sum_probs=198.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++.+.||+|+||.||++.+..+|+.||||++..... ...+.+|+.+++++ +||||+++++++...+..|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 4789999999999999999999999999999998876533 34688999999999 999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC---CceEEeecCCcccccCCCC
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~---~~vkL~Dfg~a~~~~~~~~ 174 (330)
+ +++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++. ..+||+|||+++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 9 8999999986 468999999999999999999999999999999999999976542 1399999999975433221
Q ss_pred --------CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh---HHHHHhh---cCChhHH
Q 020133 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIH---RISIPEI 240 (330)
Q Consensus 175 --------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~---~~~~~~~---~~~~~~~ 240 (330)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+... .+..+.. ....+.
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 243 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSR-RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV- 243 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCc-hhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH-
Confidence 24567999999999998877754 4999999999999999999998754322 1222211 111111
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+....| .+.+.+..+...+|.+|+ +++++.+.|.++
T Consensus 244 -----~~~~~p--~~~~li~~~l~~~p~~RP-~~~~l~~~l~~~ 279 (330)
T 2izr_A 244 -----LCENFP--EMATYLRYVRRLDFFEKP-DYDYLRKLFTDL 279 (330)
T ss_dssp -----HTTTCH--HHHHHHHHHHHCCTTCCC-CHHHHHHHHHHH
T ss_pred -----HhccCh--HHHHHHHHHHhCCCCCCC-CHHHHHHHHHHH
Confidence 111122 223333444446666654 899999888765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=324.86 Aligned_cols=210 Identities=29% Similarity=0.496 Sum_probs=177.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.++|++++.||+|+||+||+|.+. +|+.||+|++..... ....+.+|+.++++++||||+++++++.+++..|+||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 489999999999999999999995 489999999875432 2357889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CC
Q 020133 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~ 174 (330)
||+++ +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRS 175 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC-
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCccc
Confidence 99986 777777654 45999999999999999999999999999999999999987764 999999999754322 23
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.....+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 34457899999999997755445569999999999999999999998777766666554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=316.46 Aligned_cols=249 Identities=39% Similarity=0.655 Sum_probs=193.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+..++.++||||+++++++...+..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3478999999999999999999999999999999986532 334678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
||||+++++|.+++...+.+++..++.++.|++.||.+||++|++|+||||+||+++.++. ++|+|||++........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC---
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcc
Confidence 9999999999999998889999999999999999999999999999999999999987664 99999999876554444
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
.....+++.|+|||++.+..+.+.++|+||||+++|+|++|+.||...........+..... .+...++. .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~-~ 237 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF--------YIPEYLNR-S 237 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCCTTSCH-H
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--------cCchhcCH-H
Confidence 45567899999999998776655669999999999999999999987665544443332210 01111121 2
Q ss_pred cccccccCCCCCCCCccCCHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.+.++...+|.+|+ ++.++++
T Consensus 238 l~~li~~~l~~~p~~Rp-s~~~~l~ 261 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRA-TIKDIRE 261 (276)
T ss_dssp HHHHHHHHTCSSGGGSC-CHHHHHH
T ss_pred HHHHHHHHccCChhhCC-CHHHHHh
Confidence 23334444456666654 8888775
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=325.37 Aligned_cols=212 Identities=28% Similarity=0.470 Sum_probs=169.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++++.||+|+||.||+|.+..+|+.||+|.+.... .....+.+|+.++++++||||+++++++..++..|+||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 4578999999999999999999999999999999987543 33477889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 97 EYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 97 e~~~g~sL~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG 159 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence 99985 999988653 35999999999999999999999999999999999999987764 9999999997543
Q ss_pred CC-CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 171 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.. .......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 223 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 32 2334567899999999997754445559999999999999999999998877766666554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=330.18 Aligned_cols=201 Identities=32% Similarity=0.571 Sum_probs=175.7
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC------CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
++|++.+.||+|+||+||+|.+..+|+.||+|++... ....+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 6799999999999999999999999999999998642 1235678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecCCcccc
Q 020133 95 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~~~ 169 (330)
||||++|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999998877542 3589999999999999999999999999999999999997543 235999999999755
Q ss_pred cCCCC-CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 170 VLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 170 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
..... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCc
Confidence 43322 345679999999999988777555 99999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=314.49 Aligned_cols=250 Identities=33% Similarity=0.518 Sum_probs=202.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
++|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..|+||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 67999999999999999999999999999999987653 33567899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccCCCCCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~~~~~~~~ 178 (330)
++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++.. +..+.++|+|||++............
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 168 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhcc
Confidence 99999999988889999999999999999999999999999999999999932 12235999999999766555555667
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC-ChhHHhcCchhhccCCcccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-SIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
.+++.|+|||++.+. ++. ++||||||+++|+|++|+.||...+.......+.... ..+... ...++. .+.+
T Consensus 169 ~~t~~y~aPE~~~~~-~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~ 240 (277)
T 3f3z_A 169 VGTPYYVSPQVLEGL-YGP-ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-----WLNVSP-QAES 240 (277)
T ss_dssp CSCTTTCCHHHHTTC-BCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH-----HTTSCH-HHHH
T ss_pred CCCCCccChHHhccc-CCc-hhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh-----hhcCCH-HHHH
Confidence 899999999998654 544 4999999999999999999999877666555554332 111110 011222 2334
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ ++.++++
T Consensus 241 li~~~l~~dp~~R~-s~~~~l~ 261 (277)
T 3f3z_A 241 LIRRLLTKSPKQRI-TSLQALE 261 (277)
T ss_dssp HHHHHTCSSTTTSC-CHHHHTT
T ss_pred HHHHHccCChhhCc-CHHHHhc
Confidence 44555567787776 6676663
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=327.44 Aligned_cols=205 Identities=37% Similarity=0.604 Sum_probs=165.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++...+..|+||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 367999999999999999999999999999999987653 3456789999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccCCCCCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~~~~~~~~ 178 (330)
++++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++. +..+.+||+|||+++...........
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence 99999999988888999999999999999999999999999999999999975 22346999999999765544444566
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~ 226 (330)
.||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~ 257 (349)
T 2w4o_A 211 CGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQ 257 (349)
T ss_dssp --CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred cCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccH
Confidence 78999999999988777555 999999999999999999998765544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=316.40 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=206.5
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
...++|++++.||+|+||.||++.+.. ++.||+|++.......+.+.+|+..+++++||||+++++++.+.+..|+|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 456889999999999999999999874 7789999998877677889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC--CC
Q 020133 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQ 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~--~~ 174 (330)
|+++++|.+++... +.+++..++.++.|++.||.+||++|++||||||+||+++.++. +||+|||+++..... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHS
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccccc
Confidence 99999999999653 46999999999999999999999999999999999999977654 999999998744322 12
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||...........+...... ...... ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~-~~ 234 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------YKPRLA-ST 234 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------CCCTTS-CH
T ss_pred ccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC-------CCCCcC-CH
Confidence 234456778999999987777555 999999999999999 99999987766655555433211 111111 22
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+.+.+.++...+|.+|+ ++.++++.|.++.
T Consensus 235 ~~~~li~~~l~~~p~~Rp-s~~~ll~~l~~l~ 265 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRP-AFSRLLRQLAEIA 265 (269)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCcccCc-CHHHHHHHHHHHH
Confidence 233444555567777765 9999999988753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=337.10 Aligned_cols=199 Identities=27% Similarity=0.412 Sum_probs=168.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------C
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~ 90 (330)
.++|++++.||+|+||+||+|.+..+|+.||||++.... .....+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999999999999999997642 2345678999999999999999999999754 4
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.+|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 141 ~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred eEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence 67999999976 4666664 35999999999999999999999999999999999999987764 9999999998665
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
........++|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5555566789999999999998887655 9999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=326.51 Aligned_cols=267 Identities=23% Similarity=0.349 Sum_probs=201.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC--eEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~--~~~l 94 (330)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++...+ ..|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3578999999999999999999999999999999987543 23467789999999999999999999998765 7899
Q ss_pred EEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEe--cCCCCCceEEeecCCcccc
Q 020133 95 VMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli--~~~~~~~vkL~Dfg~a~~~ 169 (330)
||||+++++|.+++..... +++..++.++.|++.||.|||++||+||||||+||++ +.+....+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999999999976443 9999999999999999999999999999999999998 1122335999999999866
Q ss_pred cCCCCCCcccCCCCCCChhhhh--------cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh----HHHHHhhcCCh
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLL--------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK----NFRKTIHRISI 237 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~ 237 (330)
..........+|+.|+|||++. +..++ .++|||||||++|+|++|+.||....... ...+++.....
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBC-TTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 5555555677999999999986 34444 44999999999999999999997544332 22233221110
Q ss_pred hH------HhcCc--h---------hhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 238 PE------IRNHE--W---------FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 238 ~~------~~~~~--~---------~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
+. ....+ | +...+ ...+.+.+.++...+|.+|+ +++|+++-..+...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~ll~~~L~~dP~~R~-s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGL-QVLLTPVLANILEADQEKCW-GFDQFFAETSDILHRG 311 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHH-HHHHHHHHHHHSCCCTTTSC-CHHHHHHHHHHHTC--
T ss_pred ccchhhhcccCCccccCccCCcccccchhH-HHHhHHHHHHhccCChhhhc-cHHHhhhccHHHhhcC
Confidence 00 00000 0 00000 11233344555667787766 8888888777655443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=335.54 Aligned_cols=211 Identities=27% Similarity=0.483 Sum_probs=182.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++++.||+|+||.||+++++.+|+.||+|++.+.. .....+.+|..++..++||||+++++++.+.+.+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3578999999999999999999999999999999997532 223457889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADG 216 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCC
Confidence 999999999999998754 7999999999999999999999999999999999999987765 9999999997544332
Q ss_pred C--CCcccCCCCCCChhhhhc-------CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 Q--PKSTVGTPAYIAPEVLLK-------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 ~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
. ....+||+.|+|||++.. ..+ +.++|+|||||++|||++|+.||.+.+......+++
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2 234689999999999973 334 445999999999999999999999877766666655
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=315.57 Aligned_cols=252 Identities=31% Similarity=0.522 Sum_probs=202.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.++++++||||+++++++...+..|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4789999999999999999999999999999999876432 2356789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC-CceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~-~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+++++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||+++.++. ..+||+|||++.........
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 99999999999988889999999999999999999999999999999999999975532 35999999999765555555
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCC-hhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIS-IPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 254 (330)
....+++.|+|||++.+..++.+ +||||||+++|+|++|+.||...+.......+..... .+.. ....++. .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-~ 237 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-----EWDTVTP-E 237 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-----TTTTSCH-H
T ss_pred cCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch-----hhcccCH-H
Confidence 56779999999999988777555 9999999999999999999988766555444432211 1100 0011122 2
Q ss_pred cccccccCCCCCCCCccCCHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.+.++...+|.+|+ ++.|+++
T Consensus 238 ~~~li~~~l~~dp~~Rp-s~~~~l~ 261 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRI-TADQALK 261 (284)
T ss_dssp HHHHHHHHSCSSTTTSC-CHHHHTT
T ss_pred HHHHHHHHcccChhhCC-CHHHHhc
Confidence 23344445556676665 7777664
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=339.76 Aligned_cols=248 Identities=34% Similarity=0.540 Sum_probs=193.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++++.||+|+||.||+|.+..+|+.||+|++... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 47899999999999999999999999999999998753 22335677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHS 173 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~ 173 (330)
|||++|++|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+|+... ...
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGA 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC---
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCc
Confidence 9999999999999988899999999999999999999998 99999999999999987764 9999999997533 233
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+..... -+...+++
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------~~p~~~~~- 374 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------RFPRTLGP- 374 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCCTTSCH-
T ss_pred ccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--------CCCccCCH-
Confidence 3456789999999999988877655 9999999999999999999988776655555442211 01112222
Q ss_pred ccccccccCCCCCCCCcc----CCHHHHHH
Q 020133 254 LVVDNTTNNQFEEPDQPM----QSIDEIMQ 279 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~----~s~~el~~ 279 (330)
.+.+.+.++...+|.+|+ ++++|+++
T Consensus 375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 223344445556777776 58888764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=327.34 Aligned_cols=208 Identities=32% Similarity=0.442 Sum_probs=167.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCC--eEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~--~~~l 94 (330)
++|++++.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.+. ||||+++++++...+ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 68999999999999999999999999999999986542 22356778999999997 999999999998654 6899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC---
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~--- 171 (330)
||||++ ++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCccccccccccc
Confidence 999997 589888876 57999999999999999999999999999999999999987764 99999999974322
Q ss_pred -------------------CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 172 -------------------HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 172 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+...++..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1112345789999999999875544566999999999999999999998877666555554
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=325.00 Aligned_cols=209 Identities=25% Similarity=0.458 Sum_probs=182.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----CCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-----h~~Iv~~~~~~~~~~~~~l 94 (330)
.++|++++.||+|+||+||+|.+..+++.||||++.........+.+|+.+++.++ ||||+++++++...+..|+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 57999999999999999999999999999999999866555667888999999886 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-------------------
Q 020133 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS------------------- 153 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~------------------- 153 (330)
||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 99999 889999998654 59999999999999999999999999999999999999751
Q ss_pred ----CCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 154 ----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 154 ----~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
..+.+||+|||+++... .......+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+......
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~ 269 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269 (360)
T ss_dssp EEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 13469999999997432 23345678999999999988887655 999999999999999999998877655544
Q ss_pred HHh
Q 020133 230 KTI 232 (330)
Q Consensus 230 ~~~ 232 (330)
.+.
T Consensus 270 ~~~ 272 (360)
T 3llt_A 270 MME 272 (360)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=330.08 Aligned_cols=205 Identities=30% Similarity=0.415 Sum_probs=171.8
Q ss_pred CCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 020133 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL 87 (330)
Q Consensus 11 g~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~ 87 (330)
++.+....-.++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.++++++||||+++++++.
T Consensus 16 ~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred hcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3444455567899999999999999999999999999999999976432 2357889999999999999999999998
Q ss_pred eC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEee
Q 020133 88 TP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (330)
Q Consensus 88 ~~-----~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~D 162 (330)
.. +..|+||||++ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~D 172 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCD 172 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECC
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEcc
Confidence 76 56999999996 599999998888999999999999999999999999999999999999987764 99999
Q ss_pred cCCcccccCCC-----------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC
Q 020133 163 FGYSKSSVLHS-----------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218 (330)
Q Consensus 163 fg~a~~~~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~p 218 (330)
||+|+...... .....++|+.|+|||++......+.++|||||||++|||++|..|
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 99997543321 124567899999999975555445669999999999999984333
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=314.58 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=207.4
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
...++|++++.||+|+||.||++.+. ++..||+|.+.......+.+.+|+..+++++||||+++++++...+..|+|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 35688999999999999999999876 47789999998877677889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--C
Q 020133 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~ 174 (330)
|+++++|.+++...+ .+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhc
Confidence 999999999997654 5999999999999999999999999999999999999987764 9999999987443322 1
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||.................. ...... ++
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~-~~ 232 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-------YRPHLA-SD 232 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------CCCTTS-CH
T ss_pred ccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-------CCCCcC-hH
Confidence 223345677999999988777655 999999999999999 99999887766655554432211 111111 22
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
.+.+.+.++...+|.+| +|+.++++.|..+..
T Consensus 233 ~l~~li~~~l~~~p~~R-ps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKR-PTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHHTTCSSGGGS-CCHHHHHHHHGGGCC
T ss_pred HHHHHHHHHcCCChhhC-cCHHHHHHHHHHhhh
Confidence 23444555666777776 499999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=318.30 Aligned_cols=252 Identities=30% Similarity=0.488 Sum_probs=192.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3478999999999999999999999999999999987653 23478899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-CCCceEEeecCCcccccC
Q 020133 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 97 e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~-~~~~vkL~Dfg~a~~~~~ 171 (330)
||+++++|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.+ ..+.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999999998854 3679999999999999999999999999999999999999542 234699999999976555
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCC
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
........+++.|+|||++.+ .+ +.++||||||+++|+|++|+.||.+.+.................. ...++
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 252 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-----CRPLT 252 (285)
T ss_dssp -------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-------CCCC
T ss_pred cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-----cCcCC
Confidence 555566779999999999853 44 445999999999999999999998866554443333221100000 01111
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHH
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+ .+.+.+.++...+|.+|+ ++.|+++
T Consensus 253 ~-~~~~li~~~L~~dP~~Rp-s~~e~l~ 278 (285)
T 3is5_A 253 P-QAVDLLKQMLTKDPERRP-SAAQVLH 278 (285)
T ss_dssp H-HHHHHHHHHTCSCTTTSC-CHHHHHT
T ss_pred H-HHHHHHHHHccCChhhCc-CHHHHhc
Confidence 2 222344445556777665 7777653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=327.93 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=203.9
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCc---EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
...++|++.+.||+|+||.||++.+..+++ .||||.+.... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 345789999999999999999999986554 59999987643 2345788999999999999999999999998999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
|+||||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++....
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLED 203 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC-
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCccccccc
Confidence 9999999999999999754 57999999999999999999999999999999999999987664 99999999975433
Q ss_pred CCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchh
Q 020133 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246 (330)
Q Consensus 172 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (330)
... .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||...........+......+.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 275 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA------- 275 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC-------
Confidence 221 122345678999999987777555 999999999999999 9999988777666555544322211
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCC
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~ 287 (330)
...++. .+.+.+..+...+|.+|+ ++.++++.|..+...
T Consensus 276 ~~~~~~-~l~~li~~~l~~dp~~Rp-s~~eil~~L~~l~~~ 314 (325)
T 3kul_A 276 PMGCPH-ALHQLMLDCWHKDRAQRP-RFSQIVSVLDALIRS 314 (325)
T ss_dssp CTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHHHS
T ss_pred CCCcCH-HHHHHHHHHccCChhhCc-CHHHHHHHHHHHHhC
Confidence 112222 233444555567777765 999999998877443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=327.19 Aligned_cols=221 Identities=24% Similarity=0.393 Sum_probs=185.9
Q ss_pred cCCCCCCCcccCCCCeEEeceeccC--CceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeee
Q 020133 8 VGPGMDMPIMHDSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRF 82 (330)
Q Consensus 8 ~~pg~~~~~~~~~~~y~i~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~ 82 (330)
..+..........++|++++.||+| +||.||+|.+..+|+.||||++..... ....+.+|+.+++.++||||+++
T Consensus 12 ~~~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 91 (389)
T 3gni_B 12 LYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91 (389)
T ss_dssp SCCC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3444555566677999999999999 999999999999999999999976532 23567889999999999999999
Q ss_pred eEEEEeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEE
Q 020133 83 KEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (330)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL 160 (330)
++++..++..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl 169 (389)
T 3gni_B 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYL 169 (389)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEE
T ss_pred eEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEE
Confidence 99999999999999999999999999875 67999999999999999999999999999999999999987664 999
Q ss_pred eecCCcccccC--------CCCCCcccCCCCCCChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 020133 161 CDFGYSKSSVL--------HSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (330)
Q Consensus 161 ~Dfg~a~~~~~--------~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~ 230 (330)
+|||.+..... ........+|+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.+.......
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 248 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLE 248 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 99998753211 112233478899999999977 34544 49999999999999999999987665554443
Q ss_pred H
Q 020133 231 T 231 (330)
Q Consensus 231 ~ 231 (330)
.
T Consensus 249 ~ 249 (389)
T 3gni_B 249 K 249 (389)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=330.37 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=197.1
Q ss_pred CeEE--eceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 22 RYEL--VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 22 ~y~i--~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.|++ .+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 4555 678999999999999999999999999998654 3346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+..+..+.+||+|||+++..........
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999999888654 469999999999999999999999999999999999999544445699999999986655555556
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCC-hhHHhcCchhhccCCccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIS-IPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 256 (330)
..||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+....+.++..... .+.. ....++. .+.
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~-~~~ 320 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE-----EFQDISE-EAK 320 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG-----GGTTSCH-HHH
T ss_pred ccCCCcEeChhhccCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh-----hhccCCH-HHH
Confidence 67999999999997766654 49999999999999999999998877766666654321 1100 0011222 233
Q ss_pred cccccCCCCCCCCccCCHHHHHH
Q 020133 257 DNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.++...+|.+|+ ++.|+++
T Consensus 321 ~li~~~L~~dp~~Rp-s~~e~l~ 342 (373)
T 2x4f_A 321 EFISKLLIKEKSWRI-SASEALK 342 (373)
T ss_dssp HHHHTTSCSSGGGSC-CHHHHHH
T ss_pred HHHHHHcCCChhhCC-CHHHHhc
Confidence 445556667777766 8888876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=317.74 Aligned_cols=209 Identities=28% Similarity=0.451 Sum_probs=177.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++++.||+|+||+||+|.+..+|+.||+|++...... .+.+.+|+..+++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 6899999999999999999999999999999988665432 3567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~~ 176 (330)
|+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++..... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC-------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccccC
Confidence 9999999999888888999999999999999999999999999999999999987664 99999999975442 22234
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
...+++.|+|||++.+....+.++||||||+++|+|++|+.||.+.+.......+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 215 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5578999999999987554455699999999999999999999987766555443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=326.40 Aligned_cols=226 Identities=30% Similarity=0.500 Sum_probs=192.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
++|++++.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 689999999999999999999999999999999976532 22356789999999999999999999999999
Q ss_pred EEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 LAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~-sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.++||||+.++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceECC
Confidence 99999998766 99999998889999999999999999999999999999999999999987754 9999999998665
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh------------hhHHHHHh------
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE------------PKNFRKTI------ 232 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~------------~~~~~~~~------ 232 (330)
.........||+.|+|||++.+..+.+.++|||||||++|+|++|+.||..... ...+...+
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 261 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQP 261 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHHHHTCS
T ss_pred CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHHHHccC
Confidence 555555677999999999998887766669999999999999999999965221 12222222
Q ss_pred ---hcCChhHHhcCchhhc
Q 020133 233 ---HRISIPEIRNHEWFLK 248 (330)
Q Consensus 233 ---~~~~~~~~~~~~~~~~ 248 (330)
.|+++.++..|||+..
T Consensus 262 dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 262 VPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp SGGGSCCHHHHHHCTTTTC
T ss_pred ChhhCcCHHHHhcCccccC
Confidence 4667777777777654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=334.74 Aligned_cols=201 Identities=30% Similarity=0.441 Sum_probs=158.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC-----Ce
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-----~~ 91 (330)
.++|++++.||+|+||+||+|.+..+++.||||++..... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 5889999999999999999999999999999999875432 235688999999999999999999998543 56
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
+|+||||+ +++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDY 208 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTS
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccC
Confidence 89999998 5699999988888999999999999999999999999999999999999987765 99999999975432
Q ss_pred CC----------------------------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh---------
Q 020133 172 HS----------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--------- 214 (330)
Q Consensus 172 ~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt--------- 214 (330)
.. .....+||+.|+|||++......+.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 11 12345689999999987555444555999999999999999
Q ss_pred --CCCCCCCCC
Q 020133 215 --GAYPFEDPE 223 (330)
Q Consensus 215 --g~~pf~~~~ 223 (330)
|+++|.+.+
T Consensus 289 ~~~~p~f~g~~ 299 (458)
T 3rp9_A 289 ADRGPLFPGSS 299 (458)
T ss_dssp GGCCCSCC---
T ss_pred ccccccCCCCc
Confidence 777776543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=314.83 Aligned_cols=251 Identities=32% Similarity=0.579 Sum_probs=199.7
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999876421 3467899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC--CCceEEeecCCcccccC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL 171 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~--~~~vkL~Dfg~a~~~~~ 171 (330)
+||||+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++ ...+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999997654 23599999999976554
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC-ChhHHhcCchhhccC
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-SIPEIRNHEWFLKNL 250 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 250 (330)
........+++.|+|||++.+..++.+ +|+||||+++|+|++|+.||...........+.... ..+.. .....
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 238 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE-----YFSNT 238 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH-----HHTTC
T ss_pred CCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch-----hcccC
Confidence 444455678999999999987776555 999999999999999999998876655544443221 11110 11112
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHH
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+ ..+.+.+.++...+|.+|+ ++.++++
T Consensus 239 ~-~~~~~li~~~l~~dp~~Rp-s~~~~l~ 265 (283)
T 3bhy_A 239 S-ELAKDFIRRLLVKDPKRRM-TIAQSLE 265 (283)
T ss_dssp C-HHHHHHHHTTSCSSGGGSC-CHHHHHH
T ss_pred C-HHHHHHHHHHccCCHhHCc-CHHHHHh
Confidence 2 2233445556667777766 7887775
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=318.99 Aligned_cols=248 Identities=33% Similarity=0.535 Sum_probs=191.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---------------------------ccHHHHHHHHHHH
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------------------IDENVQREIINHR 72 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------------------~~~~~~~ei~~l~ 72 (330)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4789999999999999999999999999999999875431 1245789999999
Q ss_pred cCCCCCeeeeeEEEEe--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEe
Q 020133 73 SLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (330)
Q Consensus 73 ~l~h~~Iv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli 150 (330)
+++||||+++++++.. .+..|+||||+++++|.+++. .+++++..++.++.|++.||.|||++||+||||||+||++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9999999999999987 568999999999999988653 4679999999999999999999999999999999999999
Q ss_pred cCCCCCceEEeecCCcccccCCC-CCCcccCCCCCCChhhhhcCCC--CCCccchhhHHHHHHHHHhCCCCCCCCChhhH
Q 020133 151 DGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (330)
Q Consensus 151 ~~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~SlG~il~elltg~~pf~~~~~~~~ 227 (330)
+.++. +||+|||+++...... ......+|+.|+|||++.+... .+.++|||||||++|+|++|+.||........
T Consensus 171 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 171 GEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp CTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 87764 9999999997543322 2244578999999999876542 34558999999999999999999987655443
Q ss_pred HHHHhhc-CChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 228 FRKTIHR-ISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 228 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
...+... ...+. ...++. .+.+.+.++...+|.+|+ ++.|+++
T Consensus 249 ~~~~~~~~~~~~~-------~~~~~~-~l~~li~~~l~~dp~~R~-s~~e~l~ 292 (298)
T 2zv2_A 249 HSKIKSQALEFPD-------QPDIAE-DLKDLITRMLDKNPESRI-VVPEIKL 292 (298)
T ss_dssp HHHHHHCCCCCCS-------SSCCCH-HHHHHHHHHTCSCTTTSC-CHHHHTT
T ss_pred HHHHhcccCCCCC-------ccccCH-HHHHHHHHHhhcChhhCC-CHHHHhc
Confidence 3333221 11110 011222 233445556667787776 8888764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=326.66 Aligned_cols=215 Identities=32% Similarity=0.446 Sum_probs=178.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..++|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.++++++||||+++++++..++..|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 35789999999999999999999999999999999875432 234577999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC---CCCceEEeecCCcccccCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~---~~~~vkL~Dfg~a~~~~~~ 172 (330)
|||+++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ....+||+|||+++.....
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 999975 999999998899999999999999999999999999999999999999532 2235999999998744322
Q ss_pred -CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
.......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 23345578999999999987654455699999999999999999999988877777766654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=315.18 Aligned_cols=254 Identities=21% Similarity=0.371 Sum_probs=203.4
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
...++|++++.||+|+||.||++.+. ++..||+|++.......+.+.+|+..+++++||||+++++++...+..|+|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34589999999999999999999886 57789999998877667889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC--CC
Q 020133 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQ 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~--~~ 174 (330)
|+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++..... ..
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHS
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEcccccccccccccccc
Confidence 9999999999976 567999999999999999999999999999999999999987664 999999998744322 12
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+..++.+ +||||||+++|+|+| |+.||...+.......+...... ...... ++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~-~~ 248 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------YRPHLA-SE 248 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------CCCTTC-CH
T ss_pred ccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC-------CCCCcC-CH
Confidence 233456778999999987776544 999999999999998 99999987766655555433211 011111 22
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+.+.+.++...+|.+| +++.++++.|..+
T Consensus 249 ~l~~li~~~l~~~p~~R-ps~~~ll~~L~~~ 278 (283)
T 3gen_A 249 KVYTIMYSCWHEKADER-PTFKILLSNILDV 278 (283)
T ss_dssp HHHHHHHHTTCSSGGGS-CCHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHC-cCHHHHHHHHHHH
Confidence 33444555666777776 4999999988764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=322.77 Aligned_cols=210 Identities=28% Similarity=0.439 Sum_probs=171.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~------ 90 (330)
.++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3789999999999999999999999999999999976432 2356789999999999999999999998664
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccc
Confidence 78999999975 7888775 46999999999999999999999999999999999999987764 9999999997655
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 235 (330)
.........+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..++...
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 242 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-C
T ss_pred cccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 4444456689999999999988777655 999999999999999999999888777776666543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=327.64 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=201.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-------CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~ 88 (330)
..++|++.+.||+|+||.||+|.+. .++..||+|.+..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3478999999999999999999975 3456899999876532 235688999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC
Q 020133 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~ 152 (330)
.+.+|+||||+++++|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 999999999999999999998653 4899999999999999999999999999999999999987
Q ss_pred CCCCceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHH
Q 020133 153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~ 228 (330)
++. +||+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|+| |+.||.+.......
T Consensus 239 ~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 239 NNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp TCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 764 9999999997443322 2233456788999999988777555 999999999999999 99999887655544
Q ss_pred HHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 229 RKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..+...... -....++. .+.+.+.++...+|.+| +++.|+++.|..+
T Consensus 316 ~~~~~~~~~-------~~~~~~~~-~l~~li~~~l~~dP~~R-pt~~ell~~L~~i 362 (370)
T 2psq_A 316 KLLKEGHRM-------DKPANCTN-ELYMMMRDCWHAVPSQR-PTFKQLVEDLDRI 362 (370)
T ss_dssp HHHHTTCCC-------CCCTTSCH-HHHHHHHHHTCSSGGGS-CCHHHHHHHHHHH
T ss_pred HHHhcCCCC-------CCCCCCCH-HHHHHHHHHcCCChhhC-cCHHHHHHHHHHH
Confidence 433322110 01111222 23344555666778777 5999999988865
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=327.40 Aligned_cols=274 Identities=19% Similarity=0.240 Sum_probs=200.0
Q ss_pred cCCCCCCCcccCCCCeEEeceeccCCceEEEEEEECC---CCcEEEEEEeecCCc------------ccHHHHHHHHHHH
Q 020133 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDK------------IDENVQREIINHR 72 (330)
Q Consensus 8 ~~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~------------~~~~~~~ei~~l~ 72 (330)
+.+|..+... ..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+|+..++
T Consensus 25 l~~g~~~~~~-~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~ 103 (345)
T 2v62_A 25 FPEGKVLDDM-EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103 (345)
T ss_dssp CCTTCEEECT-TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred CCCCCeeccc-cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc
Confidence 4445444332 34789999999999999999999987 788999999876532 1234667888899
Q ss_pred cCCCCCeeeeeEEEEe----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcE
Q 020133 73 SLRHPNIVRFKEVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (330)
Q Consensus 73 ~l~h~~Iv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NI 148 (330)
.++||||+++++++.. ....|+||||+ |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 104 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 182 (345)
T 2v62_A 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182 (345)
T ss_dssp TCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHE
Confidence 9999999999999988 67899999999 999999998877899999999999999999999999999999999999
Q ss_pred EecCCCCCceEEeecCCcccccCCCC--------CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 149 LLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 149 li~~~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
|++.++.+.+||+|||+++....... .....+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCcc
Confidence 99877644699999999974432211 134578999999999988766544 999999999999999999996
Q ss_pred CCCh-hhHHHHHhhc--CChhHHhcCchhh-ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCC
Q 020133 221 DPEE-PKNFRKTIHR--ISIPEIRNHEWFL-KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287 (330)
Q Consensus 221 ~~~~-~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~ 287 (330)
.... .......... ...+.... .+.. ..++. .+.+.+.++...+|.+|+ +++++++.|.....+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLLDELPQSVL-KWAPSGSSCC-EIAQFLVCAHSLAYDEKP-NYQALKKILNPHGIP 329 (345)
T ss_dssp GGTTCHHHHHHHHHHHHHTTTHHHH-HHSCTTSCCH-HHHHHHHHHHTCCTTCCC-CHHHHHHHHCTTCCC
T ss_pred ccccccHHHHHHHHhhcccccHHHH-hhccccccHH-HHHHHHHHHhhcCcccCC-CHHHHHHHHhccCCc
Confidence 5322 2222111111 11111110 0000 02222 233445556667787775 999999999886653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=326.18 Aligned_cols=262 Identities=16% Similarity=0.221 Sum_probs=194.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC-----CcEEEEEEeecCCcc------------cHHHHHHHHHHHcCCCCCeeee
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRF 82 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~------------~~~~~~ei~~l~~l~h~~Iv~~ 82 (330)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++...... .....+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 46899999999999999999999764 578999998765311 1223345556677889999999
Q ss_pred eEEEEeC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCc
Q 020133 83 KEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (330)
Q Consensus 83 ~~~~~~~----~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~ 157 (330)
++++... ...|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+..+.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998764 4589999999 99999999875 6799999999999999999999999999999999999998434446
Q ss_pred eEEeecCCcccccCCCC--------CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 158 LKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 158 vkL~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
+||+|||+++....... .....||+.|+|||++.+..++. ++|||||||++|+|+||+.||.+........
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR-RGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc-hhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 99999999964432211 13345999999999998877654 4999999999999999999998643332222
Q ss_pred HHh---hcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 230 KTI---HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 230 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
... .+...+.+....+.....|.+ +.+.+..++..+|.+|+ +++++.+.|..+-
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~li~~cl~~~p~~RP-~~~~l~~~l~~~~ 328 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGE-IAKYMETVKLLDYTEKP-LYENLRDILLQGL 328 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHH-HHHHHHHHHTCCTTCCC-CHHHHHHHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHH-HHHHHHHHhcCCCCCCC-CHHHHHHHHHHHH
Confidence 221 122333332222211233332 33444555567777765 8999998887653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=328.67 Aligned_cols=254 Identities=25% Similarity=0.446 Sum_probs=198.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeC---------
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------- 89 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--------- 89 (330)
..++|++++.||+|+||+||+|.+..+|+.||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 357899999999999999999999999999999998765433 24799999999999999999998543
Q ss_pred -----------------------------CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhc
Q 020133 90 -----------------------------THLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM 136 (330)
Q Consensus 90 -----------------------------~~~~lv~e~~~g~sL~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~ 136 (330)
...++||||+++ +|.+.+. .+..+++..++.++.||+.||.|||++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 348999999985 7766654 457899999999999999999999999
Q ss_pred CccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCC
Q 020133 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA 216 (330)
Q Consensus 137 ~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~ 216 (330)
||+||||||+||+++... +.+||+|||+|+............+|+.|+|||++.+....+.++|||||||++|+|++|+
T Consensus 161 gi~H~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKD-NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp TEECSCCCGGGEEEETTT-TEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCccCccCHHHEEEcCCC-CcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 999999999999997422 2599999999986666666667788999999999987664455599999999999999999
Q ss_pred CCCCCCChhhHHHHHhhcCChh------------------HHhcCchh---hccCCccccccccccCCCCCCCCccCCHH
Q 020133 217 YPFEDPEEPKNFRKTIHRISIP------------------EIRNHEWF---LKNLPADLVVDNTTNNQFEEPDQPMQSID 275 (330)
Q Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~p~~~~~s~~ 275 (330)
.||.+.+....+..++.....| ......|- ....+ ..+.+.+.++...+|.+|+ |+.
T Consensus 240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dP~~R~-t~~ 317 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP-SLAIDLLEQILRYEPDLRI-NPY 317 (383)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCC-HHHHHHHHHHCCSSGGGSC-CHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCC-HHHHHHHHHHccCChhhCC-CHH
Confidence 9999988877777766432221 11112221 11122 2233455556667777766 888
Q ss_pred HHHH
Q 020133 276 EIMQ 279 (330)
Q Consensus 276 el~~ 279 (330)
|+++
T Consensus 318 e~l~ 321 (383)
T 3eb0_A 318 EAMA 321 (383)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 8774
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=326.14 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=197.0
Q ss_pred cccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC----e
Q 020133 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (330)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~----~ 91 (330)
.....++|++.+.||+|+||+||++.+. ++.||||++...........+|+..+++++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3456789999999999999999999876 789999999776555566778999999999999999999998754 4
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc----------CccccCCCCCcEEecCCCCCceEEe
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QVCHRDLKLENTLLDGSPAPRLKIC 161 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------~ivH~dikp~NIli~~~~~~~vkL~ 161 (330)
+|+||||+++++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++. +||+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEEC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEc
Confidence 7999999999999999976 4699999999999999999999999 9999999999999987764 9999
Q ss_pred ecCCcccccCCCC---CCcccCCCCCCChhhhhcCCC----CCCccchhhHHHHHHHHHhCCCCCCCCChhhH--HH-HH
Q 020133 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN--FR-KT 231 (330)
Q Consensus 162 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~----~~~~~Di~SlG~il~elltg~~pf~~~~~~~~--~~-~~ 231 (330)
|||+++....... .....+|+.|+|||++.+... .+.++|||||||++|+|+||+.||.+...... .. ..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999974433222 334578999999999976422 12347999999999999999999976432110 00 00
Q ss_pred hhcCChhHHhc---CchhhccCC--------ccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 232 IHRISIPEIRN---HEWFLKNLP--------ADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 232 ~~~~~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
........... .......++ ...+.+.+.+++..+|.+|+ |+.|+++.|..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL-SAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 01111111100 000000000 01133445556667787776 999999988765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=310.99 Aligned_cols=255 Identities=29% Similarity=0.531 Sum_probs=201.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 478999999999999999999999999999999986532 2345788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|||+++++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++..... ...
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-ccc
Confidence 999999999999998889999999999999999999999999999999999999987764 99999998853332 223
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 254 (330)
....+++.|+|||++.+..++.+ +||||||+++|+|++|+.||...+.......+... ...| ...+. .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~-~ 233 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP---------DFVTE-G 233 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---------TTSCH-H
T ss_pred cccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC---------CcCCH-H
Confidence 45578999999999987776555 99999999999999999999876655544443321 1111 11111 2
Q ss_pred cccccccCCCCCCCCccCCHHHHHH--HHHHhCCCCC
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQ--IIAEATIPAA 289 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~--~l~~~~~~~~ 289 (330)
+.+.+.++...+|.+|+ ++.|+++ .+......+.
T Consensus 234 ~~~li~~~l~~~p~~Rp-s~~e~l~h~~~~~~~~~~~ 269 (279)
T 3fdn_A 234 ARDLISRLLKHNPSQRP-MLREVLEHPWITANSSKPS 269 (279)
T ss_dssp HHHHHHHHCCSSGGGSC-CHHHHHHCHHHHHHCSSCC
T ss_pred HHHHHHHHhccChhhCC-CHHHHhhCccccCCccCcc
Confidence 23334445556676664 8888885 5555544443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=327.94 Aligned_cols=249 Identities=18% Similarity=0.174 Sum_probs=191.5
Q ss_pred CCCCeEEeceeccCCceEEEEE-----EECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC---CCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLM-----RDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~---h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+..++.++ |+||+++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3578999999999999999999 467789999999987543 457788888888887 899999999999999
Q ss_pred eEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC---------CCCC
Q 020133 91 HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---------SPAP 156 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~---------~~~~ 156 (330)
..|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +..+
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999999973 457999999999999999999999999999999999999976 1123
Q ss_pred ceEEeecCCccccc---CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhH-HHHHh
Q 020133 157 RLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTI 232 (330)
Q Consensus 157 ~vkL~Dfg~a~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~-~~~~~ 232 (330)
.+||+|||+|+... ........+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||........ .....
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 299 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTEEEECSCC
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCceeechhc
Confidence 59999999996432 2223345679999999999988887655 9999999999999999999964322100 00000
Q ss_pred hcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 233 HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+... .+...+....+...+|..|++++.++.+.|.+.
T Consensus 300 ~~~~~--------------~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 300 RRLPH--------------LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp TTCSS--------------HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred cccCc--------------HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 11100 111112222233456788888999888877765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=313.83 Aligned_cols=255 Identities=19% Similarity=0.258 Sum_probs=201.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+|+..++.+ +|+||+++++++......|+||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 478999999999999999999999999999999886543 335678999999999 799999999999999999999999
Q ss_pred cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC---CceEEeecCCcccccCCC-
Q 020133 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 99 ~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~---~~vkL~Dfg~a~~~~~~~- 173 (330)
+ +++|.+++...+ ++++..++.++.|++.||.|||++||+||||||+||+++.++. ..+||+|||+++......
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9 899999998654 6999999999999999999999999999999999999975432 249999999997443322
Q ss_pred -------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh---hHHHHHh---hcCChhHH
Q 020133 174 -------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTI---HRISIPEI 240 (330)
Q Consensus 174 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~---~~~~~~~---~~~~~~~~ 240 (330)
......||+.|+|||++.+..++. ++||||||+++|+|++|+.||.+.+.. .....+. .....+..
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCCh-HHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence 234557999999999998777654 499999999999999999999875422 2222222 11222222
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
...+|.+ +.+.+.++...+|.+|+ +++++.+.|..+.
T Consensus 246 ------~~~~~~~-l~~li~~~l~~dp~~RP-~~~~l~~~l~~~~ 282 (298)
T 1csn_A 246 ------CAGFPEE-FYKYMHYARNLAFDATP-DYDYLQGLFSKVL 282 (298)
T ss_dssp ------TTTSCHH-HHHHHHHHHHCCTTCCC-CHHHHHHHHHHHH
T ss_pred ------HhhCcHH-HHHHHHHHhcCCcccCC-CHHHHHHHHHHHH
Confidence 1122322 33344445556777766 8999999888763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.12 Aligned_cols=254 Identities=30% Similarity=0.468 Sum_probs=197.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC------CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
.++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 36799999999999999999999999999999998653 233467889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHh
Q 020133 94 IVMEYASGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSYC 133 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~----------------------------------------~~~l~~~~~~~i~~qi~~~L~~L 133 (330)
+||||++|++|.+++.. ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998842 11246788999999999999999
Q ss_pred hhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-----CCCcccCCCCCCChhhhhcC-CCCCCccchhhHHH
Q 020133 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGV 207 (330)
Q Consensus 134 H~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~SlG~ 207 (330)
|++||+||||||+||+++.++...+||+|||+++...... ......+|+.|+|||++.+. ...+.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 9999999999999999987665569999999997443211 13455789999999999652 23344599999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 208 TLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 208 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
++|+|++|+.||.+.+.................... ..++ ..+.+.+.++...+|.+|+ ++.++++
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~li~~~l~~~p~~Rp-s~~~~l~ 330 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY----NVLS-PLARDLLSNLLNRNVDERF-DAMRALQ 330 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGG----GGSC-HHHHHHHHHHSCSCTTTSC-CHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCccc----ccCC-HHHHHHHHHHcCCChhHCC-CHHHHhc
Confidence 999999999999988877776666644321111000 1122 2233445555667787776 7787765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=313.78 Aligned_cols=247 Identities=25% Similarity=0.454 Sum_probs=197.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc-cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
.|...+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+..+++++||||+++++++...+..|+||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 488899999999999999999999999999998765433 4678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCCccc
Q 020133 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (330)
Q Consensus 101 g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~ 179 (330)
|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||++....... ......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998864 57999999999999999999999999999999999999987764 9999999987544332 234567
Q ss_pred CCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccccc
Q 020133 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNT 259 (330)
Q Consensus 180 ~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (330)
||+.|+|||++.+..++.+ +||||||+++|+|++|+.||...+.......+..... +.... ...++. .+.+.+
T Consensus 203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~-~l~~li 275 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKN----SHKVSP-VLRDFL 275 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCTT----GGGSCH-HHHHHH
T ss_pred CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCcCc----cccCCH-HHHHHH
Confidence 9999999999987777655 9999999999999999999987665554444332211 11100 011222 223344
Q ss_pred ccCCCCCCCCccCCHHHHHH
Q 020133 260 TNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 260 ~~~~~~~p~~~~~s~~el~~ 279 (330)
.++...+|.+|+ ++.|+++
T Consensus 276 ~~~l~~dp~~Rp-s~~ell~ 294 (321)
T 2c30_A 276 ERMLVRDPQERA-TAQELLD 294 (321)
T ss_dssp HHHSCSSTTTSC-CHHHHHT
T ss_pred HHHccCChhhCc-CHHHHhc
Confidence 455557777765 8888875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=319.43 Aligned_cols=257 Identities=25% Similarity=0.309 Sum_probs=202.1
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEE--EEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCe
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~--~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~ 91 (330)
....++|++.+.||+|+||.||+|.+..++..+ |+|.+... ....+.+.+|+..++++ +||||+++++++...+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 345689999999999999999999999888865 99988753 22345688999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC
Q 020133 92 LAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~ 155 (330)
.|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 999999999999999997654 6999999999999999999999999999999999999987664
Q ss_pred CceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhc
Q 020133 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 156 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 234 (330)
+||+|||+++............+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.+.......+...
T Consensus 181 --~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 181 --AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp --EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred --EEEcccCcCccccccccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 99999999875444444445567889999999987766544 999999999999998 99999887765544444332
Q ss_pred CChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 235 ISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
...+ ....++ ..+.+.+.++...+|.+|+ ++.++++.|..+.
T Consensus 258 ~~~~-------~~~~~~-~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~~ 299 (327)
T 1fvr_A 258 YRLE-------KPLNCD-DEVYDLMRQCWREKPYERP-SFAQILVSLNRML 299 (327)
T ss_dssp CCCC-------CCTTBC-HHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred CCCC-------CCCCCC-HHHHHHHHHHccCChhhCc-CHHHHHHHHHHHH
Confidence 1110 011122 2233444555567777765 9999999887653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=321.71 Aligned_cols=198 Identities=36% Similarity=0.570 Sum_probs=173.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+|+..+.++ +||||+++++++.+.+..|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 36799999999999999999999999999999999876432 34688888777 799999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC--CceEEeecCCcccccCC-CCC
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLH-SQP 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~--~~vkL~Dfg~a~~~~~~-~~~ 175 (330)
++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+.++.. ..+||+|||+++..... ...
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 177 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence 999999999998889999999999999999999999999999999999999854321 35999999999754332 233
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
...++|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+
T Consensus 178 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp CCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCS
T ss_pred eccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCC
Confidence 45678999999999987766544 9999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.05 Aligned_cols=250 Identities=30% Similarity=0.574 Sum_probs=202.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++.+.||+|+||.||++.+..+++.||+|.+... ......+.+|+..+++++||||+++++++...+..|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 47899999999999999999999999999999998653 22346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||++..... ...
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LRR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SCB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-ccc
Confidence 999999999999998889999999999999999999999999999999999999987764 99999999864332 223
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 254 (330)
....+++.|+|||++.+..++.+ +|+||||+++|+|++|+.||...+.......+... ...| ..++. .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~~-~ 238 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP---------PFLSD-G 238 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC---------TTSCH-H
T ss_pred ccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC---------CcCCH-H
Confidence 45678999999999988777655 99999999999999999999877665544444321 1111 11222 2
Q ss_pred cccccccCCCCCCCCccCCHHHHHH--HHHHh
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQ--IIAEA 284 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~--~l~~~ 284 (330)
+.+.+.++...+|.+|+ +++++++ .+...
T Consensus 239 ~~~li~~~l~~~p~~Rp-s~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 239 SKDLISKLLRYHPPQRL-PLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHHHHSCSSGGGSC-CHHHHHTCHHHHHH
T ss_pred HHHHHHHHhhcCHhhCC-CHHHHhhCHHHHhh
Confidence 23344444556666655 8888875 45444
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=314.59 Aligned_cols=208 Identities=35% Similarity=0.524 Sum_probs=182.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3578999999999999999999999999999999987643 234568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-C
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~ 173 (330)
||||+++++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++..... .
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcc
Confidence 9999999999999988889999999999999999999999999999999999999987764 999999999754322 2
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
......+++.|+|||++.+..+..+ +||||||+++|+|++|+.||..........
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 251 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYL 251 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred cccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence 3345578999999999988777555 999999999999999999998766544433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=324.35 Aligned_cols=213 Identities=28% Similarity=0.428 Sum_probs=177.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
..++|++++.||+|+||.||++.+..+|+.||+|.+..... ....+.+|+.++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 45889999999999999999999999999999999875321 234678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
++||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccC
Confidence 999999986 888888654 36999999999999999999999999999999999999987764 99999999975433
Q ss_pred C-CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 172 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
. .......+|+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+.++...
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~ 228 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 2 23345678999999999976654456699999999999999999999988877777766643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=343.24 Aligned_cols=202 Identities=28% Similarity=0.438 Sum_probs=180.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 457899999999999999999999999999999998753 2334567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEG 339 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccC
Confidence 999999999999998654 3999999999999999999999999999999999999987764 999999999865544
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
......+||+.|+|||++.+..++.. +|+|||||++|+|++|+.||....
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccc
Confidence 44455689999999999988777655 999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=314.10 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=206.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..++|++.+.||+|+||.||++.+..+++.||+|.+.......+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 45889999999999999999999999999999999987776677899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--
Q 020133 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (330)
Q Consensus 99 ~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-- 174 (330)
++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSEE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCcccc
Confidence 9999999999864 45999999999999999999999999999999999999987664 99999999875443221
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||...+..............+ ....++.
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 239 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE- 239 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------CCTTCCH-
T ss_pred ccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC-------CCCCCCH-
Confidence 123346778999999988777544 999999999999999 999998876655444433322111 0112222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+.+.+..+...+|.+| +++.++++.|...
T Consensus 240 ~l~~li~~~l~~dp~~R-ps~~~~~~~l~~~ 269 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDR-PSFAEIHQAFETM 269 (288)
T ss_dssp HHHHHHHHHTCSSGGGS-CCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhC-cCHHHHHHHHHHH
Confidence 23344455556777777 4999999988765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=320.51 Aligned_cols=199 Identities=40% Similarity=0.655 Sum_probs=157.8
Q ss_pred CCeEEe---ceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELV---RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~---~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++. +.||+|+||.||+|.+..+++.||+|++... ....+.+|+..++.+. ||||+++++++.+.+..|+||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 467776 7899999999999999999999999998754 3467789999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecCCcccccCC-CC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH-SQ 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~~~~~~-~~ 174 (330)
||++|++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.++ ...+||+|||+++..... ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999999999999988999999999999999999999999999999999999997643 225999999999744332 23
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~ 222 (330)
.....+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||...
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp ------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC--
T ss_pred ccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCC
Confidence 345678999999999988777554 99999999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=322.68 Aligned_cols=263 Identities=20% Similarity=0.304 Sum_probs=196.5
Q ss_pred CCCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcE----EEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeee
Q 020133 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFK 83 (330)
Q Consensus 10 pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~ 83 (330)
|..........++|++.+.||+|+||+||+|.+..+++. ||+|.+.... .....+.+|+.++++++||||++++
T Consensus 4 p~~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp --CCSSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred hhHHHHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 334445556678999999999999999999999887765 4777765432 3446789999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEee
Q 020133 84 EVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (330)
Q Consensus 84 ~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~D 162 (330)
+++.... .++|+||+.+++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|
T Consensus 84 ~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~D 160 (327)
T 3poz_A 84 GICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITD 160 (327)
T ss_dssp EEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECC
T ss_pred EEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEcc
Confidence 9998755 7899999999999999976 457999999999999999999999999999999999999987764 99999
Q ss_pred cCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChh
Q 020133 163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIP 238 (330)
Q Consensus 163 fg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (330)
||+++....... .....+|+.|+|||++.+..++.+ +|||||||++|+|+| |+.||.+................+
T Consensus 161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (327)
T 3poz_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239 (327)
T ss_dssp TTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred CcceeEccCCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC
Confidence 999974433222 223346778999999988877655 999999999999999 999998766544433332221111
Q ss_pred HHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 239 EIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
. ....+. .+...+.+++..+|.+| +++.|+++.|..+.
T Consensus 240 ~-------~~~~~~-~~~~li~~~l~~~p~~R-ps~~ell~~l~~~~ 277 (327)
T 3poz_A 240 Q-------PPICTI-DVYMIMVKCWMIDADSR-PKFRELIIEFSKMA 277 (327)
T ss_dssp C-------CTTBCH-HHHHHHHHHTCSCGGGS-CCHHHHHHHHHHHH
T ss_pred C-------CccCCH-HHHHHHHHHcCCChhhC-CCHHHHHHHHHHHH
Confidence 0 111111 22334445555777776 59999999887663
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=329.25 Aligned_cols=208 Identities=30% Similarity=0.465 Sum_probs=176.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------CeEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~~~~l 94 (330)
.+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++... ..+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 479999999999999999999999999999999876543 234799999999999999999998642 23679
Q ss_pred EEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 95 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 95 v~e~~~g~sL~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++...
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECC
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcc
Confidence 9999976 5655543 3567999999999999999999999999999999999999986543 58999999998665
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
.........+|+.|+|||++.+....+.++|||||||++|||++|+.||.+.+...++.+++.
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 555556678999999999997764445559999999999999999999998887776666654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=309.39 Aligned_cols=252 Identities=29% Similarity=0.417 Sum_probs=199.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----------cccHHHHHHHHHHHcCC-CCCeeeeeEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKEVILT 88 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~ 88 (330)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 489999999999999999999999999999999987643 12346778999999995 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
.+..|+||||+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhh
Confidence 9999999999999999999998889999999999999999999999999999999999999987764 99999999976
Q ss_pred ccCCCCCCcccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcC
Q 020133 169 SVLHSQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243 (330)
Q Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
...........+++.|+|||++.+ ....+.++||||||+++|+|++|+.||...+.......+.........
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 250 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS--- 250 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc---
Confidence 555545556678999999999852 222244599999999999999999999877665544444332110000
Q ss_pred chhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 244 EWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+ .....+. .+.+.+.++...+|.+|+ ++.|+++
T Consensus 251 ~-~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~~ll~ 283 (298)
T 1phk_A 251 P-EWDDYSD-TVKDLVSRFLVVQPQKRY-TAEEALA 283 (298)
T ss_dssp T-TGGGSCH-HHHHHHHHHCCSSGGGSC-CHHHHTT
T ss_pred c-cccccCH-HHHHHHHHHccCCcccCC-CHHHHHh
Confidence 0 0011222 233344455556676665 7787764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.79 Aligned_cols=212 Identities=34% Similarity=0.556 Sum_probs=187.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++++.||+|+||.||++.+..+++.||||++++. ....+.+.+|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 347899999999999999999999999999999998753 33456788899999887 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~ 172 (330)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCC
Confidence 99999999999999998889999999999999999999999999999999999999987765 9999999997432 33
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
......+||+.|+|||++.+..++.. +|+|||||++|||++|+.||.+.+.......+..
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 556 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS
T ss_pred cccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 34456789999999999988887655 9999999999999999999998777666665553
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=308.71 Aligned_cols=253 Identities=31% Similarity=0.480 Sum_probs=201.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3578999999999999999999999999999999987643 234567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-C
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~ 173 (330)
||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++...... .
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCcc
Confidence 9999999999999988889999999999999999999999999999999999999987664 999999998754322 2
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC-ChhHHhcCchhhccCCc
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-SIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 252 (330)
......+++.|+|||++.+..+..+ +|+||||+++|+|++|+.||...........+.... ..| ..++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~- 239 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP---------KHIN- 239 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC---------TTSC-
T ss_pred ccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc---------cccC-
Confidence 2344578999999999987766554 999999999999999999998766554444333211 111 1111
Q ss_pred cccccccccCCCCCCCCccCCHHHHHH--HHHHhC
Q 020133 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQ--IIAEAT 285 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s~~el~~--~l~~~~ 285 (330)
..+.+.+.++...+|.+|+ ++.++++ .+....
T Consensus 240 ~~~~~li~~~l~~~p~~Rp-s~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 240 PVAASLIQKMLQTDPTARP-TINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHHHHHTCSSGGGSC-CGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHHcccChhhCc-CHHHHhhChheecCC
Confidence 1222333444455666654 7777775 344433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=316.90 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=198.1
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcE----EEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
....++|++++.||+|+||.||+|.+..+++. ||+|.+.... .....+.+|+..+++++||||+++++++. .+
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 44568999999999999999999999888775 7777765432 22346778999999999999999999986 45
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
..++||||+.+++|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCccccc
Confidence 689999999999999999764 57999999999999999999999999999999999999987664 999999999754
Q ss_pred cCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhc--CChhHHhcC
Q 020133 170 VLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR--ISIPEIRNH 243 (330)
Q Consensus 170 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~ 243 (330)
..... .....++..|+|||++.+..++.+ +|||||||++|+|+| |+.||.+.........+... ...+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 240 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ---- 240 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT----
T ss_pred CcccccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC----
Confidence 33222 234457789999999988777544 999999999999999 99999876654443333221 11111
Q ss_pred chhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 244 EWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
.++. .+.+.+.++...+|.+| +++.|+++.|..+..
T Consensus 241 -----~~~~-~~~~li~~~l~~dp~~R-ps~~el~~~l~~~~~ 276 (325)
T 3kex_A 241 -----ICTI-DVYMVMVKCWMIDENIR-PTFKELANEFTRMAR 276 (325)
T ss_dssp -----TBCT-TTTHHHHHHTCSCTTTS-CCHHHHHHHHHHHTT
T ss_pred -----cCcH-HHHHHHHHHcCCChhhC-cCHHHHHHHHHHHHh
Confidence 1111 23334455566788877 499999999987743
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.80 Aligned_cols=210 Identities=27% Similarity=0.466 Sum_probs=173.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++++.||+|+||+||+|.+..+++.||+|++...... ...+.+|+.++++++||||+++++++...+..|+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 6899999999999999999999999999999998654321 12345799999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCC
Q 020133 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~ 176 (330)
+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++..... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence 975 888888764 45999999999999999999999999999999999999987764 999999998744322 2234
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
...+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 457899999999998755445559999999999999999999998887766666554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=323.37 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=204.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
..++|++++.||+|+||.||++.+. .+++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999997 3558999999876432 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCc
Q 020133 92 LAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~N 147 (330)
.|+||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 204 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 99999999999999999763 569999999999999999999999999999999999
Q ss_pred EEecCCCCCceEEeecCCcccccCC---CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 020133 148 TLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (330)
Q Consensus 148 Ili~~~~~~~vkL~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~ 223 (330)
|+++.++. +||+|||+++..... .......+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+
T Consensus 205 Il~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 205 CLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp EEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred EEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCCcCCCCC
Confidence 99987664 999999998643222 22334567889999999988776554 999999999999999 999998876
Q ss_pred hhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCCCCC
Q 020133 224 EPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGT 291 (330)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~~~~ 291 (330)
.......+..... + .+...++. .+.+.+.++...+|.+|+ ++.++.+.|..+.....++
T Consensus 282 ~~~~~~~~~~~~~-~------~~~~~~~~-~l~~li~~~l~~~p~~Rp-s~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 282 HEEVIYYVRDGNI-L------ACPENCPL-ELYNLMRLCWSKLPADRP-SFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp HHHHHHHHHTTCC-C------CCCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHTTC-----
T ss_pred hHHHHHHHhCCCc-C------CCCCCCCH-HHHHHHHHHcccCcccCC-CHHHHHHHHHHHHhhhhhh
Confidence 6554444332211 0 11122222 233445555667777764 9999999999987655443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=339.83 Aligned_cols=202 Identities=32% Similarity=0.442 Sum_probs=179.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+.. .....+.+|+.++++++||||+++++++...+.+|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3478999999999999999999999999999999997542 334578899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 95 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~ 340 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELK 340 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeecc
Confidence 99999999999998763 36999999999999999999999999999999999999987765 9999999997554
Q ss_pred CCCC-CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 171 LHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 171 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.... ....+||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||.+..
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCc
Confidence 4333 234589999999999988777655 999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=321.46 Aligned_cols=247 Identities=30% Similarity=0.495 Sum_probs=199.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---------cHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
++|++.+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999999999999998765321 34678899999998 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999998889999999999999999999999999999999999999987764 9999999987665
Q ss_pred CCCCCCcccCCCCCCChhhhhcC------CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC---ChhHHh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI---SIPEIR 241 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~~ 241 (330)
.........||+.|+|||++.+. .+ +.++|||||||++|+|++|+.||...+.......+.... ..+..
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~- 329 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW- 329 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH-
T ss_pred CCcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc-
Confidence 55555667899999999998643 34 345999999999999999999998866655544443321 11111
Q ss_pred cCchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 242 NHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
...+. .+.+.+.++...+|.+|+ ++.++++
T Consensus 330 ------~~~~~-~~~~li~~~L~~dP~~Rp-s~~ell~ 359 (365)
T 2y7j_A 330 ------DDRSS-TVKDLISRLLQVDPEARL-TAEQALQ 359 (365)
T ss_dssp ------SSSCH-HHHHHHHHHSCSSTTTSC-CHHHHHH
T ss_pred ------ccCCH-HHHHHHHHHcCCChhHCc-CHHHHhc
Confidence 11111 233344455556777766 7887764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=330.59 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=188.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---------cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 378999999999999999999999999999999987532 11124789999999999999999999975 45
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecCCcccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~~~ 169 (330)
..|+||||+++++|.+++..++.+++..++.++.|++.||.|||++||+||||||+|||++.++ ...+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6899999999999999998888999999999999999999999999999999999999996533 235999999999866
Q ss_pred cCCCCCCcccCCCCCCChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
.........+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||............+.....+. .+-..
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~---~~~~~ 369 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---IPEVW 369 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC---CHHHH
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC---Cchhh
Confidence 55544556789999999999854 22224459999999999999999999987655444444332211100 00011
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
..++. .+.+.+.++...+|.+|+ +++|+++
T Consensus 370 ~~~~~-~~~~li~~~L~~dP~~Rp-s~~e~l~ 399 (419)
T 3i6u_A 370 AEVSE-KALDLVKKLLVVDPKARF-TTEEALR 399 (419)
T ss_dssp TTSCH-HHHHHHHHHSCSSTTTSC-CHHHHHH
T ss_pred cccCH-HHHHHHHHHccCChhHCc-CHHHHhC
Confidence 11222 233444555557777766 7777664
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=326.14 Aligned_cols=248 Identities=34% Similarity=0.540 Sum_probs=184.3
Q ss_pred CCCeEEe-ceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHH-HcCCCCCeeeeeEEEEe----CCeEE
Q 020133 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHLA 93 (330)
Q Consensus 20 ~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l-~~l~h~~Iv~~~~~~~~----~~~~~ 93 (330)
.++|.+. +.||+|+||+||++.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++.. .+.+|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 4678887 7899999999999999999999999998643 5677888887 45589999999999876 56789
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecCCccccc
Q 020133 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~~~~ 170 (330)
+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+. .+.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999999999998654 599999999999999999999999999999999999998632 3469999999998655
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh----HHHHHh-hcCChhHHhcCch
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK----NFRKTI-HRISIPEIRNHEW 245 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~----~~~~~~-~~~~~~~~~~~~~ 245 (330)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..... ....+. .....+. ..|
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~---~~~ 291 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN---PEW 291 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT---TTT
T ss_pred CCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC---ccc
Confidence 4444566788999999999987777655 999999999999999999997654321 111111 1111110 000
Q ss_pred hhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 246 FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
..++. .+.+.+.++...+|.+|+ ++.|+++
T Consensus 292 --~~~s~-~~~~li~~~L~~dP~~Rp-t~~eil~ 321 (400)
T 1nxk_A 292 --SEVSE-EVKMLIRNLLKTEPTQRM-TITEFMN 321 (400)
T ss_dssp --TTSCH-HHHHHHHTTSCSSGGGSC-CHHHHHH
T ss_pred --ccCCH-HHHHHHHHHCCCChhHCc-CHHHHhc
Confidence 11222 233445555556777666 7888876
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=323.78 Aligned_cols=208 Identities=26% Similarity=0.439 Sum_probs=174.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~------ 90 (330)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 5789999999999999999999999999999999865432 2356789999999999999999999998653
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD 179 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecccccc
Confidence 469999999 7899998876 67999999999999999999999999999999999999987764 9999999997543
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
. ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+...++..+..
T Consensus 180 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 180 S--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp S--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred c--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 334567899999999998744345559999999999999999999999887777766654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=321.29 Aligned_cols=211 Identities=27% Similarity=0.412 Sum_probs=178.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEe-------
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT------- 88 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~------- 88 (330)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 3478999999999999999999999999999999886543 334678899999999999999999999987
Q ss_pred -CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 89 -PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 89 -~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
.+..|+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhc
Confidence 3468999999986 66666654 457999999999999999999999999999999999999987764 999999998
Q ss_pred ccccC-----CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 167 KSSVL-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 167 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
+.... ........+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 74432 1223445789999999999776544556999999999999999999999877766555554
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=314.48 Aligned_cols=259 Identities=17% Similarity=0.182 Sum_probs=199.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCC-------cEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||+||++.+..++ ..||+|.+.... ...+.+.+|+..+++++||||+++++++...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3578999999999999999999998877 479999986543 34467899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC------ceEEeec
Q 020133 91 HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDF 163 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~------~vkL~Df 163 (330)
..|+||||++|++|.+++...+. +++..++.++.|++.||.|||++||+||||||+||+++.++.. .+||+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999999987654 9999999999999999999999999999999999999766531 2999999
Q ss_pred CCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChhhHHHHHhhcCChhHHhc
Q 020133 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRISIPEIRN 242 (330)
Q Consensus 164 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (330)
|++..... .....+++.|+|||++.+....+.++||||||+++|+|++| .+||..............+...+.
T Consensus 166 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--- 239 (289)
T 4fvq_A 166 GISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA--- 239 (289)
T ss_dssp CSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---
T ss_pred cccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC---
Confidence 99863322 23345788999999998744445569999999999999995 555655444433333222222221
Q ss_pred CchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCCCCC
Q 020133 243 HEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGT 291 (330)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~~~~ 291 (330)
..+ ..+.+.+.++...+|.+| +++.++++.|.++-.|.++.
T Consensus 240 ------~~~-~~l~~li~~~l~~dp~~R-ps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 240 ------PKA-AELANLINNCMDYEPDHR-PSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp ------CSS-CTTHHHHHHHSCSSGGGS-CCHHHHHHHHHTCC------
T ss_pred ------CCC-HHHHHHHHHHcCCChhHC-cCHHHHHHHHHHhcCCCCCC
Confidence 111 223344445556777777 59999999999988776543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=308.62 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=205.4
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.+.++|++.+.||+|+||.||++.+. +++.||+|.+.......+.+.+|+..+++++||||+++++++...+..|+|||
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 35578999999999999999999986 57789999998877667889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC--CC
Q 020133 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQ 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~--~~ 174 (330)
|+++++|.+++... +.+++..++.++.|++.||.+||++|++||||||+||+++.++. +||+|||++...... ..
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHS
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEcccccccccccccccc
Confidence 99999999999765 56999999999999999999999999999999999999987654 999999998744221 12
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+..++. ++|+||||+++|+|++ |+.||...+.......+...... ...... +.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~-------~~~~~~-~~ 232 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------YKPRLA-ST 232 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------CCCTTS-CH
T ss_pred cccccccccccChhhhcCCCccc-hhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC-------CCCccC-cH
Confidence 23345677899999998777654 4999999999999999 89999887665555444332111 011111 22
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+.+.+.++...+|.+|+ ++.++++.|.++.
T Consensus 233 ~l~~li~~~l~~~p~~Rp-s~~~ll~~L~~l~ 263 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRP-AFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCc-CHHHHHHHHHHHH
Confidence 233444555556777764 9999999888753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=318.31 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=189.6
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCc---EEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
....++|++.+.||+|+||.||+|.+..++. .||+|.+.... ...+.+.+|+..+++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456899999999999999999999987765 89999987642 33467889999999999999999999998776
Q ss_pred eE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCce
Q 020133 91 HL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (330)
Q Consensus 91 ~~------~lv~e~~~g~sL~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~v 158 (330)
.. ++||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~ 176 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TV 176 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CE
Confidence 54 99999999999999986532 599999999999999999999999999999999999998775 49
Q ss_pred EEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhc
Q 020133 159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 159 kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 234 (330)
||+|||+++....... .....+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.+.......+...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 9999999975433222 223346778999999988776544 999999999999999 99999987776666555543
Q ss_pred CChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 235 ISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
...+. ...++. .+.+.+.++...+|.+|+ ++.++++.|.++-.
T Consensus 256 ~~~~~-------~~~~~~-~l~~li~~~l~~dp~~Rp-s~~~l~~~l~~~l~ 298 (323)
T 3qup_A 256 NRLKQ-------PPECME-EVYDLMYQCWSADPKQRP-SFTCLRMELENILG 298 (323)
T ss_dssp CCCCC-------CTTCCH-HHHHHHHHTTCSSGGGSC-CHHHHHHHHHHHHH
T ss_pred CCCCC-------CCccCH-HHHHHHHHHccCChhhCc-CHHHHHHHHHHHHH
Confidence 22111 112222 233455556667787774 99999988887633
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=327.26 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=202.3
Q ss_pred CCCeEEeceeccCCceEEEEEE-----ECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++++.||+|+||.||+|. +..+++.||||.+.... .....+.+|+.++++++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4789999999999999999999 45578899999986542 2234688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecC
Q 020133 93 AIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFG 164 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg 164 (330)
|+||||++|++|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 99999999999999997643 499999999999999999999999999999999999997543 2359999999
Q ss_pred Cccccc---CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 165 YSKSSV---LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 165 ~a~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
+++... .........+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...+.......+......+
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~-- 306 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD-- 306 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC--
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence 987332 1223345567899999999988777655 999999999999998 999999877665555444322111
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
....++. .+.+.+.+++..+|.+|+ ++.++++.|..+..
T Consensus 307 -----~~~~~~~-~l~~li~~~l~~dP~~Rp-s~~eil~~l~~~~~ 345 (367)
T 3l9p_A 307 -----PPKNCPG-PVYRIMTQCWQHQPEDRP-NFAIILERIEYCTQ 345 (367)
T ss_dssp -----CCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHHH
T ss_pred -----CCccCCH-HHHHHHHHHcCCCHhHCc-CHHHHHHHHHHHhh
Confidence 1112222 233445556667777775 99999998887643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=314.75 Aligned_cols=212 Identities=28% Similarity=0.461 Sum_probs=180.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..++|++++.||+|+||.||+|.+..+|+.||+|++...... ...+.+|+.++++++||||+++++++...+..|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 458899999999999999999999999999999998765432 34577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~ 174 (330)
|||+++++|.++....+.+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||+++.... ...
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC---------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCccc
Confidence 999999999988887788999999999999999999999999999999999999987764 99999999974433 223
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 3456789999999999876444556999999999999999999999877666555544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=308.86 Aligned_cols=249 Identities=33% Similarity=0.578 Sum_probs=198.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++++...+..|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57999999999999999999999999999999987543 3346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC---CCC
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~---~~~ 175 (330)
+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||.+...... ...
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcc
Confidence 999999999987778999999999999999999999999999999999999987664 999999998643322 223
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhH-HHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....+++.|+|||++.+..+.+.++||||||+++|+|++|+.||........ ...+....... .+ ...++.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~- 237 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----NP--WKKIDSA- 237 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS----TT--GGGSCHH-
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc----Cc--hhhcCHH-
Confidence 4557899999999998777655669999999999999999999987654322 22222211100 00 1122222
Q ss_pred cccccccCCCCCCCCccCCHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.+.++...+|.+|+ ++.++++
T Consensus 238 ~~~li~~~l~~~p~~Rp-s~~~il~ 261 (276)
T 2yex_A 238 PLALLHKILVENPSARI-TIPDIKK 261 (276)
T ss_dssp HHHHHHHHSCSSTTTSC-CHHHHTT
T ss_pred HHHHHHHHCCCCchhCC-CHHHHhc
Confidence 23344555557777766 7888765
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=324.51 Aligned_cols=211 Identities=27% Similarity=0.456 Sum_probs=171.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe-------E
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-------L 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~-------~ 92 (330)
.++|++.+.||+|+||.||++.+..+|+.||||++...........+++..+..++||||+++++++...+. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 478999999999999999999999999999999998776666777888888999999999999999976433 8
Q ss_pred EEEEeccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHhh--hcCccccCCCCCcEEecC-CCCCceEEeecCC
Q 020133 93 AIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDG-SPAPRLKICDFGY 165 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l----~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~ 165 (330)
++||||+++ +|...+ .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++ .+||+|||+
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~ 178 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGS 178 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTT
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCC
Confidence 899999987 444333 35567999999999999999999999 999999999999999985 44 599999999
Q ss_pred cccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 166 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
++............+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 98666555556678899999999997766445569999999999999999999998877766666654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=311.65 Aligned_cols=203 Identities=31% Similarity=0.477 Sum_probs=172.0
Q ss_pred CCCeEEe-ceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.++|++. +.||+|+||.||+|.+..+++.||||++..... ....+.+|+..+.++ +||||+++++++..++.+|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4789996 789999999999999999999999999976543 356789999999885 7999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC-CceEEeecCCcccccCCC--
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS-- 173 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~-~~vkL~Dfg~a~~~~~~~-- 173 (330)
||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. ..+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99999999999998889999999999999999999999999999999999999976543 349999999986433211
Q ss_pred ------CCCcccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 174 ------QPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 174 ------~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
......||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+..
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK-RCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTT-THHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCc-ccccHhHHHHHHHHHHCCCCCcccc
Confidence 1223468999999999865 33444 4999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=325.96 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=200.5
Q ss_pred CCCCeEEeceeccCCceEEEEEE-----ECCCCcEEEEEEeecCCcc--cHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||.||++. +..+++.||||.+...... .+.+.+|+.++.++ +||||+++++++...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 45889999999999999999999 5567799999999765332 34688999999999 7899999999998765
Q ss_pred e-EEEEEeccCCCChHHHHHhcCC--------------------------------------------------------
Q 020133 91 H-LAIVMEYASGGELFERICNAGR-------------------------------------------------------- 113 (330)
Q Consensus 91 ~-~~lv~e~~~g~sL~~~l~~~~~-------------------------------------------------------- 113 (330)
. .++||||+++++|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 4 8999999999999999976543
Q ss_pred ----------CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC---CCCcccC
Q 020133 114 ----------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVG 180 (330)
Q Consensus 114 ----------l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~ 180 (330)
+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCC
Confidence 899999999999999999999999999999999999987664 9999999997543322 2234467
Q ss_pred CCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccccc
Q 020133 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNT 259 (330)
Q Consensus 181 ~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (330)
|+.|+|||++.+..++.+ +|||||||++|+|+| |+.||.+..........+.....+. .....+. .+.+.+
T Consensus 258 t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~-~l~~li 329 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------APDYTTP-EMYQTM 329 (359)
T ss_dssp CGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC------CCTTCCH-HHHHHH
T ss_pred CceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC------CCCCCCH-HHHHHH
Confidence 889999999988777644 999999999999998 9999988765555544443221110 1111222 233344
Q ss_pred ccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 260 TNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 260 ~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..+...+|.+|+ ++.|+++.|..+
T Consensus 330 ~~~l~~dP~~Rp-s~~ell~~L~~~ 353 (359)
T 3vhe_A 330 LDCWHGEPSQRP-TFSELVEHLGNL 353 (359)
T ss_dssp HHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHccCChhhCC-CHHHHHHHHHHH
Confidence 455567787776 999999988765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=328.04 Aligned_cols=211 Identities=27% Similarity=0.382 Sum_probs=183.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC------CCCCeeeeeEEEEeCCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l------~h~~Iv~~~~~~~~~~~~~ 93 (330)
.++|++++.||+|+||.||+|.+..+++.||||++.........+.+|+.+++.+ +|+||+++++++...+..|
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 5789999999999999999999999999999999987655556778888888776 5779999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||++....
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~- 253 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH- 253 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT-
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC-
Confidence 9999996 58999887654 4999999999999999999999999999999999999988765559999999986432
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
......++|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..++..
T Consensus 254 -~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 254 -QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp -CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred -CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 33445688999999999988877655 99999999999999999999998877776666543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=324.89 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=202.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC-------CcEEEEEEeecCCcc--cHHHHHHHHHHHcC-CCCCeeeeeEEEEe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILT 88 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~--~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~ 88 (330)
..++|++.+.||+|+||.||+|.+..+ +..||+|++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 347899999999999999999997543 357999998765332 35688999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC
Q 020133 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~ 152 (330)
.+..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 999999999999999999998653 4999999999999999999999999999999999999987
Q ss_pred CCCCceEEeecCCcccccCC---CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHH
Q 020133 153 SPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~ 228 (330)
++. +||+|||+++..... .......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+.....
T Consensus 227 ~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 227 DNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp TCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 764 999999999754332 22233456788999999988776555 999999999999999 99999887665544
Q ss_pred HHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 229 RKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
..+......+ ....++. .+.+.+.++...+|.+| +++.|+++.|..+.
T Consensus 304 ~~~~~~~~~~-------~~~~~~~-~l~~li~~~l~~dP~~R-ps~~ell~~L~~~~ 351 (382)
T 3tt0_A 304 KLLKEGHRMD-------KPSNCTN-ELYMMMRDCWHAVPSQR-PTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHTTCCCC-------CCSSCCH-HHHHHHHHHTCSSGGGS-CCHHHHHHHHHHHH
T ss_pred HHHHcCCCCC-------CCccCCH-HHHHHHHHHcCCChhhC-cCHHHHHHHHHHHH
Confidence 4433321111 1112222 23344455556777776 49999999888764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=313.67 Aligned_cols=252 Identities=32% Similarity=0.535 Sum_probs=196.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++.+.||+|+||.||++.+..+|+.||+|.+..... ....+.+|+..+++++||||+++++++...+..|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 3689999999999999999999999999999999986543 345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccCCCCCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||++.. +..+.++|+|||+++.... .....
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~ 166 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMST 166 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTHH
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Ccccc
Confidence 999999999988889999999999999999999999999999999999999932 2233599999999864322 22334
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..+++.|+|||++.+..++. ++||||||+++|+|++|+.||...+.......+........ .+ +...++. .+.+
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---~~-~~~~~~~-~~~~ 240 (304)
T 2jam_A 167 ACGTPGYVAPEVLAQKPYSK-AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE---SP-FWDDISE-SAKD 240 (304)
T ss_dssp HHSCCCBCCTTTBSSCSCCH-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC---TT-TTTTSCH-HHHH
T ss_pred ccCCCCccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---cc-ccccCCH-HHHH
Confidence 56899999999998776654 49999999999999999999988766555544443211000 00 0111222 2233
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ ++.++++
T Consensus 241 li~~~l~~dp~~Rp-s~~~~l~ 261 (304)
T 2jam_A 241 FICHLLEKDPNERY-TCEKALS 261 (304)
T ss_dssp HHHHHHCSSTTTSC-CHHHHHT
T ss_pred HHHHHcCCChhHCc-CHHHHhc
Confidence 44444556677666 7777765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.73 Aligned_cols=209 Identities=30% Similarity=0.458 Sum_probs=178.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC-----CeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-----~~~ 92 (330)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4789999999999999999999999999999999875432 235788999999999999999999999765 368
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+||||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 106 ~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 181 (364)
T ss_dssp EEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCC
Confidence 999999975 89888865 56999999999999999999999999999999999999987764 999999999744322
Q ss_pred CC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 173 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.. .....+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 21 2445789999999998766544556999999999999999999998877665555544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=329.89 Aligned_cols=255 Identities=27% Similarity=0.337 Sum_probs=201.4
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
...++|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.++++++||||+++++++...+..|+|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 345789999999999999999999999999999999875432 223577899999999999999999999998999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
|||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVY 268 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCce
Confidence 99999999999997654 6999999999999999999999999999999999999987764 99999999874322211
Q ss_pred ---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccC
Q 020133 175 ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 175 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
.....+++.|+|||++.+..++.+ +|||||||++|||+| |..||...+..............+ ....+
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~ 340 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP-------CPELC 340 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC-------CCTTC
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------CCCCC
Confidence 112234667999999987776555 999999999999998 999998876654433332221111 11122
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
|. .+.+.+.+++..+|.+|+ ++.++++.|..+
T Consensus 341 ~~-~l~~li~~cl~~dP~~Rp-s~~~i~~~L~~i 372 (377)
T 3cbl_A 341 PD-AVFRLMEQCWAYEPGQRP-SFSTIYQELQSI 372 (377)
T ss_dssp CH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CH-HHHHHHHHHcCCCchhCc-CHHHHHHHHHHH
Confidence 22 233444555667777765 999999988765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=315.80 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=201.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
..++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3578999999999999999999984 4568899999876432 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCc
Q 020133 92 LAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~------------------------l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~N 147 (330)
.|+||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 9999999999999999986543 8999999999999999999999999999999999
Q ss_pred EEecCCCCCceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 020133 148 TLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (330)
Q Consensus 148 Ili~~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~ 223 (330)
|+++.++ .+||+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+..
T Consensus 181 Ili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 181 ILVAEGR--KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp EEEETTT--EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCC--CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9998765 49999999987443322 2233456788999999988776554 999999999999999 999998876
Q ss_pred hhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 224 EPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.............. .....++. .+.+.+.++...+|.+|+ ++.++++.|..+
T Consensus 258 ~~~~~~~~~~~~~~-------~~~~~~~~-~~~~li~~~l~~dp~~Rp-s~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PERLFNLLKTGHRM-------ERPDNCSE-EMYRLMLQCWKQEPDKRP-VFADISKDLEKM 309 (314)
T ss_dssp GGGHHHHHHTTCCC-------CCCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCcC-------CCCccCCH-HHHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 65444333322111 11112222 233445555667777765 999999988765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.74 Aligned_cols=252 Identities=28% Similarity=0.375 Sum_probs=189.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++.+.||+|+||.||++.+. ++.||+|++.... ...+.+.+|+..++.++||||+++++++..++..|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 4589999999999999999999985 8889999986542 22367889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC---ccccCCCCCcEEecCC------CCCceEEeecC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGS------PAPRLKICDFG 164 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIli~~~------~~~~vkL~Dfg 164 (330)
+||||+++++|.+++. ++.+++..++.++.|++.||.|||++| ++||||||+||+++.+ ..+.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999998885 467999999999999999999999999 8999999999999752 13469999999
Q ss_pred CcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 165 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
+++..... ......+++.|+|||.+.+..++.+ +||||||+++|+|++|+.||.+.+................
T Consensus 162 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 234 (271)
T 3dtc_A 162 LAREWHRT-TKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP----- 234 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC-----
T ss_pred cccccccc-cccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC-----
Confidence 98744332 2234578999999999988776544 9999999999999999999998776555444432211110
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+...++. .+.+.+.++...+|.+| +++.|+++.|..
T Consensus 235 -~~~~~~~-~~~~li~~~l~~~p~~R-ps~~e~l~~L~~ 270 (271)
T 3dtc_A 235 -IPSTCPE-PFAKLMEDCWNPDPHSR-PSFTNILDQLTT 270 (271)
T ss_dssp -CCTTCCH-HHHHHHHHHTCSSGGGS-CCHHHHHHHHHC
T ss_pred -CCcccCH-HHHHHHHHHhcCCcccC-cCHHHHHHHHhc
Confidence 1112222 23344455556777776 499999998875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.88 Aligned_cols=203 Identities=32% Similarity=0.530 Sum_probs=159.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++.+.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+..+++++||||+++++++...+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 367999999999999999999999999999999986532 2346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-C
Q 020133 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~ 173 (330)
|||+++++|.+++... .++++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++...... .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCC
Confidence 9999999999999865 57999999999999999999999999999999999999987664 999999998754322 2
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
......+++.|+|||++.+..+..+ +|+||||+++|+|++|+.||......
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~ 218 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVK 218 (278)
T ss_dssp ------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC
T ss_pred cceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHH
Confidence 2334578999999999987766555 99999999999999999999875543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=313.04 Aligned_cols=208 Identities=24% Similarity=0.449 Sum_probs=179.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEe--CCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~--~~~~~lv 95 (330)
..++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.++++++ ||||+++++++.. ....++|
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 4578999999999999999999999999999999987543 467899999999997 9999999999998 5678999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|||+++++|.+++. .+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+|||+++........
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCcc
Confidence 99999999998874 4899999999999999999999999999999999999986653 5999999999866555556
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-ChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~-~~~~~~~~~~ 232 (330)
....+++.|+|||++.+....+.++|||||||++|+|++|+.||... .....+..+.
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~ 245 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH
Confidence 66789999999999987454455699999999999999999999543 3333333333
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.26 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=200.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--CeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~~~ 93 (330)
..++|++.+.||+|+||.||++.+. ++.||+|++..... ..+.+.+|+..+++++||||+++++++... +..+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 4578999999999999999999985 88899999876532 235688999999999999999999999887 7789
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++| ++||||||+||+++.++. ++|+|||++...
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~ 163 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSF 163 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTT
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceeee
Confidence 9999999999999998765 4899999999999999999999999 999999999999987765 888888765432
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCC--ccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGK--IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
......+|+.|+|||++.+...... ++||||||+++|+|++|+.||...+..............+. +.
T Consensus 164 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~ 233 (271)
T 3kmu_A 164 ----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT------IP 233 (271)
T ss_dssp ----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC------CC
T ss_pred ----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC------CC
Confidence 2234578999999999987655442 59999999999999999999998776665555543321111 11
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
..++. .+.+.+.++...+|.+|+ ++.++++.|..+.
T Consensus 234 ~~~~~-~~~~li~~~l~~~p~~Rp-s~~~il~~L~~l~ 269 (271)
T 3kmu_A 234 PGISP-HVSKLMKICMNEDPAKRP-KFDMIVPILEKMQ 269 (271)
T ss_dssp TTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHC
T ss_pred CCCCH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHHhh
Confidence 22222 233444555567777766 9999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.98 Aligned_cols=196 Identities=27% Similarity=0.391 Sum_probs=167.3
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC--------
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-------- 90 (330)
++|++++.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57999999999999999999999999999999987543 33467899999999999999999999986543
Q ss_pred -------------------------------------------------eEEEEEeccCCCChHHHHHhcCC---CCHHH
Q 020133 91 -------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSEDE 118 (330)
Q Consensus 91 -------------------------------------------------~~~lv~e~~~g~sL~~~l~~~~~---l~~~~ 118 (330)
..|+||||++|++|.+++..... .++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999987543 56677
Q ss_pred HHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-------------CCCCcccCCCCCC
Q 020133 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------------SQPKSTVGTPAYI 185 (330)
Q Consensus 119 ~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-------------~~~~~~~~~~~y~ 185 (330)
++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..... .......||+.|+
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 999999999999999999999999999999998766 4999999998754432 1223457899999
Q ss_pred ChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCC
Q 020133 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (330)
Q Consensus 186 aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf 219 (330)
|||++.+..++.+ +|||||||++|+|++|..|+
T Consensus 244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCH
T ss_pred ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCCh
Confidence 9999988877555 99999999999999987765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=315.29 Aligned_cols=205 Identities=30% Similarity=0.485 Sum_probs=175.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||+||+|.+..+|+.||||++...... ...+.+|+.++++++||||+++++++..++..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999999999999999999765322 246789999999999999999999999999999999
Q ss_pred eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+. |+|.+.+. ...++++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---A 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS---B
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecCC---C
Confidence 9997 47777775 456899999999999999999999999999999999999998766 499999999874432 2
Q ss_pred CcccCCCCCCChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~---~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
....||+.|+|||++. +..++. ++|||||||++|+|++|+.||...+.......+.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 266 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 266 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 3457899999999985 344544 4999999999999999999998776655544443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=310.75 Aligned_cols=256 Identities=22% Similarity=0.274 Sum_probs=199.6
Q ss_pred cccCCCCeEEec-eeccCCceEEEEEEE--CCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC
Q 020133 16 IMHDSDRYELVR-DIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (330)
Q Consensus 16 ~~~~~~~y~i~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~ 89 (330)
.....++|++.+ .||+|+||.||++.+ ..+++.||+|.+..... ..+.+.+|+..++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 345568999999 999999999999954 56788999999876532 245788999999999999999999999 56
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+..|+||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKAL 167 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcceee
Confidence 67899999999999999999888899999999999999999999999999999999999998766 4999999998744
Q ss_pred cCCCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 170 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
..... .....+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||...+.......+... .. +
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~------~ 239 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ER------M 239 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CC------C
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CC------C
Confidence 33221 122345688999999987776544 999999999999999 99999887665443333221 11 1
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+...++. .+.+.+.++...+|.+|+ ++.++++.|...
T Consensus 240 ~~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~~l~~~L~~~ 277 (291)
T 1xbb_A 240 GCPAGCPR-EMYDLMNLCWTYDVENRP-GFAAVELRLRNY 277 (291)
T ss_dssp CCCTTCCH-HHHHHHHHHTCSSTTTSC-CHHHHHHHHHHH
T ss_pred CCCCCCCH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 11122222 233455556667787775 999999988875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=309.11 Aligned_cols=252 Identities=33% Similarity=0.526 Sum_probs=200.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+..+++++||||+++++++...+..|+||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 368999999999999999999999999999999987542 34567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+++++|.+.+...+.+++..++.++.|++.||.+||++|++||||||+||+++.++ ...+||+|||++.........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9999999999998888999999999999999999999999999999999999997543 336999999998765544444
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
....+++.|+|||++.+. ++ .++||||||+++|+|++|+.||.+.+.......+......... +. ...++. .+
T Consensus 181 ~~~~~~~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~-~~ 253 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---PQ-WRTISD-DA 253 (287)
T ss_dssp SCHHHHHTTCCHHHHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS---GG-GTTSCH-HH
T ss_pred ccccCcccccChHHhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---hh-hhhcCH-HH
Confidence 555688999999998654 44 4499999999999999999999887665544444322110000 00 011222 23
Q ss_pred ccccccCCCCCCCCccCCHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.+.++...+|..|+ ++.|+++
T Consensus 254 ~~li~~~l~~dp~~Rp-s~~ell~ 276 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRI-TATQCLE 276 (287)
T ss_dssp HHHHHHHTCSSGGGSC-CHHHHHH
T ss_pred HHHHHHHcccChhhCc-CHHHHhc
Confidence 3444455556777665 8888876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=315.52 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=202.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEE-----CCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||.||++.+ ..+++.||+|.+..... ..+.+.+|+..++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 347899999999999999999985 45788999999876543 246788999999999 8999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC
Q 020133 91 HLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~ 152 (330)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 9999999999999999997654 4899999999999999999999999999999999999987
Q ss_pred CCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHH
Q 020133 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~ 228 (330)
++ .+||+|||+++....... .....+++.|+|||++.+..++.+ +||||||+++|+|+| |+.||.+.......
T Consensus 181 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 181 GR--ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp TT--EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred CC--CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 65 499999999875443322 223456778999999987776544 999999999999999 99999887665555
Q ss_pred HHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 229 RKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+..... +......+. .+.+.+.++...+|.+|+ ++.|+++.|.+.
T Consensus 258 ~~~~~~~~~------~~~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~ 305 (313)
T 1t46_A 258 YKMIKEGFR------MLSPEHAPA-EMYDIMKTCWDADPLKRP-TFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHTCC------CCCCTTSCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHhccCCC------CCCcccCCH-HHHHHHHHHcCCCchhCc-CHHHHHHHHHHH
Confidence 444432111 001112222 233445555667777766 999999988765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=327.16 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=200.0
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC-eEEEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVM 96 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~-~~~lv~ 96 (330)
...++|++.+.||+|+||.||++.+. |+.||||.++... ..+.+.+|+.++++++||||+++++++.... ..|+||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34578999999999999999999885 7799999987654 5678999999999999999999999987765 799999
Q ss_pred eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
||+++++|.+++...+. +++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST-- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc--
Confidence 99999999999987553 799999999999999999999999999999999999987764 999999998743322
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+..++.+ +||||||+++|||+| |+.||...+.......+......+ ....+|.
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------~p~~~~~- 413 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-------APDGCPP- 413 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC-------CCTTCCH-
T ss_pred ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------CCCcCCH-
Confidence 223356889999999988777655 999999999999998 999998876655554443322111 1122222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+.+.+.+++..+|.+|+ ++.++++.|..+.
T Consensus 414 ~l~~li~~cl~~dp~~Rp-t~~~l~~~L~~i~ 444 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRP-TFLQLREQLEHIR 444 (450)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCc-CHHHHHHHHHHHH
Confidence 233444555667777765 9999998887653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=319.72 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=202.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||.||+|.+. .+++.||+|.+... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999973 46778999998754 23457889999999999 8999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCc
Q 020133 91 HLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~N 147 (330)
..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 9999999999999999997643 37999999999999999999999999999999999
Q ss_pred EEecCCCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 020133 148 TLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (330)
Q Consensus 148 Ili~~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~ 223 (330)
|+++.++ .+||+|||++........ .....+|+.|+|||++.+..++.+ +||||||+++|+|+| |..||.+..
T Consensus 203 Ill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 203 VLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp EEEETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEEcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9998766 499999999975433322 123456788999999988776554 999999999999998 999998876
Q ss_pred hhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 224 EPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
........+.....+. ....++ ..+.+.+.++...+|.+|+ ++.++++.|.......
T Consensus 280 ~~~~~~~~~~~~~~~~------~~~~~~-~~l~~li~~~l~~dp~~Rp-s~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMD------QPFYAT-EEIYIIMQSCWAFDSRKRP-SFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSHHHHHHHHTTCCCC------CCTTCC-HHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHC---
T ss_pred cHHHHHHHHhcCCCCC------CCCCCC-HHHHHHHHHHcCCCchhCc-CHHHHHHHHHHHHHHH
Confidence 6555555543321110 011122 2233445555667777766 9999999998875543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=306.88 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=194.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc--------cHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--------DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||.||++.+..+++.||+|.+...... ...+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 458999999999999999999999999999999998654322 167889999999999999999999986655
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecCCCC---CceEEeecC
Q 020133 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPA---PRLKICDFG 164 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~~~~---~~vkL~Dfg 164 (330)
++||||+++++|.+.+... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++. ..+||+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 7999999999998888654 47999999999999999999999999 999999999999975442 238999999
Q ss_pred CcccccCCCCCCcccCCCCCCChhhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhH--HHHHhhcCChhHHh
Q 020133 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN--FRKTIHRISIPEIR 241 (330)
Q Consensus 165 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~ 241 (330)
+++... .......+++.|+|||++.+. ...+.++|||||||++|+|++|+.||........ .........
T Consensus 175 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 247 (287)
T 4f0f_A 175 LSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----- 247 (287)
T ss_dssp TCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC-----
T ss_pred cccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC-----
Confidence 987332 233456789999999998432 2224459999999999999999999986554332 222211111
Q ss_pred cCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 242 NHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
.+-+...++. .+.+.+.++...+|.+|+ ++.++++.|.+
T Consensus 248 -~~~~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~ 286 (287)
T 4f0f_A 248 -RPTIPEDCPP-RLRNVIELCWSGDPKKRP-HFSYIVKELSE 286 (287)
T ss_dssp -CCCCCTTSCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHT
T ss_pred -CCCCCcccCH-HHHHHHHHHhcCChhhCc-CHHHHHHHHHh
Confidence 0111122222 233444555567777765 99999998875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=306.56 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=195.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEe----CCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~----~~~ 91 (330)
....|++.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 4466999999999999999999999999999999987543 233568899999999999999999999875 356
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEec-CCCCCceEEeecCCccc
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYSKS 168 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~-~~~~~~vkL~Dfg~a~~ 168 (330)
+|+||||+++++|.+++...+.+++..++.++.|++.||.|||+.| ++||||||+||+++ .++ .+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGG
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCccc
Confidence 8999999999999999998889999999999999999999999999 99999999999997 444 599999999863
Q ss_pred ccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhc
Q 020133 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248 (330)
Q Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
... .......+++.|+|||++.+ .++ .++||||||+++|+|++|+.||............+.....+.. +..
T Consensus 182 ~~~-~~~~~~~~t~~y~aPE~~~~-~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~ 253 (290)
T 1t4h_A 182 KRA-SFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-----FDK 253 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG-----GGG
T ss_pred ccc-cccccccCCcCcCCHHHHhc-cCC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc-----cCC
Confidence 322 23344578999999998864 354 4599999999999999999999886665555544433221111 111
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
..+ ..+.+.+.++...+|.+|+ ++.++++
T Consensus 254 ~~~-~~l~~li~~~l~~dp~~Rp-s~~ell~ 282 (290)
T 1t4h_A 254 VAI-PEVKEIIEGCIRQNKDERY-SIKDLLN 282 (290)
T ss_dssp CCC-HHHHHHHHHHSCSSGGGSC-CHHHHHT
T ss_pred CCC-HHHHHHHHHHccCChhhCC-CHHHHhh
Confidence 111 2233444455556676665 7777764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=306.59 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=204.2
Q ss_pred cCCCCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEE
Q 020133 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEV 85 (330)
Q Consensus 8 ~~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~ 85 (330)
..|+.........++|++++.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+..+++++||||++++++
T Consensus 9 ~~p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 88 (303)
T 3a7i_A 9 GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88 (303)
T ss_dssp ----CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 455555555555678999999999999999999999999999999987653 334678999999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 86 ~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
+...+..|+||||+++++|.+++.. +++++..++.++.|++.||.+||+.|++||||||+||+++.++. +||+|||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~ 165 (303)
T 3a7i_A 89 YLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGV 165 (303)
T ss_dssp EEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTT
T ss_pred EecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeeccc
Confidence 9999999999999999999998865 67999999999999999999999999999999999999987664 99999999
Q ss_pred cccccCCC-CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 166 SKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 166 a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
+....... ......+++.|+|||++.+..++.+ +||||||+++|+|++|+.||...........+.... .+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~ 237 (303)
T 3a7i_A 166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-------PP 237 (303)
T ss_dssp CEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------CC
T ss_pred ceecCccccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-------CC
Confidence 87543322 2345578999999999988777655 999999999999999999998766544333322211 11
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+....+. .+.+.+.++...+|..|+ ++.++++
T Consensus 238 ~~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~~ll~ 270 (303)
T 3a7i_A 238 TLEGNYSK-PLKEFVEACLNKEPSFRP-TAKELLK 270 (303)
T ss_dssp CCCSSCCH-HHHHHHHHHCCSSGGGSC-CHHHHTT
T ss_pred CCccccCH-HHHHHHHHHcCCChhhCc-CHHHHhh
Confidence 11222222 233444455556676665 8888876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=315.36 Aligned_cols=262 Identities=25% Similarity=0.366 Sum_probs=195.4
Q ss_pred cCCCCeEEeceeccCCceEEEEEE----ECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--C
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--T 90 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~ 90 (330)
...++|++++.||+|+||+||+++ +..+++.||+|++..... ..+.+.+|+.++++++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 345899999999999999999998 567899999999876543 235788999999999999999999998654 5
Q ss_pred eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 91 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
.+++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+||+++.++ ++||+|||+++..
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVL 164 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCSCC--
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC--eEEEccCcccccc
Confidence 5899999999999999997754 599999999999999999999999999999999999998776 4999999999754
Q ss_pred cCCC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChh-------
Q 020133 170 VLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIP------- 238 (330)
Q Consensus 170 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------- 238 (330)
.... ......++..|+|||++.+..++.+ +||||||+++|+|+||..||.... .............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPP--AEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHH--HHHHHHHCTTCCTHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCCh--HHHHhhhcCccccchhHHHH
Confidence 3322 1223346677999999988877555 999999999999999999986432 1111111110000
Q ss_pred --HHhc--CchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 239 --EIRN--HEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 239 --~~~~--~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
.+.. ..-....++. .+.+.+.++...+|.+|+ ++.|+++.|..+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~el~~~L~~l~~ 291 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPD-EIYMIMTECWNNNVNQRP-SFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHTTCCCCCCTTCCH-HHHHHHHHHSCSSGGGSC-CHHHHHHHHHHHHH
T ss_pred HHHHhccCcCCCCcCcCH-HHHHHHHHHcCCChhhCC-CHHHHHHHHHHHHH
Confidence 0000 0001112222 233445556667777765 99999999887643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=310.73 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=190.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++.+.||+|+||.||++.+..+ +..||+|.+.... ...+.+.+|+..+++++||||+++++++. ++..|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 457999999999999999999998753 4579999886543 23457889999999999999999999974 56789
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC----------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccccCcc
Confidence 9999999999999998654 699999999999999999999999999999999999998765 4999999998754332
Q ss_pred CC--CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 173 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
.. .....+++.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.........+......+ +...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~-------~~~~ 241 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------MPPN 241 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------CCTT
T ss_pred cccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC-------CCCC
Confidence 22 233456778999999987777554 999999999999997 999999877665554443321111 1122
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
++.+ +.+.+.++...+|.+|+ ++.|+++.|..+
T Consensus 242 ~~~~-l~~li~~~l~~~p~~Rp-s~~~l~~~l~~~ 274 (281)
T 1mp8_A 242 CPPT-LYSLMTKCWAYDPSRRP-RFTELKAQLSTI 274 (281)
T ss_dssp CCHH-HHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CCHH-HHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 2222 33444555567777765 999999988765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.07 Aligned_cols=202 Identities=32% Similarity=0.516 Sum_probs=177.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
.++|++++.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++...+..|+|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 478999999999999999999999999999999987653 234578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
|++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+||+++.++. +||+|||++..... ....
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~ 188 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMAN 188 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC--
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-cccc
Confidence 999999999999888999999999999999999999996 9999999999999987764 99999999864322 2234
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
...+++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+..
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~ 236 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAK 236 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHH
T ss_pred CCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4578999999999988776554 99999999999999999999875543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=328.79 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=200.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC--eEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~--~~~lv 95 (330)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... ...+.+.+|+.++++++||||+++++++...+ ..|+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 578999999999999999999999999999999987543 23467789999999999999999999998765 78999
Q ss_pred EeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEe--cCCCCCceEEeecCCccccc
Q 020133 96 MEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli--~~~~~~~vkL~Dfg~a~~~~ 170 (330)
|||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++...+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999999987543 39999999999999999999999999999999999998 12233359999999998665
Q ss_pred CCCCCCcccCCCCCCChhhhhc--------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCh----hhHHHHHhhcCChh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLK--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----PKNFRKTIHRISIP 238 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Di~SlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~ 238 (330)
.........||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||..... .....+++......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred CCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 5555556779999999999865 233 3449999999999999999999975332 23333333221110
Q ss_pred HH------hcC--chhh-----ccCC---ccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 239 EI------RNH--EWFL-----KNLP---ADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 239 ~~------~~~--~~~~-----~~~~---~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.. ... .|-. ..++ ...+.+.+.++...+|.+|+ +++++.+.+..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~-s~~e~l~~l~~i 307 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW-GFDQFFAETSDI 307 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-CHHHHHHHHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc-cHHHHHHHHHHH
Confidence 00 000 0000 0000 11223444556667888876 899998887765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.38 Aligned_cols=256 Identities=21% Similarity=0.347 Sum_probs=205.4
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
...++|++.+.||+|+||.||++.+.. +..||||.++......+.+.+|+.++++++||||+++++++. .+..|+|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 345789999999999999999999864 678999999887766788999999999999999999999986 567899999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--
Q 020133 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (330)
Q Consensus 98 ~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-- 173 (330)
|+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCcee
Confidence 99999999999754 36899999999999999999999999999999999999987664 9999999997543211
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (330)
......++..|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+.......+......+. ...+|.
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------~~~~~~ 412 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------PENCPE 412 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-------CTTSCH
T ss_pred ccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------CCCCCH
Confidence 1223345778999999987777554 999999999999999 9999998776665555443322211 112222
Q ss_pred cccccccccCCCCCCCCccCCHHHHHHHHHHhCCC
Q 020133 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~ 287 (330)
.+.+.+.+++..+|.+|+ +++++.+.|......
T Consensus 413 -~l~~li~~cl~~dp~~RP-t~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 413 -ELYNIMMRCWKNRPEERP-TFEYIQSVLDDFYTA 445 (454)
T ss_dssp -HHHHHHHHHTCSSGGGSC-CHHHHHHHHHTSSSS
T ss_pred -HHHHHHHHHccCChhHCc-CHHHHHHHHHHHHhc
Confidence 233444555667777765 999999999887553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=323.00 Aligned_cols=202 Identities=31% Similarity=0.555 Sum_probs=173.7
Q ss_pred CCCeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCC-----cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-----~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
.++|++.+.||+|+||.||++++. .+++.||||+++... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 378999999999999999999984 589999999986432 2335667899999999 6999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecc
Confidence 99999999999999999998889999999999999999999999999999999999999987764 9999999987443
Q ss_pred CC--CCCCcccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 171 LH--SQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 171 ~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.. .......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 22 2233457999999999997632 23455999999999999999999997544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=336.25 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=207.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
...+|++.+.||+|+||.||++.+..++..||||.++......+.+.+|+.++++++||||+++++++...+.+|+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 34679999999999999999999999999999999987766678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--C
Q 020133 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 174 (330)
Q Consensus 99 ~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~ 174 (330)
+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEEC
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCceee
Confidence 9999999999863 45999999999999999999999999999999999999987654 9999999997543221 1
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....++..|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+.......+......+ ....+|.
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 446 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE- 446 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------CCTTCCH-
T ss_pred cCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------CCCCCCH-
Confidence 223345678999999988777555 999999999999999 999999877655444333222111 1112222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
.+.+.+.+++..+|.+|+ ++.++++.|.....
T Consensus 447 ~l~~li~~cl~~dP~~RP-s~~el~~~L~~~~~ 478 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRP-SFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHTSCS
T ss_pred HHHHHHHHHcCcChhHCc-CHHHHHHHHHHHHh
Confidence 233444555667777764 99999999987643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=308.10 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=194.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.+.||+|+||.||++.+..+|+.||+|.+.... ....+.+|+..+++++||||+++++++...+..|+||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 478999999999999999999999999999999987653 4577899999999999999999999999999999999999
Q ss_pred CCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCc
Q 020133 100 SGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (330)
Q Consensus 100 ~g~sL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~ 177 (330)
++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++...... .....
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCc
Confidence 9999999987 4568999999999999999999999999999999999999987764 999999998644332 22344
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
..+++.|+|||.+.+..++.+ +||||||+++|+|++|+.||................. +... ....++ ..+.+
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~-~~l~~ 257 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PTFR----KPELWS-DNFTD 257 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCS----SGGGSC-HHHHH
T ss_pred cCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-cccC----CcccCC-HHHHH
Confidence 578999999999988777655 9999999999999999999987665444433322211 0000 011111 22334
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|..|+ ++.++++
T Consensus 258 li~~~l~~dp~~Rp-t~~~ll~ 278 (314)
T 3com_A 258 FVKQCLVKSPEQRA-TATQLLQ 278 (314)
T ss_dssp HHHHHTCSCTTTSC-CHHHHTT
T ss_pred HHHHHccCChhhCc-CHHHHHh
Confidence 44555567777766 8888775
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=322.35 Aligned_cols=208 Identities=26% Similarity=0.447 Sum_probs=162.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------C
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~ 90 (330)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999999999999999875432 235678999999999999999999999754 5
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
..|+|||++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccc
Confidence 679999999 6799988865 67999999999999999999999999999999999999987764 9999999987433
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
. ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 184 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred c--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 234567899999999998744445559999999999999999999999887777666654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=311.41 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=189.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++.+.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+..+++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 468999999999999999999999999999999987532 2235688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS 188 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC--------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecC
Confidence 999999999998864 45799999999999999999999999999999999999998766 499999999874433
Q ss_pred CC-CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh-hhHHHHHhhcCChhHHhcCchhhcc
Q 020133 172 HS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
.. ......+++.|+|||++.+..++.+ +||||||+++|+|++|+.||.+... .......+.....+.. ....
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 262 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL-----PSDH 262 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC-----CTTT
T ss_pred CCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC-----cccc
Confidence 22 2234568999999999987776544 9999999999999999999976432 2222222222221111 0112
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
++. .+.+.+.++...+|.+|+ ++.++++.|..+..
T Consensus 263 ~~~-~l~~li~~~l~~dp~~Rp-s~~~il~~l~~l~~ 297 (310)
T 2wqm_A 263 YSE-ELRQLVNMCINPDPEKRP-DVTYVYDVAKRMHA 297 (310)
T ss_dssp SCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHHH
T ss_pred cCH-HHHHHHHHHcCCChhhCC-CHHHHHHHHHHHHH
Confidence 222 233444555567777765 99999988887643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.80 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=194.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC------eEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~------~~~l 94 (330)
.+|++++.||+|+||+||+|.+..+++ ||+|++...... ..+|+.+++.++||||+++++++...+ .+|+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 579999999999999999999987766 888887655432 247999999999999999999997544 3889
Q ss_pred EEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec-CCCCCceEEeecCCccccc
Q 020133 95 VMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 95 v~e~~~g~sL~~~l---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~-~~~~~~vkL~Dfg~a~~~~ 170 (330)
||||++++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+|+...
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCccccc
Confidence 99999875443332 2356799999999999999999999999999999999999998 444 59999999998666
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChh------------
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIP------------ 238 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------ 238 (330)
.........+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..++.....|
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 66666677899999999999776544556999999999999999999999988777777666432211
Q ss_pred ------HHhcCchh---hccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 239 ------EIRNHEWF---LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 239 ------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
....++|- ....++ .+.+.+.++...+|.+|+ ++.|+++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~~L~~dP~~R~-t~~e~l~ 321 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPP-DAIDLISRLLEYTPSARL-TAIEALC 321 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCH-HHHHHHHHHCCSSGGGSC-CHHHHHT
T ss_pred hhhccccccCCcHHHhccccCCH-HHHHHHHHHhCCChhhCC-CHHHHhc
Confidence 11112221 111222 233455556667777766 7888775
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.11 Aligned_cols=204 Identities=36% Similarity=0.577 Sum_probs=171.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---------cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
++|++.+.||+|+||.||+|.+..+++.||||.+.... .....+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 68999999999999999999999999999999986532 11235789999999999999999999987665
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~~~~ 170 (330)
.|+||||+++++|.+++..++.+++..++.++.||+.||.|||++||+||||||+||+++.++ ...+||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 899999999999999998888999999999999999999999999999999999999997643 2359999999987543
Q ss_pred CCCCCCcccCCCCCCChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
.........+++.|+|||++.+ ....+.++|||||||++|+|++|+.||......
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 3322234568999999999842 223345599999999999999999999865543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=314.44 Aligned_cols=264 Identities=20% Similarity=0.299 Sum_probs=198.2
Q ss_pred CCCCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEE----EEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeee
Q 020133 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83 (330)
Q Consensus 10 pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~--~~~~~~~~~ei~~l~~l~h~~Iv~~~ 83 (330)
|...+......++|++++.||+|+||.||+|.+..+++.+ |+|.+... ......+.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 83 (327)
T 3lzb_A 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp ----CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred CchhhhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEE
Confidence 4445555667799999999999999999999998887755 66666443 23456889999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEee
Q 020133 84 EVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (330)
Q Consensus 84 ~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~D 162 (330)
+++.... .++|++|+.+++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|
T Consensus 84 ~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~D 160 (327)
T 3lzb_A 84 GICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITD 160 (327)
T ss_dssp EEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECC
T ss_pred EEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEcc
Confidence 9998765 7899999999999999976 457999999999999999999999999999999999999987664 99999
Q ss_pred cCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChh
Q 020133 163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIP 238 (330)
Q Consensus 163 fg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (330)
||+++....... .....+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+................+
T Consensus 161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (327)
T 3lzb_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239 (327)
T ss_dssp TTC----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred CcceeEccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999975433222 223346778999999988877655 999999999999999 999998876655443333222111
Q ss_pred HHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 239 EIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
. ....+. .+...+.++...+|.+| +++.|+++.|.++..
T Consensus 240 ~-------~~~~~~-~l~~li~~~l~~dp~~R-ps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 240 Q-------PPICTI-DVYMIMRKCWMIDADSR-PKFRELIIEFSKMAR 278 (327)
T ss_dssp C-------CTTBCH-HHHHHHHHHTCSSGGGS-CCHHHHHHHHHHHHT
T ss_pred C-------CccCCH-HHHHHHHHHcCCChhHC-cCHHHHHHHHHHHHh
Confidence 1 111122 22334445555777776 499999999988754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=309.10 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=177.8
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCccc---HHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..++|++++.||+|+||.||+|.+..+|+.||+|.+....... ..+.++...++.++||||+++++++..++..|+|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999999999999999987643222 2334455557788999999999999999999999
Q ss_pred EeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 96 MEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 96 ~e~~~g~sL~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
|||++| +|.+++. ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccc
Confidence 999975 8877664 356899999999999999999999998 999999999999998766 49999999997655
Q ss_pred CCCCCCcccCCCCCCChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh-hHHHHHhhcCChhHHhcCchh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRISIPEIRNHEWF 246 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (330)
.........+++.|+|||++. .....+.++|||||||++|+|++|+.||...... ..+........ +.. .
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-----~ 235 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQL-----P 235 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-CCC-----C
T ss_pred ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-CCc-----c
Confidence 555555567999999999972 2333345599999999999999999999864433 33333332211 110 0
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
...++. .+.+.+.++...+|.+|+ ++.|+++
T Consensus 236 ~~~~~~-~~~~li~~~l~~~p~~Rp-t~~e~l~ 266 (290)
T 3fme_A 236 ADKFSA-EFVDFTSQCLKKNSKERP-TYPELMQ 266 (290)
T ss_dssp TTTSCH-HHHHHHHHHTCSSGGGSC-CHHHHTT
T ss_pred cccCCH-HHHHHHHHHhhcChhhCc-CHHHHHh
Confidence 111222 223334445556666665 8888775
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=313.76 Aligned_cols=200 Identities=25% Similarity=0.403 Sum_probs=168.0
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCC--CCeeeeeEEEEeCCeE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRH--PNIVRFKEVILTPTHL 92 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h--~~Iv~~~~~~~~~~~~ 92 (330)
...++|++++.||+|+||.||++.+. +++.||+|++...... .+.+.+|+.++++++| |||+++++++...+..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 34578999999999999999999984 5889999998765332 2567899999999976 9999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+|||+ .+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+++ + .+||+|||+++.....
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC---
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCcc
Confidence 999994 57899999999899999999999999999999999999999999999999963 2 5999999999754333
Q ss_pred CC---CCcccCCCCCCChhhhhc-----------CCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 173 SQ---PKSTVGTPAYIAPEVLLK-----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 173 ~~---~~~~~~~~~y~aPE~~~~-----------~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.. .....||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 22 235579999999999865 333 445999999999999999999997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=324.35 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=191.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++.+.||+|+||.||++.+. .++..||||.++... ...+.+.+|+.++++++||||+++++++...+..|
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4568999999999999999999987 467789999987643 23457889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccC
Confidence 9999999999999998654 6999999999999999999999999999999999999987764 999999998754332
Q ss_pred CC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 173 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
.. .....+++.|+|||++.+..++.+ +||||||+++|||++ |+.||...+.......+......+. .
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~-------~ 272 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-------P 272 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC-------C
T ss_pred CccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------C
Confidence 21 122235678999999988777655 999999999999998 9999988776555444433211110 0
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
..++ ..+.+.+.++...+|.+|+ ++.++++.|..+.
T Consensus 273 ~~~~-~~l~~li~~cl~~dp~~RP-s~~~i~~~L~~~~ 308 (373)
T 2qol_A 273 MDCP-AALYQLMLDCWQKDRNNRP-KFEQIVSILDKLI 308 (373)
T ss_dssp TTCB-HHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred cccc-HHHHHHHHHHhCcChhhCc-CHHHHHHHHHHHH
Confidence 1112 2233344455556777765 9999999888763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.99 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=201.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..++|++++.||+|+||.||++.+. +++.||+|.+.......+.+.+|+.++++++||||+++++++.. +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 4578999999999999999999975 46789999998776667889999999999999999999999864 568999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--C
Q 020133 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 174 (330)
Q Consensus 99 ~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~ 174 (330)
+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++....... .
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEEC
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCccccc
Confidence 99999999987543 6999999999999999999999999999999999999987654 9999999987543322 2
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||.+.+.......+......+ ....++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 237 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-------RPDNCPE- 237 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------CCTTCCH-
T ss_pred ccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC-------CcccccH-
Confidence 233456788999999987766544 999999999999999 999998877655554443322110 1112222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+.+.+.++...+|.+|+ +++++.+.|....
T Consensus 238 ~l~~li~~~l~~~p~~Rp-s~~~l~~~l~~~~ 268 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRP-TFDYLRSVLEDFF 268 (279)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHHhccChhhCC-CHHHHHHHHHHHH
Confidence 233444555567777765 9999999888764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=305.66 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=190.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||+||+|.+..+++.||+|.+.... .....+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999999999999999987643 2345678899999998 8999999999999999999999
Q ss_pred eccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-----------------C
Q 020133 97 EYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----------------A 155 (330)
Q Consensus 97 e~~~g~sL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-----------------~ 155 (330)
||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 999999999999764 6799999999999999999999999999999999999997442 2
Q ss_pred CceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC
Q 020133 156 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235 (330)
Q Consensus 156 ~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 235 (330)
..+||+|||.+..... .....+++.|+|||++.+....+.++|||||||++|+|++|.+|+..... ...+...
T Consensus 171 ~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~- 243 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG- 243 (289)
T ss_dssp CCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTT-
T ss_pred eEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcC-
Confidence 3599999999875433 23346899999999998764544569999999999999999988754322 2222211
Q ss_pred ChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 236 SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.. +.+...++. .+.+.+.++...+|.+|+ ++.++++
T Consensus 244 ~~------~~~~~~~~~-~~~~li~~~l~~dp~~Rp-s~~~ll~ 279 (289)
T 1x8b_A 244 RL------PRIPQVLSQ-EFTELLKVMIHPDPERRP-SAMALVK 279 (289)
T ss_dssp CC------CCCSSCCCH-HHHHHHHHHTCSSGGGSC-CHHHHHT
T ss_pred CC------CCCCcccCH-HHHHHHHHHhCCCcccCC-CHHHHhh
Confidence 11 111122222 233444455556777765 7887764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=312.39 Aligned_cols=210 Identities=28% Similarity=0.513 Sum_probs=176.3
Q ss_pred CCeEEe-ceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEE
Q 020133 21 DRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 21 ~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv 95 (330)
++|.+. +.||+|+||.||+|.+..+++.||+|++.... .....+.+|+..++.+. ||||+++++++...+..|+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 568888 89999999999999999999999999987532 33467889999999995 69999999999999999999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeecCCcccccCC
Q 020133 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 172 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Dfg~a~~~~~~ 172 (330)
|||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++... .+.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999999999988543 6799999999999999999999999999999999999997621 235999999999866554
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.......+++.|+|||++.+..++.+ +||||||+++|+|++|+.||...+.......+
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 245 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 44556689999999999987777655 99999999999999999999887665544443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=311.86 Aligned_cols=209 Identities=25% Similarity=0.368 Sum_probs=166.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc------------cHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFKEVIL 87 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------~~~~~~ei~~l~~l~h~~Iv~~~~~~~ 87 (330)
.++|++++.||+|+||.||++.+.. |+.||||.+...... .+.+.+|+.++++++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 5789999999999999999999865 899999988643211 267889999999999999999999986
Q ss_pred eC-----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEe
Q 020133 88 TP-----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (330)
Q Consensus 88 ~~-----~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~ 161 (330)
.. ...|+||||++ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~ 176 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITIC 176 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEEC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEE
Confidence 42 36899999997 4777777654 47999999999999999999999999999999999999987664 9999
Q ss_pred ecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
|||+++............+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999755555555566789999999999874444555999999999999999999999877655554443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=306.29 Aligned_cols=252 Identities=23% Similarity=0.259 Sum_probs=195.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEE-EeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~-~~~~~~~lv~e~ 98 (330)
.++|++.+.||+|+||.||++.+..+|+.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4789999999999999999999999999999998876543 35688999999999988766555554 567788999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec---CCCCCceEEeecCCcccccCCCC
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~---~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++ .++ .+||+|||+++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCccccccccc
Confidence 9 8899999974 45799999999999999999999999999999999999994 444 599999999975443322
Q ss_pred --------CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh---hhHHHHHhh---cCChhHH
Q 020133 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PKNFRKTIH---RISIPEI 240 (330)
Q Consensus 175 --------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~---~~~~~~~~~---~~~~~~~ 240 (330)
.....+++.|+|||++.+..++. ++|||||||++|+|++|+.||..... ...+..+.. ....+..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred ccccccccccccccccccCChhhhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 24557899999999998877654 49999999999999999999986432 122222221 1111111
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+|.+ +.+.+.++...+|.+|+ ++.++.+.|..+
T Consensus 243 ------~~~~~~~-l~~li~~~l~~dp~~Rp-s~~~l~~~l~~~ 278 (296)
T 3uzp_A 243 ------CKGYPSE-FATYLNFCRSLRFDDKP-DYSYLRQLFRNL 278 (296)
T ss_dssp ------TTTSCHH-HHHHHHHHHTSCTTCCC-CHHHHHHHHHHH
T ss_pred ------HhhCCHH-HHHHHHHHHhcCcCcCC-CHHHHHHHHHHH
Confidence 1222322 33444555567787776 999999988875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=307.04 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=191.6
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEe------CCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~------~~~ 91 (330)
..++|++++.||+|+||.||+|.+..+|+.||+|++.........+.+|+..++++ +||||+++++++.. .+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 45899999999999999999999999999999999987777778899999999998 79999999999987 467
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
.|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++...
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 179 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC--
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceec
Confidence 89999999999999999764 57999999999999999999999999999999999999987664 999999998754
Q ss_pred cCC-CCCCcccCCCCCCChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcC
Q 020133 170 VLH-SQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243 (330)
Q Consensus 170 ~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
... .......+++.|+|||++. +..++ .++|||||||++|+|++|+.||...........+.... .+..
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~--- 254 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-APRL--- 254 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCC---
T ss_pred CcCccccccccCCccccChhhhccccccCcCCC-ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cccC---
Confidence 322 2234457899999999986 33444 44999999999999999999998766554443332221 1111
Q ss_pred chhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 244 EWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
....++ ..+.+.+.++...+|.+|+ ++.++++
T Consensus 255 --~~~~~~-~~l~~li~~~l~~dp~~Rp-s~~~ll~ 286 (326)
T 2x7f_A 255 --KSKKWS-KKFQSFIESCLVKNHSQRP-ATEQLMK 286 (326)
T ss_dssp --SCSCSC-HHHHHHHHHHCCSSGGGSC-CHHHHHT
T ss_pred --CccccC-HHHHHHHHHHhccChhhCC-CHHHHhh
Confidence 111111 2223344445556666655 7777775
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=313.79 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=199.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-------CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~ 88 (330)
..++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ....+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999986 4578899999876532 235688999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC
Q 020133 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~ 152 (330)
.+..|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 999999999999999999998654 3899999999999999999999999999999999999987
Q ss_pred CCCCceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHH
Q 020133 153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~ 228 (330)
++. +||+|||+++...... ......+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||.+.......
T Consensus 193 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 193 NNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp TCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 664 9999999987443322 2233456788999999987776544 999999999999999 99999887655444
Q ss_pred HHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 229 RKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..+......+ ....++. .+.+.+..+...+|.+|+ ++.|+++.|..+
T Consensus 270 ~~~~~~~~~~-------~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~ell~~L~~l 316 (334)
T 2pvf_A 270 KLLKEGHRMD-------KPANCTN-ELYMMMRDCWHAVPSQRP-TFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHTCCCC-------CCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHhcCCCCC-------CCccCCH-HHHHHHHHHccCChhhCc-CHHHHHHHHHHH
Confidence 3333221110 1112222 233444555567777774 999999988876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=311.39 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=188.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHc--CCCCCeeeeeEEEEeC----CeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~--l~h~~Iv~~~~~~~~~----~~~~ 93 (330)
.++|++.+.||+|+||+||++.+ +++.||||++.... ...+.+|..++.. ++||||+++++++... ...|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 47899999999999999999988 58899999986543 3445556666555 7999999999997653 4589
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh--------hcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
+||||+++++|.++++. ..+++..++.++.|++.||.||| +.||+||||||+|||++.++. +||+|||+
T Consensus 83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~ 159 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGL 159 (301)
T ss_dssp EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCC
Confidence 99999999999999954 57999999999999999999999 999999999999999987664 99999999
Q ss_pred cccccCCCC-----CCcccCCCCCCChhhhhcCCCC-----CCccchhhHHHHHHHHHhC----------CCCCCCCCh-
Q 020133 166 SKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVG----------AYPFEDPEE- 224 (330)
Q Consensus 166 a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~-----~~~~Di~SlG~il~elltg----------~~pf~~~~~- 224 (330)
++....... .....||+.|+|||++.+.... +.++|||||||++|+|+|| +.||.....
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 864332221 2344789999999999766322 1359999999999999999 888865322
Q ss_pred ---hhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 225 ---PKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 225 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
....................++....+ ..+.+.+.++...+|.+|+ |+.++++.|.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~Rp-s~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTL-TSLAKLMKECWYQNPSARL-TALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHH-HHHHHHHHHHCCSSGGGSC-CHHHHHHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccH-HHHHHHHHHHhhcChhhCC-CHHHHHHHHhcc
Confidence 222222221111000001111111111 1233445555567777766 999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=322.34 Aligned_cols=255 Identities=11% Similarity=0.106 Sum_probs=196.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC--------CcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeee----------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT--------EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR---------- 81 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~---------- 81 (330)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 47999999999999999999999874 889999998765 46789999999999999887
Q ss_pred -----eeEEEEe-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC
Q 020133 82 -----FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (330)
Q Consensus 82 -----~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~ 153 (330)
+++++.. ++..|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 6778776 67899999999 99999999875 789999999999999999999999999999999999999876
Q ss_pred CCCceEEeecCCcccccCCC--------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-h
Q 020133 154 PAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-E 224 (330)
Q Consensus 154 ~~~~vkL~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~-~ 224 (330)
+...+||+|||+++...... ......+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... .
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 53359999999997443221 1233478999999999988776544 999999999999999999998754 3
Q ss_pred hhHHHHHhhcCChhHHhcCchhh-----ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 225 PKNFRKTIHRISIPEIRNHEWFL-----KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
...+........ ....++.. ..++ ..+.+.+.++...+|.+|+ +++++++.|..+.
T Consensus 275 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~dp~~Rp-s~~~l~~~L~~~~ 335 (352)
T 2jii_A 275 TEDIMKQKQKFV---DKPGPFVGPCGHWIRPS-ETLQKYLKVVMALTYEEKP-PYAMLRNNLEALL 335 (352)
T ss_dssp HHHHHHHHHHHH---HSCCCEECTTSCEECCC-HHHHHHHHHHHTCCTTCCC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcc---CChhhhhhhccccCCCc-HHHHHHHHHHHhCChhhCC-CHHHHHHHHHHHH
Confidence 333333222110 00011100 1122 2233445555667787775 8999999888753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=312.10 Aligned_cols=206 Identities=28% Similarity=0.450 Sum_probs=172.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE----
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL---- 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~---- 92 (330)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 47899999999999999999999999999999999764322 35678999999999999999999999877654
Q ss_pred --EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 93 --AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 93 --~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
|+||||+. ++|.+.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc
Confidence 99999997 58877763 45999999999999999999999999999999999999987764 9999999987433
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..++
T Consensus 196 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 255 (371)
T 4exu_A 196 --AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred --cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 233456789999999999874444455999999999999999999999877655555444
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=308.78 Aligned_cols=212 Identities=31% Similarity=0.435 Sum_probs=172.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEE-----------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVIL----------- 87 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~----------- 87 (330)
.++|++++.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+..+++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 5899999999999999999999999999999999876542 3457889999999999999999999874
Q ss_pred ---eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecC
Q 020133 88 ---TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (330)
Q Consensus 88 ---~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg 164 (330)
..+..|+||||++ ++|.+++.. +++++..++.++.|++.||.|||++||+||||||+||+++.++ ..+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg 166 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFG 166 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCT
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCc
Confidence 3467899999997 599998864 6799999999999999999999999999999999999997433 259999999
Q ss_pred CcccccCC----CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 165 YSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 165 ~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
+++..... .......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 98754321 22334567899999999876444456699999999999999999999988776666655543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.61 Aligned_cols=265 Identities=24% Similarity=0.369 Sum_probs=198.6
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEe----CCe
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILT----PTH 91 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~----~~~ 91 (330)
....++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 345689999999999999999999999999999999886543 334678899999999999999999999873 347
Q ss_pred EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
.|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~ 182 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMN 182 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCE
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcch
Confidence 8999999999999998875 467999999999999999999999999999999999999987664 9999999886
Q ss_pred cccCCCCC----------CcccCCCCCCChhhhhcCCC--CCCccchhhHHHHHHHHHhCCCCCCCCChh--hHHHHHhh
Q 020133 168 SSVLHSQP----------KSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEP--KNFRKTIH 233 (330)
Q Consensus 168 ~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~--~~~~~Di~SlG~il~elltg~~pf~~~~~~--~~~~~~~~ 233 (330)
........ ....+++.|+|||++.+... .+.++||||||+++|+|++|+.||...... ........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 43221111 12346899999999865431 234599999999999999999999531110 11111111
Q ss_pred cCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCCCCCC
Q 020133 234 RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQ 292 (330)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~~~~~ 292 (330)
....+.. ...+ ..+.+.+.++...+|.+|+ ++.++++.|..+..+..++.
T Consensus 263 ~~~~~~~-------~~~~-~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 263 QLSIPQS-------PRHS-SALWQLLNSMMTVDPHQRP-HIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp C--CCCC-------TTSC-HHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHTCCCCCC--
T ss_pred cCCCCcc-------ccCC-HHHHHHHHHHhhcChhhCC-CHHHHHHHhhhcCCCCCCCC
Confidence 1111110 1111 2233445555567777776 99999999999887766544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=307.35 Aligned_cols=253 Identities=23% Similarity=0.252 Sum_probs=191.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEE-EeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~-~~~~~~~lv~e~ 98 (330)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4789999999999999999999999999999998665432 34578899999999887766655554 667788999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEe---cCCCCCceEEeecCCcccccCCC-
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli---~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
+ +++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||++ +.++ .+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCccc
Confidence 9 8899999874 4679999999999999999999999999999999999999 4444 49999999997543322
Q ss_pred -------CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh---hHHHHHhh---cCChhHH
Q 020133 174 -------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIH---RISIPEI 240 (330)
Q Consensus 174 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~---~~~~~~~~---~~~~~~~ 240 (330)
......+|+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+.. ..+..... ....+.
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 241 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV- 241 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCc-hhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh-
Confidence 223557899999999998877654 499999999999999999999864432 12222111 111111
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
+...+|. .+.+.+.++...+|.+|+ +++++++.|..+.
T Consensus 242 -----~~~~~~~-~l~~li~~~l~~~p~~Rp-t~~~l~~~l~~~~ 279 (296)
T 4hgt_A 242 -----LCKGYPS-EFATYLNFCRSLRFDDKP-DYSYLRQLFRNLF 279 (296)
T ss_dssp -----HTTTSCH-HHHHHHHHHHTSCTTCCC-CHHHHHHHHHHHH
T ss_pred -----hhccCCH-HHHHHHHHHHhcCCCCCC-CHHHHHHHHHHHH
Confidence 1122222 233444555567777776 8999999888753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=308.90 Aligned_cols=206 Identities=32% Similarity=0.442 Sum_probs=178.0
Q ss_pred CCCeEEeceeccCCceEEEEEEE-CCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCC------CeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~------~Iv~~~~~~~~~~~~ 92 (330)
.++|++++.||+|+||.||+|.+ ..+++.||+|++.......+.+.+|+.+++.++|+ +|+++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 47999999999999999999999 56789999999987655567788999999888655 599999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC----------------
Q 020133 93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---------------- 154 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~---------------- 154 (330)
|+||||+ +++|.+++...+ ++++..++.++.|++.||.|||++||+||||||+||+++.+.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 9999999 789999998765 689999999999999999999999999999999999997643
Q ss_pred -CCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 155 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 155 -~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
.+.+||+|||+++... .......+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+......
T Consensus 172 ~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 172 INPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp SCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred cCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 3469999999987433 23345678999999999988777655 999999999999999999998876654433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=309.88 Aligned_cols=260 Identities=27% Similarity=0.374 Sum_probs=179.1
Q ss_pred cccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 16 ~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
.....++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..+++++||||+++++++...+..|
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3445689999999999999999999999999999999886542 33456789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 94 IVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
+||||+++++|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~ 167 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGV 167 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccc
Confidence 99999999999999864 456999999999999999999999999999999999999987764 99999998
Q ss_pred cccccCC------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCC--h
Q 020133 166 SKSSVLH------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIS--I 237 (330)
Q Consensus 166 a~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~ 237 (330)
+...... .......+++.|+|||++.+....+.++||||||+++|+|++|+.||................. .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 8643322 1123456899999999987633334559999999999999999999988766555544443211 1
Q ss_pred hHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 238 PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.....+......+.+ +.+.+.++...+|..|+ ++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~-~~~li~~~l~~dp~~Rp-s~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKS-FRKMISLCLQKDPEKRP-TAAELLR 287 (303)
T ss_dssp TC-----CCCCCCCHH-HHHHHHHHCCSSGGGSC-CHHHHHT
T ss_pred ccccccchhhhhhhHH-HHHHHHHHccCChhhCc-CHHHHhh
Confidence 1111111111222222 23344445556776665 8888775
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=311.61 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=197.1
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCC----cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
-...++|++.+.||+|+||.||++.+..++ ..||+|.+..... ....+.+|+.++++++||||+++++++...+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 345689999999999999999999987543 4699999876432 2346889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
..++||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVL 197 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC----
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhh
Confidence 999999999999999999764 5799999999999999999999999999999999999998766 4999999998754
Q ss_pred cCCCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 170 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
..... .....+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||...+.......+......+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~----- 271 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT----- 271 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC-----
Confidence 33211 122345778999999987776554 999999999999999 9999988776555544443221111
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
...++ ..+.+.+.+++..+|.+|+ ++.++++.|..+..
T Consensus 272 --~~~~~-~~l~~li~~~l~~~p~~Rp-s~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 272 --PMDCP-SAIYQLMMQCWQQERARRP-KFADIVSILDKLIR 309 (333)
T ss_dssp --CTTCB-HHHHHHHHHHTCSSTTTSC-CHHHHHHHHHHHHH
T ss_pred --cccCC-HHHHHHHHHHcCCChhhCc-CHHHHHHHHHHHHh
Confidence 01122 2233444555567777765 89999998887643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=314.33 Aligned_cols=260 Identities=22% Similarity=0.274 Sum_probs=197.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
..++|++.+.||+|+||.||++.+. +++.||+|.+..... ..+.+.+|+..++.++||||+++++++...+..|+|||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 4589999999999999999999964 689999998876533 34678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 98 YASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
|+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTELD 193 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeeccccccccccc
Confidence 999999999886543 5899999999999999999999999999999999999987664 9999999987433221
Q ss_pred ---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhH--HHH----HhhcCChhHHhcCc
Q 020133 174 ---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN--FRK----TIHRISIPEIRNHE 244 (330)
Q Consensus 174 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~--~~~----~~~~~~~~~~~~~~ 244 (330)
......|++.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ... ..............
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred ccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 1233458999999999988777655 9999999999999999999976433211 111 01111111110000
Q ss_pred hhhccCCc---cccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 245 WFLKNLPA---DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 245 ~~~~~~~~---~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+...++. ..+.+.+.++...+|.+|+ ++.|+++.|..+
T Consensus 273 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~~ 313 (321)
T 2qkw_B 273 -LADKIRPESLRKFGDTAVKCLALSSEDRP-SMGDVLWKLEYA 313 (321)
T ss_dssp -CTTCSCHHHHHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred -hccccCHHHHHHHHHHHHHHcCCCcccCc-CHHHHHHHHHHH
Confidence 0011111 1122333455557777764 999999988865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=309.87 Aligned_cols=243 Identities=21% Similarity=0.262 Sum_probs=183.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|+++++||+|+||+||+|.+..+|+.||||++...... ......|+..+.++ +||||+++++++...+..|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999999999999999988654322 22344555555444 8999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||+ +++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++.........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence 999 56888887654 46999999999999999999999999999999999999987764 999999998766555555
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
....||+.|+|||++.+ .++. ++|||||||++|+|++|..|+.... .+.........++. ...++. .+
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~-~l 281 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGT-AADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEF------TAGLSS-EL 281 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCST-HHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHH------HTTSCH-HH
T ss_pred cccCCCccccCHhHhcC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCccc------ccCCCH-HH
Confidence 56679999999999876 4544 5999999999999999977665422 22222222211111 122222 23
Q ss_pred ccccccCCCCCCCCccCCHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.+.++...+|.+|+ ++.|+++
T Consensus 282 ~~li~~~L~~dP~~Rp-t~~ell~ 304 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRA-TAEALLA 304 (311)
T ss_dssp HHHHHHHSCSSTTTSC-CHHHHHT
T ss_pred HHHHHHHcCCChhhCc-CHHHHHh
Confidence 3444555667777765 8888875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=306.90 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=191.8
Q ss_pred CCCCcccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEe
Q 020133 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT 88 (330)
Q Consensus 12 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~ 88 (330)
..-+.-...++|++.+.||+|+||+||++.+.. .||+|.+...... .+.+.+|+..+++++||||+++++++ .
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 333444556899999999999999999998643 5999998754332 35688999999999999999999965 5
Q ss_pred CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 89 PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
....++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~ 168 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLAT 168 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC---
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceecc
Confidence 5668999999999999999864 45699999999999999999999999999999999999998776 49999999987
Q ss_pred cccC---CCCCCcccCCCCCCChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHh
Q 020133 168 SSVL---HSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIR 241 (330)
Q Consensus 168 ~~~~---~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (330)
.... ........+++.|+|||++. +..+ +.++||||||+++|+|++|+.||........+...+.+...+...
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 4332 22233456899999999986 3334 345999999999999999999999877766666665443221110
Q ss_pred cCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 242 NHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
+.+...+|. .+.+.+.++...+|.+|+ ++.++++.|.++.
T Consensus 248 --~~~~~~~~~-~l~~li~~~l~~~p~~Rp-s~~ell~~L~~l~ 287 (289)
T 3og7_A 248 --SKVRSNCPK-RMKRLMAECLKKKRDERP-SFPRILAEIEELA 287 (289)
T ss_dssp --TSSCTTSCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHTT
T ss_pred --hhccccCCH-HHHHHHHHHccCChhhCC-CHHHHHHHHHHHh
Confidence 011122222 233444555567777765 9999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.68 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=201.9
Q ss_pred cCCCCCCCcccCCCCeEEeceeccCCceEEEEEE----ECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeee
Q 020133 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 82 (330)
Q Consensus 8 ~~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~ 82 (330)
-+++..+..+...++|++++.||+|+||.||++. +..+++.||+|.+..... ..+.+.+|+.++++++||||+++
T Consensus 10 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 89 (327)
T 3lxl_A 10 QLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89 (327)
T ss_dssp -------CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred HHhhcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEE
Confidence 3566777788888999999999999999999999 567899999999876543 23568899999999999999999
Q ss_pred eEEEE--eCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceE
Q 020133 83 KEVIL--TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (330)
Q Consensus 83 ~~~~~--~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vk 159 (330)
++++. ..+..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++. +|
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~k 167 (327)
T 3lxl_A 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VK 167 (327)
T ss_dssp EEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EE
T ss_pred EEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EE
Confidence 99987 45678999999999999999976 456999999999999999999999999999999999999987664 99
Q ss_pred EeecCCcccccCCC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh---------
Q 020133 160 ICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK--------- 226 (330)
Q Consensus 160 L~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~--------- 226 (330)
|+|||+++...... ......+++.|+|||++.+..++.+ +||||||+++|+|++|+.||.......
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 246 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc
Confidence 99999997543322 2233457788999999987776544 999999999999999999986533211
Q ss_pred -----HHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 227 -----NFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 227 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
.....+.... .+-....++. .+.+.+.++...+|.+| +++.|+++.|..+..
T Consensus 247 ~~~~~~~~~~~~~~~------~~~~~~~~~~-~l~~li~~~l~~dP~~R-ps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 247 VPALSRLLELLEEGQ------RLPAPPACPA-EVHELMKLCWAPSPQDR-PSFSALGPQLDMLWS 303 (327)
T ss_dssp CCHHHHHHHHHHTTC------CCCCCTTCCH-HHHHHHHHHTCSSGGGS-CCHHHHHHHHHHC--
T ss_pred cccHHHHHHHhhccc------CCCCCCcccH-HHHHHHHHHcCCChhhC-cCHHHHHHHHHHHHh
Confidence 1111111000 0000111222 23344555566777776 499999999987644
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=324.95 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=200.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..++|++.+.||+|+||.||++.+.. +..||||.++......+.+.+|+.++++++||||+++++++.. +..|+||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 45789999999999999999999875 4669999998776666789999999999999999999999866 678999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--C
Q 020133 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 174 (330)
Q Consensus 99 ~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~ 174 (330)
+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC---------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCceec
Confidence 999999999974 356999999999999999999999999999999999999987654 9999999997543222 1
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....++..|+|||++.+..++.+ +||||||+++|+|++ |+.||.+.........+......+ ....+|.
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------~~~~~~~- 408 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------CPPECPE- 408 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------CCTTSCH-
T ss_pred ccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------CCCCCCH-
Confidence 223346778999999987777555 999999999999999 999999877665554444332211 0112222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
.+.+.+.+++..+|.+|+ +++++.+.|.......
T Consensus 409 ~l~~li~~cl~~dP~~Rp-t~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERP-TFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHHccCChhhCc-CHHHHHHHHHHHhccC
Confidence 233444555567777765 9999999999876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=316.69 Aligned_cols=200 Identities=25% Similarity=0.399 Sum_probs=168.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCC--CCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~--h~~Iv~~~~~~~~~~~~~l 94 (330)
..+|++++.||+|+||.||++.+.. ++.||||++..... ..+.+.+|+.++++++ ||||+++++++..++.+|+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3569999999999999999999865 89999999876532 2356889999999996 5999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~- 173 (330)
||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+++ + .+||+|||+++......
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~--~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S--CEEECCCSSSCCC-----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C--eEEEEecCccccccCCCc
Confidence 999 568899999998889999999999999999999999999999999999999953 3 59999999997553322
Q ss_pred --CCCcccCCCCCCChhhhhcC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 174 --QPKSTVGTPAYIAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 174 --~~~~~~~~~~y~aPE~~~~~----------~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
.....+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 272 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence 23456799999999998752 2234559999999999999999999986543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.56 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=194.8
Q ss_pred CCCeEEeceeccCCceEEEEEE----ECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeC--Ce
Q 020133 20 SDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~--~~ 91 (330)
..+|++++.||+|+||.||+|. +..+++.||+|.+.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4679999999999999999999 56789999999987543 3346789999999999999999999999876 66
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECccccccccc
Confidence 8999999999999999954 45799999999999999999999999999999999999998776 49999999997544
Q ss_pred CCC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh--------------hhHHHHHh
Q 020133 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--------------PKNFRKTI 232 (330)
Q Consensus 171 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~--------------~~~~~~~~ 232 (330)
... ......++..|+|||++.+..++.+ +||||||+++|+|++|..|+..... ...+...+
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 332 2334567788999999988777544 9999999999999999998643211 11111111
Q ss_pred hcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 233 HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.... ..-....++ +.+.+.+.++...+|.+| +|+.++++.|..+
T Consensus 257 ~~~~------~~~~~~~~~-~~l~~li~~~l~~dp~~R-ps~~~ll~~L~~l 300 (302)
T 4e5w_A 257 KEGK------RLPCPPNCP-DEVYQLMRKCWEFQPSNR-TSFQNLIEGFEAL 300 (302)
T ss_dssp HTTC------CCCCCTTCC-HHHHHHHHHTTCSSGGGS-CCHHHHHHHHHHH
T ss_pred hccC------CCCCCCCCC-HHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHH
Confidence 1100 000111222 223445556666778777 4999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=314.26 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=201.7
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCc-----EEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~ 89 (330)
...++|++.+.||+|+||.||++.+..+++ .||+|.+..... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 346889999999999999999999977654 799999876532 345688999999999 899999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC
Q 020133 90 THLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~ 155 (330)
+..|+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~- 201 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH- 201 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG-
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC-
Confidence 9999999999999999998753 4589999999999999999999999999999999999998765
Q ss_pred CceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 020133 156 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 156 ~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~ 231 (330)
.+||+|||+++....... .....+++.|+|||++.+..++.+ +|||||||++|+|+| |..||.+..........
T Consensus 202 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 202 -VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp -EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred -eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 499999999975433222 223456778999999988776544 999999999999998 99999887665555444
Q ss_pred hhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 232 IHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
......+ ......+ ..+.+.+.++...+|..|+ ++.++++.|...
T Consensus 280 ~~~~~~~------~~~~~~~-~~l~~li~~~l~~~p~~Rp-s~~~l~~~L~~~ 324 (333)
T 2i1m_A 280 VKDGYQM------AQPAFAP-KNIYSIMQACWALEPTHRP-TFQQICSFLQEQ 324 (333)
T ss_dssp HHHTCCC------CCCTTCC-HHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HhcCCCC------CCCCCCC-HHHHHHHHHHhccChhhCc-CHHHHHHHHHHH
Confidence 4321100 0011112 2233444555567777764 999999988764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.44 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=192.0
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECC---CCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
....++|++.+.||+|+||.||+|.+.. +++.||+|.+...... .+.+.+|+..+++++||||+++++++...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3456889999999999999999998765 5668999998754322 356889999999999999999999998765
Q ss_pred -----eEEEEEeccCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceE
Q 020133 91 -----HLAIVMEYASGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (330)
Q Consensus 91 -----~~~lv~e~~~g~sL~~~l~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vk 159 (330)
..++||||+++++|.+++. ....+++..++.++.|++.||.|||++||+||||||+||+++.++. +|
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~k 187 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VC 187 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EE
Confidence 3599999999999999984 2356999999999999999999999999999999999999987764 99
Q ss_pred EeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcC
Q 020133 160 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (330)
Q Consensus 160 L~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 235 (330)
|+|||+++...... ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||................
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 99999987543322 2233456788999999987776554 999999999999999 999998877665555544322
Q ss_pred ChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 236 SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..+ ....++. .+.+.+.++...+|..|+ ++.++++.|.++
T Consensus 267 ~~~-------~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~~l~~~L~~l 306 (313)
T 3brb_A 267 RLK-------QPEDCLD-ELYEIMYSCWRTDPLDRP-TFSVLRLQLEKL 306 (313)
T ss_dssp CCC-------CBTTCCH-HHHHHHHHTTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CCC-------CCccccH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 111 1112222 233445555667777764 999999988765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=304.61 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=192.5
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeC-CeEEEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVM 96 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-~~~~lv~ 96 (330)
...++|++.+.||+|+||.||++.+. |+.||+|.+.... ..+.+.+|+..+++++||||+++++++... +..|+||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 34588999999999999999999875 8899999887543 457789999999999999999999997654 4689999
Q ss_pred eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
||+++++|.+++...+. +++..++.++.|++.||.+||++|++||||||+||+++.++. +||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC---------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc--
Confidence 99999999999976543 899999999999999999999999999999999999987664 999999998743322
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+..++.+ +||||||+++|+|+| |+.||...+.............. .+....+.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~- 241 (278)
T 1byg_A 171 QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------DAPDGCPP- 241 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-------CCCTTCCH-
T ss_pred ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------CCcccCCH-
Confidence 233457889999999987776554 999999999999998 99999876655544443322111 11112222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+.+.+.++...+|.+|+ ++.++++.|..+.
T Consensus 242 ~l~~li~~~l~~~p~~Rp-s~~~l~~~L~~i~ 272 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRP-SFLQLREQLEHIK 272 (278)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCC-CHHHHHHHHHHHH
Confidence 233444555567777764 9999999888753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=307.90 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=190.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++++.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++++...+..|+||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 478999999999999999999999999999999987543 3346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc-CCCCCC
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPK 176 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~-~~~~~~ 176 (330)
+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++.... ......
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC--
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccccc
Confidence 999999998875 467999999999999999999999999999999999999987664 9999999875221 112233
Q ss_pred cccCCCCCCChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCC
Q 020133 177 STVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~-----~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
...+++.|+|||++. +..+ +.++||||||+++|+|++|+.||...+.............. .. .....++
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~ 249 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP-TL----LTPSKWS 249 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CC----SSGGGSC
T ss_pred cccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc-cc----CCccccC
Confidence 457899999999984 3344 44599999999999999999999887765555444332110 00 0011122
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHH
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
. .+.+.+.++...+|..|+ ++.++++
T Consensus 250 ~-~l~~li~~~l~~dp~~Rp-s~~~ll~ 275 (302)
T 2j7t_A 250 V-EFRDFLKIALDKNPETRP-SAAQLLE 275 (302)
T ss_dssp H-HHHHHHHHHSCSCTTTSC-CHHHHTT
T ss_pred H-HHHHHHHHHcccChhhCC-CHHHHhc
Confidence 1 123334445556676665 7776654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=317.11 Aligned_cols=200 Identities=27% Similarity=0.436 Sum_probs=171.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC--------CCCeeeeeEEEE----
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL---- 87 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~--------h~~Iv~~~~~~~---- 87 (330)
.++|++++.||+|+||+||+|.+..+++.||||++.......+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 47899999999999999999999999999999999876655678889999999885 788999999998
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCC----------
Q 020133 88 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP---------- 154 (330)
Q Consensus 88 ~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~---------- 154 (330)
....+|+||||+. ++|.+.+... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 4567899999995 4666655543 4699999999999999999999998 999999999999997653
Q ss_pred -------------------------------------CCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCC
Q 020133 155 -------------------------------------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197 (330)
Q Consensus 155 -------------------------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 197 (330)
...+||+|||+++.... ......+|+.|+|||++.+..++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCc
Confidence 12599999999874432 344567899999999998887765
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 198 KIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 198 ~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
+ +|||||||++|+|+||+.||...+
T Consensus 273 ~-~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 273 P-ADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred H-HHHHHHHHHHHHHhhCCCCCCCCc
Confidence 5 999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=302.00 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=198.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEe------------
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------------ 88 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~------------ 88 (330)
++|++++.||+|+||.||++.+..+++.||+|.+.... +.+.+|+..+++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 57999999999999999999999999999999997654 456799999999999999999999864
Q ss_pred ----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEee
Q 020133 89 ----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (330)
Q Consensus 89 ----~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~D 162 (330)
...+|+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~D 165 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGD 165 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC--CEEECc
Confidence 34589999999999999999754 5799999999999999999999999999999999999998765 499999
Q ss_pred cCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhc
Q 020133 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRN 242 (330)
Q Consensus 163 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (330)
||++.............+++.|+|||++.+..++.+ +||||||+++|+|++|..||... ......+.....
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~~----- 236 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET---SKFFTDLRDGII----- 236 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHTTCC-----
T ss_pred chhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhcccc-----
Confidence 999876655555556679999999999988777555 99999999999999999987531 111121111111
Q ss_pred CchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 243 HEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
....+. .+.+.+.++...+|.+|+ ++.|+++.+......+
T Consensus 237 ----~~~~~~-~~~~li~~~l~~dp~~Rp-s~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 237 ----SDIFDK-KEKTLLQKLLSKKPEDRP-NTSEILRTLTVWKKSP 276 (284)
T ss_dssp ----CTTSCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHTC--
T ss_pred ----cccCCH-HHHHHHHHHccCChhhCc-CHHHHHHHHHHHhhCC
Confidence 111222 223344455567777775 9999999998876543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=310.68 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=201.8
Q ss_pred CCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCcc--cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++.+.||+|+||.||+|.+. .+++.||+|.+...... ...+.+|+.++++++||||+++++++...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 478999999999999999999886 35788999998765432 34688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEee
Q 020133 93 AIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~D 162 (330)
|+||||+++++|.+++... .++++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~D 181 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGD 181 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEECc
Confidence 9999999999999998753 45799999999999999999999999999999999999987764 99999
Q ss_pred cCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChh
Q 020133 163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIP 238 (330)
Q Consensus 163 fg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (330)
||+++....... .....+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||...+.......+......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 259 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL- 259 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC-
Confidence 999874433221 223456788999999987776544 999999999999999 89999887665554444332110
Q ss_pred HHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 239 EIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
.....++. .+.+.+.++...+|.+|+ ++.|+++.|.+...
T Consensus 260 ------~~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 260 ------DKPDNCPD-MLFELMRMCWQYNPKMRP-SFLEIISSIKEEME 299 (322)
T ss_dssp ------CCCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHGGGSC
T ss_pred ------CCCCCCCH-HHHHHHHHHcCCCcccCc-CHHHHHHHHHHhhc
Confidence 01112222 233444555556777764 99999999987644
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.05 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=199.5
Q ss_pred ccCCCCeEEec-eeccCCceEEEEEEEC--CCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 17 MHDSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 17 ~~~~~~y~i~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
....++|.+.+ .||+|+||.||++.+. .+++.||+|.+.... ...+.+.+|+..+++++||||+++++++ ..+.
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 44567888887 9999999999999864 468889999997643 2345788999999999999999999999 4566
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++||||||+||+++.++ .+||+|||++....
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALG 161 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECT
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeeec
Confidence 89999999999999998653 5699999999999999999999999999999999999998765 49999999987543
Q ss_pred CCC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCch
Q 020133 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEW 245 (330)
Q Consensus 171 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
... ......+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||...........+..... +.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~-------~~ 233 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------ME 233 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-------CC
T ss_pred cCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc-------CC
Confidence 222 1233456788999999987776554 999999999999998 9999988766554443332211 11
Q ss_pred hhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 246 FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+...++. .+.+.+..+...+|.+|+ ++.++++.|..+
T Consensus 234 ~~~~~~~-~l~~li~~~l~~~p~~Rp-s~~~l~~~l~~~ 270 (287)
T 1u59_A 234 CPPECPP-ELYALMSDCWIYKWEDRP-DFLTVEQRMRAC 270 (287)
T ss_dssp CCTTCCH-HHHHHHHHTTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CCCCcCH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 1122322 233445555667777765 999999888766
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.38 Aligned_cols=211 Identities=31% Similarity=0.410 Sum_probs=182.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CC-----CeeeeeEEEEeCCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~-----~Iv~~~~~~~~~~~~~ 93 (330)
.++|++.+.||+|+||+||+|.+..+++.||||++.........+.+|+.+++.++ |+ +|+++++++...+..|
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 47899999999999999999999999999999999866555567778888888775 44 4999999999999999
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhh--hcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+||||+++ +|.+++... +.+++..++.++.|++.||.||| +.||+||||||+|||++.+..+.+||+|||+++..
T Consensus 133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 99999965 999998765 46999999999999999999999 57999999999999997554556999999999754
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
. .......+|+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+....+..+...
T Consensus 212 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 212 G--QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp T--CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred c--cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 3 23445678999999999988877655 99999999999999999999988877777666654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=310.77 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=199.7
Q ss_pred cCCCCeEEeceeccCCceEEEEEEE-----CCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~ 89 (330)
...++|++.+.||+|+||.||+|.+ ..+++.||+|.+..... ....+.+|+..++++ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3457999999999999999999985 35678999999876543 234688999999999 799999999998875
Q ss_pred C-eEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC
Q 020133 90 T-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (330)
Q Consensus 90 ~-~~~lv~e~~~g~sL~~~l~~~~~----------------l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~ 152 (330)
+ .+++||||+++++|.+++..... +++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4 48999999999999999987554 899999999999999999999999999999999999987
Q ss_pred CCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHH
Q 020133 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~ 228 (330)
++. +||+|||+++....... .....+++.|+|||++.+..++.+ +||||||+++|+|+| |+.||.+.......
T Consensus 184 ~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 184 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 654 99999999875433222 123456789999999988777544 999999999999998 99999876655444
Q ss_pred HHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 229 RKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+.....+. +....+. .+.+.+.++...+|.+|+ ++.|+++.|..+
T Consensus 261 ~~~~~~~~~~~------~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~ 308 (316)
T 2xir_A 261 CRRLKEGTRMR------APDYTTP-EMYQTMLDCWHGEPSQRP-TFSELVEHLGNL 308 (316)
T ss_dssp HHHHHHTCCCC------CCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHhccCccCC------CCCCCCH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 44433211100 1111222 223344455556777775 999999988765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=325.33 Aligned_cols=239 Identities=13% Similarity=0.094 Sum_probs=179.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHH---HHHHcCCCCCeeeee-------EE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREI---INHRSLRHPNIVRFK-------EV 85 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei---~~l~~l~h~~Iv~~~-------~~ 85 (330)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ....+.+.+|+ ..+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999999999999999998743 22346788999 455566899999998 77
Q ss_pred EEeCCe-----------------EEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHhhhcCcccc
Q 020133 86 ILTPTH-----------------LAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQVCHR 141 (330)
Q Consensus 86 ~~~~~~-----------------~~lv~e~~~g~sL~~~l~~~~~l~~-------~~~~~i~~qi~~~L~~LH~~~ivH~ 141 (330)
+...+. .|+||||+ +|+|.+++...+.+++ ..++.++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776542 89999999 6799999987655555 8888899999999999999999999
Q ss_pred CCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcC-----------CCCCCccchhhHHHHHH
Q 020133 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-----------EYDGKIADVWSCGVTLY 210 (330)
Q Consensus 142 dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~~Di~SlG~il~ 210 (330)
||||+|||++.++ .+||+|||+|+... .......| +.|+|||++.+. .++ .++|||||||++|
T Consensus 231 Dikp~NIll~~~~--~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRG--GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTC--CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC--CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHHH
Confidence 9999999998776 49999999997422 22334567 999999999876 554 4599999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 211 VMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 211 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+|++|+.||.+.........+.... ..++. .+.+.+.++...+|.+|+ ++.++++
T Consensus 305 elltg~~Pf~~~~~~~~~~~~~~~~------------~~~~~-~~~~li~~~L~~dp~~Rp-t~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWIFRSC------------KNIPQ-PVRALLEGFLRYPKEDRL-LPLQAME 359 (377)
T ss_dssp HHHHSSCCC------CCSGGGGSSC------------CCCCH-HHHHHHHHHTCSSGGGCC-CHHHHHT
T ss_pred HHHHCCCCCcccccccchhhhhhhc------------cCCCH-HHHHHHHHHcCCCchhCC-CHHHHhh
Confidence 9999999997654332222111110 12222 223344445556676665 7777764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=306.14 Aligned_cols=211 Identities=30% Similarity=0.453 Sum_probs=178.3
Q ss_pred CCCeEEeceeccCCceEEEEEEEC-CCCcEEEEEEeecCC---cccHHHHHHHHHHHcC---CCCCeeeeeEEEE-----
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL----- 87 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l---~h~~Iv~~~~~~~----- 87 (330)
.++|++++.||+|+||.||+|.+. .+|+.||+|++.... .....+.+|+..++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999996 678999999886532 2234566777777665 8999999999987
Q ss_pred eCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 88 TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 88 ~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
.....++||||+. ++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcc
Confidence 4567899999997 59999987643 4999999999999999999999999999999999999987764 99999999
Q ss_pred cccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 166 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
++............+++.|+|||++.+..++.+ +||||||+++|+|++|+.||.+.+....+..++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 975544444455678999999999988776555 99999999999999999999988877776666543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.28 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=195.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEECC---CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++.+.||+|+||.||++.+.. ++..||+|.+.... ...+.+.+|+..+++++||||+++++++.. +..|
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998754 34569999987653 234678899999999999999999999865 4568
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC---
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCcccccc
Confidence 999999999999999765 4599999999999999999999999999999999999998766 4999999998754332
Q ss_pred C--CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
. ......+++.|+|||++.+..++.+ +||||||+++|+|++ |+.||..................+ ....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~ 238 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP-------KPDL 238 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-------CCTT
T ss_pred cccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-------CCCC
Confidence 2 1233456778999999987776554 999999999999998 999998766555444333221111 1111
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
++ ..+.+.+.++...+|.+|+ ++.|+++.|..+
T Consensus 239 ~~-~~l~~li~~~l~~~p~~Rp-s~~ell~~L~~~ 271 (281)
T 3cc6_A 239 CP-PVLYTLMTRCWDYDPSDRP-RFTELVCSLSDV 271 (281)
T ss_dssp CC-HHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CC-HHHHHHHHHHccCCchhCc-CHHHHHHHHHHH
Confidence 22 2233444555567777764 999999988765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=306.10 Aligned_cols=253 Identities=31% Similarity=0.471 Sum_probs=190.8
Q ss_pred ccCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 17 ~~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+.+.++|++.+.||+|+||.||++.+. ++.||+|.+... ...+.+.+|+..+++++||||+++++++.+ ..|+||
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 345678999999999999999999875 788999988654 345678899999999999999999998763 479999
Q ss_pred eccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhh---cCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 97 EYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHS---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
||+++++|.+++.... .++...++.++.|++.||.|||+ +||+||||||+||+++.++. .+||+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQ 157 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC-----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccc
Confidence 9999999999998655 37899999999999999999999 89999999999999986653 47999999986433
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh-HHHHHhhcCChhHHhcCchhhcc
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
. ......+++.|+|||++.+..++.+ +||||||+++|+|++|+.||....... .......... .+-+...
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~ 228 (307)
T 2eva_A 158 T--HMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------RPPLIKN 228 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC------CCCCBTT
T ss_pred c--ccccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC------CCCcccc
Confidence 2 2234468999999999988777555 999999999999999999998644322 1111111111 1111122
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
++.. +.+.+.++...+|.+|+ +++++++.|..+..
T Consensus 229 ~~~~-l~~li~~~l~~dp~~Rp-s~~ell~~L~~~~~ 263 (307)
T 2eva_A 229 LPKP-IESLMTRCWSKDPSQRP-SMEEIVKIMTHLMR 263 (307)
T ss_dssp CCHH-HHHHHHHHTCSSGGGSC-CHHHHHHHHHHHGG
T ss_pred cCHH-HHHHHHHHhcCChhhCc-CHHHHHHHHHHHHH
Confidence 3322 33444555667777775 99999999887643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=307.96 Aligned_cols=199 Identities=31% Similarity=0.493 Sum_probs=174.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCC--CCCeeeeeEEEEeCC
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTPT 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~ei~~l~~l~--h~~Iv~~~~~~~~~~ 90 (330)
.++|++.+.||+|+||.||++.+..+++.||||.+..... ....+.+|+.++++++ ||||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 5789999999999999999999999999999999876432 2245678999999986 599999999999999
Q ss_pred eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec-CCCCCceEEeecCCccc
Q 020133 91 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS 168 (330)
Q Consensus 91 ~~~lv~e~~~g-~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~-~~~~~~vkL~Dfg~a~~ 168 (330)
..++|||++.+ ++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++ .++ .+||+|||+++.
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~ 199 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGAL 199 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEE
T ss_pred cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCccccc
Confidence 99999999976 89999999888999999999999999999999999999999999999997 344 599999999875
Q ss_pred ccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
... .......+++.|+|||++.+..+.+.++||||||+++|+|++|+.||..
T Consensus 200 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 200 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 432 2234457899999999998877766668999999999999999999965
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=310.42 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=196.6
Q ss_pred CCCCeEEeceeccCCceEEEEEE-----ECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
..++|++++.||+|+||.||++. +..+++.||+|.+.... .....+.+|+..+++++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 35789999999999999999999 55678899999986542 233568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEeec
Q 020133 92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDF 163 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~Df 163 (330)
.|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++ ...+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 999999999999999998753 489999999999999999999999999999999999997433 235999999
Q ss_pred CCcccccCC---CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhH
Q 020133 164 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPE 239 (330)
Q Consensus 164 g~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (330)
|+++..... .......+++.|+|||++.+..++.+ +||||||+++|+|+| |+.||...........+......
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-- 264 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-- 264 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC--
Confidence 998633222 22334567889999999987776554 999999999999998 99999876655444433322110
Q ss_pred HhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 240 IRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.....++. .+.+.+.++...+|.+|+ ++.++++.|..+.
T Consensus 265 -----~~~~~~~~-~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~ 303 (327)
T 2yfx_A 265 -----DPPKNCPG-PVYRIMTQCWQHQPEDRP-NFAIILERIEYCT 303 (327)
T ss_dssp -----CCCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred -----CCCCCCCH-HHHHHHHHHhcCChhhCc-CHHHHHHHHHHHh
Confidence 01112222 233445555667777765 9999999887663
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=310.65 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=196.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++.+.||+|+||.||++.+. +|+.||+|++.... .....+.+|+..++.++||||+++++++...+..++||
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 106 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 106 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence 4689999999999999999999854 58899999987643 22346889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhc---CccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 97 EYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
||+++++|.+++.... ++++..++.++.|++.||.|||++ ||+||||||+||+++.++. +||+|||+++..
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 184 (326)
T 3uim_A 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLM 184 (326)
T ss_dssp ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEEC
T ss_pred EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCcccccc
Confidence 9999999999997643 499999999999999999999999 9999999999999987764 999999999754
Q ss_pred cCCCC--CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC----CChhhHHHHHhhc----CChhH
Q 020133 170 VLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED----PEEPKNFRKTIHR----ISIPE 239 (330)
Q Consensus 170 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~----~~~~~~~~~~~~~----~~~~~ 239 (330)
..... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.. ..........+.. .....
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred CcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 33222 233458999999999987776544 9999999999999999999962 1111111222211 11111
Q ss_pred HhcCchhhccCCc---cccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 240 IRNHEWFLKNLPA---DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 240 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
..... +....+. ..+.+.+.++...+|.+|+ |+.|+++.|.....
T Consensus 264 ~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~~~~ 311 (326)
T 3uim_A 264 LVDVD-LQGNYKDEEVEQLIQVALLCTQSSPMERP-KMSEVVRMLEGDGL 311 (326)
T ss_dssp SSCTT-CTTSCCHHHHHHHHHHHHHHTCSCGGGSC-CHHHHHHHHHTSSC
T ss_pred hcChh-hccccCHHHHHHHHHHHHHHhCcCCccCC-CHHHHHHHhcCcch
Confidence 10000 0001111 1223344455556777766 99999999987433
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=312.55 Aligned_cols=268 Identities=27% Similarity=0.387 Sum_probs=170.9
Q ss_pred CCCCCCcccCCCCeEEec-eeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEe
Q 020133 10 PGMDMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88 (330)
Q Consensus 10 pg~~~~~~~~~~~y~i~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~ 88 (330)
||.......-.++|++.+ .||+|+||+||+|.+..+|+.||+|++.... ....+....++.++||||+++++++..
T Consensus 17 ~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp ---CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 344444444568999965 6999999999999999999999999987643 222333344677799999999999976
Q ss_pred ----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEe
Q 020133 89 ----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKIC 161 (330)
Q Consensus 89 ----~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~ 161 (330)
....++||||++|++|.+++...+ .+++.+++.++.|++.||.|||++||+||||||+||+++.++ .+.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 455899999999999999998754 699999999999999999999999999999999999997532 3459999
Q ss_pred ecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHh
Q 020133 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIR 241 (330)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (330)
|||+++.... .......+++.|+|||++.+..++.+ +|||||||++|+|++|+.||..............+.......
T Consensus 174 Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 174 DFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp CCTTCEEC-----------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred ccccceeccc-cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 9999874432 23345678999999999877666544 999999999999999999997654432221111111111110
Q ss_pred cCchhhccCCccccccccccCCCCCCCCccCCHHHHHH--HHHHh
Q 020133 242 NHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ--IIAEA 284 (330)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~--~l~~~ 284 (330)
...-....++. .+.+.+.++...+|.+|+ ++.|+++ .+...
T Consensus 252 ~~~~~~~~~~~-~~~~li~~~L~~dP~~Rp-t~~ell~hp~~~~~ 294 (336)
T 3fhr_A 252 FPNPEWSEVSE-DAKQLIRLLLKTDPTERL-TITQFMNHPWINQS 294 (336)
T ss_dssp CCTTTSTTCCH-HHHHHHHHHSCSSGGGSC-CHHHHHHSHHHHTG
T ss_pred cCchhhccCCH-HHHHHHHHHCCCChhHCc-CHHHHhcCcccccc
Confidence 00000012222 223344455556777665 8888886 55544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=308.37 Aligned_cols=257 Identities=22% Similarity=0.344 Sum_probs=188.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHc--CCCCCeeeeeEEEEeC----CeEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~--l~h~~Iv~~~~~~~~~----~~~~l 94 (330)
++|++++.||+|+||.||++.+. ++.||||++..... ....+|..++.. ++||||+++++++... ...|+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 68999999999999999999885 88999999875543 344455555544 4899999999999887 78999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc--------CccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++. +||+|||++
T Consensus 113 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a 189 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA 189 (337)
T ss_dssp EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTC
T ss_pred EEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCc
Confidence 9999999999999966 4799999999999999999999999 9999999999999987764 999999998
Q ss_pred ccccCCCC-----CCcccCCCCCCChhhhhcCCCCCC-----ccchhhHHHHHHHHHhC----------CCCCCCCCh--
Q 020133 167 KSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDPEE-- 224 (330)
Q Consensus 167 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~-----~~Di~SlG~il~elltg----------~~pf~~~~~-- 224 (330)
+....... .....||+.|+|||++.+...... ++|||||||++|+|+|| +.||.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 64433222 234579999999999977655433 38999999999999999 777754321
Q ss_pred --hhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 225 --PKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
....................+....++ ..+.+.+.++...+|.+|+ ++.++++.|..+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~l~~ 331 (337)
T 3mdy_A 270 PSYEDMREIVCIKKLRPSFPNRWSSDECL-RQMGKLMTECWAHNPASRL-TALRVKKTLAKMSE 331 (337)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHH-HHHHHHHHHHSCSSGGGSC-CHHHHHHHHHHHHH
T ss_pred CchhhhHHHHhhhccCccccccchhhHHH-HHHHHHHHHhhhhChhhCC-CHHHHHHHHHHHHh
Confidence 122222221111000000001001111 1133445556667787776 99999999887643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=304.24 Aligned_cols=254 Identities=29% Similarity=0.423 Sum_probs=193.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC-----CcccHHHHHHHHHHHcCCCCCeeeeeEEEE--eCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~--~~~~~ 92 (330)
.++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+..+++++||||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 37899999999999999999999999999999998653 233467899999999999999999999985 34578
Q ss_pred EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 93 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
|+||||++++ |.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence 9999999876 7777664 457999999999999999999999999999999999999987664 9999999987443
Q ss_pred CC---CCCCcccCCCCCCChhhhhcCCC-CCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchh
Q 020133 171 LH---SQPKSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246 (330)
Q Consensus 171 ~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (330)
.. .......+++.|+|||++.+... .+.++||||||+++|+|++|+.||...+.......+.... . .+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~-------~~ 232 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-Y-------AI 232 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-C-------CC
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-C-------CC
Confidence 21 12234568999999999876432 3445999999999999999999998766554444333211 0 01
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHH--HHHHhCC
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ--IIAEATI 286 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~--~l~~~~~ 286 (330)
....+. .+.+.+.++...+|.+|+ ++.|+++ .+.....
T Consensus 233 ~~~~~~-~l~~li~~~l~~dp~~Rp-s~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 233 PGDCGP-PLSDLLKGMLEYEPAKRF-SIRQIRQHSWFRKKHP 272 (305)
T ss_dssp CSSSCH-HHHHHHHHHTCSSTTTSC-CHHHHHHSHHHHSCCC
T ss_pred CCccCH-HHHHHHHHHccCChhhCC-CHHHHhcCcccccCCC
Confidence 111222 223344455556777766 8888885 4554433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=313.66 Aligned_cols=208 Identities=23% Similarity=0.426 Sum_probs=178.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----c--------------HHHHHHHHHHHcCCCCCeee
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----D--------------ENVQREIINHRSLRHPNIVR 81 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~--------------~~~~~ei~~l~~l~h~~Iv~ 81 (330)
.++|++.+.||+|+||.||+|.+ +|+.||+|.+...... . +.+.+|+..+++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47899999999999999999999 7999999998753211 1 78999999999999999999
Q ss_pred eeEEEEeCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecC
Q 020133 82 FKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDG 152 (330)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~g~sL~~~------l~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~ 152 (330)
+++++...+..|+||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 655 5689999999999999999999999 99999999999999987
Q ss_pred CCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 153 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
++. +||+|||.+...... ......+++.|+|||++.+. .+.+.++|||||||++|+|++|+.||............
T Consensus 188 ~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 188 NGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 764 999999998754332 33456789999999999876 44443599999999999999999999887663333333
Q ss_pred h
Q 020133 232 I 232 (330)
Q Consensus 232 ~ 232 (330)
+
T Consensus 265 i 265 (348)
T 2pml_X 265 I 265 (348)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=308.93 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=176.4
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCC-CCCeeeeeEEEEe--------
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVILT-------- 88 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~-------- 88 (330)
...+|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+..++++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 34689999999999999999999999999999998865543 3456889999999996 9999999999952
Q ss_pred CCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecCCCCCceEEeec
Q 020133 89 PTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
...+++||||+. |+|.+++.. .+++++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDF 182 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecC
Confidence 345899999996 688888764 567999999999999999999999999 999999999999987664 999999
Q ss_pred CCcccccCCCC-------------CCcccCCCCCCChhhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhH
Q 020133 164 GYSKSSVLHSQ-------------PKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (330)
Q Consensus 164 g~a~~~~~~~~-------------~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~ 227 (330)
|+++....... .....+++.|+|||++. +..+ +.++|||||||++|+|++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99975433221 11445899999999983 3344 4459999999999999999999976443322
Q ss_pred HHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 228 FRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
..... ..+. .... ...+.+.+.++...+|.+|+ ++.|+++.|..+.
T Consensus 262 ~~~~~---~~~~-------~~~~-~~~~~~li~~~l~~~p~~Rp-s~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 VNGKY---SIPP-------HDTQ-YTVFHSLIRAMLQVNPEERL-SIAEVVHQLQEIA 307 (337)
T ss_dssp ----C---CCCT-------TCCS-SGGGHHHHHHHSCSSGGGSC-CHHHHHHHHHHHH
T ss_pred hcCcc---cCCc-------cccc-chHHHHHHHHHccCChhhCc-CHHHHHHHHHHHH
Confidence 21111 1100 0111 12233445555667788876 9999999887663
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=319.43 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=196.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC-CCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++++.||+|+||.||++.+..+++.||||++..... ...+.+|+.+++.++| ++|..+..++...+..++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4789999999999999999999999999999998775543 3457899999999986 5666777777788899999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec---CCCCCceEEeecCCcccccCCCC
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~---~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+++.......
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCcc
Confidence 9 8899999975 56799999999999999999999999999999999999993 444 599999999975443222
Q ss_pred --------CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh---HHHHHhhc---CChhHH
Q 020133 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIHR---ISIPEI 240 (330)
Q Consensus 175 --------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~---~~~~~~~~---~~~~~~ 240 (330)
.....||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+..... .+..+... ...+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 239 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA- 239 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH-
Confidence 235679999999999988777544 999999999999999999998754422 22222111 11111
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+...+|.+ +.+.+..|+..+|.+|+ ++.++.+.|..+
T Consensus 240 -----l~~~~p~~-l~~li~~cl~~dP~~RP-s~~el~~~L~~l 276 (483)
T 3sv0_A 240 -----LCRGYPTE-FASYFHYCRSLRFDDKP-DYSYLKRLFRDL 276 (483)
T ss_dssp -----HHTTSCHH-HHHHHHHHHTCCTTCCC-CHHHHHHHHHHH
T ss_pred -----HhcCCcHH-HHHHHHHHhcCChhhCc-CHHHHHHHHHHH
Confidence 11223332 33445555567777766 899988877765
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=305.05 Aligned_cols=206 Identities=28% Similarity=0.446 Sum_probs=171.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe-----
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~----- 91 (330)
.++|.+.+.||+|+||.||+|.+..+|+.||||.+...... ...+.+|+..++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 47899999999999999999999999999999998764322 3567899999999999999999999987653
Q ss_pred -EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 -~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence 599999997 58887764 35999999999999999999999999999999999999987764 9999999987433
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
. ......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 178 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 178 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred C--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2 23445789999999999774444555999999999999999999999877655554444
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=313.50 Aligned_cols=201 Identities=29% Similarity=0.436 Sum_probs=156.0
Q ss_pred CCeEE-eceeccCCceEEEEEEEC--CCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEe--CCeEEEE
Q 020133 21 DRYEL-VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIV 95 (330)
Q Consensus 21 ~~y~i-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~--~~~~~lv 95 (330)
+.|++ .++||+|+||+||+|.+. .+++.||+|.+... .....+.+|+.++++++||||+++++++.. ....|+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 45776 458999999999999966 57889999998654 345678899999999999999999999965 5789999
Q ss_pred EeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC--CCCCceEEeecC
Q 020133 96 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFG 164 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~--~~~~~vkL~Dfg 164 (330)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 999975 787777532 24999999999999999999999999999999999999932 223469999999
Q ss_pred CcccccCC----CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 165 YSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 165 ~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
+|+..... ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+..
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99754332 223446789999999999876645666999999999999999999997544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.45 Aligned_cols=256 Identities=25% Similarity=0.345 Sum_probs=193.6
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-----cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
.|...+.||+|+||.||++.+ +++.||+|.+.... ...+.+.+|+..+++++||||+++++++...+..|+||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 345568999999999999986 58899999986532 23467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 97 EYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 97 e~~~g~sL~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
||+++++|.+++.. ..++++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKFA 187 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSCS
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeeccccccccccc
Confidence 99999999999873 34699999999999999999999999999999999999998766 49999999987443322
Q ss_pred C---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH---hh--cCChhHHhcCch
Q 020133 174 Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT---IH--RISIPEIRNHEW 245 (330)
Q Consensus 174 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~---~~--~~~~~~~~~~~~ 245 (330)
. .....+++.|+|||++.+. ++ .++||||||+++|+|++|+.||...........+ +. ....+.......
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~~-~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRGE-IT-PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTTE-EC-THHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccCCCcCcCChHHhcCC-CC-ccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 1 2345689999999988653 44 4499999999999999999999875543322221 11 111222111100
Q ss_pred hhccCC---ccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 246 FLKNLP---ADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 246 ~~~~~~---~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
...+ ...+.+.+.++...+|..|+ ++.++++.|.++..
T Consensus 266 --~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~l~~~L~~l~~ 306 (307)
T 2nru_A 266 --NDADSTSVEAMYSVASQCLHEKKNKRP-DIKKVQQLLQEMTA 306 (307)
T ss_dssp --SCCCHHHHHHHHHHHHHHTCSSTTTSC-CHHHHHHHHHHHC-
T ss_pred --cccchHHHHHHHHHHHHHcCCCcccCc-CHHHHHHHHHHHhc
Confidence 0000 11223344555567777766 99999999988653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=300.07 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=193.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCc---EEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE-EE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL-AI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~-~l 94 (330)
.+|++.+.||+|+||+||+|.+..+++ .||+|.+..... ..+.+.+|+.++++++||||+++++++...+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 467888999999999999999765544 799998875433 235688999999999999999999999876654 99
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC--
Q 020133 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 171 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-- 171 (330)
||||+.+++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCc
Confidence 9999999999999976 457999999999999999999999999999999999999987764 99999999874322
Q ss_pred ---CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCC-CCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 172 ---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 172 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
........+++.|+|||.+.+..++.+ +||||||+++|+|++|.. ||...+..............+. .
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 250 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-------P 250 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC-------C
T ss_pred ccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC-------C
Confidence 122334467889999999987776554 999999999999999555 5554444333333222211110 1
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
..++ +.+.+.+.++...+|.+|+ |+.++++.|.++..
T Consensus 251 ~~~~-~~l~~li~~~l~~~p~~Rp-s~~~ll~~l~~~~~ 287 (298)
T 3pls_A 251 EYCP-DSLYQVMQQCWEADPAVRP-TFRVLVGEVEQIVS 287 (298)
T ss_dssp TTCC-HHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHHH
T ss_pred ccch-HHHHHHHHHHccCChhhCc-CHHHHHHHHHHHHH
Confidence 1122 2233445555667777775 99999998887643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=305.24 Aligned_cols=206 Identities=27% Similarity=0.416 Sum_probs=174.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCC-cEEEEEEeecCCcccHHHHHHHHHHHcCCCCC------eeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~------Iv~~~~~~~~~~~~ 92 (330)
.++|++++.||+|+||+||+|.+..++ +.||+|++.......+.+.+|+.+++.++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 479999999999999999999998776 68999999876655677889999999887655 99999999999999
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-----------------
Q 020133 93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS----------------- 153 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~----------------- 153 (330)
|+||||+ +++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 9999999 55676766654 369999999999999999999999999999999999999432
Q ss_pred CCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH
Q 020133 154 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (330)
Q Consensus 154 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~ 229 (330)
..+.+||+|||+++... .......+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+......
T Consensus 177 ~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp SCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 23469999999987432 23345678999999999988777655 999999999999999999999876654443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.70 Aligned_cols=257 Identities=22% Similarity=0.314 Sum_probs=204.3
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
...++|++.+.||+|+||.||++.+.. +..||||+++......+.+.+|+.++++++||||+++++++.. +..|+|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 345789999999999999999999875 4669999998776666789999999999999999999999866 67899999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--
Q 020133 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (330)
Q Consensus 98 ~~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-- 173 (330)
|+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCcee
Confidence 9999999999974 356999999999999999999999999999999999999987654 9999999997443211
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (330)
......++..|+|||++.+..++.+ +|||||||++|||++ |+.||.+.........+......+ ....++.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------~~~~~~~ 491 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------CPPECPE 491 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC-------CCTTCCH
T ss_pred cccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------CCCCCCH
Confidence 1223346778999999988777555 999999999999999 999999877655554443322211 1112222
Q ss_pred cccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
.+.+.+.+++..+|.+|+ +++++++.|.......
T Consensus 492 -~l~~li~~cl~~dP~~RP-t~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 492 -SLHDLMCQCWRKEPEERP-TFEYLQAFLEDYFTST 525 (535)
T ss_dssp -HHHHHHHHHTCSSGGGSC-CHHHHHHHHHTSSCCC
T ss_pred -HHHHHHHHHcCCChhHCc-CHHHHHHHHHHHhhcc
Confidence 233444555567777765 9999999999875543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=301.33 Aligned_cols=256 Identities=23% Similarity=0.278 Sum_probs=195.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEE-eCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL-TPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~-~~~~~ 92 (330)
...+|++.+.||+|+||.||++.+..+ +..||+|.+..... ..+.+.+|+.++++++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 346799999999999999999997643 34689998875432 2356889999999999999999999865 45678
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccc
Confidence 999999999999999975 45689999999999999999999999999999999999998766 499999999974432
Q ss_pred CC-----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCch
Q 020133 172 HS-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEW 245 (330)
Q Consensus 172 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
.. ......+++.|+|||.+.+..++.+ +||||||+++|+|++ |.+||...+...............
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 252 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL------- 252 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC-------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC-------
Confidence 21 2233456788999999988777554 999999999999999 677777666555444443321110
Q ss_pred hhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 246 FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
....++ +.+.+.+.++...+|.+| +++.|+++.|.++..
T Consensus 253 ~~~~~~-~~l~~li~~~l~~~p~~R-ps~~ell~~L~~~~~ 291 (298)
T 3f66_A 253 QPEYCP-DPLYEVMLKCWHPKAEMR-PSFSELVSRISAIFS 291 (298)
T ss_dssp CCTTCC-HHHHHHHHHHTCSSGGGS-CCHHHHHHHHHHHHH
T ss_pred CCccCC-HHHHHHHHHHcCCChhhC-cCHHHHHHHHHHHHH
Confidence 111122 223344455566777777 499999999887643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=308.43 Aligned_cols=209 Identities=30% Similarity=0.434 Sum_probs=175.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeC-----CeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-----~~~ 92 (330)
.++|++.+.||+|+||.||++.+..+|+.||||.+..... ....+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 5799999999999999999999999999999999865432 234678999999999999999999998764 678
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+||||+. ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDES 165 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC--
T ss_pred EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccccc
Confidence 99999997 589888876 57999999999999999999999999999999999999987664 999999998744321
Q ss_pred CC-----------CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 173 SQ-----------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 173 ~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.. .....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 11 1234689999999998765444566999999999999999999999877655554443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=298.76 Aligned_cols=251 Identities=29% Similarity=0.446 Sum_probs=194.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEe--CCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~--~~~~~l 94 (330)
.++|++++.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+..+++++||||+++++++.. .+..|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4789999999999999999999999999999999976432 23568899999999999999999998864 568999
Q ss_pred EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhcC-----ccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 95 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++||||||+||+++.++. +||+|||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~ 162 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL 162 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCch
Confidence 99999999999998753 34999999999999999999999999 999999999999987664 99999999
Q ss_pred cccccCCCC-CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 166 SKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 166 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
++....... .....+++.|+|||++.+..++.+ +||||||+++|+|++|+.||...+.......+... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-~~~------ 234 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFR------ 234 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCC------
T ss_pred heeeccccccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-ccc------
Confidence 864432211 123468999999999988776544 99999999999999999999887654443333321 111
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
.+....+. .+.+.+.++...+|.+|+ ++.|+++.+.
T Consensus 235 ~~~~~~~~-~l~~li~~~l~~~p~~Rp-s~~~ll~~~~ 270 (279)
T 2w5a_A 235 RIPYRYSD-ELNEIITRMLNLKDYHRP-SVEEILENPL 270 (279)
T ss_dssp CCCTTSCH-HHHHHHHHHTCSSGGGSC-CHHHHHTSTT
T ss_pred cCCcccCH-HHHHHHHHHcCCCcccCC-CHHHHHhChh
Confidence 11112222 233444455556777765 8998887543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.01 Aligned_cols=262 Identities=25% Similarity=0.365 Sum_probs=193.4
Q ss_pred CCcccCCCCeEEeceeccCCceEEEEEEECC-CCc--EEEEEEeecCC----cccHHHHHHHHHHHcCCCCCeeeeeEEE
Q 020133 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TEE--LVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVI 86 (330)
Q Consensus 14 ~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~----~~~~~~~~ei~~l~~l~h~~Iv~~~~~~ 86 (330)
.......++|++.+.||+|+||+||++.+.. +++ .||+|.+.... ...+.+.+|+..+++++||||+++++++
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3345566899999999999999999998643 333 68999887542 2345788999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 87 LTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 87 ~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
..+. .++||||+++++|.+++... +.+++..++.++.|++.||.+||++|++||||||+||+++.++ .+||+|||+
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~ 167 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGL 167 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTT
T ss_pred ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEEEccccc
Confidence 8765 79999999999999998764 5799999999999999999999999999999999999998765 499999999
Q ss_pred cccccCCCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 166 SKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 166 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
+........ .....++..|+|||++.+..++.+ +||||||+++|+|++ |+.||...+.......+......+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~- 245 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP- 245 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC-
Confidence 875433221 223456778999999987766544 999999999999999 9999998776655554443211100
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCC
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~ 287 (330)
....++. .+.+.+.++...+|.+|+ ++.++++.|.+....
T Consensus 246 -----~~~~~~~-~l~~li~~~l~~~p~~Rp-s~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 246 -----RPEDCPQ-DIYNVMVQCWAHKPEDRP-TFVALRDFLLEAQPT 285 (291)
T ss_dssp -----CCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHC--
T ss_pred -----CCcCcCH-HHHHHHHHHccCCcccCc-CHHHHHHHHHHhCcc
Confidence 1112222 233444555556777765 999999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=300.96 Aligned_cols=196 Identities=31% Similarity=0.481 Sum_probs=164.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEe------------
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------------ 88 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~------------ 88 (330)
++|++++.||+|+||.||+|.+..+++.||+|.+.........+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 57999999999999999999999999999999997665555778899999999999999999999865
Q ss_pred -CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 89 -PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 89 -~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
.+..|+||||+++++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~ 163 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLA 163 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcch
Confidence 356899999999999999998544 6889999999999999999999999999999999999987664 999999998
Q ss_pred ccccCC---------------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 167 KSSVLH---------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 167 ~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
...... .......+++.|+|||++.+....+.++|||||||++|+|++ ||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 744321 122345689999999999866444556999999999999998 6653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.94 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=171.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----------CCCeeeeeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL 87 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-----------h~~Iv~~~~~~~ 87 (330)
..++|++.+.||+|+||+||+|.+..+++.||||++.........+.+|+..+++++ ||||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357999999999999999999999999999999999876555677889999998876 899999999998
Q ss_pred eCC----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCC----CC
Q 020133 88 TPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP----AP 156 (330)
Q Consensus 88 ~~~----~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~----~~ 156 (330)
..+ .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ ..
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 654 789999999 88999999763 4599999999999999999999998 999999999999995322 23
Q ss_pred ceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 157 ~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
.+||+|||+++.... ......+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+
T Consensus 176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC----
T ss_pred eEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCc
Confidence 599999999874432 3345578999999999988877555 999999999999999999998644
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=308.52 Aligned_cols=261 Identities=22% Similarity=0.281 Sum_probs=183.2
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEe-----CCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~-----~~~~~ 93 (330)
..++|++++.||+|+||.||++.+ +++.||||++............++..+..++||||+++++.+.. ...+|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 458999999999999999999976 58899999987654322233344444556899999999986653 23578
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc---------CccccCCCCCcEEecCCCCCceEEeecC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICDFG 164 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~ivH~dikp~NIli~~~~~~~vkL~Dfg 164 (330)
+||||+++++|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus 89 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG 165 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFG 165 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCT
T ss_pred EEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeecc
Confidence 999999999999999764 459999999999999999999999 999999999999998766 49999999
Q ss_pred CcccccCC---------CCCCcccCCCCCCChhhhhcCC------CCCCccchhhHHHHHHHHHhCCCCCCCCChhhH--
Q 020133 165 YSKSSVLH---------SQPKSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-- 227 (330)
Q Consensus 165 ~a~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~-- 227 (330)
+++..... .......||+.|+|||++.+.. ..+.++|||||||++|+|++|..||........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 99744321 1123456899999999997631 122448999999999999999776643221100
Q ss_pred --HHHHh-hcCChhHH---hcCchhhccCCc---------cccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 228 --FRKTI-HRISIPEI---RNHEWFLKNLPA---------DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 228 --~~~~~-~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
+.... ........ .........+|. ..+.+.+.++...+|.+|+ |+.|+++.|..+-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~e~l~~L~~ll 317 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL-TAQXAEERMAELM 317 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC-CHHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCc-chHHHHHHHHHHH
Confidence 00000 00000000 000000011111 1234455566667787776 9999999888764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=307.19 Aligned_cols=264 Identities=27% Similarity=0.369 Sum_probs=194.1
Q ss_pred ccCCCCCCCcccCCCCeEEeceeccCCceEEEEEEE----CCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCee
Q 020133 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIV 80 (330)
Q Consensus 7 ~~~pg~~~~~~~~~~~y~i~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv 80 (330)
.-.||... ......|++++.||+|+||+||++.. ..+++.||+|++.... .....+.+|+.++++++||||+
T Consensus 19 ~~~pg~~~--~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 96 (318)
T 3lxp_A 19 FQGPGDPT--VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96 (318)
T ss_dssp -----CCC--BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ecCCCCCc--eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchh
Confidence 34566543 33333349999999999999988753 4578999999997653 2245688999999999999999
Q ss_pred eeeEEEEeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCce
Q 020133 81 RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (330)
Q Consensus 81 ~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~v 158 (330)
++++++.+. ..+++||||+++++|.+++... .+++..++.++.|++.||.+||+.||+||||||+||+++.++. +
T Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~ 173 (318)
T 3lxp_A 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--V 173 (318)
T ss_dssp CEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--E
T ss_pred hEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--E
Confidence 999999884 6789999999999999998764 5999999999999999999999999999999999999987764 9
Q ss_pred EEeecCCcccccCCC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhh--------
Q 020133 159 KICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-------- 226 (330)
Q Consensus 159 kL~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~-------- 226 (330)
||+|||++....... ......+++.|+|||++.+..++.+ +||||||+++|+|+||+.||.......
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 252 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence 999999997544332 1234457788999999988777544 999999999999999999997532210
Q ss_pred ------HHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 227 ------NFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.....+.+.. ..-....++. .+.+.+.++...+|.+|+ ++.|+++.|..+
T Consensus 253 ~~~~~~~~~~~~~~~~------~~~~~~~~~~-~l~~li~~~l~~dP~~Rp-s~~ell~~L~~l 308 (318)
T 3lxp_A 253 GQMTVLRLTELLERGE------RLPRPDKCPA-EVYHLMKNCWETEASFRP-TFENLIPILKTV 308 (318)
T ss_dssp HHHHHHHHHHHHHTTC------CCCCCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred cchhHHHHHHHHhccc------CCCCCccccH-HHHHHHHHHcCCCcccCc-CHHHHHHHHHHH
Confidence 0111111100 0001112222 233445555667777765 999999888765
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=312.85 Aligned_cols=196 Identities=17% Similarity=0.187 Sum_probs=151.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHH---HHHHcCCCCCeeeee-------EEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI---INHRSLRHPNIVRFK-------EVI 86 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei---~~l~~l~h~~Iv~~~-------~~~ 86 (330)
..|++.+.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+ ..++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 459999999999999999999999999999999987543 234566774 45555 799987755 565
Q ss_pred EeCC-----------------eEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHhhhcCccccC
Q 020133 87 LTPT-----------------HLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHSMQVCHRD 142 (330)
Q Consensus 87 ~~~~-----------------~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~------~~i~~qi~~~L~~LH~~~ivH~d 142 (330)
...+ .+|+||||++ ++|.+++... ..++.... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 5433 3899999998 7999999763 34555555 67789999999999999999999
Q ss_pred CCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 143 ikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
|||+|||++.++. +||+|||+|+.... ......+++.|+|||++.+ ..++ .++|||||||++|+|++|+.||.
T Consensus 220 ikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGR--LMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSC--EEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCC--EEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999987764 99999999974432 1224566799999999976 4554 55999999999999999999998
Q ss_pred CCC
Q 020133 221 DPE 223 (330)
Q Consensus 221 ~~~ 223 (330)
...
T Consensus 295 ~~~ 297 (371)
T 3q60_A 295 LVT 297 (371)
T ss_dssp BCC
T ss_pred CcC
Confidence 753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=297.57 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=188.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
+.|.....||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+..++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 33444559999999999999999999999999987654 33567899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccCC-CC
Q 020133 100 SGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH-SQ 174 (330)
Q Consensus 100 ~g~sL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~~-~~ 174 (330)
++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++. ++ .+||+|||++...... ..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC--CEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC--CEEEeecccccccCCCCCc
Confidence 9999999997642 5679999999999999999999999999999999999986 44 5999999998754332 22
Q ss_pred CCcccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+.. ..+.++||||||+++|+|++|+.||............... ....+-+...++.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~- 253 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-----FKVHPEIPESMSA- 253 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-----HCCCCCCCTTSCH-
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-----ccccccccccCCH-
Confidence 34557899999999997643 2345599999999999999999999764433221111100 0111111122222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHH
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.+.+.++...+|..|+ ++.++++
T Consensus 254 ~~~~li~~~l~~dp~~Rp-s~~~ll~ 278 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRA-CANDLLV 278 (295)
T ss_dssp HHHHHHHHTTCSSTTTSC-CHHHHHT
T ss_pred HHHHHHHHHccCChhhCC-CHHHHhc
Confidence 233444555667777765 7777754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=324.39 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=195.7
Q ss_pred CCCCeEEec-eeccCCceEEEEEEECC--CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVR-DIGSGNFGVARLMRDKK--TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~-~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..+++.+.+ .||+|+||.||++.+.. ++..||||+++... ...+.+.+|+.++++++||||+++++++.. +..|
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 345666666 89999999999998763 56679999997643 345789999999999999999999999976 5689
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC--
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccccCC
Confidence 999999999999998754 4699999999999999999999999999999999999998766 4999999999754332
Q ss_pred CC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 173 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
.. .....+++.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+.......+...... .+.
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-------~~p 561 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------ECP 561 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC-------CCC
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------CCC
Confidence 21 122345688999999988777655 999999999999998 99999987766554444332111 111
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..+|. .+.+.+..++..+|.+|+ ++.++++.|...
T Consensus 562 ~~~~~-~l~~li~~cl~~dP~~RP-s~~~l~~~L~~~ 596 (613)
T 2ozo_A 562 PECPP-ELYALMSDCWIYKWEDRP-DFLTVEQRMRAC 596 (613)
T ss_dssp TTCCH-HHHHHHHHTTCSSTTTSC-CHHHHHHHHHHH
T ss_pred CcCCH-HHHHHHHHHcCCChhHCc-CHHHHHHHHHHH
Confidence 22333 233445556667787766 999998888765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=309.64 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=188.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEe-CCeEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~-~~~~~ 93 (330)
...|++.+.||+|+||.||++.+..+ +..||+|.+..... ..+.+.+|+.++++++||||+++++++.. ++..|
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 35689999999999999999997543 34689998865432 34578899999999999999999998754 46789
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccccc
Confidence 999999999999999764 45899999999999999999999999999999999999987664 999999999744322
Q ss_pred C-----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchh
Q 020133 173 S-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246 (330)
Q Consensus 173 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (330)
. ......+++.|+|||++.+..++.+ +|||||||++|+|+| |.+||...+.............. ..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~-------~~ 317 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-------LQ 317 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC-------CC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC-------CC
Confidence 1 1123456778999999988777554 999999999999999 78888876554444333322110 01
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
...+|. .+.+.+.+++..+|.+|+ ++.|+++.|..+..
T Consensus 318 p~~~~~-~l~~li~~cl~~dp~~RP-s~~ell~~L~~i~~ 355 (373)
T 3c1x_A 318 PEYCPD-PLYEVMLKCWHPKAEMRP-SFSELVSRISAIFS 355 (373)
T ss_dssp CTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHHH
T ss_pred CCCCCH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHHHHH
Confidence 112222 233445555667777764 99999999987644
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=302.67 Aligned_cols=199 Identities=31% Similarity=0.478 Sum_probs=167.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc-------cHHHHHHHHHHHcC----CCCCeeeeeEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSL----RHPNIVRFKEVILT 88 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~ei~~l~~l----~h~~Iv~~~~~~~~ 88 (330)
.++|++.+.||+|+||.||++.+..+++.||+|.+...... ...+.+|+..+.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 47899999999999999999999999999999998765321 22345788888888 89999999999999
Q ss_pred CCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec-CCCCCceEEeecCCc
Q 020133 89 PTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYS 166 (330)
Q Consensus 89 ~~~~~lv~e~-~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~-~~~~~~vkL~Dfg~a 166 (330)
.+..++|||+ +.+++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++ .++ .+||+|||++
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~ 187 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchh
Confidence 8999999999 78999999999888999999999999999999999999999999999999998 444 5999999998
Q ss_pred ccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
+.... .......+++.|+|||++.+..+.+.++||||||+++|+|++|+.||..
T Consensus 188 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 188 ALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 75433 2334556899999999998777766569999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=304.12 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=195.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..++|++.+.||+|+||.||++.+.. .||+|.+.... ...+.+.+|+..+++++||||+++++++...+..++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 45899999999999999999999864 38999887542 2335677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC---
Q 020133 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~--- 171 (330)
|||++|++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||++++ + .+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~-~--~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-G--KVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC-------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC-C--CEEEeecCCccccccccc
Confidence 99999999999997654 6999999999999999999999999999999999999973 3 599999999764321
Q ss_pred ---CCCCCcccCCCCCCChhhhhcC--------CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHH
Q 020133 172 ---HSQPKSTVGTPAYIAPEVLLKK--------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEI 240 (330)
Q Consensus 172 ---~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (330)
........+++.|+|||++.+. ...+.++||||||+++|+|++|+.||................. +..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~ 263 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK-PNL 263 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC-CCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC-CCC
Confidence 1122334588999999998652 2234559999999999999999999988766555444332211 111
Q ss_pred hcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCCCC
Q 020133 241 RNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAG 290 (330)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~~~ 290 (330)
....++. .+.+.+.++...+|.+|+ ++.++++.|..+......
T Consensus 264 -----~~~~~~~-~l~~li~~~l~~~p~~Rp-t~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 264 -----SQIGMGK-EISDILLFCWAFEQEERP-TFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp -----CCSSCCT-THHHHHHHHHCSSTTTSC-CHHHHHHHHTTC------
T ss_pred -----CcCCCCH-HHHHHHHHHhcCChhhCc-CHHHHHHHHHHHHHhhcc
Confidence 0111222 233445555667788875 999999999987665433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=297.59 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=172.6
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCccc---HHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..++|++++.||+|+||.||++.+..+|+.||||.+....... ..+.++...++.++||||+++++++...+..|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3478999999999999999999999999999999997654322 2334455567888999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
|||+ ++.+..+... .+.+++..++.++.|++.||.|||+. |++||||||+||+++.++. +||+|||++.......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCc
Confidence 9999 5566555543 56899999999999999999999995 9999999999999987764 9999999987555444
Q ss_pred CCCcccCCCCCCChhhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh-hHHHHHhhcCChhHHhcCchhh
Q 020133 174 QPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
......+++.|+|||++. +..+ +.++||||||+++|+|++|+.||...... ..+....... .+.....
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~---- 253 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLPGH---- 253 (318)
T ss_dssp -------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCCCCSS----
T ss_pred cccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCCCCcc----
Confidence 445567899999999985 2334 44599999999999999999999874433 3333333221 1110000
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
..++. .+.+.+.++...+|.+|+ +++++++
T Consensus 254 ~~~~~-~l~~li~~~l~~dp~~Rp-s~~~ll~ 283 (318)
T 2dyl_A 254 MGFSG-DFQSFVKDCLTKDHRKRP-KYNKLLE 283 (318)
T ss_dssp SCCCH-HHHHHHHHHTCSCTTTSC-CHHHHTT
T ss_pred CCCCH-HHHHHHHHHccCChhHCc-CHHHHhh
Confidence 01122 223344455556676665 7777664
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=303.95 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=195.0
Q ss_pred CCCCeEEeceeccCCceEEEEEE----ECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC--e
Q 020133 19 DSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPT--H 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~--~ 91 (330)
..++|++++.||+|+||.||++. +..+++.||+|.+..... ..+.+.+|+..+++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 45679999999999999999998 456899999999876533 3457889999999999999999999987654 6
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.++||||+++++|.+++... ..+++..++.++.|++.||.+||++||+||||||+||+++.++ ++||+|||+++...
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLP 196 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC--cEEEecCcchhhcc
Confidence 89999999999999999875 4699999999999999999999999999999999999998765 49999999987543
Q ss_pred CCCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCCh--------h
Q 020133 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISI--------P 238 (330)
Q Consensus 171 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------~ 238 (330)
.... .....++..|+|||++.+..++.+ +||||||+++|+|+||..||.... ....+....... .
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPP--AEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHH--HHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCH--HHHHHhhccccchhhhHHHHH
Confidence 3321 223456778999999987776544 999999999999999999986421 111111100000 0
Q ss_pred HHhc---CchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 239 EIRN---HEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 239 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+... .+-....++. .+.+.+.++...+|.+|+ ++.|+++.|..+
T Consensus 274 ~~~~~~~~~~~~~~~~~-~l~~li~~cl~~dP~~Rp-s~~el~~~L~~l 320 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPD-EIYMIMTECWNNNVNQRP-SFRDLALRVDQI 320 (326)
T ss_dssp HHHHTTCCCCCCTTCCH-HHHHHHHHHSCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccH-HHHHHHHHHcCCChhhCc-CHHHHHHHHHHH
Confidence 0000 0001112222 233445556667777766 999999988765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=326.61 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=193.8
Q ss_pred CeEEe-ceeccCCceEEEEEEE--CCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 22 RYELV-RDIGSGNFGVARLMRD--KKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 22 ~y~i~-~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.+.+. +.||+|+||.||++.+ ..+++.||||+++... ...+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 34443 4899999999999955 4567899999987643 234679999999999999999999999865 458999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~- 174 (330)
|||+++++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENY 525 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCTTHHHHTTC----
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC--CEEEEEcCCccccccCccc
Confidence 99999999999999888999999999999999999999999999999999999998776 499999999975433221
Q ss_pred ---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccC
Q 020133 175 ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 175 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
.....+++.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+.......+...... .+...+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-------~~p~~~ 597 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-------GCPAGC 597 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------CCCTTC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------CCCCCC
Confidence 223346778999999988777655 999999999999998 99999987765544444332111 111222
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
|. .+.+.+..++..+|.+|+ ++.++++.|...
T Consensus 598 ~~-~l~~li~~cl~~dP~~RP-s~~~l~~~L~~~ 629 (635)
T 4fl3_A 598 PR-EMYDLMNLCWTYDVENRP-GFAAVELRLRNY 629 (635)
T ss_dssp CH-HHHHHHHHHTCSSTTTSC-CHHHHHHHHHHH
T ss_pred CH-HHHHHHHHHcCCCHhHCc-CHHHHHHHHHHH
Confidence 22 233445556667787766 999999888764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=303.96 Aligned_cols=202 Identities=27% Similarity=0.401 Sum_probs=152.0
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHH-HHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~-~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
...++|++++.||+|+||.||++.+..+|+.||||.+..... ....+.+|+. .++.++||||+++++++...+..|+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 345899999999999999999999999999999999976532 2234555655 6677899999999999999999999
Q ss_pred EEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhc-CccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 95 VMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
||||+++ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||+++.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT--EEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC--CEEEccCCCcee
Confidence 9999986 88777763 56799999999999999999999999 999999999999998766 499999999976
Q ss_pred ccCCCCCCcccCCCCCCChhhhh----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 169 SVLHSQPKSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
...........+++.|+|||++. +..++ .++|||||||++|+|++|+.||....
T Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp ------------------------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred cccccccccCCCCccccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 55444444557899999999983 34444 45999999999999999999997643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=300.67 Aligned_cols=256 Identities=23% Similarity=0.298 Sum_probs=193.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHc--CCCCCeeeeeEEEEeCC----eEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~--l~h~~Iv~~~~~~~~~~----~~~l 94 (330)
++|++.+.||+|+||.||++.+ +|+.||+|.+.... ...+.+|+.++.. ++||||+++++++.... ..|+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 6899999999999999999998 48999999986543 3567788888877 78999999999998876 7999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh--------hcCccccCCCCCcEEecCCCCCceEEeecCCc
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a 166 (330)
||||+++++|.+++.+ ..+++..++.++.|++.||.||| +.||+||||||+||+++.++. +||+|||++
T Consensus 118 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~ 194 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA 194 (342)
T ss_dssp EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTC
T ss_pred EEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCc
Confidence 9999999999999976 57999999999999999999999 899999999999999987764 999999998
Q ss_pred ccccCCC-----CCCcccCCCCCCChhhhhcCCCCC-----CccchhhHHHHHHHHHhC----------CCCCCCCCh--
Q 020133 167 KSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPEE-- 224 (330)
Q Consensus 167 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~-----~~~Di~SlG~il~elltg----------~~pf~~~~~-- 224 (330)
....... ......+++.|+|||++.+..... .++|||||||++|+|+|| +.||.....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 7544332 234557899999999997653221 458999999999999999 788875432
Q ss_pred --hhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 225 --PKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
...+...+............|..... .+.+.+.+.+++..+|.+|+ ++.++++.|..+.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rp-s~~~i~~~L~~i~ 335 (342)
T 1b6c_B 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEA-LRVMAKIMRECWYANGAARL-TALRIKKTLSQLS 335 (342)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGTSHH-HHHHHHHHHHHCCSSGGGSC-CHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhCCCCcccccchhH-HHHHHHHHHHHhccChhhCC-CHHHHHHHHHHHH
Confidence 22222222111000000000100000 11233445556667777776 9999999988764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=293.98 Aligned_cols=230 Identities=16% Similarity=0.167 Sum_probs=180.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCccc----HHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ..+.+|+..+.+++||||+++++++..++..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 478999999999999999999999999999999998664433 6788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|||++|++|.+++.. + ....++..++.|++.||.|||++||+||||||+|||++.++. +||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~----------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA----------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC-----------
T ss_pred EEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc-----------
Confidence 999999999999854 3 466678999999999999999999999999999999987765 8887554
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHH---HHhhc-CChhHHhcCchhhccCC
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR---KTIHR-ISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~ 251 (330)
|++| + +.++|||||||++|+|+||+.||.+.+....+. +.... ...+. -+...++
T Consensus 175 --------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 233 (286)
T 3uqc_A 175 --------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA-----DIDRDIP 233 (286)
T ss_dssp --------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH-----HHCTTSC
T ss_pred --------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh-----hcccCCC
Confidence 2332 2 445999999999999999999998765432111 00010 11010 0112232
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
. .+.+.+.++...+|..| |+.|+++.|..+....
T Consensus 234 ~-~l~~li~~~l~~dP~~R--s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 234 F-QISAVAARSVQGDGGIR--SASTLLNLMQQATAVA 267 (286)
T ss_dssp H-HHHHHHHHHHCTTSSCC--CHHHHHHHHHHHHC--
T ss_pred H-HHHHHHHHHcccCCccC--CHHHHHHHHHHHhccC
Confidence 2 23445566667889888 9999999999875543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.73 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=186.5
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCC--CCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~--h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++++.||+|+||.||++.+. +++.||+|++..... ....+.+|+..+++++ ||||+++++++...+..|
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 4578999999999999999999985 488999999875432 2356789999999997 599999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
+||| +.+++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++++ +.+||+|||+++......
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC-----
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccCcc
Confidence 9999 557899999998889999999999999999999999999999999999999964 359999999987543322
Q ss_pred C---CCcccCCCCCCChhhhhcC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCChhh-HHHHHhhcCChhH
Q 020133 174 Q---PKSTVGTPAYIAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRISIPE 239 (330)
Q Consensus 174 ~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~ 239 (330)
. .....+++.|+|||++.+. ...+.++||||||+++|+|++|+.||....... ...........
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 258 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-- 258 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc--
Confidence 1 2345689999999998652 223445999999999999999999998654332 22222211100
Q ss_pred HhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 240 IRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.-+... .+..+.+.+.++...+|.+|+ ++.|+++
T Consensus 259 ----~~~~~~-~~~~l~~li~~~l~~dp~~Rp-s~~ell~ 292 (313)
T 3cek_A 259 ----IEFPDI-PEKDLQDVLKCCLKRDPKQRI-SIPELLA 292 (313)
T ss_dssp ----CCCCCC-SCHHHHHHHHHHTCSSTTTSC-CHHHHHT
T ss_pred ----cCCccc-chHHHHHHHHHHccCCcccCc-CHHHHhc
Confidence 000111 122233444555567777766 8888875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=321.58 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=196.6
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++.+.||+|+||.||++.+..+ +..||+|.+.... ...+.+.+|+..+++++||||+++++++. ++..|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 347899999999999999999998653 4679999886543 22367889999999999999999999984 46689
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCCSCCC-
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCeecCCC
Confidence 9999999999999998654 699999999999999999999999999999999999998766 4999999999754332
Q ss_pred CC--CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 173 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
.. .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.........+......+ +...
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-------~~~~ 616 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------MPPN 616 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC-------CCTT
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-------CCcc
Confidence 22 223456778999999987777554 999999999999997 999999877665554444321111 1122
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+|. .+.+.+.++...+|..|+ ++.++++.|..+
T Consensus 617 ~~~-~l~~li~~~l~~dP~~RP-s~~el~~~L~~i 649 (656)
T 2j0j_A 617 CPP-TLYSLMTKCWAYDPSRRP-RFTELKAQLSTI 649 (656)
T ss_dssp CCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred ccH-HHHHHHHHHcCCChhHCc-CHHHHHHHHHHH
Confidence 222 233445555667777764 999999988765
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=322.77 Aligned_cols=240 Identities=22% Similarity=0.271 Sum_probs=188.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECC-CCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe-----
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~----- 91 (330)
.++|++.+.||+|+||+||++.+.. +|+.||||.+.... .....+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3799999999999999999999986 78999999886543 223567899999999999999999999987655
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
.|+||||++|++|.+++.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhccc
Confidence 7999999999999987754 79999999999999999999999999999999999999864 499999999875432
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCC
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
. ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+...... . ...+....
T Consensus 234 ~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----~-~~~~~~~~--------- 293 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----P-EDDPVLKT--------- 293 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----C-TTCHHHHH---------
T ss_pred C---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc-----c-cccccccc---------
Confidence 2 4567999999999987654 4559999999999999999999875221100 0 00000000
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+.+.+.++...+|.+|+.+++++.+.+...
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 112234455566688999999999988766543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=302.37 Aligned_cols=201 Identities=27% Similarity=0.337 Sum_probs=160.8
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
....+|++.+.||+|+||+|+. ....+|+.||||++..... ..+.+|+.+++++ +||||+++++++.+.+..|+||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3446799999999999999764 4556799999999865432 2356899999999 7999999999999999999999
Q ss_pred eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC---CCCCceEEeecCCcccccCC
Q 020133 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~---~~~~~vkL~Dfg~a~~~~~~ 172 (330)
||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++..++||+|||+|+.....
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9996 59999987654 4666678899999999999999999999999999999953 33345889999999754432
Q ss_pred ----CCCCcccCCCCCCChhhhhcC--CCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 020133 173 ----SQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (330)
Q Consensus 173 ----~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~SlG~il~ellt-g~~pf~~~ 222 (330)
.......||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 223445799999999998742 222445999999999999999 99999643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.91 Aligned_cols=247 Identities=32% Similarity=0.460 Sum_probs=178.2
Q ss_pred CCCCCcccCCCCeEEe-ceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHH-HcCCCCCeeeeeEEEEe
Q 020133 11 GMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT 88 (330)
Q Consensus 11 g~~~~~~~~~~~y~i~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l-~~l~h~~Iv~~~~~~~~ 88 (330)
+..+......++|.++ +.||+|+||.||++.+..+++.||+|.+... ....+|+..+ +.++||||+++++++..
T Consensus 7 ~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3334334445789988 7899999999999999999999999998643 5677888887 66699999999999987
Q ss_pred ----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEe
Q 020133 89 ----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKIC 161 (330)
Q Consensus 89 ----~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~ 161 (330)
....|+||||++|++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.+. .+.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 677899999999999999998754 699999999999999999999999999999999999998632 3469999
Q ss_pred ecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHh
Q 020133 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIR 241 (330)
Q Consensus 162 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (330)
|||++.... +..+ +.++|||||||++|+|++|+.||......................
T Consensus 163 Dfg~a~~~~---------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 163 DFGFAKETT---------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp CCTTCEECT---------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccccccccc---------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 999886322 1223 334999999999999999999997654322211111111111000
Q ss_pred cCchhhccCCccccccccccCCCCCCCCccCCHHHHHH--HHHHhC
Q 020133 242 NHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ--IIAEAT 285 (330)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~--~l~~~~ 285 (330)
..+.....++. .+.+.+.++...+|.+|+ ++.|+++ .+....
T Consensus 221 ~~~~~~~~~~~-~~~~li~~~l~~dP~~Rp-s~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 221 FPNPEWSEVSE-EVKMLIRNLLKTEPTQRM-TITEFMNHPWIMQST 264 (299)
T ss_dssp SCHHHHTTSCH-HHHHHHHHHTCSSTTTSC-CHHHHHTSHHHHTGG
T ss_pred CCchhcccCCH-HHHHHHHHHcccChhhCC-CHHHHhcChhhcccc
Confidence 00000011222 233444555567777766 8888875 454443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=298.30 Aligned_cols=199 Identities=27% Similarity=0.325 Sum_probs=156.7
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.+.|.+.+.||+|+||+||.+ ...+|+.||||.+.... .+.+.+|+.+++++ +||||+++++++.+++..|+||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 367888899999999999875 44679999999887542 35678999999876 899999999999999999999999
Q ss_pred cCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-----------CCCceEE
Q 020133 99 ASGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-----------PAPRLKI 160 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l-------~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~-----------~~~~vkL 160 (330)
+. ++|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++.+ ....+||
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 5999999865433 233457899999999999999999999999999999753 2346999
Q ss_pred eecCCcccccCCCC-----CCcccCCCCCCChhhhhcC------CCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 020133 161 CDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (330)
Q Consensus 161 ~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~SlG~il~ellt-g~~pf~~~ 222 (330)
+|||+++....... .....||+.|+|||++.+. ...+.++|||||||++|+|+| |+.||...
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999975443221 2345799999999999651 233455999999999999999 99999754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=302.34 Aligned_cols=194 Identities=21% Similarity=0.236 Sum_probs=160.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---------ccHHHHHHHHHHHcCC---------CCCee
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNIV 80 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~ei~~l~~l~---------h~~Iv 80 (330)
..++|++.+.||+|+||+||+|++ +|+.||||++..... ..+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 347899999999999999999998 589999999976532 2267889999988875 77777
Q ss_pred eeeEEEE------------------------------eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 020133 81 RFKEVIL------------------------------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130 (330)
Q Consensus 81 ~~~~~~~------------------------------~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L 130 (330)
++.+++. ..+..|+||||+++|++.+.+.+ +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 7777653 26789999999999977666644 6789999999999999999
Q ss_pred HHhh-hcCccccCCCCCcEEecCCCC------------------CceEEeecCCcccccCCCCCCcccCCCCCCChhhhh
Q 020133 131 SYCH-SMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (330)
Q Consensus 131 ~~LH-~~~ivH~dikp~NIli~~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (330)
.||| ++||+||||||+|||++.++. ..+||+|||+|+.... ...+||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhc
Confidence 9999 999999999999999987651 1599999999975432 2457999999999998
Q ss_pred cCCCCCCccchhhHHHH-HHHHHhCCCCCCC
Q 020133 192 KKEYDGKIADVWSCGVT-LYVMLVGAYPFED 221 (330)
Q Consensus 192 ~~~~~~~~~Di~SlG~i-l~elltg~~pf~~ 221 (330)
+.. +.++|||||+++ .+++++|..||..
T Consensus 251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred CCC--ccceehhhhhCCCCcccccccCCCcc
Confidence 765 455999998777 7778889999854
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=317.62 Aligned_cols=205 Identities=32% Similarity=0.448 Sum_probs=176.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEe------CCe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT------PTH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~------~~~ 91 (330)
.++|++.+.||+|+||.||++.+..+|+.||||++.... ...+.+.+|+.++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 388999999999999999999999999999999887542 234568899999999999999999998765 567
Q ss_pred EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC-CceEEeecCCcc
Q 020133 92 LAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSK 167 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~-~~vkL~Dfg~a~ 167 (330)
.|+||||++|++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++. ..+||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999998644 5999999999999999999999999999999999999986543 248999999998
Q ss_pred cccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChh
Q 020133 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (330)
Q Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~ 225 (330)
............+++.|+|||++.+..++.+ +|||||||++|+|++|+.||......
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~ 229 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQP 229 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred ccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccch
Confidence 6665555566789999999999987777655 99999999999999999999875443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=288.70 Aligned_cols=197 Identities=16% Similarity=0.117 Sum_probs=152.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCC-CCe---------ee-----
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH-PNI---------VR----- 81 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h-~~I---------v~----- 81 (330)
..|++.+.||+|+||+||+|.+..+|+.||||++... ....+.+.+|+..++.++| +|. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4588999999999999999999999999999988732 2335778999999999977 221 11
Q ss_pred -------eeEEEEe-----CCeEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHhhhcCccccC
Q 020133 82 -------FKEVILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (330)
Q Consensus 82 -------~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~d 142 (330)
+..++.. ...++++|+++ +++|.+++.. ++.+++..++.++.||+.||.|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 12467788876 6799988841 23578889999999999999999999999999
Q ss_pred CCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhh----------cCCCCCCccchhhHHHHHHHH
Q 020133 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----------KKEYDGKIADVWSCGVTLYVM 212 (330)
Q Consensus 143 ikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~----------~~~~~~~~~Di~SlG~il~el 212 (330)
|||+|||++.++. +||+|||+++..... ....+| +.|+|||++. +..+ +.++|||||||++|+|
T Consensus 237 iKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 237 LRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHH
Confidence 9999999987765 999999998744332 344567 9999999993 3334 3459999999999999
Q ss_pred HhCCCCCCCCCh
Q 020133 213 LVGAYPFEDPEE 224 (330)
Q Consensus 213 ltg~~pf~~~~~ 224 (330)
+||+.||...+.
T Consensus 311 ltg~~Pf~~~~~ 322 (413)
T 3dzo_A 311 WCADLPNTDDAA 322 (413)
T ss_dssp HHSSCCCCTTGG
T ss_pred HHCCCCCCCcch
Confidence 999999987544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=282.38 Aligned_cols=183 Identities=14% Similarity=0.040 Sum_probs=133.2
Q ss_pred eeccCCceEEEEEEECCCCcEEEEEEeecCC-----------cccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeEEEE
Q 020133 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 28 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..+.|+.|.+..++....|+.|++|.+.+.. ...+.+.+|+.+|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777777788887889999999987542 1225688999999999 699999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~ 174 (330)
|||++|++|.+++.+++++++. +|+.||+.||+|+|++|||||||||+|||++.++. +||+|||+|+..... ..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence 9999999999999999999875 47899999999999999999999999999987764 999999999755432 33
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCC
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~ 217 (330)
..+.+||+.|+|||++.+.. . ..+|+||+|++++++.++..
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~-~-~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK-S-WNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred ccCceechhhccHHHhCCCC-C-Ccccccccccchhhhccccc
Confidence 45568999999999997653 2 33899999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-29 Score=243.07 Aligned_cols=182 Identities=20% Similarity=0.119 Sum_probs=141.2
Q ss_pred EEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---------cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
...+.||+|+||.||++. ..++.+++|........ .+.+.+|+.++++++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 346689999999999993 45788999976442211 2347899999999999999966666667777899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCccc
Confidence 9999999999999865 6789999999999999999999999999999986 499999999985543221
Q ss_pred --------CCcccCCCCCCChhhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCC
Q 020133 175 --------PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 175 --------~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~SlG~il~elltg~~pf~ 220 (330)
.....||+.|+|||++.. ..|... +|+||..+-..+-+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence 124578999999999976 455444 899999988888888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=203.35 Aligned_cols=142 Identities=18% Similarity=0.163 Sum_probs=114.8
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-------------------ccHHHHHHHHHHHcCCCCCeeeee
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK 83 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~ei~~l~~l~h~~Iv~~~ 83 (330)
|.+.+.||+|+||.||+|.+ .+|+.||+|.+..... ....+.+|+.++++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44559999999999999999 8899999999864321 2346889999999999 4 6666
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeec
Q 020133 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 84 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
+++.. +..|+||||++|++|.+ +. ......++.|++.||.+||++||+||||||+|||++ ++ .+||+||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DF 236 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDF 236 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEEC
Confidence 65544 45699999999999987 42 133557999999999999999999999999999998 54 5999999
Q ss_pred CCcccccCCCCCCcccCCCCCCChhhhh
Q 020133 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (330)
Q Consensus 164 g~a~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (330)
|+|+. +..+.|||.+.
T Consensus 237 G~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE------------TTSTTHHHHHH
T ss_pred CCCeE------------CCCCCHHHHHH
Confidence 99862 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=178.44 Aligned_cols=136 Identities=15% Similarity=0.104 Sum_probs=107.4
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcE--EEEEEeecCCcc-------------------------cHHHHHHHHHHHcC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKI-------------------------DENVQREIINHRSL 74 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~-------------------------~~~~~~ei~~l~~l 74 (330)
-|++.+.||+|+||.||+|.+..+|+. ||||+++..... ...+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999999778988 999987543211 12678999999999
Q ss_pred CCCCe--eeeeEEEEeCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh-hcCccccCCCCC
Q 020133 75 RHPNI--VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLE 146 (330)
Q Consensus 75 ~h~~I--v~~~~~~~~~~~~~lv~e~~~g-~----sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~dikp~ 146 (330)
.|+++ +.+++. +..++||||+.+ | +|.+.... .++..+..++.|++.+|.+|| ++||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88764 334432 245899999942 3 66665432 345578899999999999999 999999999999
Q ss_pred cEEecCCCCCceEEeecCCccc
Q 020133 147 NTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 147 NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
|||++. .++|+|||+|..
T Consensus 201 NILl~~----~~~liDFG~a~~ 218 (258)
T 1zth_A 201 NIMYID----KVYFIDMGQAVT 218 (258)
T ss_dssp SEEESS----SEEECCCTTCEE
T ss_pred HEEEcC----cEEEEECccccc
Confidence 999976 499999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=165.96 Aligned_cols=137 Identities=15% Similarity=0.114 Sum_probs=100.9
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc---------------cc--------HHHHHHHHHHHcCCCCC
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------ID--------ENVQREIINHRSLRHPN 78 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------~~--------~~~~~ei~~l~~l~h~~ 78 (330)
-|++.+.||+|++|.||+|.+. +|+.||||+++.... .. ....+|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999985 599999998753210 00 11245777777775555
Q ss_pred eeeeeEEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC--
Q 020133 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-- 156 (330)
Q Consensus 79 Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~-- 156 (330)
+....-+.... .+|||||++|.+|.++. .......++.|++.+|.+||++|||||||||.|||+++++.+
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 43222222222 37999999999886543 123456788999999999999999999999999999766532
Q ss_pred ------ceEEeecCCcc
Q 020133 157 ------RLKICDFGYSK 167 (330)
Q Consensus 157 ------~vkL~Dfg~a~ 167 (330)
.+.++||+.+.
T Consensus 247 ~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTSEEEEEEECCCTTCE
T ss_pred ccccccceEEEEeCCcc
Confidence 37899999775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=7.5e-14 Score=122.17 Aligned_cols=138 Identities=17% Similarity=0.121 Sum_probs=110.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..|++...++.|+.+.||++... ++.+++|...... .....+.+|+..++.+. +..+.++++++...+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 46999999999999999999754 6789999886521 22346889999999884 66788999999988999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------------
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 135 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------------------------------- 135 (330)
++|.+|.+.. .+......++.+++.+|+.||+
T Consensus 92 i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 9999987652 1223345788899999999998
Q ss_pred ----------------cCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 136 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 136 ----------------~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
..++|+|++|.||+++++. .+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence 4589999999999997542 25699998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=113.99 Aligned_cols=134 Identities=13% Similarity=0.112 Sum_probs=98.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~--Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..|.+....+.|..+.||++.. .+|..+++|..... ....+.+|+..++.+.+.+ +.+++.+....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 4577655555666799999964 45778999986554 2345778998888885444 56688888888889999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ----------------------------------------- 137 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------------------- 137 (330)
++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 97 VPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp CSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 9998884 2 1122 2356677777888888643
Q ss_pred -----------------ccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 138 -----------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 138 -----------------ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
++|+|++|.||+++.+. .+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence 99999999999997543 25699999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.32 E-value=5.9e-12 Score=115.29 Aligned_cols=140 Identities=14% Similarity=0.219 Sum_probs=106.3
Q ss_pred EEeceeccCCceEEEEEEECCCCcEEEEEEee--cCC--cccHHHHHHHHHHHcCC--CCCeeeeeEEEEeC---CeEEE
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGD--KIDENVQREIINHRSLR--HPNIVRFKEVILTP---THLAI 94 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~--~~~~~~~~ei~~l~~l~--h~~Iv~~~~~~~~~---~~~~l 94 (330)
.-++.|+.|.++.||++... +..+++|... ... .....+.+|+.+++.+. +..+++++.++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 35678999999999998764 4678999775 332 22356788999999886 34578888888766 45899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------------------------------------- 135 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 135 (330)
||||++|.++.+.. -..++..+...++.+++.+|..||+
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998885421 1347888899999999999999997
Q ss_pred -------------------cCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 136 -------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 136 -------------------~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
..++|||++|.||+++.++...+.|+||+.+.
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999986643235899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.7e-11 Score=109.64 Aligned_cols=187 Identities=17% Similarity=0.126 Sum_probs=121.3
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCC--eeeeeEEEEeCC---eEEEEEecc
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN--IVRFKEVILTPT---HLAIVMEYA 99 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~--Iv~~~~~~~~~~---~~~lv~e~~ 99 (330)
++.++.|..+.||.+. ..+++|..... .....+.+|+..++.+. +.. +.+++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999873 45899975432 33467889999998873 332 344444433332 348999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh--------------------------------------------
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-------------------------------------------- 135 (330)
+|.+|.+... ..++..+...++.+++..|+.||+
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9999876433 347888888899999999998886
Q ss_pred --------------cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhc--CCCCCC-
Q 020133 136 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGK- 198 (330)
Q Consensus 136 --------------~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~- 198 (330)
..++|+|++|.||+++.+....+.|+||+.+.................-..|+.... ..|...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 136999999999999874222478999998753221110000000000023332211 001111
Q ss_pred ----------ccchhhHHHHHHHHHhCCCCCC
Q 020133 199 ----------IADVWSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 199 ----------~~Di~SlG~il~elltg~~pf~ 220 (330)
..+.|+++.++|.+.+|..+|.
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1589999999999999998773
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=3.3e-08 Score=88.35 Aligned_cols=133 Identities=18% Similarity=0.144 Sum_probs=94.2
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCC---CeeeeeEEEE-eCCeEEEEEeccCC
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG 101 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~---~Iv~~~~~~~-~~~~~~lv~e~~~g 101 (330)
++.++.|....||.+ +..+++|+. ........+.+|+..++.+.+. .+.+++.++. ..+..|+|||+++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888999988 456899974 3223346788999999998642 3566666664 34567899999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 020133 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------------------------------------------- 136 (330)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------------------------------------------- 136 (330)
.++....- ..++..+...++.++...|+.||+.
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 98876322 2345666666666666666666642
Q ss_pred ---------------CccccCCCCCcEEecC---CCCCceEEeecCCcc
Q 020133 137 ---------------QVCHRDLKLENTLLDG---SPAPRLKICDFGYSK 167 (330)
Q Consensus 137 ---------------~ivH~dikp~NIli~~---~~~~~vkL~Dfg~a~ 167 (330)
.++|+|++|.||+++. ++. .+.|+||+.+.
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~ 223 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcC
Confidence 3589999999999976 222 24799999765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=6.7e-08 Score=84.36 Aligned_cols=132 Identities=19% Similarity=0.215 Sum_probs=93.9
Q ss_pred eeccCCce-EEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEeccCCCChH
Q 020133 28 DIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 105 (330)
Q Consensus 28 ~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~g~sL~ 105 (330)
.+..|..| .||.......+..+++|.-... ....+.+|...++.+. +--+.+++.++.+.+..|+|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445554 6899888777888999975533 2356788999888774 333778889999999999999999998887
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------------
Q 020133 106 ERICNAGRFSEDEARFFFQQLISGVSYCHSM------------------------------------------------- 136 (330)
Q Consensus 106 ~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------------- 136 (330)
+..... ......+..++...|+.||+.
T Consensus 109 ~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 109 QVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred ccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 655321 222334555666666666631
Q ss_pred ---------CccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 137 ---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 137 ---------~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
.++|+|+.|.||+++.++ .+-|+||+.+.
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~--~~~viDwe~a~ 222 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGK--LIGCIDVGRVG 222 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCe--EEEEEECcccc
Confidence 268999999999997653 35699998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=3.5e-07 Score=84.56 Aligned_cols=76 Identities=17% Similarity=0.095 Sum_probs=50.2
Q ss_pred EeceeccCCceEEEEEEECCCCcEEEEEEeecCC--------cccHHHHHHHHHHHcCCC--C-CeeeeeEEEEeCCeEE
Q 020133 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------KIDENVQREIINHRSLRH--P-NIVRFKEVILTPTHLA 93 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~ei~~l~~l~h--~-~Iv~~~~~~~~~~~~~ 93 (330)
-.+.+|.|..+.||++....+++.+++|...... .....+..|...++.+.. | .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 4678999999999999876667889999764321 123456788888877632 3 34455543 344568
Q ss_pred EEEeccCCC
Q 020133 94 IVMEYASGG 102 (330)
Q Consensus 94 lv~e~~~g~ 102 (330)
+|||+++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.6e-07 Score=84.02 Aligned_cols=83 Identities=8% Similarity=0.061 Sum_probs=57.3
Q ss_pred eEEecee-ccCCceEEEEEEECC------CCcEEEEEEeecCC---c-ccHHHHHHHHHHHcCC-C--CCeeeeeEEEEe
Q 020133 23 YELVRDI-GSGNFGVARLMRDKK------TEELVAVKYIERGD---K-IDENVQREIINHRSLR-H--PNIVRFKEVILT 88 (330)
Q Consensus 23 y~i~~~l-g~G~~g~Vy~~~~~~------~~~~vavK~~~~~~---~-~~~~~~~ei~~l~~l~-h--~~Iv~~~~~~~~ 88 (330)
....+.| +.|..+.+|++.... +++.+++|...... . ....+.+|+..++.+. + -.+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3456778 888899999987541 25678999765432 1 1346778888888774 2 346777777665
Q ss_pred C---CeEEEEEeccCCCChH
Q 020133 89 P---THLAIVMEYASGGELF 105 (330)
Q Consensus 89 ~---~~~~lv~e~~~g~sL~ 105 (330)
. +..|+|||+++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.27 E-value=6.9e-06 Score=73.78 Aligned_cols=74 Identities=18% Similarity=0.243 Sum_probs=42.8
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----CCCeeeee-E--EEEeCCeEEEEEe
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFK-E--VILTPTHLAIVME 97 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-----h~~Iv~~~-~--~~~~~~~~~lv~e 97 (330)
++.|+.|..+.||++... +..+++|..... ...+..|...++.|. .|.++... + +....+..++||+
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 455666778899999764 335899988753 234445555555442 34443311 0 2234677899999
Q ss_pred ccCCCCh
Q 020133 98 YASGGEL 104 (330)
Q Consensus 98 ~~~g~sL 104 (330)
|++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.07 E-value=3.9e-05 Score=68.41 Aligned_cols=77 Identities=18% Similarity=0.109 Sum_probs=60.9
Q ss_pred EEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC---CCCeeeeeEEEEeCCeEEEEEeccC
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS 100 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~---h~~Iv~~~~~~~~~~~~~lv~e~~~ 100 (330)
.-++.|+.|....+|++.. .+..+++|..... ....+.+|+..++.|. ...+++++.++...+..|+||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3467789999999999975 3678999976543 2456888998888874 3568888888888888999999999
Q ss_pred CCCh
Q 020133 101 GGEL 104 (330)
Q Consensus 101 g~sL 104 (330)
|.++
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.4e-05 Score=72.76 Aligned_cols=73 Identities=14% Similarity=0.242 Sum_probs=45.2
Q ss_pred EeceeccCCceEEEEEEECCCCcEEEEEEeec-----CCc-----ccHHHHHHHHHHH-cCCCCCeeeeeEEEEeCCeEE
Q 020133 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDK-----IDENVQREIINHR-SLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~-----~~~~~~~ei~~l~-~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
-++.||.|..+.||++.. +++.++||.... ... ....+..|+..+. ......+.+++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 457789999999999964 467899994321 111 1223334443322 22234566676665 55679
Q ss_pred EEEecc-CC
Q 020133 94 IVMEYA-SG 101 (330)
Q Consensus 94 lv~e~~-~g 101 (330)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.02 E-value=1.2e-05 Score=71.17 Aligned_cols=72 Identities=13% Similarity=0.099 Sum_probs=45.1
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEeCCeEEEEEecc-CCCC
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE 103 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~I-v~~~~~~~~~~~~~lv~e~~-~g~s 103 (330)
++.|+.|....+|++ ..+++|+............+|+..++.+...++ .+++.+ +.+.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 688988999999999 448999776542222223567777766642222 455544 333347899999 7765
Q ss_pred hH
Q 020133 104 LF 105 (330)
Q Consensus 104 L~ 105 (330)
+.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=5.6e-05 Score=69.27 Aligned_cols=138 Identities=16% Similarity=0.125 Sum_probs=81.0
Q ss_pred eceeccCCceEEEEEEECC-------CCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEe
Q 020133 26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++.|..|-...+|++.... .++.+++|+............+|..+++.+. +.-..++++.+. + .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 3567668788899998742 3578999986443334456778999988774 333356665543 3 29999
Q ss_pred ccCCCChHH--------------HH---Hhc-----CCC--CHHHHHHHHHHHHH-------------------HHHHhh
Q 020133 98 YASGGELFE--------------RI---CNA-----GRF--SEDEARFFFQQLIS-------------------GVSYCH 134 (330)
Q Consensus 98 ~~~g~sL~~--------------~l---~~~-----~~l--~~~~~~~i~~qi~~-------------------~L~~LH 134 (330)
|++|.+|.. .+ +.. +.. -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999866531 11 111 111 23556666555432 122222
Q ss_pred ----h----cCccccCCCCCcEEecCC--CCCceEEeecCCcc
Q 020133 135 ----S----MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 167 (330)
Q Consensus 135 ----~----~~ivH~dikp~NIli~~~--~~~~vkL~Dfg~a~ 167 (330)
. ..++|+|+.+.||+++.+ ..+.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1 358999999999999765 12358999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.75 E-value=8.2e-05 Score=66.28 Aligned_cols=139 Identities=17% Similarity=0.154 Sum_probs=76.0
Q ss_pred EEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----CCCeeeee-E--EEEeCCeEEEE
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFK-E--VILTPTHLAIV 95 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-----h~~Iv~~~-~--~~~~~~~~~lv 95 (330)
.-++.|+.|....+|++.... | .+++|..... ...+.+..|+..+..+. -|.++... + +....+..+++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 446778888889999997643 4 5889987653 12345666777766653 23333211 0 12234678999
Q ss_pred EeccCCCChHH-----------H---HHh-cCCC--------CHHHHHHH---------------HHHHHHHHHHhh---
Q 020133 96 MEYASGGELFE-----------R---ICN-AGRF--------SEDEARFF---------------FQQLISGVSYCH--- 134 (330)
Q Consensus 96 ~e~~~g~sL~~-----------~---l~~-~~~l--------~~~~~~~i---------------~~qi~~~L~~LH--- 134 (330)
|+|++|.++.. . ++. ...+ ........ ...+...+..+.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99999865421 0 111 0111 11100000 001233344444
Q ss_pred ----hcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 135 ----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 135 ----~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
..+++|+|++|.||+++.+. .+.++||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence 24699999999999997643 24799998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00024 Score=63.35 Aligned_cols=76 Identities=9% Similarity=0.056 Sum_probs=49.0
Q ss_pred ceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC--eeeeeEE-----EEeCCeEEEEEecc
Q 020133 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYA 99 (330)
Q Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~--Iv~~~~~-----~~~~~~~~lv~e~~ 99 (330)
+.++ |....||++... +|+.+++|...........+..|...++.+.... +++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 777889987653 4667999988654334566777888777663212 3333332 23356778999999
Q ss_pred CCCCh
Q 020133 100 SGGEL 104 (330)
Q Consensus 100 ~g~sL 104 (330)
+|.++
T Consensus 110 ~G~~~ 114 (328)
T 1zyl_A 110 GGRQF 114 (328)
T ss_dssp CCEEC
T ss_pred CCCCC
Confidence 88554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00049 Score=60.31 Aligned_cols=79 Identities=11% Similarity=0.045 Sum_probs=55.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCC---CeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHP---NIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~---~Iv~~~~~~~~~~~~~lv~ 96 (330)
.+..-++.+|.|..+.||++.. .+|+.|++|+..... .....+.+|+..|+.|.-. -+.+++.+ .. .++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEE
Confidence 3456788999999999999986 458899999765443 2334678899999887421 24455543 22 37899
Q ss_pred eccCCCCh
Q 020133 97 EYASGGEL 104 (330)
Q Consensus 97 e~~~g~sL 104 (330)
||+.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00014 Score=67.85 Aligned_cols=75 Identities=13% Similarity=0.135 Sum_probs=50.8
Q ss_pred EeceeccCCceEEEEEEECC-------CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEeCCeEEEEE
Q 020133 25 LVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~I-v~~~~~~~~~~~~~lv~ 96 (330)
-++.|+.|....+|++.... .++.+++|+.... ...+.+.+|...++.+...++ .++++.+. + .+|+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 35678888889999998753 2578999987432 111566688888887743333 56666542 3 3899
Q ss_pred eccCCCCh
Q 020133 97 EYASGGEL 104 (330)
Q Consensus 97 e~~~g~sL 104 (330)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00011 Score=66.98 Aligned_cols=76 Identities=14% Similarity=0.035 Sum_probs=45.4
Q ss_pred EeceeccCCceEEEEEEECC--------CCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEeCCeEEEE
Q 020133 25 LVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIV 95 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~-Iv~~~~~~~~~~~~~lv 95 (330)
-++.++.|....+|++.... .++.+++|+.............|...++.+...+ +.++++.. .+ ++|
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 34667888888999998653 1367899977554322222357777777764323 44565543 33 689
Q ss_pred EeccCCCCh
Q 020133 96 MEYASGGEL 104 (330)
Q Consensus 96 ~e~~~g~sL 104 (330)
|+|++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00049 Score=61.58 Aligned_cols=77 Identities=9% Similarity=-0.023 Sum_probs=38.1
Q ss_pred eceeccCCceE-EEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC--CCeeeeeEEEEeCCeEEEEEeccCCC
Q 020133 26 VRDIGSGNFGV-ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 102 (330)
Q Consensus 26 ~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h--~~Iv~~~~~~~~~~~~~lv~e~~~g~ 102 (330)
++.|+.|.... +|++.. .+++.+++|...... ...+..|+..++.+.. -.+.+++.+....+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 45666665554 566643 236678888654432 1233455666655532 22455665533333 7899999876
Q ss_pred ChHHH
Q 020133 103 ELFER 107 (330)
Q Consensus 103 sL~~~ 107 (330)
++.+.
T Consensus 98 ~l~~~ 102 (333)
T 3csv_A 98 LFTEV 102 (333)
T ss_dssp BHHHH
T ss_pred chHHH
Confidence 66543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0015 Score=61.36 Aligned_cols=76 Identities=16% Similarity=0.104 Sum_probs=49.5
Q ss_pred EeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-eeeeEEEEeCCeEEEEEeccCCCC
Q 020133 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 103 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~I-v~~~~~~~~~~~~~lv~e~~~g~s 103 (330)
-++.|+.|-...+|++.....+..+++|+..........-.+|...++.|...++ .++++.+ .+ .+||||++|.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 3467888888999999876545789999875432221122588888888864444 5676665 23 25999999855
Q ss_pred h
Q 020133 104 L 104 (330)
Q Consensus 104 L 104 (330)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0043 Score=55.71 Aligned_cols=72 Identities=10% Similarity=-0.062 Sum_probs=42.9
Q ss_pred eceec--cCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcC---CCCCeeeeeEE------EEeCCeEEE
Q 020133 26 VRDIG--SGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFKEV------ILTPTHLAI 94 (330)
Q Consensus 26 ~~~lg--~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l---~h~~Iv~~~~~------~~~~~~~~l 94 (330)
++.+. .|....||++... +| .+++|+...... .+|+..++.| .-|++++++.. ....+..++
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~ 98 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSE-SK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKII 98 (339)
T ss_dssp EEEETTTSCSSCEEEEEECS-SC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEE
T ss_pred eEEeeccCccccceEEEEeC-CC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEE
Confidence 34453 3336789999754 35 899997765442 2444444444 22323443321 234577899
Q ss_pred EEeccCCCCh
Q 020133 95 VMEYASGGEL 104 (330)
Q Consensus 95 v~e~~~g~sL 104 (330)
||+|++|..+
T Consensus 99 l~~~i~G~~~ 108 (339)
T 3i1a_A 99 AYPFIHAPNG 108 (339)
T ss_dssp EEECCCCCBT
T ss_pred EEeccCCCcC
Confidence 9999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0028 Score=58.77 Aligned_cols=76 Identities=14% Similarity=0.040 Sum_probs=49.4
Q ss_pred EeceeccCCceEEEEEEECCC-------CcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEE
Q 020133 25 LVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
-++.+..|-...+|++..... ++.+++|+............+|...++.+. +.-..++++.+ .+ ++||
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 345677788889999987531 578999986554322223457888887774 33345555432 33 7899
Q ss_pred eccCCCCh
Q 020133 97 EYASGGEL 104 (330)
Q Consensus 97 e~~~g~sL 104 (330)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.91 E-value=0.024 Score=47.30 Aligned_cols=101 Identities=16% Similarity=0.052 Sum_probs=62.3
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCccc
Q 020133 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (330)
Q Consensus 102 ~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~~ 179 (330)
.||.+++.. +.++++.++|.+++|.+.+|..+-. ..-..+=+.|..|++..+|+ |-+.+ +.+ ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------DA 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------cc
Confidence 578898875 5689999999999999999877621 11123344678999988876 54442 111 01
Q ss_pred CCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC
Q 020133 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218 (330)
Q Consensus 180 ~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~p 218 (330)
....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 223466787653 1222336899999999998874443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.52 E-value=0.044 Score=50.30 Aligned_cols=30 Identities=40% Similarity=0.606 Sum_probs=23.4
Q ss_pred ccccCCCCCcEEecC----CCCCceEEeecCCcc
Q 020133 138 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK 167 (330)
Q Consensus 138 ivH~dikp~NIli~~----~~~~~vkL~Dfg~a~ 167 (330)
++|+|+.+.||++.. +....+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 679999999999943 122359999998764
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.05 E-value=0.25 Score=35.49 Aligned_cols=58 Identities=14% Similarity=0.198 Sum_probs=43.5
Q ss_pred CCHHHHHHHHHHhCCCCCCCCchhhhccCCCCccccc-cccCC-CCCCcCCCCCCceeec
Q 020133 272 QSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEM-DEDID-TDPDLDIDSSGEIVYA 329 (330)
Q Consensus 272 ~s~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~ 329 (330)
....|+.+++........|..+..++......+.... +++++ .+...|.|++|.|+|.
T Consensus 33 ~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~ 92 (100)
T 2lv7_A 33 DELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFE 92 (100)
T ss_dssp GGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHH
T ss_pred HHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHH
Confidence 4678899999999999999999887766554433221 23455 6778999999999984
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.28 E-value=4.5 Score=33.33 Aligned_cols=115 Identities=10% Similarity=0.069 Sum_probs=75.9
Q ss_pred CCCCCeeeeeEEEEeCCeEEEEEeccC-CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC
Q 020133 74 LRHPNIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (330)
Q Consensus 74 l~h~~Iv~~~~~~~~~~~~~lv~e~~~-g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~ 152 (330)
..||+++.. .+-.+++.+.+.++.-+ +.++.. + ..++....++++.+|+.... |...-+|--++|+|++++.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~--~~~~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEE--VNRTRYTFVLAPDELFFTR 114 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGG--GGGSSEECCCSGGGEEECT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHH--HhcCceEEEEecceEEEcC
Confidence 368888877 56677777777776544 334433 3 34789999999999988663 3444577889999999987
Q ss_pred CCCCceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccch-hhHHHHHHHHHhCCCCCC
Q 020133 153 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADV-WSCGVTLYVMLVGAYPFE 220 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~SlG~il~elltg~~pf~ 220 (330)
++. +++.--|+-.. ++|. .. +. .|. -.+=|++..+++++..|.
T Consensus 115 ~~~--p~i~~RGik~~----------------l~P~-----~~-~e-e~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 115 DGL--PIAKTRGLQNV----------------VDPL-----PV-SE-AEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TSC--EEESCCEETTT----------------BSCC-----CC-CH-HHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCC--EEEEEccCccC----------------CCCC-----CC-CH-HHHHHHHHHHHHHHHcCCCCHH
Confidence 765 78876664221 1111 01 11 232 345588888899988874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 330 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-71 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-69 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-67 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-66 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-66 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-64 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-62 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-59 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-51 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-51 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-47 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-35 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 3e-71
Identities = 86/266 (32%), Positives = 133/266 (50%), Gaps = 37/266 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ ++LV+ +G G +G +L ++ TEE VAVK + +R EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+F + +EY SGGELF+RI E +A+ FF QL++GV Y H + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKKEY 195
HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L ++E+
Sbjct: 125 THRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----------------------- 232
+ DVWSCG+ L ML G P++ P +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 233 -------HRISIPEIRNHEWFLKNLP 251
RI+IP+I+ W+ K L
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 216 bits (552), Expect = 7e-69
Identities = 73/323 (22%), Positives = 129/323 (39%), Gaps = 42/323 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 79
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ + + +++E+ SGGELF+RI + SE E + +Q G+ + H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D+K EN + + A +KI DFG + K T T + APE++ ++
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------------- 233
D+W+ GV YV+L G PF ++ + +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267
Query: 234 ------RISIPEIRNHEWF---LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284
R+++ + H W NL + + ++++ + Q ++ A
Sbjct: 268 QKEPRKRLTVHDALEHPWLKGDHSNLTSRI-----PSSRYNKIRQKIKEKYADWPAPQPA 322
Query: 285 TIPAAGTQSLNQCLNGSLDIDDE 307
A SL + I D
Sbjct: 323 IGRIANFSSLRKHRPQEYQIYDS 345
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 2e-68
Identities = 75/260 (28%), Positives = 122/260 (46%), Gaps = 35/260 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ + +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------------------- 233
K D+WS GV Y LVG PFE + +++
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 234 ----RISIPEIRNHEWFLKN 249
R + E+ H W N
Sbjct: 242 NPSQRPMLREVLEHPWITAN 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 1e-67
Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 7/282 (2%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
D +E + ++G+GN GV + K + ++A K I E I + RE+ P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ- 137
IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257
+ +D+WS G++L M VG YP P+ + ++
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 258 NTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLN 299
+ + ++E + +N+CL
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 210 bits (536), Expect = 2e-66
Identities = 76/309 (24%), Positives = 129/309 (41%), Gaps = 44/309 (14%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIIN 70
+++ H D Y++ ++G+G FGV + ++ T A K++ + D E V++EI
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 129
LRHP +V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + H H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH---------------- 233
K D+WS GV Y++L G PF + + R
Sbjct: 197 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 234 ---------------RISIPEIRNHEWFLK-NLPADLV---------VDNTTNNQFEEPD 268
R++I + H W N P + ++ +++
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315
Query: 269 QPMQSIDEI 277
+P+ + I
Sbjct: 316 EPLPPLGRI 324
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (531), Expect = 3e-66
Identities = 83/281 (29%), Positives = 130/281 (46%), Gaps = 35/281 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
D Y+ +G+G F L DK+T++LVA+K I + + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV ++ + HL ++M+ SGGELF+RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 138 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK EN L ++ I DFG SK S + GTP Y+APEVL +K Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------------------- 233
D WS GV Y++L G PF D + K F + +
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 234 --------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 266
R + + H W + D + + + Q ++
Sbjct: 247 LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 287
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-66
Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 33/263 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++Y + D+G G FG+ + +++ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
E + L ++ E+ SG ++FERI +A +E E + Q+ + + HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------------------------- 233
D+WS G +YV+L G PF + ++
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243
Query: 234 -----RISIPEIRNHEWFLKNLP 251
R++ E H W + +
Sbjct: 244 KERKSRMTASEALQHPWLKQKIE 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 7e-64
Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 47/294 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR 75
+ +R+IG G+FG RD + E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPN ++++ L +VMEY G + E E + G++Y HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L +
Sbjct: 134 HNMIHRDVKAGNILLSEPG--LVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------- 233
+YDGK DVWS G+T + P +
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 234 ----------RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEI 277
R + + H + L+ P +++D + ++ +D +
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD-----LIQRTKDAVRELDNL 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 8e-64
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 39/272 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D +E++ ++G G FG ++K+T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ + +L I++E+ +GG + + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++ +
Sbjct: 131 IIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 197 GKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------- 233
+ ADVWS G+TL M P + + K
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 234 -----------RISIPEIRNHEWFLKNLPADL 254
R + ++ H + + +
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 9e-64
Identities = 67/264 (25%), Positives = 108/264 (40%), Gaps = 36/264 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
+Y IG G G D T + VA++ + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + L L +VMEY +GG L + + E + ++ + + + HS QV
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------------ 233
K D+WS G+ M+ G P+ + +
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 234 ------RISIPEIRNHEWFLKNLP 251
R S E+ H++ P
Sbjct: 255 DMDVEKRGSAKELLQHQFLKIAKP 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 3e-62
Identities = 67/262 (25%), Positives = 106/262 (40%), Gaps = 37/262 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
+ ++ + +G G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------------------- 233
+D+W+ G +Y ++ G PF E F+K I
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244
Query: 234 -------RISIPEIRNHEWFLK 248
R+ E+ +
Sbjct: 245 LVLDATKRLGCEEMEGYGPLKA 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 195 bits (496), Expect = 2e-61
Identities = 74/273 (27%), Positives = 112/273 (41%), Gaps = 49/273 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREIIN 70
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 71 HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
R + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------- 233
+ D GK D+WS GV +Y +L G+ PF ++ R +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 234 --------------------RISIPEIRNHEWF 246
R + E H +F
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-59
Identities = 78/267 (29%), Positives = 127/267 (47%), Gaps = 41/267 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------------- 233
+ AD+WS GV Y++L GA PF + +
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247
Query: 234 --------------RISIPEIRNHEWF 246
R++I + H W
Sbjct: 248 KDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-59
Identities = 86/317 (27%), Positives = 142/317 (44%), Gaps = 49/317 (15%)
Query: 11 GMDMPIMHDSDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
G+ + D Y++ +G G G + +K+T+E A+K ++ K +RE+
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVE 56
Query: 69 INHRSLRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFF 122
++ R+ + P+IVR +V L IVME GGELF RI + G F+E EA
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+ + T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----------------- 224
P Y+APEVL ++YD D+WS GV +Y++L G PF
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 225 ---------PKNFRKTI---------HRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 266
+ + I R++I E NH W +++ +T+ E+
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295
Query: 267 PDQPMQSIDEIMQIIAE 283
++ +E+ +A
Sbjct: 296 KERWEDVKEEMTSALAT 312
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 188 bits (478), Expect = 8e-59
Identities = 65/243 (26%), Positives = 97/243 (39%), Gaps = 11/243 (4%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRS 73
H SDRYEL +G G L RD + VAVK + R +RE N +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 74 LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
L HP IV + T IVMEY G L + + G + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 187
+++ H + HRD+K N ++ + A ++ + S +Q + +GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247
E D + +DV+S G LY +L G PF + + IP HE
Sbjct: 184 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 248 KNL 250
+L
Sbjct: 243 ADL 245
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-58
Identities = 70/257 (27%), Positives = 108/257 (42%), Gaps = 33/257 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------VQREIINHRS 73
+Y++ +GSG FG VA+K++E+ D V E++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 74 LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++R + P +++E +LF+ I G E+ AR FF Q++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+CH+ V HRD+K EN L+D + LK+ DFG + + GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI------------------ 232
Y G+ A VWS G+ LY M+ G PFE EE +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 241
Query: 233 ---HRISIPEIRNHEWF 246
R + EI+NH W
Sbjct: 242 RPSDRPTFEEIQNHPWM 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-58
Identities = 72/268 (26%), Positives = 112/268 (41%), Gaps = 46/268 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 78 NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T T L IVMEY GG+L I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 132 YCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------ 233
+PE + + Y+ K +D+WS G LY + PF + + K
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 234 ----------------RISIPEIRNHEW 245
R S+ EI +
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-57
Identities = 60/270 (22%), Positives = 110/270 (40%), Gaps = 43/270 (15%)
Query: 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHR 72
+ +D + +IG G+F D +T VA ++ + + E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 73 SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
L+HPNIVRF + + + +V E + G L + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 129 GVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
G+ + H+ + HRDLK +N + G P +KI D G + S K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-------------- 232
PE+ +++YD DV++ G+ + M YP+ + + + +
Sbjct: 182 PEMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 233 ----------------HRISIPEIRNHEWF 246
R SI ++ NH +F
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-56
Identities = 78/260 (30%), Positives = 122/260 (46%), Gaps = 37/260 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLR 75
+ + L + +G G+FG L KKT + A+K +++ D ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP + T +L VMEY +GG+L I + +F A F+ ++I G+ + HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+LL ++
Sbjct: 122 KGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH--------------------- 233
Y+ D WS GV LY ML+G PF +E + F
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238
Query: 234 ------RISIP-EIRNHEWF 246
R+ + +IR H F
Sbjct: 239 VREPEKRLGVRGDIRQHPLF 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 178 bits (451), Expect = 9e-54
Identities = 76/318 (23%), Positives = 123/318 (38%), Gaps = 62/318 (19%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------S 73
+ + + R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
H+ V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFED-----------------PEEPKNF-------- 228
AD +S G L+ +L G PF E P +F
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240
Query: 229 ----------RKTIHRISIPEIRNHEWF---------LKNLPADLV--------VDNTTN 261
R E++ +F L+ P L+ D
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDI 300
Query: 262 NQFEEPDQPMQSIDEIMQ 279
F+E D + + Q
Sbjct: 301 GSFDEEDTKGIKLLDSDQ 318
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-53
Identities = 58/245 (23%), Positives = 100/245 (40%), Gaps = 17/245 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLR 75
+ + + IGSG+FG + VAVK + + +Q E+ R R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
H NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
+ + HRDLK N L +KI DFG + Q + G+ ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 192 KKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249
++ + +DV++ G+ LY ++ G P+ + + R + + N
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR--SN 237
Query: 250 LPADL 254
P +
Sbjct: 238 CPKAM 242
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-52
Identities = 68/252 (26%), Positives = 100/252 (39%), Gaps = 16/252 (6%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + + R
Sbjct: 9 TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62
Query: 67 EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISI 237
+ + Y APE++ DVWS G L +L+G F + I +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 238 PEIRNHEWFLKN 249
P N
Sbjct: 242 PTREQIREMNPN 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 173 bits (439), Expect = 2e-52
Identities = 76/263 (28%), Positives = 129/263 (49%), Gaps = 14/263 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
++++R +G+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R + ++M+Y GGELF + + RF A+F+ ++ + Y HS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ K Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256
D WS G+ +Y ML G PF D N KT +I E+R +F +++ DL+
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPPFFNEDVK-DLLS 233
Query: 257 DNTTNNQFEEPDQPMQSIDEIMQ 279
T + + +++
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-51
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 11/228 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 61
Query: 79 IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + + + GR D F + + Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRDL N L+ K+ DFG +K S + + APE L +K++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
K +DVWS G+ L+ + K+ + + + +
Sbjct: 178 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 170 bits (430), Expect = 5e-51
Identities = 58/267 (21%), Positives = 114/267 (42%), Gaps = 9/267 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N ++D +L++ D+G ++ + V + + PE+L+ +
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257
D+WS G L M+ PF + + I ++ E N+ D +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 258 NTTNNQFEEPDQPMQSIDEIMQIIAEA 284
+ + + + + EA
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEA 295
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 9e-51
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 9/222 (4%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHP 77
E + +G G F RDK T ++VA+K I+ G D I+ REI + L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+ + +++++V ++ N+ + + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK N LLD + LK+ DFG +KS + V T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIP 238
G D+W+ G L +L+ + + + P
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-49
Identities = 62/293 (21%), Positives = 117/293 (39%), Gaps = 25/293 (8%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
++ P + +YE + IG G FG R +KT + VA+K + + REI
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 69 INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 120
+ L+H N+V E+ T + +V ++ +F+ E +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 175
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ + ++
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRY 178
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK----- 230
+ V T Y PE+LL + G D+W G + M + + E
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 231 -TIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282
+I P + N+E + + L ++ + + ++D I +++
Sbjct: 239 GSITPEVWPNVDNYELY-EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-49
Identities = 68/289 (23%), Positives = 106/289 (36%), Gaps = 26/289 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
RY + IG G +G+ D + VA+K I + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 79 IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
I+ ++I PT ++ + G +L++ + S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
S V HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250
L + K D+WS G L ML F + + P + +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 242
Query: 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLN 299
N P + + + + L++ L
Sbjct: 243 ------LKARNYLLSLPHKNKVPWNRLFP-----NADSKALDLLDKMLT 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 2e-49
Identities = 79/309 (25%), Positives = 143/309 (46%), Gaps = 55/309 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN L+D +++ DFG++K + + GTP +APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFED--------------PEEPKNF-------------- 228
D W+ GV +Y M G PF P +F
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 229 ----RKTIHRISIPEIRNHEWF---------LKNLPADLV-----VDNTTNNQFEEPDQP 270
R + + +I+NH+WF + + A + +T+N E ++
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEI 335
Query: 271 MQSIDEIMQ 279
SI+E
Sbjct: 336 RVSINEKCG 344
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-49
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 10/228 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D ++++G+G FGV + + + + VA+K I+ G ++ E +L H
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V + I+ EY + G L + RF + + + + Y S Q
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 195
HRDL N L++ +K+ DFG S+ + S + PEVL+ ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIH--RISIPEI 240
K +D+W+ GV ++ + +G P+E + R+ P +
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL 225
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 4e-49
Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 15/253 (5%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
M++ + +RY L R IGSG+FG L D E VA+K +E + E +
Sbjct: 1 MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56
Query: 72 RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++ I + + +VME + +FS Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 131 SYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 181
Y HS HRD+K +N L+ G + I DFG +K + + + K+ GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIR 241
Y + L E + D+ S G L +G+ P++ + +K
Sbjct: 177 ARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 242 NHEWFLKNLPADL 254
E K P++
Sbjct: 236 PIEVLCKGYPSEF 248
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-49
Identities = 75/225 (33%), Positives = 114/225 (50%), Gaps = 9/225 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
+ ++ ++ +G G FG L+R+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL +Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-RISIPE 239
D W GV +Y M+ G PF + + + F + I P
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-48
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 15/238 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
Y ++ +GSG +G D +T VA+K + R + + RE+ + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V T +VM + G ++ + ED +F Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249
+ D+WS G + M+ G F+ + ++ + P + +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 162 bits (411), Expect = 1e-48
Identities = 50/278 (17%), Positives = 99/278 (35%), Gaps = 19/278 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ R ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 140 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
+RD+K +N L+ + + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248
L +E + D+ + G L G+ P++ + N +K +
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 249 NLPADL--VVDNTTNNQFEE-PDQPMQSIDEIMQIIAE 283
P + + N F+ PD + + + E
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPD--YDYLQGLFSKVLE 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-48
Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 7/224 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ ++ V IG G +GV R+K T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NIV+ +VI T L +V E+ + F + + QL+ G+++CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
+V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL +Y
Sbjct: 122 RVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPE 239
D+WS G M+ F E + + P+
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-48
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 10/232 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V L + +V E+ G L + G F+ + + G++Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---HRISIPEIRNHE 244
K +DVWS GV ++ + + + I R+ P + +
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 8e-48
Identities = 48/229 (20%), Positives = 87/229 (37%), Gaps = 7/229 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + + R S + Q+ S + Y
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ + +K+ DFG S+ + ++ + APE L +
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
+ K +DVW+ GV L+ + + + + + E
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 160 bits (404), Expect = 1e-47
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 7/226 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
++Y + IG G +GV ++ E A+K I + + I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ +VI T L +V E+ G A+ F QL++G++YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRN 242
D+WS G M+ G F E + + P +N
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-47
Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 6/235 (2%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + D + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIVR +V+ + L +V E+ G + + F QL+ G+ +CHS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251
D+WS G + P + + K I R+ + LP
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-47
Identities = 51/229 (22%), Positives = 86/229 (37%), Gaps = 9/229 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L + + + Q+ SG++Y M
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ ++ + + APE L
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
+ K +DVWS G+ L + + + R
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (402), Expect = 4e-47
Identities = 56/245 (22%), Positives = 100/245 (40%), Gaps = 16/245 (6%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D ++ + IG+G FG L K E VA+K ++ G +K + E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 132
HPN++ + V+ T + I+ E+ G L N G+F+ + + + +G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 186
M HRDL N L++ + K+ DFG S+ S ++ + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRISIPEIRNHEW 245
PE + +++ +DVWS G+ ++ ++ G P+ D +P +
Sbjct: 202 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260
Query: 246 FLKNL 250
L L
Sbjct: 261 ALHQL 265
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-46
Identities = 67/275 (24%), Positives = 107/275 (38%), Gaps = 16/275 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYI---ERGDKIDENVQREIINHRSL-- 74
+YE V +IG G +G RD K VA+K + + + + RE+ R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 75 -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247
EVLL+ Y D+WS G M F + K + I +P + +
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282
+ + D D +++ +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-46
Identities = 47/229 (20%), Positives = 90/229 (39%), Gaps = 9/229 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L + + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
+ K +DVWS G+ L ++ + + R ++
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 7e-46
Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 17/243 (6%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKID----ENVQR 66
+ + L+ +G G+FGV VAVK ++ ++ R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 125
E+ SL H N++R V+LTP + +V E A G L +R+ + G F + Q
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGT 181
+ G+ Y S + HRDL N LL +KI DFG + + + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEI 240
A+ APE L + + +D W GVTL+ M G P+ + K
Sbjct: 178 FAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236
Query: 241 RNH 243
Sbjct: 237 PED 239
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 9e-46
Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 12/233 (5%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 132
HP+IV+ VI T + I+ME + GEL + + QL + ++Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
S + HRD+ N L+ + +K+ DFG S+ + K++ ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
+ + +DVW GV ++ +L+ + + I + +
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-45
Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 16/234 (6%)
Query: 21 DRYELV-RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR 75
D + ++G GNFG R R +K + VA+K +++G + E + RE L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
+P IVR V L +VME A GG L + + Q+ G+ Y
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N LL + I DFG SK ++ + + APE +
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 191 LKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
+++ + +DVWS GVT++ L G P++ + P+ I + E
Sbjct: 185 NFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPE 236
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-45
Identities = 59/234 (25%), Positives = 93/234 (39%), Gaps = 19/234 (8%)
Query: 21 DRYELV---RDIGSGNFGVARL--MRDKKTEELVAVKYIERG---DKIDENVQREIINHR 72
DR L +++GSGNFG + + KK + VAVK ++ + + + E +
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 64 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 188
HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML-VGAYPFE--DPEEPKNFRKTIHRISIPE 239
+ ++ K +DVWS GV ++ G P+ E + R+ P
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 233
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-45
Identities = 55/260 (21%), Positives = 92/260 (35%), Gaps = 38/260 (14%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYI--ERGDKIDENVQREIINH 71
+ E + +GSG FG + VAVK + + E + E+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 108
L H NIV + ++ EY G+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 109 -CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ + ++ F Q+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 168 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPE 223
S + + ++APE L + Y K +DVWS G+ L+ + +G P+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 224 EPKNFRKTIHRISIPEIRNH 243
NF K I + +
Sbjct: 272 VDANFYKLIQNGFKMDQPFY 291
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-44
Identities = 57/270 (21%), Positives = 109/270 (40%), Gaps = 13/270 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L ++ + G I + ++D +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS + HRDLK N ++ LKI DFG ++ + V T Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251
+ + D+WS G + +L G F + + + + P +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281
+ + T + + + + + ++
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-43
Identities = 66/269 (24%), Positives = 118/269 (43%), Gaps = 11/269 (4%)
Query: 21 DRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHR 72
+ +EL++ +G+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 73 SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+R P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ H + + +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 192 -KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250
K D WS GV +Y +L GA PF E + + RI E +
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279
DL+ + + + DEI +
Sbjct: 264 -KDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-43
Identities = 46/239 (19%), Positives = 89/239 (37%), Gaps = 13/239 (5%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQRE 67
+ I+ +++ ++ ++ +GSG FG E V + K ++ + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
S+ +P++ R + LT T I G L + + Q+
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 184
G++Y ++ HRDL N L+ +KI DFG +K + + +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNH 243
+A E +L + Y + +DVWS GVT++ ++ D + +
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 7e-43
Identities = 55/243 (22%), Positives = 86/243 (35%), Gaps = 24/243 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKID--ENVQREIINHRSL 74
D + + IG GNFG R KK A+K ++ D + E+ L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 75 -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 117
HPNI+ +L + +EYA G L + + A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISI 237
++A E L Y +DVWS GV L+ ++ + + +
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 238 PEI 240
E
Sbjct: 245 LEK 247
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 7e-43
Identities = 56/258 (21%), Positives = 96/258 (37%), Gaps = 37/258 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYI--ERGDKIDENVQREIINHRS 73
+ E VRDIG G FG R + +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
+PNIV+ V + ++ EY + G+L E + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 114 ----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
S+ + + ++ PE + Y + +DVW+ GV L+ + +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 227 NFRKTIHRISIPEIRNHE 244
+ +I +
Sbjct: 250 EVIYYVRDGNILACPENC 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-42
Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 36/284 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ L IG G FG + + E VAVK ++ + EI LRH NI
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 80 VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+ F T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 136 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 182
+ HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 183 AYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISI 237
Y+APEVL +K K AD+++ G+ + + E+ +++
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED--------YQLPY 228
Query: 238 PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 281
++ + ++ + +V + Q +++ + +I+
Sbjct: 229 YDLVPSDPSVEEM-RKVVCEQKLRPNIPNRWQSCEALRVMAKIM 271
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-41
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 15/227 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
RY+ ++ IGSG G+ D + VA+K + R + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
NI+ V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIP 238
Y + D+WS G + M+ F + + K I ++ P
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 54/242 (22%), Positives = 91/242 (37%), Gaps = 18/242 (7%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDE--NVQRE 67
+ I S IG G+FG L+ + + AVK + R I E E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 68 IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 125
I + HPN++ + L + +V+ Y G+L + + F Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
+ G+ + S + HRDL N +LD +K+ DFG ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---HRISI 237
++A E L +++ K +DVWS GV L+ ++ P + + R+
Sbjct: 197 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255
Query: 238 PE 239
PE
Sbjct: 256 PE 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-40
Identities = 51/237 (21%), Positives = 88/237 (37%), Gaps = 14/237 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG K + E VA+K ++ G +K + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 131
H NI+R + VI + I+ EY G L + + G FS + + + +G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 187
Y +M HRDL N L++ + K+ DFG S+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244
E + +++ +DVWS G+ ++ ++ K I+
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-39
Identities = 49/238 (20%), Positives = 81/238 (34%), Gaps = 32/238 (13%)
Query: 19 DSDRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
+R + +G+G FG A + VAVK ++ + E + E+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 112
L H NIV ++ EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
++ F Q+ G+++ S HRDL N LL KICDFG ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198
Query: 173 SQPKST---VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
S ++APE + Y + +DVWS G+ L+ + +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-38
Identities = 49/252 (19%), Positives = 90/252 (35%), Gaps = 28/252 (11%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-------LVAVKYI--ERGDKIDENVQREII 69
DR L + +G G FG L ++ VAVK + + +K ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 70 NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 112
+ + +H NI+ L +++EYAS G L E +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 171
+ S + Q+ G+ Y S + HRDL N L+ ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
+ + + ++APE L + Y + +DVWS GV L+ + + K
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 232 IHRISIPEIRNH 243
+ + ++
Sbjct: 250 LKEGHRMDKPSN 261
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-37
Identities = 43/245 (17%), Positives = 94/245 (38%), Gaps = 23/245 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKIDE--NVQREIINH 71
++ + R++G G+FG+ K + E VA+K + + E E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 121
+ ++VR V+ ++ME + G+L + + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIP 238
+ +++PE L + DVWS GV L+ + A + + + +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254
Query: 239 EIRNH 243
+ ++
Sbjct: 255 DKPDN 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-36
Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 32/254 (12%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDEN---VQREIIN 70
DR +L + +G G FG ++ VAVK ++ G E+ + I
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 71 HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 113
H N+V P L +++E+ G L + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 114 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + + Q+ G+ + S + HRDL N LL +KICDFG ++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFR 229
+ + ++APE + + Y + +DVWS GV L+ + A P+ + + F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 230 KTIHRISIPEIRNH 243
+ + + ++
Sbjct: 248 RRLKEGTRMRAPDY 261
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (321), Expect = 8e-35
Identities = 59/275 (21%), Positives = 104/275 (37%), Gaps = 26/275 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
RY LVR +G G+F L +D VA+K + E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 82 ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 125
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 126 LISGVSYCHSMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
L+ G+ Y H + H D+K EN L++ SP ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRN 242
Y +PEVLL + AD+WS ++ ++ G + FE E + H I E+
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL-- 250
Query: 243 HEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEI 277
L LP+ L+ + F +++I ++
Sbjct: 251 ----LGELPSYLLRNGKYTRTFFNSRGLLRNISKL 281
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.4 bits (174), Expect = 2e-15
Identities = 29/202 (14%), Positives = 57/202 (28%), Gaps = 39/202 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------DKIDENVQREIINH 71
+ + +G G +K E VK+ + G D D + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 72 RSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
+ + + + + + A++ME R + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
V+ + + H DL N L+ + I DF SV + +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP---QSVEVGEEGW----REILER 163
Query: 188 EVL-----LKKEYDGKIADVWS 204
+V + Y D+ S
Sbjct: 164 DVRNIITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 330 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.88 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 90.65 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 87.41 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 83.6 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 83.03 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 81.38 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 80.73 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=390.10 Aligned_cols=250 Identities=33% Similarity=0.577 Sum_probs=201.4
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 67999999999999999999999999999999987643 2345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC---CCC
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 175 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~---~~~ 175 (330)
|+||+|.+++..++.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+..... ...
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCccccc
Confidence 999999999988889999999999999999999999999999999999999987764 999999999754322 223
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
...+||+.|+|||++.+..++++++|||||||++|+|+||+.||................... ..+| ..++++ .
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---~~~~--~~~s~~-~ 236 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---LNPW--KKIDSA-P 236 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---STTG--GGSCHH-H
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---CCcc--ccCCHH-H
Confidence 456899999999999988887777999999999999999999998765443333322221110 0111 122222 2
Q ss_pred ccccccCCCCCCCCccCCHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.+.++...+|.+|+ |++|+++
T Consensus 237 ~~li~~~L~~dP~~R~-t~~eil~ 259 (271)
T d1nvra_ 237 LALLHKILVENPSARI-TIPDIKK 259 (271)
T ss_dssp HHHHHHHSCSSTTTSC-CHHHHTT
T ss_pred HHHHHHHcCCChhHCc-CHHHHhc
Confidence 2344555667788876 8888865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=380.26 Aligned_cols=244 Identities=30% Similarity=0.554 Sum_probs=205.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+. ......+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 6799999999999999999999999999999998743 334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
|||+||+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.... ....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRRT 162 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCCE
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Cccc
Confidence 99999999999998899999999999999999999999999999999999999987764 99999999975433 3345
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccCCcccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 255 (330)
...||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..+... +..| ..++. ..
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p---------~~~s~-~~ 231 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP---------DFVTE-GA 231 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC---------TTSCH-HH
T ss_pred ccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---------ccCCH-HH
Confidence 5679999999999998887655 99999999999999999999887665555544322 1111 22222 23
Q ss_pred ccccccCCCCCCCCccCCHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.+.++...+|.+|+ |++|+++
T Consensus 232 ~~li~~~L~~dp~~R~-t~~eil~ 254 (263)
T d2j4za1 232 RDLISRLLKHNPSQRP-MLREVLE 254 (263)
T ss_dssp HHHHHHHTCSSGGGSC-CHHHHHT
T ss_pred HHHHHHHccCCHhHCc-CHHHHHc
Confidence 3445556667788876 9999886
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=379.19 Aligned_cols=248 Identities=28% Similarity=0.450 Sum_probs=204.9
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
++|++++.||+|+||+||+|.+..+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+++.+|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 68999999999999999999999999999999987654 33467899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCcc
Q 020133 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~~ 178 (330)
+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+..... ......
T Consensus 100 ~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp TTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCC
T ss_pred CCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeecccccccccc
Confidence 99999998765 57999999999999999999999999999999999999987764 999999999865433 334566
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDN 258 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (330)
+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+.......+..... +.... ...++. ...+.
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~----~~~~s~-~~~~l 249 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQN----PEKLSA-IFRDF 249 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCSS----GGGSCH-HHHHH
T ss_pred ccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCCC----cccCCH-HHHHH
Confidence 79999999999988887655 9999999999999999999988776666555543221 11111 112222 23344
Q ss_pred cccCCCCCCCCccCCHHHHHH
Q 020133 259 TTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 259 ~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.++...+|.+|+ |++|+++
T Consensus 250 i~~~L~~dP~~R~-s~~eil~ 269 (293)
T d1yhwa1 250 LNRCLDMDVEKRG-SAKELLQ 269 (293)
T ss_dssp HHHHTCSSTTTSC-CHHHHTT
T ss_pred HHHHccCChhHCc-CHHHHhc
Confidence 5556667788876 8998875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-54 Score=385.50 Aligned_cols=252 Identities=32% Similarity=0.558 Sum_probs=189.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
++|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 67999999999999999999999999999999987643 2335678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC-CCCCceEEeecCCcccccCCCCCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
|+||+|.+++.+.+.+++.++..++.||+.||.|||++||+||||||+||++.. +..+.+||+|||+|+..........
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 168 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 168 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence 999999999999889999999999999999999999999999999999999953 2234699999999986655555567
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcccccc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.......+......... -....++++ +.+
T Consensus 169 ~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~-~~~ 242 (307)
T d1a06a_ 169 ACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS----PYWDDISDS-AKD 242 (307)
T ss_dssp ----CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT----TTTTTSCHH-HHH
T ss_pred eeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC----ccccCCCHH-HHH
Confidence 789999999999988887655 99999999999999999999987766655555532211100 011222222 234
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ |++|+++
T Consensus 243 li~~~L~~dP~~R~-s~~eil~ 263 (307)
T d1a06a_ 243 FIRHLMEKDPEKRF-TCEQALQ 263 (307)
T ss_dssp HHHHHSCSSGGGSC-CHHHHHH
T ss_pred HHHHHccCCHhHCc-CHHHHhc
Confidence 44555556777776 8888875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-52 Score=377.18 Aligned_cols=248 Identities=30% Similarity=0.540 Sum_probs=205.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
+.|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999999999999999999753 234467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
|||+|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+... ....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~--~~~~ 159 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVP--DVTY 159 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECS--SCBC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEec--cccc
Confidence 99999999999999999999999999999999999999999999999999999987764 9999999997543 2334
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC-ChhHHhcCchhhccCCcccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-SIPEIRNHEWFLKNLPADLV 255 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 255 (330)
..+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+......++.... ..|. .+.+. ..+++
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~-----~~s~~-~~~li 232 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP-----FFNED-VKDLL 232 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT-----TSCHH-HHHHH
T ss_pred cccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC-----CCCHH-HHHHH
Confidence 5789999999999988888765 999999999999999999999877766666655431 1111 11111 12344
Q ss_pred ccccccCCCCCCCCccCCHHHHHH
Q 020133 256 VDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 256 ~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
..++..++.+++..++++++++++
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhhhCHHhccccchhhHHHHHc
Confidence 555555555555445578898875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-53 Score=387.48 Aligned_cols=211 Identities=31% Similarity=0.555 Sum_probs=188.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
++|++++.||+|+||+||+|++..+|+.||||++..... ..+.+.+|+.++++++||||+++++++.+++.+|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 689999999999999999999999999999999976543 2456889999999999999999999999999999999999
Q ss_pred CCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcc
Q 020133 100 SGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~ 178 (330)
+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+...........
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence 9999999985 456799999999999999999999999999999999999997655557999999999866665556677
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..+.
T Consensus 186 ~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 186 TGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp CSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 89999999999998887655 999999999999999999998877665555544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=373.93 Aligned_cols=252 Identities=32% Similarity=0.567 Sum_probs=209.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-------cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.++++++||||+++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 368999999999999999999999999999999987532 2246789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCC--CceEEeecCCccccc
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 170 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~--~~vkL~Dfg~a~~~~ 170 (330)
|+|||||+||+|.+++..++.+++..++.++.|++.||.|||++||+||||||+||+++.++. ..+||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999999999998889999999999999999999999999999999999999976543 359999999998766
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC-ChhHHhcCchhhcc
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-SIPEIRNHEWFLKN 249 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (330)
.........+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..+.... ..+.. +...
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~ 242 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE-----YFSN 242 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH-----HHTT
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch-----hcCC
Confidence 6656667789999999999988777655 999999999999999999999877766666554331 11111 1122
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
++. ...+.+.++...+|.+|+ |++|+++
T Consensus 243 ~s~-~~~~li~~~L~~dP~~R~-s~~eil~ 270 (293)
T d1jksa_ 243 TSA-LAKDFIRRLLVKDPKKRM-TIQDSLQ 270 (293)
T ss_dssp SCH-HHHHHHHTTSCSSGGGSC-CHHHHHH
T ss_pred CCH-HHHHHHHHHccCChhHCc-CHHHHhc
Confidence 222 223344555667777776 8999876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=375.79 Aligned_cols=243 Identities=28% Similarity=0.456 Sum_probs=199.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
.++|++++.||+|+||+||+|.++.+|+.||||++.+. ....+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999998753 23446789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC---
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 172 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~--- 172 (330)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCcc
Confidence 999999999999999899999999999999999999999999999999999999987765 999999999755332
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccCC
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 251 (330)
......+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+......++... +..| ..++
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p---------~~~s 234 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---------EKFF 234 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC---------TTCC
T ss_pred cccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC---------ccCC
Confidence 22345679999999999988887654 99999999999999999999987766665555432 1111 2222
Q ss_pred ccccccccccCCCCCCCCccCCHHH
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDE 276 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~e 276 (330)
++ ..+.+.++...+|.+|+ |++|
T Consensus 235 ~~-~~~li~~~L~~dP~~R~-t~~e 257 (288)
T d1uu3a_ 235 PK-ARDLVEKLLVLDATKRL-GCEE 257 (288)
T ss_dssp HH-HHHHHHTTSCSSGGGST-TSGG
T ss_pred HH-HHHHHHHHccCCHhHCc-CHHH
Confidence 22 23344555556777776 5555
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9e-53 Score=372.86 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=206.5
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc----ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC----e
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~----~ 91 (330)
.++|++.+.||+|+||+||+|.+..+|+.||||+++.... ....+.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4789999999999999999999999999999999976432 2346889999999999999999999998654 4
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
+|+||||++|++|.+++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence 8999999999999999999899999999999999999999999999999999999999987765 99999998864322
Q ss_pred C----CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 172 H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 172 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
. ......+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+......+.+.....+.....
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---- 238 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH---- 238 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS----
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc----
Confidence 2 23345679999999999988777655 99999999999999999999988777766666654333222111
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..++. .+.+.+.++...+|.+|++|++++.+.|.++
T Consensus 239 ~~~s~-~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 239 EGLSA-DLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SSCCH-HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCH-HHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 22332 2344556667788999999999999988764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.2e-53 Score=385.85 Aligned_cols=212 Identities=28% Similarity=0.494 Sum_probs=188.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.++++++||||++++++|.+++.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3679999999999999999999999999999999976543 235678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
|+||+|.+.+... .++++.+++.++.||+.||.|||++||+||||||+|||++....+.+||+|||+|+..........
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~ 187 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence 9999999887654 469999999999999999999999999999999999999855555799999999987666656666
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
..+|+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+....+..+.
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 241 (352)
T d1koba_ 188 TTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241 (352)
T ss_dssp ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred ccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 789999999999988888655 999999999999999999998877665555544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=383.47 Aligned_cols=202 Identities=32% Similarity=0.518 Sum_probs=180.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
..++|++++.||+|+||+||+|++..+|+.||+|+++... .....+.+|+.++++++||||++++++|.+++.+|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999999999999999997643 33467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++. +||+|||+|+.... ...
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~ 160 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 160 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-Ccc
Confidence 999999999999988899999999999999999999997 59999999999999987764 99999999974432 233
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
.+.+||+.|+|||++.+..++.+ +|||||||++|||++|+.||.+.+.
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 45689999999999999888766 9999999999999999999987554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=379.19 Aligned_cols=252 Identities=23% Similarity=0.418 Sum_probs=208.4
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
.++|++.+.||+|+||+||+|.++.+|+.||+|.++........+.+|+.+++.++||||+++++++.+++.+|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 47899999999999999999999999999999999877655667889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCcc
Q 020133 100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (330)
Q Consensus 100 ~g~sL~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~~ 178 (330)
+|++|.+++...+ ++++.+++.++.||+.||.|||++||+||||||+|||++.+...++||+|||+++...........
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~ 163 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence 9999999998655 799999999999999999999999999999999999998766667999999999866555555666
Q ss_pred cCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccCCcccccc
Q 020133 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNLPADLVVD 257 (330)
Q Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 257 (330)
.+++.|+|||.+.+..++.+ +|||||||++|+|++|+.||.+.+....+..+... ...+... .+.++.+ ..+
T Consensus 164 ~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-----~~~~s~~-~~~ 236 (321)
T d1tkia_ 164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-----FKEISIE-AMD 236 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-----HTTSCHH-HHH
T ss_pred ccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh-----ccCCCHH-HHH
Confidence 79999999999988777654 99999999999999999999987776666665532 1221111 1112221 223
Q ss_pred ccccCCCCCCCCccCCHHHHHH
Q 020133 258 NTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 258 ~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+.++...+|.+|+ |++|+++
T Consensus 237 li~~~L~~dp~~R~-s~~eil~ 257 (321)
T d1tkia_ 237 FVDRLLVKERKSRM-TASEALQ 257 (321)
T ss_dssp HHHTTSCSSGGGSC-CHHHHHH
T ss_pred HHHHHccCChhHCc-CHHHHhc
Confidence 34444556666665 7888775
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=373.42 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=201.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEecc
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 99 (330)
+.|++++.||+|+||+||+|+++.+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57999999999999999999999999999999997643 34467889999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCc
Q 020133 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (330)
Q Consensus 100 ~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~ 177 (330)
+||+|.+++.+ .+++++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+..... .....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence 99999998765 457999999999999999999999999999999999999987765 999999998643322 22345
Q ss_pred ccCCCCCCChhhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc
Q 020133 178 TVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~-----~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (330)
..||+.|+|||++.. ..++ .++|||||||++|+|+||+.||.+.+....+.++..... +.+. ....++.
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~-~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-~~~~----~~~~~s~ 243 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-PTLA----QPSRWSS 243 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTT-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC-CCCS----SGGGSCH
T ss_pred cccccccCCHHHHhhcccCCCCCC-hhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCC----ccccCCH
Confidence 679999999999853 3344 459999999999999999999998777666666553321 1110 0112222
Q ss_pred cccccccccCCCCCCCCccCCHHHHHH
Q 020133 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+ +.+.+.++...+|.+|+ |++|+++
T Consensus 244 ~-~~~li~~~L~~dp~~R~-t~~ell~ 268 (288)
T d2jfla1 244 N-FKDFLKKCLEKNVDARW-TTSQLLQ 268 (288)
T ss_dssp H-HHHHHHHHSCSSTTTSC-CHHHHTT
T ss_pred H-HHHHHHHHccCChhHCc-CHHHHhc
Confidence 2 33445556667788876 8888875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=368.37 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=197.8
Q ss_pred CCe-EEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEe----CCeE
Q 020133 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (330)
Q Consensus 21 ~~y-~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~----~~~~ 92 (330)
+|| ++.++||+|+||+||+|.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.. +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 455 78889999999999999999999999999987643 223568899999999999999999999875 3468
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCcEEecC-CCCCceEEeecCCcccc
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 169 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIli~~-~~~~~vkL~Dfg~a~~~ 169 (330)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ++ .+||+|||+|+..
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~--~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLK 165 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGC
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC--CEEEeecCcceec
Confidence 999999999999999998889999999999999999999999999 999999999999964 44 4999999999743
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
. .......+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||........+.+.+.....|. .+.+.
T Consensus 166 ~-~~~~~~~~GT~~Y~aPE~~~~-~~~~-~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~-----~~~~~ 237 (270)
T d1t4ha_ 166 R-ASFAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-----SFDKV 237 (270)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-----GGGGC
T ss_pred c-CCccCCcccCccccCHHHhCC-CCCC-cCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc-----ccCcc
Confidence 2 223446689999999999865 4654 49999999999999999999987666655555443322111 12222
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+++ +.+.+.++...+|.+|+ |++|+++
T Consensus 238 ~~~~-~~~li~~~l~~dp~~R~-s~~ell~ 265 (270)
T d1t4ha_ 238 AIPE-VKEIIEGCIRQNKDERY-SIKDLLN 265 (270)
T ss_dssp CCHH-HHHHHHHHSCSSGGGSC-CHHHHHT
T ss_pred CCHH-HHHHHHHHccCCHhHCc-CHHHHhC
Confidence 2222 33455566667788776 8888864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=377.56 Aligned_cols=246 Identities=32% Similarity=0.567 Sum_probs=204.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||.||+|++..+|+.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6799999999999999999999999999999999753 234467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~ 175 (330)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... ....
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATM 162 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCB
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCccc
Confidence 99999999999999999999999999999999999999999999999999999987764 99999999985543 3344
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc-CChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 254 (330)
...+||+.|+|||++.+..++.+ +|+|||||++|||++|++||.+.+.......+... +..| +.++++
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p---------~~~s~~- 231 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---------RTLSPE- 231 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------TTSCHH-
T ss_pred ccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC---------ccCCHH-
Confidence 56789999999999999888665 99999999999999999999987766555554432 1111 122222
Q ss_pred cccccccCCCCCCCCccC----CHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQ----SIDEIMQ 279 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~----s~~el~~ 279 (330)
..+.+.++...+|.+|+. +++|+++
T Consensus 232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHhhccCCchhhcccccccHHHHHc
Confidence 223333344456666654 5777765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-52 Score=373.09 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=198.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----cHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
+|++++.||+|+||+||+|++..+|+.||||++...... .+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 599999999999999999999999999999999765432 2457899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCCc
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~~ 177 (330)
||.+|+|..++..++++++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... ...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~~ 170 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANS 170 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CCc
Confidence 9999999888888889999999999999999999999999999999999999987764 99999999975432 345
Q ss_pred ccCCCCCCChhhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 178 TVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~---~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
..||+.|+|||++.+. .++. ++|||||||++|+|++|+.||.+.+....+..+...... .. ....++ +.
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~-~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~-~~-----~~~~~s-~~ 242 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-AL-----QSGHWS-EY 242 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CC-----SCTTSC-HH
T ss_pred cccCccccCHHHHhccCCCCcCc-hhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-CC-----CCCCCC-HH
Confidence 6799999999998643 3444 499999999999999999999987776666655533211 11 111122 22
Q ss_pred cccccccCCCCCCCCccCCHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
+.+.+.++...+|.+|+ |++|+++
T Consensus 243 ~~~li~~~L~~dP~~Rp-t~~ell~ 266 (309)
T d1u5ra_ 243 FRNFVDSCLQKIPQDRP-TSEVLLK 266 (309)
T ss_dssp HHHHHHHHTCSSGGGSC-CHHHHTT
T ss_pred HHHHHHHHCcCChhHCc-CHHHHHh
Confidence 33444455556677665 8888775
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-51 Score=375.53 Aligned_cols=245 Identities=29% Similarity=0.508 Sum_probs=202.7
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 96 (330)
++|++++.||+|+||+||+|+++.+|+.||||++.+. ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 7899999999999999999999999999999998753 233467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCCC
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~~ 176 (330)
||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... ...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--~~~ 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RTW 196 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CBC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--ccc
Confidence 99999999999999899999999999999999999999999999999999999987764 99999999985432 334
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccccc
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADLVV 256 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
...||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+......++...... +...++++ +.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~--------~p~~~s~~-~~ 266 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--------FPSHFSSD-LK 266 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------CCTTCCHH-HH
T ss_pred cccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC--------CCccCCHH-HH
Confidence 5679999999999998888655 99999999999999999999987766655555433211 11222222 22
Q ss_pred cccccCCCCCCCCcc----CCHHHHHH
Q 020133 257 DNTTNNQFEEPDQPM----QSIDEIMQ 279 (330)
Q Consensus 257 ~~~~~~~~~~p~~~~----~s~~el~~ 279 (330)
+.+.++...+|.+|+ ++++++++
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHhhhCHHhccccccccHHHHHc
Confidence 333333445555554 68888875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-52 Score=372.95 Aligned_cols=258 Identities=21% Similarity=0.233 Sum_probs=210.4
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
...++|++.+.||+|+||+||+|.+..+|+.||||+++.+....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 34578999999999999999999999999999999998877777889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC-
Q 020133 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~- 174 (330)
||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCce
Confidence 99999999998754 57899999999999999999999999999999999999987764 99999999985443322
Q ss_pred -CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+++.|+|||++.+..++.+ +|||||||++|||++|..||........+.+.+.....+ -+...+|.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~------~~~~~~~~- 243 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM------ERPEGCPE- 243 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC------CCCTTCCH-
T ss_pred eeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC------CCCccchH-
Confidence 223457889999999988887655 999999999999999776665545555555544332111 11122333
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
.+.+.+.+++..+|.+|+ |++|+.+.|..+..
T Consensus 244 ~l~~li~~cl~~dP~~Rp-s~~ei~~~L~~~~~ 275 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRP-SFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHTTS
T ss_pred HHHHHHHHHcCCCHhHCc-CHHHHHHHHHHHHH
Confidence 234455666678888876 99999999887643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=367.26 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=189.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEe--CCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~--~~~~~l 94 (330)
.++|++++.||+|+||+||+|+++.+|+.||+|.+...... .+.+.+|+.++++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999999999999999998765432 3467899999999999999999999965 456899
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhcC-----ccccCCCCCcEEecCCCCCceEEeecCC
Q 020133 95 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGY 165 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivH~dikp~NIli~~~~~~~vkL~Dfg~ 165 (330)
|||||+||+|.+++.+ ++.+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~ 160 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL 160 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccc
Confidence 9999999999998864 457999999999999999999999976 999999999999987764 99999999
Q ss_pred cccccCCC-CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 166 SKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 166 a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
|+...... ......||+.|+|||++.+..++.+ +|||||||++|||+||+.||.+.+......++... ..+
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~------ 232 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFR------ 232 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCC------
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCC------
Confidence 97554332 3345689999999999988877655 99999999999999999999987765554444322 111
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.+...++. .+.+.+.++...+|.+|+ |++|+++
T Consensus 233 ~~~~~~s~-~l~~li~~~L~~dp~~Rp-s~~ell~ 265 (269)
T d2java1 233 RIPYRYSD-ELNEIITRMLNLKDYHRP-SVEEILE 265 (269)
T ss_dssp CCCTTSCH-HHHHHHHHHTCSSGGGSC-CHHHHHT
T ss_pred CCCcccCH-HHHHHHHHHcCCChhHCc-CHHHHHh
Confidence 11122222 233445556667788875 9998874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-52 Score=363.81 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=198.2
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
+++++|++.+.||+|+||+||+|.+. +++.||||+++......+.+.+|+..+++++||||+++++++..++..|+|||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 45689999999999999999999986 46789999998877777889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--
Q 020133 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-- 174 (330)
|+++|+|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+|+.......
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCcee
Confidence 99999999988754 56899999999999999999999999999999999999987765 99999999975443322
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....||+.|+|||++.+..++.+ +|||||||++|||+| |++||...+.......+..... +.....+++
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-------~~~p~~~~~- 229 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------LYKPRLAST- 229 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-------CCCCTTSCH-
T ss_pred ecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-------CCCccccCH-
Confidence 234568999999999988887655 999999999999999 5666766555444444332211 111122222
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+.+.+.+++..+|.+|+ |++|+++.|+++
T Consensus 230 ~l~~li~~cl~~~p~~Rp-s~~~il~~L~~i 259 (263)
T d1sm2a_ 230 HVYQIMNHCWKERPEDRP-AFSRLLRQLAEI 259 (263)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCc-CHHHHHHHHHHH
Confidence 334455566667888876 999999988875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-51 Score=361.88 Aligned_cols=250 Identities=29% Similarity=0.421 Sum_probs=205.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc----------cHHHHHHHHHHHcCC-CCCeeeeeEEEEeC
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLR-HPNIVRFKEVILTP 89 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~ 89 (330)
++|++.+.||+|+||+||+|++..+|+.||||++.+.... .+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999999999999999999765321 235789999999997 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 90 ~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
+..|+||||++||+|.+++..++++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEc
Confidence 999999999999999999999999999999999999999999999999999999999999987765 999999999876
Q ss_pred cCCCCCCcccCCCCCCChhhhhcC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC-ChhHHhcC
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-SIPEIRNH 243 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 243 (330)
..........||+.|+|||.+.+. ...+.++||||+||++|+|++|+.||.+.+.......+.... ..+..
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 237 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP--- 237 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc---
Confidence 665556667899999999998642 222445999999999999999999999887766665555432 11100
Q ss_pred chhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 244 EWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
....++++ +.+.+.++...+|.+|+ |++|+++
T Consensus 238 --~~~~~s~~-~~~li~~~L~~~p~~R~-s~~eil~ 269 (277)
T d1phka_ 238 --EWDDYSDT-VKDLVSRFLVVQPQKRY-TAEEALA 269 (277)
T ss_dssp --TGGGSCHH-HHHHHHHHCCSSGGGSC-CHHHHTT
T ss_pred --ccccCCHH-HHHHHHHHccCChhHCc-CHHHHHc
Confidence 11223332 33445556667777777 8888764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=374.17 Aligned_cols=261 Identities=31% Similarity=0.453 Sum_probs=198.7
Q ss_pred CCCCcccCCCCeEEec-eeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHc-CCCCCeeeeeEEEEe-
Q 020133 12 MDMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILT- 88 (330)
Q Consensus 12 ~~~~~~~~~~~y~i~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~-l~h~~Iv~~~~~~~~- 88 (330)
+++......++|+++. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ ++||||++++++|.+
T Consensus 2 ~~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CCCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccCCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 3444433347899875 599999999999999999999999998653 567889988654 589999999999976
Q ss_pred ---CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCC-CCceEEee
Q 020133 89 ---PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICD 162 (330)
Q Consensus 89 ---~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~-~~~vkL~D 162 (330)
+..+|+|||||+||+|.+++.+. ..+++.+++.++.||+.||.|||++||+||||||+|||++.+. .+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 35689999999999999999864 3699999999999999999999999999999999999997533 34699999
Q ss_pred cCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhc
Q 020133 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRN 242 (330)
Q Consensus 163 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (330)
||+|+...........+||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+.......+..+........
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 999987666666677889999999999988877655 9999999999999999999987654443333333222111111
Q ss_pred CchhhccCCccccccccccCCCCCCCCccCCHHHHHH
Q 020133 243 HEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQ 279 (330)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~ 279 (330)
.......++++ ..+.+.++...+|.+|+ |+.|+++
T Consensus 237 ~~~~~~~~s~~-~~~li~~~L~~dP~~R~-s~~eil~ 271 (335)
T d2ozaa1 237 PNPEWSEVSEE-VKMLIRNLLKTEPTQRM-TITEFMN 271 (335)
T ss_dssp CTTHHHHSCHH-HHHHHHHHSCSSTTTSC-CHHHHHH
T ss_pred CCcccccCCHH-HHHHHHHHccCChhHCc-CHHHHHc
Confidence 11111122222 22334445557777776 8888876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=356.17 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=209.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+.+.|+++++||+|+||+||+++++ +++.||||.++......+.+.+|+..+++++||||+++++++.+++.+++||||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 4678999999999999999999985 688899999998877778999999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--C
Q 020133 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (330)
Q Consensus 99 ~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~--~ 175 (330)
+++|+|.+++.. ...+++..++.++.|+++||.|||++||+||||||+||+++.++. +||+|||+|+....... .
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceee
Confidence 999999998654 457999999999999999999999999999999999999987765 99999999975443322 2
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....+|+.|+|||.+.+..++.+ +|||||||++|||+| |+.||.+.+.......+......+ .....+ ..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------~p~~~~-~~ 229 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------RPHLAS-EK 229 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-------CCTTCC-HH
T ss_pred cccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC-------Cccccc-HH
Confidence 34568899999999998887655 999999999999998 899999888766555554322111 112222 23
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+.+.+.+++..+|.+|+ |++|+++.|.+
T Consensus 230 l~~li~~cl~~dP~~RP-t~~eil~~L~d 257 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERP-TFKILLSNILD 257 (258)
T ss_dssp HHHHHHHTTCSSGGGSC-CHHHHHHHHHC
T ss_pred HHHHHHHHccCCHhHCc-CHHHHHHHhhC
Confidence 44556666777888876 99999988754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-51 Score=365.92 Aligned_cols=255 Identities=20% Similarity=0.342 Sum_probs=195.6
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCc---EEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~ 93 (330)
..++|++.+.||+|+||+||+|.+..+++ .||||.+.... ...+.+.+|+.++++++|||||++++++..++.+|
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 35789999999999999999999987654 58899876543 23457899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
+|||||++|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCC
Confidence 999999999999988764 57999999999999999999999999999999999999987765 999999999754332
Q ss_pred CCC------CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCch
Q 020133 173 SQP------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEW 245 (330)
Q Consensus 173 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
... ....+|+.|+|||.+.+..++.+ +|||||||++|||+| |+.||.+.+.......+......+.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------ 254 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP------ 254 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 221 22357889999999988877655 999999999999998 8999998776655555443322111
Q ss_pred hhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 246 FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
...+|. .+.+.+.+|+..+|.+|+ |+.|+++.|.++-
T Consensus 255 -~~~~~~-~l~~li~~cl~~~P~~RP-s~~ei~~~L~~~l 291 (299)
T d1jpaa_ 255 -PMDCPS-ALHQLMLDCWQKDRNHRP-KFGQIVNTLDKMI 291 (299)
T ss_dssp -CTTCCH-HHHHHHHHHTCSSTTTSC-CHHHHHHHHHHHH
T ss_pred -CccchH-HHHHHHHHHcCCCHhHCc-CHHHHHHHHHHHh
Confidence 112222 234455666778888886 9999999887753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-50 Score=371.60 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=194.3
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC----cccHHHHH---HHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQR---EIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~---ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. .....+.+ ++.+++.++||||+++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999999999999999986432 12223334 46677778899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC
Q 020133 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~ 172 (330)
|+|||||+||+|.+++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC
Confidence 999999999999999999899999999999999999999999999999999999999987765 999999999754432
Q ss_pred CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc
Q 020133 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (330)
.....+||+.|+|||++.+....+.++|||||||++|+|+||+.||.+.+...... +........ +-+...+++
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~----~~~~~~~s~ 234 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA----VELPDSFSP 234 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCC----CCCCSSSCH
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCC----CCCCCCCCH
Confidence 34556899999999999765444455999999999999999999998754432221 111110000 001112222
Q ss_pred cccccccccCCCCCCCCccCC----HHHHHH
Q 020133 253 DLVVDNTTNNQFEEPDQPMQS----IDEIMQ 279 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s----~~el~~ 279 (330)
+ +.+.+.++...+|.+|+.+ ++|+++
T Consensus 235 ~-~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 235 E-LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp H-HHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred H-HHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 2 2334445555677777754 777764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=363.18 Aligned_cols=209 Identities=35% Similarity=0.583 Sum_probs=183.3
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC----CcccHHHHHHHHHHH-cCCCCCeeeeeEEEEeCCeEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~ei~~l~-~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
++|++++.||+|+||+||+|.++.+|+.||||++++. ....+.+.+|+.++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999999999999999999753 233345666776654 68999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-C
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~ 174 (330)
|||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence 999999999999999899999999999999999999999999999999999999987764 9999999997554333 3
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....||+.|+|||++.+..++.+ +|||||||++|+|+||+.||.+.+....+.++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 216 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 216 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 345679999999999998888765 999999999999999999999877666555543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=359.28 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=200.9
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
...++|++.+.||+|+||+||+|.++ +++.||||+++......+.+.+|+.++++++|||||++++++.+ +..|+|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 34578999999999999999999985 57889999998877777889999999999999999999998754 56799999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--
Q 020133 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (330)
Q Consensus 98 ~~~g~sL~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-- 173 (330)
|+++|+|.+++... .++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCccc
Confidence 99999999877543 36999999999999999999999999999999999999987765 9999999998554322
Q ss_pred CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCc
Q 020133 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPA 252 (330)
Q Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (330)
......+|+.|+|||++.+..++.+ +|||||||++|||+|| .+||...+.......+...... .....+|.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-------~~p~~~~~ 237 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------VRPDNCPE 237 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------CCCTTCCH
T ss_pred cccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-------CCcccChH
Confidence 2344578899999999988777654 9999999999999995 5555554444444333322111 11122333
Q ss_pred cccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 253 DLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 253 ~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+ +.+.+.+++..+|.+|+ |++|+.+.|.+.
T Consensus 238 ~-l~~li~~cl~~~P~~Rp-t~~ei~~~L~~~ 267 (272)
T d1qpca_ 238 E-LYQLMRLCWKERPEDRP-TFDYLRSVLEDF 267 (272)
T ss_dssp H-HHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred H-HHHHHHHHcCCCHhHCc-CHHHHHHHhhhh
Confidence 2 34455666667888875 999999988764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=361.26 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=197.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv 95 (330)
..++|++.+.||+|+||+||+|+.. ..||||+++... ...+.+.+|+.++++++||||+++++++. .+.+|+|
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 4578999999999999999999753 459999986542 33467889999999999999999999875 4568999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC--
Q 020133 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-- 172 (330)
||||+||+|.+++... +++++..+..++.||++||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCC
Confidence 9999999999999754 57999999999999999999999999999999999999987765 999999999754322
Q ss_pred -CCCCcccCCCCCCChhhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcC-ChhHHhcCchhhc
Q 020133 173 -SQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-SIPEIRNHEWFLK 248 (330)
Q Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 248 (330)
.......||+.|+|||++.+.. ..+.++|||||||++|||+||+.||.+.+....+...+.+. ..|.... +..
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~---~~~ 236 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK---VRS 236 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG---SCT
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh---ccc
Confidence 2234557899999999996543 22455999999999999999999999877666665555432 1221111 112
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+|. .+.+.+.+++..+|.+|+ |++|+++.|..+
T Consensus 237 ~~~~-~l~~li~~cl~~dp~~RP-t~~~il~~Le~l 270 (276)
T d1uwha_ 237 NCPK-AMKRLMAECLKKKRDERP-LFPQILASIELL 270 (276)
T ss_dssp TCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred cchH-HHHHHHHHHcCCCHhHCc-CHHHHHHHHHHH
Confidence 2332 233455566667788876 999999888765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=361.87 Aligned_cols=208 Identities=26% Similarity=0.391 Sum_probs=179.2
Q ss_pred EeceeccCCceEEEEEEECCCCcEEEEEEeecCCc------ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 25 i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++.||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46889999999999999999999999999865422 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCCc
Q 020133 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (330)
Q Consensus 99 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~~ 177 (330)
+.|+++..+...+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+..... .....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence 999888777776778999999999999999999999999999999999999987764 999999999755433 33445
Q ss_pred ccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
.++|+.|+|||++.+....+.++|||||||++|+|+||+.||.+.+..+.+.++...
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~ 216 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHh
Confidence 689999999999976665566699999999999999999999988887777766643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=355.96 Aligned_cols=200 Identities=31% Similarity=0.491 Sum_probs=175.6
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-------ccHHHHHHHHHHHcCC--CCCeeeeeEEEEeCC
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTPT 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~ei~~l~~l~--h~~Iv~~~~~~~~~~ 90 (330)
.++|++.+.||+|+||+||+|++..+|+.||||++.+... ....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 3789999999999999999999999999999999875321 1234678999999886 899999999999999
Q ss_pred eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 91 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 91 ~~~lv~e~~~g-~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
..|+||||+.+ +++.+++.+++.+++.+++.++.||+.||.|||++||+||||||+|||++.+. +.+||+|||+|+..
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceec
Confidence 99999999975 67888888888999999999999999999999999999999999999998553 25999999999743
Q ss_pred cCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 020133 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (330)
Q Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~ 221 (330)
. ........||+.|+|||++.+..+.++++|||||||++|+|+||+.||..
T Consensus 162 ~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 162 K-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp C-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred c-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 3 23345568999999999998888777778999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=364.76 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=201.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCc-----EEEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~--~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||+||+|++..+++ .||+|.+... ......+.+|+.+++++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34789999999999999999999876543 6999988653 33456789999999988 8999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCc
Q 020133 91 HLAIVMEYASGGELFERICNA-----------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~-----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~N 147 (330)
..|+|||||++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999999999999754 248999999999999999999999999999999999
Q ss_pred EEecCCCCCceEEeecCCcccccCCCCC---CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 020133 148 TLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (330)
Q Consensus 148 Ili~~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~ 223 (330)
||++.++. +||+|||+|+........ ....+|+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+
T Consensus 195 ill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 195 VLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp EEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCCC
Confidence 99987764 999999999755443322 34457999999999988887655 999999999999998 899999877
Q ss_pred hhhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHH
Q 020133 224 EPKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIA 282 (330)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~ 282 (330)
....+.+++.....++ ....++. .+.+.+.+++..+|.+|+ |++|+++.|.
T Consensus 272 ~~~~~~~~~~~~~~~~------~p~~~~~-~l~~li~~cl~~dP~~RP-t~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDANFYKLIQNGFKMD------QPFYATE-EIYIIMQSCWAFDSRKRP-SFPNLTSFLG 322 (325)
T ss_dssp CSHHHHHHHHTTCCCC------CCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCC------CCCcCCH-HHHHHHHHHcCCChhHCc-CHHHHHHHHh
Confidence 6666666654321111 1112222 233445555667777774 9999998875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=354.36 Aligned_cols=211 Identities=30% Similarity=0.447 Sum_probs=181.2
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++++.||+|+||+||+|.+..+|+.||||+++... ...+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999999999999999986542 345788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC-CCCC
Q 020133 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~-~~~~ 175 (330)
|+.++.+...... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.... ....
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence 9976544433333 456999999999999999999999999999999999999987764 99999999975433 3344
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
....||+.|+|||++....+.+.++|+|||||++|+|++|+.||.+.+....+.++..
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 5568999999999998888777779999999999999999999998877766666553
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=353.47 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=201.1
Q ss_pred ccCCCCeEEece-eccCCceEEEEEEECC--CCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 17 MHDSDRYELVRD-IGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 17 ~~~~~~y~i~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
.+..++|.+.+. ||+|+||+||+|.++. ++..||||.++.... ..+.+.+|+.++++++|||||++++++.. +.
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 345578999985 9999999999998764 455799999876432 34678999999999999999999999875 45
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
+|+||||+++|+|.+++.. ++.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccc
Confidence 8999999999999998765 457999999999999999999999999999999999999987764 9999999997543
Q ss_pred CCC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCch
Q 020133 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEW 245 (330)
Q Consensus 171 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
... ......+|+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+.......+..... +-
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-------~~ 232 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------ME 232 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-------CC
T ss_pred ccccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------CC
Confidence 322 2234568899999999988877655 999999999999998 9999998776554444432211 11
Q ss_pred hhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 246 FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
+.+.+|.+ +.+.+.+|+..+|.+|+ ++.++.+.|+..
T Consensus 233 ~p~~~~~~-l~~li~~cl~~~p~~RP-s~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 CPPECPPE-LYALMSDCWIYKWEDRP-DFLTVEQRMRAC 269 (285)
T ss_dssp CCTTCCHH-HHHHHHHTTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CCCcCCHH-HHHHHHHHcCCCHhHCc-CHHHHHHHHHHH
Confidence 12233332 33455666667787775 899998887754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=354.15 Aligned_cols=259 Identities=20% Similarity=0.246 Sum_probs=195.9
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCC----cEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
..++|++.+.||+|+||.||+|....++ ..||||.+..... ....+.+|+.++++++|||||++++++.+.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 4578999999999999999999987654 4799999875432 234688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
++||||+.++++.+.+... +.+++.++..++.||+.||.|||+++|+||||||+|||++.++. +||+|||+|+....
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLED 162 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccC
Confidence 9999999999999887654 57999999999999999999999999999999999999987765 99999999975433
Q ss_pred CC----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhh
Q 020133 172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFL 247 (330)
Q Consensus 172 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
.. ......||+.|+|||++.+..++.+ +|||||||++|||++|..||........+.+.+.....++ ..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~------~~ 235 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP------TP 235 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------CC
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC------Cc
Confidence 22 1223457899999999988877655 9999999999999996555444333344444332211110 11
Q ss_pred ccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCCCC
Q 020133 248 KNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPA 288 (330)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~~ 288 (330)
..+| ..+.+.+.+|+..+|.+|+ ++.|+++.|.++...+
T Consensus 236 ~~~~-~~l~~li~~cl~~~p~~RP-t~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 236 MDCP-SAIYQLMMQCWQQERARRP-KFADIVSILDKLIRAP 274 (283)
T ss_dssp TTCB-HHHHHHHHHHTCSSTTTSC-CHHHHHHHHHHHHHSG
T ss_pred hhhH-HHHHHHHHHHCcCCHhHCc-CHHHHHHHHHHHhhCc
Confidence 1222 2244556666778888886 9999999888765443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=353.70 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=194.5
Q ss_pred CCeEEe-ceeccCCceEEEEEEEC--CCCcEEEEEEeecCCc---ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 21 DRYELV-RDIGSGNFGVARLMRDK--KTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 21 ~~y~i~-~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~---~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
..+.+. ++||+|+||+||+|... .+++.||||+++.... ..+.+.+|+.++++++||||+++++++..+ ..|+
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~l 84 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWML 84 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEE
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEE
Confidence 334444 47999999999999864 4567899999865432 245789999999999999999999998654 5789
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC
Q 020133 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~ 174 (330)
||||+++|+|.+++....++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.......
T Consensus 85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADEN 162 (277)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCS
T ss_pred EEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhcccccc
Confidence 9999999999999999899999999999999999999999999999999999999987764 99999999975433222
Q ss_pred ----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhcc
Q 020133 175 ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKN 249 (330)
Q Consensus 175 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (330)
.....||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+.......+..... +-+...
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-------~~~p~~ 234 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------MGCPAG 234 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------CCCCTT
T ss_pred ccccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-------CCCCcc
Confidence 233468899999999988877655 999999999999998 8999998776544443332111 111123
Q ss_pred CCccccccccccCCCCCCCCccCCHHHHHHHHHH
Q 020133 250 LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAE 283 (330)
Q Consensus 250 ~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~ 283 (330)
+|.+ +.+.+.+++..+|.+|+ |+.++.+.|+.
T Consensus 235 ~~~~-~~~li~~cl~~dp~~RP-s~~~i~~~L~~ 266 (277)
T d1xbba_ 235 CPRE-MYDLMNLCWTYDVENRP-GFAAVELRLRN 266 (277)
T ss_dssp CCHH-HHHHHHHHTCSSTTTSC-CHHHHHHHHHH
T ss_pred cCHH-HHHHHHHHcCCCHhHCc-CHHHHHHHhhC
Confidence 3332 33455666778888876 99999887765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=349.21 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=197.3
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEec
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
+.++|++.+.||+|+||.||+|.+..+ +.||||+++......+.+.+|+.++++++|||||++++++. ++.+|+||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 457899999999999999999999765 56999999877766788999999999999999999999985 4567999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC--C
Q 020133 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 174 (330)
Q Consensus 99 ~~g~sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~--~ 174 (330)
+++|+|..++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...... .
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC---------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCcee
Confidence 999999988754 357999999999999999999999999999999999999987764 9999999997543222 2
Q ss_pred CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCCChhhHHHHHhhcCChhHHhcCchhhccCCcc
Q 020133 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPAD 253 (330)
Q Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
.....+|+.|+|||++.+..++.+ +|||||||++|||+||..| |........+..+......+ ....++.
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-------~~~~~~~- 241 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------CPPECPE- 241 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------CCTTSCH-
T ss_pred eccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-------CCcccCH-
Confidence 234568999999999988887655 9999999999999996555 45444443443333322111 1122333
Q ss_pred ccccccccCCCCCCCCccCCHHHHHHHHHHhCCC
Q 020133 254 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 287 (330)
Q Consensus 254 ~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~~ 287 (330)
.+.+.+.+++..+|.+|+ +++++.+.|.+....
T Consensus 242 ~l~~li~~cl~~dP~~Rp-s~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERP-TFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHHHTCSSGGGSC-CHHHHHHHHHTTTSC
T ss_pred HHHHHHHHHcccCHhHCc-CHHHHHHHHhhhhcC
Confidence 233455566667777775 999999998876544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-48 Score=348.18 Aligned_cols=210 Identities=30% Similarity=0.449 Sum_probs=181.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|+++++||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+.++++++||||+++++++..++..|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 68999999999999999999996 78999999986642 335789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCC-CCCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~-~~~~ 176 (330)
++.++.+..+....+.+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||.|...... ....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence 9998887777777888999999999999999999999999999999999999987765 999999998754332 2334
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~ 233 (330)
...+++.|+|||.+.+..+.+.++|||||||++|||++|+.||.+.+....+.++..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~ 215 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 557899999999998777766779999999999999999999998877766666553
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=344.61 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=193.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCC---CcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~l 94 (330)
.++|++.+.||+|+||.||+|.+..+ +..||||.++.... ..+.+.+|+.++++++||||+++++++. ++.+|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 47899999999999999999998754 45688998865432 2456889999999999999999999985 567899
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 95 v~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
||||+++|+|.+++.. .+++++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+|+......
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCc
Confidence 9999999999998765 457999999999999999999999999999999999999987764 9999999997544322
Q ss_pred --CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccC
Q 020133 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNL 250 (330)
Q Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (330)
......+|+.|+|||++.+..++.+ +|||||||++|||+| |.+||.+.+.......+......+ +.+.+
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~-------~~~~~ 234 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------MPPNC 234 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------CCTTC
T ss_pred ceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------CCCCC
Confidence 2334567899999999988877655 999999999999998 899999877766665554332111 12233
Q ss_pred CccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 251 PADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 251 ~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
|. .+.+.+.+++..+|.+|+ |+.|+++.|.++
T Consensus 235 ~~-~~~~li~~cl~~dp~~Rp-s~~ei~~~L~~i 266 (273)
T d1mp8a_ 235 PP-TLYSLMTKCWAYDPSRRP-RFTELKAQLSTI 266 (273)
T ss_dssp CH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CH-HHHHHHHHHcCCCHhHCc-CHHHHHHHHHHH
Confidence 33 234555666778888886 999999888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=353.31 Aligned_cols=208 Identities=30% Similarity=0.446 Sum_probs=178.5
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeC------CeEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAI 94 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~~~~l 94 (330)
-+|+.+++||+|+||+||+|++..+|+.||||++...... ..+|+.++++++||||++++++|... .++|+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3699999999999999999999999999999999876533 34799999999999999999998643 35799
Q ss_pred EEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 95 VMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 95 v~e~~~g~sL~~~l---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
|||||+++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccC
Confidence 99999876443332 34567999999999999999999999999999999999999987653 599999999987666
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
........|++.|+|||.+.+....+.++|||||||++|||++|+.||...+....+.+++
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence 6666778899999999998776555566999999999999999999999888777666655
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=347.87 Aligned_cols=255 Identities=24% Similarity=0.290 Sum_probs=202.6
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCcE--EEEEEeecC--CcccHHHHHHHHHHHcC-CCCCeeeeeEEEEeCCeE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~--~~~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~~~ 92 (330)
++.++|++.+.||+|+||+||+|.++.+|.. ||||.+... ....+.+.+|+.+++++ +||||+++++++.+++..
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 3568999999999999999999999888764 677877543 23345789999999998 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCC
Q 020133 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~ 156 (330)
|+||||++||+|.++++++ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~- 165 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 165 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-
Confidence 9999999999999999754 56999999999999999999999999999999999999987764
Q ss_pred ceEEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCC-CCCCCCChhhHHHHHhhcC
Q 020133 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRI 235 (330)
Q Consensus 157 ~vkL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~-~pf~~~~~~~~~~~~~~~~ 235 (330)
+||+|||+|+............+|..|+|||.+.+..++.+ +|||||||++|||++|. +||.+.+.......+....
T Consensus 166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred -eEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999986655555556678999999999988887655 99999999999999965 6787766655554444321
Q ss_pred ChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 236 SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
..+ ....+++ .+.+.+.+++..+|.+|+ |+.|+++.|.++
T Consensus 244 ~~~-------~~~~~~~-~~~~li~~cl~~dP~~RP-s~~eil~~L~~i 283 (309)
T d1fvra_ 244 RLE-------KPLNCDD-EVYDLMRQCWREKPYERP-SFAQILVSLNRM 283 (309)
T ss_dssp CCC-------CCTTBCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CCC-------CCccCCH-HHHHHHHHHcCCChhHCc-CHHHHHHHHHHH
Confidence 111 1112222 234555666667888875 999999988775
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=345.84 Aligned_cols=211 Identities=30% Similarity=0.429 Sum_probs=178.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCC-CcEEEEEEeecC---CcccHHHHHHHHHHHcC---CCCCeeeeeEEEEe-----
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERG---DKIDENVQREIINHRSL---RHPNIVRFKEVILT----- 88 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~---~~~~~~~~~ei~~l~~l---~h~~Iv~~~~~~~~----- 88 (330)
++|++++.||+|+||+||+|++..+ ++.||||+++.. ......+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999765 677999998653 22234566788777655 79999999999863
Q ss_pred CCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 89 PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
....|++|||+.++++..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhh
Confidence 246899999999877754443 3456999999999999999999999999999999999999987664 9999999998
Q ss_pred cccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhc
Q 020133 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (330)
Q Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 234 (330)
............||+.|+|||++.+..++.+ +|||||||++|||+||+.||.+.+....+..++..
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 230 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 6665556667789999999999988888665 99999999999999999999988877777766543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=339.34 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=193.6
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEe-CCeEEEEEe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~-~~~~~lv~e 97 (330)
+.++|++.+.||+|+||.||+|..+ |..||||.++.+ ...+.+.+|+.++++++||||+++++++.+ ++.+|+|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 4478999999999999999999984 778999999654 345789999999999999999999999865 456899999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
|+++|+|.+++.+.+ .+++..++.++.||+.||.|||+.+|+||||||+||+++.++. +||+|||+++.... ..
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~--~~ 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQ 157 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC----------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--CC
Confidence 999999999986543 5999999999999999999999999999999999999987765 99999999974332 23
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCCccc
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLPADL 254 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (330)
....+++.|+|||++.+..++. ++|||||||++|||+| |++||...+.......+..... +-+...+++ .
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~-~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~-------~~~~~~~~~-~ 228 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------MDAPDGCPP-A 228 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-------CCCCTTCCH-H
T ss_pred ccccccccCCChHHHhCCCCCh-HHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------CCCCccCCH-H
Confidence 4456788999999998887754 4999999999999998 7888887665554444432211 111222222 2
Q ss_pred cccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 255 VVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 255 ~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
+.+.+.+++..+|.+|+ |+.++++.|..+.
T Consensus 229 ~~~li~~cl~~dP~~Rp-s~~~l~~~L~~i~ 258 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRP-SFLQLREQLEHIK 258 (262)
T ss_dssp HHHHHHHHTCSSGGGSC-CHHHHHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCc-CHHHHHHHHHHHH
Confidence 33455666677888875 9999999988753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=336.02 Aligned_cols=202 Identities=28% Similarity=0.471 Sum_probs=178.8
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC---cccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeEEEEEe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++|++++.||+|+||+||+|++..+|+.||||+++... .....+.+|+.++++++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999999999999999987543 234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC-CCC
Q 020133 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (330)
Q Consensus 98 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~-~~~ 176 (330)
++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||.|+...... ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence 9999999999888889999999999999999999999999999999999999987664 9999999997554333 334
Q ss_pred cccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
...+++.|+|||.+.+..+.+.++|||||||++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 207 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC
Confidence 456788999999998777666669999999999999999998654433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=345.48 Aligned_cols=207 Identities=27% Similarity=0.439 Sum_probs=173.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeCC------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~------ 90 (330)
.++|++++.||+|+||+||+|.+..+|+.||||+++..... .+.+.+|+.++++++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57999999999999999999999999999999999764322 356789999999999999999999998654
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.+|+||||+ +.+|..+.+ ++.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD 172 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred eEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC
Confidence 479999999 567777664 467999999999999999999999999999999999999987765 9999999997443
Q ss_pred CCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.......+|+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+....+....
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~ 232 (346)
T d1cm8a_ 173 --SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232 (346)
T ss_dssp --SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred --CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHH
Confidence 334567799999999999877666666999999999999999999999877665554444
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=345.59 Aligned_cols=205 Identities=26% Similarity=0.405 Sum_probs=165.0
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeC------Ce
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP------TH 91 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~------~~ 91 (330)
++|+++++||+|+||+||+|++..+|+.||||++...... ...+.+|+.++++++||||++++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6899999999999999999999999999999999765332 34678999999999999999999999643 67
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
+|+|||||.++++ +.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|||+++....
T Consensus 97 ~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred eEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence 8999999977554 444 356999999999999999999999999999999999999987765 99999999887766
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.......++|+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.+.......+
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i 230 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHH
Confidence 666677789999999999988877665 99999999999999999999877655544443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=343.78 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=199.4
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCC-------cEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~ 87 (330)
+..++|++.+.||+|+||.||+|++..++ ..||||+++.... ....+.+|+..+.++ +||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34589999999999999999999986554 4799999876543 235678888888887 8999999999999
Q ss_pred eCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEec
Q 020133 88 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (330)
Q Consensus 88 ~~~~~~lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~ 151 (330)
+++..++||||+++|+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 999999999999999999999754 3489999999999999999999999999999999999998
Q ss_pred CCCCCceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhH
Q 020133 152 GSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (330)
Q Consensus 152 ~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~ 227 (330)
.++. +||+|||+++...... ......+++.|+|||.+.+..++.+ +|||||||++|||++ |++||.+.+....
T Consensus 170 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 170 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp TTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 7765 9999999997543332 2344578899999999988888655 999999999999998 7999987776554
Q ss_pred HHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 228 FRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+......+ +...++. .+.+.+.+++..+|..|+ |+.|+++.|.++
T Consensus 247 ~~~i~~~~~~~-------~p~~~~~-~l~~li~~cl~~dP~~Rp-s~~eil~~L~~i 294 (299)
T d1fgka_ 247 FKLLKEGHRMD-------KPSNCTN-ELYMMMRDCWHAVPSQRP-TFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHTTCCCC-------CCSSCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHcCCCCC-------CCccchH-HHHHHHHHHccCCHhHCc-CHHHHHHHHHHH
Confidence 44433322111 1122333 234455666678888876 999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=341.55 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=193.7
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECC-CC--cEEEEEEeecC----CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKK-TE--ELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~----~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~ 90 (330)
.+.++|++.+.||+|+||.||+|+... ++ ..||||++.+. ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 445789999999999999999998653 33 46899988653 2233578999999999999999999999965 4
Q ss_pred eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccc
Q 020133 91 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~ 169 (330)
..++||||++++++.+.+.. .+++++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc--ceeeccchhhhhc
Confidence 67899999999999987764 45799999999999999999999999999999999999998776 4999999999854
Q ss_pred cCCCC----CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCc
Q 020133 170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHE 244 (330)
Q Consensus 170 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (330)
..... .....++..|+|||++.+..++.+ +||||||+++|||+| |+.||.+.+.......+......++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~----- 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP----- 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC-----
Confidence 33322 223457789999999988777544 999999999999998 8999998887776666554321111
Q ss_pred hhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 245 WFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
....+|.+ +.+.+..++..+|.+|+ |+.|+.+.|.++
T Consensus 236 -~~~~~~~~-l~~li~~cl~~dp~~RP-t~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 -RPEDCPQD-IYNVMVQCWAHKPEDRP-TFVALRDFLLEA 272 (273)
T ss_dssp -CCTTCCHH-HHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred -CcccccHH-HHHHHHHHcCCChhHCc-CHHHHHHHHHhc
Confidence 11233332 33555666667888775 999999988875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=341.19 Aligned_cols=211 Identities=26% Similarity=0.364 Sum_probs=177.1
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecC---CcccHHHHHHHHHHHcCCCCCeeeeeEEEEe--------
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-------- 88 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~-------- 88 (330)
.++|++++.||+|+||+||+|++..+|+.||||++... ......+.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37999999999999999999999999999999998654 3345778999999999999999999999865
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 89 ~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
++..|+||||+.++++.........+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~ 166 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARA 166 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeee
Confidence 3468999999988777666666678999999999999999999999999999999999999987765 99999999964
Q ss_pred ccC-----CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 169 SVL-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 169 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 332 2233445799999999999877555556999999999999999999998876655544433
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=342.78 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=194.5
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECCCCc----EEEEEEeecC--CcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~--~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
.....|++++.||+|+||+||+|.+..+|+ .||+|.++.. ....+.+.+|+.++++++|||||++++++.++ .
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 344679999999999999999999988776 5888887643 33456799999999999999999999999865 5
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCccccc
Q 020133 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~ 170 (330)
.++++|++.+++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~ 162 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG 162 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecc
Confidence 6788899999999887765 457999999999999999999999999999999999999987764 9999999997544
Q ss_pred CCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHHHHHhhcCChhHHhcCchh
Q 020133 171 LHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRISIPEIRNHEWF 246 (330)
Q Consensus 171 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (330)
.... .....||+.|+|||++.+..++.+ +|||||||++|||+| |++||.+.+.......+......+ .
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-------~ 234 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-------Q 234 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC-------C
T ss_pred cccccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------C
Confidence 3322 233468999999999988877655 999999999999998 899998766554433332221111 1
Q ss_pred hccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 247 LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...++. .+.+.+.+++..+|.+|+ |+.|+++.|...
T Consensus 235 p~~~~~-~~~~li~~cl~~dP~~RP-s~~eil~~l~~~ 270 (317)
T d1xkka_ 235 PPICTI-DVYMIMVKCWMIDADSRP-KFRELIIEFSKM 270 (317)
T ss_dssp CTTBCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred CcccCH-HHHHHHHHhCCCChhhCc-CHHHHHHHHHHH
Confidence 112222 233455566667787775 999998877654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-47 Score=342.88 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=203.7
Q ss_pred CCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCCeE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~~ 92 (330)
.++|++.+.||+|+||+||+|+.. .+++.||||+++.... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 368999999999999999999975 3567899999876432 245789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcE
Q 020133 93 AIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (330)
Q Consensus 93 ~lv~e~~~g~sL~~~l~~~~------------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NI 148 (330)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999999999999986532 389999999999999999999999999999999999
Q ss_pred EecCCCCCceEEeecCCcccccCC---CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCh
Q 020133 149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEE 224 (330)
Q Consensus 149 li~~~~~~~vkL~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~-~pf~~~~~ 224 (330)
|++.++. +||+|||+|+..... .......+++.|+|||.+.+..++.+ +|||||||++|||++|. +||.+.+.
T Consensus 172 Lld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCCCH
Confidence 9987765 999999999743222 22345578899999999998887655 99999999999999985 67887776
Q ss_pred hhHHHHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhC
Q 020133 225 PKNFRKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEAT 285 (330)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~ 285 (330)
.+....+.... .++ +...+|++ +.+.+.+++..+|.+|+ |+.|+.+.|+++.
T Consensus 249 ~e~~~~v~~~~-~~~------~p~~~~~~-~~~li~~cl~~~P~~RP-t~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 EEVIYYVRDGN-ILA------CPENCPLE-LYNLMRLCWSKLPADRP-SFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHTTC-CCC------CCTTCCHH-HHHHHHHHTCSSGGGSC-CHHHHHHHHHHTT
T ss_pred HHHHHHHHcCC-CCC------CCccchHH-HHHHHHHHcCCChhHCc-CHHHHHHHHHHhc
Confidence 66555544321 111 12234433 34556666778888876 9999999998753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.4e-47 Score=341.85 Aligned_cols=200 Identities=26% Similarity=0.481 Sum_probs=177.1
Q ss_pred CCCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEeC--CeEEEE
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV 95 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~--~~~~lv 95 (330)
..++|+++++||+|+||+||+|++..+|+.||||+++... .+.+.+|+.++++++ ||||+++++++... ...++|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 4578999999999999999999999999999999987543 467889999999995 99999999999854 569999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCCC
Q 020133 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (330)
Q Consensus 96 ~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~~ 175 (330)
||||++++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|+........
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 9999999997764 56999999999999999999999999999999999999986543 5899999999876666667
Q ss_pred CcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
...++|+.|+|||.+.+....+.++|+|||||++|+|++|+.||.....
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 7788999999999998776555669999999999999999999976554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=342.60 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=190.9
Q ss_pred cCCCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCc--ccHHHHHHHHHHHcC-CCCCeeeeeEEEEeC
Q 020133 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (330)
Q Consensus 18 ~~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~ 89 (330)
...++|++.+.||+|+||.||+|.+.. +++.||||.++.... ..+.+.+|+..+.++ +|+||+.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 345789999999999999999999754 457899999875432 234567777777766 689999999998765
Q ss_pred -CeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC
Q 020133 90 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (330)
Q Consensus 90 -~~~~lv~e~~~g~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~ 152 (330)
..+++|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 4689999999999999999653 24899999999999999999999999999999999999987
Q ss_pred CCCCceEEeecCCcccccCCC---CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChhhHH
Q 020133 153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNF 228 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg-~~pf~~~~~~~~~ 228 (330)
++. +||+|||+|+...... ......||+.|+|||++.+..++.+ +|||||||++|||+|| .+||.+......+
T Consensus 170 ~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 170 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp GGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 765 9999999997443322 2344578999999999988877655 9999999999999986 5688877666665
Q ss_pred HHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 229 RKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
...+.....+. +...++++ +.+.+.+++..+|.+|+ |++|+++.|.++
T Consensus 247 ~~~~~~~~~~~------~~~~~~~~-l~~li~~cl~~dP~~Rp-t~~eil~~L~~i 294 (299)
T d1ywna1 247 CRRLKEGTRMR------APDYTTPE-MYQTMLDCWHGEPSQRP-TFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHTCCCC------CCTTCCHH-HHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHhcCCCCC------CCccCCHH-HHHHHHHHcCCChhHCc-CHHHHHHHHHHH
Confidence 55554322111 11222232 33445556667788876 999999888764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-46 Score=335.02 Aligned_cols=202 Identities=22% Similarity=0.288 Sum_probs=173.9
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC-CCeeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|++.++.++| +||+.+++++......|+||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 479999999999999999999999999999999876543 23457889999999975 8999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC---CCCceEEeecCCcccccCC--
Q 020133 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLH-- 172 (330)
Q Consensus 99 ~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~---~~~~vkL~Dfg~a~~~~~~-- 172 (330)
+ +++|.+++... ..++..++..++.|++.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+.....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9 67999888764 479999999999999999999999999999999999999642 2346999999999743321
Q ss_pred ------CCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 020133 173 ------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (330)
Q Consensus 173 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~ 224 (330)
.......||+.|+|||++.+..++.+ +|||||||++|||+||+.||.+...
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccc
Confidence 12344579999999999988877655 9999999999999999999986544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=339.53 Aligned_cols=210 Identities=30% Similarity=0.446 Sum_probs=173.0
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc--ccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC----eEE
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT----HLA 93 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~----~~~ 93 (330)
..||++++.||+|+||+||+|.+..+|+.||||++.+... ..+.+.+|+.++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 5789999999999999999999999999999999975432 2356789999999999999999999997653 234
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCC
Q 020133 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (330)
Q Consensus 94 lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~ 173 (330)
++++++.|++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 87 ~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGG
T ss_pred EEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCCC
Confidence 44455668999999876 47999999999999999999999999999999999999987764 9999999997443322
Q ss_pred ----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHh
Q 020133 174 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (330)
Q Consensus 174 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~ 232 (330)
.....++|+.|+|||++......+.++||||+||++|+|++|+.||.+.+.........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~ 226 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh
Confidence 23456789999999998666665666999999999999999999998877655544443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=336.81 Aligned_cols=260 Identities=23% Similarity=0.232 Sum_probs=188.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCC-eeeeeEEEEeCCeEEEEEec
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~-Iv~~~~~~~~~~~~~lv~e~ 98 (330)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++.++|++ |+.+..++...+..++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 3689999999999999999999999999999998876543 346789999999998766 55566667788889999999
Q ss_pred cCCCChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCC-CCCceEEeecCCcccccCCC---
Q 020133 99 ASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS--- 173 (330)
Q Consensus 99 ~~g~sL~~~l-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~-~~~~vkL~Dfg~a~~~~~~~--- 173 (330)
+.+ +|.+.+ ...+.+++..+..++.|++.||+|||++||+||||||+|||++.. ....++|+|||+|+......
T Consensus 85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 955 555554 445689999999999999999999999999999999999998532 23359999999997543222
Q ss_pred -----CCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhc
Q 020133 174 -----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248 (330)
Q Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
......||+.|+|||++.+..++.+ +|||||||++|||+||+.||........................+.+..
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence 2234579999999999988877555 9999999999999999999987554333222211100000011111223
Q ss_pred cCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+|+++ .+.+..+...+|.+|+ +++++.+.|+..
T Consensus 243 ~~p~~~-~~li~~cl~~~p~~RP-~~~~i~~~l~~~ 276 (299)
T d1ckia_ 243 GYPSEF-ATYLNFCRSLRFDDKP-DYSYLRQLFRNL 276 (299)
T ss_dssp TSCHHH-HHHHHHHHHSCTTCCC-CHHHHHHHHHHH
T ss_pred CCCHHH-HHHHHHHccCChhHCc-CHHHHHHHHHHH
Confidence 343332 2233344446677764 788877776653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-47 Score=339.21 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=204.0
Q ss_pred CCCCeEEeceeccCCceEEEEEEEC-----CCCcEEEEEEeecCCcc--cHHHHHHHHHHHcC-CCCCeeeeeEEEEeCC
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~ei~~l~~l-~h~~Iv~~~~~~~~~~ 90 (330)
..++|++.+.||+|+||.||+|... .+++.||||+++..... ...+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 4589999999999999999999863 46789999999765432 34688999999998 6999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecC
Q 020133 91 HLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (330)
Q Consensus 91 ~~~lv~e~~~g~sL~~~l~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~ 152 (330)
..|+|||||++|+|.+++.+.. .+++..+..++.||+.||+|||++|++||||||+||+++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 9999999999999999987543 5899999999999999999999999999999999999987
Q ss_pred CCCCceEEeecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChhhHH
Q 020133 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (330)
Q Consensus 153 ~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~ellt-g~~pf~~~~~~~~~ 228 (330)
++. +|++|||.++....... .....+|+.|+|||++.+..++.+ +|||||||++|||+| |.+||.+.+....+
T Consensus 181 ~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 181 GRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp TTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 764 99999999985543322 234568999999999988777555 999999999999998 67777776666666
Q ss_pred HHHhhcCChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 229 RKTIHRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.+++..... +.....++. .+.+.+.+++..+|.+|+ |+.++++.|.+.
T Consensus 258 ~~~i~~~~~------~~~~~~~~~-~l~~Li~~cl~~dP~~RP-s~~~il~~L~~~ 305 (311)
T d1t46a_ 258 YKMIKEGFR------MLSPEHAPA-EMYDIMKTCWDADPLKRP-TFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHTCC------CCCCTTSCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHhcCCC------CCCcccccH-HHHHHHHHHcCCChhHCc-CHHHHHHHHHHh
Confidence 666543211 111122222 234455566667788876 999999988753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=339.20 Aligned_cols=207 Identities=26% Similarity=0.426 Sum_probs=173.2
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcc---cHHHHHHHHHHHcCCCCCeeeeeEEEEeC-----Ce
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~-----~~ 91 (330)
++||++++.||+|+||+||+|++..+|+.||||++.+.... .+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 58999999999999999999999999999999999765332 34678999999999999999999998643 33
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
.+++++++.|++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +|++|||.+....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT-
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC-
Confidence 4666777889999998855 57999999999999999999999999999999999999987765 9999999986332
Q ss_pred CCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 020133 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (330)
Q Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~ 231 (330)
.......|++.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i 231 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23345678899999999888777667799999999999999999999877655444443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=340.94 Aligned_cols=252 Identities=29% Similarity=0.517 Sum_probs=197.3
Q ss_pred CCeEEeceeccCCceEEEEEEEC---CCCcEEEEEEeecC-----CcccHHHHHHHHHHHcCCC-CCeeeeeEEEEeCCe
Q 020133 21 DRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERG-----DKIDENVQREIINHRSLRH-PNIVRFKEVILTPTH 91 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~-----~~~~~~~~~ei~~l~~l~h-~~Iv~~~~~~~~~~~ 91 (330)
++|++++.||+|+||+||+|.+. .+|+.||||.+++. ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999974 47899999998643 2334567899999999976 899999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccC
Q 020133 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~ 171 (330)
+++||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999987764 99999999974432
Q ss_pred --CCCCCcccCCCCCCChhhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhc
Q 020133 172 --HSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLK 248 (330)
Q Consensus 172 --~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
........+++.|+|||.+.+.. +.+.++|||||||++|+|+||+.||.+.........+.... ....+-+.+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~----~~~~~~~~~ 257 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----LKSEPPYPQ 257 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----HHCCCCCCT
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc----ccCCCCCcc
Confidence 23345567999999999997654 33555999999999999999999998765544333333211 011111112
Q ss_pred cCCccccccccccCCCCCCCCccC----CHHHHHH
Q 020133 249 NLPADLVVDNTTNNQFEEPDQPMQ----SIDEIMQ 279 (330)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~p~~~~~----s~~el~~ 279 (330)
.++. .+.+.+.++...+|.+|+. +++|+++
T Consensus 258 ~~s~-~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 258 EMSA-LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TSCH-HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCH-HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2222 2333445555567777764 6888864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=334.72 Aligned_cols=256 Identities=20% Similarity=0.281 Sum_probs=203.7
Q ss_pred CCCCeEEeceeccCCceEEEEEEECC-----CCcEEEEEEeecCCccc--HHHHHHHHHHHcCCCCCeeeeeEEEEeCCe
Q 020133 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (330)
Q Consensus 19 ~~~~y~i~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~--~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~~ 91 (330)
..++|++.+.||+|+||+||+|.+.. ++..||||+++...... ..+.+|+.++++++||||+++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 35899999999999999999998853 35789999997654332 457899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEe
Q 020133 92 LAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (330)
Q Consensus 92 ~~lv~e~~~g~sL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~ 161 (330)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++. +||+
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~ 175 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG 175 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEEC
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEe
Confidence 99999999999999988642 24799999999999999999999999999999999999987764 9999
Q ss_pred ecCCcccccCCCC---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChhhHHHHHhhcCCh
Q 020133 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRISI 237 (330)
Q Consensus 162 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~ 237 (330)
|||+|+....... .....+|+.|+|||.+.+..++.+ +|||||||++|||+|| +.||.+.+....+..+......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999974433222 233468999999999988887655 9999999999999998 5788877766655554432111
Q ss_pred hHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 238 PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
+ ....+|. .+.+.+.+|+..+|..|+ |+.++++.|++...
T Consensus 255 ~-------~p~~~~~-~l~~li~~cl~~~P~~RP-s~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 255 D-------KPDNCPD-MLFELMRMCWQYNPKMRP-SFLEIISSIKEEME 294 (308)
T ss_dssp C-------CCTTCCH-HHHHHHHHHTCSSGGGSC-CHHHHHHHHGGGSC
T ss_pred C-------CcccchH-HHHHHHHHHcCCChhHCc-CHHHHHHHHHHhcC
Confidence 1 1122222 234455566667787775 99999999887644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=332.57 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=185.6
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCeeeeeEEEEeCC----eEEEEE
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~~~----~~~lv~ 96 (330)
.+|.+.+.||+|+||+||+|+. +|+.||||.+............|+..+.+++||||+++++++.+++ .+|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4699999999999999999986 5889999998765433333445566667789999999999998754 589999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh--------cCccccCCCCCcEEecCCCCCceEEeecCCccc
Q 020133 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (330)
Q Consensus 97 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~--------~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~ 168 (330)
||+++|+|.+++++. ++++...+.++.|++.||.|||+ +||+||||||+|||++.++. +||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcccc
Confidence 999999999999764 69999999999999999999996 59999999999999987764 99999999975
Q ss_pred ccCCC-----CCCcccCCCCCCChhhhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCCCCCh--------------
Q 020133 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEE-------------- 224 (330)
Q Consensus 169 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-----~~~~~Di~SlG~il~elltg~~pf~~~~~-------------- 224 (330)
..... ......||+.|+|||++.+... .+.++|||||||++|||+||..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 43322 2344679999999999875432 13348999999999999999988743221
Q ss_pred hhHHHHHhhc----CChhHHhcCchhhccCCccccccccccCCCCCCCCccCCHHHHHHHHHHh
Q 020133 225 PKNFRKTIHR----ISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 284 (330)
Q Consensus 225 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~ 284 (330)
.......... +..|.. +..... ...+.+.+.+|+..+|.+|+ |+.|+.+.|.++
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~----~~~~~~-~~~l~~li~~cl~~dp~~Rp-s~~ei~~~L~~i 295 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNR----WQSCEA-LRVMAKIMRECWYANGAARL-TALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGG----GGGCHH-HHHHHHHHHTTCCSSGGGSC-CHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcc----cCChHH-HHHHHHHHHHHcccCHhHCc-CHHHHHHHHHHH
Confidence 1112222211 111110 000000 01133445566667777766 999999888765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=330.46 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=190.8
Q ss_pred EEeceeccCCceEEEEEEECCCC---cEEEEEEeecCC--cccHHHHHHHHHHHcCCCCCeeeeeEEEEe-CCeEEEEEe
Q 020133 24 ELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (330)
Q Consensus 24 ~i~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~--~~~~~~~~ei~~l~~l~h~~Iv~~~~~~~~-~~~~~lv~e 97 (330)
...++||+|+||+||+|.+..++ ..||||.++... ...+++.+|+.++++++||||+++++++.. ++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 44678999999999999987643 368999987532 234679999999999999999999999876 568999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeecCCcccccCCCC--
Q 020133 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (330)
Q Consensus 98 ~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~~~~~~~~-- 174 (330)
||++++|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++. +||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhcccccccc
Confidence 99999999988754 46888999999999999999999999999999999999987664 99999999975433222
Q ss_pred ---CCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCChhhHHHHHhhcCChhHHhcCchhhccCC
Q 020133 175 ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRISIPEIRNHEWFLKNLP 251 (330)
Q Consensus 175 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
.....||+.|+|||.+.+..++.+ +||||||+++|||+||..||........+...+.....+ .....++
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~------~~p~~~~ 260 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------LQPEYCP 260 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC------CCCTTCC
T ss_pred ceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------CCcccCc
Confidence 223468899999999988877555 999999999999999888776544333333333211111 1111222
Q ss_pred ccccccccccCCCCCCCCccCCHHHHHHHHHHhCC
Q 020133 252 ADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATI 286 (330)
Q Consensus 252 ~~~~~~~~~~~~~~~p~~~~~s~~el~~~l~~~~~ 286 (330)
+.+.+.+.+|+..+|..|+ ++.|+++.|.++..
T Consensus 261 -~~l~~li~~cl~~dP~~RP-s~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 261 -DPLYEVMLKCWHPKAEMRP-SFSELVSRISAIFS 293 (311)
T ss_dssp -HHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHHHH
T ss_pred -HHHHHHHHHHcCCCHhHCc-CHHHHHHHHHHHHH
Confidence 2334555666667787774 99999998887643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-39 Score=295.90 Aligned_cols=201 Identities=26% Similarity=0.402 Sum_probs=162.8
Q ss_pred CCCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCC-----------CCCeeeeeEEEEe
Q 020133 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVILT 88 (330)
Q Consensus 20 ~~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-----------h~~Iv~~~~~~~~ 88 (330)
.+||+++++||+|+||+||+|++..+|+.||||++++.....+.+.+|+.+++.++ |+||+++++++..
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 36899999999999999999999999999999999877655677888998888764 5789999999865
Q ss_pred C--CeEEEEEeccCCCChH-HHH--HhcCCCCHHHHHHHHHHHHHHHHHhhh-cCccccCCCCCcEEecCCCC----Cce
Q 020133 89 P--THLAIVMEYASGGELF-ERI--CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA----PRL 158 (330)
Q Consensus 89 ~--~~~~lv~e~~~g~sL~-~~l--~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIli~~~~~----~~v 158 (330)
. ...+++++++..+... ... .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++. ..+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 3 4566677666544332 222 234579999999999999999999998 89999999999999975443 248
Q ss_pred EEeecCCcccccCCCCCCcccCCCCCCChhhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 020133 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (330)
Q Consensus 159 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~SlG~il~elltg~~pf~~~~ 223 (330)
+++|||.|.... ......++|+.|+|||++.+..++.+ +|+||+||++++|++|+.||....
T Consensus 172 kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 172 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC----
T ss_pred eEeecccccccc--cccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCc
Confidence 999999987433 33456789999999999998888665 999999999999999999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.7e-26 Score=190.66 Aligned_cols=131 Identities=17% Similarity=0.166 Sum_probs=105.7
Q ss_pred eEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCc-------------------ccHHHHHHHHHHHcCCCCCeeeee
Q 020133 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK 83 (330)
Q Consensus 23 y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~ei~~l~~l~h~~Iv~~~ 83 (330)
|.+.++||+|+||+||+|.+. +|+.||||+++.+.. ......+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999985 689999998753210 012345688889999999999887
Q ss_pred EEEEeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhcCccccCCCCCcEEecCCCCCceEEeec
Q 020133 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (330)
Q Consensus 84 ~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIli~~~~~~~vkL~Df 163 (330)
++. . .+++|||+++..+.+ ++...+..++.|++.+|.+||++||+||||||+|||+++++ ++|+||
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 653 2 279999999866532 55666788999999999999999999999999999998543 899999
Q ss_pred CCccc
Q 020133 164 GYSKS 168 (330)
Q Consensus 164 g~a~~ 168 (330)
|.|..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 99864
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=7.5e-08 Score=81.53 Aligned_cols=85 Identities=15% Similarity=0.057 Sum_probs=61.1
Q ss_pred CCeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCC-cccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEec
Q 020133 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 98 (330)
Q Consensus 21 ~~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~ 98 (330)
..|++++..+.++.+.||++. ..++.+++|...... .....+.+|...+..+. +--+.+++.+...++..|+||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 467888876655667899885 346678889776543 23345778888877664 33367788888888999999999
Q ss_pred cCCCChHHH
Q 020133 99 ASGGELFER 107 (330)
Q Consensus 99 ~~g~sL~~~ 107 (330)
++|.++.+.
T Consensus 92 l~G~~~~~~ 100 (263)
T d1j7la_ 92 ADGVLCSEE 100 (263)
T ss_dssp CSSEEHHHH
T ss_pred ccccccccc
Confidence 999887543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.42 E-value=8.2e-07 Score=79.85 Aligned_cols=77 Identities=17% Similarity=0.102 Sum_probs=49.8
Q ss_pred eceeccCCceEEEEEEECCCCcEEEEEEeecC--------CcccHHHHHHHHHHHcCC-C--CCeeeeeEEEEeCCeEEE
Q 020133 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR-H--PNIVRFKEVILTPTHLAI 94 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~~~ei~~l~~l~-h--~~Iv~~~~~~~~~~~~~l 94 (330)
.+.+|.|....||++.+..+++.++||.-... .....+...|+..++.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55789999999999998888889999964321 112345667887776652 2 345566544 4445579
Q ss_pred EEeccCCCCh
Q 020133 95 VMEYASGGEL 104 (330)
Q Consensus 95 v~e~~~g~sL 104 (330)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=1.8e-05 Score=65.87 Aligned_cols=75 Identities=13% Similarity=0.065 Sum_probs=51.9
Q ss_pred eeccCC-ceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC--CCeeeeeEEEEeCCeEEEEEeccCCCCh
Q 020133 28 DIGSGN-FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 28 ~lg~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h--~~Iv~~~~~~~~~~~~~lv~e~~~g~sL 104 (330)
.+..|. -+.||++.. .++..+++|...... ...+..|+..++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344454 367898875 446668899765443 2346777877776642 2367788888888889999999998766
Q ss_pred H
Q 020133 105 F 105 (330)
Q Consensus 105 ~ 105 (330)
.
T Consensus 94 ~ 94 (255)
T d1nd4a_ 94 L 94 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.61 E-value=0.00013 Score=63.15 Aligned_cols=70 Identities=13% Similarity=0.144 Sum_probs=47.3
Q ss_pred ceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCCCCe-----eee--eEEEEeCCeEEEEEeccCCCCh
Q 020133 34 FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-----VRF--KEVILTPTHLAIVMEYASGGEL 104 (330)
Q Consensus 34 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h~~I-----v~~--~~~~~~~~~~~lv~e~~~g~sL 104 (330)
-..||++.. .+|+.|++|+........+.+..|...+..|...++ +.. -..+...+..+.++++++|..+
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 368999977 458889999887766666778889888877642221 111 1123446678899999987543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.60 E-value=0.00015 Score=64.67 Aligned_cols=74 Identities=14% Similarity=0.099 Sum_probs=51.4
Q ss_pred eceeccCCceEEEEEEECC-------CCcEEEEEEeecCCcccHHHHHHHHHHHcCC-CCCeeeeeEEEEeCCeEEEEEe
Q 020133 26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (330)
Q Consensus 26 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e 97 (330)
++.|+.|-.-.+|++.... ..+.|++++... ........+|..+++.+. +.-..++++++. + .+|+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEE
Confidence 4678888889999998764 245678887653 333345668888888774 433457777663 2 68999
Q ss_pred ccCCCCh
Q 020133 98 YASGGEL 104 (330)
Q Consensus 98 ~~~g~sL 104 (330)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9988655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.88 E-value=0.0018 Score=55.25 Aligned_cols=141 Identities=16% Similarity=0.083 Sum_probs=72.8
Q ss_pred CeEEeceeccCCceEEEEEEECCCCcEEEEEEeecCCcccHHHHHHHHHHHcCCC-----CCeeeee---EEEEeCCeEE
Q 020133 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-----PNIVRFK---EVILTPTHLA 93 (330)
Q Consensus 22 ~y~i~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~ei~~l~~l~h-----~~Iv~~~---~~~~~~~~~~ 93 (330)
...-++.|..|--.+.|++.... | .+++|++... ...+.+..|+.++..|.. |..+... .+....+..+
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred CceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 34555667778778899988653 4 4899988653 233455666666665532 2222110 0122345566
Q ss_pred EEEeccCCCChHH-----------HH---Hh---c------CC------------------CCHHHHHHHHHHHHHHHHH
Q 020133 94 IVMEYASGGELFE-----------RI---CN---A------GR------------------FSEDEARFFFQQLISGVSY 132 (330)
Q Consensus 94 lv~e~~~g~sL~~-----------~l---~~---~------~~------------------l~~~~~~~i~~qi~~~L~~ 132 (330)
.++.+..|..... .+ +. . .. .........+..+...+..
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 6777766543311 00 00 0 00 0011111222222232333
Q ss_pred hh----hcCccccCCCCCcEEecCCCCCceEEeecCCcc
Q 020133 133 CH----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (330)
Q Consensus 133 LH----~~~ivH~dikp~NIli~~~~~~~vkL~Dfg~a~ 167 (330)
.+ ..|++|+|+.+.||+++.+. ..-++||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhccccc--ceeEecccccc
Confidence 22 25799999999999998654 25799999764
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=90.65 E-value=0.015 Score=36.37 Aligned_cols=54 Identities=17% Similarity=0.321 Sum_probs=38.6
Q ss_pred HHHHHHHHHhCCCCCCCCchhhhccCCCCcccccc-ccCC-CCCCcCCCCCCceee
Q 020133 275 DEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMD-EDID-TDPDLDIDSSGEIVY 328 (330)
Q Consensus 275 ~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~ 328 (330)
+|+.+++........|..+..++......+..... ++++ .+...|.|++|.|+|
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~ 56 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDY 56 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECH
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeH
Confidence 46777777777777777777766666555543332 3455 778999999999998
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=87.41 E-value=0.018 Score=38.23 Aligned_cols=57 Identities=14% Similarity=0.214 Sum_probs=41.9
Q ss_pred CHHHHHHHHHHhCCCCCCCCchhhhccCCCCccccccccCC-CCCCcCCCCCCceeec
Q 020133 273 SIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDID-TDPDLDIDSSGEIVYA 329 (330)
Q Consensus 273 s~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 329 (330)
.+.++.+++........|..+..++......+..-..+++. .+...|.|++|.|+|.
T Consensus 4 e~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~ei~~~~~~~D~d~~G~I~~~ 61 (81)
T d2opoa1 4 DIADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGDGFISFD 61 (81)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCSSEECHH
T ss_pred HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHH
Confidence 46778888888888888888887776655555432223444 7789999999999984
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=83.60 E-value=0.041 Score=34.65 Aligned_cols=55 Identities=20% Similarity=0.324 Sum_probs=37.1
Q ss_pred HHHHHHHHHhCCCCCCCCchhhhccCCCCcccccc-ccCC-CCCCcCCCCCCceeec
Q 020133 275 DEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMD-EDID-TDPDLDIDSSGEIVYA 329 (330)
Q Consensus 275 ~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~ 329 (330)
+++.+++........|..+..++......+..... ++++ .+...|.|++|.|.|-
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~ 59 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYE 59 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHH
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHH
Confidence 56777777777777777777666555444433222 2344 6778999999999983
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=83.03 E-value=0.036 Score=35.37 Aligned_cols=55 Identities=16% Similarity=0.238 Sum_probs=39.9
Q ss_pred HHHHHHHHHhCCCCCCCCchhhhccCCCCccccc--cccCC-CCCCcCCCCCCceeec
Q 020133 275 DEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEM--DEDID-TDPDLDIDSSGEIVYA 329 (330)
Q Consensus 275 ~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 329 (330)
+|+.+++........|..+..++......+.... +++++ .+...|.|++|.|+|.
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~ 59 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIP 59 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHH
Confidence 4677788888888888888877776666554432 23455 6778999999999983
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=81.38 E-value=0.095 Score=34.49 Aligned_cols=59 Identities=19% Similarity=0.201 Sum_probs=45.6
Q ss_pred cCCHHHHHHHHHHhCCCCCCCCchhhhccCCCCcccccc-ccCC-CCCCcCCCCCCceeec
Q 020133 271 MQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMD-EDID-TDPDLDIDSSGEIVYA 329 (330)
Q Consensus 271 ~~s~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~ 329 (330)
..+-+++.+++........|..+..++......+..... ++++ .+.+.|.|++|.|.|.
T Consensus 11 ~~~ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~ 71 (81)
T d1fi5a_ 11 GKTEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYD 71 (81)
T ss_dssp CCCHHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHH
T ss_pred CCCHHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHH
Confidence 346678999999999999999998887776665544333 3455 7779999999999984
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=80.73 E-value=0.075 Score=34.52 Aligned_cols=57 Identities=14% Similarity=0.103 Sum_probs=30.7
Q ss_pred CHHHHHHHHHHhCCC--CCCCCchhhhccCCCCcccc---ccccCC-CCCCcCCCCCCceeec
Q 020133 273 SIDEIMQIIAEATIP--AAGTQSLNQCLNGSLDIDDE---MDEDID-TDPDLDIDSSGEIVYA 329 (330)
Q Consensus 273 s~~el~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~ 329 (330)
|.+++.+++...... -.|..+.+++......+... ..++++ .+...|.|++|.|+|.
T Consensus 3 s~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~ 65 (76)
T d1qx2a_ 3 SPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFE 65 (76)
T ss_dssp CHHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHH
T ss_pred CHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHH
Confidence 455555555543221 23445544443333222111 123455 7789999999999984
|